Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),-0.6283741708327221,-2.2332514729155446,0.0,0.0,0.0,63/91,25.69%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;EIF4A1;RPL18;RPL34;RPL32;RPS9;RPS8;RPL27A;RPL12;RPL37;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPS27;RPL26;EIF4A2;RPL14;RWDD1;RPL10;RPL7;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;RPL31;RPL15;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;RPL36A;DRG2;FTSJ1;RPS26;RPL35A;RPL8;RPS29;RPL36;TMA7;RPL13A;RPS3
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6185011802984655,-2.1568447340044816,0.0,0.0,0.0,58/87,23.57%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPL34;RPL32;RPS9;RPS8;RPL27A;RPL12;RPL37;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPLP2;RPS27;RPL26;RPL14;RPL10;RPL7;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;RPL31;RPL15;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;SEC61B;RPL35A;RPL8;RPS29;RPL36
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6057632055612803,-2.1201937190466764,0.0,0.0014936539549231715,0.004,68/91,31.45%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPL34;RPL32;RPS9;RPS8;RPL27A;RPL12;RPL37;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPLP2;RPS27;RPL26;RPL14;RPL10;RPL7;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;RPL31;RPL15;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPL8;RPS29;RPL36;RPL13A;RPS3;TRAM1;RPL29;RPL21;RPS2;RPL19;SRP14;RPS21;RPL23A;SEC63
prerank,muscle contraction (GO:0006936),0.6683439709820926,2.1117623261920824,0.0,0.03575196548182784,0.033,20/126,3.68%,SNTB1;ITGA1;GJC1;EDNRA;CALD1;CASQ2;UTRN;DMD;DYSF;KCNJ12;MYLK;UTS2;CACNA1H;VCL;MYH11;ROCK1;TACR2;MYL9;ITGB5;TMOD1
prerank,transition metal ion transport (GO:0000041),0.8018387083991106,2.095842386910821,0.0,0.02815467281693942,0.052,7/35,3.66%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1;ATP7A
prerank,bone development (GO:0060348),-0.6840686261706068,-2.082631932959637,0.0,0.0033607213985771362,0.012,16/39,11.89%,RANBP3L;SULF1;AKAP13;CYP26B1;TGM2;FGFR2;GJA1;LRP6;SKI;SULF2;SFRP4;RPL13;GNAS;NOTUM;MYOC;DYM
prerank,manganese ion transport (GO:0006828),0.9275817751395675,2.0822135323345408,0.0,0.026813974111370875,0.075,6/14,2.36%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6396075769201855,2.069173885947518,0.0,0.030389170659553662,0.107,16/142,4.17%,TRPC3;TRPC4;TRPC6;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;ATP1A2;TRPC1;GPER1;CCRL2;ACKR3;ADCY8;ATP2B3;TACR1
prerank,protein targeting to ER (GO:0045047),-0.5730404164790739,-2.050465736260307,0.0,0.004480961864769514,0.017,73/99,31.45%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPL34;RPL32;RPS9;RPS8;RPL27A;RPL12;RPL37;RPS18;RPL11;CHMP4B;CHMP4A;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPLP2;RPS27;RPL26;RPL14;RPL10;RPL7;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;RPL31;RPL15;SPCS1;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPL8;RPS29;RPL36;RPL13A;RPS3;RPL29;RPL21;RPS2;EDEM1;RPL19;SRP14;RPS21;SPCS2;RPL23A;GET3;SEC63
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5552555738820969,-2.0361959624276915,0.0,0.005414495586596497,0.026,64/110,23.65%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;CTIF;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;SMG6;RPL34;RPL32;UPF3A;RPS9;RPS8;RPL27A;RPL12;RPL37;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPLP2;RPS27;RPL26;RPL14;RPL10;RPL7;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;RPL31;SMG5;RPL15;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;PNRC2;UPF2;RPL36A;RPS26;RPL35A;DHX34;RPL8;RPS29;RPL36;HELZ2
prerank,response to ATP (GO:0033198),0.8930623495373474,2.033345668186322,0.0,0.06310221907542612,0.234,2/18,0.02%,ABCC9;TRPC3
prerank,positive regulation of calcium ion transport (GO:0051928),0.7905120323230194,2.0284391281811134,0.0,0.05794797738512928,0.253,5/36,1.44%,TRPC3;TRPC6;PDGFRB;CACNB2;MYLK
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6559412331575906,2.025732629261913,0.0,0.05235109231267648,0.263,25/107,6.61%,GRM3;GRM7;PTEN;CEL;MEF2C;SLC12A2;CLSTN1;CDH2;ATP1A2;BEGAIN;LRRC4C;EIF4EBP2;IL1B;GRIK1;NMU;GRM5;RIMS1;CLSTN3;NRG3;RIMS2;ITGB1;GRID1;GRM1;SYN1;CHRNA7
prerank,response to organophosphorus (GO:0046683),0.8902932399069331,2.0246758199227606,0.0,0.0465892800185069,0.263,2/16,0.02%,ABCC9;TRPC3
prerank,embryonic skeletal system development (GO:0048706),-0.6820139468252587,-2.011630635871959,0.0,0.008801889377225832,0.044,13/35,6.61%,SULF1;COL1A1;PDGFRA;PCSK5;OSR1;KIAA1217;RBP4;HOXB3;WNT9A;HOXA3;SULF2;SIX1;WNT5A
prerank,regulation of cardiac conduction (GO:1903779),0.7213544814375722,2.005889444894976,0.0,0.0663397581718361,0.393,14/54,6.43%,ABCC9;ACE2;CASQ2;ATP2A3;ATP1A2;TRPC1;ITPR2;ATP1A4;FXYD2;ITPR1;ATP2B3;ATP1B2;ATP2A2;RYR2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7423038737562092,2.001942132319122,0.0,0.06444291778099467,0.415,11/46,5.93%,GRM3;GRM7;MEF2C;CDH2;ATP1A2;NRXN1;CACNG7;GRIK1;GRM5;ATAD1;GRM1
prerank,response to purine-containing compound (GO:0014074),0.8811897838742211,1.9939584545816247,0.002012072434607646,0.06906629695353106,0.458,2/17,0.02%,ABCC9;TRPC3
prerank,sprouting angiogenesis (GO:0002040),-0.6242852202339406,-1.9676456211382083,0.0,0.01988426827491472,0.12,23/51,10.16%,ROBO1;EFNB2;NRP1;TEK;CCBE1;RECK;SLIT2;RSPO3;RNF213;THBS1;BMP4;EPHB4;ANGPT1;RAMP2;VEGFD;VEGFC;BMPER;ACVRL1;PTK2B;SEMA3E;AKT1;CDH13;KDR
prerank,metal ion transport (GO:0030001),0.6497104381411842,1.9592799131637768,0.0,0.1284091426888983,0.692,10/86,3.68%,TRPC3;TRPC4;CACNA1C;ATP2A3;TRPC1;ATP2C1;NDFIP2;CACNG7;CACNA2D1;ITPR1
prerank,regulation of heart contraction (GO:0008016),0.6600678429449633,1.9519958097455166,0.0,0.13805758978367363,0.744,15/90,3.90%,ABCC9;ACE2;PDE4D;TBX2;CASQ2;ATP2A3;KCNJ12;ATP1A2;TRPC1;CACNA1H;ITPR2;ATP1A4;FXYD2;ITPR1;ATP2B3
prerank,amino acid import (GO:0043090),-0.7252503501510249,-1.949019088119349,0.0,0.025516588396604183,0.167,15/21,21.33%,SLC6A13;SLC47A1;SLC1A3;SLC6A6;SLC16A2;SFXN2;SLC7A5;SLC22A4;SLC6A1;SLC25A38;SLC7A1;SLC22A2;SH3BP4;SLC36A1;SLC1A1
prerank,inorganic ion transmembrane transport (GO:0098660),0.9009100622787286,1.9468442942864521,0.0021231422505307855,0.1418586916082526,0.768,3/12,1.70%,ABCC9;KCNJ8;CACNA1H
prerank,cellular calcium ion homeostasis (GO:0006874),0.6158007129330653,1.9387648455750444,0.0,0.15379303818099607,0.815,21/133,7.60%,TRPC3;ATP13A5;TRPC4;TRPC6;PTH1R;ATP2A3;TRPC1;GPER1;ATP2C1;STIM2;ADCY8;ATP2B3;ATP13A4;SLC24A4;SLC24A2;ATP2A2;RYR2;HTR2C;CHRNA7;STC1;STIM1
prerank,potassium ion import across plasma membrane (GO:1990573),0.7295954806395555,1.9250709341005228,0.0,0.1844577969078055,0.877,9/41,4.96%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;ATP1A4;FXYD2;ATP1B2;SLC12A6
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8124363568520168,1.9091386791794007,0.0,0.227813627107,0.931,7/21,6.43%,CACNA1C;PDE4D;CASQ2;DMD;ATP1A2;AKAP6;RYR2
prerank,androgen receptor signaling pathway (GO:0030521),-0.8359417475274196,-1.900997476134957,0.0,0.060829057314246156,0.372,6/11,12.29%,ZMIZ1;DDX5;AR;TMF1;KDM3A;PLPP1
prerank,platelet degranulation (GO:0002576),-0.5062857129874807,-1.8946787559139495,0.0,0.06293714619153547,0.408,38/118,15.84%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;VWF;SERPING1;PECAM1;ACTN2;APP;PCDH7;SPARC;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;GAS6;IGF2;SRGN;TMSB4X;ECM1;PSAP;ITGB3;LGALS3BP;TGFB1;ACTN1;F5;APOOL;SCG3;APLP2;CD109;CALM1;SERPINE1;SYTL4
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.7778523726391072,1.8945184864357003,0.0019455252918287938,0.2690335402507545,0.961,11/24,10.38%,PDE4D;PDE3A;RAPGEF2;PRKAR1B;GPR61;PEX5L;PRKAR2B;PRKAR2A;GPR62;CGAS;PRKAR1A
prerank,skin development (GO:0043588),-0.5629897113159963,-1.887339886364755,0.0,0.06609418750535034,0.445,21/65,14.65%,COL1A2;COL3A1;COL5A2;COL1A1;ERRFI1;CLIC4;COL5A1;ITGA6;ADAM9;ANXA1;ITGA3;LSR;TXNIP;WNT5A;ITGB4;MET;WNT16;GATA6;CLDN1;UGCG;PKD1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.7283832438970576,1.8819732087930463,0.008912655971479501,0.30718465078465235,0.973,12/35,7.52%,GUCY1B1;PDE4D;CAP2;PDE3A;RAPGEF2;PDE7B;IRAG1;PDE9A;AKAP6;RIMS2;HTR2C;CAP1
prerank,eye morphogenesis (GO:0048592),-0.7210983855920099,-1.8798063173739294,0.0020161290322580645,0.06988577062169378,0.492,11/19,7.60%,FBN1;EFEMP1;COL5A2;COL5A1;SHROOM2;MFAP5;NKD1;SKI;RARG;FBN2;STAT3
prerank,skeletal system morphogenesis (GO:0048705),-0.5977648609551278,-1.8761249673669735,0.0,0.06985499478471047,0.52,15/42,14.53%,PDGFRA;WWOX;CYP26B1;HOXB3;FGFR2;TGFBR1;LRP6;SKI;HOXA3;SIX1;SFRP4;FBN2;HOXB9;SPEF2;HOXC4
prerank,ATP transport (GO:0015867),-0.8356147478442961,-1.8746927934259683,0.0,0.06736379336703503,0.532,5/10,10.76%,CD47;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,regulation of adenylate cyclase activity (GO:0045761),0.783088886671753,1.8712999499968561,0.0019880715705765406,0.3427272791001721,0.982,4/22,2.16%,GRM3;CACNA1C;CAP2;NF1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.8516443801537774,1.8708207897574973,0.002136752136752137,0.3284924637961277,0.983,2/15,0.09%,GRM3;GRM7
prerank,bone morphogenesis (GO:0060349),-0.7675621953637868,-1.8675166963299195,0.0,0.07092522451580496,0.572,6/14,6.25%,CYP26B1;FGFR2;BMPR2;LRP6;SKI;SFRP4
prerank,chordate embryonic development (GO:0043009),-0.5741442861400835,-1.8624165704305466,0.0,0.07176128633432355,0.597,24/55,14.65%,SULF1;ALDH1A2;COL1A1;CHD7;BMP7;PCSK5;KIAA1217;RBP4;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;SULF2;WNT5A;HINFP;TBX1;FUT8;FLCN;TGFB1;PTCH1;ZNF568;PKD1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.7543394304103754,-1.853808599104813,0.0038095238095238095,0.0786035393778319,0.648,8/15,10.16%,NTRK3;F3;VEGFD;VEGFC;IL16;CXCL12;CDH13;KDR
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8219033674176444,1.8536249968230958,0.0020964360587002098,0.3956279998432267,0.992,6/17,6.43%,GJD3;GJC1;CACNA1C;ATP1A2;ATP1B2;RYR2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.8376455153360569,-1.85206765528884,0.0,0.07629427175015463,0.654,7/11,11.72%,TGFBR3;TGFBR2;TGFBR1;SMAD7;ACVR1;USP15;TGFB1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.6307516836405361,1.840816871890278,0.0,0.4486483059648939,0.994,13/75,4.96%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;TRPV2;ATP1A4;SLC5A1;FXYD2;CACNA2D1;SLC24A2;ATP1B2;SLC12A6
prerank,chemical synaptic transmission (GO:0007268),0.5336534550580844,1.8379395125168547,0.0,0.44540990329443847,0.995,67/284,12.64%,GRM3;GRM7;LIN7A;PTEN;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;SLC1A4;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;GRM5;SNAP25;RIMS1;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;HTR1B;GABRG2;GRID1;CDH8;ASIC2;GRIA2;GRM1;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;OPRK1;CHRNA7;CHRFAM7A;SLC32A1;RIMBP2;ERC2;SYT1;PRKAR2A;KCNQ3;SLC5A7;GRM4;CACNA1A;PLP1;SLC12A5;GRIN2B;STXBP2;PRKAR1A;APBA2;BRSK1;SCN2B;DLG2;GAD1;NTSR1;KCNC4;GABRA5;GABRA4;SLC12A4;GRIK5;GRIK2;DLGAP2
prerank,mesenchymal cell development (GO:0014031),0.7990140049615497,1.8282103906816125,0.012903225806451613,0.48093543966154806,0.996,6/18,2.83%,HEY2;CDH2;HEYL;NOTCH1;TBX20;NRG1
prerank,cGMP metabolic process (GO:0046068),0.8660268003976899,1.8268105812292694,0.0021645021645021645,0.4694164313984222,0.996,4/12,3.79%,GUCY1B1;GUCY1A1;PDE9A;GUCY2D
prerank,proteoglycan metabolic process (GO:0006029),-0.6686008734247832,-1.8243806001845593,0.002074688796680498,0.1097835656868531,0.794,8/26,8.81%,SULF1;IGF1;CHST11;ADAMTS12;BMPR2;CSGALNACT1;SULF2;FOXL1
prerank,renal system development (GO:0072001),-0.5617799692997384,-1.824359288931063,0.0,0.104555776844622,0.794,15/52,8.82%,SULF1;WNT4;GLI2;PCSK5;GREB1L;RBP4;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STAT1;STRA6;ARL3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.79890255612959,1.8241301784949424,0.01327433628318584,0.46590107610300463,0.997,6/18,2.44%,IL34;DAAM2;TNFRSF21;NOTCH1;NF1;PTN
prerank,calcium ion transport (GO:0006816),0.5876255433720601,1.8231808691555862,0.0,0.4543053328012266,0.997,21/113,7.60%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;ATP2A3;TRPC1;CACNA1H;TRPV2;ATP2C1;CACNG7;CACNA2D1;STIM2;ITPR1;SLC24A4;SLC24A2;ATP2A2;RYR2;CHRNA7;CACNA1D;STIM1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6347777153383468,-1.8194189474087383,0.0022371364653243847,0.1065246843306571,0.812,12/30,12.49%,TGFBR3;SMAD3;FSTL1;DKK3;SMURF2;SMAD7;LTBP4;ITGA3;SFRP4;FKBP1A;TGFB1;TWSG1
prerank,cation transport (GO:0006812),0.5615775523601213,1.8185649821175836,0.0,0.4624640017714023,0.998,19/167,5.65%,ABCC9;ANO1;TRPC6;KCNJ8;SLC12A2;NEDD4L;KCNJ12;ATP1A2;KCNG1;KCNMB1;KCNQ4;ATP1A4;SLC5A1;NDFIP2;FGF13;SCN2A;KCNH4;KCNAB3;SCN5A
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8223804033836221,1.8169913471767785,0.002145922746781116,0.4547352076242819,0.998,4/16,1.25%,CACNA1C;CASQ2;DMD;ATP1A2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7972585427731583,1.8160968863981437,0.012170385395537525,0.44485248017671103,0.998,4/17,1.66%,PTEN;MEF2C;PRKG1;GPER1
prerank,respiratory tube development (GO:0030323),-0.6376815724750525,-1.8151692350273076,0.004098360655737705,0.10764049696891986,0.835,10/28,8.29%,GLI2;PDPN;PCSK5;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6
prerank,positive regulation of blood coagulation (GO:0030194),-0.6886588371305777,-1.8120168695086323,0.002004008016032064,0.10791649824319914,0.843,7/17,15.78%,ST3GAL4;F3;THBS1;THBD;ANO6;USF1;SERPINE1
prerank,positive regulation of behavior (GO:0048520),0.855603246012044,1.8107832066379899,0.006787330316742082,0.45796033284378845,0.999,2/10,0.66%,SGIP1;MEF2C
prerank,inorganic cation transmembrane transport (GO:0098662),0.5277126334587888,1.80804897956443,0.0,0.45854604212677674,0.999,42/268,9.14%,ABCC9;TRPC3;TRPC4;TRPC6;CACNA1C;KCNJ8;SLC30A10;SLC12A2;ATP2A3;KCNJ12;ATP1A2;TRPC1;KCNG1;CACNA1H;TRPV2;ATP2C1;KCNQ4;KCNV2;ATP1A4;KCND2;SLC24A4;SLC24A2;SCN2A;KCNH4;KCNH8;KCNAB3;SCN5A;ASIC2;KCNQ5;ATP6V0E2;ATP2A2;HCN2;SCN8A;CACNA1D;KCNA4;SLC9A7;KCNQ3;PKD2;RYR3;SLC6A15;HCN3;SCN9A
prerank,secondary palate development (GO:0062009),-0.7429721196936614,-1.8055383245365322,0.0,0.1135027640346118,0.865,5/14,6.61%,TGFBR3;CHD7;TGFBR2;LEF1;WNT5A
prerank,chloride transmembrane transport (GO:1902476),0.6505280262185208,1.802017698734602,0.007079646017699115,0.47713100992292296,0.999,7/48,6.03%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;GABRG2;GABRA2
prerank,positive regulation of transporter activity (GO:0032411),0.8124138457733442,1.8016954244737036,0.02145922746781116,0.46523521939138535,0.999,4/13,7.53%,TRPC6;NR1H3;STK39;PDZK1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5554686031406315,1.800214400946021,0.0,0.45931344542626035,0.999,16/140,6.45%,TRPC3;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;GPER1;CCRL2;CACNA2D1;ACKR3;ADCY8;TACR1;CXCR2;GRM1;RYR2;HTR2C
prerank,respiratory system development (GO:0060541),-0.6101885765592586,-1.7992077382505893,0.0063025210084033615,0.11995190222613777,0.887,13/32,13.85%,GLI2;PDPN;CHD7;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6;DISP1;ZIC3;SPEF2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.46151164798387667,-1.7982104936781527,0.0,0.11691991236037491,0.887,88/168,24.14%,SAMD4A;RPLP1;RPS14;DDX5;CNOT7;TUT4;RPL9;RPS12;TUT7;THRAP3;RPL41;RPS20;RPL18A;CTIF;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RC3H2;RPL18;SMG6;RPL34;RPL32;UPF3A;RPS9;RPS8;RPL27A;RPL12;RPL37;ZC3H12A;MTPAP;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPLP2;RPS27;RPL26;CNOT8;ATM;RPL14;RPL10;RPL7;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;EXOSC5;NBDY;RPL31;XRN1;SMG5;RPL15;CNOT3;RPSA;RPL38;RPS25;RPS7;PNLDC1;RPLP0;RPL27;CNOT11;AGO1;PNRC2;UPF2;TENT4B;RPL36A;PAN3;RPS26;RPL35A;DHX34;RPL8;RPS29;RPL36;HELZ2;CSDE1;EXOSC7;SAMD4B;POLR2G
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.6568248298298469,-1.792169395232925,0.004106776180698152,0.12250629669575226,0.91,7/23,4.27%,TGFBR3;SMAD3;DKK3;SMURF2;SMAD7;LTBP4;ITGA3
prerank,positive regulation of phosphatase activity (GO:0010922),0.7439460100549913,1.7901166856141195,0.01680672268907563,0.4965416557290346,0.999,3/21,0.66%,ITGA1;PDGFRB;MEF2C
prerank,mesonephros development (GO:0001823),-0.7920624167430239,-1.7882945867148707,0.0018975332068311196,0.12465572360009676,0.92,5/11,5.19%,ZBTB16;BMP7;OSR1;BMP4;FGF1
prerank,prostaglandin metabolic process (GO:0006693),-0.6376412082490396,-1.7865800847726074,0.0,0.12397327825862324,0.924,9/26,11.74%,PTGDS;PTGIS;PLA2G4A;PTGS1;DAGLB;ACOX1;TBXAS1;GSTM1;PTGS2
prerank,visual perception (GO:0007601),-0.5068569949160625,-1.7813339087116233,0.0028328611898017,0.1304538091275641,0.93,17/84,12.45%,EFEMP1;COL1A1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,digestive tract development (GO:0048565),-0.6086998292244168,-1.78020352357773,0.002145922746781116,0.1283725559227329,0.933,15/32,17.17%,CLMP;GLI2;PCSK5;RARB;FGFR2;SMO;STRA6;KIT;BBS7;ZIC3;GLI3;GATA6;PKD1;PKDCC;EPHB3
prerank,arachidonic acid metabolic process (GO:0019369),-0.5887806472845355,-1.7793446556093517,0.00631578947368421,0.12567061229830864,0.933,14/35,19.15%,PTGDS;PTGIS;PLA2G4A;PTGS1;CYP1B1;DAGLB;GPX4;TBXAS1;MGLL;PTGS2;EPHX2;GPX1;ALOX12;EPHX1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7809968581507595,1.778998426960853,0.006289308176100629,0.5409131251221018,1.0,6/20,6.43%,CACNA1C;CASQ2;DMD;ATP1A2;ATP2A2;RYR2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5297529334040394,1.7786566067665952,0.0,0.5288082381587792,1.0,53/224,12.53%,GRM3;GRM7;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;GRM5;SNAP25;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;HTR1B;GABRG2;ASIC2;GRIA2;GRM1;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;OPRK1;CHRNA7;CHRFAM7A;SYT1;PRKAR2A;KCNQ3;GRM4;CACNA1A;PLP1;SLC12A5;GRIN2B;PRKAR1A;APBA2;SCN2B;DLG2;GAD1;NTSR1;KCNC4;GABRA5;GABRA4;SLC12A4;GRIK2
prerank,regulation of multicellular organism growth (GO:0040014),-0.7245434327935023,-1.7757856952977822,0.0018832391713747645,0.12797099913797644,0.941,5/15,12.93%,IGF1;APP;GHR;PTCH1;MFSD2A
prerank,calcium ion import (GO:0070509),0.7089746506025578,1.773722842589172,0.020833333333333332,0.5413071023732996,1.0,4/28,1.70%,TRPC4;CACNA1C;CACNB2;CACNA1H
prerank,neurotransmitter secretion (GO:0007269),0.65659932371967,1.7734277679441353,0.0018867924528301887,0.5297612885206696,1.0,14/44,10.91%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;RIMS2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;BRSK1;GAD1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5811926973113395,-1.7727799725271443,0.0,0.1292757497986005,0.945,17/38,16.84%,SMAD3;ROCK2;PTGIS;CAV1;KLF4;KLF2;CD34;DDAH1;CD47;P2RX4;AKT1;NOS1AP;ZC3H12A;PTGS2;HSP90AB1;TLR4;SIRPA
prerank,negative regulation of cell aging (GO:0090344),0.780204887829802,1.770523811966242,0.0189873417721519,0.5315338344283416,1.0,4/16,2.55%,SLC30A10;CDK6;AKT3;FOXM1
prerank,regulation of bone mineralization (GO:0030500),-0.5483452571886338,-1.7694635849913325,0.0022222222222222222,0.13091254559087048,0.95,25/55,12.78%,BMP6;WNT4;BMP7;OSR1;ENPP1;SGMS2;ANKH;BMP4;BMPR2;ADGRV1;ACVR1;SRGN;BMP2K;ANO6;KL;PTK2B;FBN2;ATRAID;ECM1;NOTUM;P2RX7;TGFB1;S1PR1;CCN1;TMEM119
prerank,extracellular matrix organization (GO:0030198),-0.42621645256708995,-1.7693015501606955,0.0,0.12752575252979187,0.95,109/276,12.38%,FLRT2;ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;ADAMTS6;COL1A1;THSD4;DCN;ADAMTS2;ITGA9;ELN;COL22A1;GSN;COL12A1;LAMA1;COL5A1;VWF;LOXL1;JAM2;PECAM1;COL6A3;APP;ADAMTS9;RECK;COL25A1;SH3PXD2A;COL8A2;COL6A1;SPARC;ITGA6;ADAMTS5;VIT;TLL1;BSG;ITGB8;MFAP5;COL4A5;COL6A2;THBS1;ITGA5;PLEC;TGFBR1;COL11A1;TIMP2;CAPN2;NID2;CDH1;FBLN5;VCAM1;ITGA3;COL4A6;HTRA1;COL23A1;ADAM10;HSPG2;GAS6;PLOD2;COL13A1;BGN;SPOCK2;SERPINH1;NDNF;ADAMTS1;ITGA10;ITGA11;ST7;P4HB;TNC;DDR1;ADAMTS15;ICAM1;ADAMTSL1;CD47;GFOD2;FBN2;CYP1B1;COL18A1;KLK2;ADAMTSL4;CAPNS1;ITGB4;TGFBI;COL14A1;ADAM15;CAPN1;LAMA5;MMP14;DPT;KDR;SLC39A8;MMP19;COL16A1;LAMA3;ITGB3;ADAMTS14;TGFB1;ADAMTS3;COL20A1;F11R;CTSS;COL9A2;LUM;SMOC2
prerank,skeletal system development (GO:0001501),-0.44879693556856215,-1.7632981724173054,0.0,0.134104575808135,0.96,41/148,9.99%,BMP6;SULF1;IGF1;FBN1;COL1A2;EXT1;ZBTB16;COL1A1;WWOX;GLI2;AKAP13;CHD7;BMP7;PCSK5;KIAA1217;RBP4;TLL1;ITGB8;NPR3;TGM2;ANKH;SUFU;FGFR2;GJA1;TGFBR1;TNFRSF11B;CREB3L2;IGF2;COL13A1;TEAD4;PAPSS2;SULF2;WNT5A;ALPL;PRELP;EVC;RPL13;GNAS;CMKLR1;MMP14;NOTUM
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.6992861846134769,1.7598195123920828,0.005504587155963303,0.5725303123438755,1.0,7/32,6.31%,TRPC3;TRPC1;GPER1;AKAP6;CXCL10;NPSR1;SNCA
prerank,cGMP-mediated signaling (GO:0019934),0.8260872885219702,1.759173390464012,0.016701461377870562,0.562849692937776,1.0,4/13,2.40%,GUCY1B1;PDE3A;IRAG1;PDE9A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.7781021539863318,1.7587974050315567,0.016701461377870562,0.5523082800851037,1.0,4/17,1.60%,NOTCH3;HEYL;NOTCH1;MAML2
prerank,cGMP biosynthetic process (GO:0006182),0.8611313474757585,1.757334729671849,0.013245033112582781,0.547141084784125,1.0,3/10,3.79%,GUCY1B1;GUCY1A1;GUCY2D
prerank,diacylglycerol metabolic process (GO:0046339),0.7445619930778743,1.7561451264894137,0.014198782961460446,0.5414140730147013,1.0,4/23,1.90%,DGKB;PLCE1;DGKH;DGKG
prerank,prostanoid biosynthetic process (GO:0046457),-0.713336343587432,-1.7535986252251738,0.0019455252918287938,0.14698129398734364,0.979,7/15,11.74%,PTGDS;PTGIS;PLA2G4A;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.8343843934693151,1.7514245466072913,0.01859504132231405,0.55236786669424,1.0,2/10,0.97%,PDE4D;PDE3A
prerank,cellular response to BMP stimulus (GO:0071773),-0.5242745070603322,-1.7513220369900586,0.0024449877750611247,0.14725560928098816,0.98,19/66,9.01%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;BMP7;BMP4;BMPR2;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8027946964808537,1.7505297456434477,0.019148936170212766,0.5446884904351332,1.0,2/12,0.33%,GJD3;PDE4D
prerank,signal release from synapse (GO:0099643),0.6488630139122867,1.747557789763429,0.001893939393939394,0.548238514681089,1.0,13/43,10.91%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;BRSK1;GAD1
prerank,negative regulation of cell junction assembly (GO:1901889),0.7167838305376752,1.7472064946730133,0.016,0.5393113891040628,1.0,7/25,2.65%,DLC1;PTEN;ARHGAP6;PHLDB2;SLIT1;ROCK1;IL1B
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.6078477048220514,-1.7468254948205044,0.0021598272138228943,0.15344562093015604,0.986,11/30,15.95%,ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;F11R;LPAR6;PRAG1;LPAR4;NET1
prerank,negative regulation of nuclear division (GO:0051784),-0.7701838548493911,-1.7461226328006125,0.0019083969465648854,0.15120579054391892,0.986,4/11,6.34%,BMP7;TOM1L2;BMP4;TOM1L1
prerank,peptide cross-linking (GO:0018149),-0.6350344518626552,-1.7453510477627785,0.003929273084479371,0.14891382569199152,0.986,6/25,5.93%,FN1;COL3A1;TGM2;THBS1;ANXA1;NDNF
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.7691532379824604,-1.7448892017174629,0.0,0.14654782098643937,0.986,8/11,17.36%,NUPR1;ARHGEF2;BIRC3;SLC25A4;CASP8;YBX3;PELI1;RIPK1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5546832110467954,-1.744238785109452,0.0044444444444444444,0.14463549130172712,0.986,15/43,12.97%,NFIB;SMAD3;FOXO3;NR3C1;BMP4;KLF4;DDX5;TEAD1;STAT3;HIF1A;GATA2;TGFB1;PPARA;RELA;ATOH8
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.7756911569793219,1.7431085836838074,0.021551724137931036,0.5375442923270105,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.7756911569793219,1.7431085836838074,0.021551724137931036,0.5375442923270105,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.8069898198726497,1.7429054086330236,0.029850746268656716,0.5286325340549155,1.0,2/12,3.82%,ANO1;ADCY8
prerank,positive regulation of protein secretion (GO:0050714),-0.5046619187794606,-1.7411223243058274,0.0024509803921568627,0.14789609459100686,0.989,21/69,16.00%,BMP6;IGF1;UNC13B;CD2AP;MCU;MYRIP;RBP4;MYO18A;EZR;ADAM9;TCF7L2;NNAT;GOLPH3;C1QTNF3;MYH10;NLGN2;TGFB1;PPID;PPIA;SYTL4;TLR4
prerank,kidney development (GO:0001822),-0.5141853053033089,-1.7397107927467046,0.0025188916876574307,0.14706135481716973,0.989,17/65,8.82%,SULF1;ZBTB16;WNT4;GLI2;CTSH;BMP7;PCSK5;OSR1;GREB1L;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STRA6;ARL3
prerank,central nervous system neuron development (GO:0021954),0.7901553649002157,1.7377420672416173,0.020618556701030927,0.5425198252933365,1.0,7/15,8.93%,PTEN;RAPGEF2;MAP2;ATP7A;NTRK2;B4GALT6;ARHGAP35
prerank,lung development (GO:0030324),-0.590761310167208,-1.7355028636781424,0.004357298474945534,0.15183925985515864,0.992,11/33,8.29%,ERRFI1;GLI2;PDPN;RBP4;FGFR2;BMP4;ITGA3;FGF1;RCN3;ABCA3;STRA6
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.7430560515181543,-1.7320675982080924,0.005628517823639775,0.15553052839809697,0.993,3/12,1.15%,NFIB;EPHA4;GLI2
prerank,sensory perception of light stimulus (GO:0050953),-0.49132701204559714,-1.7293531821135015,0.0,0.1572593566440861,0.993,17/87,12.45%,EFEMP1;COL1A1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5300452235556689,-1.7272144828205367,0.0,0.1584371467185417,0.993,19/58,14.97%,ST3GAL4;PLPP3;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA
prerank,embryonic appendage morphogenesis (GO:0035113),-0.7412295053769582,-1.7256079125184736,0.003838771593090211,0.15862174139566315,0.993,5/12,12.21%,CYP26B1;MBNL1;LRP6;SKI;PTCH1
prerank,aorta morphogenesis (GO:0035909),0.7595629783876969,1.7249151778933385,0.03711340206185567,0.593498587697218,1.0,4/17,1.44%,PDGFRB;TBX2;HEY2;MYLK
prerank,collagen fibril organization (GO:0030199),-0.48970843008901793,-1.723547852384768,0.0,0.15932778555015378,0.995,38/88,12.26%,COL1A2;COL3A1;COL5A2;COL1A1;ADAMTS2;COL22A1;COL12A1;COL5A1;LOXL1;COL6A3;COL25A1;COL8A2;COL6A1;ITGA6;TLL1;COL4A5;COL6A2;PLEC;TGFBR1;COL11A1;COL4A6;COL23A1;PLOD2;COL13A1;SERPINH1;P4HB;CYP1B1;COL18A1;ITGB4;COL14A1;DPT;COL16A1;LAMA3;ADAMTS14;ADAMTS3;COL20A1;COL9A2;LUM
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.685980566447427,1.7226711791306575,0.021484375,0.5937178372975648,1.0,3/32,0.19%,DLC1;ITGA1;PDGFRB
prerank,response to cholesterol (GO:0070723),-0.6664394116039185,-1.7215628393702087,0.005535055350553505,0.1598624635644161,0.995,8/17,12.21%,TGFBR2;TGFBR1;LRP6;SMO;GRAMD1C;GRAMD1A;TGFB1;PTCH1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6191357834350988,-1.7209267875163814,0.008385744234800839,0.15823905785179254,0.995,15/24,20.53%,SEC23A;SEC24D;B2M;SEC31A;TAPBP;ACE;SEC24A;ERAP1;IDE;CALR;HFE;BCAP31;PDIA3;SAR1B;CANX
prerank,prostaglandin biosynthetic process (GO:0001516),-0.6756952682163848,-1.7201917123876698,0.002053388090349076,0.15709372108944197,0.995,7/18,11.74%,PTGDS;PTGIS;PLA2G4A;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.8061170887700015,1.7189326327741794,0.03373015873015873,0.6014189469221098,1.0,2/11,0.56%,DLC1;FAP
prerank,negative regulation of cellular senescence (GO:2000773),0.7753027499027518,1.7178442708955222,0.031914893617021274,0.5970123761327768,1.0,3/13,2.33%,SLC30A10;CDK6;AKT3
prerank,T cell migration (GO:0072678),0.7777139002953273,1.7176901380282386,0.03640256959314775,0.5878218991303861,1.0,3/13,5.43%,SLC12A2;PIK3CD;CXCL10
prerank,tight junction assembly (GO:0120192),-0.5437476299003902,-1.7175712082581713,0.0070921985815602835,0.15903483951629346,0.995,15/49,11.81%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;LSR;PDCD6IP;PARD6G;CLDN11;ACTG1;PARD3;PATJ;F11R
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7419913400388961,1.714868919461188,0.038539553752535496,0.591504546940946,1.0,7/17,7.58%,CACNA1C;CACNB2;ATP1A2;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,substrate-dependent cell migration (GO:0006929),-0.7137602893970325,-1.714152426503568,0.009259259259259259,0.16253144005187703,0.996,10/14,19.82%,NRP1;CD2AP;ANKS1A;VEGFC;SDCBP;ITGA11;EPHA8;OPHN1;NTN1;ITGA2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7457865916031934,-1.7130780481815842,0.0053285968028419185,0.16226398345898418,0.996,4/10,6.86%,PODXL;DPP4;PIEZO1;WNK1
prerank,BMP signaling pathway (GO:0030509),-0.5154474480538156,-1.7124437771614383,0.004830917874396135,0.1609225429685352,0.996,18/62,9.01%,BMP6;TGFBR3;SMAD3;SMAD6;BMP7;BMP4;BMPR2;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,lipid phosphorylation (GO:0046834),0.8088657837415977,1.7124368957397285,0.03524229074889868,0.5931366402356147,1.0,3/10,1.90%,DGKB;DGKH;DGKG
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.578234894609994,-1.711762763622296,0.0021321961620469083,0.15922106298176922,0.996,10/31,10.22%,PDGFRA;OSR1;HOXB3;TGFBR2;FGFR2;TGFBR1;HOXA3;SIX1;TBX1;HOXB9
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7720277286908772,1.7116273307716883,0.029661016949152543,0.5873962804936975,1.0,3/14,3.09%,ACE2;ENPEP;ECE1
prerank,lipid oxidation (GO:0034440),-0.7205023805745778,-1.7109315005292474,0.00927643784786642,0.15818879486313348,0.996,5/12,19.51%,ADIPOR2;ACOX1;ALOX12;PPARGC1A;ADIPOR1
prerank,negative regulation of wound healing (GO:0061045),0.6904220236246299,1.710215914680396,0.01782178217821782,0.5848937759157937,1.0,7/28,5.20%,PTEN;SLC12A2;VTN;AJAP1;PHLDB2;FGF2;CLASP2
prerank,mesenchyme morphogenesis (GO:0072132),0.7364288513781111,1.7093135269154853,0.046370967741935484,0.5799243816271566,1.0,4/17,1.24%,TBX2;HEYL;NOTCH1;TBX20
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.6967675270548034,-1.7073276447336099,0.007707129094412331,0.16239930440849196,0.997,6/15,7.84%,PDGFRA;TGFBR2;FGFR2;TGFBR1;SIX1;TBX1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.48024209202648155,-1.7055978258754598,0.002638522427440633,0.16269742395715872,0.997,36/92,13.24%,DOCK5;ANXA3;NRP2;ROCK2;FOXP1;NRP1;CTSH;TEK;SPARC;PLCG1;SASH1;THBS1;BMP4;BMPR2;ANGPT1;RAB11A;FOXC2;ADAM9;FGF1;PRKCE;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;RREB1;HIF1A;KDR;ZC3H12A;ITGB3;PFN1;SMOC2;FLT4;ATOH8;CALR;PLCG2
prerank,glutamate receptor signaling pathway (GO:0007215),0.6669360801531757,1.7050749198602162,0.016885553470919325,0.5903407876075147,1.0,6/37,5.93%,GRM3;GRM7;GRIK1;GRM5;GRIA2;GRM1
prerank,response to interferon-gamma (GO:0034341),-0.5015587487796103,-1.7043579018749857,0.0024752475247524753,0.16248657100402686,0.997,21/67,16.84%,DAPK1;SP100;IFITM3;LGALS9;CCL15;WNT5A;CD47;STAT1;CCL14;GBP4;GBP6;GBP5;GCH1;CCL25;GBP7;IFITM2;GBP2;CCL13;CXCL16;TLR4;SIRPA
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.708747165339325,1.7037877814573679,0.033268101761252444,0.5872260330390223,1.0,6/21,3.98%,GUCY1B1;GUCY1A1;GUCY2D;ADCY3;ADCY8;ADCY6
prerank,in utero embryonic development (GO:0001701),-0.6082150399098121,-1.7037355018851068,0.012396694214876033,0.1613825204932899,0.997,12/25,14.65%,CHD7;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;HINFP;FUT8;FLCN;ZNF568;PKD1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.6741931750584534,1.7023125608115142,0.011472275334608031,0.5847155089923203,1.0,5/32,1.69%,DLC1;PTEN;ARHGAP6;AJAP1;PHLDB2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.6190486522583698,-1.7022271254343506,0.0063025210084033615,0.16186638736131967,0.997,7/23,12.50%,TGFBR3;ADAMTS9;FGFR2;SMAD7;FKBP1A;TGFB1;ID2
prerank,diol metabolic process (GO:0034311),-0.6594124782412621,-1.7004240245008264,0.013972055888223553,0.16284672071046563,0.997,10/19,15.58%,PLPP3;NOS3;NAAA;AKT1;DEGS2;GCH1;PLPP1;SPHK1;PTS;CALM1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7815738959307008,1.6986250470293585,0.03711790393013101,0.5924981525865236,1.0,3/13,0.75%,GJC1;CACNA1C;CACNB2
prerank,monocyte chemotaxis (GO:0002548),-0.5751871977447852,-1.6983083167296955,0.00663716814159292,0.16449675947045186,0.997,9/32,15.34%,FLT1;IL6R;ANXA1;CCL15;RPS19;CCL14;CCL25;TNFRSF11A;CCL13
prerank,inorganic anion transmembrane transport (GO:0098661),0.5807162498853818,1.6951266097459932,0.01658374792703151,0.5999690550214738,1.0,8/63,6.03%,ANO1;ANO4;SLC12A2;SLC5A1;XPR1;SLC12A6;GABRG2;GABRA2
prerank,calcium ion transmembrane transport (GO:0070588),0.5826440680100429,1.6943337727568366,0.003284072249589491,0.594879974944991,1.0,12/86,4.84%,TRPC3;TRPC4;TRPC6;CACNA1C;ATP2A3;TRPC1;TRPV2;ATP2C1;CACNA2D1;ATP2B3;SLC24A4;SLC24A2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.571148610838611,-1.69426913706294,0.004347826086956522,0.17075665391818112,0.997,12/35,11.81%,NOTCH2;PDGFRA;NTRK3;NRP1;BAIAP2L1;TEK;BAIAP2;PTK2B;SEMA3E;IQGAP2;ARHGDIA;F11R
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.7109774065401572,-1.694177868852029,0.0076045627376425855,0.1684778549014397,0.997,4/13,2.18%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5137683127559151,1.6937787521038488,0.004178272980501393,0.589088114574534,1.0,31/172,10.73%,INPP4B;PIP5K1B;DGKB;PTEN;PIK3CD;PLD1;DGKH;PIK3R1;DGKG;CDS2;PLD6;PIP4K2A;PIK3CA;SLC44A2;FGF2;PITPNM2;CPNE7;INPP5J;PIP4K2C;LIPH;PIK3C2A;ABHD3;PIKFYVE;ACHE;MTMR12;STARD7;MTMR14;MTMR7;FIG4;DGKD;PGS1
prerank,negative regulation of cyclase activity (GO:0031280),0.7752883656942834,1.6927942816510222,0.020876826722338204,0.5853159965269794,1.0,1/14,0.04%,GRM3
prerank,response to laminar fluid shear stress (GO:0034616),-0.7625916578161305,-1.6926787113954562,0.0038314176245210726,0.16881401469704596,0.998,6/10,7.36%,ABCA1;SMAD6;KLF4;SMAD7;KLF2;MAP2K5
prerank,regulation of BMP signaling pathway (GO:0030510),-0.49563089513924147,-1.6908486340421391,0.0,0.17001567294445702,0.998,21/73,7.14%,SULF1;ZNF423;FSTL1;SMAD6;CDH5;SKIL;HTRA3;BMP4;BMPR2;SMURF2;FOXD1;SMAD9;SMAD7;ITGA3;SKI;BMPER;ACVRL1;SFRP4;SMURF1;NBL1;VWC2
prerank,negative regulation of neurogenesis (GO:0050768),0.6552320925426807,1.6903263290500143,0.02952029520295203,0.5875883840405273,1.0,7/34,2.65%,PTEN;RAPGEF2;NOTCH1;LINGO1;NF1;PTN;IL1B
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.486828360591776,-1.6901493189060828,0.0,0.16902006493294472,0.998,28/75,11.15%,SULF1;ROCK2;DCN;WNT4;TEK;SEMA6A;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;HOXA5;HSPG2;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;HGS;STAB1;DAB2IP;EMILIN1;PML;ECSCR
prerank,leukotriene biosynthetic process (GO:0019370),0.7591388127105891,1.6900821648187287,0.0423728813559322,0.5807549272868113,1.0,3/14,1.45%,GGT5;GGT1;GGTA1
prerank,icosanoid secretion (GO:0032309),-0.7142525601407138,-1.6899100270368652,0.01717557251908397,0.1670950679372552,0.998,4/12,6.48%,ABCC4;ANXA1;ACE;BDKRB2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.49272393904032663,-1.6891087181105557,0.002457002457002457,0.16639992924797053,0.998,27/73,11.23%,ITGBL1;DAB2;FN1;COL3A1;NRP1;FBLN1;PLPP3;NEDD9;FYB1;ITGB8;ITGA5;SEMA7A;ADAM9;ADAM10;ADAMTS1;ITGA10;ITGA11;PTK2B;PTPRA;CD47;ZYX;ITGB4;ADAM15;LAMA5;COL16A1;LAMA3;ITGB3
prerank,cAMP-mediated signaling (GO:0019933),0.7068562951870945,1.6878738390682193,0.031189083820662766,0.5825218270545712,1.0,8/24,7.52%,PDE4D;CAP2;PDE3A;RAPGEF2;PDE7B;AKAP6;RIMS2;CAP1
prerank,cardiac ventricle development (GO:0003231),0.7200784078766659,1.687131917010413,0.0389344262295082,0.57838090391657,1.0,4/20,5.65%,HEY2;HEYL;NOTCH1;SCN5A
prerank,actin filament depolymerization (GO:0030042),-0.73579300366941,-1.6859903735389858,0.0018796992481203006,0.17126585413008677,0.998,5/11,12.93%,MICAL3;GSN;MICAL2;DSTN;TWF1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7402802764541558,-1.6859890851516461,0.0019646365422396855,0.1690701380514959,0.998,7/11,16.02%,DAB2;RSPO3;NKD1;MLLT3;WNT5B;SFRP1;PLEKHA4
prerank,negative regulation of lyase activity (GO:0051350),0.7575580848050912,1.6821346717365726,0.02268041237113402,0.5922908948156145,1.0,1/16,0.04%,GRM3
prerank,type I interferon signaling pathway (GO:0060337),-0.5446648178971987,-1.6818330989055836,0.0044943820224719105,0.17260104982859073,0.998,19/41,17.34%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;SAMHD1;IFIT1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.5446648178971987,-1.6818330989055836,0.0044943820224719105,0.17260104982859073,0.998,19/41,17.34%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;SAMHD1;IFIT1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,potassium ion transmembrane transport (GO:0071805),0.5293666721903495,1.6817003733186224,0.001451378809869376,0.5865585121645197,1.0,33/135,11.67%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;KCNG1;KCNQ4;KCNV2;ATP1A4;FXYD2;KCNE4;KCND2;SLC24A4;SLC24A2;ATP1B2;SLC12A6;KCNH4;KCNH8;KCNAB3;KCNQ5;HCN2;KCNA4;KCNE5;SLC9A7;KCNQ3;PKD2;HCN3;KCNJ3;SLC12A5;KCNJ6;HPN;KCNG2;KCNC4
prerank,regulation of DNA binding (GO:0051101),-0.5401043488857423,-1.6812691330549505,0.0022271714922048997,0.17145211184428294,0.998,18/44,21.40%,IGF1;SP100;LEF1;SKI;SMO;FOXC1;CEBPG;MDFI;TGFB1;NME1;TXN;HMGB2;SIRT2;NFKBIA;PLAUR;E2F1;RSF1;HJURP
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6613633084915297,-1.6793544137173362,0.013725490196078431,0.17321376671772157,0.998,5/17,3.83%,NTRK3;NRP1;BAIAP2L1;TEK;BAIAP2
prerank,retinoic acid metabolic process (GO:0042573),-0.7069061484352439,-1.6789005003861142,0.00186219739292365,0.17203114436250672,0.998,4/14,13.62%,ALDH1A2;CYP26B1;SCPEP1;ADH1A
prerank,placenta development (GO:0001890),0.7893571098607169,1.6785986813893166,0.03621730382293763,0.5920637208682821,1.0,3/12,2.43%,PTK2;NODAL;ADAM19
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7780542326480158,1.6780804612981,0.03164556962025317,0.5870053418940727,1.0,1/13,0.04%,GRM3
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.5899355993434137,-1.6772906821282012,0.01646090534979424,0.1733972207313489,0.998,11/26,12.26%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;ST3GAL3;PRELP;OMD;LUM
prerank,heart morphogenesis (GO:0003007),0.6145843376692239,1.6765756922273016,0.02385008517887564,0.5861469340808816,1.0,8/50,1.88%,DLC1;TBX2;HEY2;HEYL;NOTCH1;TBX20;PTK2;TBX3
prerank,mesonephric tubule development (GO:0072164),-0.6804962649160086,-1.6753456439134051,0.022727272727272728,0.1749947401188518,0.998,7/15,6.87%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7076098564978379,1.6752016873186586,0.029296875,0.5848030835711273,1.0,4/21,1.41%,PDE4D;PTEN;DMD;NCK2
prerank,keratan sulfate metabolic process (GO:0042339),-0.5633189902717463,-1.6744333121206918,0.008350730688935281,0.17464027825861883,0.998,15/31,16.04%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;HEXA;ST3GAL3;HEXB;PRELP;OMD;LUM;GALNS;SLC35D2
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4722443754468078,-1.673823223159836,0.0,0.17376603553179482,0.998,36/84,13.23%,ANXA3;NRP2;ROCK2;FOXP1;NRP1;PLPP3;TEK;SPARC;PLCG1;SASH1;NOS3;THBS1;BMP4;BMPR2;ANGPT1;FOXC2;FGF1;WNT5A;MAPK14;PTK2B;RHOB;P2RX4;TMSB4X;PIK3CB;AKT1;HIF1A;KDR;ZC3H12A;GATA2;ITGB3;TGFB1;SMOC2;FLT4;ATOH8;CALR;MET
prerank,peptidyl-arginine modification (GO:0018195),0.7374587176154186,1.6727168878806673,0.04430379746835443,0.5888753052561899,1.0,1/15,0.14%,ART3
prerank,cellular response to zinc ion (GO:0071294),-0.6784772711445198,-1.6725849160375423,0.009900990099009901,0.17418466248761724,0.998,13/15,30.71%,P2RX4;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ATP13A2;MT2A;HVCN1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6713270965248843,-1.6724524501472309,0.007434944237918215,0.1724415099644448,0.998,11/15,28.66%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SPHK1;SIRT3;ORMDL3;ORMDL2;RACK1;SPHK2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.572643706481298,1.6723174034744652,0.014778325123152709,0.5832933168360211,1.0,10/75,4.08%,RGS5;RGS6;RGS4;PLCE1;METAP2;GPER1;ROCK1;RGS3;GUCY2D;RGS11
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.642972946651938,-1.672178464061961,0.00945179584120983,0.17094869514095698,0.998,6/18,11.72%,EGFR;ESR1;BMP4;DDX5;ZC3H12A;TGFB1
prerank,phospholipid translocation (GO:0045332),-0.5966799479268686,-1.6714910038541004,0.004149377593360996,0.1703134818656215,0.998,14/28,16.80%,ABCA1;ATP10A;PLSCR2;ANO6;ABCA4;PLSCR4;P2RX7;ATP9A;ATP8A1;MFSD2A;TMEM30A;PLSCR3;ATP11B;ATP11A
prerank,eye development (GO:0001654),-0.5148786375651019,-1.670885806951721,0.0044943820224719105,0.16967990104772604,0.998,16/54,9.83%,PBX1;FBN1;SMOC1;EFEMP1;COL5A2;LAMA1;COL5A1;SHROOM2;PBX3;RBP4;SKI;RAB3GAP1;FOXC1;FBN2;STRA6;ATF6
prerank,dendrite morphogenesis (GO:0048813),0.6395780576815243,1.6687636242361084,0.032846715328467155,0.5911026269706273,1.0,9/35,4.32%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;PTN;WASL;MINK1
prerank,positive regulation of embryonic development (GO:0040019),-0.6549232151422028,-1.6686510520514246,0.003816793893129771,0.1719027063766821,0.999,5/19,7.52%,PLCB1;WNT4;OSR1;NIBAN2;NR2C2
prerank,inositol lipid-mediated signaling (GO:0048017),0.6211888827450943,1.6684104455600108,0.026881720430107527,0.5857569149172115,1.0,9/50,4.99%,ADAP2;PDGFRB;PLCL1;PLCE1;PIK3CD;PIK3R1;PIK3CA;PITPNM2;OGT
prerank,neuron cell-cell adhesion (GO:0007158),0.7601643844603451,1.6669429081116207,0.04194260485651214,0.5848594966875262,1.0,7/14,7.83%,CEL;NRXN1;ASTN1;ASTN2;CNTN4;NINJ2;NRXN3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7253013937405599,1.6665305305574696,0.05793991416309013,0.5797643166477305,1.0,2/17,0.19%,ITGA1;PDGFRB
prerank,sodium ion homeostasis (GO:0055078),0.7162603704882512,1.6659974420417494,0.044,0.5754676088361099,1.0,6/21,5.73%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,negative regulation of chemokine production (GO:0032682),-0.6858633049703933,-1.6650745741219783,0.013358778625954198,0.1765928002982837,0.999,7/14,21.52%,APOD;KLF4;LGALS9;MAP2K5;C1QTNF3;SIRPA;SIGIRR
prerank,response to muscle stretch (GO:0035994),0.7423922910383237,1.6621753503880219,0.04421052631578947,0.5844267720054176,1.0,5/15,6.43%,DMD;CDH2;PTK2;PIK3CA;RYR2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.6154428583424917,-1.6616059682433193,0.006122448979591836,0.18147895552316534,0.999,7/21,11.81%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,Notch signaling pathway (GO:0007219),0.588022288786083,1.660410985026219,0.021996615905245348,0.5851275481085672,1.0,6/59,1.60%,NOTCH3;HEY2;HEYL;NOTCH1;DTX3;MAML2
prerank,bicellular tight junction assembly (GO:0070830),-0.5271305924804763,-1.659439175547613,0.013729977116704805,0.1838477973423013,0.999,13/46,11.81%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;CLDN11;PARD3;PATJ;F11R
prerank,glycolipid metabolic process (GO:0006664),-0.5145960615945738,-1.658052412093615,0.0,0.18478193256781503,1.0,16/47,15.31%,ST3GAL4;ST3GAL6;ESYT2;ST3GAL2;ST6GALNAC3;SMPD3;HEXA;HEXB;FUCA1;PSAP;B3GALNT1;NAGA;ST6GALNAC6;ESYT3;UGCG;SUMF2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6324973385293138,-1.6579618258952777,0.008146639511201629,0.18313645417212343,1.0,12/20,17.11%,ENTPD1;APP;TXNIP;ANO6;P2RX4;IL18;NT5E;P2RX7;ENTPD5;TXN;HSP90AB1;SUGT1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.6990979044789205,-1.657899896265087,0.0148975791433892,0.1814450088423716,1.0,4/14,4.38%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6267668867444139,-1.6575834457983698,0.006147540983606557,0.18033631024764912,1.0,7/20,11.81%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6057850112110268,-1.657522793887828,0.014344262295081968,0.17862844265374514,1.0,10/23,15.16%,UACA;BMP7;HDAC7;CCN3;TMSB4X;C1QTNF3;IFI35;ZC3H12A;RELA;PPM1B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.6377582974265682,1.6560203758504257,0.0285204991087344,0.5959237558242518,1.0,8/37,12.41%,DYNLL1;IFT43;IFT81;IFT20;KIF3A;IFT57;KIF3C;TRIP11
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.5756528136282129,1.6559550387520738,0.0214168039538715,0.5898789049457855,1.0,14/69,7.18%,PDGFRB;PLCL1;PTEN;PLCE1;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;PITPNM2;OGT;NYAP2;IRS1;PIK3C2A
prerank,protein O-linked mannosylation (GO:0035269),-0.6444458541875466,-1.655772606817324,0.01646090534979424,0.1803916633059786,1.0,5/18,7.47%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6978643333393402,-1.654942657393022,0.0018796992481203006,0.1801085642732601,1.0,6/13,17.01%,NOS3;AKT1;GCH1;PTS;CALM1;FPGS
prerank,regulation of interleukin-1 production (GO:0032652),-0.6716627924528277,-1.6545937189041373,0.018214936247723135,0.17900150064600912,1.0,6/15,16.84%,FOXP1;ANXA1;GAS6;CEACAM1;TLR4;SIRPA
prerank,positive regulation of DNA binding (GO:0043388),-0.5654376333426453,-1.6540297613786328,0.014957264957264958,0.17819291682233435,1.0,15/31,24.29%,IGF1;SKI;NIBAN2;FOXC1;PINX1;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;PARK7;PLAUR;TRIM6;PRKN
prerank,cardiac muscle cell action potential (GO:0086001),0.6621625132138742,1.6507578251766244,0.039473684210526314,0.6043399344104551,1.0,8/30,7.58%,CACNA1C;DMD;ATP1A2;FGF12;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,odontogenesis (GO:0042476),-0.5503008358660237,-1.6459278623769875,0.008113590263691683,0.19181475906973278,1.0,9/35,7.84%,COL1A2;GLI2;OSR1;WNT6;FGFR2;BMP4;LRP6;FOXC1;TBX1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6624830924711683,1.6446944554046494,0.04431599229287091,0.6217955767458,1.0,6/25,8.54%,PDE4D;GLMN;IL1B;SPTBN1;PDE4B;PRKD2
prerank,cellular response to interferon-gamma (GO:0071346),-0.4639039933948535,-1.6443097298743374,0.0,0.19330953240912224,1.0,28/88,17.63%,DAPK1;SP100;B2M;VCAM1;LGALS9;CCL15;IRF1;WNT5A;ICAM1;IRF2;CD47;STAT1;CCL14;GBP4;PRKCD;IRF9;OAS2;PML;GBP6;CAMK2A;GBP5;CCL25;GBP7;GBP2;CCL13;TLR4;SIRPA;TRIM8
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6592577250186237,1.6429847475725643,0.039473684210526314,0.6221026282319908,1.0,10/30,7.85%,GJC1;CACNA1C;NEDD4L;FGF12;CACNA2D1;KCNE4;SCN5A;RYR2;CACNA1D;KCNE5
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.5591405627863815,-1.641820259100198,0.008658008658008658,0.19678890856112785,1.0,14/30,22.09%,FLT1;BMP4;MLLT3;ACE;KIT;KDR;TGFB1;FLT4;SFRP1;LMBR1L;CSF1R;PLEK;FSTL3;SP7
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7272791157528256,1.6388557947555247,0.05668016194331984,0.6322260834694656,1.0,4/16,3.04%,SOX5;PTN;TCF15;RBM24
prerank,extracellular structure organization (GO:0043062),-0.4092544303104263,-1.6377077119414643,0.0,0.2035034997346357,1.0,87/204,12.38%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;ADAMTS6;COL1A1;THSD4;DCN;ADAMTS2;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;JAM2;PECAM1;COL6A3;APP;ADAMTS9;RECK;SH3PXD2A;COL8A2;COL6A1;SPARC;ITGA6;ADAMTS5;VIT;BSG;ITGB8;MFAP5;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;COL11A1;NID2;CDH1;FBLN5;VCAM1;ITGA3;COL4A6;COL23A1;HSPG2;COL13A1;BGN;SPOCK2;NDNF;ADAMTS1;ITGA10;ITGA11;ST7;TNC;DDR1;ADAMTS15;ICAM1;ADAMTSL1;CD47;GFOD2;FBN2;COL18A1;ADAMTSL4;ITGB4;TGFBI;COL14A1;ADAM15;LAMA5;MMP14;KDR;SLC39A8;MMP19;COL16A1;LAMA3;ITGB3;ADAMTS14;ADAMTS3;F11R;COL9A2;LUM;SMOC2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6208533421066655,-1.6371657024181094,0.005758157389635317,0.20259039630877262,1.0,10/19,12.38%,ROBO1;DCN;SEMA6A;CCBE1;JCAD;XDH;PIK3CB;DAB2IP;ADAMTS3;SMOC2
prerank,myelin maintenance (GO:0043217),0.7744770083916424,1.6365469592968176,0.036,0.6353918754242626,1.0,2/10,3.41%,PTEN;ABCD2
prerank,cellular sodium ion homeostasis (GO:0006883),0.7451584982138538,1.6364735109165827,0.04612159329140461,0.6293686623507267,1.0,5/15,4.90%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2
prerank,lymphocyte chemotaxis (GO:0048247),0.6318477204918604,1.6363430944880246,0.04159132007233273,0.6236682592405487,1.0,3/34,0.77%,CYP7B1;SLC12A2;PIK3CD
prerank,nucleotide catabolic process (GO:0009166),-0.6580306901119318,-1.6360075024334293,0.019083969465648856,0.20322776817762095,1.0,12/16,24.63%,XDH;SAMHD1;NT5E;DERA;NUDT3;GDA;GPX1;NT5C1A;PNP;VCP;NT5C2;NT5C
prerank,carnitine shuttle (GO:0006853),-0.7205868821550363,-1.6355290926315365,0.0248565965583174,0.20252347285235073,1.0,7/11,18.61%,PRKAG2;CPT1A;SLC25A20;CPT2;ACACA;PRKAA2;ACACB
prerank,cellular response to increased oxygen levels (GO:0036295),-0.7208503522754472,-1.6354027606953554,0.015748031496062992,0.20093941601109136,1.0,10/11,26.91%,FOXO1;CAV1;ATP6V1G1;ATP6V0A2;CCDC115;ATG7;TMEM199;FAS;ATP6AP1;ATP6V0D1
prerank,regulation of epithelial cell migration (GO:0010632),-0.520582415347756,-1.6353403907493784,0.0069605568445475635,0.1992947096039266,1.0,23/51,15.69%,MCC;DOCK5;GLUL;CTSH;PLCG1;MACF1;SASH1;BMPR2;ARSB;RAB11A;PTPRG;PRKCE;BMPER;RREB1;HIF1A;DAB2IP;PFN1;EVL;RHOJ;PLCG2;CORO1C;DUSP10;CEACAM1
prerank,regulation of biosynthetic process (GO:0009889),0.7786433010583911,1.6337766464348078,0.03171247357293869,0.6280603857707178,1.0,4/11,7.43%,SLC25A33;CCN6;SNCA;PIKFYVE
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5185289324799961,1.6331775140422946,0.0121580547112462,0.6243056807341315,1.0,20/109,10.50%,INPP4B;PDGFRB;PIP5K1B;PTEN;PIK3CD;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;INPP5B;MTMR7;FIG4;PLA2G4E
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6889245965475559,1.6314130894959635,0.038910505836575876,0.625049206136504,1.0,4/24,4.21%,PDE4D;CASQ2;DMD;AKAP6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7354439807115452,1.6313131094710231,0.04801670146137787,0.6195900741728102,1.0,6/14,10.38%,RAPGEF2;PRKAR1B;PKIA;PRKAR2B;PRKAR2A;PRKAR1A
prerank,lipid catabolic process (GO:0016042),0.7127972500651494,1.6308282835109087,0.06804123711340206,0.615372273788631,1.0,5/18,7.31%,CEL;PLA1A;LIPC;LIPH;PPT1
prerank,macrophage differentiation (GO:0030225),-0.694395253408626,-1.6288454137907926,0.013307984790874524,0.21122864581665685,1.0,5/13,10.39%,IL31RA;IL15;BMP4;CSF1;CASP8
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.536433996889907,-1.6284768181458493,0.010822510822510822,0.21021891782823876,1.0,9/38,14.61%,BMP6;SASH1;DDX60;USP15;IFI35;GBP5;PUM1;CYBA;CD180
prerank,cyclooxygenase pathway (GO:0019371),-0.7283522347956523,-1.6282501373562643,0.009242144177449169,0.20879558842954873,1.0,5/10,11.74%,PTGDS;PTGIS;PTGS1;TBXAS1;PTGS2
prerank,vascular transport (GO:0010232),0.5563938755147944,1.6269379566117166,0.01620745542949757,0.6246653576393849,1.0,15/81,5.23%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,cellular metal ion homeostasis (GO:0006875),0.535555582777791,1.6265171205143065,0.0093603744149766,0.6204207398787471,1.0,21/102,8.29%,ATP13A5;PTH1R;SLC12A2;ATP2A3;NEDD4L;ATP1A2;ATP2C1;ATP1A4;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;ATP1B2;ATP2A2;RYR2;HTR2C;CHRNA7;STC1;STIM1;STC2
prerank,primary alcohol metabolic process (GO:0034308),-0.5886117192623805,-1.6262587461773557,0.009596928982725527,0.2108520402892604,1.0,8/25,13.62%,IGF1;DHRS3;RBP4;GPD2;NAAA;CYP1B1;ALDH3A2;ADH1A
prerank,sensory perception of smell (GO:0007608),0.7540669309994107,1.6261141178143148,0.047619047619047616,0.616213005052385,1.0,3/11,6.90%,ADCY3;SLC24A4;UBR3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6512492849218511,1.625704642572659,0.0497131931166348,0.6121305271757954,1.0,3/28,2.86%,NOTCH3;CHAC1;TSPAN15
prerank,protein mannosylation (GO:0035268),-0.5931086577416165,-1.6255731966737972,0.01440329218106996,0.2105016560044351,1.0,5/22,7.47%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4802719262859304,-1.6252149509188512,0.005154639175257732,0.20946629650353826,1.0,15/63,5.29%,IGF1;WWOX;SP100;SH3RF1;CAV1;ITGA6;THBS1;BMP4;TGFBR1;DEPTOR;ACVR1;TCF7L2;CFLAR;TNFSF10;AR
prerank,regulation of endothelial cell migration (GO:0010594),-0.4639157012458875,-1.6245505172698942,0.0,0.2089850251517402,1.0,38/85,13.20%,ANXA3;NRP2;ROCK2;DCN;GLUL;FOXP1;NRP1;TEK;SP100;APOE;ADAMTS9;SLIT2;SPARC;SASH1;PTPRM;THBS1;BMP4;BMPR2;ANGPT1;FOXC2;FGF1;BMPER;ACVRL1;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;PRCP;DAB2IP;KDR;ZC3H12A;ITGB3;SMOC2;FLT4;RHOJ;ATOH8;CALR
prerank,smooth muscle contraction (GO:0006939),0.7301063661919519,1.6226896725825957,0.037894736842105266,0.6179292412332136,1.0,6/14,7.18%,EDNRA;MYLK;MYH11;ROCK1;SMTN;PIK3C2A
prerank,external encapsulating structure organization (GO:0045229),-0.4059303533133,-1.6224973251911239,0.0,0.2114132499476502,1.0,86/205,12.38%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;ADAMTS6;COL1A1;THSD4;DCN;ADAMTS2;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;JAM2;PECAM1;COL6A3;APP;ADAMTS9;RECK;SH3PXD2A;COL8A2;COL6A1;SPARC;ITGA6;ADAMTS5;VIT;BSG;ITGB8;MFAP5;COL4A5;COL6A2;THBS1;ITGA5;COL11A1;NID2;CDH1;FBLN5;VCAM1;ITGA3;COL4A6;COL23A1;HSPG2;COL13A1;BGN;SPOCK2;NDNF;ADAMTS1;ITGA10;ITGA11;ST7;TNC;DDR1;ADAMTS15;ICAM1;ADAMTSL1;CD47;GFOD2;FBN2;COL18A1;ADAMTSL4;ITGB4;TGFBI;COL14A1;ADAM15;LAMA5;MMP14;KDR;SLC39A8;MMP19;COL16A1;LAMA3;ITGB3;ADAMTS14;ADAMTS3;F11R;COL9A2;LUM;SMOC2
prerank,striated muscle contraction (GO:0006941),0.5864473884309539,1.6222657579316395,0.03904923599320883,0.6140001054032036,1.0,11/53,10.60%,CASQ2;DMD;ATP1A2;RCSD1;PIK3CA;SCN5A;RYR2;MYL3;KCNE5;STAC;SCN2B
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.5094343840445174,1.6205777673968043,0.009259259259259259,0.6150524521905866,1.0,23/119,10.57%,INPP4B;PIP5K1B;PTEN;PIK3CD;PIGU;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;ITPKB;SOCS5;PIGO;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;PIGZ;FIG4;SOCS6
prerank,pore complex assembly (GO:0046931),-0.6233068869979165,-1.6199848632942662,0.021696252465483234,0.2146854330820061,1.0,8/19,17.43%,AFDN;ADAM10;ANO6;PLEKHA7;GSDMD;P2RX7;NUP98;TPR
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5598975727580097,1.6196916678413826,0.024179620034542316,0.6131540483566549,1.0,10/76,6.47%,ANO1;PLCE1;PTH1R;GRM5;TACR1;CXCR2;GRM1;HTR2C;TRHR;OPRK1
prerank,ganglion development (GO:0061548),-0.7096635156198392,-1.6195357364174352,0.016483516483516484,0.21398399743736035,1.0,2/11,1.09%,NRP2;NRP1
prerank,muscle cell differentiation (GO:0042692),0.6346239008263557,1.6189892209086525,0.04672897196261682,0.6102083291107103,1.0,6/32,1.27%,GLMN;MEF2C;DMD;HEY2;RORA;SYNE1
prerank,focal adhesion assembly (GO:0048041),0.6856185963369,1.6185783595608132,0.04961832061068702,0.6065505867951481,1.0,4/21,2.11%,DLC1;PTPRK;PEAK1;FERMT2
prerank,B cell homeostasis (GO:0001782),0.7814465522083268,1.616843730814952,0.0625,0.6083028861938006,1.0,2/10,0.74%,MEF2C;DOCK10
prerank,transport across blood-brain barrier (GO:0150104),0.5523206563967735,1.6164424263866901,0.01468189233278956,0.604518773970169,1.0,15/83,5.23%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,negative regulation of stem cell differentiation (GO:2000737),0.7264053497105174,1.6157826968144358,0.058695652173913045,0.6017671685795304,1.0,6/12,13.69%,NOTCH1;TCF15;N4BP2L2;JAG1;YTHDF2;HNRNPU
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7626824497536369,1.6156609901062888,0.03711790393013101,0.5972216867216499,1.0,2/11,3.41%,SLC30A10;ABCD2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5863320571422991,1.615526554229923,0.021487603305785124,0.5928399780320366,1.0,6/55,2.55%,PDGFRB;ACE2;PID1;SLC25A33;CCN6;FOXM1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.5409208557188795,1.6153263900923263,0.017543859649122806,0.5886546464138084,1.0,15/85,4.99%,DLC1;STARD8;EPS8;PLCE1;NOTCH1;SPRY4;FOXM1;STARD13;CADM4;SH3BP1;PDCD10;RALGPS1;EPS8L1;SPRY2;OGT
prerank,presynapse assembly (GO:0099054),0.7142094813057703,1.6139732354552692,0.0471311475409836,0.5886212316919716,1.0,3/16,2.49%,PTEN;CEL;LRRTM3
prerank,positive regulation of ossification (GO:0045778),-0.5351864106489457,-1.613761597550267,0.00631578947368421,0.22446034173003454,1.0,20/39,15.74%,BMP6;ZBTB16;WNT4;BMP7;OSR1;BMP4;BMPR2;ADGRV1;ACVR1;WNT5A;ANO6;KL;FBN2;ATRAID;P2RX7;TGFB1;CCN1;TMEM119;PKDCC;BMPR1A
prerank,inositol phosphate metabolic process (GO:0043647),0.6046983806703816,1.6127521549448887,0.034926470588235295,0.5885378995143634,1.0,8/46,5.78%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;FGF2;ITPKB;INPP5J
prerank,vasoconstriction (GO:0042310),0.7678352998717954,1.6121839678039904,0.050505050505050504,0.5858245559921346,1.0,2/11,7.18%,EDNRA;PIK3C2A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7659374351004943,1.6118805733979549,0.04932735426008968,0.5823881678686639,1.0,3/11,1.03%,MEF2C;PIK3CD;RAPGEF2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6644731816957105,1.6111677806365157,0.0446927374301676,0.580434567155171,1.0,9/27,7.19%,CACNA1C;PDE4D;FGF13;CTNNA3;SCN5A;PDE4B;ATP2A2;RYR2;STC1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.7303538212538713,1.6110562150250747,0.05555555555555555,0.5763747528908268,1.0,2/13,0.51%,PDE4D;CASQ2
prerank,ureteric bud development (GO:0001657),-0.6425711117458939,-1.6107540367008204,0.023575638506876228,0.22900915816018483,1.0,7/17,6.87%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,cation transmembrane transport (GO:0098655),0.6074259048435531,1.6095280874227458,0.0248565965583174,0.5772833837238239,1.0,4/44,1.70%,ABCC9;KCNJ8;ATP1A2;CACNA1H
prerank,neuron projection extension (GO:1990138),-0.5523267144285715,-1.608836910467539,0.004228329809725159,0.23106944293209097,1.0,6/32,5.74%,ALCAM;AUTS2;NRP2;NRP1;IQGAP1;MAP1B
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.667758257694565,-1.6082512500834172,0.025,0.23046322028315552,1.0,7/13,16.01%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NNMT;PARP16
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.6990222449914414,-1.6070882520908052,0.020793950850661626,0.23112558145511747,1.0,5/11,7.70%,SLIT2;RIN3;CCN3;NBL1;DUSP1
prerank,cellular protein metabolic process (GO:0044267),-0.3702326437291832,-1.6068476337324076,0.0,0.2299078126000974,1.0,136/396,18.41%,IGF1;FBN1;FN1;FSTL1;IGFBP2;ST3GAL6;CTSH;IGFBP5;PCSK5;APOE;PAPPA;APP;ST3GAL1;CP;CPE;RPLP1;BMP4;RPS14;IGFBP6;YES1;ITIH2;CSF1;ADAM10;PHKA2;IGFBP4;IGFBP3;DENND3;GAS6;IGF2;PLOD2;WWP2;RPL9;VWA1;RPS12;SERPIND1;P4HB;RPL41;RPS20;TNC;RPL18A;RPS13;RPS19;ABCA3;RPS23;RPS4X;SRBD1;CALU;SEPHS1;CST3;DUSP12;MSLN;RPS11;RPL13;RPL18;RPL34;GOLM1;RPL32;EEF1A1;RPS9;MRRF;RPS8;RPL27A;RPL12;IDE;NOTUM;RPL37;DAB2IP;SFTPA2;SFTPA1;PRSS23;ST8SIA2;MXRA8;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;CCN1;LMCD1;CKAP4;RPS24;RPLP2;RPS27;RPL26;RPL14;GATA6;MRPS7;SPG7;F5;MRPS6;SPP1;UBE2G2;RPL10;SARS1;RPL7;SCG3;MSRB3;NEDD8;MRPS18A;LTBP1;MRPL52;RCN1;RPL10A;RPS6;FBXL2;HARS1;UBA3;APLP2;MRPL24;RPS15;RPL23;RPL17;RPL22;DNAJC3;RPL31;AFG3L2;PDIA6;MANBA;RPL15;UBA7;RIPK1;RPN2;SPCS1;RPSA;RPL38;RPS25;PSEN2;RPS7;RPLP0;QSOX1;MMP2;RPL27;UBE2M
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7117154658760141,-1.6044910154060916,0.023853211009174313,0.23305277423771675,1.0,5/11,17.36%,EGFR;BMP4;DDX5;TGFB1;RIPK1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.6413389460915243,-1.6041379144852688,0.019801980198019802,0.23207648324618774,1.0,7/17,10.16%,ROBO1;EFNB2;NRP1;SLIT2;EPHB4;AKT1;KDR
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4741780673271793,-1.603934100300976,0.007425742574257425,0.2307948046175742,1.0,12/61,8.24%,AUTS2;NOTCH2;IGF1;ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;ALS2;RAPGEF1;PIK3CB
prerank,ERBB signaling pathway (GO:0038127),0.553564276682637,1.603424128616884,0.023529411764705882,0.5945139336949332,1.0,10/64,3.05%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;ERBB4;NRG1;PIK3CA
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.4422436142174873,-1.6026839041207022,0.0,0.23137145628612144,1.0,25/108,10.19%,NXN;SULF1;TRABD2B;WWOX;VGLL4;APP;MDFIC;RSPO3;MACF1;ESR1;FGFR2;NKD1;NFATC1;LRRK2;ITGA3;RNF43;SKI;SULF2;SFRP4;RSPO2;TIAM1;FOXL1;FZD7;NOTUM;TLE1
prerank,potassium ion transport (GO:0006813),0.5159070918403099,1.6026661353319431,0.011976047904191617,0.5924933073428335,1.0,27/120,11.67%,ABCC9;KCNJ8;KCNJ12;ATP1A2;KCNG1;KCNMB1;KCNQ4;KCNV2;ATP1A4;KCND2;SLC24A4;SLC24A2;KCNH4;KCNH8;KCNAB3;KCNQ5;HCN2;KCNA4;SLC9A7;KCNQ3;PKD2;HCN3;KCNJ3;KCNJ6;HPN;KCNG2;KCNC4
prerank,positive regulation of glucose import (GO:0046326),-0.6000127881951847,-1.6025441637557662,0.022,0.22988164174020345,1.0,5/21,1.65%,SORBS1;IGF1;OSBPL8;OCLN;RHOQ
prerank,dendritic spine morphogenesis (GO:0060997),0.697657149359939,1.6018174359121267,0.061855670103092786,0.5911939595110585,1.0,3/15,3.97%,PTEN;DOCK10;WASL
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6989288741614271,1.6012589830764263,0.0811965811965812,0.588590252774513,1.0,4/16,4.21%,TRPC3;ROCK1;PDE9A;AKAP6
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7608228864317398,1.600985148987114,0.055793991416309016,0.58093633540796,1.0,4/11,5.78%,PTEN;IMPA2;INPP5A;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7608228864317398,1.600985148987114,0.055793991416309016,0.58093633540796,1.0,4/11,5.78%,PTEN;IMPA2;INPP5A;INPP5J
prerank,regulation of necroptotic process (GO:0060544),-0.5805720677802692,-1.5999027339477592,0.022587268993839837,0.23408083506069866,1.0,11/23,17.36%,ARHGEF2;CFLAR;SDCBP;PDCD6IP;BIRC3;SLC25A4;CASP8;FLOT2;YBX3;PELI1;RIPK1
prerank,regulation of tissue remodeling (GO:0034103),-0.6216783405248504,-1.5994576902884046,0.022813688212927757,0.2334352177289053,1.0,7/18,15.69%,LEPR;IL15;CST3;IL18;TGFB1;FLT4;CEACAM1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.6352935951478562,-1.596757699093424,0.02626641651031895,0.23786439232151502,1.0,6/16,9.38%,BMPR2;ACE;DDAH1;PLCB3;KLK2;PRCP
prerank,response to calcium ion (GO:0051592),0.5074407230415896,1.595423420487482,0.010954616588419406,0.5968146576048285,1.0,22/102,11.39%,TRPC3;CASQ2;MEF2C;TRPC1;RASGRP2;KCNMB1;ADCY8;PPP3CA;ITPKB;CPNE7;SLC25A13;SCN5A;RYR2;STIM1;SYT1;PKD2;RYR3;HPCA;SYT2;CPNE4;BRAF;CHP2
prerank,response to interleukin-1 (GO:0070555),-0.4640673295126226,-1.5950699314114627,0.0079155672823219,0.2396831040615924,1.0,21/73,15.34%,ADAMTS12;HDAC4;PTGIS;APP;IL1R1;ANXA1;IRAK2;LGALS9;CCL15;CD47;CCL14;HIF1A;DAB2IP;ZC3H12A;IRAK3;CCL25;RELA;TNFRSF11A;SFRP1;GBP2;CCL13
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.49785859527445286,-1.5937933940159912,0.013544018058690745,0.2408276950785144,1.0,15/51,7.14%,FBN1;FSTL1;SMAD6;SKIL;HTRA3;BMPR2;SMURF2;SMAD9;SMAD7;SKI;BMPER;GREM2;SMURF1;NBL1;VWC2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6228730895479013,-1.5931577942897903,0.030120481927710843,0.24047828674263066,1.0,9/18,15.59%,FN1;SMAD3;ITGB8;CD34;LGALS9;HIF1A;PTGS2;LTBP1;CD200
prerank,regulation of blood circulation (GO:1903522),0.6237282616809473,1.592501912737803,0.04945054945054945,0.6032491766929217,1.0,6/34,3.09%,ACE2;TBX2;KCNJ12;PER2;CACNA1H;ECE1
prerank,membrane depolarization during action potential (GO:0086010),0.6537862206703223,1.5923262040328405,0.05631067961165048,0.5995513936027755,1.0,10/26,10.60%,CACNA1C;ATP1A2;CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;CACNA1D;SCN9A;SCN2B
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5176634088375635,-1.5920164472317107,0.013856812933025405,0.2413487083255172,1.0,17/47,12.50%,ZBTB16;MEDAG;BMP7;TMEM64;SOX13;SIX1;SYAP1;NOCT;WDFY2;AKT1;RREB1;CMKLR1;CARM1;ZC3H12A;METRNL;PTGS2;ID2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.43893605069622366,-1.5919651597618014,0.0028328611898017,0.23981763210872228,1.0,29/95,12.83%,TGFBR3;DAB2;LDLRAD4;SMAD3;SMAD6;DKK3;SKIL;CAV1;HTRA3;TGFBR2;THBS1;SMURF2;TGFBR1;SNX6;SMAD7;LTBP4;ITGA3;SKI;SDCBP;SMURF1;PRDM16;FKBP1A;FLCN;EMILIN1;BCL9L;TGFB1;STRAP;PPARA;UBB
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6509917478776265,-1.5917887268258188,0.017716535433070866,0.23843229200229316,1.0,7/15,14.36%,EGFR;IGF1R;DDR1;PTK2B;BMX;KDR;MAPK3
prerank,polyol metabolic process (GO:0019751),0.5949907827626155,1.5908637244842645,0.038112522686025406,0.600510846111946,1.0,7/46,5.78%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;ITPKB;INPP5J
prerank,heart looping (GO:0001947),0.6110678844530578,1.5899219012143666,0.02772963604852686,0.5994583126574475,1.0,6/39,3.42%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,regulation of transmembrane transport (GO:0034762),0.6242227575758226,1.5890769154379214,0.04752851711026616,0.5983446407438318,1.0,4/31,1.14%,ACE2;KCNJ8;NEDD4L;KCNJ12
prerank,regulation of focal adhesion assembly (GO:0051893),0.5714678237018612,1.588501966830864,0.03204047217537943,0.5959877823261182,1.0,10/54,2.15%,DLC1;PTEN;LIMS1;ARHGAP6;PTK2;PEAK1;PHLDB2;VCL;FERMT2;ROCK1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.49854833718177954,1.5880448334102673,0.011594202898550725,0.5933638704696437,1.0,18/140,3.91%,DLC1;STARD8;CHN1;PLCE1;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;ARHGAP6;ARHGAP32;ARHGEF6;ARHGAP1;FOXM1;STARD13;ARAP2;SH3BP1;RAC3
prerank,protein localization to cell surface (GO:0034394),0.6564382452553066,1.5870590819346448,0.05019305019305019,0.5926446903073618,1.0,7/26,7.54%,PTPRK;PIGU;JAM3;VCL;GGA3;EMP2;FGF10
prerank,positive regulation of organelle organization (GO:0010638),-0.5396421582936659,-1.5862639539128571,0.019693654266958426,0.24889425419899086,1.0,17/32,19.81%,ANXA2;SORBS3;ANXA1;RAB3GAP1;IRGM;C2CD5;P2RX7;LMAN1;UVRAG;SURF4;PFDN2;SYNJ1;RAB3GAP2;ADRB2;STX18;PPARGC1A;TMED9
prerank,stabilization of membrane potential (GO:0030322),-0.6329164628710132,-1.585601175824516,0.01818181818181818,0.24872407501432975,1.0,2/16,2.73%,KCNK2;KCNK5
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.41768983720271835,-1.5848911601021245,0.0,0.24863241802716016,1.0,36/128,9.01%,BMP6;TGFBR3;ZMIZ1;COL1A2;SMAD3;COL3A1;SMAD6;CDH5;BMP7;CLDN5;TGFBR2;BMP4;BMPR2;SMURF2;TGFBR1;DDX5;SMAD9;SMAD7;ADAM9;PXN;ACVR1;ID1;PDCD4;SKI;RGMB;APPL2;ACVRL1;PRKCZ;SMURF1;RHOA;FKBP1A;HIVEP1;ZYX;USP15;PARD3;TMEM100
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4575726492951323,-1.5848267575124149,0.007731958762886598,0.24709628391115,1.0,20/74,8.87%,EYA2;IGF1;EYA1;SH3RF1;ITGA6;EYA4;NOS3;THBS1;BMP4;TGFBR1;ARHGEF2;ACVR1;TCF7L2;CFLAR;TNFSF10;AR;ICAM1;MAP2K5;AKT1;MCL1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5599745554492997,-1.582755337156816,0.018072289156626505,0.2498963262771965,1.0,12/25,17.80%,EPHA4;TAF1;PML;PRKCG;RPL11;TRIM39;HSP90AB1;HIPK2;RPL23;HFE;OPHN1;RPS7
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5684799792050702,-1.5827202254679695,0.02186878727634195,0.24829756519665344,1.0,9/23,15.58%,PRKAG2;BMP7;CEMIP;APP;CALM2;IRGM;TGFB1;SPHK1;CALM1
prerank,regulation of angiogenesis (GO:0045765),-0.39534698803035967,-1.5825747674899933,0.0,0.2469054500354209,1.0,59/192,11.15%,SULF1;ANXA3;FLT1;CDH5;ROCK2;DCN;GLUL;PTGIS;CTSH;TEK;SEMA6A;SP100;F3;SPARC;PLCG1;CLDN5;SASH1;ITGB8;NOS3;THBS2;PTPRM;THBS1;KLF4;RAMP2;CD34;HOXA5;VEGFD;HSPG2;VEGFC;NIBAN2;FGF1;NPR1;GTF2I;BMPER;ADAMTS1;PRKCB;WNT5A;FOXC1;RHOB;STAT1;SERPINF1;SEMA3E;CYP1B1;HK2;PIK3R6;TIE1;PPP1R16B;HGS;PLXND1;STAB1;ECM1;HIF1A;DAB2IP;KDR;ZC3H12A;EMILIN1;PML;GATA2;ECSCR
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.47863881327622537,-1.5824209294992913,0.011441647597254004,0.24560535220961194,1.0,13/56,6.22%,BMP6;DAB2;LDLRAD4;SMAD6;BMP7;BMP4;BMPR2;TGFBR1;SMAD7;ACVR1;SDCBP;BMPER;ACVRL1
prerank,regulation of vasoconstriction (GO:0019229),0.658280949296584,1.5813805935386382,0.04780876494023904,0.6080669632621359,1.0,5/27,3.09%,ACE2;TBXA2R;SMTNL2;PER2;ECE1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.6388002683867143,-1.5809762941738372,0.017578125,0.24702400554508805,1.0,7/15,16.18%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;SDC1
prerank,response to nitric oxide (GO:0071731),0.7319018048867847,1.5802560133112915,0.06852248394004283,0.6078140227505611,1.0,1/13,0.12%,GUCY1B1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5021709459920808,-1.58024650677563,0.002242152466367713,0.24693300561926287,1.0,21/48,13.47%,PLCG1;HDAC7;JCAD;NOS3;THBS1;ANGPT1;FOXC2;ANXA1;HDAC9;MAPK14;P2RX4;TMSB4X;AKT1;HIF1A;KDR;FGFBP1;GATA2;TGFB1;PTGS2;RHOJ;SRPX2
prerank,cardiac muscle contraction (GO:0060048),0.6173653443068003,1.580060097493388,0.046468401486988845,0.6043784640975658,1.0,8/34,7.85%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;MYL3;KCNE5
prerank,regulation of aerobic respiration (GO:1903715),0.7074371920566611,1.5794337735062212,0.06060606060606061,0.6024085400020822,1.0,3/15,3.66%,CBFA2T3;SLC25A33;ATP7A
prerank,vesicle transport along actin filament (GO:0030050),0.6824316782399936,1.5792702099524456,0.04408817635270541,0.5989473989033665,1.0,4/19,8.19%,MYO1B;WASL;ACTN4;MYO6
prerank,chloride transport (GO:0006821),0.5327650385999857,1.5773674694679911,0.026845637583892617,0.6017532483464716,1.0,9/74,6.30%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;SLC26A1;GABRG2;GABRA2;TTYH1
prerank,regulation of calcium ion transport (GO:0051924),0.5582144192436166,1.5760962917955887,0.03281519861830743,0.6022489615808896,1.0,13/54,12.56%,TRPC6;CACNB2;MYLK;EPB41;CACNA2D1;STIM2;STC1;CACNA1D;STIM1;PKD2;CASQ1;PACSIN3;SLC8B1
prerank,negative regulation of cartilage development (GO:0061037),-0.6863168292480362,-1.5760116463091285,0.03102189781021898,0.25458368013952604,1.0,4/13,4.38%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7190850169339054,1.5758456240291658,0.0598669623059867,0.599145314952125,1.0,2/16,0.30%,GUCY1B1;GUCY1A1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6370681091507253,1.5754693080744002,0.04474708171206226,0.5965495848215381,1.0,6/26,7.43%,SLC30A10;SLC25A33;CCN6;ABCD2;SNCA;PIKFYVE
prerank,negative regulation of T cell activation (GO:0050868),0.6057565391534209,1.5742731372182908,0.056466302367941715,0.5964310033724929,1.0,4/35,3.86%,GLMN;TNFRSF21;PTPN22;PAG1
prerank,neuron projection regeneration (GO:0031102),0.7561419261712538,1.5712108011699544,0.07488986784140969,0.6034701115490722,1.0,4/10,9.11%,RTN4RL1;PTN;DHFR;GAP43
prerank,negative regulation of biosynthetic process (GO:0009890),0.70481317862792,1.5711641401381335,0.05485232067510549,0.5997506799209574,1.0,3/16,3.41%,SLC30A10;GPER1;ABCD2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.43712349020149005,-1.570922308307136,0.007957559681697613,0.26491532716860927,1.0,27/87,8.63%,TGFBR3;ZMIZ1;COL1A2;SMAD3;COL3A1;SMAD6;CDH5;FMOD;CLDN5;TGFBR2;TGFBR1;SMAD9;SMAD7;ADAM9;PXN;ACVR1;ID1;SKI;APPL2;ACVRL1;PRKCZ;SMURF1;RHOA;FKBP1A;ZYX;USP15;PARD3
prerank,ethanol metabolic process (GO:0006067),-0.6726993379289672,-1.5708824590021544,0.03512014787430684,0.2633564036095191,1.0,3/12,13.62%,ALDH1A1;SULT1A1;ADH1A
prerank,vasculogenesis (GO:0001570),0.6224625089980114,1.5705758331098087,0.05350553505535055,0.5979117717666321,1.0,6/32,2.18%,PDGFRB;GLMN;HEY2;NOTCH1;TBX20;SPRED1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.40228128084758635,-1.5698619971233019,0.0,0.26401515341522536,1.0,38/151,15.04%,ST3GAL4;LARGE1;PLA2G4A;PLPP3;PAM;PCSK5;APOE;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;HACD3;LPCAT3;ACER3;CSNK1G2;GSTA4;GOLPH3;GSTM1;SPNS2;DEGS2;MGST1;ALAS1;GCH1;PLPP1;MFSD2A;GSTT1;ALDH3A2;SPHK1;LPIN3;SPTLC2;ASL;GSTM2;GCNT1;VAPA;TYW5
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.5353163690254057,-1.568972496848168,0.015250544662309368,0.26431334018369235,1.0,14/33,24.51%,IGF1;IAPP;TFRC;AKT1;FLCN;BNIP3;ADCK1;GPX1;PRELID1;VAT1;TMEM14A;BCL2L1;PRKN;PSMD10
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5381430966623363,-1.568820066991314,0.020161290322580645,0.26314448550858976,1.0,14/33,12.53%,CDH5;TEK;NUPR1;CAST;ANGPT1;TCF7L2;RAMP2;GAS6;NDNF;YAP1;ICAM1;KDR;GATA2;PPARA
prerank,amyloid fibril formation (GO:1990000),-0.48290243076815714,-1.5686887782087777,0.018912529550827423,0.2618370744303441,1.0,13/51,8.68%,TSPAN5;SNCAIP;GSN;APP;B2M;ADAM10;HSPG2;IAPP;FKBP1A;GGA2;H3-3A;CST3;TGFBI
prerank,determination of heart left/right asymmetry (GO:0061371),0.5984732855858116,1.5686693991812701,0.033101045296167246,0.6005425087896903,1.0,6/42,3.42%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,blood vessel diameter maintenance (GO:0097746),0.6255971461422392,1.567420321337677,0.04477611940298507,0.6008353897106425,1.0,7/34,3.98%,ACE2;EDNRA;PER2;GPER1;ROCK1;ECE1;ADCY6
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6963904849438917,1.567161675834211,0.06941431670281996,0.5979013464821118,1.0,3/15,2.72%,GGT5;GGT1;CHAC1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5042711979994868,1.5642179873977489,0.02527646129541864,0.6044968971095139,1.0,17/116,7.15%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY3;ADCY8;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.512241001766638,-1.56419588076026,0.022727272727272728,0.27088382581576576,1.0,19/40,15.74%,BMP6;WNT4;BMP7;OSR1;WNT6;BMP4;BMPR2;ADGRV1;ACVR1;ANO6;KL;FBN2;ATRAID;P2RX7;TGFB1;CCN1;TMEM119;PKDCC;BMPR1A
prerank,heart contraction (GO:0060047),0.5939926223105282,1.5638613218838795,0.04553734061930783,0.6019240632926626,1.0,9/41,7.85%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;SGCZ;MYL3;KCNE5
prerank,inositol phosphate catabolic process (GO:0071545),0.7334231303105541,1.5627387150571463,0.07203389830508475,0.6017297061524325,1.0,4/12,5.78%,PTEN;IMPA2;INPP5A;INPP5J
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6090106041882559,-1.5608030393233137,0.0311284046692607,0.27759971110700954,1.0,4/18,9.92%,IGF1;IGFBP2;IGF2;IL18
prerank,detection of calcium ion (GO:0005513),0.712100885495081,1.5593966077793773,0.06170212765957447,0.608682662322857,1.0,5/13,8.31%,CASQ2;KCNMB1;RYR2;STIM1;SYT1
prerank,sulfur compound transport (GO:0072348),-0.5541200318660654,-1.5587404160733123,0.019067796610169493,0.2807090363303402,1.0,10/27,16.68%,SLC13A4;SLC6A13;SLC6A6;SLC26A7;ABCG2;SLC5A6;MGST1;SLC35F3;SLC25A19;SLC25A26
prerank,amino acid import across plasma membrane (GO:0089718),-0.5552048673421373,-1.5574192636301551,0.014705882352941176,0.28205618137876476,1.0,9/24,6.84%,SLC6A13;SLC47A1;SLC1A3;SLC6A6;SLC16A2;SLC7A2;SLC6A9;SLC7A5;SLC22A4
prerank,positive regulation of cell communication (GO:0010647),0.6242203731678875,1.5574062503060964,0.051587301587301584,0.6115698713534669,1.0,10/28,12.53%,CLSTN1;NMU;RIMS1;CLSTN3;RIMS2;ANK3;SYT1;KCTD13;WLS;GRIK2
prerank,negative regulation of proteolysis (GO:0045861),-0.5200532308663751,-1.5567648899670758,0.024844720496894408,0.28194967878022636,1.0,9/34,9.24%,TIMP3;EPHA4;PTPN3;GAS1;TIMP2;LRRK2;CST3;AKT1;ECM1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.573610233006989,1.5567309503253433,0.04063604240282685,0.6101202133445541,1.0,8/45,3.05%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;PIK3CA
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4907707575989603,-1.5566430044857587,0.013636363636363636,0.280576634607357,1.0,12/49,9.92%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5810345231764945,1.5564707585865858,0.03304347826086956,0.6073820063929989,1.0,9/48,6.31%,PDE4D;CASQ2;DMD;TRPC1;GPER1;AKAP6;CXCL10;NPSR1;SNCA
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6191760446908763,-1.5563038273141339,0.03231939163498099,0.2798267331176379,1.0,6/16,4.66%,IGF1;IGFBP2;IGFBP5;IGFBP6;IGFBP4;IGFBP3
prerank,leukotriene metabolic process (GO:0006691),0.6695522924536302,1.556283819484851,0.06525911708253358,0.6042986606031867,1.0,2/19,0.90%,GGT5;GGT1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.7419306500463023,1.555091130829842,0.0772626931567329,0.6045890068077857,1.0,4/10,6.84%,RAPGEF2;ZEB2;ATP7A;APPL1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5575013782308337,-1.5542290487189294,0.038461538461538464,0.2833214083194949,1.0,6/24,10.71%,SORBS1;IGF1;ENPP1;IGF2;AKT1;PPP1R3B
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.6147161767891568,-1.553171570218565,0.029880478087649404,0.28399413747937025,1.0,5/17,6.25%,SULF1;FSTL1;SLIT2;ITGA3;SFRP4
prerank,calcium ion homeostasis (GO:0055074),0.5141842750930976,1.5528274152709343,0.0171875,0.608635151192258,1.0,18/95,8.29%,ATP13A5;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;TFAP2B;SNCA;ATP2A2;RYR2;HTR2C;CHRNA7;STC1;STIM1;STC2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5844446440096466,1.5528032754659726,0.0693950177935943,0.6051595116308571,1.0,13/41,12.63%,ACE2;GNG2;KCNJ12;KCNMB1;AKAP6;ANK3;PDZK1;KCNE5;STAC;KCNJ3;KCNJ6;PIRT;KCNMA1
prerank,regulation of keratinocyte migration (GO:0051547),0.717500880306544,1.5525361125501866,0.08421052631578947,0.602420618368799,1.0,5/12,8.26%,PTEN;MAPRE2;FGF10;MAP4K4;MTOR
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.4935427480040511,-1.552187216529213,0.015659955257270694,0.28481622519403427,1.0,19/45,18.71%,SMAD3;BMP7;PTPN3;TOM1L2;BMP4;GAS1;WEE1;TOM1L1;FOXC1;PLK2;CHFR;BTG3;NABP1;TGFB1;TRIM35;ZW10;CDKN1B;PRCC;ZFP36L2
prerank,dendritic cell migration (GO:0036336),0.6793422274731695,1.5520548333128508,0.049484536082474224,0.6005348571837026,1.0,2/16,5.82%,EPS8;CXCR2
prerank,anion transport (GO:0006820),-0.5187383554562532,-1.551708258808817,0.02832244008714597,0.28425450527034984,1.0,6/33,4.58%,SLC13A4;SLC13A3;SLCO2B1;SLC26A7;ABCG2;SLC22A6
prerank,positive regulation of axonogenesis (GO:0050772),-0.4991865836896221,-1.5510310406496712,0.018604651162790697,0.2842367356272512,1.0,11/43,10.75%,PLXNA2;ROBO1;TIAM2;PLXNA4;SLIT2;MACF1;SEMA7A;RHOA;TIAM1;PLXND1;ARHGDIA
prerank,xenobiotic transport (GO:0042908),-0.6024206699558918,-1.550945392624633,0.0311284046692607,0.2828929085315696,1.0,8/17,16.46%,SLC47A1;GJA1;ABCG2;SLC7A5;SLC22A4;ABCA3;SLC22A18;SLC22A2
prerank,base conversion or substitution editing (GO:0016553),0.7367773743015602,1.550872293191292,0.08260869565217391,0.6009874576835361,1.0,2/11,6.34%,APOBEC1;ADARB2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6962388378834197,1.5507946704300717,0.08114035087719298,0.5977881851270822,1.0,6/13,4.13%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6575163190867553,-1.5498519051189685,0.031835205992509365,0.2840737781041096,1.0,7/13,18.94%,SP100;MDFIC;APOD;SUFU;TPR;PARK7;CHP1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.46726005336360343,-1.549793231563447,0.019753086419753086,0.28258065759702755,1.0,26/63,20.86%,TIMP3;LEPR;PTPN3;NUPR1;TIMP2;DAP;RASIP1;STAT3;CST3;ATRAID;AKT1;MCL1;FOXK1;DAPL1;DAB2IP;ZKSCAN3;EIF4G3;MFSD2A;MET;RGP1;WASHC1;TIMP4;SIRT2;MT3;TBC1D14;CDK5RAP3
prerank,positive regulation of calcium ion import (GO:0090280),0.7362950270808045,1.5478927567372283,0.08280254777070063,0.6039542964335025,1.0,3/12,9.32%,PDGFRB;STC1;PDGFB
prerank,actin filament bundle organization (GO:0061572),0.6028161914492638,1.5471544582865437,0.07142857142857142,0.6030215341728016,1.0,4/33,1.11%,MYO1B;EPS8;CALD1;AIF1L
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5690696284810518,-1.5466094622255095,0.029469548133595286,0.28891444656054177,1.0,8/21,19.11%,IGF1;CTSH;LGALS9;KDR;KARS1;MAPK3;ZFP36L2;MT3
prerank,cell cycle checkpoint signaling (GO:0000075),-0.6694847590348872,-1.546485136397605,0.03766478342749529,0.2875053102082384,1.0,6/12,17.56%,WEE1;PLK2;CHFR;NABP1;ZW10;PRCC
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3703762454307749,-1.544996929129754,0.0,0.28953522306102913,1.0,139/306,31.16%,EXT1;ST3GAL4;LARGE1;APOE;RPLP1;RPS14;ST3GAL2;REV1;THRB;RPL9;RPS12;RPL41;PTMS;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;SRBD1;EEF1D;GOLPH3;POLR2A;RPS11;RPL13;RPL18;RPL34;RPL32;EEF1A1;RPS9;MRRF;RPS8;NR4A2;RPL27A;RPL12;RPL37;MMS19;RPS18;RPL11;EEF1B2;PWP1;ALAS1;RPS16;RPS5;RPL24;RPS15A;RPL39;MEF2A;RPL28;POLR2F;RPS24;RPLP2;RPS27;RPL26;ATM;RPL14;MRPS7;MRPS6;RPL10;SARS1;RPL7;DTX1;RPA1;MRPS18A;GCNT1;MRPL52;RAD50;RPL10A;RPS6;DBF4;HARS1;MRPL24;RPS15;RPL23;RPL17;RPL22;RPL31;POLR2E;RPL15;EEFSEC;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;GAL3ST2;RFC3;TYMS;E2F1;THAP1;RPL36A;TOP3A;POLE2;RPS26;MCM8;RPL35A;RMI2;CDC45;RPL8;RPS29;RPL36;RRBP1;BRCA1;POLR2G;RPA3;MRPL35;GTPBP2;EPC1;FARSB;PPP5C;ING4;ABCF1;RPL13A;HUS1;RPS3;POLA1;RRAGC;MRPL34;ALAS2;POLD1;MCM3;RPL29;RPL21;TOP1;ASMT;RPS2;EXT2;AGO2;B4GALT5;WRN;RPL19;MCM5;MCM10;EXO1;RPS21;EEF1A2;MRPL43;RPL23A
prerank,actin filament network formation (GO:0051639),0.7217253403426007,1.544082961060762,0.07773109243697479,0.6096362889302297,1.0,3/11,7.30%,CARMIL1;SPIRE1;PLS3
prerank,myotube cell development (GO:0014904),-0.7086234113218914,-1.5432306856513196,0.029906542056074768,0.2924387736995204,1.0,4/10,13.88%,IGF1;SKI;SIX1;CAV2
prerank,positive regulation of lipid transport (GO:0032370),-0.6601185266012685,-1.5431775488389283,0.045275590551181105,0.290934494996161,1.0,5/12,21.47%,APOE;ABCA3;SPP1;PRELID1;DBI
prerank,cellular response to leucine (GO:0071233),0.7329926354314769,1.5428934338094422,0.07407407407407407,0.6066463020667207,1.0,4/10,12.05%,UBR1;SESN3;MTOR;UBR2
prerank,response to leucine (GO:0043201),0.7329926354314769,1.5428934338094422,0.07407407407407407,0.6066463020667207,1.0,4/10,12.05%,UBR1;SESN3;MTOR;UBR2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.6565974592391135,-1.5425672311846987,0.038112522686025406,0.29059160796378236,1.0,4/12,8.79%,SORBS1;IGF1;IGF2;AKT1
prerank,embryonic digit morphogenesis (GO:0042733),0.6769023177512119,1.5423316148816182,0.06679389312977099,0.6050625108457021,1.0,4/18,3.09%,TBX2;MAP3K20;TBX3;ECE1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5994883171262251,1.5397245778167932,0.06498194945848375,0.6103420359954733,1.0,17/32,18.08%,NEDD4L;RAPGEF2;SDC2;HECW2;CHRNA3;CAPRIN2;IL1RAPL1;ADGRB3;HECW1;SARM1;CUX2;LZTS1;CHRNB2;GSK3B;NSMF;GORASP1;KNDC1
prerank,regulation of platelet activation (GO:0010543),-0.5819155473889152,-1.5393495280216918,0.028282828282828285,0.2972616231601197,1.0,5/21,3.28%,PDGFRA;PLA2G4A;APOE;NOS3;THBD
prerank,hemopoiesis (GO:0030097),-0.42407889312198493,-1.5389164679558773,0.008426966292134831,0.2967541347997224,1.0,24/87,15.19%,TGFBR3;NOTCH2;FLT1;ZBTB16;MECOM;TEK;MFAP5;TGFBR2;FGFR2;BMP4;CD34;ETV6;WNT5A;KIT;KDR;FLCN;CD164;MKNK2;TGFB1;FLT4;FLT3LG;TAL1;SFRP1;ZFPM1
prerank,endocardial cushion development (GO:0003197),0.6391997786779345,1.5382893417284762,0.09552845528455285,0.6116614269332279,1.0,4/21,1.24%,TBX2;HEYL;NOTCH1;TBX20
prerank,translation (GO:0006412),-0.3836764066137822,-1.5373447029829204,0.00390625,0.29907392770400854,1.0,91/208,25.69%,RPLP1;RPS14;LARS2;RPL9;RPS12;RPL41;RPS20;RPL18A;RARS2;RPS13;RPS19;RPS23;RPS4X;SRBD1;EEF1D;RPS11;RPL13;RPL18;RPL34;RPL32;EEF1A1;RPS9;MRRF;RPS8;RPL27A;RPL12;RPL37;KARS1;RPS18;RPL11;EEF1B2;RPS16;RPS5;RPL24;RPS15A;RPL39;CARS1;RPL28;RPS24;RPLP2;RPS27;RPL26;RPL14;MRPS7;RWDD1;QARS1;MRPS6;RPL10;SARS1;RPL7;MRPS24;MRPS18A;MRPL52;RPL10A;RPS6;HARS1;MRPL24;RPS15;RPL23;RPL17;RPL22;RPL31;RPL15;EEFSEC;MARS2;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27;RPL36A;DRG2;FARSA;FTSJ1;RPS26;RPL35A;RPL8;APEH;RPS29;RPL36;TRMT112;RRBP1;PPA1;MRPL35;GTPBP2;FARSB;TMA7;ABCF1;RPL13A;RPS3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6846171515188,1.5371357853221819,0.061386138613861385,0.6121212535681483,1.0,5/18,4.13%,ITGA4;MEF2C;COL4A3;AKT3;FGF2
prerank,negative regulation of heart contraction (GO:0045822),0.7455679085569058,1.5356908016360495,0.09029345372460497,0.6134699082413586,1.0,2/11,1.25%,PDE4D;ATP1A2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.7212766207110519,1.5352862633473594,0.08842105263157894,0.6114354956865287,1.0,3/11,3.45%,NR1H3;SCARB1;LDLR
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.46104079592579017,-1.5352617748481312,0.01909307875894988,0.3025311766522009,1.0,15/66,3.56%,NFIB;TGFBR3;MCC;SULF1;ROBO1;MTSS1;APOE;CAV1;SPARC;NUPR1;XDH;FGFR2;PTPRM;THBS1;B2M
prerank,regulation of cell killing (GO:0031341),-0.5966801370769603,-1.534332364732137,0.03653846153846154,0.30324370266662143,1.0,6/16,13.16%,CD55;CFH;WNT5A;ICAM1;FZD7;CYBA
prerank,cellular response to inorganic substance (GO:0071241),0.6543477206645792,1.5338664171633545,0.06692913385826772,0.6125965454424369,1.0,1/21,0.12%,GUCY1B1
prerank,epithelial cell differentiation (GO:0030855),-0.4236992043981264,-1.5327849446175053,0.005649717514124294,0.3056051744128113,1.0,21/88,16.15%,DAB2;MAF;FSTL1;ANXA4;FGFR2;BMP4;ANXA1;CPT1A;CNN3;SIX1;TBX1;AKT1;CTSB;FZD7;KDR;ANXA7;HDAC1;GATA6;BDH2;CASP6;KDM6B
prerank,apical junction assembly (GO:0043297),-0.4793054822577554,-1.5327194474714647,0.02493765586034913,0.30416010456681536,1.0,15/53,11.81%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;RHOA;CLDN11;PARD3;CTNNA1;PATJ;F11R
prerank,activin receptor signaling pathway (GO:0032924),-0.6285991572979566,-1.5326860823776038,0.04604051565377532,0.3026300139406442,1.0,3/15,4.20%,SMAD3;TGFBR1;ACVR1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6466700518180822,1.5326137346301656,0.07920792079207921,0.6133126067888612,1.0,5/24,2.35%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,cell-matrix adhesion (GO:0007160),0.5074882111669481,1.5325752177049716,0.020061728395061727,0.6101999812282709,1.0,12/95,3.44%,DLC1;PTPRK;ITGA1;ITGA4;ITGA7;ECM2;VTN;PEAK1;VCL;FERMT2;CD96;ITGB5
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6404261586010538,1.5325576713258076,0.08130081300813008,0.607049557057499,1.0,5/22,7.82%,DYNLL1;ROCK1;TESK1;ANKLE2;CDKN1A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7104411200385383,1.5323159424435844,0.08210526315789474,0.6046013010801252,1.0,2/12,1.88%,PTEN;BTRC
prerank,central nervous system myelination (GO:0022010),0.7230550918872577,1.5322835416115024,0.08733624454148471,0.6015640608624636,1.0,4/11,9.93%,PTEN;B4GALT6;TENM4;PLP1
prerank,actin filament-based transport (GO:0099515),0.6430236457701957,1.532257007981905,0.07142857142857142,0.5985582946366949,1.0,4/21,8.19%,MYO1B;WASL;ACTN4;MYO6
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.43183199016560864,-1.5322233464708293,0.0,0.30226551133869334,1.0,30/88,12.97%,SULF1;NRP2;NRP1;TEK;APOE;F3;CAV1;SPARC;XDH;PTPRM;THBS1;BMP4;BMPR2;TGFBR1;ANGPT1;VEGFD;VEGFC;ACVRL1;WNT5A;STAT1;TIE1;PPP1R16B;AKT1;ECM1;HIF1A;CDH13;KDR;ITGB3;FLT4;ATOH8
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.5998437608956529,1.5321945574424312,0.0718232044198895,0.5956249806000237,1.0,4/33,1.66%,PTEN;MEF2C;PRKG1;GPER1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.4916083937056728,-1.5311800120873753,0.032719836400818,0.30340429417953063,1.0,16/43,12.78%,BMP6;IGF1;WNT4;BMP7;IL6R;BMP4;BMPR2;IL6ST;ACVR1;ZHX3;YAP1;FBN2;ATRAID;CCN4;CCN1;TMEM119
prerank,response to metal ion (GO:0010038),0.5314867439360338,1.5308143244294883,0.044722719141323794,0.5967965591833885,1.0,6/67,6.31%,TRPC3;NEDD4L;TRPC1;PPP3CA;SLC25A13;SNCA
prerank,response to iron ion (GO:0010039),-0.6598573761297524,-1.5299205634516866,0.049429657794676805,0.304809885189775,1.0,4/12,9.33%,BMP6;B2M;ACO1;HIF1A
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4966225624353992,1.5297903106350983,0.028662420382165606,0.5969939807510216,1.0,17/117,7.15%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY3;ADCY8;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,endocardial cushion morphogenesis (GO:0003203),0.6653510385256145,1.5296491532858254,0.08936170212765958,0.5944308707528728,1.0,4/18,1.24%,TBX2;HEYL;NOTCH1;TBX20
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7135047462417293,1.5295391326044445,0.09745762711864407,0.5917446842318644,1.0,2/10,1.47%,CARMIL1;SEMA5A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5977080434841001,1.5289774441211406,0.07170542635658915,0.5907518236047553,1.0,5/35,7.31%,SGIP1;VTN;LDLRAP1;IL4;PPT1
prerank,cellular response to heat (GO:0034605),0.5897917653341499,1.5284025063608422,0.07536764705882353,0.5894962828471182,1.0,1/35,0.04%,ANO1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.6451001925438098,-1.528401907335577,0.04436229205175601,0.3068592712058206,1.0,4/13,8.79%,SORBS1;IGF1;IGF2;AKT1
prerank,regulation of interleukin-12 production (GO:0032655),-0.49406353275490245,-1.5240588364740693,0.015555555555555555,0.31606866650755017,1.0,15/47,22.36%,PLCB1;FOXP1;THBS1;IL16;LGALS9;MAPK14;CD47;CMKLR1;MAST2;IRAK3;PLCG2;TLR4;SYK;MDK;CCL19
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6606246809317841,-1.5238540032691135,0.04150943396226415,0.31489045022654544,1.0,7/12,21.04%,PTPN14;BMP4;IFI27;TGFB1;SIRT7;TPR;NUP214
prerank,clathrin coat assembly (GO:0048268),0.675959170315296,1.5227043720633868,0.07775377969762419,0.6046173187354685,1.0,4/15,10.46%,SGIP1;PIK3C2A;AP2S1;HIP1
prerank,tube closure (GO:0060606),0.6008632715552336,1.5219015784827532,0.06666666666666667,0.6041816681536712,1.0,3/31,2.47%,DLC1;VASP;GRHL3
prerank,positive regulation of bone mineralization (GO:0030501),-0.5130334955608783,-1.520990189086295,0.032719836400818,0.320678784822268,1.0,18/35,15.74%,BMP6;WNT4;BMP7;OSR1;BMP4;BMPR2;ADGRV1;ACVR1;ANO6;KL;FBN2;ATRAID;P2RX7;TGFB1;CCN1;TMEM119;PKDCC;BMPR1A
prerank,actin filament bundle assembly (GO:0051017),0.599447277915361,1.5209893217160975,0.07879924953095685,0.6040893369547119,1.0,4/33,1.11%,MYO1B;EPS8;CALD1;AIF1L
prerank,sphingolipid metabolic process (GO:0006665),-0.4166205247090542,-1.520592195668051,0.008902077151335312,0.32000970206215723,1.0,46/108,26.97%,PLPP3;SGMS1;ESYT2;CERT1;SGMS2;ST6GALNAC3;ELOVL7;ACER2;SMPD3;HACD4;HACD3;HEXA;HEXB;ACER3;CSNK1G2;NSMAF;SPNS2;PSAP;B3GALNT1;DEGS2;ST6GALNAC6;PLPP1;ESYT3;PLA2G15;ALDH3A2;SPHK1;SPTLC2;UGCG;VAPA;SUMF2;SERINC1;CLN8;ELOVL1;NEU3;GLB1;ORMDL3;ENPP2;PPM1L;SUMF1;ORMDL2;SGPL1;SPTSSA;PDXDC1;GLA;GAL3ST1;PLPP2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5143314739056114,-1.5205760148618443,0.035940803382663845,0.31844101855060536,1.0,13/35,12.29%,ZMIZ1;RBFOX2;NR3C1;ESR1;NR3C2;DDX5;AR;TMF1;YAP1;EGLN2;PGR;KDM3A;PLPP1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6756105133788384,1.5198912035667727,0.10625,0.6045806329499929,1.0,6/17,7.85%,KCNJ8;NEDD4L;KCNE4;SCN5A;RYR2;KCNE5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5524246408420004,1.5193828105218226,0.05391304347826087,0.6032315775858259,1.0,9/48,7.15%,GUCY1B1;GUCY1A1;GUCY2D;ADCY3;ADCY8;ADCY6;SLC26A1;ADSL;ADCY9
prerank,negative regulation of angiogenesis (GO:0016525),-0.4260053495757159,-1.5191336618485425,0.005376344086021506,0.320282350486732,1.0,30/84,11.15%,SULF1;ROCK2;DCN;TEK;SEMA6A;ADAMTS9;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;KLF2;HOXA5;HSPG2;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;PIK3CB;HGS;STAB1;DAB2IP;EMILIN1;PML;ECSCR
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6609038272666872,-1.5190558159717544,0.050724637681159424,0.3188672526978336,1.0,5/11,8.24%,SEMA6A;ADAMTS9;THBS1;KLF2;PIK3CB
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.581465964910342,1.5175303946787484,0.06884057971014493,0.6059524266093582,1.0,2/35,0.19%,ITGA1;PDGFRB
prerank,defense response to tumor cell (GO:0002357),0.7253765223535406,1.5168156748992787,0.09292035398230089,0.6053222271615271,1.0,2/10,1.38%,DLEC1;RBMS3
prerank,regulation of peptide hormone secretion (GO:0090276),0.5203967427392461,1.5159890521136505,0.04363636363636364,0.6049086457743252,1.0,19/67,13.84%,CACNA1C;RAPGEF4;PER2;ITPR2;IL1B;FFAR2;GIPR;ITPR1;SNAP25;TFAP2B;HTR2C;RAP1A;CACNA1D;GCK;CACNA1A;KCNG2;SLC8B1;RASL10B;KCNS3
prerank,regulation of autophagosome maturation (GO:1901096),-0.6261022893424565,-1.5152593645971484,0.04672897196261682,0.32699375548564963,1.0,6/13,17.77%,CLEC16A;IRGM;PHF23;UVRAG;TBC1D25;ADRB2
prerank,glutathione biosynthetic process (GO:0006750),0.7062502133238373,1.5150667255173407,0.10044642857142858,0.6048839116842935,1.0,2/11,2.72%,GGT1;CHAC1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6284755018847257,1.5144076377232687,0.07768924302788845,0.6041358614746534,1.0,2/26,3.82%,ANO1;ADCY8
prerank,pinocytosis (GO:0006907),0.7547186934903691,1.5143060282734349,0.09111111111111111,0.6016157755439712,1.0,2/10,7.31%,CARMIL1;PPT1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5398097351712859,-1.5137546686348504,0.045454545454545456,0.32945554715345415,1.0,5/26,1.65%,SORBS1;IGF1;OSBPL8;OCLN;RHOQ
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6050638646382341,-1.513356972883405,0.055984555984555984,0.3287905768274631,1.0,6/15,28.67%,MOXD1;DDC;SAT1;SRM;SMOX;ASMT
prerank,lipid modification (GO:0030258),0.579717176909024,1.5126146065872048,0.061452513966480445,0.6038245575793473,1.0,5/37,3.81%,DGKB;MBOAT2;DGKH;DGKG;PLPPR5
prerank,positive regulation of signal transduction (GO:0009967),-0.3688675239180731,-1.5124135253708897,0.0,0.3296621785560372,1.0,54/238,11.23%,TSPAN5;BMP6;SULF1;SORBS1;IGF1;ROBO1;ZMIZ1;NTRK3;NRP1;PTGIS;VWF;TEK;CCBE1;F3;LIMS2;RSPO3;MACF1;JCAD;SHANK3;SASH1;FGFR2;NOS3;IL6ST;ITGA5;TGFBR1;KAT2B;LRRK2;KLF2;SKI;SMO;GAS6;IGF2;MN1;FGF1;CCN3;SULF2;SLC39A14;BMP2K;YAP1;PRKCZ;RSPO2;PRKCB;PTK2B;STAT3;EVC;TTC23;HIF1A;TRIM16;NLGN2;DAB2IP;POGLUT1;ERN1;VPS35;ITGB3
prerank,positive regulation of endocytosis (GO:0045807),0.5583483132854761,1.5123022177092371,0.06,0.6018457334778354,1.0,10/45,7.31%,SGIP1;NEDD4L;VTN;LDLRAP1;AXL;GPC3;IL4;CBLL1;SNCA;PPT1
prerank,regulation of glucose import (GO:0046324),-0.5276718528896852,-1.511974289593917,0.04149377593360996,0.3291549268820014,1.0,7/30,2.43%,PRKAG2;SORBS1;IGF1;OSBPL8;OCLN;RHOQ;ENPP1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.5768993132685755,1.5110243060801118,0.0616822429906542,0.603067996248435,1.0,9/39,7.85%,TRPC6;UTRN;NEDD4L;FGF12;FXYD2;STK39;PDZK1;CACNA1D;KCNE5
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5732362692840064,1.510693787352624,0.056140350877192984,0.6012981729408812,1.0,8/42,4.32%,LIMS1;ECM2;GCNT2;NOTCH1;PTK2;NF1;CORO2B;MINK1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6616988013313034,1.5102649434048983,0.09090909090909091,0.5998178421780502,1.0,10/17,20.66%,KCNG1;KCNE4;AKAP6;ANK3;KCNE5;RNF207;SUMO1;VAMP2;KCNS2;KCNAB1
prerank,regulation of muscle contraction (GO:0006937),0.6173087597613214,1.509757062256609,0.0945945945945946,0.5983882250270122,1.0,4/26,3.44%,PLCE1;ATP1A2;MYL9;CHRNA3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.574990813271936,1.5096922362960399,0.07007575757575757,0.5958319247301181,1.0,15/39,11.99%,UTRN;DMD;NEDD4L;HECW2;FGF12;FXYD2;STK39;FGF13;ANK3;HECW1;NETO1;SCN2B;RANGRF;FGF11;FGF14
prerank,B cell receptor signaling pathway (GO:0050853),0.6025506059439378,1.5096072652135442,0.06857142857142857,0.593384676407981,1.0,4/32,2.28%,MEF2C;PIK3CD;BCAR1;RFTN1
prerank,neural crest cell differentiation (GO:0014033),0.6706544305825791,1.5093061853831353,0.09267241379310345,0.5916584642140988,1.0,5/18,9.62%,MEF2C;CDH2;NRG1;KLHL12;SNAI2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5827678839511241,1.508620451191535,0.08029197080291971,0.5910762447062959,1.0,9/33,7.18%,PTEN;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;NYAP2;IRS1;PIK3C2A
prerank,primary neural tube formation (GO:0014020),0.6039992263186718,1.5082154852816545,0.07169811320754717,0.5897141765826899,1.0,3/30,2.47%,DLC1;VASP;GRHL3
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6328017575299684,1.5078685399184422,0.0741444866920152,0.5880076062754523,1.0,4/20,3.73%,CASQ2;NEDD4L;HECW2;STK39
prerank,aorta development (GO:0035904),0.6668941121134891,1.5076011814318269,0.12240663900414937,0.5861965679615321,1.0,7/14,10.07%,PDGFRB;TBX2;TFAP2B;ROBO2;PKD2;JAG1;EFEMP2
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.3905300238357436,-1.507069932845509,0.0031545741324921135,0.34078039688953665,1.0,37/132,13.73%,IGF1;DAPK1;DCN;VGLL4;FOXO1;APOE;FOXO3;APP;EZR;SNX9;ADAM9;LRRK2;CNOT7;TPCN1;MOV10;TNFRSF1B;PLK2;PRKCD;DAGLB;PIK3CB;DTX3L;IRGM;HIF1A;ATF6;FLCN;ZC3H12A;OPTN;P2RX7;VPS35;TRIM27;SH3GLB1;PPARA;GRSF1;ENTPD5;CNOT8;BNIP3;TICAM1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6463945205008275,1.506965357206767,0.08811475409836066,0.5853947379182309,1.0,5/18,7.85%,NEDD4L;ATP1A2;STK39;BIN1;KCNE5
prerank,regulated exocytosis (GO:0045055),-0.37906804482866113,-1.5066908534850618,0.009900990099009901,0.34021918389121425,1.0,42/173,15.84%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;VWF;SERPING1;PECAM1;ACTN2;APP;PCDH7;SPARC;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;GAS6;IGF2;SRGN;ARHGAP17;TMSB4X;ECM1;PSAP;STX1A;ITGB3;LGALS3BP;TGFB1;ACTN1;RAB11FIP1;F5;APOOL;SCG3;RAB11FIP5;APLP2;CD109;CALM1;SERPINE1;SYTL4
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.675683532498141,-1.5062186579345789,0.04293381037567084,0.338296617354867,1.0,8/10,28.66%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.675683532498141,-1.5062186579345789,0.04293381037567084,0.338296617354867,1.0,8/10,28.66%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,fatty acid transmembrane transport (GO:1902001),-0.5869621896021131,-1.5061764952769912,0.0326530612244898,0.3367676446021269,1.0,6/19,10.05%,PRKAG2;SLC2A1;CPT1A;SLC25A20;CPT2;ACACA
prerank,sensory organ development (GO:0007423),-0.46881503905003963,-1.5049285895110698,0.036613272311212815,0.3385187027626526,1.0,13/51,17.12%,PBX1;SMOC1;CHD7;SHROOM2;PBX3;RBP4;FOXC1;STRA6;ATF6;MEIS2;HIPK2;RAB18;MEIS1
prerank,regulation of feeding behavior (GO:0060259),0.7100944951693424,1.5044179033731155,0.09772727272727273,0.5905718475077862,1.0,1/11,0.11%,SGIP1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.5001536635743284,-1.5043869926901785,0.02252252252252252,0.33822321192659943,1.0,13/40,16.21%,SORBS1;WNT4;APOE;VIM;BMP4;RAB27A;AKT1;TGFB1;PPARA;CYBA;PLCG2;TLR4;CREB3L1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6584283851233154,1.5035479649611072,0.0865979381443299,0.5905571082369987,1.0,5/17,7.88%,IL34;NOTCH1;PTN;BIN1;TENM4
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6288429822052671,1.503378528239071,0.09292929292929293,0.5884922484831703,1.0,7/22,12.13%,PTEN;HEXIM1;CDKN1A;NR2F2;INCA1;LATS2;APC
prerank,blood vessel endothelial cell migration (GO:0043534),-0.5670737072822405,-1.5032079432948842,0.026262626262626262,0.3397678864424417,1.0,9/22,10.16%,ROBO1;EFNB2;CDH5;NRP1;SLIT2;EPHB4;ID1;AKT1;KDR
prerank,atrioventricular valve development (GO:0003171),0.6708096675853203,1.5030717224569692,0.10082304526748971,0.5867927941560002,1.0,4/14,1.75%,HEYL;NOTCH1;TBX20;SLIT3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6705041005595604,-1.502938444700026,0.04397705544933078,0.3388597149712621,1.0,6/11,13.42%,TGFBR2;FGFR2;WNT5A;STAT1;TBX1;CHRD
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.6142568659597868,1.5023300814915455,0.08678500986193294,0.5863477782347948,1.0,5/27,2.35%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,mesenchyme development (GO:0060485),-0.6154068579243825,-1.501370258392244,0.0670391061452514,0.3415748025180382,1.0,5/15,3.54%,BMP7;FGFR2;BMP4;BMPR2;TGFBR1
prerank,negative regulation of cellular component movement (GO:0051271),-0.6113398948647998,-1.4992873675591267,0.044061302681992334,0.34567936339496713,1.0,7/15,14.19%,TGFBR3;FBLN1;SP100;CD9;CCDC125;ACTN1;FRMD5
prerank,activation of adenylate cyclase activity (GO:0007190),0.5719931198029663,1.4987764023176802,0.06776556776556776,0.5942216557220464,1.0,8/35,7.52%,EDNRA;CAP2;GIPR;ADCY3;ADCY8;ADCY6;ADCY9;CAP1
prerank,lung epithelium development (GO:0060428),-0.6668161681411153,-1.498190912897844,0.043557168784029036,0.34702788606836565,1.0,5/10,14.65%,ERRFI1;BMP4;RCN3;STRA6;PKD1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6696981065228924,-1.4978739245694814,0.05056179775280899,0.3446623474325615,1.0,3/10,7.36%,KLF4;WNK1;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6696981065228924,-1.4978739245694814,0.05056179775280899,0.3446623474325615,1.0,3/10,7.36%,KLF4;WNK1;MAP2K5
prerank,artery morphogenesis (GO:0048844),0.6078033460069256,1.4975012196306428,0.08897485493230174,0.5954590018143096,1.0,5/30,2.16%,PDGFRB;TBX2;HEY2;NOTCH1;NF1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5675284413867462,1.4960449510622813,0.06055363321799308,0.5973647073704031,1.0,6/43,3.42%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5748888916429784,-1.495471234453554,0.0637065637065637,0.3497634045599109,1.0,5/19,7.36%,APP;KLF4;SLCO1C1;KLF2;MAP2K5
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.568047723385591,-1.49506179312391,0.05976095617529881,0.3491819809891001,1.0,9/20,17.36%,NUPR1;CFLAR;SDCBP;PDCD6IP;BIRC3;CASP8;FLOT2;PELI1;RIPK1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6845997736838735,1.4947351803277653,0.10805500982318271,0.5986849963344798,1.0,5/13,18.10%,PIGU;PTPRT;MGAT5;JAK2;TSLP
prerank,cellular component disassembly (GO:0022411),-0.4631810785317504,-1.4937260366924678,0.009478672985781991,0.35123808590002203,1.0,16/53,12.18%,GSN;ADAMTS5;TLL1;BSG;TIMP2;CAPN2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;ADAM15;CAPN1;MMP14;MMP19;CTSS
prerank,aggrephagy (GO:0035973),0.6088975203194623,1.4935273237107944,0.07518796992481203,0.5996707597471649,1.0,1/27,0.06%,DYNLL1
prerank,regulation of T cell migration (GO:2000404),-0.5873573460432568,-1.492908353256401,0.045454545454545456,0.35173050101685793,1.0,5/18,6.67%,APP;APOD;LRCH1;CXCL12;RHOA
prerank,purine-containing compound catabolic process (GO:0072523),-0.6348120793539067,-1.492627105213191,0.052336448598130844,0.3509240390161663,1.0,9/13,24.63%,XDH;DPYD;NT5E;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,regulation of exosomal secretion (GO:1903541),-0.559318705777531,-1.491989443317979,0.045627376425855515,0.35098719986998295,1.0,8/19,16.18%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;ATP9A;RAB7A;SDC1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.450180178333941,-1.4919040390788179,0.014184397163120567,0.34965813987281325,1.0,13/57,9.92%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;CNOT7;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,activation of protein kinase B activity (GO:0032148),-0.5199585901232648,-1.4908504644386462,0.032467532467532464,0.3510381594192135,1.0,13/29,19.11%,IGF1;NTRK3;OSBPL8;GAS6;FGF1;WNT5A;AKT1;IL18;TXN;PPIA;PDPK1;PARK7;MT3
prerank,axon development (GO:0061564),0.5166465867820033,1.4908464846029863,0.04433497536945813,0.6049505244007759,1.0,19/78,10.95%,GRM7;RTN4RL1;SEMA5A;SVBP;DHFR;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;MARK2;SLITRK1;ARHGAP35;GAP43;PLP1;CTNNA2;BRSK1;PAK3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.4349511669721624,-1.4907802056317352,0.024930747922437674,0.34969113312356326,1.0,22/71,17.05%,LARGE1;PLPP3;SGMS1;CERT1;SGMS2;ELOVL7;ACER2;A4GALT;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA;ST3GAL5;CLN8;ELOVL1
prerank,rRNA metabolic process (GO:0016072),-0.38010000414648915,-1.4906154517414987,0.016025641025641024,0.3485214208646167,1.0,64/160,23.84%,RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;RPL13;UTP14A;RPL18;RPL34;RPL32;KRR1;RPS9;UTP11;RPL27A;RPL12;RPL37;NOP58;SENP3;RPL11;RPS16;RPL24;RPL39;RPL28;UTP6;RPS24;RPLP2;RPS27;DDX49;RPL26;RPL14;RPL10;RPL7;BYSL;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;EXOSC5;MPHOSPH6;RPL31;WDR18;EBNA1BP2;XRN1;RPL15;RPL38;RPS25;RPS7;RPLP0;RPL27;ESF1;RRP12;RPL36A;RRP7A;DEDD2;RPL35A;PIH1D1;LYAR;RPL8;RPL36;MRM2;EXOSC7
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.6345830750995614,-1.4902872794438735,0.05019305019305019,0.3479049828772348,1.0,6/13,18.83%,ENTPD1;ENPP1;ENPP3;ENTPD5;SMPDL3A;ENTPD2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.4022855945308058,-1.489791025814282,0.0028169014084507044,0.3476077194858756,1.0,33/113,12.42%,BMP6;NOTCH2;IGF1;EGFR;NRP2;NRP1;TEK;TGFA;OSR1;F3;FGFR2;BMP4;BMPR2;TGFBR1;TCF7L2;VEGFD;VEGFC;FGF1;YAP1;WNT5A;STXBP4;TBX1;PPP1R16B;AKT1;RREB1;ECM1;HIF1A;CDH13;FZD7;KDR;ITGB3;NME1;FLT4
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.5786026694579989,-1.4896375289784693,0.0496031746031746,0.346514896478185,1.0,7/19,10.57%,ELF1;KLF4;PARP9;IRAK2;WNT5A;MAP2K5;MAVS
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5501352146223433,1.4892102291851304,0.06086956521739131,0.606991439272172,1.0,5/46,2.75%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7130966717862137,1.4883858230057923,0.0899581589958159,0.6066793083747226,1.0,4/10,3.73%,NEDD4L;ATP1A2;HECW2;STK39
prerank,heterochromatin organization (GO:0070828),-0.6319139098091038,-1.4877533701590755,0.052434456928838954,0.3496538586721913,1.0,7/14,20.46%,MECOM;SETD7;PRDM16;EZH1;SNAI1;HP1BP3;SETDB1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.6074987354312997,1.4872167723549696,0.09448818897637795,0.607701138793521,1.0,3/27,0.75%,PDE4D;DMD;CACNB2
prerank,visual system development (GO:0150063),-0.4906088782437607,-1.4869204698184229,0.0367965367965368,0.35048272253558405,1.0,10/37,17.12%,PBX1;SMOC1;PBX3;RBP4;FOXC1;ATF6;MEIS2;HIPK2;RAB18;MEIS1
prerank,extracellular matrix disassembly (GO:0022617),-0.4636939339932332,-1.4867993668769548,0.009523809523809525,0.3492681928069289,1.0,16/53,12.18%,GSN;ADAMTS5;TLL1;BSG;TIMP2;CAPN2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;ADAM15;CAPN1;MMP14;MMP19;CTSS
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6732790690660567,-1.4867212513986552,0.056074766355140186,0.34795992370781414,1.0,3/10,2.43%,ERRFI1;CAV1;ENPP1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6330841726684953,-1.4867017374556561,0.04716981132075472,0.34656851061237326,1.0,6/12,10.06%,ADAMTS12;DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,positive regulation of angiogenesis (GO:0045766),-0.3996460346923076,-1.486375695164834,0.0027472527472527475,0.34602774969115546,1.0,33/108,10.78%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;SASH1;ITGB8;NOS3;THBS1;ITGA5;KLF4;FOXC2;RAMP2;CD34;VEGFD;VEGFC;FGF1;BMPER;PRKCB;WNT5A;RHOB;CYP1B1;HK2;PIK3R6;TIE1;ECM1;HIF1A;KDR;ZC3H12A;GATA2
prerank,positive regulation of response to wounding (GO:1903036),0.6008846392712928,1.4854768864788883,0.08928571428571429,0.6102003950241677,1.0,8/24,7.27%,VTN;PTK2;MYLK;SCARF1;PTN;ITGB1;ARFGEF1;HRAS
prerank,positive regulation of hemostasis (GO:1900048),-0.6669702541401468,-1.485316243467549,0.057539682539682536,0.3460195033334467,1.0,2/10,3.18%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.6669702541401468,-1.485316243467549,0.057539682539682536,0.3460195033334467,1.0,2/10,3.18%,ST3GAL4;THBS1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6579649178454418,1.4850713065476167,0.11670020120724346,0.608844104283169,1.0,4/15,6.74%,NR1H3;SCARB1;LDLR;SIK1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.63032105395372,-1.484644464582063,0.064030131826742,0.3463718714167137,1.0,6/13,19.23%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,regulation of cell morphogenesis (GO:0022604),-0.5099596389852861,-1.4845775005575887,0.04925053533190578,0.34508016401796016,1.0,10/30,12.93%,FMNL2;PDPN;SPARC;MACF1;CAPZB;MOV10;EFNA5;MYO9A;BCL9L;MFSD2A
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4422444388211858,-1.484455608182616,0.023746701846965697,0.34400564611009243,1.0,23/65,12.83%,FBN1;LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;TGFBR1;SNX6;SMAD7;SKI;SMURF1;PRDM16;FKBP1A;FBN2;EMILIN1;BCL9L;TGFB1;STRAP;PPARA;UBB
prerank,blood circulation (GO:0008015),0.5447632360895325,1.4841857929221194,0.06468531468531469,0.6088766551107656,1.0,6/49,2.15%,GUCY1B1;ACE2;GUCY1A1;COL4A3;ADORA2A;ROCK1
prerank,acidic amino acid transport (GO:0015800),-0.5964881222870279,-1.4840329385031705,0.05410821643286573,0.3436074716466321,1.0,7/17,15.86%,SLC6A13;SLC1A3;SLC6A6;GJA1;SLC6A1;ARL6IP5;SLC25A22
prerank,regulation of autophagy (GO:0010506),-0.3680760293827304,-1.483613760904358,0.0,0.3433172723036977,1.0,67/216,19.33%,PRKAG2;DAPK1;LEPR;DCN;FOXO1;FOXO3;NUPR1;SNX6;LRRK2;WDR41;ACER2;TPCN1;DAP;SNX32;RASIP1;PLK2;EXOC4;STAT3;CAPNS1;PIK3CB;ATP6V1G1;AKT1;MCL1;EEF1A1;IRGM;CAPN1;FOXK1;DAPL1;ATF6;GFAP;ATP6V0B;PSAP;FLCN;ZKSCAN3;ZC3H12A;OPTN;ERN1;VPS35;TRIM27;PIP4K2B;ATP6V0A1;RAB8A;SH3GLB1;PRKAG3;EIF4G3;PRKAB1;MET;ATM;BNIP3;TICAM1;PRKAA2;WASHC1;FBXL2;ATP6V0A2;SREBF1;GPR137;MTMR3;RRAGB;TRIM8;SIRT2;TRIM14;SH3BP4;TMEM59;LAMTOR5;MT3;PIM2;ATG101
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.395848304123596,-1.483531646499888,0.003125,0.3421268808389558,1.0,34/136,12.50%,HDAC4;PTGIS;BMP7;SP100;ANXA4;NUPR1;ESR1;SUFU;KLF4;SMAD7;ID1;TAF1;TCF7L2;GAS6;IRAK2;ARRB1;WWP2;GLIS2;DAP;BHLHE40;SFRP4;ID3;MAP2K5;TMSB4X;CYP1B1;CMKLR1;NLRC5;DAB2IP;ZC3H12A;IRAK3;CEBPG;MDFI;PTCH1;ID2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.47522801073452264,1.4831640752748418,0.0343796711509716,0.6092988257197269,1.0,17/107,8.29%,ATP13A5;SLC30A10;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;ATP2A2;RYR2;HTR2C;CHRNA7;STC1;STIM1;STC2
prerank,embryonic organ morphogenesis (GO:0048562),-0.48162157274548056,-1.4826511144070247,0.029017857142857144,0.34308267696872397,1.0,17/42,14.53%,FBN1;EFEMP1;PDGFRA;RBP4;HOXB3;MFAP5;FGFR2;ACVR1;HOXA3;RARG;SIX1;FBN2;TBX1;HOXB9;ID2;SOX17;HOXC4
prerank,purine nucleotide catabolic process (GO:0006195),-0.6300163285302883,-1.4820454755589725,0.06395348837209303,0.3430635201166009,1.0,9/13,24.63%,XDH;NT5E;HINT1;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,regulation of adaptive immune response (GO:0002819),-0.568502517439382,-1.4809004184535823,0.05660377358490566,0.3446800675999358,1.0,5/18,12.48%,IL6ST;IRF1;ADCY7;TRIM27;AHR
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6152226245135409,1.4807392440350284,0.09320388349514563,0.6139777342596973,1.0,7/25,6.31%,CACNB2;TRPC1;GPER1;AKAP6;CXCL10;NPSR1;SNCA
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7088798252761062,1.4799542746433172,0.0945054945054945,0.6136715430163456,1.0,5/11,7.85%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,neural tube closure (GO:0001843),0.5780130470888651,1.4797469011865148,0.08856088560885608,0.6118236759569058,1.0,3/34,2.47%,DLC1;VASP;GRHL3
prerank,osteoclast differentiation (GO:0030316),-0.5483568337924158,-1.4793355018852488,0.05555555555555555,0.3470156841728678,1.0,10/22,20.99%,FOXP1;ANXA2;CSF1;SBNO2;MAPK14;TNFRSF11A;SNX10;CSF1R;GLO1;TYROBP
prerank,NAD biosynthetic process (GO:0009435),-0.5589281727477605,-1.4789055816157657,0.0509433962264151,0.3467633236719702,1.0,11/20,24.06%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NMNAT1;NNMT;PARP16;QPRT;NAPRT;KYNU
prerank,ruffle organization (GO:0031529),0.6584279188328526,1.4786556319162323,0.11561866125760649,0.6127119736147826,1.0,2/16,1.11%,CARMIL1;AIF1L
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6209557063079394,1.4781510580439703,0.10493827160493827,0.6117514488761027,1.0,6/20,12.13%,PTEN;HEXIM1;NR2F2;INCA1;LATS2;APC
prerank,positive regulation of cell differentiation (GO:0045597),-0.36557441162128845,-1.4777186276019956,0.0,0.3483505067065336,1.0,58/237,10.34%,BMP6;RANBP3L;IGF1;DAB2;PLCB1;SMAD3;ZBTB16;COL1A1;WNT4;BOC;PDPN;PRKCH;MEDAG;CCN2;BMP7;SLC6A6;TMEM64;CDON;IL6R;TGFBR2;BMP4;BMPR2;GJA1;IL6ST;TGFBR1;LEF1;CSF1;ARHGEF2;ACVR1;TCF4;CD34;HOXA5;ZHX3;IGFBP3;SDCBP;AR;YAP1;ACVRL1;NBL1;MAPK14;RHOA;FOXC1;SYAP1;VWC2;FBN2;NOCT;ATRAID;TIAM1;WDFY2;AKT1;TMEM100;CMKLR1;CTNNA1;CCN4;IL18;KDR;CARM1;ZC3H12A
prerank,epithelial structure maintenance (GO:0010669),-0.6614557808216889,-1.4772733358439831,0.05956678700361011,0.34816103402241166,1.0,3/11,12.11%,CXADR;RBP4;STRAP
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4271567808585357,-1.4771258058219072,0.017456359102244388,0.3472437928205654,1.0,23/76,13.22%,EGFR;NFAT5;UACA;BMP7;APP;DLG1;HDAC7;SASH1;EZR;NR3C2;RASSF2;NOD1;PDCD4;CCN3;LGALS9;RHOA;TMSB4X;C1QTNF3;IFI35;ZC3H12A;TRIP6;RELA;SPHK1
prerank,carboxylic acid metabolic process (GO:0019752),-0.5090852951641993,-1.4764893291280163,0.04573804573804574,0.3475371008789012,1.0,15/33,25.61%,PTGIS;PLA2G4A;DDO;ST3GAL1;SLC2A1;CSGALNACT1;CARNMT1;TBXAS1;PON3;AGXT;CYB5R3;GNE;GSTO2;SIRT4;GRHPR
prerank,nitric oxide metabolic process (GO:0046209),-0.6177595810886213,-1.4762202486521214,0.05725190839694656,0.3468822424108541,1.0,6/14,19.23%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,positive regulation of inflammatory response (GO:0050729),-0.41651495897225793,-1.4761989349872036,0.023809523809523808,0.3455768157511055,1.0,25/86,18.89%,APP;IL15;NUPR1;LBP;IL6ST;PDCD4;IL16;WNT5A;CD47;RPS19;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;KARS1;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;CD81;AGTR1;AGT
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6490010149875021,1.4761260051431295,0.0973630831643002,0.6151061049162668,1.0,3/18,2.80%,DLC1;TNFAIP1;CUL3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6347428147918863,-1.4754678072823273,0.05730129390018484,0.34622350809768854,1.0,5/12,17.77%,IGF1R;IRGM;UVRAG;BNIP3;ADRB2
prerank,regulation of macrophage migration (GO:1905521),-0.6679327894480425,-1.4752788874751845,0.057971014492753624,0.34541322189888696,1.0,7/10,25.94%,CSF1;PTK2B;EMILIN1;CD200;CD81;P2RY12;CD200R1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6248695332139018,-1.4745054742933938,0.0741444866920152,0.34621868568943304,1.0,6/13,8.31%,GLUL;NOS3;DDAH1;ALDH4A1;PRODH;GLS
prerank,positive regulation of lyase activity (GO:0051349),0.6488985483999916,1.4741113861905164,0.11632653061224489,0.618401746939176,1.0,4/14,7.60%,CACNA1C;NF1;CACNA1D;STIM1
prerank,protein ADP-ribosylation (GO:0006471),0.5925174570624784,1.474106232335178,0.08604206500956023,0.6159451168648132,1.0,2/28,0.86%,ART3;PARP8
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6366736450021616,1.473848336389908,0.11045364891518737,0.6142102546050685,1.0,4/20,1.66%,ITGA4;PLA2R1;RGCC;GPER1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6368792400219618,1.4732346567637395,0.11740890688259109,0.6136160708008062,1.0,6/20,5.73%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5573384986498076,1.4725876596535206,0.07599309153713299,0.6130124900322146,1.0,3/47,0.80%,PDGFRB;ACE2;PID1
prerank,second-messenger-mediated signaling (GO:0019932),0.5016850392456738,1.471517109452858,0.06435643564356436,0.6137035180635053,1.0,12/82,8.85%,GUCY1B1;GUCY1A1;PLCE1;INPP5A;CCRL2;ACKR3;CXCR2;RYR2;MAFA;ACKR2;CCR9;GPR62
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5798465571995355,1.4703911391643791,0.07635009310986965,0.6144973809275532,1.0,8/35,8.93%,DLC1;TNFAIP1;SPRY4;CUL3;SPRY2;LZTR1;KCTD13;ARHGAP35
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6388157434036131,-1.4697270389878916,0.05938697318007663,0.3568222428440938,1.0,6/12,19.19%,CYP26B1;DHRS3;KLF2;TRIM16;CALR;EZH2
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5640566272659291,-1.4688228467669546,0.06355140186915888,0.35778691513014227,1.0,9/18,22.30%,ESR1;KAT2B;RPS13;ZC3H12A;TGFB1;TMBIM6;PTBP3;RPS26;NUDT16
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5242410546831182,-1.4672682045768495,0.04285714285714286,0.36023368991263555,1.0,10/26,16.00%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;AKT1;NOS1AP;PTGS2;HSP90AB1;TLR4
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6587406111149294,-1.4672250062089693,0.0599250936329588,0.35897154591569136,1.0,3/10,5.60%,CD55;TGFBR2;LGALS9
prerank,regulation of cholesterol transport (GO:0032374),0.6130152770272157,1.4666142790691967,0.1037344398340249,0.6232249235742752,1.0,4/20,6.20%,NR1H3;ARV1;ABCA5;OSBPL6
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4996331056827955,-1.4659169633590667,0.04477611940298507,0.3610880359824607,1.0,11/33,12.97%,SMAD3;FOXO3;NR3C1;KLF4;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;ATOH8
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5858669797725236,1.4658128071052554,0.09213051823416507,0.6231061790172481,1.0,8/33,4.13%,MEF2C;TBXA2R;NOTCH1;RGCC;STARD13;MECP2;PDCD10;FGF2
prerank,cell-substrate junction assembly (GO:0007044),0.5828966390088122,1.4655747001285213,0.09340659340659341,0.6213905560380661,1.0,5/33,2.11%,DLC1;PTPRK;LAMC1;PEAK1;FERMT2
prerank,positive regulation of insulin secretion (GO:0032024),0.5608650734752931,1.4654025405933875,0.08957952468007313,0.6194268657955877,1.0,3/36,3.82%,ANO1;GPER1;ADCY8
prerank,endocrine system development (GO:0035270),-0.551941249805882,-1.465334101761824,0.04642166344294004,0.3611579741175047,1.0,7/21,8.29%,WNT4;GLI2;DKK3;TGFBR1;SIX1;TBX1;STRA6
prerank,artery development (GO:0060840),-0.5426496978683664,-1.4648639154136183,0.05058365758754864,0.360909710193964,1.0,8/23,8.29%,ROBO1;NRP1;BMPR2;TGFBR1;SMAD7;ACVRL1;TBX1;STRA6
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.5883102863610916,-1.4644230666801914,0.046181172291296625,0.3606299763972543,1.0,8/16,15.00%,BMP7;SOX13;SIX1;RREB1;FLCN;METRNL;PTGS2;FTO
prerank,embryonic heart tube development (GO:0035050),0.6705903601916028,1.4643593749451373,0.1125,0.619834291211241,1.0,3/14,6.43%,TBX2;TBX20;RYR2
prerank,peptide catabolic process (GO:0043171),0.6156629767549923,1.4640503143649937,0.09276437847866419,0.6184782998118299,1.0,6/23,3.09%,ENPEP;GGT5;GGT1;CHAC1;ANPEP;ECE1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5726311424795019,1.4640454190285659,0.09302325581395349,0.6161504606260789,1.0,11/38,10.60%,CACNA1C;CACNB2;CACNA2D1;KCNE4;CTNNA3;SCN5A;BIN1;CACNA1D;KCNE5;KCNJ3;SCN2B
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6918630473315417,1.4640274368363506,0.11279826464208242,0.6138978118331359,1.0,2/12,1.34%,IL34;PTK2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6704714793441857,-1.4629244663624335,0.0661625708884688,0.363132170674405,1.0,5/10,13.42%,TGFBR2;FGFR2;STAT1;TBX1;CHRD
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5767397544489311,-1.462384185878413,0.06300813008130081,0.3632886093389336,1.0,3/17,2.38%,PRKAG2;ADIPOR2;CAV1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.41337777162242695,-1.462171020984491,0.026385224274406333,0.36253370234038285,1.0,20/86,6.79%,BMP6;IGF1;EGFR;EPHA7;NRP1;PECAM1;APP;IL15;IL6R;ITGA5;PTPRJ;ANGPT1;ARHGEF2;ACVR1;GHR;IGF2;CNOT7;PRKCZ;EFNA5;PTK2B
prerank,arachidonic acid secretion (GO:0050482),-0.6394362394970201,-1.4615177123735397,0.07129455909943715,0.3614042928815383,1.0,3/10,6.48%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.6394362394970201,-1.4615177123735397,0.07129455909943715,0.3614042928815383,1.0,3/10,6.48%,ANXA1;ACE;BDKRB2
prerank,homotypic cell-cell adhesion (GO:0034109),-0.4811146560180604,-1.461350766139594,0.0430327868852459,0.36057485405461237,1.0,14/39,13.89%,FN1;PDGFRA;TJP2;PLPP3;MEGF11;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;ACTB;MEGF10;PPIA
prerank,endoderm formation (GO:0001706),0.5637739288170704,1.4612277209818227,0.10131332082551595,0.6192881258569708,1.0,10/35,7.62%,ITGA4;ITGA7;VTN;TBX20;NODAL;MMP15;ITGB5;LAMB1;COL7A1;COL4A2
prerank,glycerolipid metabolic process (GO:0046486),0.701691871393863,1.460660581752167,0.1118421052631579,0.6186467688680233,1.0,2/11,1.90%,DGKB;DGKG
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5250808685228548,-1.460513871218021,0.04233870967741935,0.3613830802460312,1.0,10/25,16.00%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;AKT1;NOS1AP;PTGS2;HSP90AB1;TLR4
prerank,membrane assembly (GO:0071709),0.5677474343749871,1.4602033240157453,0.09302325581395349,0.6175783805131545,1.0,10/34,11.09%,PTEN;CEL;RFTN1;NRXN1;SPTBN1;ANK3;EMP2;IL1RAPL1;UBXN2B;STX4
prerank,bile acid biosynthetic process (GO:0006699),0.6047017209668266,1.4597763512270596,0.0998003992015968,0.616551315919779,1.0,5/24,6.20%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5384612095209294,-1.4592260966664916,0.05893909626719057,0.3633946835024634,1.0,7/22,6.33%,TIMP3;APOE;PTPN3;SNX9;TIMP2;ADAM9;TNFRSF1B
prerank,positive regulation of neurogenesis (GO:0050769),-0.4287016154052896,-1.4572750955632383,0.042821158690176324,0.36723739081286416,1.0,13/68,9.04%,PLXNA2;ROBO1;CUX1;TIAM2;PLXNA4;SLIT2;SHANK3;TGM2;RHOA;SERPINF1;TIAM1;OBSL1;PLXND1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5902063913243552,1.456368577258298,0.10204081632653061,0.6240279633063759,1.0,5/33,4.21%,KCNJ8;CASQ2;NEDD4L;KCNJ12;AKAP6
prerank,sulfur compound catabolic process (GO:0044273),0.5614225508022475,1.4557374245144887,0.08348794063079777,0.6234778639641608,1.0,8/38,6.29%,CSPG4;GGT5;GGT1;CHAC1;CTH;ACAN;TXN2;GNS
prerank,inorganic anion transport (GO:0015698),0.5306735102026138,1.4547894952552645,0.09123434704830054,0.6239311643902458,1.0,2/53,0.26%,ANO1;ANO4
prerank,histone H4 deacetylation (GO:0070933),-0.6607950234302092,-1.4538971550295556,0.04093567251461988,0.3746260787694671,1.0,6/10,18.49%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT2;SMARCAD1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6327082998582292,-1.4534625852596559,0.07930367504835589,0.3743563577898381,1.0,4/12,6.67%,JAM2;APP;CXCL12;RHOA
prerank,regulation of dendrite development (GO:0050773),0.5640667367881684,1.4526044482510823,0.10233393177737882,0.6282027802410803,1.0,13/37,10.64%,NEDD4L;BMP5;SDC2;HECW2;MARK1;PTN;CHRNA3;CSMD3;BCL11A;ADGRB3;HECW1;SARM1;VLDLR
prerank,organic acid transport (GO:0015849),-0.40158440765028364,-1.4513687294913562,0.021917808219178082,0.3783462676281904,1.0,20/94,11.23%,SLC7A11;ABCC4;SLC6A13;SLC13A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLC6A12;ABCG2;SLCO1C1;SLC16A1;SLC22A6;SLC7A2;SLC7A7;SLC25A17;SLC7A14;SLC5A6;SLC38A5;SLC3A2
prerank,phosphatidic acid metabolic process (GO:0046473),0.5334205600046564,1.451125343412577,0.07317073170731707,0.6299810620891311,1.0,5/48,2.75%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,glutathione metabolic process (GO:0006749),0.5650494746248924,1.450957454442084,0.09908256880733946,0.6281287607011243,1.0,4/38,4.08%,GGT5;GGT1;CHAC1;GSTT2
prerank,urogenital system development (GO:0001655),-0.6367095541825932,-1.4503279920304362,0.05813953488372093,0.379729738167835,1.0,4/11,17.17%,OSR1;ANXA1;EPHB2;EPHB3
prerank,ribosome biogenesis (GO:0042254),-0.36819368640822997,-1.449458910995094,0.01060070671378092,0.3808540493772697,1.0,71/187,23.84%,GLUL;RPLP1;RPS14;SDAD1;RPL9;RPL41;RPL18A;RPS19;RPL13;UTP14A;RPL18;RPL34;RPL32;KRR1;RPS9;NAF1;UTP11;RPL27A;RPL12;RPL37;NOP58;SENP3;CUL4A;RPL11;RPS16;PAK1IP1;RPL24;RPL39;RPL28;UTP6;RPS24;RPLP2;RPS27;RAN;DDX49;RPL26;RPL14;RPL10;RPL7;BYSL;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;EXOSC5;MPHOSPH6;RPL31;WDR18;EBNA1BP2;RBIS;RPL15;RPL38;RPS25;RPS7;RPLP0;RPL27;ESF1;RRP12;RPL36A;RRP7A;RIOK2;URB2;RPL35A;PIH1D1;LYAR;RPL8;RPL36;MRM2;EXOSC7
prerank,cellular response to fatty acid (GO:0071398),0.6732124400556962,1.4488978009121192,0.12087912087912088,0.6316884773836953,1.0,3/12,6.72%,PID1;FFAR2;IRS1
prerank,regulation of nervous system development (GO:0051960),0.5653501821007567,1.448225733465959,0.10112359550561797,0.6311420116530682,1.0,6/37,2.65%,HEY2;HEYL;PER2;PTN;GBX2;IL1B
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6220988354148588,-1.4480575584368889,0.07889908256880734,0.38326424175040946,1.0,5/12,12.18%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,action potential (GO:0001508),0.5519777822480288,1.4469727626520095,0.08635578583765112,0.6325355185350354,1.0,12/44,9.14%,DMD;GPER1;CACNA1H;KCNE4;KCND2;AKAP6;SCN2A;SCN5A;ANK3;SCN8A;KCNE5;SCN9A
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7049254756342667,1.4465053818202334,0.10367170626349892,0.6317423742315931,1.0,3/10,1.24%,BMP5;NOTCH1;TBX20
prerank,response to alcohol (GO:0097305),-0.5067275807663918,-1.44602237794218,0.058315334773218146,0.38763464664898245,1.0,4/27,3.54%,TGFBR3;SLIT2;TGFBR2;TGFBR1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3792842626274544,-1.4453247549222017,0.012861736334405145,0.388061481493278,1.0,43/151,10.16%,BMP6;SMAD3;ADAMTS12;FLT1;EGFR;WNT4;WWOX;NTRK3;NRP1;BMP7;SEMA6A;IQGAP1;NR3C1;PLCG1;TGFBR2;BMP4;BMPR2;GAS1;TGFBR1;MAGI2;CLEC3B;KLF4;SMAD9;SMAD7;ANXA1;ACVR1;RAMP2;APPL2;NDNF;ACVRL1;WNT5A;MAPK14;FOXC1;SYAP1;MAP2K5;TBX1;RAPGEF1;EHD1;AKT1;TMEM100;EEF1A1;DAB2IP;KDR
prerank,negative regulation of programmed cell death (GO:0043069),-0.33536537909892644,-1.4452136074827364,0.0,0.3870099032159385,1.0,74/355,13.94%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;MECOM;SMAD6;FHL2;CTSH;IL31RA;PDPN;TEK;FOXO1;SH3RF1;OSR1;ANXA4;NUPR1;ANXA5;MYO18A;THBS1;BMP4;IGF1R;USP47;IL6ST;ANGPT1;TXNDC5;LEF1;ANXA1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;RNF144B;ZFAND6;CCND2;WNT5A;PTK2B;CARD14;PLK2;SH3RF2;HSPA5;TFRC;ERC1;GOLPH3;ERCC5;TPT1;BIRC3;GPX4;AKT1;SON;MCL1;BAG3;PRDX2;IFIT3;CD38;GCLC;KDR;ARHGDIA;BNIP3L;RAB7A;FLT4;RELA;CBX4;HDAC1;UBB;SPHK1;MET;PIM3;GATA6;BNIP3;RPL10;HYPK
prerank,cellular response to purine-containing compound (GO:0071415),0.6840621246346166,1.4447136820661837,0.1282051282051282,0.6347767878460805,1.0,3/10,8.72%,CASQ2;RYR2;RYR3
prerank,small GTPase mediated signal transduction (GO:0007264),0.46847861260538914,1.4446922767110184,0.060790273556231005,0.6325639942656651,1.0,15/103,5.09%,RAPGEF5;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP32;RASGRP2;ARHGAP1;RASGRP3;NF1;RRAD;FGF2;RIN2;SIAH2;RIT2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.4668900633010281,-1.4443331447936592,0.017817371937639197,0.3879727250674529,1.0,20/43,20.86%,GLUL;BMP4;LIMK2;PARP9;YAP1;MFHAS1;TFRC;AKT1;DTX3L;CARD10;CTNNA1;FLCN;TGFB1;BYSL;TPR;PARK7;LAMTOR5;ORMDL3;SIN3A;CDK5RAP3
prerank,rRNA processing (GO:0006364),-0.366367718278104,-1.4440761154282293,0.003424657534246575,0.38731635772298434,1.0,67/172,23.84%,NSA2;RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;RPL13;UTP14A;RPL18;RPL34;RPL32;KRR1;RPS9;UTP11;RPL27A;RPL12;RPL37;NOP58;SENP3;RPL11;RPS16;RPL24;RPL39;RPL28;UTP6;RPS24;RPLP2;RPS27;DDX49;RPL26;RPL14;RPL10;RPL7;BYSL;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;EXOSC5;MPHOSPH6;RPL31;WDR18;EBNA1BP2;RPL15;RPL38;RPS25;RPS7;RPLP0;RPL27;TFB1M;NAT10;ESF1;RRP12;RPL36A;RRP7A;RIOK2;MRPL1;RPL35A;PIH1D1;LYAR;RPL8;RPL36;MRM2;EXOSC7
prerank,regulation of postsynapse organization (GO:0099175),-0.5041210059339,-1.442829647698265,0.057569296375266525,0.3893917231503115,1.0,13/28,22.52%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2;WNT5A;VPS35;ABHD17C;TANC2;HOMER1;ZDHHC15;ARHGAP44;LZTS3
prerank,amino sugar metabolic process (GO:0006040),-0.663522741418763,-1.4425161804145685,0.06739526411657559,0.38895056956087004,1.0,6/10,19.87%,ST3GAL1;CSGALNACT1;EXTL2;GFPT2;GFPT1;GNE
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6290455986377987,-1.4417124933369005,0.07648183556405354,0.389893555954333,1.0,3/12,6.25%,SORBS1;IGF2;PRKCZ
prerank,response to zinc ion (GO:0010043),-0.5195398031746098,-1.4412455930156782,0.0691699604743083,0.3898169188108408,1.0,19/25,37.69%,PAM;P2RX4;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CRIP1;ATP13A2;MT2A;KHK;HVCN1;HAAO;SLC30A3;D2HGDH
prerank,substantia nigra development (GO:0021762),0.5592433120488207,1.4404884116858583,0.10564663023679417,0.6422598859541988,1.0,2/37,0.69%,DYNLL1;GNB4
prerank,regulation of calcium ion import (GO:0090279),0.6139870633301366,1.4399816575283126,0.116600790513834,0.6413864573434083,1.0,4/21,9.32%,PDGFRB;STC1;PKD2;PDGFB
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5186590695674768,-1.439979793553895,0.06092436974789916,0.39169931865343655,1.0,7/26,10.06%,EGFR;IQGAP1;PLCG1;FOXC1;SYAP1;EEF1A1;DAB2IP
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5703226687960398,-1.4393161674219348,0.07514450867052024,0.3922246679037702,1.0,8/15,28.52%,IGF1;AKT1;GPX1;PRELID1;BCL2L1;PRKN;PSMD10;CLU
prerank,iron ion homeostasis (GO:0055072),-0.4402009191939342,-1.4391785421776646,0.035211267605633804,0.3912591212023665,1.0,25/58,28.21%,BMP6;CP;SCARA5;NEO1;B2M;ABCG2;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;BDH2;HFE;ATP6V0A2;CYB561A3;FTH1;FRRS1;CCDC115;NUBP1;TMEM199;ATP6AP1;SMAD4;ATP6V0D1;ALAS2;ATP13A2
prerank,negative regulation of bone mineralization (GO:0030502),-0.6117423503465856,-1.4388224977657356,0.05688073394495413,0.39092997602034646,1.0,4/13,9.24%,ENPP1;SRGN;PTK2B;ECM1
prerank,cellular glucan metabolic process (GO:0006073),-0.64234225278779,-1.4384971263266633,0.06363636363636363,0.39052785594248807,1.0,2/11,1.78%,PRKAG2;PHKB
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.4263805213985342,-1.4380545521659462,0.016908212560386472,0.3904543818870861,1.0,13/66,12.58%,IGF1;FOXP1;APP;LGALS9;WNT5A;STAT3;TRIM16;ZC3H12A;CASP8;GSDMD;P2RX7;GBP5;GIT1
prerank,regulation of cellular senescence (GO:2000772),0.5685018319021423,1.4373054318707812,0.10256410256410256,0.6469273937725021,1.0,7/28,11.65%,SLC30A10;CDK6;AKT3;NEK6;CGAS;NUAK1;RBL1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.5286637199281075,-1.4373050718119424,0.05893909626719057,0.39129252657122326,1.0,5/23,15.69%,IGF1;GAS6;ZC3H12A;GIT1;CEACAM1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5579979237238781,-1.437220746559539,0.082,0.39023074206379826,1.0,3/17,2.88%,BMP6;CD55;SASH1
prerank,negative regulation of blood pressure (GO:0045776),-0.6068018340678695,-1.4368766617263362,0.05860805860805861,0.3899364173728776,1.0,5/13,15.83%,NOS3;BMPR2;PRCP;SCPEP1;NOS1
prerank,ribosomal small subunit assembly (GO:0000028),-0.5648948759619231,-1.4368441993143628,0.08964143426294821,0.38875671623804825,1.0,9/16,22.26%,RPS14;RPS19;RPS5;RPS27;MRPS7;RPS15;RPSA;RRP7A;RPS27L
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.471469413060159,-1.4368234116728886,0.05032822757111598,0.38754792627956003,1.0,10/39,7.60%,TSPAN5;ROBO1;ZMIZ1;NOS3;IL6ST;KAT2B;CCN3;BMP2K;YAP1;STAT3
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.5412711279681272,-1.4365833571985107,0.07789473684210527,0.3869714591380217,1.0,5/22,4.10%,SP100;MDFIC;APOD;SUFU;LRRK2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6162102509530762,-1.4356578686879051,0.07977736549165121,0.388159660619103,1.0,5/13,7.37%,FBN1;FSTL1;GREM2;NBL1;FBN2
prerank,synapse assembly (GO:0007416),0.5072715962336809,1.4356128288847794,0.08020477815699659,0.6495811115681996,1.0,13/67,6.03%,PTEN;ADGRL3;CDH2;FARP1;PCDHB11;LRRTM3;PLXNB1;NRXN1;FGF13;DNER;RYK;GABRG2;GABRA2
prerank,epithelial cell-cell adhesion (GO:0090136),0.6866382138487319,1.4355646064903382,0.13125,0.6474680948759022,1.0,3/11,3.44%,SERPINB8;VCL;ITGB5
prerank,peripheral nervous system development (GO:0007422),0.5896888407011777,1.4351244123185796,0.1324376199616123,0.6463355326127365,1.0,4/23,6.75%,SERPINI1;NF1;ASIC2;SCN8A
prerank,cardiac muscle cell development (GO:0055013),0.6057464953251384,1.4348571359708624,0.11244979919678715,0.644843377410041,1.0,3/20,2.06%,PDGFRB;HEY2;MYH11
prerank,UV protection (GO:0009650),-0.6541490649730165,-1.4345747062155083,0.07183364839319471,0.3899932908965565,1.0,5/10,23.89%,SCARA3;ERCC5;MFAP4;GPX1;ERCC2
prerank,exit from mitosis (GO:0010458),0.6618700006258549,1.4345471549366944,0.129979035639413,0.6435384821421268,1.0,2/12,5.20%,EPS8;CLASP2
prerank,regulation of cartilage development (GO:0061035),0.6175801440349278,1.4318120103334033,0.13665943600867678,0.6492476520504906,1.0,3/18,1.40%,SOX5;MBOAT2;TRPS1
prerank,regulation of interleukin-4 production (GO:0032673),-0.5365830310631922,-1.4315345135450641,0.07142857142857142,0.39655785074336053,1.0,8/21,22.21%,LEF1;LGALS9;PRKCZ;SLC7A5;ZFPM1;CEBPB;SYK;RARA
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6269271855713646,1.431326650371627,0.11842105263157894,0.6484666842566015,1.0,7/16,4.21%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2;AKAP6
prerank,filopodium assembly (GO:0046847),-0.567497577261429,-1.4309862222253629,0.06990291262135923,0.39680077432110694,1.0,5/16,4.51%,FGD5;FGD6;EZR;SRGAP2;DNM3
prerank,protein export from nucleus (GO:0006611),-0.5153460176742762,-1.4304624270217294,0.056155507559395246,0.3968325372724189,1.0,16/27,29.39%,RANBP3L;SMURF1;CCHCR1;DUSP16;TGFB1;RAN;CALR;PKD1;STYX;TPR;CHP1;NUP214;XPO4;RANBP17;CSE1L;XPO5
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4850446917690909,-1.4297655380215637,0.05054945054945055,0.3975340790044678,1.0,25/36,34.85%,CSF1;PARP9;GAS6;PARP14;CASP4;WNT5A;IRGM;HIF1A;NLRC5;MAVS;RIPK1;AGPAT2;TRIM6;PRKN;HSPA1B;LAPTM5;IL7;ZBP1;CXCR4;AGPAT1;EDN1;ADAM17;FADD;C1QTNF4;CD74
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.47839975302640986,-1.4294603156048094,0.06365503080082136,0.3970570254932186,1.0,13/35,13.23%,PLXNA2;NRP2;NRP1;SEMA3D;SEMA6A;SEMA3C;PLXNA4;SEMA7A;SEMA3E;PLXND1;ARHGDIA;SEMA3B;MET
prerank,negative regulation of nervous system development (GO:0051961),0.6223544675488872,1.4290922947069757,0.12875536480686695,0.652325939257866,1.0,5/17,8.07%,NOTCH1;SLIT1;IL1B;ROBO2;HOOK3
prerank,regulation of response to biotic stimulus (GO:0002831),-0.501891812349174,-1.4289902056136843,0.05660377358490566,0.39696597785067567,1.0,11/28,13.49%,FOXP1;CD55;APPL2;IRF1;ERAP1;BIRC3;SAMHD1;RNF135;CASP8;LRP8;GATA6
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.47753093842278405,-1.4287183954387812,0.04904051172707889,0.3965330162289309,1.0,8/37,12.77%,ALCAM;HMCN1;CXADR;VCAM1;ADGRL1;ICAM1;CD164;FAT4
prerank,regulation of response to stress (GO:0080134),0.6896815484001683,1.428450708388504,0.13777777777777778,0.6519958609153473,1.0,4/10,14.03%,ADCY8;CORO2B;DYRK3;MLC1
prerank,neuronal action potential (GO:0019228),0.6097803535868512,1.4276414830685842,0.12424849699398798,0.6522201777963451,1.0,7/22,9.14%,GPER1;CACNA1H;SCN2A;SCN5A;ANK3;SCN8A;SCN9A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5648178382647306,1.4273368186716304,0.12363636363636364,0.6508894606882533,1.0,10/29,13.05%,PTEN;BMP5;IL17RD;SPRED1;SPRY2;HPN;SFRP2;VASN;FUZ;SPRED2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.41373563832670535,-1.426909818925344,0.022613065326633167,0.40019257035120115,1.0,27/69,28.66%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;OAS2;IL33;MAVS;EPHB2;CYBA;PLCG2;TLR4;ARFGEF2;RIPK1;SYK;TYROBP;CCL19;LPL;SETD4;TWIST1;FZD5;CCR2;CLU;SPHK2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.46344432638767213,1.425450740377878,0.06528662420382166,0.6541791629727028,1.0,15/100,4.13%,PDGFRB;PIP5K1B;PTEN;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PIP4K2A;PLXNB1;PIK3CA;NCF1;FGF2
prerank,sphingosine metabolic process (GO:0006670),-0.5671705076411103,-1.425202471226859,0.08076923076923077,0.4035311772981401,1.0,7/17,13.74%,PLPP3;ACER2;NAAA;ACER3;PLPP1;SPHK1;SPTLC2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6575865151244964,1.4250142048189107,0.14187643020594964,0.6532765814300274,1.0,2/12,2.72%,GGT1;CHAC1
prerank,cellular response to amino acid stimulus (GO:0071230),0.5538016277571597,1.4244432261572937,0.11873840445269017,0.6526539355255895,1.0,4/33,2.46%,SPAAR;UBR1;CPEB1;SESN3
prerank,cellular response to glucagon stimulus (GO:0071377),0.6153515338088139,1.424204707650486,0.12606837606837606,0.6511836598791646,1.0,9/17,10.38%,CYSLTR2;PRKAR1B;ADCY3;ADCY8;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,import into cell (GO:0098657),-0.45491585591915273,-1.4238637209539873,0.05542725173210162,0.4059617161980501,1.0,11/41,9.01%,SLC6A13;GLUL;SLC47A1;SLC1A3;SLC6A6;SLC16A2;SLC12A7;SLC39A14;SLC7A5;SLC22A4;SLC5A6
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5656761949771335,1.423524204648263,0.10325047801147227,0.6509189367615394,1.0,9/31,17.73%,PTEN;BTRC;MAGEC2;CDC14B;SKP1;RAB1A;BMI1;DCUN1D2;GORASP1
prerank,keratan sulfate catabolic process (GO:0042340),-0.6274060046347328,-1.4233015177659765,0.07116788321167883,0.4062456935890098,1.0,8/11,14.28%,OGN;FMOD;HEXA;HEXB;PRELP;OMD;LUM;GALNS
prerank,dicarboxylic acid transport (GO:0006835),-0.49722995821344973,-1.423009253635221,0.0536480686695279,0.4058044750839896,1.0,6/28,4.58%,SLC13A3;SLC1A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5946769320606837,1.4228852316528895,0.12033195020746888,0.6505099912723142,1.0,6/19,4.13%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,positive regulation of ion transport (GO:0043270),0.5122799844158827,1.4227336574263347,0.09057971014492754,0.6488090905247055,1.0,9/48,7.58%,TRPC6;CACNB2;MYLK;STIM2;SCN5A;ANK3;RAB3B;PRSS8;CACNA1D
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.5370737764779623,-1.422185645683387,0.0743801652892562,0.4068188260492192,1.0,5/21,6.25%,ERRFI1;ROCK2;BMP4;MAFG;SFRP4
prerank,positive regulation of binding (GO:0051099),-0.4136599135624063,-1.4219097294799987,0.03611111111111111,0.40625293666496826,1.0,29/84,16.12%,IGF1;APOE;APP;CAV1;CLDN5;BMP4;B2M;LRRK2;TAF1;TCF7L2;SKI;PARP9;FOXC1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;CEBPG;ADD1;RPL11;NME1;RAN;MET;TXN;PKD1;HIPK2;HFE;HMGB2
prerank,regulation of catabolic process (GO:0009894),0.6025886819282247,1.4216823538521297,0.14489795918367346,0.6496676694409761,1.0,3/18,5.46%,FAP;NEDD4L;ITGB1
prerank,sulfation (GO:0051923),-0.6241564690755582,-1.4215776547297527,0.0741444866920152,0.40583668044329047,1.0,1/11,0.04%,UST
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6260393652909744,-1.421345207946171,0.07915057915057915,0.40527733571654556,1.0,4/11,6.61%,MECOM;CD34;ETV6;WNT5A
prerank,axon extension (GO:0048675),-0.5227432748256269,-1.4212392531368891,0.08523908523908524,0.4043376576493875,1.0,6/23,5.74%,ALCAM;AUTS2;NRP2;NRP1;SLIT2;MAP1B
prerank,Golgi to plasma membrane transport (GO:0006893),-0.45099799292897946,-1.420346770981786,0.05133928571428571,0.40554428323035163,1.0,12/47,11.05%,VAMP5;STXBP6;MACF1;KIF13A;VPS35L;GGA2;EXOC4;GOLPH3;EXOC6;ARL3;EXOC5;OPTN
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6586302964159428,1.420045417340826,0.13402061855670103,0.6520692430407994,1.0,3/12,8.32%,IL1B;CARD9;IL12RB1
prerank,metanephric mesenchyme development (GO:0072075),-0.6339717563661089,-1.4196481329700177,0.08671586715867159,0.40615245908325764,1.0,4/10,7.28%,WNT4;OSR1;SIX1;STAT1
prerank,axoneme assembly (GO:0035082),0.5669199940149093,1.4190810362575366,0.09826589595375723,0.6526644784114763,1.0,8/30,8.49%,RSPH6A;SPEF1;TTLL3;JHY;GAS8;RSPH1;LRGUK;CFAP46
prerank,positive regulation of phosphorylation (GO:0042327),-0.34454823538307644,-1.4184118886506123,0.004098360655737705,0.40821973685469065,1.0,74/240,15.05%,IGF1;DAB2;EPHA4;EPHA3;FLT1;EGFR;LEPR;ROCK2;PDGFRA;EPHA7;NTRK3;NRP1;LMO4;TEK;PECAM1;APP;ITGA6;FGFR2;THBS1;BMP4;IGF1R;EPHB4;ANGPT1;LRRK2;NIBAN1;VEGFD;LIMK2;VEGFC;SDCBP;GAS6;IGF2;ARRB1;FGF1;AR;EFNA5;DDR1;CCND2;CARD14;FNIP1;TFRC;CCND3;TBX1;TIE1;KIT;WDFY2;AKT1;IRGM;HIF1A;EPHA8;FZD7;KDR;FLCN;MAVS;P2RX7;ITGB3;TGFB1;FGFR4;CCN1;FLT4;EPHB2;ENTPD5;TMEM119;LIMCH1;KCTD20;CDK2AP1;MET;CCND1;RET;PPIA;MAPK3;PRKAA2;FXR2;RAD50;KRAS
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5231325857810434,-1.4182695905617593,0.08130081300813008,0.40737476245740345,1.0,11/24,5.00%,ROBO1;SMAD6;NRP2;NRP1;SEMA3C;TGFBR2;FGFR2;BMP4;BMPR2;ACVR1;ZFPM2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5246486020873722,-1.4180673806584443,0.06504065040650407,0.4066779341038083,1.0,7/22,12.83%,MAN1C1;RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.37946668191727934,-1.4180060964052013,0.0121580547112462,0.40562209946786343,1.0,33/112,23.23%,IGF1;FOXP1;APP;LBP;THBS1;PTPRJ;ARHGEF2;CD34;GAS6;LGALS9;WNT5A;CD47;STAT3;OAS2;IL33;ZC3H12A;MAVS;IRAK3;TRIM27;EPHB2;CYBA;PLCG2;TLR4;SIRPA;ARFGEF2;RIPK1;SYK;TYROBP;DICER1;RARA;CCL19;PTPN6;LPL
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6512591906551881,1.4179992035115019,0.12663755458515283,0.6537745071477786,1.0,4/14,5.97%,DMD;FXYD2;ACTN4;ANK3
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.40145218049849024,-1.417752546933146,0.038461538461538464,0.40514122576120015,1.0,17/85,6.22%,BMP6;TGFBR3;MCC;IGF1;EGFR;MTSS1;TGFA;OSR1;NUPR1;FGFR2;BMP4;B2M;ANGPT1;TCF7L2;FGF1;YAP1;ACVRL1
prerank,primary miRNA processing (GO:0031053),-0.6436002958262688,-1.4172698735539533,0.0865561694290976,0.4053043503557112,1.0,1/10,0.61%,SMAD3
prerank,positive regulation of vasculature development (GO:1904018),-0.3922825481663427,-1.417216859854145,0.0160857908847185,0.40418141456801665,1.0,34/94,14.76%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;SASH1;ITGB8;NOS3;THBS1;RAMP2;CD34;VEGFD;VEGFC;FGF1;PRKCB;WNT5A;RHOB;CYP1B1;HK2;PIK3R6;TIE1;ECM1;HIF1A;KDR;ZC3H12A;GATA2;SMOC2;SPHK1;GATA6;NINJ1;HIPK2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.533367067370276,-1.416937004597894,0.08151093439363817,0.4025508875231001,1.0,6/21,8.87%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.533367067370276,-1.416937004597894,0.08151093439363817,0.4025508875231001,1.0,6/21,8.87%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,Golgi localization (GO:0051645),0.6748036367080339,1.4164804348606777,0.13577586206896552,0.6560076738205649,1.0,4/11,8.07%,ARHGAP21;PDCD10;YWHAZ;HOOK3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6343936243582956,-1.4164285683460514,0.0936936936936937,0.40266976876304916,1.0,5/10,14.38%,TUT4;TUT7;CHFR;UBB;NEDD8
prerank,receptor clustering (GO:0043113),0.5619705032585272,1.416367582406402,0.11392405063291139,0.6541707149843926,1.0,4/27,4.02%,ITGA4;PTN;NRXN1;AGRN
prerank,bile acid metabolic process (GO:0008206),0.57465416433017,1.4163129228331421,0.12598425196850394,0.6522412144233461,1.0,5/27,6.20%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,cardiac muscle cell contraction (GO:0086003),0.5947846272502691,1.415967165100723,0.16297786720321933,0.6510994069686115,1.0,6/19,7.58%,CACNA1C;FGF12;PIK3CA;CACNA2D1;SCN5A;CACNA1D
prerank,regulation of protein import into nucleus (GO:0042306),-0.4720785235754656,-1.4159070887308427,0.04612159329140461,0.4028112135661539,1.0,12/36,12.89%,SMAD3;MDFIC;APOD;SUFU;BMP4;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,regulation of cell migration (GO:0030334),-0.3247851542796338,-1.4152428194239415,0.0,0.4034323979491157,1.0,91/382,10.28%,PLXNA2;AFDN;SULF1;IGF1;ROBO1;DAB2;PHACTR1;PDGFD;LDLRAD4;EPHA4;DPYSL3;FLT1;EGFR;CDH5;COL1A1;ROCK2;PDGFRA;NTRK3;LMO4;CTSH;CLIC4;PDPN;SEMA3D;IGFBP5;SEMA6A;CEMIP;NEDD9;SEMA3C;PECAM1;FOXO3;PODXL;PLXNA4;RECK;SLIT2;F3;CAV1;ITGA6;CLDN5;MACF1;PODN;SASH1;THBS1;IGF1R;PTPRJ;SEMA7A;TGFBR1;MAGI2;NKD1;ARSB;SRGAP3;SRGAP2;LEF1;CDH1;CSF1;SMAD7;ADAM9;ANXA1;ACVR1;ADAM10;SMO;SDCBP;FGF1;CXCL12;APPL2;SCAI;SYNE2;ACE;ACVRL1;RHOA;PTK2B;RHOB;SH3RF2;HSPA5;STAT3;TMSB4X;SEMA3E;CYP1B1;ACTG1;TBCCD1;KIT;TIAM1;AKT1;PLXND1;ADAM15;CDH13;TWIST2;ZMYND8;MMP14;ROBO4;KDR;FLCN
prerank,ceramide metabolic process (GO:0006672),-0.45171933490771904,-1.4151860326217989,0.046620046620046623,0.4023844272768359,1.0,18/49,24.67%,PLPP3;SGMS1;SGMS2;ST6GALNAC3;ACER2;ACER3;NSMAF;DEGS2;ST6GALNAC6;PLPP1;PLA2G15;SPTLC2;CLN8;ORMDL3;CLN6;ORMDL2;SGPL1;SPTSSA
prerank,response to glucagon (GO:0033762),0.5946434770561363,1.414965824506431,0.13569937369519833,0.6518851925467215,1.0,9/19,10.38%,CYSLTR2;PRKAR1B;ADCY3;ADCY8;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.5936122509329358,-1.4146048702027483,0.08029197080291971,0.40270667864675674,1.0,3/13,13.52%,BCL2L11;BNIP3L;BNIP3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6583470776120666,1.4132613208357754,0.13291139240506328,0.65459722072592,1.0,3/13,4.13%,ITGA4;AKT3;FGF2
prerank,B cell proliferation (GO:0042100),0.6139063047398744,1.4127047843874292,0.11066398390342053,0.6539945474208301,1.0,1/17,0.66%,MEF2C
prerank,negative regulation of cytokine production (GO:0001818),-0.3668849926529676,-1.4121815417120258,0.006430868167202572,0.40761312704912533,1.0,44/163,17.07%,FN1;LGR4;ANXA4;HDAC7;APOD;THBS1;EZR;KLF4;LEF1;ANXA1;HDAC9;PDCD4;CD34;GAS6;ARRB1;SRGN;APPL2;LGALS9;ADCY7;IKBKE;MAP2K5;TMSB4X;C1QTNF3;CMKLR1;PCBP2;NLRC5;RNF135;ZC3H12A;MAVS;IRAK3;TRIM27;RNF125;TWSG1;PPARA;SARS1;SSC5D;ZFPM1;CD200;CEACAM1;TLR4;ASB1;HOMER3;SIRPA;UBA7
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5965289868043491,1.4117072045658976,0.12298387096774194,0.6546064945014192,1.0,2/20,1.03%,PDE4D;RAPGEF2
prerank,negative regulation of immune response (GO:0050777),0.43400722862069024,1.4114826602961632,0.058992805755395686,0.653182147066047,1.0,19/154,7.15%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY3;ADCY8;ADCY6;CD300A;NPSR1;PRKAR2B;GPR45;CACTIN;ADCY9
prerank,female gamete generation (GO:0007292),0.5641381325683041,1.4110230523858556,0.11962616822429907,0.6523513593675073,1.0,6/29,8.08%,DIAPH2;PTN;BCL2L10;FMN2;MEI4;NANOS1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5816530530721487,1.4103546055330347,0.12121212121212122,0.6522272924328423,1.0,7/25,9.10%,TRPC6;DMD;STK39;ATP1B2;ANK3;PDZK1;STAC
prerank,positive regulation of ATPase activity (GO:0032781),0.5371452804625818,1.4103538717858712,0.11713286713286714,0.6501726126432656,1.0,8/41,10.70%,DYNLL1;FXYD2;ATP1B2;RYR2;FGF10;MYL3;MSH3;SETMAR
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.36457492442296746,-1.4097645976241762,0.009523809523809525,0.4128970518286962,1.0,24/152,7.35%,RNF220;SULF1;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;RSPO3;MACF1;FGFR2;USP47;SMURF2;RNF146;LRRK2;SKI;TNKS2;SULF2;LYPD6;SFRP4;RSPO2;WNK1;USP8;CSNK1G2
prerank,protein O-linked glycosylation (GO:0006493),-0.38751046494026226,-1.408915750956444,0.025495750708215296,0.41381617501002665,1.0,17/96,11.17%,TMTC1;GXYLT2;ST3GAL4;LARGE1;TMTC4;ST3GAL1;ST3GAL2;EOGT;TMTC2;PLOD2;ST3GAL3;TET3;RXYLT1;ST6GALNAC2;GALNT12;POGLUT1;POGLUT2
prerank,ncRNA processing (GO:0034470),-0.347781968873665,-1.4088833097325135,0.01107011070110701,0.4127206859413473,1.0,71/200,24.24%,SMAD3;RPLP1;RPS14;TUT4;RPL9;TUT7;RPL41;RPL18A;RPS19;RPL13;UTP14A;RPL18;RPL34;RPL32;KRR1;RPS9;UTP11;RPL27A;RPL12;RPL37;KARS1;NOP58;SENP3;RPL11;RPS16;RPL24;RPL39;RPL28;UTP6;RPS24;RPLP2;RPS27;DDX49;RPL26;RPL14;RPL10;SARS1;INTS11;RPL7;BYSL;RPL10A;RPS6;RPS15;RPL23;RPL17;RPL22;EXOSC5;MPHOSPH6;RPL31;WDR18;EBNA1BP2;RPL15;RPL38;RPS25;RPS7;RPLP0;RPL27;AGO1;ESF1;RRP12;RPL36A;RRP7A;DICER1;RPL35A;PIH1D1;LYAR;RPL8;RPL36;MRM2;EXOSC7;INTS5
prerank,intestinal lipid absorption (GO:0098856),0.671643450137638,1.4087819260137844,0.14736842105263157,0.6525492586493337,1.0,2/11,3.45%,CEL;LDLR
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6500714150458683,1.408732940468314,0.15113871635610765,0.6506605548657136,1.0,3/14,1.66%,ITGA4;RGCC;GPER1
prerank,organic hydroxy compound transport (GO:0015850),-0.46826513261877245,-1.408674959900156,0.04670912951167728,0.4120861378680428,1.0,7/36,8.29%,ABCC4;SLCO2B1;RBP4;SLCO1C1;SLC16A1;NPC2;STRA6
prerank,glycoprotein catabolic process (GO:0006516),-0.5548928673876361,-1.4080377510491044,0.06924643584521385,0.41250103131706994,1.0,11/17,34.21%,ADAMTS12;ADAMTS9;STT3B;EDEM2;MANBA;NGLY1;FBXO17;EDEM1;FBXO44;NEU2;FBXO2
prerank,endothelial cell proliferation (GO:0001935),-0.5544119628906451,-1.4079742177366052,0.09041591320072333,0.4114640003965914,1.0,7/17,6.22%,TEK;DLG1;BMP4;BMPR2;CD34;BMPER;ACVRL1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5911952255083033,-1.407755950123845,0.09090909090909091,0.41083853373065665,1.0,7/13,7.54%,BMP7;NR3C1;ESR1;BMP4;NR3C2;AR;PGR
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5515923488111641,-1.4074021490337576,0.09033613445378151,0.4105793653627494,1.0,2/17,3.10%,PLA2G4A;LPGAT1
prerank,negative regulation of blood coagulation (GO:0030195),-0.46607471559385816,-1.407330772675376,0.051224944320712694,0.40956951650107243,1.0,7/38,4.45%,PDGFRA;SERPING1;APOE;F3;NOS3;THBD;CD34
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5744763331339906,1.4070011846716137,0.1338432122370937,0.6533476173242808,1.0,10/26,12.56%,ITPR2;ITPR1;FGF2;RYR2;HTR2C;PKD2;RYR3;LETM1;CHERP;SLC8B1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.49621550867880393,1.4063252158441795,0.10221465076660988,0.6532251637100319,1.0,11/57,9.78%,GRM7;ADCY3;ADCY8;ADCY6;HTR1B;OPRK1;ADCY9;GPR37;AKAP12;GRM4;NPY1R
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5119965319511541,-1.406081391052246,0.060041407867494824,0.4116484767222023,1.0,10/26,19.23%,NOS3;ACER2;ACER3;CYP1B1;AKT1;GCH1;SPHK1;SPTLC2;NOS1;CYB5R3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5414105390040163,1.4060614429531169,0.10363636363636364,0.651926542621004,1.0,10/37,10.07%,PTEN;MEF2C;PRKG1;GPER1;LDLRAP1;FGF2;HTR1B;CDKN1A;PDGFB;EFEMP2
prerank,negative regulation of T cell proliferation (GO:0042130),0.5662700436471496,1.405938986713937,0.13320825515947468,0.6502513245107026,1.0,2/28,1.00%,GLMN;TNFRSF21
prerank,actin cytoskeleton reorganization (GO:0031532),-0.41812587321870615,-1.4058842767943311,0.06310679611650485,0.4110327760528707,1.0,16/63,9.06%,AUTS2;PHACTR1;GSN;NRP1;NEDD9;MCU;SIPA1L1;CXADR;NRK;EZR;PARVB;ANXA1;RHOA;DTNBP1;KIT;EFS
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.48698045783685884,1.405466834010908,0.09816971713810316,0.6495685228479595,1.0,11/70,4.54%,ITGA4;LAMC3;MEF2C;PIK3R1;LAMC1;PEAK1;FERMT2;RILPL2;ABI2;NTNG2;LAMB1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5005918925045886,-1.40474553065645,0.07014028056112225,0.41282289247772114,1.0,7/26,9.12%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1;PPP2R1B
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5422808051330483,1.4042799688597696,0.10727272727272727,0.6507792769097576,1.0,2/40,3.17%,SLC38A11;SLC19A1
prerank,regulation of DNA repair (GO:0006282),-0.45257604679807684,-1.4037383368295449,0.05066079295154185,0.4144193530271794,1.0,17/44,25.69%,EYA2;EYA1;EGFR;EYA4;PML;CEBPG;POLH;CDK9;SIRT7;NPAS2;BABAM2;BABAM1;RAD52;WRAP53;BRCA1;RNF8;RPS3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5411679332912832,-1.4036503186701024,0.07824427480916031,0.4134918006959215,1.0,11/18,13.47%,HDAC7;JCAD;FOXC2;ANXA1;HDAC9;KDR;FGFBP1;GATA2;PTGS2;RHOJ;SRPX2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.4100253497917952,-1.4034209671100162,0.020202020202020204,0.41289672059260324,1.0,15/76,10.91%,PTGIS;BMP7;ANXA4;KLF4;IRAK2;ARRB1;DAP;MAP2K5;TMSB4X;CYP1B1;CMKLR1;NLRC5;DAB2IP;ZC3H12A;IRAK3
prerank,positive regulation of signaling (GO:0023056),0.5388168178114521,1.4033708038254173,0.10964083175803403,0.6512066976466859,1.0,11/37,12.53%,CLSTN1;ECE1;NMU;RIMS1;CLSTN3;RIMS2;SNCA;SYT1;KCTD13;WLS;GRIK2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5358096329504508,-1.4029654390908834,0.09126984126984126,0.41295766339453616,1.0,8/19,15.59%,IGF1;NUPR1;TNFRSF1B;IL33;IL18;PTGS2;SPHK1;CD200
prerank,neuropeptide signaling pathway (GO:0007218),0.49957683482233417,1.4029176072954157,0.10314685314685315,0.6504206386919167,1.0,9/58,11.23%,CYSLTR2;RAPGEF2;SORCS1;NMU;SORT1;OPRK1;GPR37;NXPH4;NTSR1
prerank,endoderm development (GO:0007492),0.6324464186933039,1.4025794962634384,0.15,0.6493368980715909,1.0,2/13,1.67%,TBX20;LAMC1
prerank,muscle tissue morphogenesis (GO:0060415),0.6191613607781434,1.4021304262077454,0.15546218487394958,0.6485748844456055,1.0,4/16,1.44%,HEY2;NOTCH1;TBX20;MYLK
prerank,cell junction assembly (GO:0034329),0.45804597218489457,1.4020858182249585,0.07951070336391437,0.6467015944038296,1.0,20/100,7.04%,GJC1;PTEN;LIMS1;ADGRL3;CDH2;FARP1;VASP;FERMT2;PCDHB11;NRXN1;SH3BP1;DNER;GJA4;RYK;CDH8;FBLIM1;CDH19;CDH20;CDH7;CDH22
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3256277090550131,-1.4017491741341175,0.0,0.41498650945800863,1.0,102/476,13.77%,NFIB;IGF1;ZMIZ1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;ZBTB16;EGFR;MECOM;COL1A1;WNT4;HDAC4;TBL1XR1;GLI2;CREB5;IL31RA;BMP7;SP100;ELF2;FOXO1;APOE;FOXO3;ZIC2;MDFIC;KAT6B;HIVEP3;ESR1;BMP4;ELF1;ELF4;TGFBR1;KLF4;FOXC2;LEF1;NFATC1;CDH1;MLLT3;LRP6;KLF2;FZD2;ACVR1;TCF4;RGMB;CREB3L2;PARP9;NIBAN2;QRICH1;ARNT2;AR;BRD7;GLIS2;YAP1;THRAP3;SIX1;ACVRL1;IRF1;TEAD1;PRDM16;WNT5A;FOXC1;STAT1;HINFP;STAT3;SFR1;TBX1;FZD4;AKT1;DTX3L;RREB1;HIF1A;TRIM16;FOXK1;CD38;FZD7;MMS19;ZKSCAN3;KARS1;ESRRG;PML;BRCA2;KDM3A;TGFB1;NSD1;ATXN7L3;ZIC3;AHR;ID2;PPARA;RELA;PRDM11;HDAC1;GLI3;ATOH8;FBXW11;SOX17;GATA6;RET;TAL1;CLOCK;SPP1
prerank,sulfate transport (GO:0008272),-0.5838666282133989,-1.4014959655838948,0.0944558521560575,0.41449209293816114,1.0,3/14,2.89%,SLC13A4;SLC26A7;SLC26A2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5268443166528185,1.4003587181926604,0.10881801125703565,0.6493680256095135,1.0,3/35,1.45%,GGT5;GGT1;GGTA1
prerank,regulation of actin filament-based movement (GO:1903115),0.691780103574315,1.4000366567624436,0.14130434782608695,0.6483058969585787,1.0,4/10,7.19%,PDE4D;SCN5A;PDE4B;STC1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.32570498788872465,-1.3991356970743847,0.0,0.41954250170533686,1.0,100/390,13.23%,FLRT2;SULF1;SORBS1;IGF1;PDGFD;EPHA4;PLCB1;EPHA3;FLT1;EGFR;EFNB2;NRP2;MTSS1;COL1A1;ROCK2;PDGFRA;EPHA7;NTRK3;NRP1;IL31RA;TEK;RHOQ;NEDD9;RBFOX2;FOXO1;ELMO1;SIPA1L1;FGFR2;ANKS1A;CYFIP2;VAV2;IGF1R;EPHB4;MPZL1;PTPRJ;SHB;ANGPT1;YES1;BAIAP2;FOXC2;CSF1;PXN;SOCS2;GHR;ATP6V0A4;AP3S1;ARHGEF28;COL4A6;VEGFD;VEGFC;SDCBP;IGF2;AP2A2;FGF1;SULF2;PTPRG;SLC39A14;EFNA5;BDKRB2;DDR1;MAPK14;RHOA;KL;PTK2B;FOXC1;NAMPT;STAT3;EFNB1;ACTG1;POLR2A;RAPGEF1;PIK3CB;ARPC2;TIE1;KIT;TIAM1;ATP6V1G1;AKT1;EFS;GRB14;EPHA8;FRS2;IDE;ATP6V0B;KDR;FGFBP1;ARPC1B;ITGB3;ATP6V0A1;FGFR4;TCIRG1;POLR2F;FLT4;AP2A1;GIT1;EPHB2;ACTB;FER;CYBA;MET
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4025152815966782,-1.3990762433348352,0.038560411311053984,0.4185758331393113,1.0,28/73,28.66%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;OAS2;IL33;MAVS;EPHB2;CYBA;PLCG2;TLR4;ARFGEF2;RIPK1;SYK;TYROBP;CCL19;LPL;SETD4;BCL10;TWIST1;FZD5;CCR2;CLU;SPHK2
prerank,positive regulation of vasoconstriction (GO:0045907),0.6633614584206893,1.3986880686384826,0.1550925925925926,0.6500228036405871,1.0,2/13,1.04%,TBXA2R;SMTNL2
prerank,positive regulation of ruffle assembly (GO:1900029),0.6339557898365418,1.3983631882471483,0.14285714285714285,0.6489623985828671,1.0,3/13,7.27%,EPS8;EPS8L1;HRAS
prerank,Notch signaling involved in heart development (GO:0061314),0.6642112384479192,1.398263872084777,0.17016806722689076,0.6473480323052542,1.0,3/11,1.19%,HEY2;HEYL;NOTCH1
prerank,positive regulation of cyclase activity (GO:0031281),0.619668938923959,1.3982026946860342,0.178,0.6455810082454848,1.0,4/14,7.60%,CACNA1C;NF1;CACNA1D;STIM1
prerank,positive regulation of heart rate (GO:0010460),0.6164062954295451,1.3981805991334857,0.13877551020408163,0.6437475565095885,1.0,3/17,6.43%,PDE4D;ATP2A2;RYR2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4970262699645374,-1.3979442359142185,0.07066381156316917,0.4204058226883067,1.0,5/30,9.92%,IGF1;IGFBP2;IGF2;LGALS9;IL18
prerank,endodermal cell differentiation (GO:0035987),0.5499774962365936,1.397706092990018,0.12844036697247707,0.6430911234805233,1.0,9/31,7.62%,ITGA4;ITGA7;VTN;NODAL;MMP15;ITGB5;LAMB1;COL7A1;COL4A2
prerank,regulation of monocyte differentiation (GO:0045655),0.633540646512448,1.3974916339871817,0.16559139784946236,0.6417214146425546,1.0,2/14,1.10%,IL34;CDK6
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6476459137925108,1.3962955073055368,0.16356107660455488,0.6430621908944651,1.0,6/12,17.14%,PTEN;B4GALT6;ARHGAP35;EPHB1;CHRNB2;SPTBN4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5333088334434342,-1.3962659894026688,0.07518796992481203,0.42371938360517847,1.0,6/21,6.44%,FOXP1;PRKCH;ELF2;ELF1;SLC39A10;PRKCB
prerank,lipoprotein biosynthetic process (GO:0042158),-0.6231197729236282,-1.395330037440639,0.0946969696969697,0.42520511892876767,1.0,4/11,14.53%,APOE;WIPI2;ATG10;UGCG
prerank,mitochondrial membrane organization (GO:0007006),-0.47950753818921676,-1.3948368009627428,0.06722689075630252,0.4253200097656812,1.0,15/32,29.32%,MICOS10;MTX2;SLC25A4;BNIP3;SPG7;APOOL;CHCHD6;MICOS13;MAIP1;RCC1L;HSPA9;BCL2L1;TIMM50;DNAJC11;MTX3
prerank,glucan biosynthetic process (GO:0009250),0.6557583967488055,1.394427531010483,0.17291666666666666,0.6444030433322554,1.0,2/12,3.26%,PER2;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.6557583967488055,1.394427531010483,0.17291666666666666,0.6444030433322554,1.0,2/12,3.26%,PER2;UGP2
prerank,negative regulation of reproductive process (GO:2000242),-0.549123491836242,-1.394238219204174,0.11900191938579655,0.42581074703884564,1.0,6/17,14.69%,SULF1;IGF1;GJA1;DUSP1;CALR;PAEP
prerank,embryonic digestive tract development (GO:0048566),-0.5465202166722266,-1.3937082126964997,0.08812260536398467,0.4259508333918678,1.0,9/18,14.88%,PDGFRA;GLI2;PCSK5;RARB;FGFR2;STRA6;ID2;GLI3;PKDCC
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6226942386113387,-1.393137640692805,0.11753731343283583,0.4262849828349177,1.0,2/10,2.03%,ABCA1;APOE
prerank,regulation of cell adhesion (GO:0030155),-0.365203690260298,-1.3917971876347253,0.015772870662460567,0.4288517303382157,1.0,33/129,14.19%,PLXNA2;PKP4;EPHA4;ROCK2;EPHA7;FBLN1;PODXL;PLXNA4;TGM2;PTPRJ;ANGPT1;ADAM10;CXCL12;P4HB;ACVRL1;EFNA5;PTK2B;STX3;DUSP1;TGFBI;PLXND1;CDH13;PPP1CB;EPHA8;IL18;FLCN;ARHGDIA;CD164;EPHB2;CHRD;ATM;RET;FRMD5
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5416603397661496,-1.3903113120127641,0.09272727272727273,0.43163167930085916,1.0,6/18,10.28%,MDFIC;APOD;SUFU;MFHAS1;CTNNA1;FLCN
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.4025718720036149,-1.3899932670927224,0.044386422976501305,0.43127748190365883,1.0,30/77,24.51%,IGF1;SH3RF1;ITGA6;THBS1;BMP4;TGFBR1;ACVR1;TCF7L2;CFLAR;AR;AKT1;MCL1;NR4A2;RELA;QARS1;MAZ;TMBIM6;PSME3;GPX1;RIPK1;PRELID1;PARK7;PLAUR;ZMYND11;NDUFA13;TMEM14A;PIH1D1;BCL2L1;PRKN;PSMD10
prerank,fatty acid metabolic process (GO:0006631),0.4482195052502733,1.3891939912039877,0.08108108108108109,0.656952789042138,1.0,15/115,7.25%,GGT5;CEL;GGT1;PER2;ACSF2;SLC27A2;ABCD2;PPARD;SLC27A4;BAAT;ACOT12;PON2;LIPC;LIPH;AOAH
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.488980801167767,-1.3881514268243746,0.06638115631691649,0.4350809195552217,1.0,9/29,14.65%,IL31RA;IL15;SOCS2;GHR;STAT2;STAT1;STAT3;FER;PKD1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6185506580738969,-1.3880979991442126,0.11380597014925373,0.43404362577637734,1.0,5/10,21.47%,APOE;ABCA3;TMEM30A;PRELID1;DBI
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.502430999367776,-1.3879924444192364,0.0918580375782881,0.43318261085884485,1.0,10/24,17.24%,EPHA4;APOE;CTSC;TMF1;PTK2B;PSME2;UBB;PKD1;PSME3;GPX1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43598356063512084,-1.3879269782710872,0.0660377358490566,0.43218279724119996,1.0,23/50,27.20%,SH3RF1;THBS1;USP47;KLF4;GAS6;MAP2K5;FNIP1;AKT1;DNAJB6;GPX1;PARK7;LAMTOR5;MT3;PLAUR;RFFL;VEGFA;PIH1D1;YWHAE;RPS6KA3;CD44;CDKN2D;PAK2;SFN
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3802570139068247,-1.3878617317465485,0.05277777777777778,0.4311942605069798,1.0,31/95,11.52%,UST;EXT1;CHST11;ST3GAL4;DCN;B4GALT1;ST3GAL6;OGN;CEMIP;FMOD;ST3GAL1;HS3ST3A1;ST3GAL2;ANGPT1;NDST1;CSGALNACT1;HSPG2;CHSY1;HEXA;SDC4;BGN;HS6ST1;ST3GAL3;PRELP;HS3ST3B1;GLCE;DSEL;OMD;PXYLP1;CHST15;HS3ST1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.44170535214043727,-1.3878614177910524,0.06164383561643835,0.4300505091528498,1.0,16/46,9.92%,IGF1;FOXP1;ELN;IGFBP5;OGN;IL6R;APOD;THBS1;BMP4;TCF7L2;IGFBP3;STAT1;AKT1;CDH13;CCN4;IL18
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4034129338921986,-1.3873145452178077,0.033419023136246784,0.4303886817534079,1.0,21/79,10.40%,SULF1;ADAMTS12;SMAD6;SKIL;SLIT2;HTRA3;THBS1;BMPR2;SMURF2;SMAD9;SMAD7;SKI;NIBAN2;SULF2;BMPER;SMURF1;NBL1;VWC2;HGS;DAB2IP;EMILIN1
prerank,dendritic spine organization (GO:0097061),0.5584389761979154,1.387302145344087,0.12890625,0.6602395491730951,1.0,4/26,6.61%,PTEN;DOCK10;WASL;CHRNA7
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5837328541009441,1.386195705814516,0.14031620553359683,0.6611678335329967,1.0,3/19,1.42%,IL34;PTK2;JAM3
prerank,regulation of neurogenesis (GO:0050767),0.498840926170537,1.3858484330366854,0.10975609756097561,0.6602644052957563,1.0,6/55,2.65%,HEY2;HEYL;NOTCH1;PER2;GPER1;IL1B
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5837704151173815,1.385704381063238,0.16110019646365423,0.6587582976929012,1.0,7/19,9.24%,RAPSN;CHRNA3;CHRNA7;CHRFAM7A;ACHE;SLC5A7;COLQ
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.525816905609179,-1.3856939053604478,0.10187110187110188,0.4324246119551654,1.0,6/20,14.67%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),-0.525816905609179,-1.3856939053604478,0.10187110187110188,0.4324246119551654,1.0,6/20,14.67%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5852464808704254,-1.3851941851194687,0.09800362976406533,0.4326127578812321,1.0,6/13,11.74%,BMP7;SOX13;SIX1;RREB1;METRNL;PTGS2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6351518716946697,-1.385187425632968,0.10556621880998081,0.43148612888398385,1.0,5/10,24.83%,BMP4;IRF1;GLI3;MDK;LAG3
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6461382217108917,1.3851643220675045,0.17255717255717257,0.6582959063757793,1.0,4/11,8.70%,HEY2;TBX20;SOX4;JAG1
prerank,regulation of protein export from nucleus (GO:0046825),-0.5098281179360837,-1.3850703185491764,0.08771929824561403,0.43061400040271686,1.0,13/23,25.20%,PTPN14;SP100;TCF7L2;GAS6;IFI27;ANP32B;BAG3;SIRT7;TPR;PARK7;XPO4;YWHAE;TP53
prerank,regulation of stem cell proliferation (GO:0072091),-0.5501842357037322,-1.3849306926967193,0.08846153846153847,0.4298689405582796,1.0,4/17,5.95%,FBLN1;GJA1;ACE;YAP1
prerank,negative regulation of axonogenesis (GO:0050771),0.5530907789141265,1.3843670834256805,0.1526032315978456,0.6584713000690343,1.0,4/27,4.12%,PTEN;MAP2;LINGO1;FGF13
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6380363551243546,1.382557028739247,0.1643002028397566,0.6616003360885047,1.0,2/13,1.41%,HEY2;PER2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.577060991962178,-1.3822075220706216,0.11787819253438114,0.4361896306648496,1.0,9/14,28.74%,SEMA7A;WNT5A;KIT;MAVS;PLCG2;TICAM1;NR4A3;BCL10;LAPTM5
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5909387499653155,-1.382199437261708,0.10526315789473684,0.435077018779182,1.0,3/13,6.25%,SORBS1;IGF2;PRKCZ
prerank,negative regulation of cell population proliferation (GO:0008285),0.39182178867371625,1.3820279637930133,0.021013597033374538,0.66109305687783,1.0,36/351,5.73%,DLC1;PTPRK;ITGA1;PTEN;GLMN;FAP;RERG;CBFA2T3;IGFBP7;RAPGEF2;CDK6;BMP5;NOTCH1;COL4A3;NCK2;PER2;RGCC;CCN6;GPER1;FRK;TBX3;NODAL;TNS2;NF1;ERBB4;IL1B;PLXNB1;ETS1;SH2B3;MYO16;RPS6KA2;GAS8;CD300A;TNFRSF8;FABP3;TFAP2B
prerank,negative regulation of synaptic transmission (GO:0050805),0.5830628246041207,1.382014202145234,0.14587332053742802,0.6592454220277355,1.0,5/23,8.27%,PTEN;IL1B;ATAD1;SLC24A2;ACHE
prerank,glycosphingolipid metabolic process (GO:0006687),-0.43987135396103266,-1.38199088455284,0.06756756756756757,0.43450856697228213,1.0,19/42,22.61%,LARGE1;ESYT2;ST6GALNAC3;SMPD3;A4GALT;HEXA;HEXB;PSAP;B3GALNT1;ST6GALNAC6;ESYT3;UGCG;SUMF2;ST3GAL5;NEU3;GLB1;ST8SIA5;SUMF1;CLN6
prerank,stem cell development (GO:0048864),0.620369308071973,1.3813733829320292,0.15913978494623657,0.6590768492201716,1.0,4/16,9.62%,CDH2;NRG1;KLHL12;SNAI2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5836476077519894,-1.3811098494169645,0.11088709677419355,0.4357215714303006,1.0,5/13,13.24%,SEMA7A;WNT5A;IRAK3;TGFB1;PLCG2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6093441337282579,1.3808675408585842,0.16265060240963855,0.6586895663015686,1.0,3/16,3.45%,NR1H3;SCARB1;LDLR
prerank,negative regulation of secretion (GO:0051048),0.6571485603228504,1.3805843706871652,0.15904139433551198,0.6575138936274861,1.0,2/10,2.83%,NR1H3;NRG1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.47256310815665337,-1.3804513877875386,0.0915032679738562,0.4363840580039324,1.0,11/33,8.64%,GLUL;SEMA6A;ADAMTS9;THBS1;ITGA5;KLF4;KLF2;FGF1;BMPER;PIK3CB;PPP1R16B
prerank,regulation of dendrite extension (GO:1903859),0.5867542175655908,1.3801905413872297,0.13610586011342155,0.6567164052725918,1.0,5/18,10.80%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,lipid translocation (GO:0034204),-0.5196958533692363,-1.3797086439022257,0.10271317829457365,0.43727294012666196,1.0,8/21,16.80%,ABCA1;ATP10A;ABCA4;ATP9A;ATP8A1;TMEM30A;ATP11B;ATP11A
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5816688967785892,1.3791971197561663,0.130859375,0.6576759319671142,1.0,5/25,5.46%,ITGA4;ITGA7;JAM3;CTNNA3;ITGB1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4701277281698773,-1.3788339077866016,0.08924485125858124,0.438526868939656,1.0,9/32,15.69%,PRKAG2;SORBS1;APOE;ADIPOR2;AKT1;AVIL;PPARA;PRKAA2;CEACAM1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5389286924741734,-1.3784104178032777,0.0928030303030303,0.43859414680835535,1.0,7/18,21.48%,DDX60;USP15;BIRC3;PUM1;RNF125;NPLOC4;SEC14L1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.613540220748885,-1.3777512352848256,0.10909090909090909,0.43919982389428885,1.0,4/10,10.78%,DCN;LRRK2;KDR;MYOC
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5954292008517311,-1.3770157819685545,0.10412926391382406,0.43999008097158476,1.0,3/12,7.36%,FOXP1;KLF4;MAP2K5
prerank,heart development (GO:0007507),0.4341997600140192,1.376949103926501,0.0715307582260372,0.6617558985113354,1.0,15/150,3.09%,DLC1;ADAP2;CACNA1C;PTEN;TBX2;PLCE1;MEF2C;BMP5;NOTCH1;PTK2;NF1;FGF12;ERBB4;UTY;ECE1
prerank,positive regulation of cell motility (GO:2000147),-0.334109361204746,-1.3766753958181712,0.007380073800738007,0.43969580100641514,1.0,73/205,16.98%,IGF1;DAB2;PDGFD;FLT1;EGFR;CDH5;COL1A1;ROCK2;PDGFRA;NTRK3;CTSH;PDPN;SEMA3D;SEMA6A;CEMIP;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;ITGA6;THBS1;IGF1R;SEMA7A;TGFBR1;LEF1;CSF1;ADAM9;ACVR1;ADAM10;SMO;SDCBP;FGF1;CXCL12;SYNE2;SPOCK2;CAVIN1;PTK2B;SH3RF2;HSPA5;STAT3;SEMA3E;ACTG1;KIT;TIAM1;CDH13;TWIST2;MMP14;KDR;MYOC;SEMA3B;TRIP6;TGFB1;WNT5B;CCN1;EPHB2;FER;SPHK1;ATM;RET;MAZ;CLDN1;WASHC1;LAMC2;CXCL16;NTN1;SEMA3G;SEMA6B;RUFY3;SNAI1;PDGFC;WNT11
prerank,gland development (GO:0048732),-0.41097886542838297,-1.376661082176068,0.04645476772616137,0.43862506253550676,1.0,14/59,8.29%,TGFBR3;WNT4;GLI2;DKK3;CAV1;FGFR2;EZR;TGFBR1;IGSF3;ANXA1;LSR;SIX1;TBX1;STRA6
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5634450386354567,1.3764473235616572,0.1670235546038544,0.6612470417953052,1.0,3/23,3.46%,CASQ2;ATP1A2;CACNA2D1
prerank,negative regulation of potassium ion transport (GO:0043267),0.6449058949441437,1.3763294952604102,0.15575620767494355,0.659745419133377,1.0,5/13,7.85%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5446343590967446,-1.3763061363256979,0.10546139359698682,0.43844293046978744,1.0,5/18,9.29%,PRKAG2;OCLN;SLC2A1;PRKCB;C2CD5
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5441898483512828,-1.3761602372324468,0.11775700934579439,0.4377241108037883,1.0,8/17,14.62%,NPR3;FGFR2;MN1;RHOA;ATRAID;CCN1;TMEM119;SFRP1
prerank,cardiac atrium morphogenesis (GO:0003209),0.6100263319023831,1.3759054112902658,0.1629327902240326,0.6591137281750936,1.0,3/16,1.24%,HEY2;NOTCH1;TBX20
prerank,positive regulation of autophagy (GO:0010508),-0.4033030115629299,-1.3758302715489379,0.03768115942028986,0.4374974201614722,1.0,29/81,20.10%,DAPK1;DCN;FOXO1;FOXO3;LRRK2;TPCN1;PLK2;PIK3CB;IRGM;ATF6;KDR;FLCN;ZC3H12A;BNIP3L;OPTN;TRIM27;SH3GLB1;LARP1;BNIP3;TICAM1;PRKAA2;TRIM8;TRIM14;SH3BP4;PARK7;TMEM59;PIM2;IKBKG;ORMDL3
prerank,purine ribonucleotide transport (GO:0015868),-0.5594838366285947,-1.375760707164283,0.09456740442655935,0.4365913168891557,1.0,5/16,10.76%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,endothelial cell differentiation (GO:0045446),-0.6025389401720019,-1.375559942853955,0.09622641509433963,0.4360249668898759,1.0,7/12,16.15%,FSTL1;BMPR2;ACVRL1;TIE1;KDR;SOX18;KDM6B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6395906912901551,1.3751732735953177,0.1716101694915254,0.6592830330819547,1.0,2/11,5.01%,LIMD1;AJUBA
prerank,cellular response to interferon-beta (GO:0035458),-0.5625818365266053,-1.3748829264545432,0.11560693641618497,0.4366541283819616,1.0,8/14,24.18%,IRF1;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6
prerank,positive regulation of macroautophagy (GO:0016239),-0.44190670189224035,-1.3747037935787885,0.06132075471698113,0.43609599269890553,1.0,20/48,19.24%,DCN;HSPB8;RAB3GAP1;VPS13D;SLC25A4;IRGM;BAG3;KDR;BNIP3L;OPTN;PIP4K2B;SH3GLB1;UVRAG;LARP1;BNIP3;SPTLC2;PRKAA2;RAB3GAP2;ADRB2;IKBKG
prerank,positive regulation of dendrite extension (GO:1903861),0.5920740085241476,1.3746612835862706,0.1512770137524558,0.658811218469682,1.0,5/17,10.80%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,negative regulation of secretion by cell (GO:1903531),0.5283143941351174,1.3745010954357024,0.13595706618962433,0.6574015427577831,1.0,5/38,6.31%,GRM7;NOTCH1;RHBDF1;HTR1B;SNCA
prerank,supramolecular fiber organization (GO:0097435),-0.317694598971186,-1.3744422686654985,0.0,0.4357485854968657,1.0,82/333,12.83%,TSPAN5;COL1A2;SNCAIP;COL3A1;COL5A2;COL1A1;ADAMTS2;COL22A1;GSN;COL12A1;RHOBTB1;COL5A1;FIGN;LOXL1;SHROOM2;CD2AP;ELMO1;COL6A3;APP;COL25A1;DLG1;COL8A2;COL6A1;ITGA6;VIM;TLL1;SHROOM3;COL4A5;COL6A2;PLEC;TGFBR1;COL11A1;B2M;CLIP4;FBLN5;ARHGEF2;COL4A6;COL23A1;ADAM10;HSPG2;HDGFL3;PLOD2;COL13A1;ARHGAP17;PGM5;IAPP;SERPINH1;SHROOM4;P4HB;RHOA;RHOB;FKBP1A;GGA2;H3-3A;CST3;CYP1B1;COL18A1;FAT1;ITGB4;TGFBI;TRIOBP;COL14A1;GFAP;DPT;SPAST;EMILIN1;MAP7D3;COL16A1;LAMA3;AVIL;MFAP4;ADAMTS14;ADAMTS3;COL20A1;COL9A2;LUM;TRPV4;EVL;CCDC88C;ACTN1;MDM2;UBB
prerank,regulation of cholesterol esterification (GO:0010872),-0.6148172734940465,-1.3743253712692591,0.10036496350364964,0.43496032975115484,1.0,4/10,18.89%,APOE;STARD4;AGTR1;AGT
prerank,regulation of monooxygenase activity (GO:0032768),-0.5011331026035903,-1.3742177792426773,0.10843373493975904,0.43416216097381966,1.0,8/23,9.87%,EGFR;POR;CAV1;NOS3;DDAH1;AKT1;NOS1AP;LYPLA1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6035030866074321,-1.3735502458835673,0.11065573770491803,0.43477440796006916,1.0,4/12,5.52%,IQGAP1;PODXL;MAGI2;PROM1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5869708394476632,1.3735069539643026,0.15587044534412955,0.6583112252288839,1.0,4/19,1.75%,HEY2;HEYL;NOTCH1;SLIT3
prerank,cellular component assembly (GO:0022607),0.3989070177311658,1.3734717685969307,0.04291287386215865,0.6566053594965856,1.0,35/253,8.49%,MYO1B;LIN7A;EPS8;CALD1;LIMS1;AIF1L;LAMC1;VASP;WASF3;FERMT2;WAS;RSPH6A;LRRTM3;SPEF1;WIPF1;SH3BP1;TTLL3;SPTBN1;JHY;RAC3;WASL;RIMS1;PDCD10;GAS8;YTHDF3;ANK3;FBLIM1;YWHAZ;PLS3;RSPH1;LRGUK;DARS1;REC8;TEX12;CFAP46
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.5319341628023748,-1.373448631655207,0.08946322067594434,0.43395864196610695,1.0,3/18,2.80%,EPHA4;ROCK2;SLC2A13
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4852252220516554,-1.3733455043600835,0.0970464135021097,0.43319342761007434,1.0,15/27,22.02%,SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;ARL6IP5;SLC7A1;SLC25A22;SLC22A2;SLC25A29;SLC1A1;SLC38A1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.45615002174087455,-1.3730348348282497,0.09090909090909091,0.43295108183279446,1.0,14/36,18.96%,PDGFD;ERRFI1;EPHA7;ENPP1;RASSF2;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC;CHP1;PPP2R5C
prerank,regulation of wound healing (GO:0061041),0.5006642640269615,1.3721070146125394,0.11764705882352941,0.6583963114637807,1.0,9/42,7.27%,VTN;AJAP1;PTK2;MYLK;CADM4;FGF2;ITGB1;ARFGEF1;HRAS
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.611931055203369,1.3706359847874292,0.17832957110609482,0.6604787014447239,1.0,2/12,2.65%,GCNT2;IL1B
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4215202438490851,-1.370499025974383,0.07390300230946882,0.4387717518422942,1.0,23/57,22.59%,GLUL;SDAD1;RPS19;NAF1;CUL4A;RPL11;RPS16;PAK1IP1;RPS24;RPL26;RPL14;RPL7;BYSL;RPS6;RPS15;EBNA1BP2;RBIS;RPL38;RPS25;RPS7;RIOK2;URB2;RPL35A
prerank,response to interferon-beta (GO:0035456),-0.5126703165466031,-1.3700474567311316,0.1069182389937107,0.43887051681241085,1.0,11/22,25.35%,IFITM3;IRF1;IKBKE;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6;PLSCR1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5388285229126794,1.3698889568533055,0.1270718232044199,0.6607282954066419,1.0,5/32,3.59%,CARMIL1;PLCE1;PIK3R1;PIK3CA;ABI2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3880185830745117,-1.3698545560466973,0.0387409200968523,0.4383422283257946,1.0,25/82,9.84%,BMP6;RANBP3L;IGF1;SMOC1;SMAD6;WNT4;BMP7;TMEM64;HDAC7;IL6R;SUFU;FGFR2;BMP4;BMPR2;IL6ST;DDX5;ACVR1;SKI;ZHX3;YAP1;FBN2;NOCT;ATRAID;TWIST2;CCN4
prerank,carnitine metabolic process (GO:0009437),-0.5907905791229999,-1.3693538675888115,0.09719626168224299,0.43853896588131985,1.0,5/12,17.16%,CPT1A;CPT2;TMLHE;ACADL;CPT1C
prerank,phospholipid homeostasis (GO:0055091),-0.5984700091828931,-1.3683816728976455,0.10752688172043011,0.44002505637113165,1.0,3/11,8.52%,ABCA1;RCN3;TLCD2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5725312170646418,-1.3676859045489331,0.10566037735849057,0.4408011590180208,1.0,9/14,29.26%,LRRK2;TMBIM6;CREB3;CREB3L1;PARK7;XBP1;BCL2L1;PRKN;SYVN1
prerank,retinol metabolic process (GO:0042572),-0.5671398625922849,-1.3676323413259253,0.12244897959183673,0.4398972082927329,1.0,4/14,13.62%,DHRS3;RBP4;CYP1B1;ADH1A
prerank,regulation of stress fiber assembly (GO:0051492),0.48148340148114244,1.3673188026502,0.08928571428571429,0.6657209226583811,1.0,11/74,3.13%,DLC1;CARMIL1;ARHGAP6;PIK3R1;RGCC;PHLDB2;PPM1E;FERMT2;ROCK1;WAS;LIMK1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5883060791587915,1.3672338538424207,0.1448692152917505,0.6641337145805578,1.0,4/21,2.15%,ASPN;HEY2;NOTCH1;ROCK1
prerank,positive regulation of cell migration (GO:0030335),-0.32642781811294797,-1.3669036275957867,0.0,0.44072618340989633,1.0,74/253,13.56%,IGF1;DAB2;DOCK5;PDGFD;FN1;FLT1;EGFR;CDH5;COL1A1;ROCK2;PDGFRA;NTRK3;NRP1;CTSH;PDPN;SEMA3D;SEMA6A;CEMIP;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;PLCG1;ITGA6;THBS1;IGF1R;BMPR2;SMURF2;SEMA7A;TGFBR1;RAB11A;LEF1;CSF1;ARHGEF2;ADAM9;ACVR1;ADAM10;SMO;SDCBP;FGF1;CXCL12;SYNE2;PRKCE;PTK2B;SH3RF2;HSPA5;STAT3;SEMA3E;ACTG1;KIT;TIAM1;RREB1;HIF1A;CDH13;TWIST2;MMP14;CCN4;DAB2IP;KDR;MYOC;SEMA3B;PFN1;TRIP6;TGFB1;WNT5B;CCN1;EPHB2;FER;SPHK1;PLCG2;ATM;RET
prerank,pyroptosis (GO:0070269),-0.5642731765534057,-1.366765542259453,0.0935672514619883,0.44004328842403634,1.0,4/15,10.47%,GSDME;CASP4;CASP8;GSDMD
prerank,negative regulation of B cell proliferation (GO:0030889),0.639895829700702,1.366460448140264,0.1917808219178082,0.6645156315349521,1.0,3/11,9.19%,TNFRSF21;CD300A;LYN
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6217018000584735,1.366093179671141,0.1830065359477124,0.6637189447086541,1.0,3/11,6.88%,CACNB2;CACNA2D1;BIN1
prerank,regulation of plasminogen activation (GO:0010755),-0.59794606190854,-1.365525861732274,0.09003831417624521,0.44223892918228846,1.0,6/12,21.57%,THBS1;CLEC3B;ENO1;SERPINE1;PLGRKT;SERPINE2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6003687322666645,-1.364546206323502,0.14416058394160583,0.44379084425771326,1.0,3/11,10.66%,DAB2;EZR;RAB21
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5632578289268739,-1.3639877604027029,0.10384615384615385,0.44417534484527815,1.0,7/16,16.84%,APOD;PDCD4;APPL2;ADCY7;ZC3H12A;PPARA;SIRPA
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5578238704536007,1.36372998135485,0.15648854961832062,0.6679356171467956,1.0,5/27,6.81%,MAP3K20;MAP3K5;BTRC;TNIP2;KAT7
prerank,embryonic limb morphogenesis (GO:0030326),0.544484472068388,1.3636528707125164,0.1425959780621572,0.6663665838295962,1.0,5/34,3.09%,CACNA1C;TBX2;MAP3K20;TBX3;ECE1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.5115858667319962,-1.363245623805537,0.10784313725490197,0.44505591211480283,1.0,4/22,12.22%,ALDH1A2;RBP1;CUBN;VKORC1L1
prerank,protein depolymerization (GO:0051261),-0.48942755871416493,-1.3630948141367474,0.08739837398373984,0.4444237000429717,1.0,3/27,1.87%,MICAL3;GSN;MICAL2
prerank,muscle organ development (GO:0007517),0.4969368463290895,1.3630904424172177,0.11052631578947368,0.6660942983818469,1.0,6/54,1.70%,LAMA2;UTRN;MEF2C;DMD;ITGA7;CACNA1H
prerank,glucose transmembrane transport (GO:1904659),0.5893020333438416,1.3625599902257954,0.17025440313111545,0.6657333662595293,1.0,7/18,12.83%,SLC5A1;SORT1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.47568591615967654,-1.3616482300291062,0.084,0.4471182824464635,1.0,10/28,19.51%,PRKAG2;ADIPOR2;TNFRSF1B;CD47;NOS1AP;AVIL;FGFR4;PRKAA2;SIRPA;ADIPOR1
prerank,regulation of interleukin-2 production (GO:0032663),0.5137269748498543,1.3599912689772078,0.12363636363636364,0.6707726068729788,1.0,6/43,6.28%,PDE4D;GLMN;IL1B;SPTBN1;NAV3;PDE4B
prerank,protein deacylation (GO:0035601),-0.499710291093827,-1.3599446382125016,0.09683794466403162,0.4505312631710692,1.0,12/23,20.77%,HDAC4;HDAC7;LYPLA1;NOTUM;HDAC1;ABHD17C;HDAC5;LYPLAL1;SIRT7;SIRT2;SIRT3;SIN3A
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.39726644316870907,-1.3598512052567175,0.04738154613466334,0.4496939064861111,1.0,34/68,36.14%,APP;IL6R;LBP;ARHGEF2;IL16;LGALS9;WNT5A;STAT3;IL33;IL17RA;MAVS;CYBA;PLCG2;TLR4;POU2F2;SYK;TYROBP;RAB7B;XBP1;LPL;IL17D;MYD88;SETD4;BCL10;TWIST1;SPHK2;F2R;AIF1;TLR7;C1QTNF4;TLR6;CD74;TLR1;NOS2
prerank,protein localization to cell-cell junction (GO:0150105),-0.5682966043231635,-1.3587999040027376,0.11350293542074363,0.45134174296778923,1.0,7/15,13.17%,CDH5;TJP2;LSR;ACTG1;F11R;ACTB;ARHGEF18
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.44057978248837004,1.3584717541589584,0.08333333333333333,0.6731510239579138,1.0,29/118,11.25%,CHN1;MEF2C;PID1;NEDD4L;CDH2;SDC2;HECW2;PHLDB2;FERMT2;NF1;LRRC4C;CDX1;ETS1;CHRNA3;ABI2;FGF2;TSPAN12;CLASP2;EMP2;MARK2;ADGRB3;ARHGAP35;HECW1;ZMYM3;EPHA2;SARM1;BRSK1;PAK3;PAK1
prerank,regulation of macroautophagy (GO:0016241),-0.36995925128021756,-1.3578645264812037,0.03722084367245657,0.4528226089566908,1.0,33/105,21.15%,PRKAG2;DCN;SNX6;LRRK2;SNX32;EXOC4;CLEC16A;NRBP2;CAPNS1;ATP6V1G1;AKT1;CAPN1;ATP6V0B;KDR;BNIP3L;ERN1;VPS35;ATP6V0A1;SH3GLB1;PRKAG3;PRKAB1;LARP1;BNIP3;PRKAA2;ATP6V0A2;TBC1D25;RRAGB;QSOX1;LAMTOR5;IKBKG;ATG101;USP36;PRKAG1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6027510841540427,-1.3575792135932463,0.10861423220973783,0.45255891186901553,1.0,7/11,15.74%,THBS1;CD34;LGALS9;PTGS2;GATA6;CD200;BMPR1A
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.6082263304394717,-1.3573915222575785,0.14625228519195613,0.4520001335308284,1.0,5/10,14.08%,EPHA4;ANXA2;ATRAID;DAB2IP;RGP1
prerank,amino acid transport (GO:0006865),0.5004377831373842,1.3572014578057516,0.12321428571428572,0.6747642501006793,1.0,3/49,2.21%,SLC38A11;SLC1A5;SLC1A4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4769916933854895,-1.35696871294404,0.11776859504132231,0.45200406236248825,1.0,8/28,12.83%,NOD1;IRAK2;LACC1;MAP2K6;IRGM;CASP8;RELA;UBB
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4421778910212521,-1.3565469000532158,0.06132075471698113,0.4520364318118498,1.0,21/42,31.70%,REV1;POLH;UBB;RPA1;RFC3;VCP;USP43;UBE2L6;POLI;RFC1;USP10;RPA3;POLA1;CDKN2D;POLD1;DTL;ISG15;WRN;PCNA;PARP10;RFC5
prerank,intracellular lipid transport (GO:0032365),-0.5056960328865525,-1.356344416005348,0.09166666666666666,0.45150336946168407,1.0,7/21,10.05%,PRKAG2;CERT1;CPT1A;SLC25A20;NPC2;CPT2;ACACA
prerank,dopamine metabolic process (GO:0042417),-0.5190245326313573,-1.3562501643404816,0.11316872427983539,0.45073068302158315,1.0,5/18,11.69%,SNCAIP;MOXD1;MAOA;MAOB;GCH1
prerank,cellular potassium ion homeostasis (GO:0030007),0.6252660017283435,1.3561030826132001,0.18947368421052632,0.6759397027674213,1.0,4/13,4.90%,SLC12A2;ATP1A2;ATP1A4;ATP1B2
prerank,regulation of cation channel activity (GO:2001257),0.4507700099814318,1.3557811883777109,0.1069182389937107,0.6750616864544553,1.0,23/89,12.45%,PDE4D;MEF2C;DMD;CACNB2;KCNG1;FGF12;CACNG7;FGF13;MINK1;ITGB1;GRIA2;ANK3;KCNE5;STAC;HPCA;NETO1;GRIN2B;GSG1L;DLG2;FGF11;FGF14;PIRT;DLG3
prerank,cellular response to drug (GO:0035690),0.5641892825512246,1.3557767391849138,0.15151515151515152,0.6733061243420707,1.0,5/25,6.28%,MEF2C;PPM1E;IL1B;HTR1B;PDE4B
prerank,cellular iron ion homeostasis (GO:0006879),-0.42420479913472103,-1.3552641565755787,0.05755395683453238,0.4522739639953661,1.0,23/55,28.21%,BMP6;CP;SCARA5;ABCG2;SLC39A14;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;HFE;ATP6V0A2;CYB561A3;FTH1;FRRS1;CCDC115;NUBP1;TMEM199;ATP6AP1;SMAD4;ATP6V0D1;ALAS2;ATP13A2
prerank,regulation of establishment of cell polarity (GO:2000114),-0.5495980721261801,-1.354236950967423,0.10865191146881288,0.45384094365026295,1.0,5/16,6.79%,CDH5;ROCK2;GSN;RAP1B;PTK2B
prerank,cellular amino acid catabolic process (GO:0009063),-0.3830510372326432,-1.353657693982731,0.056555269922879174,0.4542575090410095,1.0,43/87,36.14%,GLUL;DDO;NOS3;ALDH7A1;IVD;ASPA;DDAH1;CARNMT1;ALDH4A1;PRODH;GLS;BCKDHB;AUH;PIPOX;CARNS1;CBS;NOS1;HOGA1;BCKDK;HNMT;BCKDHA;GCDH;ABAT;AMT;HMGCL;KYNU;ALDH6A1;AASS;MTRR;BLMH;FAH;HYKK;BCAT1;ALDH5A1;SHMT1;GLDC;IL4I1;HGD;HAAO;ACADSB;HMGCLL1;HSD17B10;NOS2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.3419173532333813,-1.3533904538062536,0.017241379310344827,0.4538887738533904,1.0,45/186,14.70%,NXN;MCC;DAB2;TRABD2B;IGFBP2;WWOX;BICC1;VGLL4;TMEM64;DKK3;APOE;CAV1;RNF213;IGFBP6;NKD1;TLE4;NFATC1;MLLT3;LRP6;TCF7L2;RNF43;IGFBP4;SOX13;PFDN5;SFRP4;WNT5A;SCYL2;AMFR;FZD4;TLE2;NOTUM;DAB2IP;TLE1;ZNRF3;PSME2;MDFI;CCDC88C;HDAC1;PSMB4;GLI3;SOX17;PSMD8;PSMB1;SFRP1;PSMD11
prerank,response to cytokine (GO:0034097),-0.35483828752419694,-1.3532773497278854,0.0379746835443038,0.4531449065779957,1.0,27/141,7.60%,TIMP3;DPYSL3;ALDH1A2;AFF3;SMAD3;COL3A1;NFAT5;PTPN14;HDAC4;PTPN13;SP100;APP;IL6R;IL1R1;IL6ST;TIMP2;LEF1;ADAM9;ANXA1;ADAM10;IRAK2;IFITM3;LGALS9;IKBKE;RHOA;STAT1;STAT3
prerank,erythrocyte differentiation (GO:0030218),-0.42769153975306107,-1.3531432196171058,0.07900677200902935,0.4524475967231817,1.0,22/44,27.65%,TGFBR3;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;CEBPG;ALAS1;ID2;TAL1;HIPK2;ZFPM1;PTPN2;CDK5RAP3;HSPA9;VEGFA;LYAR;NCKAP1L;ACIN1;ALAS2;HCLS1
prerank,adenine nucleotide transport (GO:0051503),-0.5413405727243161,-1.3531399463331772,0.09879032258064516,0.45143156306860116,1.0,5/17,10.76%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,protein import into peroxisome matrix (GO:0016558),0.624386086617661,1.3531100616522,0.19037199124726478,0.6785913911808312,1.0,7/12,24.23%,PEX7;PEX5L;PEX1;PEX12;PEX2;PEX5;PEX6
prerank,alcohol catabolic process (GO:0046164),0.6515358916989288,1.353047568859703,0.1839080459770115,0.6770052544100122,1.0,2/10,2.21%,CEL;SCARF1
prerank,regulation of cellular component size (GO:0032535),0.5368197386862428,1.352474151988119,0.154,0.6767981367134748,1.0,2/30,0.42%,EPS8;PTEN
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.43332699772311467,1.3522724174528609,0.08588957055214724,0.6755966696818632,1.0,12/110,3.98%,S1PR3;PTH1R;ADGRL3;TBXA2R;GNG2;RAPGEF2;UCN2;ADORA2A;GPER1;ADCY3;ADCY8;ADCY6
prerank,lymphocyte migration (GO:0072676),-0.4671507665218203,-1.3520583375131046,0.084070796460177,0.45307531396664175,1.0,25/32,51.42%,CCL15;CCL14;CCL25;S1PR1;RET;CCL13;CCL19;CKLF;CCL2;MYO1G;CX3CL1;ZAP70;CCL5;ADAM8;CCL4;GATA3;CRTAM;CCL8;MSMP;CCL7;CCR6;CCL1;CCL3;CCL11;TBX21
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5615204188605897,1.3519330674863324,0.14901960784313725,0.674601809503309,1.0,5/23,9.65%,PTEN;INPP5J;MTMR12;INPP5B;MTMR7
prerank,regulation of fat cell differentiation (GO:0045598),-0.39348525050179467,-1.35108337471384,0.0582010582010582,0.4545981226962707,1.0,24/74,15.19%,SMAD3;ZBTB16;MEDAG;TMEM64;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;SYAP1;NOCT;TRIO;WDFY2;AKT1;CMKLR1;ANKRD26;CARM1;ZC3H12A;GATA2;TGFB1;ID2;SFRP1;FTO;ZFPM1
prerank,ketone body metabolic process (GO:1902224),-0.6227167872554048,-1.3510234402178662,0.11262135922330097,0.45374270190542226,1.0,4/10,14.78%,ACSS3;HMGCS2;BDH1;BDH2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.43952475592161355,-1.3507572041103288,0.08430913348946135,0.45343616681579674,1.0,13/39,14.65%,NRP1;GLI2;SLIT2;TGFBR2;BMP4;LRP6;RASIP1;SIX1;SEMA3E;TIE1;KDR;MET;PKD1
prerank,regulation of peptidase activity (GO:0052547),-0.5186700524267481,-1.3502896494786476,0.11844660194174757,0.45370240106950704,1.0,6/19,12.75%,CTSH;CAV1;RCN3;CST3;ECM1;HDAC1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.61967744056535,1.3500761543163133,0.17913385826771652,0.6777708726111552,1.0,2/14,0.66%,MEF2C;PRKG1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4550067916270265,-1.3490788592340806,0.1036036036036036,0.45565780962375,1.0,5/34,2.80%,IGF1;EPHA4;ROCK2;APOE;SLC2A13
prerank,oogenesis (GO:0048477),0.6107635648974964,1.3483954366934754,0.19047619047619047,0.6806486689942293,1.0,6/15,18.23%,PTN;FMN2;MEI4;NANOS1;TRIP13;KMT2D
prerank,neuron projection development (GO:0031175),0.41243266940927,1.3483139720576534,0.0715307582260372,0.6791250430326566,1.0,29/168,11.25%,GRM7;FRY;PTEN;DOCK10;RAPGEF2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;SVBP;MINK1;CNTNAP2;LAMB1;RYK;CNTN4;NYAP2;TAOK3;MAP4K4;MARK2;BLOC1S1;TMEM108;LYN;PLP1;NCKAP1;PRMT1;PAK3;PAK1
prerank,microtubule bundle formation (GO:0001578),0.5093353779215289,1.3476161403111457,0.1282952548330404,0.6792645431563349,1.0,13/42,11.55%,MTCL1;RSPH6A;SPEF1;NCKAP5;TTLL3;JHY;GAS8;TPPP;RSPH1;LRGUK;CFAP46;KIF20A;CCDC66
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5632262383731523,-1.3472179172337317,0.12737642585551331,0.45978261485923455,1.0,8/14,24.63%,DPYD;UPB1;UPP2;NT5E;NT5C1A;ERH;CAD;NT5C
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5375916054103064,1.3468763532999024,0.15310077519379844,0.6795193225567102,1.0,3/31,5.44%,GLMN;TNFRSF21;CD300A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5622794039623836,1.346776787285391,0.17564870259481039,0.6780600717355875,1.0,8/24,10.32%,ITPR2;ITPR1;FGF2;RYR2;HTR2C;PKD2;RYR3;CHERP
prerank,response to thyroid hormone (GO:0097066),-0.5674201415590834,-1.3466166242846094,0.13693693693693693,0.4604163421818094,1.0,5/13,12.18%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.5121098310216012,-1.3454821113180324,0.11088295687885011,0.4625028266186716,1.0,10/21,19.50%,MCU;TGM2;SLC8A3;RAP1GDS1;MCUB;AFG3L2;BCAP31;MICU2;MICU1;MAIP1
prerank,purine nucleotide metabolic process (GO:0006163),-0.49163644532025086,-1.343131896505328,0.11568627450980393,0.4677425275732059,1.0,12/24,24.63%,FHIT;XDH;PRPS2;NT5E;GDA;GPX1;PRPS1;PRPS1L1;NT5C1A;PNP;NT5C2;NT5C
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.29972238756362096,-1.3426980442585583,0.0,0.4677684004031332,1.0,125/572,14.00%,NFIB;BMP6;FOXP2;PRDM6;DAB2;AEBP1;SMAD3;SMARCA2;ZBTB16;FOXP1;WWOX;HDAC4;CUX1;TBL1XR1;GLI2;FHL2;WWC2;NFIX;LCOR;SP100;GLIS3;OSR1;SKIL;FOXO3;NR3C1;DLG1;HDAC8;CAV1;RARB;ESR1;SUFU;FGFR2;BMP4;EZR;SMURF2;RPS14;DNMT3A;KLF4;DDX5;FOXC2;SMAD7;KLF2;HDAC9;ID1;TAF1;TCF7L2;ETV6;THRB;SKI;MXI1;PARP9;SDCBP;IGF2;ZFPM2;GATAD2A;WWP2;GTF2IRD1;AR;CREM;RARG;GLIS2;FOXP4;SOX13;YAP1;BHLHE40;ATN1;KMT5A;PRDM16;ATXN1;ID3;IRF2;FOXC1;CHD3;BPTF;HIVEP1;GLIS1;STAT1;MAP2K5;FNIP1;NR2C2;STAT3;KLF10;IFI27;ZNF219;RTF1;ZBTB18;RREB1;BAG3;IL33;KLF12;NR4A2;BHLHE41;DAB2IP;FLCN;ZKSCAN3;TGIF1;PRDM5;TRIM27;MDFI;CPEB3;ZMYM5;NSD1;PTCH1;MEF2A;LRRFIP1;ID2;PPARA;RELA;CBX4;MDM2;HDAC1;UBB;GLI3;CALR;ZGPAT;EZH1;GATA6;CCND1;ZNF568;RPL10;PPID;ZBTB4;KCNIP3;SARS1;HDAC5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5873513473012343,-1.3423567451128584,0.13717693836978131,0.4676609147950998,1.0,6/11,25.20%,HSPA5;ATF6;CREB3L1;CEBPB;ATF3;TP53
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.51605267794735,1.341920080317322,0.14629629629629629,0.688818184573049,1.0,12/41,10.32%,ITPR2;TRPV2;CACNA2D1;ITPR1;FGF2;SLC24A2;RYR2;HTR2C;PKD2;RYR3;GRIN2B;CHERP
prerank,smooth muscle cell differentiation (GO:0051145),0.6340877453803666,1.3413313519477141,0.17782426778242677,0.6887422042180734,1.0,2/12,0.70%,MEF2C;HEY2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5648201942593571,-1.3409497806682378,0.11695906432748537,0.47052069233646837,1.0,2/13,3.19%,GLI2;BMP4
prerank,cytosolic calcium ion transport (GO:0060401),0.5435791762047609,1.3408499919786716,0.1797752808988764,0.688371675434274,1.0,6/28,6.43%,CACNA1C;ATP2A3;CACNA2D1;ATP2B3;ATP2A2;RYR2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.44633968328000534,-1.3400932770744598,0.10752688172043011,0.4719086663866065,1.0,12/36,11.69%,EGFR;APOE;CAV1;NPR3;NOS3;DDAH1;PIK3CB;AKT1;NOS1AP;HIF1A;LYPLA1;GCH1
prerank,positive regulation of cell junction assembly (GO:1901890),0.4855992611215727,1.34008484282498,0.12564543889845095,0.6886677436407588,1.0,16/56,13.35%,ACE2;LIMS1;CLSTN1;FERMT2;ROCK1;NRXN1;CLSTN3;CNTNAP2;MAP4K4;IL1RAPL1;EPHA2;NPHP4;CUX2;EPHB1;SLITRK2;NLGN3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5129940090126213,1.33974227000187,0.11895910780669144,0.6878826005177472,1.0,3/40,1.34%,PTEN;GLMN;PTK2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5374378474590858,-1.3392315923231106,0.13709677419354838,0.47318025800987623,1.0,5/16,6.92%,RBFOX2;ESR1;DDX5;AR;EGLN2
prerank,ERBB2 signaling pathway (GO:0038128),0.5306560186920166,1.33882408758306,0.14857142857142858,0.6886320141325416,1.0,5/31,3.05%,GAB1;PIK3R1;ERBB4;NRG1;PIK3CA
prerank,thyroid hormone generation (GO:0006590),-0.6037424842167862,-1.3387934877039618,0.13805970149253732,0.47332605636510516,1.0,2/10,12.46%,CPQ;SLC5A5
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.48910637465389084,-1.338411137847987,0.11673151750972763,0.4733223421600983,1.0,9/24,10.78%,CDH5;TEK;ANGPT1;RAMP2;GAS6;NDNF;ICAM1;KDR;GATA2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5642716736809876,-1.3383872102076915,0.12403100775193798,0.47235182787537777,1.0,4/13,12.60%,NFIB;BMP4;PPARA;RELA
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5080369204613522,-1.338094364964697,0.12015503875968993,0.47201489994491586,1.0,8/21,19.24%,FOXP1;PRKCH;SLC39A10;PRKCB;RELA;RAB29;CD81;IKBKG
prerank,prostanoid metabolic process (GO:0006692),-0.5565561000836721,-1.3376925536794717,0.13988657844990549,0.4720625431173096,1.0,6/13,26.39%,PTGS1;ACOX1;GSTM1;PTGR2;PTGR1;PTGES
prerank,nucleoside catabolic process (GO:0009164),-0.6007477525830902,-1.336390935167148,0.14744801512287334,0.47450531107412164,1.0,7/11,24.63%,DPYD;UPB1;UPP2;NT5E;DERA;NT5C1A;NT5C
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5828837377874054,1.3362788040036513,0.1910828025477707,0.693706263400486,1.0,5/18,6.61%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7
prerank,regulation of receptor internalization (GO:0002090),-0.4478670340525396,-1.3361395171894372,0.10438413361169102,0.4741200485137783,1.0,16/35,29.01%,RIN3;ANGPT1;MAGI2;SDCBP;ARRB1;SFRP4;SCYL2;ATXN2;ANKRD13D;VEGFA;NTF3;ANKRD13A;TBC1D5;CD63;PICK1;MKLN1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.3163015373807073,-1.335452884955369,0.0,0.4748060919579728,1.0,81/348,13.42%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;CDH5;ROCK2;GSN;NTRK3;CTSH;OCLN;BMP7;OSR1;APP;F3;WNT6;CLDN5;ITGB8;ANXA2;NOS3;BMP4;EZR;GJA1;FOXD1;TGFBR1;ANGPT1;MAGI2;KLF4;LEF1;CSF1;KLF2;RAMP2;CD34;HOXA5;SMO;GAS6;ARRB1;MED26;FGF1;RAB27A;AR;LGALS9;MOV10;YAP1;SFRP4;WNT5A;MAPK14;MAP2K5;SCYL2;HINFP;TFRC;STAT3;ACTG1;PIK3CB;DTNBP1;AKT1;DTX3L;HGS;NOS1AP;HIF1A;IL33;TLE1;ZC3H12A;EMILIN1;GATA2;P2RX7;VPS35;RPL11;SEC16B;TGFB1;FGFR4;ID2;EPHB2;TMEM119;EPHX2;PRKAB1;PLCG2;WNT16;ATM
prerank,regulation of mitochondrial fission (GO:0090140),-0.48919649394572173,-1.3353075125172629,0.10493827160493827,0.4742102898766249,1.0,13/24,25.06%,DCN;MCU;LRRK2;STAT2;KDR;VPS35;BNIP3;MYO19;CYRIB;DDHD1;RALBP1;PRKN;INF2
prerank,regulation of mitochondrial fusion (GO:0010635),0.6287777913607604,1.3353023467465783,0.17758985200845667,0.694590875150464,1.0,2/11,2.75%,PID1;PLD6
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5138434290958547,-1.3346011511677167,0.12781954887218044,0.4751066953620182,1.0,4/19,2.55%,ROCK2;PRKCH;OCLN;CLDN5
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5187659159916611,-1.334463672497173,0.11422845691382766,0.47449604139497653,1.0,6/18,12.83%,RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,acute inflammatory response (GO:0002526),-0.48930381865566175,-1.3339254238293214,0.12450592885375494,0.4748720833341296,1.0,4/23,6.64%,F3;IL6R;LBP;ANO6
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4275749317937011,-1.3338167310997344,0.0915032679738562,0.47410960019615067,1.0,19/44,27.20%,SH3RF1;THBS1;USP47;CAST;KLF4;GAS6;MAP2K5;FNIP1;AKT1;DNAJB6;GPX1;LAMTOR5;MT3;VEGFA;YWHAE;RPS6KA3;CD44;CDKN2D;SFN
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5548820983440534,1.333584522675629,0.17835671342685372,0.6976224247154157,1.0,2/21,1.88%,PTEN;BTRC
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.476196102564479,1.3334824307329123,0.15198618307426598,0.6961367853125012,1.0,16/54,12.63%,NEDD4L;GNG2;KCNJ12;KCNMB1;STK39;AKAP6;DPP10;KCNAB3;BIN1;CACNA1D;KCNE5;KCNJ3;KCNJ6;KCNIP1;KCNIP4;KCNMA1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5660774368207968,-1.3330353947584364,0.12643678160919541,0.4751246634574402,1.0,2/13,0.59%,IGF1;PLCB1
prerank,positive regulation of translational initiation (GO:0045948),0.5706396232035342,1.3325397615784507,0.18661257606490872,0.6969227735476478,1.0,10/18,18.93%,DAZL;RPS6KB2;YTHDF3;BOLL;DDX3X;MTOR;YTHDF2;RPS6KB1;HABP4;POLR2D
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6380561663045695,1.3318396441244502,0.18762886597938144,0.6970180294989802,1.0,3/10,3.73%,NEDD4L;HECW2;STK39
prerank,peptidyl-amino acid modification (GO:0018193),0.6225930686146952,1.331483801560614,0.18629550321199143,0.6962651356252456,1.0,2/10,3.66%,METAP2;ATP7A
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5205984977153697,-1.3311569568696882,0.12,0.4792089667127902,1.0,6/17,22.21%,LGALS9;PRKCZ;SLC7A5;CEBPB;SYK;RARA
prerank,protein N-linked glycosylation (GO:0006487),-0.3934578722503719,-1.3302410162199014,0.07532467532467532,0.48072999912740555,1.0,21/66,20.67%,B4GALT1;MAN1C1;ST3GAL1;STT3A;STT3B;FUT8;MGAT1;SLC39A8;LMAN1;MGAT2;ENTPD5;GFPT2;ALG6;MCFD2;OST4;ASGR1;RPN2;GFPT1;DOLPP1;OSTC;MOGS
prerank,acylglycerol homeostasis (GO:0055090),0.5783702862435272,1.3299388564317782,0.17083333333333334,0.698635466650777,1.0,4/20,6.99%,RORA;NR1H3;SCARB1;LIPC
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4554621552604273,1.3297886627932316,0.1302170283806344,0.6972944465734491,1.0,12/72,4.13%,PDGFRB;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PLXNB1;PIK3CA;NCF1;FGF2
prerank,regulation of chemokine production (GO:0032642),-0.44819640282545153,-1.3290206950809134,0.08958333333333333,0.4830198011793244,1.0,20/36,34.85%,FOXP1;APP;IL6R;LGALS9;WNT5A;HIF1A;IL33;IL18;TLR4;CSF1R;SIGIRR;LPL;EGR1;IL7;HMOX1;AIF1;ADAM17;TREM2;TLR7;CD74
prerank,cellular response to alkaloid (GO:0071312),0.5806874111938369,1.3286699135528797,0.1891348088531187,0.6985803255275446,1.0,4/17,8.72%,CASQ2;HTR1B;RYR2;RYR3
prerank,plasma membrane tubulation (GO:0097320),-0.5701077719074634,-1.3277298431825433,0.14230019493177387,0.4854273156124444,1.0,6/13,17.18%,SNX9;CAVIN2;FNBP1L;CHMP4A;EHD2;MICALL1
prerank,Ras protein signal transduction (GO:0007265),0.41697726241004496,1.327618324113107,0.11487481590574374,0.6996881463557647,1.0,25/137,8.68%,EPS8;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP6;RASGRP2;ARHGAP1;RASGRP3;ROCK1;NF1;WAS;LIMK1;CDC42EP1;ABI2;FGF2;RTKN;EPS8L1;RIT2;RAP1A;HACE1;HRAS;CDKN1A;ARHGDIB;GNA12
prerank,positive regulation of peptidase activity (GO:0010952),-0.5048145019022258,-1.326869270837993,0.12815126050420167,0.48672094809701305,1.0,11/20,33.03%,CTSH;RCN3;PSME2;PSME3;PRELID1;VCP;NDUFA13;NCSTN;VSIR;APH1A;PINK1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.46229411853586944,1.326779625214006,0.11932773109243698,0.7002786073830156,1.0,20/75,13.57%,MEF2C;FARP1;BTBD3;SDC2;MAP2;MINK1;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;CTNNA2;BRSK1;PAK3;ZDHHC17;RB1;SLITRK2;ABITRAM
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5695229453685102,-1.326377179479032,0.13099630996309963,0.48697815955510876,1.0,3/12,12.93%,LPCAT3;P4HB;MFSD2A
prerank,negative regulation of leukocyte activation (GO:0002695),0.5933180132186617,1.3263156728687495,0.21158129175946547,0.6997862919176752,1.0,5/15,6.10%,GPER1;NR1H3;LRFN5;CD300A;IL4
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5149630697815382,-1.3262498409190686,0.12601626016260162,0.48632029108698843,1.0,6/18,16.00%,LBP;THBS1;WNT5A;IL33;KARS1;TLR4
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5655008474840496,-1.32615368144418,0.13980582524271845,0.4855950082617711,1.0,3/13,5.97%,GLUL;DDO;ASPA
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.5258348930665655,-1.3261108245971391,0.13221601489757914,0.48468370686965545,1.0,7/16,22.94%,CLEC16A;FLCN;GPR137;RRAGB;SIK3;LAMTOR5;PIH1D1
prerank,regulation of membrane repolarization (GO:0060306),0.6346912217801525,1.3260813870666701,0.2065439672801636,0.6987371905934842,1.0,5/13,7.85%,CASQ2;NEDD4L;CACNA2D1;AKAP6;KCNE5
prerank,retinoid metabolic process (GO:0001523),-0.3899059393558054,-1.3258035755162998,0.07272727272727272,0.48450050815481643,1.0,14/71,9.61%,ALDH1A1;ALDH1A2;RBP1;APOE;CYP26B1;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;ABCA4;CYP1B1;STRA6;SCPEP1
prerank,inhibitory synapse assembly (GO:1904862),0.6321029394982127,1.3258000786218436,0.18237704918032788,0.6977685258294014,1.0,4/11,6.03%,PLXNB1;FGF13;GABRG2;GABRA2
prerank,regulation of cytokine production (GO:0001817),0.42433844524322284,1.3251510872496997,0.11509715994020926,0.6978078935810124,1.0,15/126,9.62%,ACE2;GLMN;PLA2R1;PIK3CD;AFAP1L2;RGCC;RPS6KA4;CARD9;MOG;SCAMP5;NLRP4;TRAF3;LYN;LURAP1;SNAI2
prerank,histone H3 acetylation (GO:0043966),-0.4411128517776888,-1.3240520850233701,0.09565217391304348,0.4883876568543603,1.0,23/40,32.00%,KAT6B;KAT2B;LEF1;KAT14;TADA1;TRIM16;MEAF6;TADA2A;BRCA2;YEATS2;BRPF3;PHF14;TAF5;JADE1;BRD1;BRPF1;SGF29;ING4;TAF6L;JADE3;NAA60;POLE3;MAP3K7
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6392267355417446,1.3236831478306041,0.19480519480519481,0.6999668982895416,1.0,3/10,6.28%,CACNB2;CACNA2D1;PDE4B
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.48120117344967733,-1.3233198577594862,0.12698412698412698,0.48924588906739697,1.0,7/25,6.22%,SULF1;ZNF423;CDH5;BMP4;BMPR2;FOXD1;ACVRL1
prerank,regulation of ossification (GO:0030278),-0.44706471670134873,-1.3233136458053434,0.14224137931034483,0.4882605104642166,1.0,14/36,9.99%,ZBTB16;SMAD6;ENPP1;SGMS2;ANKH;BMP4;BMPR2;LRP6;ACVR1;CHSY1;BMP2K;WNT5A;ECM1;NOTUM
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.4469810963062286,-1.322419500445834,0.11231101511879049,0.48975989272267956,1.0,14/37,16.84%,APOD;PDCD4;APPL2;ADCY7;MAPK14;STAT3;HIF1A;IL17RA;ZC3H12A;GBP5;PPARA;TICAM1;TLR4;SIRPA
prerank,negative regulation of inflammatory response (GO:0050728),0.40321379552057385,1.3224116921547253,0.08442503639010189,0.7014847815749954,1.0,24/182,7.25%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;RORA;ADORA2A;GPER1;NR1H3;MYH9;PRKAR1B;ADCYAP1R1;GIPR;LRFN5;ADCY3;ADCY8;ADCY6;PPARD;NPSR1;IL4;PRKAR2B;GPR45;ADCY9;AOAH
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5357421673516405,1.321986123002824,0.1588785046728972,0.700894245011855,1.0,7/27,9.32%,PDGFRB;RGCC;FGF2;TNKS;CDKN1A;PRKD2;PDGFB
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.404533579082098,-1.3218618302795053,0.10513447432762836,0.49022967512207594,1.0,26/55,27.14%,WWOX;CAV1;NUPR1;TGFBR1;GSDME;TNFSF10;BCL2L11;BECN1;DAB2IP;PML;TRIM39;BCAP31;BID;RIPK1;AGT;TPD52L1;BBC3;DEDD2;BCL2L1;CRADD;TP53;RACK1;FAS;RPS3;BCL10;PAK2
prerank,positive regulation of protein transport (GO:0051222),-0.38762977633380735,-1.321154672219522,0.0851063829787234,0.4911506850513308,1.0,19/67,19.62%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;GOLPH3;MYH10;TGFB1;PPID;PPIA;SYTL4;RUFY3;TPR;OAZ1;RAB29;CHP1;VPS28
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5216376853363308,1.32099271350334,0.1586998087954111,0.7017365991468599,1.0,10/33,13.35%,CEL;LRRC4C;EIF4EBP2;GRIK1;NRG3;GRID1;CACNA1A;GRIK5;GRIK2;NLGN3
prerank,negative regulation of transport (GO:0051051),0.47019512138494013,1.3208458494789348,0.15232974910394265,0.7004243137709449,1.0,7/51,6.31%,PTEN;DYSF;NR1H3;NRG1;NDFIP2;SCAMP5;SNCA
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.43604491756794805,-1.3208240477726638,0.10559006211180125,0.49100506925168086,1.0,9/36,11.70%,AFDN;VAMP5;MACF1;KIF13A;RILPL1;GGA2;GOLPH3;OPTN;RAB7A
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5655444873268305,1.320700296565829,0.1864754098360656,0.6991775519651462,1.0,2/21,3.41%,SLC30A10;ABCD2
prerank,secretory granule organization (GO:0033363),-0.5893918123098494,-1.3206089459639812,0.15955473098330242,0.490596597783293,1.0,3/10,8.42%,ABCA1;SRGN;DTNBP1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.5125658913855774,-1.3204089598899065,0.12845849802371542,0.4901577866749257,1.0,3/19,12.58%,IGF1;ZC3H12A;GIT1
prerank,protein autoubiquitination (GO:0051865),-0.38853052867176074,-1.3200030124539628,0.07674418604651163,0.49026149005271796,1.0,24/61,26.21%,RNF220;SH3RF1;RNF213;RNF146;WWP2;SH3RF2;AMFR;SH3RF3;RNF185;DTX3L;MDM2;RNF181;RNF115;TRIM17;RNF187;UBE3D;RNF122;BRCA1;PRKN;RNF19B;RNF8;BFAR;RNF11;OBI1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.48298640223063033,-1.3198110435516972,0.14942528735632185,0.4898046516389677,1.0,7/24,7.48%,DPYSL3;NRP1;PALM;RHOQ;FNBP1L;ARAP1;DOCK11
prerank,regulation of metal ion transport (GO:0010959),0.5768930652814973,1.3195803715392027,0.18979591836734694,0.7004490423994396,1.0,4/16,7.60%,SLC30A10;EPB41;CACNA2D1;STIM1
prerank,positive regulation of neuron differentiation (GO:0045666),0.4996838893180688,1.319308401745582,0.1696113074204947,0.6994463091254082,1.0,6/40,8.37%,MEF2C;HEYL;ZEB1;BRINP1;BEND6;BRINP3
prerank,cellular defense response (GO:0006968),0.4984446900892372,1.3190933365243085,0.1586452762923351,0.698332626472578,1.0,8/40,8.04%,IL1RL2;NCF2;ADORA2A;NCF1;ITGB1;CXCR2;KLRG1;CCR9
prerank,signal transduction by p53 class mediator (GO:0072331),-0.45443303762388476,-1.319002791640584,0.12606837606837606,0.4910220741987369,1.0,4/30,4.94%,PPP1R13B;FHIT;DDX5;ACER2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6200691019515255,1.318755306099598,0.18502202643171806,0.6975766565435255,1.0,4/10,12.11%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,cytoskeleton organization (GO:0007010),0.4230600837618024,1.3185212524648515,0.10802919708029197,0.6965751358944487,1.0,14/114,5.01%,MAST4;PLCE1;LIMD1;ARHGAP10;SH3KBP1;DPYSL2;MARK1;WASF3;RND3;SIPA1;ABI2;RAC3;FMNL3;AJUBA
prerank,postreplication repair (GO:0006301),-0.4234387674532385,-1.3181295895817866,0.1066350710900474,0.49227538640075696,1.0,21/45,31.70%,REV1;POLH;UBB;RPA1;RFC3;VCP;USP43;UBE2L6;POLI;RFC1;BRCA1;USP10;RPA3;WDR33;POLD1;DTL;ISG15;PCNA;UBE2V1;PARP10;RFC5
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5379293956076572,-1.3180661620422132,0.1391941391941392,0.491423466729988,1.0,6/15,12.75%,GLI2;WNT6;LRP6;FOXC1;TBX1;HDAC1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5354022735604006,1.3177219937156608,0.1727447216890595,0.6970254980567526,1.0,9/31,12.45%,LIN7A;MTCL1;SH3BP1;CRB1;MARK2;CAMSAP3;DLG2;PARD3B;DLG3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5047930881094527,-1.3173841071811916,0.1317365269461078,0.4922350159745274,1.0,10/21,24.29%,LRRK2;BCL2L11;TMBIM6;CREB3;CREB3L1;PARK7;XBP1;EIF2AK3;BCL2L1;PRKN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6153494208159351,1.317356588533153,0.19402985074626866,0.6963778670479359,1.0,2/13,2.18%,PLA2R1;SPRED1
prerank,modulation by symbiont of host process (GO:0044003),-0.5936109865224717,-1.3170980802893006,0.14205607476635515,0.4920740772936104,1.0,5/10,23.25%,B2M;HGS;UBB;ENO1;MRC1
prerank,negative regulation of gene expression (GO:0010629),-0.32036023546046477,-1.3168512527528013,0.028708133971291867,0.4917968120526931,1.0,67/302,13.40%,NOTCH2;IGF1;ROBO1;SLC24A3;DAPK1;LGR4;SAMD4A;ROCK2;FOXP1;WNT4;OCLN;IGFBP5;APOE;APP;CLDN5;ITGB8;ESR1;XDH;BMP4;DNMT3A;KLF4;KAT2B;HDAC9;TAF1;CD34;RBBP7;ADAM10;PARP9;SMO;CNOT7;WWP2;SRGN;PARP14;LGALS9;MOV10;RNF139;YAP1;ACVRL1;SLC7A5;DDX6;RPS13;HINFP;PGR;NOCT;H3-3A;IGF2BP2;HIF1A;KDR;FLCN;ZC3H12A;EMILIN1;FLOT2;JARID2;GATA2;ANXA7;ERN1;TRIM27;CPEB3;TGFB1;TWSG1;ID2;NUDT12;HDAC1;ATOH8;CALR;CNOT8;LARP1
prerank,nervous system development (GO:0007399),0.36734366396917506,1.315952864807418,0.045077105575326216,0.6984042526742853,1.0,94/429,13.73%,RAPGEF5;SERPINI1;PTEN;MEF2C;ADGRL3;CDH2;KALRN;DPF3;FARP1;BTBD3;SEMA5A;ST8SIA4;ADORA2A;DPYSL2;TBX3;MERTK;NF1;PCDHB11;GFRA2;LSAMP;ZEB2;PTN;FGF12;ERBB4;GBX2;CHAC1;NRG1;NAB1;LIMK1;NRXN1;TBX6;CHRNA3;GRIK1;AXL;FGF13;FGF2;DNER;NAV3;ACAN;ROGDI;RYK;MYLIP;SCN2A;FEZ2;SREBF2;MOG;CNTN4;NINJ2;RBFOX3;ASIC2;PCDH1;ANKLE2;SCN8A;LIG4;ROBO2;CNTN6;PPT1;IGSF8;NES;ACHE;ITM2B;PKD2;ADAM23;JAG1;SLITRK1;ACTL6B;MARCKS;TRAK1;GDF11;BTBD6;NCKAP1;CHERP;APBA2;VLDLR;SPOCK1;FGF11;SOX6;AHI1;IL1RAPL2;TRAK2;EP300;APC;MYT1L;PPP2R5D;EPHB1;ARHGAP26;GFRA1;ZC4H2;NLGN3;APC2;RPS6KA6;DSCAM;FEZ1;RITA1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5824727082381926,-1.3158479853829896,0.15625,0.49343337328006787,1.0,5/11,8.79%,IGF1;PLCB1;IGF1R;GHR;AKT1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5288512608297146,1.3158199179735823,0.16996047430830039,0.6971488104363405,1.0,8/27,13.81%,PTEN;MARK1;NTNG2;IL1RAPL1;CTNNA2;BRSK1;PSEN1;ULK4
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6005560024300365,1.3157218090913037,0.18736383442265794,0.6957936624772996,1.0,2/14,1.34%,IL34;PTK2
prerank,positive regulation of T cell migration (GO:2000406),-0.49730819310578633,-1.314414264505152,0.1350806451612903,0.49632253854653335,1.0,6/20,6.86%,APP;ADAM10;CXCL12;WNT5A;RHOA;WNK1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5042403029368311,1.314335410269441,0.15855855855855855,0.6978300638962566,1.0,5/41,1.24%,MEF2C;HEY2;HEYL;NOTCH1;TBX20
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6454230020395458,1.3141928768279991,0.189010989010989,0.6966525845316167,1.0,2/11,1.66%,MEF2C;GPER1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.420575580611894,-1.3126624785366008,0.09772727272727273,0.5000252575085917,1.0,12/45,11.18%,SP100;B2M;VCAM1;IRF1;ICAM1;IRF2;STAT1;PRKCD;IRF9;OAS2;PML;CAMK2A
prerank,regulation of filopodium assembly (GO:0051489),-0.4317410808110406,-1.312150675110888,0.11416490486257928,0.5003413454301308,1.0,10/38,8.64%,DPYSL3;NRP1;PALM;RHOQ;CAPZB;FNBP1L;ARAP1;DOCK11;PRKCD;PPP1R16B
prerank,regulation of synapse assembly (GO:0051963),0.4937412962350469,1.312131653522087,0.17086330935251798,0.7004056603169259,1.0,17/46,15.64%,MEF2C;CLSTN1;SLIT1;NRXN1;LRFN5;CLSTN3;SNCA;ROBO2;IL1RAPL1;SLITRK1;IL1RAPL2;CUX2;EPHB1;SLITRK2;NLGN3;CHRNB2;SYNDIG1
prerank,defense response to protozoan (GO:0042832),-0.552445170729254,-1.312047239732303,0.17055655296229802,0.4996227936853547,1.0,8/12,32.46%,GBP4;GBP6;GBP7;GBP2;MYD88;LYST;BATF2;CD40
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6135614543250806,1.3116044127521795,0.19917864476386038,0.7002301239346803,1.0,5/12,11.73%,GGT1;CTH;SEPHS2;PSAT1;SRR
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.4783439703688316,-1.311477101101344,0.13473684210526315,0.5001984816515854,1.0,6/23,14.67%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.33704100423445715,-1.3111226968845242,0.032846715328467155,0.5000664709164664,1.0,48/182,12.97%,NOTCH2;IGF1;ROBO1;SLC24A3;ROCK2;FOXP1;WNT4;OCLN;APOE;APP;CLDN5;ITGB8;RIN3;ESR1;XDH;BMP4;KLF4;TAF1;CD34;ADAM10;PARP9;SMO;SDCBP;CNOT7;WWP2;PARP14;LGALS9;MOV10;YAP1;ACVRL1;SLC7A5;HINFP;PGR;NOCT;HIF1A;KDR;FLCN;ZC3H12A;EMILIN1;FLOT2;GATA2;ATXN2;OPTN;ANXA7;TGFB1;ID2;HDAC1;ATOH8
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5549821904074304,-1.311009763810911,0.15355805243445692,0.4994058565253201,1.0,4/12,11.72%,ESR1;STAT3;ZC3H12A;TGFB1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.45754770803093003,-1.3104537462866988,0.14221218961625282,0.49992995589787254,1.0,14/29,26.15%,TLE4;LEF1;TCF7L2;TRRAP;TLE2;TLE1;BCL9L;HDAC1;PYGO2;SMARCA4;PYGO1;TCF7;CTNNB1;BCL9
prerank,limb morphogenesis (GO:0035108),-0.5019126014306056,-1.3104534170816826,0.13840155945419103,0.49894584181145946,1.0,7/20,12.87%,PCSK5;CYP26B1;MBNL1;LRP6;SKI;PTCH1;GLI3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6180755000131433,1.3103475656592334,0.2028985507246377,0.7019391186233355,1.0,4/12,6.88%,CACNA1C;CTNNA3;RYR2;BIN1
prerank,neurotransmitter transport (GO:0006836),0.4462233214169744,1.3099927162835414,0.1423841059602649,0.701287454877308,1.0,19/73,13.36%,LIN7A;ATP1A2;NRXN1;SNAP25;RIMS1;SYN2;GABRA2;SYN1;SLC32A1;SYT1;SLC5A7;SLC6A15;GRM4;STXBP2;BRSK1;GAD1;GLS2;PPFIA2;SLC29A2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5965296068898926,-1.3096741510321643,0.1634980988593156,0.5000564166662164,1.0,5/10,23.38%,FN1;GATA6;HSP90AB1;TYROBP;CDH3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.35855852354346424,-1.3096313782324083,0.06017191977077364,0.49920111723466093,1.0,23/104,7.15%,LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;BMPR2;SMURF2;TGFBR1;SNX6;MAGI2;SMAD9;SMAD7;ACVR1;SKI;CCN3;BMPER;SMURF1;NBL1;PRDM16;VWC2;FKBP1A
prerank,mitochondrion morphogenesis (GO:0070584),0.6286475380850198,1.3093706123608313,0.20518358531317496,0.7013086003421691,1.0,3/11,12.59%,PID1;SUPV3L1;MFF
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4778353736438517,-1.3091885528882734,0.13995943204868155,0.49944090655266904,1.0,13/24,25.11%,COL5A1;PDPN;ITGA5;ACVRL1;DDR1;RHOA;CCN1;CEACAM1;CD151;TMEFF2;RHOC;LCP1;CD44
prerank,positive regulation of nuclear division (GO:0051785),0.5337066601600826,1.3089704859135012,0.19019607843137254,0.700748680252201,1.0,3/25,2.65%,PDGFRB;RGCC;IL1B
prerank,regulation of water loss via skin (GO:0033561),-0.5348624225390999,-1.3087295032549124,0.1568627450980392,0.49865549936925574,1.0,9/15,36.11%,LSR;MET;CLDN1;UGCG;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,establishment of skin barrier (GO:0061436),-0.5348624225390999,-1.3087295032549124,0.1568627450980392,0.49865549936925574,1.0,9/15,36.11%,LSR;MET;CLDN1;UGCG;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5923692341998642,-1.3084126808282097,0.15487571701720843,0.4985157252802481,1.0,6/10,25.20%,MLLT3;ACE;SFRP1;LMBR1L;SP7;TP53
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5154174151823633,1.3080347909034642,0.1856060606060606,0.7016363760916968,1.0,11/34,15.42%,MEF2C;MPP2;CHRNA3;GABRG2;GABRA2;GRIN2B;GABRA5;GABRA4;NLGN3;GRIN2A;INSYN2A
prerank,positive regulation of vascular permeability (GO:0043117),-0.5610037405438053,-1.3073716088203822,0.18482490272373542,0.5003602984792899,1.0,4/12,3.58%,BMP6;TJP2;OCLN;ANGPT1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6296303186644905,1.307211013750123,0.21348314606741572,0.7021277542292338,1.0,3/10,6.72%,PTH1R;SNCA;IRS1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.46235323531719075,-1.306315394135326,0.1447084233261339,0.502386599922829,1.0,6/26,14.66%,ST3GAL4;LARGE1;ST3GAL2;GOLPH3;ALG6;GCNT1
prerank,sphingoid metabolic process (GO:0046519),-0.5563943322783675,-1.3053369030086361,0.17623762376237623,0.5040627067889107,1.0,5/12,13.22%,PLPP3;NAAA;DEGS2;PLPP1;SPHK1
prerank,positive regulation of kinase activity (GO:0033674),-0.3493382833890488,-1.305257394741622,0.050156739811912224,0.5032885743875609,1.0,31/107,13.56%,PRKAG2;EPHA4;EPHA3;FLT1;EGFR;PDGFRA;EPHA7;NTRK3;LMO4;TEK;IQGAP1;FGFR2;IGF1R;EPHB4;SNX9;RASSF2;CSF1;GAS6;DDR1;PTK2B;ALS2;TIE1;KIT;EPHA8;KDR;FGFR4;CCN1;FLT4;EPHB2;MET;RET
prerank,regulation of developmental growth (GO:0048638),-0.4512471926141758,-1.3050825808504398,0.11789473684210526,0.502793707967859,1.0,6/29,6.19%,IGF1;PLCB1;APOE;APP;GHR;SIX1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.475844119101043,1.3040969882838285,0.1616871704745167,0.7085547262811055,1.0,8/46,4.54%,ITGA4;LAMC3;PIK3R1;LAMC1;PEAK1;FERMT2;NTNG2;LAMB1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4466188339231967,-1.304007845641783,0.12678936605316973,0.5048751436441944,1.0,9/31,22.36%,PLCB1;IL16;LGALS9;MAPK14;PLCG2;TLR4;SYK;MDK;CCL19
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4530741619241121,-1.3033567014770622,0.13125,0.5056670856752259,1.0,10/33,6.22%,MCC;DCN;SP100;APOE;ADAMTS9;SLIT2;PTPRM;THBS1;PTPRG;ACVRL1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5711700575496392,1.3031904305087567,0.19696969696969696,0.7093202029961359,1.0,2/16,5.35%,TNFRSF21;TRIB2
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.5065504919046012,-1.302133922658173,0.14519427402862986,0.5078831197100041,1.0,9/18,22.58%,ADAMTS9;STT3B;FUCA1;SAMHD1;DERA;NAGA;MANBA;NGLY1;FBXO17
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.438155119639605,-1.302059369518127,0.11403508771929824,0.5070962316801428,1.0,16/37,26.75%,CAV1;NUPR1;GSDME;BCL2L11;BECN1;EIF5A;UBB;BCAP31;BID;RPS7;BBC3;BCL2L1;TP53;RACK1;RPS3;MSX1
prerank,response to retinoic acid (GO:0032526),-0.3927931483335806,-1.3018858826304387,0.09336609336609336,0.5065753042483757,1.0,17/59,13.56%,EPHA3;CTSH;WNT6;RBP4;WNT9A;ACER2;RARG;WNT5A;PTK2B;TBX1;FZD4;TRIM16;FZD7;WNT5B;ATM;GATA6;RET
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.47936283484886455,-1.3015545586212465,0.14663951120162932,0.506421239625337,1.0,3/22,2.80%,EPHA4;ROCK2;SLC2A13
prerank,ion transport (GO:0006811),0.4206140760279514,1.3010313088894534,0.11782477341389729,0.7133019247971307,1.0,12/111,7.04%,ANO1;TRPC6;SLC12A2;ATP1A4;CHRNA3;SLC24A4;SLC24A2;SLC12A6;SLC26A1;CHRNA7;SLC32A1;SLC15A2
prerank,response to growth factor (GO:0070848),-0.4193615483885347,-1.3004005403533434,0.11496746203904555,0.5086892691834902,1.0,13/41,15.83%,TGFBR2;BMPR2;TGFBR1;KLF4;ACVR1;ACVRL1;MAP2K5;AKT1;SPHK1;GATA6;SFRP1;BMPR1A;NOS1
prerank,striated muscle cell differentiation (GO:0051146),0.5610442688461583,1.3003337163120823,0.20436507936507936,0.7135042196388505,1.0,5/16,6.74%,MEF2C;NRG1;SORT1;POPDC3;SIK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5631856548023241,-1.2999365847316746,0.14629629629629629,0.508995179106829,1.0,3/12,16.00%,RBP4;STRAP;TLR4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5107846460662394,-1.2995039429509556,0.15090543259557343,0.5091365618791385,1.0,8/18,17.80%,CDH5;ROCK2;TEK;RAP1B;PTK2B;LLGL2;RUFY3;CYRIB
prerank,protein localization to organelle (GO:0033365),-0.34034886802497144,-1.2993480989277928,0.036923076923076927,0.5085362302304424,1.0,47/133,25.00%,ZNF423;COL1A1;LAMP2;BMP7;APP;BMP4;TRAM2;RAB11A;LRRK2;SIX1;EHD1;OBSL1;ARL3;TULP3;STX1A;TOR1AIP1;OPTN;VPS35;GBP5;RPL11;MDM2;ALDH3A2;CALR;SCG3;RPA1;TTC21B;TMEM30A;VAPA;SNX10;GBP2;HHEX;MICALL1;LAMP5;RAB6A;GET1;CEP68;WDR35;TULP1;FAM83H;SEC61B;GAK;CNTLN;RIPOR1;CCDC47;WDR83OS;YWHAE;BBS9
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.580405314473996,-1.299047470579566,0.15789473684210525,0.5083989421382129,1.0,4/11,15.69%,SMAD7;AHR;HFE;CEACAM1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3895747940420361,-1.2985023992893578,0.10526315789473684,0.5069308794790588,1.0,33/61,33.26%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;LMAN1;SEC16B;TRAPPC3;TRAPPC4;F5;ANKRD28;MCFD2;NAPA;SEC23IP;SAR1B;BET1;TMED2;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;PREB;TRAPPC2L;SEC16A;GOLGA2;CNIH2;TMED10;SEC24B;SCFD1
prerank,vesicle coating (GO:0006901),-0.3895747940420361,-1.2985023992893578,0.10526315789473684,0.5069308794790588,1.0,33/61,33.26%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;LMAN1;SEC16B;TRAPPC3;TRAPPC4;F5;ANKRD28;MCFD2;NAPA;SEC23IP;SAR1B;BET1;TMED2;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;PREB;TRAPPC2L;SEC16A;GOLGA2;CNIH2;TMED10;SEC24B;SCFD1
prerank,COPII vesicle coating (GO:0048208),-0.3895747940420361,-1.2985023992893578,0.10526315789473684,0.5069308794790588,1.0,33/61,33.26%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;LMAN1;SEC16B;TRAPPC3;TRAPPC4;F5;ANKRD28;MCFD2;NAPA;SEC23IP;SAR1B;BET1;TMED2;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;PREB;TRAPPC2L;SEC16A;GOLGA2;CNIH2;TMED10;SEC24B;SCFD1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3419846219488742,-1.297984944767211,0.06086956521739131,0.507433268099145,1.0,27/121,9.92%,BMP6;IGF1;EPHA4;NRP1;IL31RA;NEDD9;PECAM1;IL15;IL6R;IL6ST;ITGA5;PTPRJ;ANGPT1;ARHGEF2;ACVR1;GHR;PARP9;GAS6;IGF2;PARP14;ACE;EFNA5;PTK2B;STAT3;KIT;TNFRSF1A;IL18
prerank,axonogenesis (GO:0007409),0.3866069213263131,1.2977611144722454,0.09711286089238845,0.7185305250577687,1.0,35/237,7.83%,NOTCH3;PTEN;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PIK3CA;NRXN1;SPTBN1;NTNG2;RYK;SEMA6C;GRB10;FEZ2;SPTB;CNTN4;SLITRK5;ANK3;DOK4;B4GALT6;SPTA1;ROBO2;CNTN6;CCK;NRXN3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6076163780009565,1.2964023245839902,0.21555555555555556,0.720356217449563,1.0,3/13,4.42%,NOTCH1;TBX3;SOSTDC1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.515147644027805,-1.2959760961431808,0.15310077519379844,0.5118158829754567,1.0,6/17,7.75%,ANXA4;KLF4;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,defense response to symbiont (GO:0140546),0.43564170514504325,1.2955623734724462,0.14691943127962084,0.7208679151449527,1.0,1/92,0.01%,ABCC9
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6152912655283936,1.2954587507818494,0.23689727463312368,0.7195380986263534,1.0,2/13,2.46%,SPAAR;SESN3
prerank,regulation of anoikis (GO:2000209),0.5461857152940126,1.2952233720726787,0.2210953346855984,0.7185074881062462,1.0,8/19,12.36%,NOTCH1;PTK2;PIK3CA;ITGB1;SIK1;SNAI2;ANKRD13C;SRC
prerank,secretion (GO:0046903),-0.5409428927364335,-1.2944835014306806,0.15555555555555556,0.5149741243084625,1.0,6/14,16.46%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;SLC22A2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5858764832656105,-1.2944797636393723,0.1704119850187266,0.5140213991633789,1.0,5/10,10.06%,DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.40551831299825186,1.2942571076624851,0.11396011396011396,0.7193857045551993,1.0,24/163,11.25%,PDE4D;MEF2C;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;RFTN1;WAS;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;PRKD2;CSK;TEC;EIF2B3;BLNK;PAK3;PAK1
prerank,regulation of interleukin-6 production (GO:0032675),-0.35594801008650495,-1.2942331755642025,0.06233062330623306,0.5137635165555928,1.0,36/96,26.85%,APP;IL6R;LBP;ARHGEF2;GAS6;ARRB1;IL16;LGALS9;WNT5A;CD47;STAT3;C1QTNF3;IL33;IL17RA;ZC3H12A;MAVS;IRAK3;CYBA;PLCG2;CD200;TLR4;SIRPA;POU2F2;SYK;TYROBP;RAB7B;XBP1;PTPN6;LPL;IL17D;MYD88;NCKAP1L;CD200R1;SETD4;BCL10;TWIST1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.41100470244076404,-1.2941130369750016,0.15258215962441316,0.5131387196671008,1.0,23/47,29.32%,MICOS10;MTX2;ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;AFG3L2;TIMM13;TIMM8B;MAIP1;TIMM9;NDUFA13;HSPA9;ATP5MC2;ATP5F1E;DNAJC11;TIMM10;MTX3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.44444565660995294,1.2939842084531372,0.15639810426540285,0.7185099336587717,1.0,16/87,8.93%,DLC1;PDGFRB;EPS8;RND3;ROCK1;GRHL3;PIK3CA;SH3BP1;RAC3;CORO2B;ESAM;TESK1;MTOR;ARHGDIB;CORO1A;ARHGAP35
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5436376820696792,1.2933352785296217,0.1797752808988764,0.7185416635237909,1.0,2/21,0.78%,MBOAT2;PLA1A
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5270035509081863,-1.2930447232429623,0.16226415094339622,0.5150201817350368,1.0,4/15,8.47%,PIEZO2;COL11A1;ADGRV1;KIT
prerank,response to hydroxyurea (GO:0072710),0.6055435614902768,1.2928969792872462,0.2184873949579832,0.7181351941200381,1.0,6/11,19.96%,KAT7;TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.3590890474330005,-1.2923864005706323,0.06906077348066299,0.5158386390674943,1.0,43/88,28.65%,TRABD2B;SMAD3;CDH5;BMP7;SDCBP;SMPD3;SYNPO2;PDCD6IP;SDC4;SYNPO;FNIP1;TFRC;HGS;BCL2L11;DAB2IP;EMILIN1;PFN1;RAB7A;TGFB1;SH3GLB1;TAL1;SDC1;BID;TPR;STX18;PARK7;VCP;SYK;RHOC;PLEK;VEGFA;PIH1D1;ERCC1;SLX4;ICE1;RACK1;RPS3;BIK;SLF1;MPP7;ATP13A2;CLU;CHGA
prerank,mesenchymal cell differentiation (GO:0048762),0.46502509230937233,1.2922409412540365,0.161231884057971,0.7182734512508668,1.0,7/51,2.15%,LIMS1;MEF2C;HEY2;HEYL;NOTCH1;TBX20;ROCK1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5459541561936191,1.2921936315807425,0.21825396825396826,0.7168366868946421,1.0,5/17,10.34%,WASF3;ABI2;WASF2;NCKAP1;CTNNA2
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.5728131045922901,-1.2920175886349063,0.17184643510054845,0.5158852027318916,1.0,5/11,21.41%,LPCAT3;ATL2;BNIP1;STX18;MOSPD3
prerank,embryonic organ development (GO:0048568),-0.3885693463588775,-1.291708101617298,0.09685230024213075,0.5157149738064567,1.0,25/61,15.93%,PBX1;GLI2;PBX3;PCSK5;RBP4;RARB;TGFBR2;FGFR2;COL13A1;TEAD4;TEAD1;STRA6;KIT;KDR;TGFB1;FLT3LG;GLI3;MFSD2A;SOX17;TAL1;RPL10;PKDCC;ZFPM1;BMPR1A;SOX18
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.46154695185564465,-1.291471203380956,0.12364425162689804,0.515382688743194,1.0,6/26,10.91%,LGR4;APPL2;IRF1;BIRC3;FLOT2;IRAK3
prerank,cellular response to cadmium ion (GO:0071276),-0.46070032653918513,-1.2914070829258821,0.14087301587301587,0.5146199707849333,1.0,12/24,19.78%,EGFR;AKT1;MAPK3;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5272181855790709,-1.29107715987155,0.16824196597353497,0.514502235797066,1.0,6/15,22.36%,ATL2;REEP1;RAB18;ZFYVE27;REEP2;TMEM33
prerank,microtubule anchoring (GO:0034453),0.5940842578684539,1.291072543352763,0.18840579710144928,0.7181578489837163,1.0,5/12,18.67%,CLASP2;BICD2;CAMSAP3;GCC2;BCCIP
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5886037065564294,1.290913524027279,0.22340425531914893,0.7169495862235761,1.0,3/13,6.43%,HEY2;NOTCH1;RYR2
prerank,positive regulation of cellular component organization (GO:0051130),-0.3527111374402661,-1.2903366194619104,0.06470588235294118,0.5154683082618339,1.0,35/107,20.04%,DAB2;TRABD2B;ATP10A;CDH5;BMP7;APOE;FRMPD4;SHANK3;IGF1R;TGFBR1;ASAP1;ADGRL1;AR;FNIP1;TFRC;BCL2L11;DAB2IP;ADD1;LMAN1;TGFB1;SH3GLB1;BNIP3;TAL1;SURF4;TMEM30A;BID;GPX1;CD151;PARK7;NOX1;VCP;SYK;LRP4;TMED9;RHOC
prerank,regulation of cell division (GO:0051302),-0.3711025047286936,-1.2896797690704673,0.0797872340425532,0.5162857142703441,1.0,32/72,28.43%,FGFR2;RAB11A;KIF13A;MLLT3;FGF1;TXNIP;PLK2;CALM2;BECN1;FLCN;EFHC1;SH3GLB1;GIT1;UVRAG;TAL1;CALM1;MYO19;SIRT2;SMYD5;PLK4;CETN2;CCP110;BCL2L1;RACK1;KLHL21;PLK5;DLL1;KIF18B;SFN;TLE6;KLHL9;FSD1
prerank,regulation of mononuclear cell migration (GO:0071675),0.5390256317508242,1.2887155987148566,0.23588709677419356,0.7211793210997403,1.0,3/23,1.34%,IL34;BMP5;PTK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4982935419577619,-1.2885022812599,0.16135458167330677,0.5185509457058958,1.0,2/17,3.10%,PLA2G4A;LPGAT1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3936623275846981,1.288434999833392,0.11014492753623188,0.7203846550179774,1.0,26/152,9.78%,S1PR3;PTH1R;ADGRL3;TBXA2R;UCN2;ADORA2A;GPER1;GNAZ;ADCYAP1R1;GIPR;ADCY3;ADCY8;ADCY6;CXCL10;HTR1B;OPRK1;ADCY9;WASF2;CACNA1D;GPR37;AKAP12;GRK5;GNA12;ADGRB3;ADGRE5;NPY1R
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4077425615072669,-1.2884050204254898,0.08836206896551724,0.5178892043215844,1.0,9/45,6.22%,BMP6;DAB2;BMP7;BMP4;BMPR2;TGFBR1;ACVR1;SDCBP;ACVRL1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4758707679171317,-1.2881390910925634,0.145748987854251,0.5167636799807291,1.0,13/23,29.71%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;YWHAH;E2F1;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4758707679171317,-1.2881390910925634,0.145748987854251,0.5167636799807291,1.0,13/23,29.71%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;YWHAH;E2F1;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4229916011976551,1.2881009242713564,0.1217008797653959,0.7196882259272943,1.0,23/108,11.25%,DLC1;PDGFRB;PTK2;PHLDB2;RND3;ROCK1;GRHL3;SPEF1;PLXNB1;SH3BP1;RAC3;CORO2B;SYDE1;TESK1;TPPP;MTOR;CORO1A;MARK2;ARHGAP35;BICD2;CAMSAP3;PAK3;PAK1
prerank,synapse organization (GO:0050808),0.4128882291397791,1.2880860394333253,0.12220566318926974,0.7181685718420666,1.0,22/125,8.86%,PTEN;ADGRL3;CACNB2;CDH2;APBB2;FARP1;PCDHB11;LRRC4C;DOK7;NRXN1;LRFN5;RAB39B;GRM5;AGRN;DNER;RYK;ANK3;SNCA;CHRNA7;PPFIBP2;ACHE;SLITRK1
prerank,positive regulation of synapse assembly (GO:0051965),0.5265835115015713,1.2880341046860118,0.2,0.7167363722221973,1.0,10/27,15.64%,CLSTN1;NRXN1;CLSTN3;AGRN;IL1RAPL1;CUX2;EPHB1;SLITRK2;NLGN3;SYNDIG1
prerank,maintenance of blood-brain barrier (GO:0035633),0.5183906897703737,1.2873087965065735,0.19140625,0.7170133563327845,1.0,8/30,5.46%,LAMA2;SLC12A2;DMD;JAM3;LAMC1;VCL;ESAM;ITGB1
prerank,acylglycerol metabolic process (GO:0006639),0.49443152452705563,1.2872519296572524,0.18371212121212122,0.7156223889019255,1.0,3/37,1.90%,DGKB;DGKH;DGKG
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5332504874755042,-1.2869210545914753,0.17105263157894737,0.5191149753806991,1.0,9/14,32.91%,ENTPD1;ENTPD5;ENTPD2;NUDT16;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,regulation of vasculogenesis (GO:2001212),0.5977616715323179,1.2869158341030167,0.21868365180467092,0.7149818921331063,1.0,5/14,7.06%,HEY2;RAPGEF2;RIN2;EMP2;RAP1A
prerank,negative regulation of cell cycle (GO:0045786),0.4378212807559143,1.2864303180446168,0.14904679376083188,0.7146573441933748,1.0,17/73,12.21%,PTPRK;PTEN;CDK6;GPER1;SIPA1;RPS6KA2;HEXIM1;BRINP1;NUPR2;NR2F2;BRINP3;INCA1;HTRA2;TAF6;LATS2;APC;RB1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.507182011434356,1.2858444596268315,0.18702290076335878,0.7145819284150408,1.0,16/32,18.40%,MEF2C;GPER1;CHRNA3;RIMS1;RIMS2;SYN1;VPS18;BAIAP3;MCTP2;RAB5A;PNKD;PREPL;FMR1;SYT11;GSK3B;CPLX1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5414142296168388,1.2855413791426917,0.21485943775100402,0.7137423500376947,1.0,10/22,18.20%,DMD;CACNB2;PDE4B;STAC;HPCA;CBARP;FMR1;GPR35;CACNB4;GNB5
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5579377997327647,-1.2851584039528312,0.17286245353159851,0.522899535873801,1.0,5/11,30.22%,LGALS9;TWSG1;CD274;CBFB;VSIR
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5301203890898668,1.2850771936946057,0.19569471624266144,0.7133162318946512,1.0,8/26,9.72%,CASQ2;NEDD4L;KCNG1;STK39;ATP1B2;ITGB1;CACNA1D;NETO1
prerank,regulation of T cell cytokine production (GO:0002724),-0.532561156617316,-1.2845681938639157,0.15922330097087378,0.5236326891189648,1.0,4/15,6.33%,CD55;B2M;SMAD7;TNFRSF1B
prerank,negative regulation of apoptotic process (GO:0043066),-0.2940225229335653,-1.2843912507579685,0.01282051282051282,0.5231321495020173,1.0,98/444,14.67%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;SMAD6;FHL2;CTSH;IL31RA;PDPN;PRKCH;TEK;FOXO1;SH3RF1;OSR1;APOE;CAV1;ANXA4;NUPR1;RNF213;ANXA5;MYO18A;THBS1;BMP4;IGF1R;USP47;IL6ST;ITGA5;SNX6;ANGPT1;KLF4;TXNDC5;LEF1;ANXA1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;RNF144B;ZFAND6;NDNF;YAP1;SIX1;CCND2;WNT5A;PTK2B;CARD14;PLK2;SH3RF2;MAP2K5;MAEA;FNIP1;HSPA5;TFRC;NRBP2;TBX1;ERC1;GOLPH3;ERCC5;PRKCD;TPT1;BIRC3;AKT1;SON;MCL1;BAG3;PRDX2;NR4A2;IFIT3;CD38;GCLC;KDR;TLE1;ZC3H12A;ARHGDIA;PRKCG;BNIP3L;TRIM27;FOXQ1;FLT4;RELA;CBX4;HDAC1;UBB;SPHK1;PIM3;GATA6;BNIP3;DNAJB6;QARS1;RPL10;HYPK;MAPK3;MAZ;SFRP1;PRKAA2
prerank,T cell receptor signaling pathway (GO:0050852),0.4094441536973878,1.2842521919785912,0.14285714285714285,0.7139637208445186,1.0,22/138,11.25%,PDE4D;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;RFTN1;WAS;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;PRKD2;CSK;TEC;EIF2B3;PAK3;PAK1
prerank,response to UV-A (GO:0070141),-0.5259172341350797,-1.2841654825015993,0.15860735009671179,0.5227661465996165,1.0,5/14,18.18%,EGFR;AKT1;CCND1;PPID;MMP2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5427288618818725,1.2840338232728488,0.21052631578947367,0.7130740853183167,1.0,2/21,1.34%,IL34;PTK2
prerank,"phagocytosis, engulfment (GO:0006911)",-0.42859328516302236,-1.284021157146726,0.1511111111111111,0.5222027031947997,1.0,5/36,3.18%,GULP1;GSN;RHOBTB1;ELMO1;THBS1
prerank,cAMP metabolic process (GO:0046058),0.5873759161372574,1.2838655320524017,0.19098712446351931,0.7119920957009749,1.0,6/13,9.71%,PDE4D;ADCY3;ADCY8;ADCY6;ADCY9;EPHA2
prerank,cell part morphogenesis (GO:0032990),0.594486839248634,1.2834117095802666,0.23395445134575568,0.7116767431988712,1.0,3/13,12.59%,PID1;SUPV3L1;MFF
prerank,eye photoreceptor cell development (GO:0042462),0.5813190059496677,1.2822588680396245,0.2097457627118644,0.713161580357049,1.0,1/15,0.82%,RORB
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5502017874647582,1.282235569982712,0.2153209109730849,0.711722696486513,1.0,2/17,0.87%,PID1;CBFA2T3
prerank,axon guidance (GO:0007411),0.38708260350096657,1.281995715868447,0.10569105691056911,0.7108096576532987,1.0,26/201,5.60%,NOTCH3;CHN1;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PLXNB1;PIK3CA;NRXN1;SPTBN1;RYK;SEMA6C;GRB10;FEZ2;SPTB;CNTN4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5493779493182784,-1.281838808203966,0.1856060606060606,0.5272524980585843,1.0,7/11,27.52%,GSN;LGALS9;PARK7;PLAUR;PIH1D1;FAS;PRR7
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5733972799556122,-1.2814640954145728,0.16789667896678967,0.5273091900131761,1.0,3/10,8.99%,APOD;PTPRJ;HGS
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4394145515826978,1.280467072266964,0.15599343185550082,0.7132927626798244,1.0,9/72,5.09%,DLC1;STARD8;EPS8;TNFAIP1;CUL3;STARD13;PDCD10;EPS8L1;RIT2
prerank,DNA strand elongation (GO:0022616),0.549033311751099,1.280148588259346,0.21272365805168986,0.7126726040049212,1.0,5/18,10.76%,DCLRE1B;GINS1;GINS3;GINS4;MCM7
prerank,aminoglycan catabolic process (GO:0006026),0.5036015754692901,1.2797857168474862,0.2179732313575526,0.7120698896344798,1.0,7/28,6.29%,SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3618256832557721,-1.2792380277204574,0.08571428571428572,0.5323917854784579,1.0,14/86,6.22%,BMP6;SULF1;DAB2;ZNF423;CDH5;BMP7;THBS1;BMP4;BMPR2;FOXD1;TGFBR1;ACVR1;SDCBP;ACVRL1
prerank,positive regulation of dephosphorylation (GO:0035306),0.5321176367519737,1.2790548947854647,0.19103313840155944,0.7123931449714859,1.0,1/27,0.07%,DLC1
prerank,regulation of actin filament-based process (GO:0032970),0.4547569057126504,1.2789349475881346,0.16586151368760063,0.7111939377798674,1.0,8/70,4.03%,DLC1;PDGFRB;RND3;ROCK1;GRHL3;SH3BP1;RAC3;CORO2B
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.49149785592255985,-1.2786028426537788,0.16427104722792607,0.5331527361796116,1.0,4/18,6.79%,CAMK1D;SLIT2;IL6R;PTK2B
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.442652525602666,-1.278100029555788,0.14861995753715498,0.5335309376259784,1.0,5/28,2.80%,EPHA4;APOE;APP;SHANK3;ADCY1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5427806912371838,1.2776819107373332,0.22090729783037474,0.7128085051788065,1.0,4/20,1.88%,HEY2;HEYL;NOTCH1;TBX3
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.42346204636609014,1.277630375986182,0.13814756671899528,0.7114622702035553,1.0,18/93,11.56%,PDE4D;PTEN;DMD;NCK2;TNKS1BP1;FNIP2;PDCD10;SPRY2;INPP5J;SNCA;CAPRIN2;RIPK2;PRKD2;CNOT9;DDIT4;BRAF;PAK1;SFRP2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5361816357243709,-1.2772069475819874,0.18518518518518517,0.5350379696084635,1.0,5/13,11.49%,NUPR1;LRRK2;CHMP4B;CHMP4A;PHF23
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5281647851074746,-1.27707531416767,0.1650853889943074,0.5344082359889631,1.0,6/13,28.31%,TGFBR2;GLI3;PNP;CBFB;NCKAP1L;SOCS1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4994160283983075,-1.2761273680080232,0.16023166023166024,0.535963811029267,1.0,6/20,14.75%,ZMIZ1;TGFBR1;HIF1A;DNAJB2;HSP90AB1;WASHC1
prerank,negative regulation of autophagy (GO:0010507),-0.39433717510488026,-1.2752282941586064,0.13501144164759726,0.5373400345508663,1.0,20/54,20.83%,LEPR;NUPR1;LRRK2;DAP;RASIP1;STAT3;NRBP2;AKT1;MCL1;FOXK1;DAPL1;ZKSCAN3;EIF4G3;MET;WASHC1;SIRT2;QSOX1;MT3;TBC1D14;USP36
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3276171723396185,-1.2736016622827335,0.04559270516717325,0.5407704457479262,1.0,39/138,13.56%,EPHA4;EPHA3;FLT1;EGFR;MTSS1;PDGFRA;EPHA7;NTRK3;IL31RA;TEK;NEDD9;FGFR2;IGF1R;BMPR2;EPHB4;IL6ST;MPZL1;YES1;CSF1;NPR1;PTPRG;BDKRB2;DDR1;PTK2B;TRIO;RAPGEF1;PIK3CB;TIE1;KIT;EFS;EPHA8;FRS2;KDR;FGFR4;FLT4;EPHB2;FER;MET;RET
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5273248370027956,1.2734889538475767,0.2037037037037037,0.7204848636381871,1.0,2/26,1.25%,CASQ2;ATP1A2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4730633394254133,1.2734235395324365,0.1953405017921147,0.719166936452195,1.0,10/40,11.20%,SGIP1;VTN;LDLRAP1;WASL;ATAD1;IL4;PPT1;HIP1;DGKD;AHI1
prerank,COPII-coated vesicle budding (GO:0090114),-0.374462447757808,-1.273404412659319,0.0971563981042654,0.540402819618304,1.0,36/68,33.26%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;LMAN1;SEC16B;TRAPPC3;TRAPPC4;F5;ANKRD28;MCFD2;VAPA;NAPA;SEC23IP;SAR1A;SAR1B;BET1;TMED2;TRAPPC6B;CNIH3;TRAPPC2;SEC31B;TBC1D20;TRAPPC5;PREB;TRAPPC2L;SEC16A;GOLGA2;CNIH2;TMED10;SEC24B;SCFD1
prerank,negative regulation of cell differentiation (GO:0045596),-0.32356845986647076,-1.2731217602132243,0.055350553505535055,0.5401760221296625,1.0,48/181,13.42%,RANBP3L;LDLRAD4;ABCA1;SMAD3;ADAMTS12;ZBTB16;EGFR;SMAD6;EFEMP1;COL5A2;COL5A1;BMP7;TMEM64;FOXO1;OSR1;CAV1;ENPP1;HDAC7;XDH;SUFU;BMP4;TGFBR1;SMAD7;ADGRV1;PDCD4;WNT9A;SKI;IGF2;ZFPM2;YAP1;WNT5A;PTK2B;NOCT;TBX1;TRIO;ANP32B;TWIST2;DAB2IP;ANKRD26;GATA2;ITGB3;TGFB1;PTCH1;ID2;PPARA;CALR;PTHLH;CHRD
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.3082185123162195,-1.2722628489987182,0.016260162601626018,0.5416647128414228,1.0,64/248,16.98%,RNF220;MCC;DAB2;LRRK1;LGR4;EGFR;COL1A1;IGFBP2;BICC1;TBL1XR1;TMEM64;DKK3;APOE;CAV1;FGFR2;USP47;SMURF2;IGFBP6;NKD1;RNF146;TLE4;MLLT3;LRP6;LRRK2;TCF7L2;IGFBP4;TNKS2;SOX13;PFDN5;LYPD6;SFRP4;WNT5A;WNK1;USP8;CSNK1G2;SCYL2;AMFR;FZD4;TLE2;USP34;FZD7;NOTUM;DAB2IP;TLE1;ZNRF3;PSME2;TGFB1;CCDC88C;HDAC1;PSMB4;GLI3;SOX17;PSMD8;PSMB1;SFRP1;PSMD11;SOX7;PPM1B;PSME3;HHEX;PLEKHA4;TPBG;GSKIP;WNT11
prerank,positive regulation of proteolysis (GO:0045862),-0.3836956345441124,-1.2720974939534633,0.11951219512195121,0.5411525252027047,1.0,14/55,13.18%,CTSH;CCBE1;APOE;CYFIP2;SNX9;ADAM9;CTSC;RCN3;TNFRSF1B;ZC3H12A;CASP8;TBC1D10A;FGFR4;FBXW11
prerank,neurotrophin signaling pathway (GO:0038179),0.5363232208196755,1.2711933112058833,0.22796934865900384,0.7234351605468385,1.0,6/21,10.68%,RAPGEF2;BCAR1;SORT1;NTRK2;RAP1A;DDIT4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.517614837801582,-1.2709945954275668,0.18888888888888888,0.5431328519256037,1.0,7/16,24.31%,PRKAG2;APPL2;ACADL;PPARA;PPARGC1A;NR4A3;SIRT4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.41323788216719753,-1.270727941953255,0.13822894168466524,0.5428950721996494,1.0,11/37,13.22%,PRKAG2;BMP7;CEMIP;APP;SMAD7;CALM2;PARD3;IRGM;TGFB1;PPEF2;SPHK1
prerank,response to ketone (GO:1901654),-0.46175529540794125,-1.270516353690171,0.1762208067940552,0.5424983635019109,1.0,5/24,5.95%,TGFBR3;SLIT2;CAV1;THBS1;YAP1
prerank,regulation of Notch signaling pathway (GO:0008593),0.43758906488075733,1.2700927847987398,0.16474464579901152,0.7248217492714617,1.0,8/76,5.31%,NOTCH3;NOTCH1;MAML2;CHAC1;TSPAN15;CD46;PDCD10;SREBF2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6163162706045723,1.2699382922764781,0.2511013215859031,0.7236526147898827,1.0,2/10,1.19%,FAP;NOTCH1
prerank,ear morphogenesis (GO:0042471),-0.477519015117587,-1.2695073923388076,0.17,0.5443123954065857,1.0,6/20,12.69%,CHD7;OSR1;FGFR2;SIX1;TBX1;EPHB2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.4656393169417615,-1.2692990040110288,0.15833333333333333,0.5439281958552111,1.0,8/24,15.91%,SLIT2;CCN3;CXCL12;NBL1;ANO6;DUSP1;SERPINE1;CREB3
prerank,receptor catabolic process (GO:0032801),-0.4574874817069267,-1.2687653752832733,0.172,0.5443418980870679,1.0,10/24,13.06%,RNF43;AP2A2;SMURF1;CLTA;BECN1;ZNRF3;TGFB1;SH3GLB1;AP2A1;UVRAG
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2795738984215103,-1.2683105523558846,0.0,0.5445645623739325,1.0,179/807,14.00%,BMP6;FOXP2;PRDM6;DAB2;FOXN3;ZNF423;AEBP1;PLCB1;SMAD3;SMARCA2;ZBTB16;MECOM;FOXP1;WNT4;WWOX;HDAC4;CUX1;TBL1XR1;GLI2;FHL2;WWC2;NFIX;BMP7;LCOR;SP100;VGLL4;GLIS3;RBFOX2;DKK3;FOXO1;OSR1;SKIL;FOXO3;ZIC2;NR3C1;MDFIC;DLG1;HDAC8;CAV1;KAT6B;RARB;ESR1;SUFU;FGFR2;BMP4;USP47;EZR;SMURF2;FOXD1;RPS14;SNX6;DNMT3A;KLF4;DDX5;TFDP2;FOXC2;LEF1;SMAD7;KLF2;HDAC9;ID1;TAF1;TCF7L2;PDCD4;ETV6;THRB;SKI;SBNO2;ZHX3;MXI1;PARP9;SDCBP;GAS6;IGF2;CNOT7;ZFPM2;GATAD2A;WWP2;GTF2IRD1;NIBAN2;AR;BRD7;CREM;RARG;GLIS2;FOXP4;SCMH1;SOX13;DAP;PFDN5;YAP1;BHLHE40;MIDEAS;ATN1;IRF1;KMT5A;PRDM16;WNT5A;ATXN1;ID3;IRF2;FOXC1;CHD3;BPTF;HIVEP1;GLIS1;STAT1;SFMBT1;MAP2K5;FNIP1;HINFP;NR2C2;STAT3;KLF10;IFI27;ZNF219;RTF1;ZBTB18;RREB1;TLE2;CBFA2T2;IL33;RCOR3;TWIST2;KLF12;NR4A2;FOXK1;ZMYND15;BHLHE41;CD38;PHF10;IKZF1;GCLC;DAB2IP;TLE1;FLCN;ZKSCAN3;TGIF1;JARID2;PML;EHMT1;PRDM5;TRIM27;MDFI;PATZ1;CPEB3;ELK3;TGFB1;ZMYM5;NSD1;PTCH1;MEF2A;LRRFIP1;AHR;ID2;PPARA;RELA;PRDM11;CBX4;MDM2;HDAC1;UBB;GLI3;ATOH8;FBXW11;CALR;ZGPAT;EZH1;GATA6;CCND1;QARS1;CLOCK;ZNF568;RPL10;PPID;ZBTB4;KCNIP3;SARS1;HDAC5
prerank,fluid transport (GO:0042044),-0.5555188231516837,-1.268233228162179,0.19005328596802842,0.5438477746002053,1.0,2/12,15.17%,PDPN;AQP11
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4308956797161433,1.2675892650585017,0.17406143344709898,0.7281823437902633,1.0,22/75,12.70%,PTEN;SPRY4;PRKAR1B;NF1;IL1B;SH2B3;PKIA;SPRY2;HEXIM1;CD300A;UCHL1;TESK1;PRKAR2B;NR2F2;PRKAR2A;INCA1;LYN;PRKAR1A;LATS2;APC;RB1;PTPN1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4849831368373724,1.266690815528881,0.20419847328244276,0.7290548794379947,1.0,5/35,3.61%,PIGU;NOTCH1;ERBB4;CRLF3;SH2B3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4116843192922045,-1.2666589320196266,0.14317180616740088,0.5470166974537738,1.0,15/39,22.26%,RPS14;RPS19;RPS16;RPS5;RPS24;RPS27;MRPS7;RPS6;RPS15;RPSA;RPS25;RPS7;RRP7A;RIOK2;RPS27L
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.39502657869721075,1.2662208545003577,0.12463343108504399,0.7287762590511515,1.0,8/138,2.77%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,amide transport (GO:0042886),-0.4584682824401934,-1.2660020394782276,0.1656441717791411,0.5477783398500974,1.0,7/26,10.48%,PDPN;PLTP;CERT1;ABCG2;SLC5A6;SLC38A5;DISP1
prerank,regulation of mitochondrial translation (GO:0070129),0.5138860172015409,1.2648836427554468,0.20833333333333334,0.730738692454665,1.0,11/21,21.75%,FASTKD2;MRPS27;NSUN3;MALSU1;FASTKD3;MTG2;TRMT10C;RMND1;C1QBP;ALKBH1;TSFM
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.47595394701320826,1.2646268870041544,0.18574108818011256,0.7298781809663376,1.0,4/38,3.61%,PTEN;PHLPP1;GPER1;SH2B3
prerank,sodium ion export across plasma membrane (GO:0036376),0.5832252751127668,1.2646229674796785,0.22317596566523606,0.7284120584188473,1.0,4/13,4.90%,ATP1A2;ATP1A4;FXYD2;ATP1B2
prerank,positive regulation of immune effector process (GO:0002699),-0.45080838586863337,-1.264070723055543,0.1875,0.552120985993687,1.0,7/27,7.29%,LBP;MYO18A;PTPRJ;DDX60;APPL2;LGALS9;RPS19
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.51850797149553,1.263653493868325,0.20793950850661624,0.7292897409483275,1.0,8/27,6.72%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,response to cadmium ion (GO:0046686),-0.4471179973762191,-1.263621275914943,0.16973415132924335,0.5523591150718495,1.0,12/26,19.78%,EGFR;AKT1;MAPK3;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,cellular response to oxygen-containing compound (GO:1901701),0.36856717520735194,1.2633801649990044,0.09786700125470514,0.7285144982328199,1.0,38/291,9.32%,GUCY1B1;PTPRK;MEF2C;PID1;RORB;SPAAR;GNG2;PDE3A;RAPGEF2;RORA;CPEB1;GPER1;NR1H3;IL1B;FFAR2;NCF1;CXCL5;AXL;NCOA3;ADCY6;AKAP6;BRINP1;CXCL10;TNIP2;PDE4B;HCN2;CACTIN;IRS1;RAP1A;FAM210B;MTOR;BRINP3;PKD2;RYR3;HCN3;LYN;HTRA2;PDGFB
prerank,metanephros development (GO:0001656),-0.4513878975600495,-1.2629689124422903,0.13052631578947368,0.5531996364383787,1.0,9/26,14.65%,CTSH;BMP7;OSR1;BMP4;FOXD1;SIX1;PTCH1;SOX17;PKD1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5803355345325059,-1.2628463948046043,0.21682242990654205,0.5526073576147286,1.0,6/10,24.63%,DPYD;UPB1;UPP2;NT5E;NT5C1A;NT5C
prerank,regulation of histone modification (GO:0031056),-0.5308433364522666,-1.2624716055097802,0.18199608610567514,0.5526831341238695,1.0,5/13,18.50%,IGF2;FLCN;NNMT;CDK9;PARK7
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3730893835388707,-1.261634701694074,0.125,0.5539874880950444,1.0,23/67,13.16%,SULF1;FLT1;NRP2;ROCK2;NRP1;ELMO1;CYFIP2;VAV2;SHB;BAIAP2;PXN;VEGFD;CLEC14A;VEGFC;MAPK14;RHOA;PTK2B;PIK3CB;DAB2IP;KDR;ITGB3;FLT4;CYBA
prerank,negative regulation of macrophage activation (GO:0043031),0.5551334095327606,1.261580318377643,0.22538293216630198,0.7316865424616122,1.0,5/16,6.10%,NR1H3;LRFN5;LDLR;TAFA3;IL4
prerank,protein polymerization (GO:0051258),0.45950366456995073,1.261288324077086,0.19230769230769232,0.7309417838828737,1.0,9/55,6.27%,CASQ2;ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL;FGF13;TPPP
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5116413012620159,-1.2610828115211052,0.19734345351043645,0.5545038152750245,1.0,1/14,0.09%,AUTS2
prerank,lamellipodium organization (GO:0097581),0.5230734529781274,1.2608457784323264,0.2084942084942085,0.7306335177341944,1.0,5/29,5.46%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.414878267555547,-1.2597554320193316,0.1324200913242009,0.5571240645272882,1.0,13/39,13.46%,AFDN;EPHA7;PODXL;DPP4;CDH1;SMAD7;PTPRG;EFNA5;CD47;FLOT2;TGFB1;MDGA1;MEGF10
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4986417275047023,-1.2595274275958508,0.1989247311827957,0.5568561821946948,1.0,8/16,31.65%,APPL2;ACADL;CEACAM1;ERLIN2;BRCA1;SIRT4;TRIB3;APOC1
prerank,cellular response to osmotic stress (GO:0071470),0.5278160673289551,1.2583492992802763,0.234251968503937,0.7355076659701769,1.0,6/21,8.54%,MYLK;RCSD1;STK39;SCN2A;DDX3X;PKD2
prerank,potassium ion homeostasis (GO:0055075),0.5213994408407855,1.258245908953315,0.23135755258126195,0.7342995260310663,1.0,9/23,12.63%,SLC12A2;ATP1A2;ATP1A4;ATP1B2;SLC12A6;TFAP2B;SLC12A5;SLC12A4;KCNMA1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5064392525303257,-1.2576432678258453,0.17509727626459143,0.5611666739370751,1.0,5/16,15.92%,IGF1R;CLEC16A;IRAK3;BNIP3;TBC1D25
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.49671372111246404,-1.257473594772015,0.1896551724137931,0.5606454048493116,1.0,4/16,12.60%,ST3GAL4;NFAT5;RHOA;RELA
prerank,replicative senescence (GO:0090399),0.5983897528465899,1.2556729977806746,0.24025974025974026,0.7394911003143069,1.0,1/12,0.60%,PLA2R1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5539807264537762,-1.2554011115577464,0.20522388059701493,0.5655045538554136,1.0,5/11,15.58%,NOS3;AKT1;GCH1;PTS;CALM1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.570116856172035,1.25504187506347,0.25766871165644173,0.7395471049844217,1.0,1/15,0.41%,KCNJ8
prerank,regulation of MAPK cascade (GO:0043408),-0.3278690309881852,-1.2549261311735487,0.05338078291814947,0.5658795870223784,1.0,39/157,14.36%,TGFBR3;IGF1;FN1;FLT1;EGFR;ROCK2;EPHA7;NTRK3;LPAR1;TEK;IQGAP1;CAV1;JCAD;KSR1;FGFR2;NRK;IGF1R;PTPRJ;GSDME;IGF2;IAPP;DUSP1;TBX1;ADRA1B;KIT;TAOK2;EPHA8;DAB2IP;KDR;MYOC;P2RX7;PPEF2;CCN1;FLT4;PRDM11;PLCG2;RET;CAV2;MAPK3
prerank,regulation of smooth muscle contraction (GO:0006940),0.5433451467586706,1.254733544972463,0.21621621621621623,0.7389051597168421,1.0,3/20,3.65%,PLCE1;CHRNA3;NMU
prerank,positive regulation of macrophage migration (GO:1905523),0.5359146873898337,1.2546383234834009,0.22699386503067484,0.7376751694386608,1.0,2/19,1.34%,IL34;PTK2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5576278724630339,1.254106241364299,0.2577777777777778,0.7376182945296815,1.0,3/14,10.68%,LIMS1;EMP2;LOXL3
prerank,lamellipodium assembly (GO:0030032),0.5182141353283649,1.2537713180327095,0.23047619047619047,0.7370155300690261,1.0,5/26,5.46%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,negative chemotaxis (GO:0050919),-0.4256627443431343,-1.2536490192726846,0.14502164502164502,0.5685201569945345,1.0,14/33,16.42%,ROBO1;EPHA7;SEMA3D;SEMA6A;SEMA3C;SLIT2;SEMA7A;RHOA;SEMA3E;ITGB3;SEMA3B;NTN1;SEMA3G;SEMA6B
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2900768775209656,-1.2532471575635764,0.019417475728155338,0.5687218784848423,1.0,85/348,15.83%,PRKAG2;BMP6;IGF1;DAB2;PDGFD;EGFR;LEPR;ROCK2;NTRK3;NRP1;BMP7;TEK;CEMIP;IQGAP1;PECAM1;APP;IL15;CAV1;IL6R;BMP4;BMPR2;ITGA5;PTPRJ;SNX9;TGFBR1;ANGPT1;RASSF2;CSF1;ARHGEF2;LRRK2;ACVR1;GHR;NIBAN1;VEGFD;LIMK2;VEGFC;SDCBP;GAS6;IGF2;ARRB1;FGF1;ACVRL1;TOM1L1;EFNA5;CCND2;PTK2B;CARD14;CALM2;FNIP1;TFRC;CCND3;TBX1;ALS2;TAOK2;WDFY2;AKT1;IRGM;KDR;FLCN;MAVS;AKAP9;ITGB3;TGFB1;CCN1;FLT4;TWSG1;TMEM119;LIMCH1;CDK2AP1;SPHK1;LRP8;PLCG2;TXN;CCND1;PPIA;HSP90AB1;MAPK3;FXR2;RAD50;KRAS;CDK9;HFE;CALM1;BMPR1A;NOS1
prerank,epithelial to mesenchymal transition (GO:0001837),0.46272827905186487,1.2532117009090737,0.17636363636363636,0.7369496563254692,1.0,6/47,2.15%,LIMS1;HEY2;HEYL;NOTCH1;TBX3;ROCK1
prerank,regulation of stem cell population maintenance (GO:2000036),0.5435873682157984,1.2526085566411995,0.21020408163265306,0.7371096765861509,1.0,4/18,5.65%,NODAL;PTN;NCOA3;CNOT2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4321921536714142,1.252548358194004,0.1792,0.7358393422887042,1.0,7/67,3.91%,CARMIL1;LIMS1;UTRN;ECM2;CDK6;FERMT2;RAC3
prerank,protein prenylation (GO:0018342),0.6149350048504014,1.2519533947854131,0.26215644820295986,0.7359782531629022,1.0,2/10,3.02%,PTAR1;CHML
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.321731420269393,-1.2518779852392503,0.06666666666666667,0.5714612628325249,1.0,54/148,25.52%,PRKAG2;PPP1R13B;TAF1;RBBP7;BRD7;MAP2K6;RPS20;KMT5A;MAPK14;CHD3;AKT1;MEAF6;CCNG1;RPL37;PML;EHMT1;PIP4K2B;RPL11;PAK1IP1;PRKAG3;MDM2;HDAC1;PRKAB1;ATM;RPA1;PRKAA2;HIPK2;RAD50;TAF4B;RPS15;RPL23;TP53RK;PDPK1;RFC3;PPP2R5C;CHD5;TAF9B;RFFL;CDK5RAP3;TOP3A;PRKAG1;TAF5;RMI2;USP2;BRPF1;TTC5;CHEK2;BRCA1;STK11;RPA3;RRS1;TP53;HUS1;L3MBTL1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.48354786418644313,1.251614695835256,0.2290909090909091,0.7353549814616636,1.0,4/34,2.80%,PDGFRB;RGCC;IL1B;CUL3
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.44785547649490887,-1.2514694596080405,0.164969450101833,0.5715526704414882,1.0,8/26,8.79%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;CCND3;UBE2E2;AKT1
prerank,myoblast differentiation (GO:0045445),-0.5171954501502357,-1.250361370099695,0.19797979797979798,0.5735649857579415,1.0,5/14,7.43%,IGF1;MBNL1;DDX5;TCF7L2;HINFP
prerank,regulation of T cell proliferation (GO:0042129),0.4453537032789802,1.249947843091158,0.18914185639229422,0.7380507324677973,1.0,5/61,2.88%,GLMN;TNFRSF21;NCK2;IL1B;CD46
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4363819124803863,1.2499405205240293,0.18412162162162163,0.7366290624352728,1.0,15/59,16.11%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;LIPC;LIPH;SRR;GATM;OSBPL7;MLYCD;HSD3B7;GAMT;ACOX2
prerank,regulation of inflammatory response (GO:0050727),-0.3110930748094279,-1.2498719537200291,0.04529616724738676,0.5739023595637874,1.0,45/190,12.60%,ADAMTS12;CDH5;FOXP1;PTGIS;TEK;APOE;CASP12;APP;IL15;IL1R1;SEMA7A;SNX6;KLF4;ANXA1;PDCD4;SBNO2;IL16;CCN3;LPCAT3;LACC1;TNFRSF1B;CASP4;ENPP3;WNT5A;MFHAS1;PIK3AP1;CD47;TMSB4X;PRKCD;DAGLB;C1QTNF3;BIRC3;USP18;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;MGLL;METRNL;VPS35;PTGS2;PPARA;RELA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5619316510961513,-1.2496662203238358,0.2154696132596685,0.5734831015143412,1.0,7/10,38.28%,INO80;SSBP1;DBF4;WIZ;STOML2;ATRX;E2F8
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5333100417235429,-1.2494518422409888,0.17863720073664824,0.5731098207240783,1.0,4/13,20.37%,PLA2G4A;MGLL;ABHD16A;DGAT2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4763217117447279,1.2494408777724422,0.21761658031088082,0.7364783871965251,1.0,8/42,7.93%,LIMS1;UTRN;CDK6;FERMT2;ROCK1;RIN2;EMP2;MAP4K4
prerank,negative regulation of viral genome replication (GO:0045071),-0.40304244378391685,-1.2492343752295247,0.1496881496881497,0.5727081007187848,1.0,22/40,36.01%,IFITM3;OAS2;IFIT1;MAVS;IFITM2;RNASEL;RSAD2;SETDB1;MPHOSPH8;SRPK1;INPP5K;TRIM6;SRPK2;PLSCR1;ISG15;BST2;ILF3;PARP10;OASL;FAM111A;PROX1;ISG20
prerank,regulation of programmed cell death (GO:0043067),-0.3193470591970362,-1.2487586252680136,0.06930693069306931,0.5730779897613368,1.0,60/161,28.80%,DAPK1;MECOM;PPP1R13B;STEAP3;ACTN2;TGM2;GAS1;FBXO10;LRRK2;TRIM24;IGFBP3;ACER2;RARG;ACER3;STAT1;ANP32E;TPT1;BIRC3;ANP32B;AKT1;PRDX2;BCL2L11;CTSB;BNIP3L;NME1;ACTN1;CALR;LRP8;ATM;BNIP3;CASP6;PLSCR3;BID;RIPK1;ALK;PRELID1;AGT;VCP;LGALS1;SLK;USP36;LCMT1;OSGIN1;STK26;PTPN6;NTF3;PRKN;PSMC5;CRADD;TP53;FAS;PLK5;RPS3;APAF1;SRA1;DAPK2;NUP62;FANK1;CLU;ABL1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5103155832362367,1.2487127048656934,0.23076923076923078,0.7369184082036212,1.0,3/24,2.83%,MEF2C;CDH2;NRG1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.47030564627556243,-1.248614747895688,0.22,0.5725482473770662,1.0,6/20,13.89%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.5255300421330042,-1.2485167127340018,0.20071047957371227,0.5718430789631646,1.0,3/13,12.89%,RHOQ;LRRK2;RAN
prerank,cortical cytoskeleton organization (GO:0030865),-0.3996944242666959,-1.2467791312007714,0.1497695852534562,0.575768592108314,1.0,17/41,23.22%,FMNL2;ROCK2;RHOBTB1;RHOQ;DLG1;EZR;RHOA;RHOB;FHOD1;TRPV4;LLGL2;RHOH;PPP2R3C;RHOC;PLEK;RHOBTB2;LCP1
prerank,regulation of protein phosphorylation (GO:0001932),-0.3033461230177264,-1.2464198853851238,0.05179282868525897,0.5757281811350109,1.0,68/256,15.14%,DAB2;FN1;EGFR;LEPR;CDH5;ROCK2;EPHA7;NTRK3;PTPN13;FBLN1;PLPP3;OCLN;BMP7;TEK;PECAM1;APP;SLIT2;XDH;BMP4;ANGPT1;LRP6;LRRK2;NIBAN1;VEGFD;IGFBP3;LIMK2;VEGFC;GAS6;IGF2;ARRB1;FGF1;STAT2;BMPER;EFNA5;CCND2;CARD14;FNIP1;TFRC;CCND3;TBX1;WDFY2;AKT1;IRGM;DAB2IP;KDR;FLCN;ZC3H12A;MAVS;PML;ITGB3;TGFB1;NSD1;CCN1;FLT4;CCDC88C;EPHB2;TMEM119;LIMCH1;TWF1;FER;CDK2AP1;CCND1;PPIA;NDUFS4;MAPK3;FXR2;KRAS;CORO1C
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4428350714077636,-1.246392732130251,0.16869918699186992,0.5748578228358513,1.0,10/26,23.91%,PRKAG2;ADIPOR2;LPGAT1;ACADL;PRKAA2;CEACAM1;ERLIN2;ADIPOR1;SLC45A3;BRCA1
prerank,positive regulation of nervous system development (GO:0051962),0.4663074181197208,1.2462791160458628,0.20255474452554745,0.7416070153922484,1.0,14/42,16.67%,CLSTN1;GPER1;NRXN1;CLSTN3;LIG4;IL1RAPL1;CUX2;SPEN;EPHB1;SLITRK2;NLGN3;FAIM;SYNDIG1;NAP1L1
prerank,regulation of cell communication (GO:0010646),0.4862158243862757,1.2462722295172828,0.23622047244094488,0.7402014741888874,1.0,10/35,14.59%,CASQ2;IGFBP7;GRK3;RYR2;GRK5;TBX18;NCLN;PTPN1;GRK4;ANK2
prerank,camera-type eye morphogenesis (GO:0048593),0.5863622137596306,1.2460311608285344,0.2535496957403651,0.7394086315976586,1.0,2/10,2.16%,TBX2;NF1
prerank,brain morphogenesis (GO:0048854),0.5718261041922633,1.2456466622745141,0.2260127931769723,0.7388927881388241,1.0,1/12,0.42%,PTEN
prerank,regulation of cellular component movement (GO:0051270),-0.3837682370054394,-1.245508652211779,0.16097560975609757,0.5762527958818304,1.0,12/49,7.29%,TGFBR3;EGFR;ROCK2;PDPN;SP100;ARHGAP18;DIAPH1;TGFBR1;CD9;ARAP1;RHOA;RPS19
prerank,fatty acid elongation (GO:0030497),-0.5258244576361968,-1.2449019722630432,0.22134387351778656,0.5771105468334404,1.0,3/13,5.46%,ELOVL7;HACD4;HACD3
prerank,organic substance transport (GO:0071702),-0.32985791387549224,-1.2448836527537115,0.09174311926605505,0.5762147808706695,1.0,27/121,12.93%,ABCA1;SLC47A1;SLCO2B1;PLTP;SLCO2A1;ABCG2;CALCRL;RAMP2;ABCA9;SLC22A6;RCN3;TXNIP;SLC22A4;ABCA3;ABCA4;TOM1;CUBN;SPNS2;SLC22A5;ARRDC1;DISP1;SLC50A1;RAB7A;ATP8A1;SLC35F3;SLC22A18;MFSD2A
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5383062391056157,-1.2445873382544888,0.17635658914728683,0.5761064659378466,1.0,4/12,8.99%,F3;APOD;PTPRJ;HGS
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.48266941298395527,1.244413924945648,0.2158671586715867,0.740590343858297,1.0,2/29,1.76%,MBOAT2;NR1H3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4713140344611103,1.2443354951925574,0.21180555555555555,0.7393680445443482,1.0,3/40,1.59%,PID1;SLC25A33;CCN6
prerank,endothelial cell migration (GO:0043542),-0.41280719596071425,-1.2442260040755218,0.15777262180974477,0.5761314748812805,1.0,14/37,9.33%,FSTL1;CDH5;NRP1;DPP4;NOS3;PXN;ID1;CCN3;RHOA;STAT1;CYP1B1;LGALS8;PLXND1;CDH13
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4812924005767123,1.2439060022146422,0.19746376811594202,0.7390629279657983,1.0,11/39,17.67%,MYO1B;WASL;ACTN4;MYO6;TRAK1;TRAK2;PPFIA2;RAB1A;HTT;NDE1;HAP1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3569854336923527,-1.2438514843576562,0.116751269035533,0.5763346227010128,1.0,39/80,33.26%,PLPP3;ERGIC1;COPZ2;TAPBP;KLC1;GOLPH3;RINT1;COPA;ATP9A;UVRAG;ZW10;SURF4;SCYL1;NAPA;RER1;BNIP1;STX18;RAB6A;TMED9;COPB1;CENPE;TMED2;ARFGAP2;KIF26A;TMEM115;PICK1;ERGIC3;ARF4;USE1;KIF4A;NBAS;ATP9B;KIF23;TMED10;KIF18A;KIF1C;KLC2;DNAJC28;SCFD1
prerank,regulation of cholesterol storage (GO:0010885),0.5532836562718334,1.2436039802954117,0.2345924453280318,0.7384004323287701,1.0,5/15,5.38%,NR1H3;SCARB1;PPARD;SREBF2;MSR1
prerank,response to peptide hormone (GO:0043434),-0.39456191756929837,-1.2434384002502508,0.16375545851528384,0.5764935370250757,1.0,10/43,9.38%,TGFBR3;ROCK2;IGFBP5;CAV1;ANXA1;STAT2;STAT1;STAT3;AKT1;TRIM16
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.42088798989973397,-1.2434084452208345,0.19057377049180327,0.5756531466152872,1.0,16/34,13.22%,FLT1;NRP1;SEMA6A;GAS1;ANXA1;RAMP2;VEGFD;VEGFC;MAPK14;FOXC1;DAB2IP;KDR;ERN1;FLT4;RELA;SPHK1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.47618881997065005,-1.2428193993421324,0.20155038759689922,0.5763628149767654,1.0,4/20,2.31%,FMNL2;ROCK2;RHOQ;DLG1
prerank,vascular process in circulatory system (GO:0003018),0.5725205269523079,1.2423158747407488,0.2696629213483146,0.7388604108799413,1.0,3/13,3.98%,ACE2;ROCK1;ADCY6
prerank,regulation of tube diameter (GO:0035296),0.5725205269523079,1.2423158747407488,0.2696629213483146,0.7388604108799413,1.0,3/13,3.98%,ACE2;ROCK1;ADCY6
prerank,receptor signaling pathway via STAT (GO:0097696),-0.458830650879137,-1.2419951152638609,0.18655097613882862,0.5777170426127176,1.0,6/25,7.60%,IL31RA;SOCS2;GHR;STAT2;STAT1;STAT3
prerank,organophosphate ester transport (GO:0015748),0.5248351078737598,1.2409462591183813,0.23047619047619047,0.7409155549746566,1.0,3/24,3.45%,PITPNC1;SCARB1;LDLR
prerank,engulfment of apoptotic cell (GO:0043652),-0.49818162585097675,-1.240885960481861,0.1926782273603083,0.5798985204896406,1.0,5/15,22.24%,RHOBTB1;THBS1;MEGF10;RHOH;RHOBTB2
prerank,regulation of multicellular organismal development (GO:2000026),0.5100952129464728,1.2407796147787982,0.2336448598130841,0.7399594414254704,1.0,3/25,2.64%,SPAAR;PTN;GBX2
prerank,motor neuron axon guidance (GO:0008045),0.5702743477054224,1.2407565953395534,0.25557809330628806,0.7386164179465361,1.0,2/15,1.74%,CHN1;SLIT1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4802929548955137,-1.2405369604104413,0.1837160751565762,0.579960376143738,1.0,10/22,19.31%,GSN;SLIT2;KANK3;TMSB4X;PRKCD;PFN1;TWF1;TMSB10;CYRIB;SSH3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4625756447211893,-1.2403359509461522,0.18089430894308944,0.5795221506406769,1.0,10/22,16.69%,PDGFD;RASSF2;ACE;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC
prerank,positive regulation of phospholipase C activity (GO:0010863),0.47053830840060334,1.240325203138343,0.1996527777777778,0.7383452901423798,1.0,6/40,7.27%,PDGFRB;EDNRA;ARHGAP6;FGF2;NTRK2;HRAS
prerank,regulation of gene expression (GO:0010468),-0.27018578634022716,-1.240301484326938,0.0,0.5786778063318153,1.0,181/903,13.42%,BMP6;AFDN;BNC2;PRDM6;NOTCH2;IGF1;ROBO1;SLC24A3;FOXN3;ZNF423;FN1;AFF3;SMAD3;SMARCA2;CDH5;EFEMP1;ROCK2;FOXP1;AHNAK;WNT4;GSN;NTRK3;HDAC4;DENND4A;CTSH;WWC2;CHD7;OCLN;BMP7;OSR1;APOE;APP;NFIA;NR3C1;F3;KAT6B;WNT6;CLDN5;MBNL1;ITGB8;ESR1;XDH;SUFU;NOS3;BMP4;EZR;GJA1;FOXD1;PRRX2;TGFBR1;ANGPT1;KLF4;LEF1;CDH1;CSF1;TAF1;RAMP2;CD34;HOXA5;ADAM10;SBNO2;PARP9;SMO;GAS6;IGF2;CNOT7;TAPBP;WWP2;MED26;SSBP2;GTF2IRD1;FGF1;ARNT2;RBM20;RAB27A;AR;CREM;PARP14;LGALS9;MOV10;SOX13;PFDN5;YAP1;BHLHE40;SIX1;ACVRL1;SFRP4;WNT5A;MAPK14;ATXN1;SLC7A5;IRF2;FOXC1;CHD3;HINFP;NR2C2;PGR;TFRC;STAT3;NOCT;ZNF219;ERC1;ACTG1;POLR2A;NOVA2;AFF2;PIK3CB;TRRAP;ATRAID;DTNBP1;VSX1;AKT1;SON;IGF2BP2;GON4L;RREB1;HGS;REXO4;AFF1;PCBP2;NOS1AP;HIF1A;IL33;CRABP2;CCN4;FZD7;KDR;SLC39A8;TLE1;TULP3;FLCN;CARM1;ZC3H12A;CASP8;EMILIN1;FLOT2;ESRRG;PML;GATA2;BRCA2;NFYC;CLK1;PRDM5;ANXA7;P2RX7;VPS35;TRIM27;RPL11;PATZ1;HINT1;SEC16B;TGFB1;FGFR4;PUM1;NSD1;NOVA1;SRSF10;AHR;ID2;ZNF462;RELA;PRDM11;EPHB2;YBX3;GRSF1;MBNL2;HDAC1;TMEM119;EPHX2;PRKAB1;ATOH8;GLRX2;TDG;TRIM39;CALR;PTHLH;PLCG2;WNT16;LARP1;SOX17;ATM
prerank,regulation of intracellular signal transduction (GO:1902531),0.3468406538216988,1.2401721793390037,0.08907363420427554,0.7373239188902158,1.0,74/420,12.26%,DLC1;STARD8;CHN1;PIP5K1B;PTEN;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PRDM1;PLEKHG2;ARHGAP6;ARHGAP32;PHLPP1;ARHGEF6;LBH;ARHGAP1;PRKAR1B;SPRED1;IL1B;PTPN22;PIP4K2A;STARD13;ARAP2;RAC3;TRAF5;AKAP6;MINK1;SYDE1;RIT2;PEX5L;ROS1;PIP4K2C;NTRK2;PRKAR2B;ARHGEF12;TAOK3;ARHGEF26;SLC15A2;SOS2;TRAF3;PAK6;MAP4K4;STK3;RAD1;MTOR;ARHGDIB;PRKAR2A;AKAP12;PRKD2;GNA12;ANKRD54;ARHGAP35;LYN;ARHGEF9;ATR;INPP5B;PAK5;TBP;AKAP7;NUAK1;PRKAR1A;TAF6;DDIT4;ARHGEF7;PAK3;KAT6A;PAK1;HIPK1;ARHGEF4;EP300;WWC1;TTI1;ARHGAP9
prerank,cellular response to virus (GO:0098586),-0.43017369682073947,-1.240150270765058,0.15714285714285714,0.5781390769468004,1.0,8/30,10.64%,GSDME;LGALS9;MAPK14;LGALS8;IRGM;HIF1A;ZC3H12A;EIF5A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5380218010524815,1.2400616895202279,0.22653061224489796,0.7362461168769481,1.0,3/17,1.19%,HEY2;HEYL;NOTCH1
prerank,positive regulation of reproductive process (GO:2000243),0.47938608846558955,1.2399677747364406,0.22407407407407406,0.7350938233582325,1.0,5/31,4.64%,PDE3A;CACNA1H;TACR2;TACR1;SYDE1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5445251453632233,1.2399004965352252,0.2554585152838428,0.7338958033710955,1.0,3/14,3.05%,PIK3CD;GAB1;PIK3CA
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.41877475149100607,-1.239554137034022,0.19753086419753085,0.5789281041819431,1.0,11/33,13.50%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;STXBP4;CCND3;UBE2E2;AKT1;PLCG2;CCND1
prerank,glycoprotein metabolic process (GO:0009100),-0.38118618326412346,-1.2391471707037025,0.11794871794871795,0.5790964276598723,1.0,20/53,19.97%,ST3GAL4;LARGE1;MAN1C1;ADAMTS9;ST3GAL2;MAN2A1;ST6GALNAC3;STT3B;GOLPH3;FUT8;HIF1A;ST8SIA2;ST6GALNAC6;GCNT1;GANAB;MANBA;PARK7;GAL3ST2;NGLY1;ST8SIA5
prerank,cell-cell junction assembly (GO:0007043),0.44459598574140363,1.238267220301839,0.20135363790186125,0.7365304352558008,1.0,11/63,7.04%,GJD3;GJC1;CDH2;JAM3;VCL;GJA4;CDH8;CDH19;CDH20;CDH7;CDH22
prerank,actin filament polymerization (GO:0030041),0.49894490396594227,1.2378680473919352,0.23091603053435114,0.7361598829251477,1.0,6/29,3.97%,ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL
prerank,heterocycle biosynthetic process (GO:0018130),-0.5147700512327784,-1.2374477631690755,0.22093023255813954,0.5828996451237,1.0,9/14,39.86%,GCH1;PYCR2;GPHN;NOXRED1;PYCR1;MOCS2;ALOX5;NFS1;PYCR3
prerank,cellular response to organic substance (GO:0071310),-0.33074613929017893,-1.2373622446772297,0.08433734939759036,0.5822062458485767,1.0,23/116,7.87%,DPYSL3;SMAD3;NFAT5;PTPN14;PTPN13;IGFBP5;SLIT2;TGFBR2;BMPR2;TGFBR1;CLEC3B;KLF4;LEF1;LRRK2;SOCS2;ACVR1;GHR;RAMP2;ACVRL1;RHOA;MAP2K5;STAT3;CYP1B1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.48804202837639843,-1.2372600688622954,0.21611001964636542,0.58159150869821,1.0,4/18,4.20%,VGLL4;APOE;EZR;CTSC
prerank,alpha-amino acid catabolic process (GO:1901606),-0.42452985070177485,-1.2367410740804425,0.19921875,0.5819995413455631,1.0,14/29,35.89%,DDO;ALDH4A1;PRODH;CBS;HOGA1;KYNU;MTRR;BLMH;FAH;IL4I1;HGD;HAAO;ACADSB;HSD17B10
prerank,positive regulation of DNA repair (GO:0045739),-0.39270539545829575,-1.2364699575306628,0.13574660633484162,0.5818709779706301,1.0,4/46,2.97%,EYA2;EYA1;EGFR;EYA4
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.2658284224143883,-1.236439180018706,0.0,0.5810402371259842,1.0,262/1082,19.38%,NFIB;BMP6;AUTS2;IGF1;DAB2;PBX1;ZMIZ1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;ZBTB16;EGFR;MECOM;COL1A1;DCN;NFAT5;WNT4;WWOX;HDAC4;TBL1XR1;GLI2;NFIX;CREB5;IL31RA;CDK8;BMP7;RHOQ;SP100;GLIS3;ELF2;FOXO1;OSR1;APOE;FOXO3;APP;NFIA;ZIC2;NR3C1;MDFIC;HDAC8;KAT6B;HIVEP3;ERG;ITGA6;HOXB3;RARB;ESR1;MLXIP;FGFR2;BMP4;BMPR2;ELF1;MEOX2;ELF4;TGFBR1;KLF4;PLAGL1;KAT2B;MRTFB;TFDP2;FOXC2;LEF1;NFATC1;CDH1;SMAD7;ARHGEF2;MLLT3;LRP6;KLF2;FZD2;ACVR1;TCF4;TCF7L2;THRB;PCGF5;HOXA5;SKI;SBNO2;RGMB;CREB3L2;PARP9;DCAF6;IGF2;ZFPM2;ARRB1;SSBP2;NIBAN2;QRICH1;FGF1;ARNT2;AR;BRD7;RARG;TMF1;GLIS2;YAP1;THRAP3;SIX1;ACVRL1;IRF1;HLF;TEAD1;TET3;PRDM16;WNT5A;LMO2;INO80;IRF2;FOXC1;BPTF;HIVEP1;NAMPT;GLIS1;STAT1;MAP2K5;HINFP;NR2C2;PGR;STAT3;KLF10;SFR1;TBX1;SSBP3;FZD4;FIZ1;ZBTB18;TFCP2;AKT1;DTX3L;RREB1;HIF1A;CDH13;IL33;TRIM16;TNFRSF1A;NLRC5;NR4A2;FOXK1;ATF6;CD38;FOSL2;FZD7;IL18;PHF10;DAB2IP;MMS19;FLCN;ZKSCAN3;ZC3H12A;KARS1;FHOD1;MAVS;ESRRG;EIF5A;PML;GATA2;BRCA2;CEBPG;KDM3A;BCL9L;ELK3;TGFB1;NSD1;MEF2A;ATXN7L3;ZIC3;CCN1;AHR;ID2;PPARA;ZNF462;RELA;PRDM11;HDAC1;UBB;GLI3;ATOH8;USF1;FBXW11;MET;SOX17;ATM;GATA6;RET;TAL1;LPIN3;MPND;CLOCK;SPP1;HDAC5;HSF2;MAPK3;MAZ;HOXC4;SFRP1;PKD1;MEIS2;HIPK2;HOXB7;DYRK1B;SMARCC1;JUND;ZFPM1;CDK9;POU2F1;CEBPZ;SREBF1;BMPR1A;HHEX;SERPINE1;RNF187;NOS1;CREB3;SOX18;NKRF;TLR4;HMGB2;KDM6B;ZMIZ2;NKX6-1;USF2;SNAI1;HNRNPAB;RNASEL;WNT11;SIRT7;MEIS1;JUNB;PTOV1;MYRF;ATF1;RIPK1;NFYB;NFIL3;CSRNP3;MED21;SIRT2;SOX12;RAI1;NFKBIA;KLF15;CEBPB;MAFF;HMGN1;FZD1;PPARGC1A;PLAG1;NPAS2;PARK7;CD81;HMGN5;AGT;ETV4;MT3;IRF2BPL;PIM2;IKBKG;THOC1;AGO1;POU2F2
prerank,establishment of melanosome localization (GO:0032401),-0.4762007401281038,-1.2362503441281862,0.20776699029126214,0.580662686818512,1.0,7/19,20.47%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5374072632789934,1.2361039124419861,0.23214285714285715,0.7392780146202246,1.0,3/21,2.05%,CSPG4;CHST3;CHST7
prerank,regulation of lamellipodium organization (GO:1902743),0.5523496727213061,1.2358006125522454,0.2329059829059829,0.738686917545764,1.0,2/14,2.35%,CARMIL1;WAS
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.56071961172123,1.2357811067923776,0.2613168724279835,0.7373677668217187,1.0,6/15,17.67%,BCAR1;SORT1;NTRK2;DDIT4;SOS1;HAP1
prerank,circulatory system development (GO:0072359),0.4055087831124584,1.2355521904781774,0.16516516516516516,0.7365828371759756,1.0,13/118,3.09%,ADAP2;CACNA1C;PTEN;PLCE1;MEF2C;HEY2;NOTCH1;NF1;FGF12;ERBB4;UTY;PIK3CA;ECE1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5122707752193939,-1.2353688785698418,0.23062015503875968,0.5821316351382086,1.0,3/13,5.46%,ELOVL7;HACD4;HACD3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4830971329714449,1.2350621395800108,0.22077922077922077,0.7364657983417572,1.0,5/27,6.72%,PDGFRB;PTK2;AGAP2;FGF2;IRS1
prerank,DNA conformation change (GO:0071103),-0.49195825953737016,-1.234838900968583,0.1843137254901961,0.5826747600924054,1.0,10/17,31.18%,TOP2B;HHEX;HMGB2;TOP3A;TOP2A;HAT1;ERCC3;TOP1;ABL1;NAA10
prerank,heart trabecula morphogenesis (GO:0061384),-0.4747206414600752,-1.2347250161825312,0.21022727272727273,0.582069560032684,1.0,7/18,7.15%,TGFBR3;BMP7;TEK;ADGRG6;RBP4;TGFBR1;FKBP1A
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.41384699129500035,-1.2343213123530616,0.16559139784946236,0.5822669305884847,1.0,15/36,27.74%,SGMS1;TGFBR1;DEPTOR;NR4A2;DAB2IP;TRIM39;QARS1;PPIA;MAZ;TMBIM6;TPD52L1;CRADD;FAS;RPS3;DAPK2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3830514480481248,-1.2342576208266454,0.13958810068649885,0.5815170013119608,1.0,18/51,27.27%,APP;IL16;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;CCL19;LPL;EGR1;MYD88;PYDC1;FZD5
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.46390289695695336,1.2341568885810337,0.20781527531083482,0.737464795705558,1.0,8/39,7.18%,PIK3CD;PIK3R1;PIP4K2A;PIK3CA;ITPKB;SOCS5;PIP4K2C;PIK3C2A
prerank,regulation of cell population proliferation (GO:0042127),0.3314882927769662,1.2337853327279356,0.06043956043956044,0.7370562883793795,1.0,62/691,6.93%,DLC1;PTPRK;ITGA1;PDGFRB;ACE2;PTEN;IL34;TBX2;S1PR3;GLMN;LIMS1;RERG;CBFA2T3;IGFBP7;GCNT2;RAPGEF2;CDK6;BMP5;NOTCH1;COL4A3;SLC25A33;PTK2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;TNS2;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;CADM4;ETS1;MECP2;TBX6;SH2B3;CXCL5;MYO16;PDCD10;FGF2;SPDYA;RPS6KA2;GAS8;TSPAN31;CXCL10;TNFRSF8;FABP3;TFAP2B;CXCR2;NTRK2;IL4;NUPR2;AGO3;SOX4;CHRNA7;IRS1;EMP2;CDCA7
prerank,protein deacetylation (GO:0006476),-0.40273339565941685,-1.2337140637596484,0.15584415584415584,0.5821487116384254,1.0,14/41,20.77%,HDAC4;TBL1XR1;HDAC7;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3;MORF4L2;SIN3A
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5547222635224995,-1.2336627268707883,0.22241992882562278,0.581422278404175,1.0,5/10,18.50%,DIP2B;FLCN;PRKAA2;KLF15;PARK7
prerank,negative regulation of innate immune response (GO:0045824),-0.4092837124143503,-1.2324194974967027,0.19333333333333333,0.5839715834581576,1.0,9/34,10.91%,SERPING1;CNOT7;STAT2;RPS19;USP15;USP18;NLRC5;SAMHD1;IRAK3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5707221104766188,1.2316878537550606,0.24946695095948826,0.7409512996370994,1.0,2/10,3.41%,NR1H3;ABCD2
prerank,early endosome to Golgi transport (GO:0034498),-0.5456198236094713,-1.2315725071559183,0.23473282442748092,0.5853247724809563,1.0,7/11,22.74%,TRAPPC10;LMAN1;SURF4;RAB6A;TMED9;SNX8;SNX2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3911835786720026,-1.2308822842393108,0.1548974943052392,0.5862075720270699,1.0,17/45,27.27%,APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;CCL19;LPL;EGR1;MYD88;PYDC1;FZD5
prerank,negative regulation of cell migration (GO:0030336),-0.325237734694338,-1.2308307696594807,0.0749185667752443,0.5854463516667587,1.0,26/137,6.22%,AFDN;MCC;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;COL3A1;CLIC4;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;GJA1;PTPRJ;MAGI2;SRGAP3;SRGAP2;CDH1;SMAD7;IGFBP3;PTPRG;SCAI;ACVRL1
prerank,regulation of neuron projection development (GO:0010975),0.38106219040237566,1.2302505220357505,0.16381766381766383,0.743245453518975,1.0,36/163,11.97%,CHN1;SERPINI1;PTEN;CDH2;RAPGEF2;ROR1;RTN4RL1;PTPN9;MARK1;SCARF1;LRRC4C;PTN;ABI2;PLPPR5;ADCY6;NTNG2;MYLIP;ATP1B2;RIT2;NTRK2;CSMD3;RAP1A;IL1RAPL1;FUT9;MARK2;ARHGAP35;LYN;CTNNA2;BRSK1;ABL2;TOX;SPOCK1;PAK3;PAK1;PLXNB3;EP300
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.49477622593765036,1.2300285907713566,0.2379110251450677,0.7424241408610043,1.0,4/28,3.68%,ATP2A3;MAP3K5;CHAC1;ITPR1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5628617051887608,1.2292580863295173,0.26195426195426197,0.7429994305466164,1.0,3/12,3.32%,SEMA5A;PIK3CA;SH3BP1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5342395332357243,-1.2290220263314797,0.21626617375231053,0.58938348056832,1.0,5/11,22.75%,P2RX7;TMEM119;SFRP1;GPR137;UBASH3B
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5625783819155772,1.228873431172237,0.2386117136659436,0.7426349517205075,1.0,1/13,0.21%,CSPG4
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.38900792220270664,-1.2287934960455233,0.15164835164835164,0.5891148959197713,1.0,15/47,18.89%,APOE;FOXO3;APP;KLF4;CSF1;AKT1;ATXN2;VPS35;TGFB1;TCOF1;RPL10;GEMIN5;NFKBIA;AGTR1;AGT
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.4762614564535895,-1.228018901615205,0.216,0.5904739091847785,1.0,13/18,35.75%,AKT1;HIF1A;PPIA;PARK7;NONO;PRKN;BAG5;SOD2;HSPB1;PINK1;MAPK7;VNN1;NME5
prerank,positive regulation of innate immune response (GO:0045089),-0.4172496689378199,-1.227279501051406,0.1794871794871795,0.5915646407581717,1.0,7/30,11.31%,LBP;WNT5A;RPS19;NLRC5;IFI35;MAVS;GBP5
prerank,regulation of cell aging (GO:0090342),0.5621164631704337,1.2270003127220204,0.2619047619047619,0.7459264772744644,1.0,5/11,20.04%,FOXM1;NEK6;NUAK1;RSL1D1;NEK4
prerank,protein localization to plasma membrane (GO:0072659),-0.3234872195686873,-1.2269191970443394,0.09850746268656717,0.5915869260680976,1.0,28/129,12.21%,TSPAN5;AFDN;ROCK2;ATP1B3;TTC7B;ACTN2;DLG1;FYB1;BSG;EZR;FCHO2;RAB11A;CDH1;LRP6;EFR3B;RAMP2;GAS6;SMURF1;S100A10;EHD1;C2CD5;KCNB1;TNFRSF1A;SLMAP;FLOT2;F11R;RAB8A;PTCH1
prerank,regulation of apoptotic process (GO:0042981),-0.27377520271624106,-1.226910340638666,0.011235955056179775,0.5906988399844206,1.0,134/676,14.01%,NOTCH2;IGF1;DAB2;DAPK1;UNC13B;PAWR;FSTL1;EGFR;SMAD6;FHL2;CTSH;PPP1R13B;AKAP13;IL31RA;TIAM2;PDPN;TEK;STEAP3;FOXO1;SH3RF1;OSR1;ACTN2;FOXO3;ARHGEF3;SLIT2;ANXA4;ITGA6;NUPR1;ANXA5;MYO18A;TGM2;STK17B;VAV2;THBS1;BMP4;IGF1R;USP47;IL6ST;GAS1;ANGPT1;RASSF2;FBXO10;MCF2L;TXNDC5;LEF1;ARHGEF2;ANXA1;SOCS2;TRIM24;CFLAR;HOXA5;ADAM10;IGFBP3;ACER2;GAS6;TNFSF10;NIBAN2;QRICH1;NAA35;RNF144B;ZFAND6;RARG;IAPP;SFRP4;CCND2;WNT5A;ANO6;PTK2B;EGLN2;CARD14;PLK2;PTPA;RHOB;STAT1;SH3RF2;HSPA5;TFRC;ANP32E;ERC1;CYP1B1;ADAMTSL4;IFIT2;GOLPH3;ERCC5;ARHGEF1;TRIO;TPT1;BIRC3;TIAM1;ANP32B;AIFM1;AKT1;SON;MCL1;BAG3;PRDX2;EGLN3;BCL2L11;CTSB;UTP11;IFIT3;ATF6;CD38;GCLC;DAB2IP;KDR;FLCN;CASP8;ARHGDIA;BNIP3L;FGD4;PLEKHG5;NME1;FLT4;ACTN1;RELA;CBX4;HDAC1;UBB;TRIM35;ARHGEF18;CALR;SPHK1;LRP8;PIM3;ATM;GATA6;BNIP3;ARHGEF19;RPL10;PPID;PPIA;HYPK;RASGRF2
prerank,positive regulation of gene expression (GO:0010628),-0.28210689549926415,-1.2268605361905096,0.02976190476190476,0.5899011042626194,1.0,94/442,13.42%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;EGFR;SAMD4A;CDH5;ROCK2;GSN;NTRK3;CTSH;OCLN;BMP7;OSR1;APP;IL15;F3;WNT6;CLDN5;VIM;ITGB8;NOS3;THBS1;BMP4;EZR;GJA1;FOXD1;TGFBR1;ANGPT1;KLF4;LARP4B;DDX5;KAT2B;LEF1;CSF1;RAMP2;NIBAN1;CD34;HOXA5;SMO;GAS6;MED26;FGF1;RBM20;RAB27A;AR;LGALS9;MOV10;YAP1;SFRP4;WNT5A;MAPK14;RPS4X;HINFP;TFRC;STAT3;BAZ1B;ACTG1;POLR2A;PIK3CB;C1QTNF3;DTNBP1;AKT1;HGS;UPF3A;NOS1AP;HIF1A;IL33;TLE1;ZC3H12A;EMILIN1;GATA2;P2RX7;ERN1;VPS35;RPL11;CPEB3;SEC16B;TGFB1;FGFR4;POLR2F;ID2;EPHB2;TMEM119;EPHX2;PRKAB1;ACTB;PLCG2;RPL26;WNT16;ATM
prerank,pulmonary valve development (GO:0003177),-0.46178822923934326,-1.2266371827720817,0.21637426900584794,0.5896153239618026,1.0,11/18,9.53%,NOTCH2;ROBO1;SMAD6;SLIT2;NOS3;BMP4;BMPR2;NFATC1;TNFRSF1B;STRA6;TNFRSF1A
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4438435179989501,-1.2257771110552775,0.21169354838709678,0.5910775816367013,1.0,8/25,23.92%,APP;RIN3;SDCBP;ATXN2;ITGB3;NEU3;ANKRD13D;ANKRD13A
prerank,neural crest cell migration (GO:0001755),-0.40201341044623146,-1.2257644410177557,0.19868995633187772,0.5902110892216682,1.0,13/36,16.42%,FN1;NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;TBX1;SEMA3B;RADIL;CORO1C;SEMA3G;SEMA6B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5701668128867038,1.225163673413931,0.2692307692307692,0.749180169789833,1.0,6/11,23.67%,MSH3;TIMELESS;BLM;FBXO5;FBH1;TIPIN
prerank,amino acid transmembrane transport (GO:0003333),0.4599573983357159,1.2244436737621243,0.21228070175438596,0.749666348898884,1.0,1/45,0.03%,SLC38A11
prerank,regulation of protein kinase B signaling (GO:0051896),0.3665313979935841,1.224349186849092,0.16186556927297668,0.7485341902939677,1.0,18/193,4.63%,PDGFRB;PTEN;PIK3CD;GAB1;GCNT2;PHLPP1;PTK2;PIK3R1;SEMA5A;GPER1;FERMT2;ERBB4;NRG1;PIK3CA;SH2B3;AXL;FGF2;SPRY2
prerank,blood vessel morphogenesis (GO:0048514),-0.376145368027195,-1.2241488875397086,0.14215686274509803,0.5938282004165724,1.0,17/54,8.29%,TGFBR3;FLT1;EFNB2;NRP1;LAMA1;CCBE1;CAV1;ITGB8;TGFBR2;TGFBR1;SMAD7;ID1;RAMP2;RASIP1;TBX1;CYP1B1;STRA6
prerank,epithelium development (GO:0060429),-0.33354558419576397,-1.2234301363462352,0.1078167115902965,0.5949124807562434,1.0,27/107,15.93%,ALDH1A2;ERRFI1;WNT4;OSR1;ANXA4;FGFR2;MEOX2;CPT1A;CD34;SMO;RCN3;CNN3;SIX1;STAT1;TBX1;CTSB;KDR;ANXA7;TGFB1;PTCH1;MFSD2A;SOX17;GATA6;PKD1;BDH2;CASP6;SOX18
prerank,leukocyte tethering or rolling (GO:0050901),0.5507670862011211,1.2233120993034594,0.25413223140495866,0.7497058325627651,1.0,3/17,5.46%,ITGA4;ROCK1;ITGB1
prerank,histone modification (GO:0016570),-0.33031420019918445,-1.223036084055405,0.10086455331412104,0.5950230443384537,1.0,28/109,20.83%,EYA2;EYA1;HDAC4;TBL1XR1;KAT6B;EYA4;HDAC9;MIDEAS;BAZ1B;PRKCD;TRRAP;RCOR3;CARM1;EHMT1;PRDM5;NSD1;ATXN7L3;HDAC1;HDAC5;SIRT7;SIRT2;PARK7;MT3;EZH2;USP22;MORF4L2;SIN3A;USP36
prerank,glycine transport (GO:0015816),-0.5462761273576628,-1.223032224508775,0.2361904761904762,0.5941303256714714,1.0,4/10,19.97%,SLC6A9;SLC25A38;SLC38A5;SLC36A1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5533962808251395,-1.2228939270006218,0.2456813819577735,0.5936052390311033,1.0,4/10,16.00%,NAMPT;IL33;KDR;TLR4
prerank,gene expression (GO:0010467),-0.28484745787459465,-1.2225026331448412,0.024752475247524754,0.5937223627833245,1.0,125/348,26.36%,CELF2;TSPAN5;RBMS2;RPLP1;RPS14;THRB;RPL9;RPS12;RPL41;RPS20;ATXN1;RPL18A;RPS13;RPS19;RPS23;RPS4X;SRBD1;GOLPH3;POLR2A;RPS11;RPL13;RPL18;SMG6;RPL34;RPL32;EEF1A1;RPS9;MRRF;RPS8;NR4A2;RPL27A;RPL12;RPL37;MMS19;NXF1;RPS18;RPL11;PWP1;RPS16;RPS5;RPL24;RPS15A;RPL39;MEF2A;NOVA1;RPL28;POLR2F;RPS24;RPLP2;RPS27;RPL26;RPL14;MRPS7;MRPS6;RPL10;SARS1;RPL7;DTX1;MRPS18A;DNAJB11;MRPL52;NUP98;RPL10A;RPS6;HARS1;MRPL24;RPS15;RPL23;RPL17;RPL22;AGFG1;HHEX;RPL31;RNASEL;SMG5;POLR2E;RPL15;TPR;RPSA;RPL38;SRSF2;RPS25;RPS7;RPLP0;SRSF6;RPL27;SNRNP40;THOC1;NUP88;UPF2;MCM3AP;E2F1;THAP1;RPL36A;HNRNPL;NUP214;DEDD2;RPS26;SRSF5;RPL35A;RPL8;RPS29;RPL36;FIP1L1;NXT1;RRBP1;THOC7;POLR2G;DHX8;MRPL35;NUP37;EPC1;FARSB;PPP5C;HNRNPF;SRSF11;ABCF1;RPL13A;RPS3;ALKBH5;DDX54;RRAGC;NUP155;TSPAN33;MRPL34
prerank,calcium ion import across plasma membrane (GO:0098703),0.5495438408085797,1.2223785830564498,0.2611336032388664,0.7506128368014563,1.0,3/14,4.84%,TRPV2;CACNA2D1;SLC24A2
prerank,Rac protein signal transduction (GO:0016601),0.5304730122370053,1.2219418364063284,0.2647058823529412,0.7503355498851333,1.0,4/18,10.24%,EPS8;ABI2;HACE1;NCKAP1
prerank,neuron migration (GO:0001764),0.45536480008923563,1.2219122292424505,0.2060931899641577,0.7490837663727022,1.0,14/48,10.88%,MEF2C;ADGRL3;RAPGEF2;MARK1;ASTN1;FGF13;DNER;ASTN2;NTRK2;TUBB2B;CCK;MARK2;DDIT4;SPOCK1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.43320104893567374,-1.2219052177530985,0.21146245059288538,0.594419559394155,1.0,11/27,25.94%,GAS6;ARRB1;C1QTNF3;ZC3H12A;IRAK3;CD200;TLR4;SIRPA;PTPN6;NCKAP1L;CD200R1
prerank,regulation of macrophage activation (GO:0043030),-0.43641476167768356,-1.2209830328135975,0.19703389830508475,0.5959983417826584,1.0,12/30,16.00%,IL31RA;LBP;MYO18A;THBS1;WNT5A;MFHAS1;IL33;ZC3H12A;KARS1;SPHK1;CD200;TLR4
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5677498243260914,1.2209039080078543,0.26057906458797325,0.7502428438053136,1.0,4/12,14.59%,CASQ2;RYR2;CASQ1;ANK2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.48299224155592585,-1.220851542749906,0.23137254901960785,0.5954179304360643,1.0,5/16,6.63%,RANBP3L;PLCB1;BOC;IGFBP3;MAPK14
prerank,cellular response to cytokine stimulus (GO:0071345),-0.28207669173988564,-1.2204599211360554,0.04678362573099415,0.5956899736129594,1.0,106/416,17.47%,DAPK1;DPYSL3;COL1A2;FN1;SMAD3;ADAMTS12;LEPR;NFAT5;PTPN14;ST3GAL6;PTPN13;PTGIS;IL31RA;FOXO1;FOXO3;F3;IL6R;VIM;IL1R1;LBP;IL6ST;PTPRJ;LRCH1;LEF1;CSF1;ARHGEF2;ANXA1;VCAM1;SOCS2;GHR;GSDME;SBNO2;GAS6;IRAK2;IL16;MAOA;ZFAND6;CXCL12;STAT2;LGALS9;GREM2;CCL15;IRF1;TNFRSF1B;WNT5A;RHOA;ICAM1;WNK1;FOXC1;CD47;STAT1;CCL14;STX3;STAT3;DUSP1;GBP4;RAPGEF1;PIK3CB;KIT;AKT1;MCL1;IRGM;HIF1A;TNFRSF1A;BCL2L11;LAMA5;IFIT1;IL18;DAB2IP;STX1A;ZC3H12A;IRAK3;GBP6;INPP5D;GBP5;TGFB1;PTGS2;CCL25;S1PR1;FLT3LG;RELA;YBX3;UBB;GBP7;FER;LRP8;OXSR1;CCND1;UBE2G2;SFRP1;CNTFR;IFITM2;GBP2;CCL13;CDK9;POU2F1;TLR4;CDKN1B;IL10RB;SDC1;PNPT1;SIRPA;JUNB;RIPK1;TPR;CSF3R
prerank,cristae formation (GO:0042407),-0.42957282036628885,-1.219794825051098,0.18220338983050846,0.5965801915724446,1.0,10/27,16.37%,ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;AFG3L2
prerank,ether lipid metabolic process (GO:0046485),-0.49923618255363644,-1.2196010459390325,0.22884615384615384,0.5962400104064342,1.0,4/14,10.98%,AGMO;NCEH1;PLA2G6;LIPE
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4942320748781449,1.2192139004318938,0.24344569288389514,0.7531965524389701,1.0,8/28,6.72%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4031343603845006,-1.2189940001983168,0.1901840490797546,0.5969774860392673,1.0,10/36,16.84%,MECOM;FOXO1;DLG1;EZR;SH3RF2;DUSP1;QARS1;PPIA;DUSP10;SIRPA
prerank,cholesterol homeostasis (GO:0042632),0.42666747601144756,1.2188243377599384,0.21140939597315436,0.7528353825922341,1.0,9/64,6.99%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,positive regulation of viral life cycle (GO:1903902),0.52794307107765,1.218742651540064,0.2546583850931677,0.7516803030856596,1.0,4/22,8.45%,TMPRSS4;AXL;CHMP2B;TMPRSS2
prerank,regulation of neuron projection arborization (GO:0150011),-0.4947614155281663,-1.2184757413302423,0.2297029702970297,0.5975503304665902,1.0,7/15,17.39%,MACF1;MOV10;WNT5A;MYO9A;FZD4;MFSD2A;MAP3K13
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4976548436944632,-1.2180818143545702,0.22574626865671643,0.5977118247400748,1.0,4/15,15.44%,SMAD7;IRAK3;TGFB1;HFE
prerank,negative regulation of cell development (GO:0010721),-0.4395491665469561,-1.2179484369279951,0.21442885771543085,0.5971900085229189,1.0,4/25,5.49%,IGF1;FBN1;B2M;APPL2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36450980260544985,-1.2177050515668841,0.16136919315403422,0.5969698097408062,1.0,13/59,9.94%,SDK1;ROBO1;HMCN1;PECAM1;BSG;PTPRM;MPZL2;CDH1;SDK2;PALLD;OBSL1;CDH13;ROBO4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.42973854589441846,1.2176684186589721,0.19966996699669967,0.7529487760548768,1.0,17/60,15.70%,PTEN;HEY2;MECP2;MED10;MED13;RUNX2;AGO3;CDKN1A;CCNC;MED1;TNRC6C;MED20;TNRC6B;ATF7IP;MED4;DHX36;MED6
prerank,clathrin-dependent endocytosis (GO:0072583),0.4983264827887214,1.2171346594831092,0.2594059405940594,0.7528847301893729,1.0,1/26,0.11%,SGIP1
prerank,calcium ion transport into cytosol (GO:0060402),0.5171252261579862,1.2170075712560822,0.23856858846918488,0.7518527604652123,1.0,6/21,15.28%,CACNA1C;CACNA2D1;RYR2;GRIN2B;JPH4;GRIN2A
prerank,glucose import (GO:0046323),0.5506528308868865,1.2168932557432883,0.2606060606060606,0.7507912751183846,1.0,4/13,8.07%,SLC5A1;SORT1;SLC27A4;SLC2A3
prerank,positive regulation of DNA replication (GO:0045740),-0.4908766699855142,-1.2168119177773535,0.21292775665399238,0.5984830592839095,1.0,2/16,1.15%,EGFR;GLI2
prerank,sterol homeostasis (GO:0055092),0.42426818141396283,1.2159014210288677,0.21680672268907564,0.7518884253818481,1.0,9/65,6.99%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,modified amino acid transport (GO:0072337),0.5365247010526344,1.2157881128095012,0.25894736842105265,0.7509030000105152,1.0,3/15,3.17%,SLC16A12;SLC1A4;SLC19A1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5725092671148682,1.2155569565974074,0.26652452025586354,0.7501786535657522,1.0,6/10,16.07%,MAPRE2;FGF10;MAP4K4;MTOR;IQSEC1;EPB41L4B
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3985529519816039,-1.2155429771652375,0.21382289416846653,0.6010156584235832,1.0,17/38,25.84%,NDUFV3;NDUFS4;NDUFB8;NDUFC1;NDUFS5;NDUFA11;NDUFA4;NDUFB5;NDUFA13;NDUFA10;NDUFB4;NDUFB7;NDUFS1;NDUFS7;NDUFS8;NDUFB10;NDUFA3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.341834960023046,-1.2154360072749186,0.15083798882681565,0.6004654860341696,1.0,31/88,26.94%,DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;CST3;ATRAID;AKT1;IGF2BP2;DAB2IP;CPEB3;CALR;CNOT8;LARP1;RGP1;FXR2;CLN8;PAIP2B;EIF4E2;TYMS;CDK5RAP3;SERPINE2;EIF2AK3;SAMD4B;RPL13A;RACK1;RPS3;EDNRB;EIF4ENIF1
prerank,response to estradiol (GO:0032355),0.4811113937033939,1.214933513367188,0.26127819548872183,0.750371032717107,1.0,4/31,3.92%,GGT5;GGT1;GPER1;NCOA3
prerank,excitatory postsynaptic potential (GO:0060079),0.5319402655236244,1.2147401877937327,0.2757201646090535,0.749557801002812,1.0,3/19,3.44%,MEF2C;MPP2;CHRNA3
prerank,metal ion homeostasis (GO:0055065),0.4589754214229378,1.2145660383453865,0.21666666666666667,0.7487442875842414,1.0,10/40,12.37%,SLC12A2;SLC12A6;TFAP2B;ANK3;SNCA;LETM1;COX11;SLC12A5;FAM20A;SLC12A4
prerank,activation of phospholipase C activity (GO:0007202),0.4872424119098102,1.2144765676315843,0.2413793103448276,0.7476762369391868,1.0,2/29,1.06%,EDNRA;ARHGAP6
prerank,regulation of signal transduction (GO:0009966),0.36192962530285344,1.2144525975974225,0.16690442225392296,0.7464406221760401,1.0,18/190,5.31%,RGS5;RGS6;RGS4;PLCE1;IGFBP7;RORA;NCK2;SEMA5A;RGS3;TSPAN15;CD46;GRK3;RGS11;IFT81;OGT;SOCS5;TSPAN12;SREBF2
prerank,positive regulation of receptor internalization (GO:0002092),-0.4466199661558711,-1.2141384537186728,0.21176470588235294,0.6030837749993012,1.0,5/22,7.39%,ANGPT1;MAGI2;ARRB1;SFRP4;SCYL2
prerank,defense response to virus (GO:0051607),0.40472560427906007,1.214075350488489,0.19626168224299065,0.746082896707756,1.0,1/100,0.01%,ABCC9
prerank,regulation of ion transport (GO:0043269),0.41588723417148676,1.2139722309284744,0.22523961661341854,0.7450653743966855,1.0,15/76,10.80%,KCNJ8;NEDD4L;KCNJ12;CLDN10;CHRNA3;NKAIN2;ANK3;SNCA;SIK1;STC1;PDZK1;SYT1;KCNJ3;KCNJ6;SYT2
prerank,positive regulation of GTPase activity (GO:0043547),0.3730257015336189,1.2133455423780335,0.17099863201094392,0.7452828700380821,1.0,35/188,9.71%,ARHGAP42;TBC1D1;RGS6;LIMS1;DOCK10;RAPGEF2;RASGRP2;FERMT2;SIPA1;NF1;PLXNB1;SH3BP1;GRTP1;GARNL3;AGRN;SYDE1;SLC27A4;TBC1D30;MAPRE2;ITGB1;TBC1D12;RIC1;ARHGEF26;RUNDC1;RAP1A;HRAS;RGS7;MAP4K4;TBC1D2B;MTSS2;RAB11FIP2;RALGAPA1;RGS10;TBC1D10C;EPHA2
prerank,peptide biosynthetic process (GO:0043043),-0.3163581604925684,-1.212990174596975,0.1064516129032258,0.6053567676084008,1.0,62/153,18.32%,PCSK5;RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;SRBD1;RPS11;RPL13;RPL18;RPL34;RPL32;EEF1A1;RPS9;MRRF;RPS8;RPL27A;RPL12;RPL37;RPS18;RPL11;RPS16;RPS5;RPL24;RPS15A;RPL39;RPL28;RPS24;RPLP2;RPS27;RPL26;RPL14;MRPS7;MRPS6;RPL10;SARS1;RPL7;MRPS18A;MRPL52;RPL10A;RPS6;HARS1;MRPL24;RPS15;RPL23;RPL17;RPL22;CARNS1;RPL31;RPL15;RPSA;RPL38;RPS25;RPS7;RPLP0;RPL27
prerank,positive regulation of synaptic transmission (GO:0050806),0.41666603210684505,1.2128181907653757,0.22039473684210525,0.7452599264796087,1.0,19/72,11.09%,CLSTN1;GPER1;MPP2;NRXN1;CACNG7;NMU;ADCY8;RIMS1;CLSTN3;SLC24A2;RIMS2;CHRNA7;SYT1;KCTD13;NFATC4;ZDHHC2;GRIN2B;BAIAP3;STX4
prerank,peptidyl-methionine modification (GO:0018206),0.5714817922163958,1.2127187980866285,0.2576419213973799,0.7442151363898618,1.0,4/12,17.88%,METAP2;NAA30;NAA15;METAP1
prerank,wound healing (GO:0042060),-0.36324559994193956,-1.2126893322683778,0.17048346055979643,0.6052718720632088,1.0,15/62,11.23%,IGF1;SMAD3;COL3A1;MYOF;PDGFRA;MACF1;PLEC;TGFBR1;CFLAR;FGF1;WNT5A;PRCP;FZD7;PPL;ITGB3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2561687726867544,-1.2124302707030843,0.0,0.6051492802888087,1.0,369/1668,18.10%,NFIB;BMP6;AUTS2;TSHZ2;FOXP2;PRDM6;IGF1;DAB2;PBX1;ZMIZ1;PKNOX2;MAF;AEBP1;SMAD3;FLI1;SMARCA2;ZBTB16;EGFR;MECOM;SMAD6;DCN;NFAT5;FOXP1;KDM7A;ZKSCAN2;WWOX;HDAC4;CUX1;TBL1XR1;GLI2;FHL2;WWC2;NFIX;CREB5;ZFHX4;CDK8;TGFA;RHOQ;LCOR;SP100;GLIS3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;OSR1;KLF3;APOE;SKIL;FOXO3;APP;NFIA;ZIC2;NR3C1;DLG1;HDAC8;CAV1;KAT6B;HIVEP3;ERG;ANXA4;ITGA6;HOXB3;RARB;ESR1;MLXIP;SUFU;FGFR2;ZIC5;BMP4;BMPR2;ELF1;EZR;VGLL3;SMURF2;MEOX2;ZBTB7C;MAFG;ELF4;FOXD1;PRRX2;RPS14;NR3C2;DNMT3A;TBX15;KLF4;PLAGL1;DDX5;KAT2B;MRTFB;TFDP2;FOXC2;SMAD9;LEF1;NFATC1;SMAD7;ARHGEF2;LRP6;KLF2;HDAC9;ACVR1;ID1;TAF1;TCF4;TCF7L2;ETV6;THRB;PCGF5;HOXA5;SKI;SBNO2;ZHX3;MXI1;ZNF23;CREB3L2;SP140;PARP9;DCAF6;SDCBP;HDGFL3;IGF2;HOXA3;ZFPM2;TEAD4;ZNF697;GATAD2A;ARRB1;WWP2;MED26;SSBP2;GTF2IRD1;FGF1;ARNT2;AR;BRD7;CREM;RARG;HIF3A;STAT2;TMF1;GLIS2;FOXP4;MOV10;SOX13;YAP1;THRAP3;PRRX1;BHLHE40;MIDEAS;SIX1;ACVRL1;ATN1;IRF1;HLF;KMT5A;PRKCB;TEAD1;TET3;PRDM16;WNT5A;BAZ1A;KDM5B;HOXC6;MAPK14;LMO2;ATXN1;INO80;ID3;IRF2;ZNF292;FOXC1;CHD3;BPTF;HIVEP1;NAMPT;GLIS1;STAT1;MAP2K5;FNIP1;HINFP;NR2C2;PGR;STAT3;KLF10;IFRD1;BAZ1B;IFI27;TBX1;ZNF219;SSBP3;RTF1;ZBTB8A;KIT;FIZ1;ZBTB18;IRF9;TFCP2;FOXL1;RREB1;BBS7;LHX6;MKX;TADA1;BAZ2B;HIF1A;CDH13;IL33;RCOR3;TWIST2;TNFRSF1A;NLRC5;KLF12;NR4A2;TADA2A;FOXK1;BHLHE41;ATF6;FOSL2;IL18;PHF10;IKZF1;DAB2IP;HOXB9;ZKSCAN7;FLCN;ZKSCAN3;ZC3H12A;TGIF1;TFCP2L1;FHOD1;MAVS;ZFHX2;SIX5;ESRRG;EIF5A;GATA2;NFYC;PRDM5;CEBPG;TRIM27;FOXQ1;MDFI;ZSCAN25;PATZ1;KDM3A;BCL9L;CPEB3;ELK3;TGFB1;BACH2;ZMYM5;MED27;NSD1;PTCH1;MEF2A;LRRFIP1;ATXN7L3;ZIC3;CCN1;AHR;ID2;PPARA;ZNF462;RELA;ZSCAN22;CBX4;MDM2;HDAC1;UBB;GLI3;ATOH8;USF1;CHD2;CALR;MET;ZGPAT;DACH2;SOX17;ATM;EZH1;GATA6;CCND1;SP110;RFX2;TAL1;LPIN3;MPND;ZNF585A;ZNF585B;CLOCK;ZNF568;RPL10;PPID;TOX4;ZBTB4;KCNIP3;SARS1;HDAC5;HSF2;MAPK3;TTC21B;MAZ;ENO1;HOXC4;SLTM;PKD1;MEIS2;HIPK2;HOXB7;SMARCC1;HOXB5;BEND3;JUND;ZFPM1;RPL23;PCGF3;CDK9;POU2F1;CEBPZ;YEATS2;SREBF1;BMPR1A;HHEX;SERPINE1;NOS1;CREB3;SOX18;NKRF;TLR4;HMGB2;KDM6B;ZMIZ2;CREB3L1;NKX6-1;ZNF436;MNT;USF2;TNRC6A;SNAI1;ZFP69;HCFC2;RNASEL;PHF21A;TSHZ1;SIRT7;MEIS1;JUNB;PTOV1;ZFP14;ATF1;RIPK1;FBXL19;NFYB;TPR;NFIL3;PSIP1;CSRNP3;MED21;SIRT2;SOX12;RAI1;NFKBIA;KLF15;CEBPB;CIR1;NR6A1;MAFF;ELP3
prerank,chondrocyte differentiation (GO:0002062),-0.4211891010659899,-1.2119870132693888,0.20985010706638116,0.6054669082026767,1.0,9/32,5.61%,NFIB;SULF1;OSR1;BMP4;BMPR2;CREB3L2;CCN3;SULF2;SLC39A14
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.4250913864102453,-1.2115087282370296,0.19678714859437751,0.6059053327959434,1.0,6/27,6.88%,IGF1;FN1;PDGFRA;GAS6;WNT5A;S100A6
prerank,regulation of cytokinesis (GO:0032465),-0.34331758117704675,-1.2109623585240197,0.1282051282051282,0.606441026566314,1.0,16/78,13.06%,PKP4;RAB11A;KIF13A;CDC14A;PRKCE;RHOA;PLK2;CALM2;ZFYVE19;BECN1;SPAST;FLCN;SVIL;SH3GLB1;GIT1;UVRAG
prerank,negative regulation of endopeptidase activity (GO:0010951),0.44404542095639354,1.2103235524762925,0.21626297577854672,0.7488588197427719,1.0,9/47,10.88%,SERPINB8;SERPINI1;VTN;SERPINA10;BIN1;PCID2;SERPINA2;SPOCK3;SPOCK1
prerank,endoplasmic reticulum organization (GO:0007029),-0.36025336734049335,-1.21024100173321,0.1683673469387755,0.6075328116558132,1.0,32/72,28.03%,APP;TRAM2;LRRK2;SEC31A;LPCAT3;STX1A;LMAN1;SEC16B;ATL2;ALDH3A2;DOP1B;CAV2;REEP1;VAPA;REEP5;RAB18;BNIP1;STX18;GET1;SEC61A1;MOSPD3;SEC61B;REEP2;GAK;TMEM33;EIF2AK3;CCDC47;WDR83OS;SEC31B;ATL3;TRAM1;TLE6
prerank,negative regulation of peptidase activity (GO:0010466),0.45036662054549775,1.2100202120150176,0.21908127208480566,0.7482821763360755,1.0,3/47,1.04%,SERPINB8;SERPINI1;VTN
prerank,adherens junction organization (GO:0034332),0.4546681958209484,1.2094613595244572,0.22508591065292097,0.7484078107529294,1.0,14/48,10.52%,CDH2;CDH4;JAM3;VCL;FERMT2;CADM2;CDH8;CDH19;CDH20;CDH7;CDH22;CSK;CDH10;CDH18
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.49753530975869675,-1.208466797769771,0.22138836772983114,0.6114334700059457,1.0,5/15,9.38%,PRKCH;BMP4;SFRP4;FOXC1;TRIM16
prerank,regulation of myoblast fusion (GO:1901739),-0.5283230328013209,-1.208305794292546,0.24763705103969755,0.6109791502613233,1.0,4/11,16.03%,CFLAR;MAPK14;EHD1;EHD2
prerank,cellular senescence (GO:0090398),0.48937965517537274,1.2081124912163306,0.25343811394891946,0.7504877206944822,1.0,4/27,7.82%,TBX2;TBX3;HRAS;CDKN1A
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.49585528079154384,-1.2079260758775134,0.22286821705426357,0.611058514236042,1.0,4/15,8.24%,DAB2;BMP2K;SCYL2;PIK3CB
prerank,regulation of B cell differentiation (GO:0045577),-0.46497545388019135,-1.207840582563595,0.22030651340996169,0.6104218020934273,1.0,8/17,25.30%,MMP14;ID2;SFRP1;ZFP36L2;PPP2R3C;SYK;XBP1;NCKAP1L
prerank,striated muscle tissue development (GO:0014706),0.4696501996060913,1.2077873067991798,0.25140712945590993,0.7499893046598025,1.0,6/29,7.71%,TBX2;MEF2C;BMP5;POPDC3;SGCZ;IGSF8
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.40173936837002794,-1.2073689170545228,0.20210526315789473,0.6107801773180548,1.0,13/37,26.80%,APOE;RIN3;SDCBP;ATXN2;OPTN;ITGB3;SIRT2;MT3;ANKRD13D;BRCA1;ANKRD13A;PRKN;EDNRB
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4694609360340115,1.207217737386269,0.24806201550387597,0.7501511010356117,1.0,4/31,1.19%,LIMD1;RORB;CDK6;NOTCH1
prerank,error-prone translesion synthesis (GO:0042276),-0.4505285478417441,-1.2072113158274007,0.2290836653386454,0.6103457022415432,1.0,13/21,35.93%,REV1;POLH;UBB;RPA1;RFC3;POLI;POLE2;RFC1;RPA3;PCNA;RFC5;MAD2L2;PRIMPOL
prerank,cartilage development (GO:0051216),-0.37976715072450734,-1.2067132685058055,0.18834080717488788,0.6107242549668419,1.0,10/49,5.61%,NFIB;SULF1;ZBTB16;OSR1;ITGB8;BMP4;CREB3L2;CCN3;SULF2;SLC39A14
prerank,ovarian follicle development (GO:0001541),-0.5055989050822243,-1.206373431693109,0.24814814814814815,0.6107693686168584,1.0,7/13,27.80%,KIT;EIF2B2;CEBPB;VEGFA;FOXL2;EIF2B5;EIF2B4
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.46461790016333604,-1.2062604344744985,0.24,0.6101959532417512,1.0,4/17,5.67%,PODXL;FOXC2;ADAM9;PIEZO1
prerank,protein localization to nucleus (GO:0034504),-0.3311975563429383,-1.2062209214834987,0.1388888888888889,0.609425362186137,1.0,38/102,29.53%,COL1A1;BMP7;BMP4;APPL2;SIX1;STAT3;AKT1;PINX1;TOR1AIP1;PML;IPO7;RPL11;FAM53C;IPO13;MDM2;RAN;CALR;GBP2;HHEX;IPO8;NXT2;TPR;NUP88;SYK;NUP214;NXT1;YWHAE;RRS1;NUP155;MSX1;RANBP17;EIF4ENIF1;CSE1L;PTTG1IP;NUP62;TNPO2;MORC3;WRN
prerank,negative regulation of phosphorylation (GO:0042326),0.4034761302450768,1.2057863236323034,0.22410865874363328,0.7523089033459622,1.0,7/85,3.09%,DYNLL1;PTEN;PID1;CBFA2T3;ROCK1;PRR5L;CADM4
prerank,renal absorption (GO:0070293),-0.5385533756567078,-1.2057735480719975,0.2523540489642185,0.6097110509670283,1.0,3/10,10.16%,GSN;WNK4;KCNQ1
prerank,regulation of B cell activation (GO:0050864),0.4981103526300701,1.205401647795441,0.2231237322515213,0.7519819921970383,1.0,3/25,6.10%,SH3KBP1;TNIP2;IL4
prerank,negative regulation of cellular process (GO:0048523),0.3303624155247202,1.205387904846914,0.10501750291715285,0.7507395928553582,1.0,49/521,6.60%,DLC1;PTPRK;ITGA1;PTEN;GLMN;RERG;CBFA2T3;APBB2;IGFBP7;TNFRSF21;RAPGEF2;CDK6;DYSF;BMP5;NOTCH1;COL4A3;NCK2;SEMA5A;RGCC;CCN6;GPER1;SLIT3;NR1H3;FRK;MYH9;TNS2;FERMT2;SIPA1;SPEF1;FOXM1;ERBB4;IL1B;PLXNB1;ETS1;CRLF3;SH2B3;MYO16;FGF2;RPS6KA2;BRINP1;GAS8;TNFRSF8;FABP3;TFAP2B;NUPR2;CBLL1;DDX3X;CAPRIN2;SOX4
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.47578254291234706,-1.2049845957367764,0.2196078431372549,0.6109678672638221,1.0,5/18,16.82%,HDAC7;EZR;CD34;TRIM27;HOMER3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5161427596659466,-1.204920731771904,0.22868217054263565,0.6102767466126935,1.0,7/13,34.23%,ENPP1;SULT1A1;TPST1;TPST2;SULT4A1;ABHD14B;SULT2B1
prerank,regulation of lipid kinase activity (GO:0043550),0.5802343895027716,1.204185764193542,0.3012295081967213,0.7524787193295812,1.0,3/11,12.21%,PIK3R1;RBL1;RB1
prerank,triglyceride homeostasis (GO:0070328),0.4866472843531915,1.2040429364078422,0.2780952380952381,0.751548732014186,1.0,4/26,6.99%,RORA;NR1H3;SCARB1;LIPC
prerank,peroxisome organization (GO:0007031),0.49226698839299,1.2039301292928666,0.2571428571428571,0.7505659348960161,1.0,9/25,15.33%,ABCD2;PEX7;PEX1;TMEM135;MFF;PEX3;PEX19;LONP2;PEX12
prerank,glycoprotein biosynthetic process (GO:0009101),-0.35323179367655966,-1.2036621950170776,0.17403314917127072,0.6127940362504545,1.0,16/79,10.24%,IGF1;CHST11;ST3GAL4;LARGE1;ST3GAL6;BMPR2;ST3GAL2;CSGALNACT1;ST3GAL3;GOLPH3;MGAT1;ST6GALNAC2;FOXL1;SERP2;ST8SIA2;B3GALNT1
prerank,response to lipid (GO:0033993),-0.3302412516914443,-1.2035847265919348,0.13031161473087818,0.6121327732514367,1.0,32/105,16.60%,SMAD6;FOXP1;CTSH;FOXO1;FOXO3;RBP4;LBP;ESR1;NOS3;ANXA1;SOCS2;ACER2;RARG;LGALS9;ALPL;STAT3;NOCT;TRIM16;IRAK3;GCH1;TGFB1;FGFR4;PPARA;TNFRSF11A;FER;GATA6;SPP1;MAPKAPK3;NOS1;TLR4;HMGB2;PELI1
prerank,actin filament organization (GO:0007015),0.3717912854821335,1.2033630918972176,0.17908309455587393,0.7506569032886599,1.0,25/151,10.71%,MYO1B;EPS8;CARMIL1;MPRIP;BCAR1;RND3;WAS;CORO7;SH3BP1;ABI2;TMOD1;SPIRE1;RAC3;WASL;TMOD3;EMP2;SPTA1;PLS3;MYO6;CORO1A;MARCKS;ERMN;HIP1;LMOD1;ARPC4
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5761299031801475,1.2031955235599467,0.2857142857142857,0.7498281424901009,1.0,3/10,5.11%,PID1;IL1B;GRB10
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3197654822916705,-1.2028813437015848,0.10869565217391304,0.6131673853579458,1.0,30/129,16.02%,RNF220;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;FGFR2;USP47;SMURF2;RNF146;LRRK2;TNKS2;LYPD6;SFRP4;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;PSMB4;PSMD8;PSMB1;SFRP1;PSMD11;PPM1B;PSME3;HHEX;PLEKHA4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.34275199367277137,-1.2028448727321805,0.17158176943699732,0.6123954542792951,1.0,31/72,31.26%,ELF1;CFLAR;GAS6;IRAK2;STAT1;BIRC3;USP18;TNFRSF1A;CASP8;IRAK3;SPHK1;HSP90AB1;VRK2;RNASEL;RIPK1;AGPAT2;IKBKG;SYK;PTPN2;SIGIRR;PTPN6;CBFB;RACK1;TAX1BP1;LIFR;SOCS1;IL7;ZBP1;TRADD;SPATA2;AGPAT1
prerank,anion transmembrane transport (GO:0098656),-0.35148649036936025,-1.2027327878618603,0.16962025316455695,0.6118398656894135,1.0,19/67,15.86%,SLC13A4;SLC6A13;SLC13A3;SLC1A3;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A4;SLC5A6;SLC25A38;SLC39A8;SLC38A5;SLC35A2;SLC3A2;SLC25A19;ARL6IP5;SLC7A1;SLC25A22
prerank,mitotic DNA replication (GO:1902969),0.5706318792683688,1.202638702087286,0.2875536480686695,0.7499049995430985,1.0,4/10,10.77%,GINS1;GINS3;MCM6;MCM2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4264230175854658,-1.202561486272658,0.23689320388349513,0.611456608875974,1.0,8/26,19.66%,IGF1;FHL2;LMCD1;PLCG2;HOMER3;EFHB;CHP1;SLC9A1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.38293124865345574,-1.202122747900324,0.19852941176470587,0.611767621075935,1.0,14/43,22.96%,IGF1;LBP;CD34;GAS6;LGALS9;ZC3H12A;IRAK3;TRIM27;TLR4;SIRPA;DICER1;CD274;RARA;PTPN6
prerank,positive regulation of metabolic process (GO:0009893),-0.3231256894641231,-1.2017384144746197,0.1264705882352941,0.6119822746787774,1.0,33/103,19.55%,LEPR;CAMK1D;ADIPOR2;CAV1;IGF1R;GJA1;APPL2;PRDM16;CPT2;GNAS;CMKLR1;IL18;ACACA;ESRRG;EHMT1;ACADL;UCP2;KDM3A;PRKAB1;BEND3;KDM6B;PDGFC;CNOT3;MFAP2;FABP5;ADRB2;CEBPB;GADD45G;PPARGC1A;ACACB;DYNC1H1;ADIPOR1;SYK
prerank,post-translational protein modification (GO:0043687),-0.2815730831507092,-1.2016442341605804,0.04072398190045249,0.6114129455056787,1.0,102/332,22.62%,FBXL7;FBN1;FN1;FSTL1;ZBTB16;IGFBP5;APOE;APP;CP;BMP4;FBXO10;RAB11A;ITIH2;PTP4A2;CSF1;ASB2;STT3A;SOCS2;RBBP7;ADAM10;SPSB1;IGFBP4;IGFBP3;DCAF6;GAS6;HIF3A;VWA1;SERPIND1;P4HB;TNC;KLHL2;STT3B;CALU;CST3;MSLN;DCAF11;OBSL1;GOLM1;HIF1A;NOTUM;PRSS23;ASB7;RAB2A;MXRA8;KLHL5;PSME2;CUL4A;ASB5;RAB8A;COPS4;CCN1;CKAP4;PSMB4;COPS8;FBXW11;ELOB;F5;SPP1;PSMD8;PSMB1;SCG3;NEDD8;LTBP1;PSMD11;RCN1;DDB1;UBA3;APLP2;NEURL2;FBXL14;SUMF2;DNAJC3;PSME3;ASB1;PDIA6;SPSB4;CCDC8;DCAF4;FBXL19;SPSB2;QSOX1;PSMA2;UBE2M;DCAF8;FBXO41;HSP90B1;PSMD4;PSMD3;ASB6;LGALS1;ELOC;PSMB7;CISH;FAM20C;FSTL3;GAN;CUL5;SUMF1;CUL9;DDA1;FBXO17;CCNF
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4643547644715684,-1.2013976815563807,0.26,0.6111816186515303,1.0,8/18,23.05%,MFHAS1;PTPA;SH3RF2;PPP1R16B;CHP1;ARPP19;INPP5K;SH2D4A
prerank,regulation of innate immune response (GO:0045088),-0.3592007410324377,-1.201221994776279,0.18632075471698112,0.6107354543862167,1.0,14/57,13.93%,PARP9;APPL2;IRF1;ERAP1;BIRC3;USP18;IFI35;SAMHD1;RNF135;CASP8;IRAK3;GBP5;LRP8;HSP90AB1
prerank,cellular response to light stimulus (GO:0071482),0.41872159436493145,1.2009959992405492,0.23397435897435898,0.7526374585459966,1.0,17/66,20.05%,PTPRK;OPN1MW;OPN1MW3;CASP9;ERCC4;ATR;RRH;EP300;OPN3;PDE6A;DHX36;PARP1;FMR1;RHNO1;SAG;SDE2;CREBBP
prerank,regulation of neuron migration (GO:2001222),-0.42689102295545217,-1.200467108855054,0.22435897435897437,0.6119028739677683,1.0,5/26,4.03%,PHACTR1;COL3A1;SEMA6A;SRGAP2;ARHGEF2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4465526175863268,-1.2000705356613153,0.22420634920634921,0.6120731622483354,1.0,3/23,3.54%,ERRFI1;CAV1;SNX6
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.47917814344475873,-1.1996724006759762,0.24390243902439024,0.6123076607860191,1.0,7/16,11.69%,APOE;NPR3;PIK3CB;AKT1;NOS1AP;HIF1A;GCH1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4262277339237104,1.1996434145937678,0.24835526315789475,0.7545179376277111,1.0,8/60,9.57%,PDGFRB;RGCC;FGF2;TNKS;PARM1;PRKD2;PDGFB;ATR
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4782169652349754,-1.199568484288,0.2446183953033268,0.6117158934990048,1.0,1/16,0.09%,AUTS2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5727648744210216,1.1989470024422393,0.29375,0.7549353890402314,1.0,1/11,0.44%,IL34
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4403540586797262,-1.198935135828465,0.23284823284823286,0.6125103553479784,1.0,4/23,2.79%,CAMK1D;MCU;SLIT2;DPP4
prerank,chromatin organization (GO:0006325),-0.31649087951093613,-1.1988744058873426,0.10029498525073746,0.6118366919814465,1.0,34/132,21.32%,SMARCA2;MECOM;HDAC4;HDAC8;ESR1;SETD7;KAT2B;PRDM16;BAZ1A;KDM5B;INO80;BPTF;BAZ1B;BAZ2B;TADA2A;JARID2;EHMT1;HDAC1;EZH1;MPND;HDAC5;SMARCC1;HMGB2;KDM6B;SNAI1;HCFC2;HMGN1;SMARCAD1;EZH2;MCM3AP;HP1BP3;SETDB1;RSF1;CHRAC1
prerank,positive regulation of protein binding (GO:0032092),-0.3668486718124261,-1.1987949993382208,0.17,0.6112245362682036,1.0,20/56,15.44%,APOE;APP;CAV1;CLDN5;BMP4;B2M;LRRK2;TAF1;TCF7L2;FKBP1A;AMFR;TIAM1;DTX3L;IDE;ADD1;RPL11;RAN;PKD1;HIPK2;HFE
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.44683317585549515,-1.1987689440642197,0.23047619047619047,0.6104292140324652,1.0,5/21,5.28%,BMP6;DAB2;BMP4;TGFBR1;CCN3
prerank,selective autophagy (GO:0061912),0.43053204153134755,1.1984454370297508,0.24025974025974026,0.7549374269681586,1.0,1/56,0.06%,DYNLL1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5818909880810987,1.1980884362715698,0.2938496583143508,0.7532864643759705,1.0,1/11,0.51%,CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5818909880810987,1.1980884362715698,0.2938496583143508,0.7532864643759705,1.0,1/11,0.51%,CASQ2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4489797920900035,-1.1980663062407064,0.24308300395256918,0.6114244302008183,1.0,2/19,0.12%,BMP6;AFDN
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4267997004270906,-1.1980199041915756,0.2037037037037037,0.6107232292175823,1.0,12/27,28.30%,NFAT5;RHOA;CD47;RELA;SIRPA;CYRIB;MDK;NR4A3;ITGB2;CD44;HAS2;CCR2
prerank,regulation of T cell mediated immunity (GO:0002709),0.5819187736603115,1.1977518622906427,0.2867132867132867,0.7528064129398436,1.0,2/10,2.65%,WAS;IL1B
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.35524182450910813,-1.197557390299151,0.17266187050359713,0.6111223787777529,1.0,22/67,14.88%,EPHA4;EPHA3;FLT1;EGFR;EFEMP1;PDGFRA;TEK;IL15;FGFR2;IGF1R;GHR;DDR1;PTK2B;KIT;BMX;KDR;FGFR4;FLT4;EPHB2;FER;MAPK3;PKDCC
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4630206976292627,1.1971190180577298,0.2509025270758123,0.753107432350596,1.0,9/39,8.70%,GCNT2;NOTCH1;AJAP1;SPRY4;CORO2B;ACTN4;AP1AR;MAP4K4;JAG1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.42518429005959857,1.1970711263700413,0.2380191693290735,0.7519622557456915,1.0,8/64,2.16%,UTRN;CDK6;AJAP1;PTK2;PEAK1;VCL;ROCK1;NF1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.38918404642945936,-1.1967576322305065,0.20574162679425836,0.6124365535048232,1.0,10/42,16.45%,IL6R;LBP;RPS19;IRGM;GSDMD;OPTN;SERPINE1;TLR4;HMGB2;MR1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4684419595182139,1.1967265599720467,0.259047619047619,0.7515592912642898,1.0,15/35,18.29%,PCDHB11;ATP2C1;CDH8;CDH19;CDH20;CDH7;CDH22;CDH10;CDH18;CDH12;PCDHB16;CDH6;PCDHGB4;PCDHGC3;DCHS1
prerank,regulation of myotube differentiation (GO:0010830),-0.4350670124439712,-1.1965010496649828,0.24550898203592814,0.6122627591288354,1.0,12/24,16.80%,HDAC4;HDAC9;CCN3;PIEZO1;MAPK14;DMPK;MMP14;BHLHE41;HDAC1;TMEM119;HDAC5;ATP11A
prerank,ceramide catabolic process (GO:0046514),-0.4811828648511273,-1.196302144693243,0.2414448669201521,0.61196204085621,1.0,5/14,11.59%,ACER2;HEXA;HEXB;ACER3;NAGA
prerank,positive regulation of cell division (GO:0051781),-0.3968996621493496,-1.1959451335912816,0.20833333333333334,0.6120143641658158,1.0,9/38,13.57%,PKP4;FGFR2;CDC14A;FGF1;PRKCE;RHOA;SPAST;SVIL;TAL1
prerank,regulation of protein dephosphorylation (GO:0035304),0.4633107445520898,1.1950311947152563,0.24864864864864866,0.7544757958585365,1.0,1/37,0.07%,DLC1
prerank,regulation of double-strand break repair (GO:2000779),0.4529622698601044,1.1946724027707913,0.24028268551236748,0.7540641138726822,1.0,12/39,17.44%,WAS;FOXM1;SPIRE1;FMN2;DEK;SLF2;TIMELESS;OTUB1;PPP4C;MRNIP;DDX11;RPA2
prerank,regulation of microglial cell activation (GO:1903978),0.5104114858330422,1.1945404994503055,0.2836438923395445,0.7531560879916883,1.0,3/15,6.39%,LDLR;TAFA3;TTBK1
prerank,muscle tissue development (GO:0060537),-0.49668091493475625,-1.1941352891676242,0.23985239852398524,0.6160114005878787,1.0,7/13,12.21%,BMP4;SMO;PGM5;CSRP2;STRA6;POGLUT1;PTCH1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5271870507491981,1.19400571557633,0.27530364372469635,0.7531992405566754,1.0,3/18,5.46%,ITGA4;ROCK1;ITGB1
prerank,cellular component maintenance (GO:0043954),-0.5028019670456735,-1.1935674722345746,0.27167630057803466,0.6167991398877543,1.0,3/12,14.51%,IGF1R;ITGA3;CLDN1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.41306539517358176,-1.1935295039395224,0.22535211267605634,0.6160488178055677,1.0,8/29,15.91%,JAM2;GAS6;CXCL12;LGALS9;ANO6;CALR;SERPINE1;CREB3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5521700018017508,1.1933493133554522,0.28695652173913044,0.7535431197521458,1.0,1/12,0.83%,APOBEC1
prerank,regulation of macrophage differentiation (GO:0045649),0.5403343342135009,1.1930916594431111,0.30165289256198347,0.7529202753579376,1.0,1/15,0.44%,IL34
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.46888076520708777,-1.19274780539791,0.24609375,0.6172725562742878,1.0,4/16,6.19%,BMP4;FOXD1;FGF1;SIX1
prerank,negative regulation of receptor binding (GO:1900121),0.5660733355197517,1.192598958521606,0.27615062761506276,0.7529153280594489,1.0,2/10,6.32%,ATP2A3;ATP2A2
prerank,epithelial cell morphogenesis (GO:0003382),-0.46104317344303936,-1.1925635691165486,0.2413127413127413,0.6169119560975459,1.0,6/17,13.91%,COL22A1;RILPL1;COL18A1;CCDC88C;MET;COL15A1
prerank,carbohydrate homeostasis (GO:0033500),-0.348850719081289,-1.1921704888049243,0.1675,0.6171278547322182,1.0,18/67,20.27%,LEPR;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;KCNB1;FGFR4;USF1;PRKAA2;RPS6;BACE2;PARK7;ADIPOR1;PTPN2;TENT4B
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.48443150280649844,1.1920989687431975,0.25384615384615383,0.7528271509305442,1.0,9/31,12.21%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;APC;RB1
prerank,regulation of sensory perception of pain (GO:0051930),-0.5178968888290055,-1.1918393443845845,0.25806451612903225,0.6171264890280668,1.0,4/11,10.58%,CCN3;TMEM100;MGLL;ZFHX2
prerank,negative regulation of immune effector process (GO:0002698),-0.4887994189437783,-1.1916844807973226,0.24618320610687022,0.6166893074869423,1.0,5/13,13.10%,CD55;ENPP3;CD47;RPS19;FER
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4952904499330731,1.1914330921018759,0.2662835249042146,0.7530877410904024,1.0,3/27,2.05%,CSPG4;CHST3;CHST7
prerank,synaptic membrane adhesion (GO:0099560),0.5569888964474621,1.1913370008605064,0.28541666666666665,0.7521086826412288,1.0,5/14,17.68%,LRRC4C;LRFN5;SLITRK1;SLITRK2;GPC6
prerank,cellular protein-containing complex assembly (GO:0034622),0.36997840551844463,1.1909308871442168,0.18604651162790697,0.7518725540744203,1.0,13/159,7.18%,SGIP1;CASQ2;DMD;HIGD1B;NCK2;IMMP2L;NRG1;CHRNA3;PSMG3;CENPW;SNCA;BIN1;PIK3C2A
prerank,mucosal immune response (GO:0002385),0.5378149986791658,1.1906493172048351,0.2800829875518672,0.7513034684550358,1.0,3/15,6.10%,FFAR2;CAMP;IL4
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.530154742943775,-1.190640486994844,0.2835538752362949,0.6186378558069363,1.0,7/11,33.03%,HIF1A;PARK7;NONO;NR4A3;PRKN;RACK1;PINK1
prerank,cellular response to ATP (GO:0071318),-0.48753357332761066,-1.1906163055254992,0.24606299212598426,0.6178493463007096,1.0,6/14,25.03%,TAF1;P2RX4;P2RX7;P2RY1;HSP90B1;P2RY12
prerank,regulation of insulin secretion (GO:0050796),0.38067002505462455,1.190242330016935,0.20352564102564102,0.7510187086103072,1.0,16/101,9.59%,CACNA1C;RAPGEF4;PER2;GPER1;ITPR2;IL1B;GIPR;ITPR1;SNAP25;TFAP2B;SOX4;IRS1;RAP1A;CACNA1D;GCK;CACNA1A
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4267867881214845,1.1896764634056471,0.24955436720142601,0.7510949932717497,1.0,11/55,6.29%,CSPG4;SDC2;CEMIP2;SDC3;HYAL4;AGRN;FGF2;ACAN;GPC5;GPC3;GNS
prerank,B cell activation (GO:0042113),0.4152758542405811,1.1896481732862163,0.23825503355704697,0.7499624533014795,1.0,3/68,0.77%,ITGA4;MEF2C;PIK3CD
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5060389287412338,-1.189205265865178,0.26908396946564883,0.6207996702990572,1.0,5/12,17.42%,HSPA5;GPAA1;INSIG2;RER1;TAPT1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.49581533723515026,1.1891559432581678,0.26719056974459726,0.7499580236648162,1.0,3/25,5.07%,ACE2;CNRIP1;SOCS5
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4398587072519795,1.189108468169336,0.24074074074074073,0.7488928515084599,1.0,9/47,6.12%,CARMIL1;LIMS1;PTK2;SPRY4;FERMT2;RAC3;ACTN4;TESK1;AP1AR
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.36779237538626175,1.1884286224453127,0.19799139167862267,0.7493557359899141,1.0,21/151,7.54%,PDGFRB;SLC30A10;GCNT2;RAPGEF2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ERBB4;PTPN22;ACKR3;FGF2;SPRY2;CARD9;NTRK2;HTR2C;CHRNA7;RAP1A;HRAS;FGF10
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.568930104477954,1.1879908173981681,0.29473684210526313,0.7491700985134703,1.0,4/10,10.51%,DGKH;GAP43;PRKD3;DGKD
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.48917022388985165,-1.18771890431196,0.23653846153846153,0.6239907280140161,1.0,6/15,26.76%,BMP4;SMO;SIX1;AGT;VEGFA;GDNF
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5327854604126303,-1.187605709744202,0.24299065420560748,0.623449636648243,1.0,3/10,18.30%,BMP4;FZD7;BASP1
prerank,negative regulation of chemotaxis (GO:0050922),-0.4031236954855297,-1.1876042008860186,0.2268041237113402,0.6226056024692813,1.0,7/31,3.51%,ROBO1;SEMA3D;SEMA6A;SEMA3C;SLIT2;THBS1;SEMA7A
prerank,calcium import into the mitochondrion (GO:0036444),-0.5381944148707456,-1.187279062075568,0.277882797731569,0.6226424191150375,1.0,6/10,19.50%,MCU;MCUB;AFG3L2;MICU2;MICU1;MAIP1
prerank,sodium ion import across plasma membrane (GO:0098719),0.5242963076186887,1.1871249641296775,0.28865979381443296,0.7499476089457565,1.0,4/17,8.47%,SLC12A2;SLC5A1;HCN2;SLC9A7
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4702184918539437,-1.1867436192565144,0.2613861386138614,0.6232180050456267,1.0,7/15,33.02%,OSBPL8;PPARA;PLIN2;LPL;OSBPL11;FITM2;TREM2
prerank,cardiac muscle tissue development (GO:0048738),0.42937535773592583,1.186613879492252,0.25524475524475526,0.7498974759813389,1.0,9/50,7.28%,TBX2;HEY2;BMP5;NOTCH1;TBX20;NRG1;SCN5A;SIK1;SGCZ
prerank,O-glycan processing (GO:0016266),-0.3646341023330969,-1.1865458011326824,0.18872549019607843,0.6229037234727653,1.0,7/54,9.88%,GXYLT2;ST3GAL4;ST3GAL1;ST3GAL2;ST3GAL3;ST6GALNAC2;GALNT12
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.4980416510573511,-1.1863776510063253,0.26204238921001927,0.6225494176709292,1.0,6/13,27.39%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,calcium ion import into cytosol (GO:1902656),0.532606449127841,1.1863276404676237,0.27494908350305497,0.7493891812644248,1.0,3/15,4.84%,TRPV2;CACNA2D1;SLC24A2
prerank,positive regulation of viral genome replication (GO:0045070),-0.41546831339336654,-1.1858849164654424,0.2515090543259557,0.6230608151865905,1.0,12/29,21.81%,CNOT7;HACD3;TOP2B;IFIT1;PPARA;LARP1;PPID;PPIA;DDB1;SRPK1;NR5A2;TOP2A
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.583724396529968,1.1858618227684075,0.2914046121593291,0.7492716740337105,1.0,4/10,17.71%,CPEB1;NCBP2;DHX36;HSF1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.48990498230394147,1.185781452769126,0.27703984819734345,0.7482849370923694,1.0,4/24,3.59%,PLCE1;PIK3R1;PIK3CA;ABI2
prerank,P-body assembly (GO:0033962),0.5551241353132734,1.1856822459759786,0.28289473684210525,0.747341125190329,1.0,2/12,5.23%,LIMD1;LSM3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5205790080116435,-1.185129982267347,0.2912801484230056,0.6243694962758157,1.0,8/12,39.15%,RAB27A;CYBA;PLCG2;TLR4;TLR6;CD36;ZNF205;SLC5A3
prerank,histone deubiquitination (GO:0016578),-0.46708982869833027,-1.1848685496481324,0.27071823204419887,0.6242287453741165,1.0,7/18,27.04%,USP15;TRRAP;USP49;ATXN7L3;USP22;USP36;ENY2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5752990759307386,1.1847687983228796,0.2910284463894967,0.7482489131285656,1.0,2/10,3.61%,PRKG1;SH2B3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4904155576344131,1.1846941499599082,0.29559748427672955,0.7472203280114238,1.0,3/24,1.40%,SOX5;MBOAT2;TRPS1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.3773151376604254,-1.1846674845829008,0.2222222222222222,0.6239453313776796,1.0,8/41,11.17%,IGF1;LBP;CD34;GAS6;LGALS9;ZC3H12A;IRAK3;TRIM27
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5405133246439484,-1.1846435411255574,0.2581888246628131,0.6231799974327125,1.0,4/10,28.31%,SH3RF1;CBFB;NCKAP1L;SOCS1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5230273471891094,-1.1846387017772486,0.2765957446808511,0.6223611537969155,1.0,7/11,25.11%,PDPN;RREB1;CORO1C;ENPP2;ARPIN;KANK1;CD44
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2916762316172198,-1.1846273508075627,0.0912863070539419,0.6215654976494696,1.0,69/234,19.55%,ANXA3;SMAD3;HDAC4;CAMK1D;PRKCH;PLPP3;APP;ZIC2;CAV1;ADCY1;ESR1;NOD1;ARHGEF2;LRP6;FZD2;TAF1;CFLAR;SMO;IRAK2;AR;LGALS9;PRKCZ;PRKCB;IKBKE;WNT5A;CARD14;TFRC;STAT3;ERC1;FZD4;KIT;AKT1;IL18;FLOT2;MAVS;IRAK3;CEBPG;TRIM27;CAMK2A;RELA;TNFRSF11A;UBB;FER;SPHK1;LRP8;PLCG2;CLOCK;TICAM1;PPIA;HDAC5;HIPK2;CD200;TLR4;NKX6-1;RIPK1;MAP3K13;ALK;TRIM8;NFKBIA;TRIM14;FZD1;PPARGC1A;PARK7;TRIM41;EDA;AGT;LAMTOR5;IKBKG;STK36
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3474261234600008,-1.183772370941115,0.19794344473007713,0.6230184404479908,1.0,22/68,15.18%,WNT4;PLPP3;CAV1;WNT6;LEF1;LRP6;LRRK2;FZD2;TCF7L2;WNT9A;RARG;SFRP4;WNT5A;SCYL2;FZD4;NR4A2;FZD7;BCL9L;WNT5B;WNT16;SFRP1;FZD8
prerank,establishment of epithelial cell polarity (GO:0090162),-0.4565670074432169,-1.1835653637939854,0.25149700598802394,0.6227310560544609,1.0,8/19,16.16%,MYO18A;EZR;RHOA;MYO9A;GOLPH3;PARD3;OPHN1;CYTH1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4906445698905696,1.1827827431565467,0.29865125240847784,0.7506003528343638,1.0,3/25,3.44%,MEF2C;MPP2;CHRNA3
prerank,negative regulation of anoikis (GO:2000811),0.5299996887527892,1.1824528722995848,0.30603448275862066,0.7501558728882572,1.0,6/14,12.36%,NOTCH1;PTK2;PIK3CA;ITGB1;SNAI2;SRC
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.47169078108809537,1.1822070373059208,0.2556390977443609,0.7495661781939481,1.0,9/33,12.21%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;APC;RB1
prerank,positive regulation of protein modification process (GO:0031401),-0.2948566317093001,-1.18209127019157,0.09747292418772563,0.6258260705732596,1.0,56/203,15.05%,DAB2;TRABD2B;EGFR;LEPR;CDH5;ROCK2;NTRK3;TEK;PECAM1;APP;BMP4;ANGPT1;LRRK2;NIBAN1;VEGFD;LIMK2;VEGFC;GAS6;IGF2;ARRB1;FGF1;ACE;RAB3GAP1;EFNA5;CCND2;CARD14;PTPA;CALM2;FNIP1;TFRC;CCND3;TBX1;PRKCD;WDFY2;PPP1R16B;AKT1;IRGM;NOS1AP;KDR;FLCN;MAVS;ITGB3;TGFB1;CCN1;FLT4;TMEM119;LIMCH1;CDK2AP1;ATG10;TXN;CCND1;PPIA;NNMT;MAPK3;FXR2;KRAS
prerank,cellular response to oxygen levels (GO:0071453),-0.5371534935836542,-1.1820841365841357,0.2509727626459144,0.6250210885470071,1.0,7/10,27.04%,ATP6V1G1;ATP6V0A2;CCDC115;TMEM199;ATP6AP1;ATP6V0D1;PICK1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.49897014041145005,-1.1818761150483628,0.26591760299625467,0.6247038835899451,1.0,3/14,12.00%,DDX60;USP15;PUM1
prerank,regulation of protein processing (GO:0070613),-0.44332264691750883,-1.1816017722531897,0.24285714285714285,0.6245615824103846,1.0,4/21,5.79%,CCBE1;GAS1;LRRK2;RNF139
prerank,positive regulation of cellular metabolic process (GO:0031325),0.38613523570869696,1.1815957496951435,0.2323076923076923,0.7497370144039794,1.0,9/98,6.31%,PDGFRB;ACE2;PID1;NR1H3;ECE1;PPARD;ATAD1;IL4;SNCA
prerank,negative regulation of binding (GO:0051100),-0.3447496594230701,-1.1813395163006017,0.18251928020565553,0.6243884583562472,1.0,26/81,21.74%,DAB2;ARHGAP28;SP100;CAV1;LEF1;LRRK2;SMO;IFIT2;PRKCD;AKT1;IFIT1;MDFI;DNAJB2;ACTB;ZFPM1;TMBIM6;MITD1;STYX;NFKBIA;EFHB;PARK7;E2F1;CTNNBIP1;RSF1;BAG2;PLN
prerank,ventricular septum morphogenesis (GO:0060412),-0.41499790119451013,-1.1812925767746998,0.22851153039832284,0.623730602667227,1.0,10/27,5.00%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMP4;BMPR2;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,neuron projection morphogenesis (GO:0048812),0.37121981716420316,1.181093307542084,0.20600858369098712,0.7497175918782856,1.0,33/137,13.57%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;MINK1;CNTNAP2;NTNG2;RYK;CNTN4;SLITRK5;NYAP2;ANK3;TAOK3;CCK;MAP4K4;SLITRK1;NCKAP1;CTNNA2;BRSK1;PAK3;PAK1;ZDHHC17;EPHB1;SLITRK2;CPNE1;ABITRAM
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5673658154713236,1.1810354980482967,0.3056179775280899,0.7486837612975955,1.0,5/10,8.54%,VTN;IL1B;GRB10;ARNT;PRKD2
prerank,cardiac muscle cell differentiation (GO:0055007),0.48977546261255905,1.18091137147529,0.2708757637474542,0.7477988692300936,1.0,4/21,6.74%,MEF2C;MYH11;NRG1;SIK1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5068927078178698,1.1803743996520575,0.2859960552268245,0.7479504205842065,1.0,7/20,12.53%,LIMD1;AJUBA;AGO3;TNRC6C;EIF6;CELF1;TNRC6B
prerank,protein-containing complex assembly (GO:0065003),-0.2834802572115961,-1.1797694178802842,0.08064516129032258,0.6269153117926891,1.0,66/259,16.37%,AFDN;FBXL7;FN1;OCLN;TGFA;CD2AP;MCU;SEC23A;SLC2A1;SEC24D;SNX9;TLE4;LEF1;LRRK2;CTSC;TCF7L2;SEC31A;ADAM10;REPS2;TAPBP;CXCL12;TRAPPC10;YAP1;TEAD1;ANO6;PTK2B;SEC24A;PLEKHA7;TRRAP;TIAM1;PARD3;TLE2;TNFRSF1A;CARD10;TLE1;ZC3H12A;CASP8;GSDMD;USO1;PML;COL16A1;GPAA1;P2RX7;LMAN1;BCL9L;SEC16B;TRAPPC3;TRAPPC4;MDM2;HDAC1;ZW10;ELOB;SPG7;F5;PPID;ANKRD28;GEMIN5;SKAP2;MCFD2;CAPZA2;CLDN1;PYGO2;HFE;NAPA;SEC23IP;AFG3L2
prerank,positive regulation of cell killing (GO:0031343),-0.49738196697966697,-1.1795751920316466,0.28346456692913385,0.6266154578093839,1.0,5/13,19.55%,WNT5A;FZD7;CYBA;NOX1;SYK
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.25040708707245335,-1.1785442521240856,0.0,0.6285021940074312,1.0,383/1646,19.19%,NFIB;TSHZ2;BNC2;FOXP2;IGF1;PBX1;ZMIZ1;PKNOX2;FOXN3;ZNF423;MAF;PLCB1;SMAD3;FLI1;SMARCA2;ZBTB16;EGFR;MECOM;SMAD6;EFEMP1;COL1A1;NFAT5;FOXP1;KDM7A;ZKSCAN2;WNT4;HDAC4;DENND4A;CUX1;TBL1XR1;GLI2;WWC2;NFIX;CREB5;IL31RA;CHD7;ZFHX4;BMP7;TGFA;LCOR;SP100;VGLL4;GLIS3;HOXB6;IKZF2;RBFOX2;ELF2;DKK3;FOXO1;PBX3;OSR1;KLF3;APOE;FOXO3;NFIA;ZIC2;NR3C1;MDFIC;KAT6B;HIVEP3;ERG;ANXA4;HOXB3;ESR1;MLXIP;SUFU;ZIC5;BMP4;ELF1;USP47;VGLL3;SMURF2;MEOX2;ZBTB7C;MAFG;ELF4;FOXD1;PRRX2;TGFBR1;SNX6;NR3C2;TBX15;KLF4;PLAGL1;DDX5;TFDP2;FOXC2;SMAD9;LEF1;NFATC1;CDH1;SMAD7;MLLT3;LRP6;KLF2;FZD2;HDAC9;ACVR1;ID1;TCF4;TCF7L2;PDCD4;ETV6;PCGF5;HOXA5;SBNO2;ZHX3;MXI1;ZNF23;RGMB;CREB3L2;SP140;PARP9;GAS6;HDGFL3;IGF2;HOXA3;CNOT7;ZFPM2;TEAD4;ZNF697;GATAD2A;ARRB1;WWP2;MED26;SSBP2;GTF2IRD1;NIBAN2;QRICH1;ARNT2;AR;BRD7;CREM;HIF3A;STAT2;GLIS2;FOXP4;SCMH1;SOX13;DAP;PFDN5;YAP1;THRAP3;PRRX1;BHLHE40;MIDEAS;SIX1;ACVRL1;IRF1;HLF;KMT5A;PRKCB;TEAD1;CDK17;PRDM16;WNT5A;BAZ1A;KDM5B;HOXC6;MAPK14;ATXN1;ID3;IRF2;ZNF292;FOXC1;CHD3;BPTF;HIVEP1;GLIS1;STAT1;SFMBT1;HINFP;NR2C2;PGR;STAT3;KLF10;IFRD1;BAZ1B;SFR1;TBX1;ZNF219;ERC1;FZD4;POLR2A;TRRAP;ZBTB8A;KIT;VSX1;ZBTB18;IRF9;TFCP2;AKT1;FOXL1;GON4L;DTX3L;RREB1;TLE2;BBS7;REXO4;LHX6;MKX;TADA1;BAZ2B;HIF1A;CBFA2T2;TRIM16;RCOR3;TWIST2;CRABP2;KLF12;NR4A2;TADA2A;FOXK1;ZMYND15;BHLHE41;ATF6;CD38;FOSL2;FZD7;PHF10;IKZF1;GCLC;DAB2IP;SLC39A8;TLE1;HOXB9;TULP3;MMS19;ZKSCAN7;ZKSCAN3;CARM1;KARS1;TGIF1;TFCP2L1;JARID2;ZFHX2;SIX5;ESRRG;PML;GATA2;EHMT1;BRCA2;NFYC;PRDM5;CEBPG;FOXQ1;ZSCAN25;PATZ1;KDM3A;HINT1;ELK3;TGFB1;BACH2;MED27;NSD1;MEF2A;LRRFIP1;ATXN7L3;ZIC3;SRSF10;AHR;ID2;PPARA;RELA;ZSCAN22;PRDM11;CBX4;MDM2;HDAC1;GLI3;ATOH8;USF1;GLRX2;CHD2;FBXW11;CALR;ZGPAT;DACH2;SOX17;GATA6;SP110;RET;RFX2;TAL1;ZNF585A;ZNF585B;QARS1;CLOCK;ZNF568;SPP1;TOX4;ZBTB4;HDAC5;WWP1;HSF2;TTC21B;MAZ;ENO1;HOXC4;SFRP1;SLTM;MEIS2;HIPK2;HOXB7;DYRK1B;SOX7;SMARCC1;HOXB5;JUND;PCGF3;POU2F1;L3MBTL2;YEATS2;SREBF1;HHEX;RNF187;NOS1;CREB3;SOX18;NKRF;CDKN1B;HMGB2;ZMIZ2;CREB3L1;NKX6-1;ZNF436;MNT;USF2;SNAI1;ZFP69;HCFC2;HNRNPAB;ASCC1;TSHZ1;WNT11;MEIS1;JUNB;TCIM;MYRF;ZFP14;ATF1;FBXL19;NFYB;ACTR8;NFIL3;PSIP1;CSRNP3;MED21;SIRT2;RHOH;SOX12;RAI1;KLF15;CEBPB;RRP8;CIR1;NR6A1;MAFF;ELP3;FZD1;BASP1;PPARGC1A;PLAG1;NPAS2;NFXL1;PCGF6;CC2D1A;POU5F2;ZSCAN2;ATF7;SCML4;BRF2;TYMS;HMGN5;AGT;ETV4;ZFP57;SBNO1;MT3;PIAS4;IRF2BPL;PIM2;EZH2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3780177756971073,-1.1778789104298242,0.20484581497797358,0.6294496868754443,1.0,12/41,19.15%,PLA2G4A;PTGS1;CYP1B1;DAGLB;GPX4;ACOX1;MGLL;GSTM2;ELOVL1;GPX1;ALOX12;EPHX1
prerank,cardiac cell development (GO:0055006),0.5596933047946236,1.1778788414508468,0.3006396588486141,0.7528218750328602,1.0,3/11,8.70%,NOTCH1;MYH11;JAG1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5412241021013509,1.1777399152677503,0.2796610169491525,0.7519695282709643,1.0,4/14,4.10%,TBXA2R;NOTCH1;STARD13;PDCD10
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5137889286370935,1.1774417645202093,0.28354978354978355,0.7515013024702433,1.0,6/14,16.76%,FASTKD2;MRPS27;FASTKD3;TRMT10C;RMND1;C1QBP
prerank,phosphorylation (GO:0016310),0.3344908106946342,1.1769259999587718,0.16807738814993953,0.7515891611287489,1.0,72/384,11.25%,DGKB;LIMD1;PRKG1;MAP3K20;PIK3CD;CDK6;DGKH;MAP3K5;SNRK;PEAK1;FRK;PKN1;MARK1;DGKG;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;PIK3CA;RPS6KA4;LIMK1;GRK3;CDK15;CDC42BPA;STK39;JAK1;STK38L;MINK1;RYK;TESK2;TRIB2;ROS1;NEK1;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;XYLB;MAP4K4;STK24;STK3;MTOR;ACVR2B;NEK6;PRKD2;GRK5;MARK2;CSK;GK;LYN;PDGFB;BIRC6;GNPTG;MAP4K1;CSNK1E;PAK5;COQ8A;MAPK10;NUAK1;TEC;DGKD;BRSK1;DYRK3;PAK3;LATS2;BRAF;PAK1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.47462285197657944,1.1768346533615022,0.2868525896414343,0.7506150134873212,1.0,5/27,5.65%,UTRN;NEDD4L;FGF12;FXYD2;SCN5A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3917676113868216,-1.1765207142579712,0.24553571428571427,0.6322917251306333,1.0,11/32,25.20%,PPP1R13B;FHIT;DDX5;PML;HINT1;HIPK2;RRP8;RPS27L;TMEM109;STK11;TP53
prerank,Rho protein signal transduction (GO:0007266),0.42587977451779807,1.1763593329287838,0.2616984402079723,0.7505764861784743,1.0,9/53,4.59%,EPS8;ARHGAP6;ARHGAP1;ROCK1;WAS;LIMK1;CDC42EP1;RTKN;EPS8L1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.37499055924248803,1.1763112081944183,0.22122571001494767,0.7495045364226377,1.0,16/124,9.93%,FRY;CARMIL1;RAPGEF2;MAP2;ROCK1;CNTNAP2;LAMB1;RYK;ATP1B2;CNTN4;FAM161A;PKD2;BLOC1S1;TMEM108;LYN;PLP1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.39516894356292426,-1.1762068047290992,0.24839400428265523,0.6322734347393161,1.0,6/31,7.15%,TGFBR3;FGFR2;TGFBR1;SMAD7;ZFPM2;FKBP1A
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.44876894685382757,-1.1758491319367417,0.25889328063241107,0.6324227873846504,1.0,8/21,20.40%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.44762422429035953,-1.175439865344539,0.2898832684824903,0.6326304767447384,1.0,6/20,19.03%,IGF1;NIBAN2;FOXC1;TGFB1;PARK7;LAMTOR5
prerank,epidermal cell differentiation (GO:0009913),-0.3881463035732306,-1.1753108331989497,0.22958057395143489,0.6321411378323637,1.0,15/41,26.05%,CLIC4;ADAM9;ANXA1;TXNIP;WNT5A;HDAC1;WNT16;GATA6;UGCG;GLI1;DSP;ERCC2;ERCC3;USH2A;CTNNB1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5007944518814373,-1.1750008982752624,0.2698706099815157,0.6321729283883851,1.0,6/12,19.01%,GMDS;CSGALNACT1;FUT8;EXTL2;GFPT2;GFPT1
prerank,detection of visible light (GO:0009584),-0.4723268757979384,-1.1747319158790588,0.276,0.6320540030839237,1.0,5/16,26.31%,ABCA4;RP1;CACNA2D4;TULP1;GNAQ
prerank,organic anion transport (GO:0015711),-0.34401106726702413,-1.174153204153761,0.1889168765743073,0.6327620581633916,1.0,16/76,11.16%,ABCC4;SLCO2B1;SLC16A2;SLC26A7;SLCO2A1;SLC4A10;ABCG2;SLCO1C1;SLC22A6;ABCC6;SLC25A17;SLC25A4;SLC39A8;SLC35A2;SLC25A24;MGST1
prerank,proteolysis (GO:0006508),0.34571729404784957,1.1739548242939635,0.18840579710144928,0.7538967781478726,1.0,21/252,5.01%,ENPEP;GGT5;TMPRSS4;FAP;NAALAD2;GGT1;CPM;METAP2;TMPRSS7;USP25;ADAM19;ATG4A;ANPEP;ECE1;MMP15;SVBP;TASP1;CTSF;ACAN;OGT;PSMB11
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5525889603744667,1.173419500206659,0.30131004366812225,0.7540616420226058,1.0,1/10,0.56%,SOX5
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3506290315836667,-1.173345118500425,0.2191142191142191,0.6340356828147213,1.0,20/61,24.73%,PRKAG2;CAV1;PSME2;FGFR4;PPARA;PSMB4;PSMD8;PSMB1;PSMD11;PSME3;ODC1;OAZ1;PSMA2;PSMD4;PSMD3;PSMB7;AZIN1;PSMC2;PSMD10;PSMC5
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4489974897294214,1.1730270730079404,0.2774674115456238,0.7538279886733703,1.0,4/34,4.13%,PDGFRB;PTK2;PIK3R1;FGF2
prerank,regulation of viral genome replication (GO:0045069),-0.3597432177481375,-1.172570635017488,0.20567375886524822,0.635263749308935,1.0,27/56,33.53%,CNOT7;IFITM3;HACD3;OAS2;IFIT1;MAVS;PPARA;LARP1;PPID;PPIA;DDB1;IFITM2;RNASEL;RSAD2;SRPK1;NR5A2;TRIM6;SRPK2;PLSCR1;ADARB1;ISG15;BST2;ILF3;PARP10;OASL;PPIE;FAM111A
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.46012243907368133,-1.1721520620044599,0.2632612966601179,0.6355924336470931,1.0,6/18,13.10%,IL6R;IL6ST;YAP1;STAT1;STAT3;FER
prerank,triglyceride metabolic process (GO:0006641),-0.36513050444417783,-1.1719690363024298,0.2304147465437788,0.6352620696067016,1.0,4/48,3.10%,AGMO;APOE;CAV1;LPGAT1
prerank,regulation of neuron differentiation (GO:0045664),0.4059468703096732,1.1713036153488348,0.2282958199356913,0.7567481025978954,1.0,12/76,9.48%,MEF2C;HEYL;ZEB1;ZFHX3;ROCK1;MOSMO;BRINP1;CNTN4;BIN1;BEND6;BRINP3;MED1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.44474854113375384,-1.1711518714001314,0.25946969696969696,0.6357777670910656,1.0,6/20,16.06%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),-0.44474854113375384,-1.1711518714001314,0.25946969696969696,0.6357777670910656,1.0,6/20,16.06%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,cellular response to interleukin-6 (GO:0071354),-0.4125991322614656,-1.1704087018988762,0.2641509433962264,0.636920387950926,1.0,10/26,13.10%,ST3GAL6;PTGIS;IL6R;IL6ST;SBNO2;YAP1;STAT1;STAT3;RELA;FER
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.46009527471568146,-1.1702475959370033,0.26714801444043323,0.6365206328905095,1.0,4/15,6.33%,APOE;SNX9;ADAM9;TNFRSF1B
prerank,histone mRNA catabolic process (GO:0071044),-0.4672092841497801,-1.1698187718819548,0.2706333973128599,0.6368595922480637,1.0,6/15,20.27%,TUT4;TUT7;MTPAP;ATM;XRN1;TENT4B
prerank,positive regulation of cell projection organization (GO:0031346),-0.3125645958759542,-1.169722150576711,0.1536231884057971,0.636290817793584,1.0,27/115,11.36%,PLXNA2;ROBO1;DPYSL3;EPHA3;NTRK3;CUX1;CAMK1D;TIAM2;APOE;PLXNA4;SLIT2;ITGA6;MAGI2;ARSB;NDNF;WNT5A;RHOA;PTK2B;FZD4;RAPGEF1;TIAM1;OBSL1;PLXND1;CBFA2T2;DAB2IP;ARHGDIA;AVIL
prerank,cellular response to peptide (GO:1901653),-0.3561814298289077,-1.1694091018770298,0.20631067961165048,0.636296584797271,1.0,13/56,6.72%,IGF1;EPHA4;APP;CAV1;VIM;IGF1R;GJA1;SNX6;NOD1;ARHGEF2;VCAM1;CASP4;ICAM1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3589190116742508,-1.1693687446555328,0.19907407407407407,0.6355991308484863,1.0,9/55,9.92%,IGF1;IGFBP2;IL15;IL6ST;ANXA1;VCAM1;IGF2;TFRC;IL18
prerank,cellular response to amyloid-beta (GO:1904646),-0.3970816097926612,-1.1693242087451023,0.23608017817371937,0.634929316946226,1.0,9/35,6.72%,IGF1;EPHA4;APP;IGF1R;GJA1;SNX6;VCAM1;CASP4;ICAM1
prerank,regulation of RNA metabolic process (GO:0051252),-0.34706684814334254,-1.1691257139829132,0.19471153846153846,0.6346312849493205,1.0,15/59,12.72%,AHNAK;MBNL1;RBM20;TNFRSF1B;NOVA2;AFF2;RC3H2;SON;IGF2BP2;OAS2;PCBP2;CLK1;NOVA1;GRSF1;MBNL2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.48164060037675294,-1.168663597344814,0.2947976878612717,0.6350832297143236,1.0,4/14,7.01%,SEC23A;SEC24D;SEC31A;SEC24A
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.5237249442201243,-1.1680973932256855,0.29044117647058826,0.6358015615516739,1.0,7/10,40.51%,ABCA3;MFSD2A;MTMR3;MTMR1;PHB2;MTMR4;GNB3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.3806727203913247,-1.1679866943707298,0.2363238512035011,0.63527779467942,1.0,15/40,21.94%,TIMP3;EGFR;PTPN3;TIMP2;CST3;ATRAID;DAB2IP;PRKCG;IRAK3;RGP1;TIMP4;SIRT2;SNX3;CDK5RAP3;AZIN1
prerank,positive regulation of cilium assembly (GO:0045724),0.4961337392416344,1.1678111271132248,0.2938856015779093,0.7638948372750115,1.0,9/18,18.91%,ARHGAP35;FUZ;CEP120;CEP135;KCTD17;HTT;HAP1;MARK4;SEPTIN9
prerank,limb development (GO:0060173),-0.4142127510608904,-1.1677368621114101,0.23790322580645162,0.6351677819835665,1.0,9/28,12.87%,SMOC1;CHD7;PCSK5;KAT2B;RSPO2;INTU;ZNRF3;PTCH1;GLI3
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.48872337187503745,-1.1674909431662475,0.2727272727272727,0.6350466472796492,1.0,3/14,10.91%,THBS1;CMKLR1;IRAK3
prerank,regulation of endopeptidase activity (GO:0052548),0.4128091558563485,1.1670855249749525,0.2579034941763727,0.7642626924799614,1.0,3/59,1.04%,SERPINB8;SERPINI1;VTN
prerank,long-chain fatty acid transport (GO:0015909),-0.4100681348673721,-1.167028383438925,0.24074074074074073,0.6354709946188827,1.0,10/30,18.61%,PRKAG2;APOE;CPT1A;SLC25A20;CPT2;ACACA;MFSD2A;PRKAA2;FABP5;ACACB
prerank,macromolecule catabolic process (GO:0009057),-0.41034063716742947,-1.1663608177205125,0.2665289256198347,0.636545369164763,1.0,12/26,22.61%,TRIM24;SMURF1;BECN1;IDE;TGFB1;SH3GLB1;UVRAG;CLN8;TPP1;CLN5;CLPX;CLN6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.3608141195713969,-1.1661498384543425,0.22033898305084745,0.6363306605528967,1.0,22/54,34.12%,CFLAR;GAS6;CASP4;BIRC3;TNFRSF1A;CASP8;SPHK1;RIPK1;IKBKG;SYK;PTPN2;RFFL;PRKN;RACK1;PYDC1;TAX1BP1;HSPA1B;LAPTM5;TRADD;SPATA2;ADAM17;FADD
prerank,regulation of JNK cascade (GO:0046328),-0.3252550699734637,-1.1656341475602074,0.16901408450704225,0.6369020818593776,1.0,18/101,10.06%,TGFBR3;PLCB1;EGFR;MECOM;CCN2;SH3RF1;APP;IGF1R;RASSF2;SDCBP;PTK2B;MFHAS1;SH3RF2;SH3RF3;TAOK2;TNFRSF19;FZD7;DAB2IP
prerank,atrial septum development (GO:0003283),0.5437770265923172,1.1652604532608897,0.30721649484536084,0.7675722512595489,1.0,2/13,1.24%,HEY2;TBX20
prerank,negative regulation of cell death (GO:0060548),-0.32891259091029756,-1.1650533023584315,0.19791666666666666,0.6376391738768544,1.0,30/88,19.24%,MECOM;CCN2;BMP7;BMP4;SRGAP2;CSF1;LRRK2;CD34;CCN3;TNFRSF1B;AKT1;BECN1;CCN4;BNIP3L;VPS35;CHMP4B;CHMP4A;CCN1;WNT16;BNIP3;CD200;PARP16;WNT11;CCN5;SRSF6;PPARGC1A;NPAS2;PARK7;MT3;IKBKG
prerank,regulation of fibrinolysis (GO:0051917),0.5412771439076707,1.1647358207621072,0.30686695278969955,0.7676668588251739,1.0,1/13,0.56%,FAP
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.47278364050213806,-1.164654211163929,0.2704280155642023,0.6378213565429218,1.0,6/15,28.30%,CD55;GLI3;PNP;SYK;HSPH1;CCR2
prerank,import into nucleus (GO:0051170),-0.3336623880959149,-1.1644795365188145,0.19704433497536947,0.6374832203478406,1.0,29/73,28.85%,APPL2;STAT3;GEMIN7;AKT1;IPO7;FAM53C;BACH2;IPO13;RAN;GEMIN5;SNRPF;IPO8;SNRPD1;SNRPD2;NXT2;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;SNRPB;SNRPE;CSE1L;PTTG1IP;NUP62;TNPO2
prerank,positive regulation of secretion by cell (GO:1903532),-0.3404175331960145,-1.1642919753364152,0.20046082949308755,0.6371826188183906,1.0,18/70,13.89%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;RAB27A;P2RX4;GOLPH3;DTNBP1;MYH10;KCNB1;STX1A;TGFB1;GRK2;PPID;PPIA
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5169608953486745,1.164277458538161,0.3045267489711934,0.7675769593699864,1.0,4/17,2.65%,S1PR3;VCL;ROCK1;IL1B
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.4806036307069464,-1.1641114357783935,0.2905027932960894,0.636867273336652,1.0,4/13,3.54%,BMP6;DAB2;BMP4;TGFBR1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3281437128874362,-1.163828159157645,0.17473118279569894,0.6368496683440218,1.0,30/91,19.78%,BMP6;APP;CP;SCARA5;ABCG2;ATOX1;SLC39A14;SLC39A13;SLC39A10;TFRC;ATP6V1G1;ACO1;FTL;SLC39A8;NEDD8;HFE;ATP6V0A2;CYB561A3;SLC30A1;FTH1;FRRS1;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.48240356053539807,1.1628475509632408,0.27695167286245354,0.7697449943187544,1.0,3/24,5.53%,COX4I2;PID1;SLC25A13
prerank,positive regulation of phagocytosis (GO:0050766),-0.35995141240329,-1.1622202022415484,0.22444444444444445,0.6403123025035592,1.0,13/47,13.20%,CAMK1D;IL15;MYO18A;PTPRJ;GAS6;RAB27A;APPL2;ANO6;CD47;GATA2;C4B;CYBA;CALR
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3572080583753443,1.1620914999713712,0.21700879765395895,0.7703269761959739,1.0,8/166,2.77%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,glucose homeostasis (GO:0042593),-0.3289072356482231,-1.1615014478637693,0.19338422391857507,0.6414583945644257,1.0,22/83,20.12%,LEPR;FOXO1;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;HK2;HIF1A;KCNB1;FOXK1;FGFR4;USF1;PRKAA2;RPS6;BACE2;PPARGC1A;PARK7;ADIPOR1;PTPN2
prerank,ceramide transport (GO:0035627),-0.5006008975756888,-1.1600515986194238,0.2963636363636364,0.6443850294148727,1.0,3/12,10.12%,PLTP;CERT1;PSAP
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.484605436611286,-1.1598379088544204,0.26798561151079137,0.6441508707658623,1.0,9/14,29.93%,SUFU;TMSB4X;MDFI;PKD1;NFKBIA;PSMD10;G3BP2;NFKBIE;KEAP1
prerank,sensory perception of chemical stimulus (GO:0007606),0.5158374958261087,1.1597352236223815,0.3060796645702306,0.774808391443772,1.0,3/15,6.90%,ADCY3;SLC24A4;UBR3
prerank,cell projection assembly (GO:0030031),-0.4272905756230039,-1.1594378078998338,0.27310924369747897,0.6443410581574939,1.0,6/22,17.71%,GSN;RHOQ;PARVB;RHOJ;PARVA;RHOH
prerank,central nervous system neuron differentiation (GO:0021953),0.45611293097310873,1.159427950726174,0.28867924528301886,0.7743772644859485,1.0,10/33,12.92%,MAP2;ATP7A;CEND1;RYK;NTRK2;SOX4;MDGA2;TOX;SPOCK1;ZC4H2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.47727586637748864,1.1592378896777444,0.29672447013487474,0.7736400312399526,1.0,6/24,7.93%,LIMS1;PIK3R1;FERMT2;ROCK1;MAPRE2;MAP4K4
prerank,organelle transport along microtubule (GO:0072384),0.4613815444464807,1.159201213395781,0.29080675422138835,0.772572389338554,1.0,10/31,17.67%,ARHGAP21;TRAK1;BICD2;UXT;TRAK2;COPG2;RAB1A;HTT;NDE1;HAP1
prerank,acute-phase response (GO:0006953),-0.494365024516262,-1.159017547917623,0.3031423290203327,0.6446397223341376,1.0,5/12,25.35%,IL6R;LBP;CEBPB;SIGIRR;PLSCR1
prerank,protein catabolic process (GO:0030163),-0.3489035038573426,-1.1585542543652896,0.2158273381294964,0.6450464580276056,1.0,23/59,24.29%,LAMP2;APOE;ADAMTS9;TRIM24;DENND3;STT3B;IDE;DAB2IP;UBE2G2;DDB1;CEACAM1;MANBA;CLN8;RIPK1;TPP1;VCP;NGLY1;CLN5;CLPX;FBXO17;CLN6;CHEK2;PRKN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4995326939819533,1.1584834407797449,0.31620553359683795,0.7729917875208654,1.0,2/19,2.34%,NDST3;EXTL3
prerank,regulation of neutrophil migration (GO:1902622),0.5676508684668854,1.1582935455424601,0.3236514522821577,0.772299075167294,1.0,1/10,1.42%,JAM3
prerank,epidermis development (GO:0008544),-0.3555545494735825,-1.1582551228067568,0.2607655502392344,0.6450606551111392,1.0,20/56,23.24%,SVEP1;CCN2;FGFR2;EMP1;CRABP2;FLOT2;LAMA3;HDAC1;ALDH3A2;PTHLH;GATA6;UGCG;LAMC2;PLOD1;FABP5;EDA2R;KRTDAP;GLI1;EDAR;DSP
prerank,oligosaccharide metabolic process (GO:0009311),-0.3646950278158346,-1.1581835011611763,0.21588089330024815,0.6444527703529898,1.0,15/46,19.97%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST6GALNAC3;ST3GAL3;FUT8;ST8SIA2;NAGA;ST6GALNAC6;MANBA;MAN2C1;MAN2B2;NEU3;ST8SIA5
prerank,negative regulation of developmental process (GO:0051093),0.3932760609508956,1.1580692490072124,0.2699490662139219,0.7716609465351865,1.0,6/69,2.55%,TBX2;HEY2;CDK6;NOTCH1;ROCK1;FOXM1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4627652869680636,1.157753277343348,0.28888888888888886,0.7712263459148397,1.0,6/34,7.19%,PDE4D;SCN5A;PDE4B;ATP2A2;RYR2;STC1
prerank,camera-type eye development (GO:0043010),-0.42018415840661766,-1.1573572016119087,0.25413223140495866,0.6459270391276023,1.0,9/25,8.29%,FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;FBN2;CYP1B1;STRA6
prerank,glucan catabolic process (GO:0009251),-0.4800687109723862,-1.1571560593048742,0.30642201834862387,0.645716599423766,1.0,7/15,28.00%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL
prerank,regulation of cell death (GO:0010941),-0.32000365699801947,-1.1570736839355131,0.184,0.6451212513409772,1.0,33/94,19.11%,CCN2;BMP7;RRAS2;BMP4;SRGAP2;LRRK2;RILPL1;ACER2;CCN3;TNFRSF1B;ACER3;PRODH;BECN1;CCN4;ZC3H12A;SLC25A24;BNIP3L;VPS35;CHMP4B;CCN1;UBB;WNT16;BNIP3;PARP16;CDKN1B;WNT11;CCN5;SRSF6;RAB29;NPAS2;PARK7;CHP1;MT3
prerank,negative regulation of phagocytosis (GO:0050765),0.49579258524345815,1.1569021936473682,0.30387931034482757,0.7721216707403129,1.0,3/17,6.84%,DYSF;CD300A;APPL1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.48445628191408446,-1.1560637023486067,0.28654970760233917,0.6470212602121783,1.0,6/14,19.55%,CD55;TGFBR2;LGALS9;IL18;CD81;SYK
prerank,mitochondrial genome maintenance (GO:0000002),0.5490058340721018,1.1555258009552853,0.32916666666666666,0.7742578575590806,1.0,2/11,2.33%,SLC25A33;AKT3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4805019598538337,1.1555017883842593,0.305019305019305,0.7731683660883728,1.0,3/24,5.46%,ITGA4;ROCK1;ITGB1
prerank,glycogen catabolic process (GO:0005980),-0.4845365730189961,-1.154055000677289,0.30297397769516726,0.6515982397577063,1.0,9/15,33.67%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL;RB1CC1;STBD1
prerank,cellular response to nutrient levels (GO:0031669),-0.3474566354127073,-1.1538965924360152,0.23648648648648649,0.6512078003737776,1.0,24/62,26.08%,LAMP2;FOXO1;BMPR2;LRRK2;WIPI2;FNIP1;KLF10;CLEC16A;KCNB1;FLCN;PPARA;MFSD2A;SFRP1;PRKAA2;SREBF1;RRAGB;ZFYVE1;FAM107A;STK26;XBP1;LPL;RIPOR1;ATG7;RRAGC
prerank,negative regulation of protein processing (GO:0010955),-0.499119686482962,-1.1537830833558589,0.3173996175908222,0.6506982968989733,1.0,6/12,21.57%,THBS1;GAS1;LRRK2;SERPINE1;TMEM59;SERPINE2
prerank,positive regulation of locomotion (GO:0040017),0.46470752087330924,1.1534933527617275,0.31334622823984526,0.7767795872466549,1.0,1/27,0.19%,PDGFRB
prerank,GTP metabolic process (GO:0046039),-0.46999893505001983,-1.153088496989215,0.2877442273534636,0.6518022009916903,1.0,3/15,12.89%,RHOQ;LRRK2;RAN
prerank,oxoacid metabolic process (GO:0043436),-0.4093664147333693,-1.152647013536555,0.24948875255623723,0.6521850076255156,1.0,17/27,43.23%,DDO;ENPP1;SULT1A1;TPST1;AGXT;TPST2;PPA1;SULT4A1;GRHPR;ABHD14B;SULT2B1;GNMT;LIPT2;SULT6B1;MIF;PPA2;HAO1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.5142385547887434,-1.1525314806099356,0.28544423440453687,0.6516954239908334,1.0,4/10,20.41%,PLA2G4A;PLA2G6;PLA2G15;ENPP2
prerank,regulation of extracellular matrix organization (GO:1903053),0.5201442463248656,1.151525675099962,0.3114406779661017,0.7803026549836455,1.0,5/15,12.21%,FAP;NOTCH1;RIC1;EFEMP2;RB1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5012591101718769,-1.1514266034950522,0.3247232472324723,0.6529795294143613,1.0,3/12,18.94%,FHL2;HOMER3;CHP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5012591101718769,-1.1514266034950522,0.3247232472324723,0.6529795294143613,1.0,3/12,18.94%,FHL2;HOMER3;CHP1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5212401120776723,-1.1510793310299958,0.3133208255159475,0.6530892358931768,1.0,3/10,9.92%,ROCK2;IL15;IL18
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2662602560011647,-1.1509662686440303,0.10126582278481013,0.6526173531032631,1.0,113/428,20.10%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;VPS35L;CTSC;ADAM10;CRISPLD2;CD93;SDCBP;PGRMC1;AP2A2;RAB27A;BRI3;SNAP23;PYGB;FGL2;TNFRSF1B;MAPK14;ANO6;RHOA;HEXB;NPC2;STOM;CD47;CST3;FUCA1;PRKCD;TOM1;NHLRC3;EEF1A1;PGLYRP1;PRCP;CAPN1;STK10;CTSB;PLEKHO2;IQGAP2;FTL;PSAP;GSDMD;COTL1;TMC6;DERA;YPEL5;MGST1;ATP6V0A1;RAB7A;DNASE1L1;ATP8A1;TCIRG1;CTSS;CKAP4;NBEAL2;CYBA;PPIA;HSP90AB1;PSMB1;GALNS;SURF4;PSMD11;TMEM30A;VAPA;S100A11;DNAJC3;CEACAM1;NIT2;RAB18;ATP11B;RAP2C;MANBA;ATP11A;SIRPA;FABP5;LRG1;UBR4;ACTR10;VAT1;FTH1;QSOX1;GAA;PSMA2;CANT1;RAB6A;PNP;AGPAT2;APRT;CYB5R3;DYNC1H1;CREG1;PSMD3;VCP;SYK;GLB1;PLAUR;COPB1;ORMDL3
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.4402062015552821,-1.1501856764127727,0.3007662835249042,0.6537764345106022,1.0,3/19,5.97%,DDO;ALDH7A1;ASPA
prerank,thymus development (GO:0048538),-0.48249727930896263,-1.1492755888305286,0.2962962962962963,0.6554361865259928,1.0,4/13,17.17%,TGFBR1;SIX1;TBX1;EPHB3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5314572763522927,1.1492252503573026,0.3199152542372881,0.7845212032082075,1.0,3/12,5.97%,DMD;ATP1B2;ANK3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4824960048273633,-1.1485442608331995,0.3333333333333333,0.6566230891199709,1.0,5/14,13.32%,ADAM10;WNT5A;PTK2B;WNK1;OXSR1
prerank,regulation of cellular respiration (GO:0043457),0.5120065235716671,1.1482842856712598,0.3270042194092827,0.7856201801818944,1.0,3/17,6.10%,CBFA2T3;NOA1;IL4
prerank,melanosome localization (GO:0032400),-0.4321527277985648,-1.1482786239335636,0.2795275590551181,0.6564949423644991,1.0,7/21,20.47%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,neutrophil degranulation (GO:0043312),-0.2652072440914067,-1.1482082695935296,0.08641975308641975,0.6558817597438336,1.0,112/425,20.10%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;VPS35L;CTSC;ADAM10;CRISPLD2;CD93;SDCBP;PGRMC1;AP2A2;RAB27A;BRI3;SNAP23;PYGB;FGL2;TNFRSF1B;MAPK14;ANO6;RHOA;HEXB;NPC2;STOM;CD47;CST3;FUCA1;PRKCD;TOM1;NHLRC3;EEF1A1;PGLYRP1;PRCP;CAPN1;STK10;CTSB;PLEKHO2;IQGAP2;FTL;PSAP;GSDMD;COTL1;TMC6;DERA;YPEL5;MGST1;ATP6V0A1;RAB7A;DNASE1L1;ATP8A1;TCIRG1;CTSS;CKAP4;NBEAL2;CYBA;PPIA;HSP90AB1;PSMB1;GALNS;SURF4;PSMD11;TMEM30A;VAPA;S100A11;DNAJC3;CEACAM1;NIT2;RAB18;ATP11B;RAP2C;MANBA;ATP11A;SIRPA;FABP5;LRG1;UBR4;ACTR10;VAT1;FTH1;QSOX1;GAA;PSMA2;CANT1;RAB6A;PNP;AGPAT2;APRT;CYB5R3;DYNC1H1;CREG1;PSMD3;VCP;GLB1;PLAUR;COPB1;ORMDL3
prerank,metal ion export (GO:0070839),0.4651713044258329,1.147980846211435,0.2914285714285714,0.7851275052657537,1.0,7/31,7.85%,ATP1A2;ATP1A4;FXYD2;KCNE4;ATP7A;ATP1B2;KCNE5
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4709057610002064,-1.1474974763925396,0.2859848484848485,0.6569524611266268,1.0,5/15,7.15%,MAGI2;SMAD7;ACVR1;SKI;FKBP1A
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2538277070954423,-1.147279334846759,0.06,0.6567226642903986,1.0,140/532,19.71%,COL1A2;FN1;PLCB1;LEPR;IL31RA;SP100;FOXO1;FOXO3;ADIPOR2;IL15;F3;IL6R;VIM;IL1R1;LBP;ANXA2;IL6ST;PTPRJ;B2M;RAP1B;MAP3K14;CSF1;NOD1;ANXA1;VCAM1;SOCS2;PITPNA;GHR;PDCD4;TNFRSF11B;IRAK2;IL16;MAOA;IFITM3;CXCL12;STAT2;APPL2;YAP1;GREM2;P4HB;CCL15;IRF1;TNFRSF1B;ICAM1;MAP3K8;PTK2B;IRF2;FOXC1;CARD14;STAT1;CCL14;STX3;STAT3;TALDO1;TMSB4X;IFI27;IFIT2;PRKCD;RAPGEF1;PIK3CB;BIRC3;KIT;IRF9;AKT1;MCL1;OAS2;HIF1A;IL33;TNFRSF1A;BCL2L11;IL17RA;IFI35;LAMA5;IFIT3;SAMHD1;IFIT1;IL18;STX1A;EIF5A;PML;IRAK3;CAMK2A;INPP5D;PSME2;TGFB1;PTGS2;CCL25;S1PR1;FLT3LG;RELA;TNFRSF11A;PSMB4;UBB;FER;FBXW11;LRP8;CCND1;PPIA;PSMD8;PSMB1;MAPK3;UGCG;IP6K2;PSMD11;CNTFR;IFITM2;GBP2;CCL13;POU2F1;PSME3;CEACAM1;CDKN1B;IL10RB;SDC1;JAGN1;PELI1;RNASEL;JUNB;RSAD2;RIPK1;CSF3R;TRIM8;NFKBIA;RPLP0;TRAF3IP2;MAP3K3;MMP2;PSMA2;IL17RE;EDA;HSP90B1;NDN;MT3;PSMD4;IKBKG;CSF2RA;ADIPOR1;PSMD3;SYK;IL20RB
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.32838083035363475,-1.1471417016110832,0.21836228287841192,0.6563024269317272,1.0,18/80,13.29%,EPHA4;SAMD4A;ROCK2;VIM;SLC2A13;THBS1;LARP4B;NIBAN1;SMPD3;RPS4X;NSMAF;PRKCD;PLA2G6;UPF3A;TNFRSF1A;CPEB3;RELA;RPL26
prerank,N-glycan processing (GO:0006491),0.4976852050776293,1.1469230614990251,0.3227722772277228,0.7865008050328749,1.0,3/18,2.97%,PRKCSH;ST8SIA4;ST8SIA1
prerank,MAPK cascade (GO:0000165),0.32965141556021704,1.1462784946339886,0.20859671302149177,0.7869113534299883,1.0,38/295,7.95%,PDGFRB;MEF2C;MAP3K20;RAPGEF2;MAP3K5;PTK2;PIK3R1;BTRC;RASGRP3;IL17RD;NF1;SPRED1;GFRA2;ERBB4;IL1B;CUL3;NRG1;PIK3CA;IL2RA;RBX1;SPTBN1;JAK1;RASAL2;FGF13;FGF2;MINK1;PSMB11;RIT2;SPTB;TNIP2;TAOK3;PSMF1;IRS1;SPTA1;HRAS;FGF10;MAP4K4;PPP1CC
prerank,mRNA splice site selection (GO:0006376),-0.40088580091162557,-1.1460920496044211,0.27292110874200426,0.6582373331550511,1.0,10/30,26.40%,CELF2;LUC7L;SRSF10;PSIP1;SRSF6;SRSF5;SF3A3;CELF5;SNRPC;PUF60
prerank,dorsal/ventral pattern formation (GO:0009953),-0.438292264009079,-1.1458601746018748,0.28629856850715746,0.6580324929983621,1.0,8/20,15.74%,GLI2;ACVR1;ACVRL1;NBL1;MDFI;PTCH1;SFRP1;BMPR1A
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3416107763827129,1.1451075943282978,0.2472375690607735,0.7885397445897672,1.0,12/198,4.61%,INPP4B;PTEN;PLCE1;LIMD1;IMPA2;PIK3CD;INPP5A;PIP4K2A;PIK3CA;PLPPR5;PPP3CA;ITPKB
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5102758234642254,1.1448242785219716,0.30434782608695654,0.7880733930371931,1.0,5/19,9.01%,PLCE1;INPP5A;PPP3CA;GPR62;NFATC4
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4900482840750937,-1.1447799563633474,0.3151183970856102,0.6601847004733421,1.0,7/12,31.65%,ACADL;CEACAM1;ERLIN2;BRCA1;PIBF1;TRIB3;APOC1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4336648170817884,-1.1446631493528505,0.290448343079922,0.659732662420321,1.0,4/19,7.21%,LBP;LGALS9;PRKCE;PIK3AP1
prerank,neutrophil mediated immunity (GO:0002446),-0.2639347216553305,-1.1445597512573589,0.0949367088607595,0.6592116959680981,1.0,113/432,20.10%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;VPS35L;CTSC;ADAM10;CRISPLD2;CD93;SDCBP;PGRMC1;AP2A2;RAB27A;BRI3;SNAP23;ACE;PYGB;FGL2;TNFRSF1B;MAPK14;ANO6;RHOA;HEXB;NPC2;STOM;CD47;CST3;FUCA1;PRKCD;TOM1;NHLRC3;EEF1A1;PGLYRP1;PRCP;CAPN1;STK10;CTSB;PLEKHO2;IQGAP2;FTL;PSAP;GSDMD;COTL1;TMC6;DERA;YPEL5;MGST1;ATP6V0A1;RAB7A;DNASE1L1;ATP8A1;TCIRG1;CTSS;CKAP4;NBEAL2;CYBA;PPIA;HSP90AB1;PSMB1;GALNS;SURF4;PSMD11;TMEM30A;VAPA;S100A11;DNAJC3;CEACAM1;NIT2;RAB18;ATP11B;RAP2C;MANBA;ATP11A;SIRPA;FABP5;LRG1;UBR4;ACTR10;VAT1;FTH1;QSOX1;GAA;PSMA2;CANT1;RAB6A;PNP;AGPAT2;APRT;CYB5R3;DYNC1H1;CREG1;PSMD3;VCP;GLB1;PLAUR;COPB1;ORMDL3
prerank,positive regulation of exocytosis (GO:0045921),-0.3781983966663824,-1.1443906549181564,0.25256673511293637,0.658866807779392,1.0,16/35,30.18%,SDCBP;SMPD3;RAB27A;PDCD6IP;SDC4;HGS;RAB7A;SYTL4;SDC1;RAB2B;EXPH5;RAB3D;ATP6AP1;ATP13A2;RAB3A;CADPS2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.40317303755003436,-1.143924709328717,0.3031578947368421,0.6592856922060031,1.0,6/26,17.86%,EPHA4;ROCK2;STAT3;PSME2;PSME3;PRELID1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.3344805600437481,-1.1438972440334496,0.25,0.658559183954153,1.0,22/75,11.23%,NRP2;NRP1;TEK;F3;PLCG1;JCAD;BMP4;BMPR2;TGFBR1;VEGFD;VEGFC;IGF2;WNT5A;PPP1R16B;AKT1;ECM1;HIF1A;CDH13;KDR;FGFBP1;GATA2;ITGB3
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.48491336680334646,-1.1438050393543107,0.32136105860113423,0.658040773846199,1.0,6/12,8.79%,PLCB1;SLIT2;CCN3;NBL1;DUSP1;AKT1
prerank,generation of neurons (GO:0048699),0.34630372176077995,1.1435063560657055,0.24204702627939143,0.7900077009721241,1.0,29/190,11.54%,MEF2C;HEY2;ADGRL3;HEYL;RAPGEF2;CDK6;PER2;MARK1;IL1B;ASTN1;FGF13;DNER;RYK;ASTN2;TAFA3;NTRK2;RUNX2;TUBB2B;CCK;IL1RAPL1;FUT9;MARK2;RNF112;LHX4;BRSK1;DDIT4;SPOCK1;WNT3;YTHDF2
prerank,embryonic hemopoiesis (GO:0035162),-0.485175467904867,-1.1434543149812428,0.2945590994371482,0.6581606806822397,1.0,6/12,15.19%,TGFBR2;KIT;KDR;FLT3LG;TAL1;ZFPM1
prerank,heme catabolic process (GO:0042167),-0.46955019121976604,-1.1434479938905453,0.2963636363636364,0.6566117918212485,1.0,2/14,3.79%,SLCO2B1;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.46955019121976604,-1.1434479938905453,0.2963636363636364,0.6566117918212485,1.0,2/14,3.79%,SLCO2B1;ABCG2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.46230345576317694,-1.1422250056684222,0.31539888682745826,0.6589814542376666,1.0,3/15,3.36%,IGF1;ROCK2;IL6ST
prerank,iron ion transmembrane transport (GO:0034755),-0.5179964555492097,-1.1417860150742605,0.31891891891891894,0.6593847274851575,1.0,3/10,10.17%,SCARA5;SLC39A14;SLC39A8
prerank,sodium ion transport (GO:0006814),0.3855738920436938,1.1417569104597574,0.2840909090909091,0.7930473076637512,1.0,17/85,9.14%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;SLC5A1;FGF13;SLC24A4;SLC24A2;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;PKD2;SLC6A15;HCN3;SCN9A
prerank,regulation of axon regeneration (GO:0048679),0.5355169790336952,1.1417290107694096,0.3182751540041068,0.7919520397898345,1.0,4/12,8.10%,RTN4RL1;SCARF1;PTN;STK24
prerank,pancreas development (GO:0031016),-0.49287881055160304,-1.1407263719460436,0.3207207207207207,0.661460751278937,1.0,4/12,16.22%,TCF7L2;ZIC3;MET;NKX6-1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.47259564014019184,-1.1405986325562494,0.32264150943396225,0.6610083187347722,1.0,4/14,10.92%,ATP1B3;ACTN2;AKAP9;LRRC38
prerank,activation of protein kinase activity (GO:0032147),-0.31170299229698706,-1.1404962437325559,0.19373219373219372,0.6605025390412882,1.0,27/106,13.89%,IGF1;NTRK3;ADCY5;OSBPL8;ADCY1;TGFBR2;NRK;ANGPT1;GHR;GAS6;FGF1;ADCY7;TOM1L1;WNT5A;PTK2B;CARD14;PRKCD;PRRC1;TAOK2;AKT1;CARD10;IL18;ITGB3;COPS8;PRKACB;TXN;PPIA
prerank,epiboly involved in wound healing (GO:0090505),-0.45672060894978184,-1.1401945379144969,0.30343511450381677,0.6604805215834029,1.0,10/16,25.11%,PDPN;DDR1;RHOA;CCN1;CEACAM1;CD151;TMEFF2;RHOC;LCP1;CD44
prerank,regulation of defense response (GO:0031347),-0.3265693824023823,-1.14005409583973,0.22950819672131148,0.6601155983975884,1.0,26/76,13.22%,ADAMTS12;FOXP1;APOE;CASP12;IL1R1;SEMA7A;ANXA1;SBNO2;APPL2;LACC1;IRF1;CASP4;WNT5A;ERAP1;PIK3AP1;TMSB4X;DAGLB;BIRC3;USP18;SAMHD1;RNF135;CASP8;MGLL;PTGS2;RELA;LRP8
prerank,superoxide anion generation (GO:0042554),0.5259233656365612,1.1398710524924665,0.3191919191919192,0.7951793614838552,1.0,3/13,10.01%,NCF2;NCF1;NOX3
prerank,cellular response to unfolded protein (GO:0034620),-0.40760156266834585,-1.1392809204266379,0.28512396694214875,0.6614338814920201,1.0,10/26,24.29%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;PRKN
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3749490411166908,1.139262991948426,0.26858877086494687,0.795486474194347,1.0,17/102,9.00%,CYSLTR2;SLC30A10;SLC25A33;PIK3R1;CPEB1;GPER1;PRKAR1B;RAB8B;ADCY3;ADCY8;ADCY6;PRKAR2B;IRS1;ADCY9;GOT1;PRKAR2A;GCK
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5213953766741999,1.1391324817349164,0.3368200836820084,0.7946580992368455,1.0,6/14,18.74%,WAS;FANCB;TIMELESS;PARP1;MRNIP;FUS
prerank,regulation of secretion by cell (GO:1903530),0.41138469978088693,1.1390683919520999,0.296028880866426,0.7936439781889643,1.0,13/54,12.57%,MEF2C;RAB8B;RHBDF1;RIMS1;RIMS2;RAB3B;SYN1;RIC1;LGI3;SYT1;STX4;STXBP5L;MCTP2
prerank,negative regulation of transposition (GO:0010529),-0.457396031342705,-1.1387143244125322,0.31669865642994244,0.6622127138842546,1.0,5/16,19.60%,TUT4;MOV10;TUT7;SIRT7;SMYD5
prerank,cellular response to hydroxyurea (GO:0072711),0.5493285962270783,1.1387119384843498,0.3426724137931034,0.793373953713255,1.0,5/10,19.96%,TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,positive regulation of viral process (GO:0048524),-0.3438899164846705,-1.1385393791444407,0.24056603773584906,0.6618813464456459,1.0,25/60,29.68%,MDFIC;CNOT7;HACD3;POLR2A;IFIT1;RAB7A;POLR2F;PPARA;LARP1;PPID;PPIA;KPNA6;DDB1;CDK9;POLR2E;RSF1;SRPK1;NR5A2;NELFCD;POLR2G;SRPK2;TBC1D20;CTDP1;ADARB1;SUPT4H1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.41172261630577167,-1.1383398232626778,0.2615062761506276,0.6616548751619858,1.0,9/27,20.40%,PLTP;APOE;CAV1;LPCAT3;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,regulation of B cell proliferation (GO:0030888),0.43303325776653584,1.1383389891019355,0.3351851851851852,0.7931372893357638,1.0,4/44,6.10%,MEF2C;TNFRSF21;CD300A;IL4
prerank,eosinophil migration (GO:0072677),-0.4581748737479049,-1.1381690001349842,0.3114119922630561,0.6605106087707439,1.0,11/14,51.89%,CCL13;CCL2;CX3CL1;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.4581748737479049,-1.1381690001349842,0.3114119922630561,0.6605106087707439,1.0,11/14,51.89%,CCL13;CCL2;CX3CL1;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,transition metal ion homeostasis (GO:0055076),-0.40216265005907725,-1.1378762188469647,0.29324894514767935,0.66048353516757,1.0,8/28,19.11%,CP;NEO1;B2M;SLC39A14;FTL;BDH2;HFE;MT3
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4783105219224362,1.1373169494151505,0.28489483747609945,0.7943376374416109,1.0,2/21,2.40%,PDE4D;PDE9A
prerank,pharyngeal system development (GO:0060037),-0.4627280232432035,-1.1371196859405845,0.2945590994371482,0.6616961353205534,1.0,7/15,15.74%,BMP7;BMP4;BMPR2;TGFBR1;TBX1;PTCH1;BMPR1A
prerank,chromatin remodeling (GO:0006338),-0.31573130104041486,-1.1371126558503408,0.20055710306406685,0.6609392546079684,1.0,29/100,24.09%,SMARCA2;HDAC4;ESR1;KAT2B;BAZ1A;KDM5B;INO80;CHD3;BPTF;BAZ1B;BAZ2B;TADA2A;JARID2;HDAC1;ACTB;EZH1;MPND;HDAC5;SMARCC1;KDM6B;HCFC2;ACTR8;SMARCAD1;RSF1;CHRAC1;PIH1D1;MBD2;SMARCA4;SATB1
prerank,transport along microtubule (GO:0010970),0.5275345451563004,1.1369395291652078,0.33405172413793105,0.7941002603388677,1.0,5/13,16.49%,ARHGAP21;DYNC1I2;CAMSAP3;COPG2;APBA1
prerank,response to tumor necrosis factor (GO:0034612),0.3780659398270214,1.1363476235196301,0.29874213836477986,0.794359118395133,1.0,5/91,1.66%,GGT5;PID1;GGT1;TNFRSF21;GPER1
prerank,regulation of hydrolase activity (GO:0051336),-0.32740970387366586,-1.1362595033791725,0.2183288409703504,0.6624782796181177,1.0,20/71,13.18%,PLXNA2;EPHA4;EPHA3;FGD5;FGD6;SIPA1L1;PLXNA4;CHN2;CAV1;VAV2;RASIP1;RAB3GAP1;EFNA5;PLXND1;DAB2IP;ADAP1;CAMK2A;FGD4;TDG;FBXW11
prerank,bile acid and bile salt transport (GO:0015721),-0.4114297685054371,-1.1361199433876343,0.29471544715447157,0.6620712656751956,1.0,3/24,3.80%,ABCC4;SLCO2B1;SLCO1C1
prerank,negative regulation of insulin secretion (GO:0046676),-0.4482625016938563,-1.1359904052038083,0.299009900990099,0.6616234199525155,1.0,9/17,28.65%,CCN3;KCNB1;PIM3;SFRP1;MIDN;PRKN;SIRT4;ADRA2A;CHGA
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.44630692605008343,-1.1352764995274462,0.31589147286821706,0.6627585164614266,1.0,2/17,1.99%,CAMK1D;MCU
prerank,negative regulation of cell projection organization (GO:0031345),0.4220709295244191,1.1352592548244418,0.31494661921708184,0.7956807175751694,1.0,7/48,4.72%,PTEN;RAPGEF2;RTN4RL1;PTPN9;ADCY6;SPRY2;MYLIP
prerank,glycerophospholipid metabolic process (GO:0006650),0.38743334645636657,1.1351547491578082,0.2730210016155089,0.7947840427740447,1.0,10/75,10.50%,PDGFRB;PLA1A;DGKH;CPNE7;GPCPD1;PLAAT1;ABHD3;GDPD1;PIGZ;PLA2G4E
prerank,keratinocyte differentiation (GO:0030216),-0.40144503319338926,-1.1349916791111452,0.2886178861788618,0.6627003920643867,1.0,7/29,14.53%,CLIC4;ADAM9;ANXA1;TXNIP;WNT5A;WNT16;UGCG
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5090338900901642,1.1349334892109206,0.32908704883227174,0.7942012392758538,1.0,3/13,8.31%,CACNA1H;SCAMP5;SYT1
prerank,stress-activated MAPK cascade (GO:0051403),0.39977686207513263,1.1347703527820703,0.2991735537190083,0.7934434215283429,1.0,7/61,7.77%,MAP3K20;MAP3K5;ARHGEF6;BTRC;MINK1;TNIP2;RIPK2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4192505036539604,-1.1345190303066885,0.2795275590551181,0.6632226898470402,1.0,10/21,22.15%,IGF1;IGFBP5;GJA1;ADAMTS1;ERN1;BMPR1A;MMP2;P2RY6;DNMT1;NR4A3
prerank,organelle organization (GO:0006996),0.31651360406442586,1.1342117026658585,0.22384428223844283,0.7936627242163343,1.0,64/388,11.65%,MAST4;PLCE1;LIMD1;ARHGAP21;ARHGAP10;SH3KBP1;SYNE1;SLC25A33;DPYSL2;MARK1;WASF3;SIPA1;ABCD2;PTCD2;TMCC1;ABI2;TOR1B;ATP7A;SORT1;MREG;COG7;WASL;FMNL3;CENPW;FANCG;PEX7;AJUBA;ATP8B2;CLASP2;COG1;YTHDF3;FAF2;ESRRA;CHMP2B;ARFGEF1;GABPA;BIN1;LIG4;HACE1;PIKFYVE;VPS18;PAK6;BLZF1;PEX1;FAM161A;MIA3;TFAM;PKD2;RAB38;RNF112;TMED7;ZMYM3;PAK5;KIF3A;TMED4;UBXN2B;VPS11;DYRK3;TMEM135;ARHGEF7;STX4;KIF5C;YTHDF2;PACSIN3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.353861814511308,-1.1338595658692752,0.2566585956416465,0.6641531444177278,1.0,20/51,14.62%,ROCK2;NRP1;LPAR1;CCN2;TGFBR1;SORBS3;PXN;SYNPO2;ARHGEF10L;SYNPO;RHOA;CD47;S100A10;FHOD1;MYOC;PFN1;EVL;LIMCH1;ARHGEF15;SFRP1
prerank,lymphocyte proliferation (GO:0046651),0.46813022570982776,1.133840321795576,0.3148854961832061,0.7933965580121787,1.0,1/22,0.66%,MEF2C
prerank,renal water homeostasis (GO:0003091),0.45960262486178965,1.1338225136112,0.3281853281853282,0.792293862059538,1.0,10/23,10.38%,PRKAR1B;ADCY3;ADCY8;ADCY6;TFAP2B;PRKAR2B;ADCY9;PRKAR2A;RAB11FIP2;PRKAR1A
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4193797501913164,1.1337018990519658,0.29537366548042704,0.7914610593815183,1.0,9/44,10.71%,CARMIL1;NCK2;VASP;CDC42EP1;SPIRE1;BIN1;NCKAP1;LMOD1;ARPC4
prerank,positive regulation of protein depolymerization (GO:1901881),0.5220285196264034,1.1335608536270485,0.3495575221238938,0.7906921076546938,1.0,3/11,12.04%,SEMA5A;NES;CFL2
prerank,neurogenesis (GO:0022008),0.42879078072098253,1.1334479505518602,0.29814814814814816,0.7898588645806981,1.0,12/43,14.40%,CDK6;BTBD3;CHAC1;ROGDI;RYK;TRAK1;BTBD6;SPOCK1;TRAK2;EPHB1;RITA1;SIX4
prerank,aspartate family amino acid metabolic process (GO:0009066),0.47743380547423286,1.133433753671914,0.31875,0.7887764615869166,1.0,4/18,8.24%,NAALAD2;SLC25A13;MSRA;GOT1
prerank,histone H3-K36 demethylation (GO:0070544),-0.5204619079681712,-1.133270209907752,0.33458646616541354,0.6649217791894777,1.0,1/10,0.95%,KDM7A
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.35216058040616544,1.133190226600337,0.2593123209169054,0.7882823875658763,1.0,15/150,5.46%,PDGFRB;PIK3CD;GAB1;GCNT2;PTK2;PIK3R1;SEMA5A;FERMT2;ERBB4;NRG1;PIK3CA;AXL;FGF2;SPRY2;ITGB1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4607963034558951,1.1328675874346157,0.3060428849902534,0.7878724803424856,1.0,3/22,3.53%,NOTCH1;ERBB4;CRLF3
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3616185693270229,-1.132279577981134,0.2688679245283019,0.6667570121957173,1.0,25/46,36.29%,PIEZO2;MAP3K1;MAP3K14;PIEZO1;IRF1;TNFRSF1A;CASP8;F11R;BNIP3;MAPK3;TLR4;SLC9A1;CRADD;MYD88;FAS;BCL10;LTBR;KCNK4;CD40;TLR7;FADD;CHEK1;TNFRSF10B;AQP1;TLR5
prerank,negative regulation of cell adhesion (GO:0007162),-0.3331556806085713,-1.1321499880978783,0.25474254742547425,0.666330684972378,1.0,22/72,12.69%,PLXNA2;FBLN1;SEMA6A;PODXL;PLXNA4;ANGPT1;CDH1;ADAM10;ACER2;ACVRL1;RHOA;DUSP1;CYP1B1;FZD4;TGFBI;PLXND1;CDH13;FZD7;ARHGDIA;CD164;TGFB1;EPHB2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.45614861072097124,1.1320753998285715,0.3253012048192771,0.7886715759564208,1.0,2/28,1.34%,PTEN;PTK2
prerank,myeloid cell development (GO:0061515),-0.446100543364332,-1.1318501563799124,0.2841121495327103,0.666382673437805,1.0,5/18,11.55%,FOXP1;APP;ANXA2;KIT;ALAS1
prerank,regulation of neurotransmitter transport (GO:0051588),0.5087884036602265,1.1313404579192532,0.3139784946236559,0.7892665348458986,1.0,3/16,6.15%,MEF2C;RIMS1;SYN1
prerank,detection of mechanical stimulus (GO:0050982),0.4912849873295812,1.1310198467095212,0.3452631578947368,0.7889013489617798,1.0,2/19,1.34%,CDH2;PTK2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.461461165241922,-1.1309006821914784,0.3090551181102362,0.6680664493679034,1.0,4/15,5.91%,APOE;APP;IAPP;PFDN5
prerank,glycine metabolic process (GO:0006544),0.5293138944311618,1.1308002415331975,0.34192037470725994,0.7883004547676621,1.0,5/12,15.69%,BAAT;GCSH;GLYAT;GCAT;DLD
prerank,regulation of secretion (GO:0051046),0.5089244993560643,1.1307978320515626,0.33986928104575165,0.7871968391205132,1.0,4/13,8.19%,NRG1;OPRK1;FGF10;MYO6
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4727993919602482,-1.130409509949894,0.3063583815028902,0.6686054555699209,1.0,4/14,16.46%,MOXD1;DAGLB;NOS1;SLC22A2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5296986314518238,1.1303860984924536,0.3407079646017699,0.7869939274532144,1.0,2/12,0.66%,MEF2C;PRKG1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.29104191547762015,-1.129703744125707,0.20066889632107024,0.6696782037524514,1.0,37/161,14.70%,MCC;DAB2;IGFBP2;BICC1;TMEM64;DKK3;APOE;CAV1;IGFBP6;NKD1;TLE4;MLLT3;LRP6;TCF7L2;IGFBP4;SOX13;PFDN5;SFRP4;WNT5A;SCYL2;AMFR;FZD4;TLE2;NOTUM;DAB2IP;TLE1;ZNRF3;PSME2;CCDC88C;HDAC1;PSMB4;GLI3;SOX17;PSMD8;PSMB1;SFRP1;PSMD11
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.4856669443081212,-1.1294965603193194,0.32196969696969696,0.6694608531274445,1.0,1/11,0.33%,ZMIZ1
prerank,response to amyloid-beta (GO:1904645),-0.3626005259673152,-1.1294832901253509,0.26218097447795824,0.668730825987213,1.0,9/44,6.72%,IGF1;EPHA4;APP;IGF1R;GJA1;SNX6;VCAM1;CASP4;ICAM1
prerank,positive regulation of developmental process (GO:0051094),-0.2920696105398384,-1.1294615275900142,0.18575851393188855,0.6680127506566259,1.0,41/164,18.30%,PLCB1;ZBTB16;DCN;CCN2;BMP7;SLC6A6;MCU;APOE;SHANK3;BMP4;BMPR2;SMURF2;GJA1;FOXD1;ACVR1;ADGRL1;NIBAN2;AR;WNT5A;NR2C2;TFRC;FZD4;RREB1;DAB2IP;KDR;VPS35;CPEB3;TMEM119;LRP8;SHLD1;BNIP3;HSP90AB1;KMT5C;CORO1C;BMPR1A;EDN3;MAP3K13;TAPT1;ALK;CEBPB;BASP1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.43322762897088934,-1.129329268427033,0.30278884462151395,0.667576059715834,1.0,6/19,19.65%,ENPP1;SLC26A2;PAPSS2;SULT1A1;TPST1;TPST2
prerank,cellular response to interleukin-1 (GO:0071347),-0.2927843246451751,-1.1289068537856173,0.20189274447949526,0.667933764919727,1.0,45/143,25.07%,PLCB1;ADAMTS12;PTGIS;IL1R1;NOD1;IRAK2;CCL15;MAP3K8;CD47;CCL14;HIF1A;DAB2IP;ZC3H12A;IRAK3;PSME2;CCL25;RELA;PSMB4;UBB;FBXW11;PSMD8;PSMB1;MAPK3;SFRP1;PSMD11;GBP2;CCL13;PSME3;PELI1;SIRPA;NFKBIA;MAP3K3;PSMA2;PSMD4;IKBKG;PSMD3;PSMB7;CCL19;PSMC2;USP10;GBP3;PSMD10;EGR1;PSMC5;MYD88
prerank,cytoplasmic microtubule organization (GO:0031122),-0.3442736392238816,-1.1285884620895408,0.2548076923076923,0.6680589227695759,1.0,15/54,20.92%,FIGN;DLG1;EZR;CLIP4;RAB11A;LIMK2;RHOA;SPAST;TRPV4;CCDC88C;TUBGCP5;CHP1;DYNC1H1;SLK;NUMA1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5398443115687366,1.1285865597077454,0.34249471458773784,0.790134825566987,1.0,1/11,0.85%,NEDD4L
prerank,Wnt signaling pathway (GO:0016055),-0.3132646835490889,-1.1284527733061405,0.22832369942196531,0.667679942423786,1.0,26/92,13.37%,NXN;WNT4;PLPP3;WNT6;CPE;LEF1;LRP6;LRRK2;FZD2;TCF7L2;WNT9A;RARG;SFRP4;WNT5A;CSNK1G2;FZD4;NR4A2;USP34;FZD7;VPS35;BCL9L;WNT5B;CCDC88C;UBB;PLCG2;WNT16
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4153405185370699,-1.128344165863084,0.28024193548387094,0.6672009152865053,1.0,5/24,9.38%,ERRFI1;ROCK2;PRKCH;FOXC1;TRIM16
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.40545841135271565,-1.1282070257388328,0.2880658436213992,0.6667803948408568,1.0,6/25,8.47%,CD55;B2M;LACC1;WNT5A;SLC7A5;KIT
prerank,regulation of B cell apoptotic process (GO:0002902),-0.4849784862342845,-1.1281734025861887,0.3248175182481752,0.6661059414573844,1.0,2/12,7.40%,FOXP1;FNIP1
prerank,actin crosslink formation (GO:0051764),0.511743964719799,1.127884911508978,0.34051724137931033,0.7906635287347907,1.0,1/12,0.31%,EPS8
prerank,cellular response to interleukin-12 (GO:0071349),-0.35315329724147804,-1.1272578543763865,0.26521739130434785,0.6677282408776756,1.0,8/48,7.63%,PLCB1;ANXA2;RAP1B;PITPNA;PDCD4;P4HB;CD47;TALDO1
prerank,diterpenoid metabolic process (GO:0016101),-0.3463978256953397,-1.1272207440819821,0.2910284463894967,0.6670758591725864,1.0,10/55,8.29%,ALDH1A1;RBP1;APOE;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;ABCA4;STRA6
prerank,regulation of cytoplasmic translation (GO:2000765),0.5107088264646943,1.1266012568856894,0.3165618448637317,0.7926313829640834,1.0,6/14,16.97%,CPEB1;RBM24;CPEB4;DHX36;FMR1;PKM
prerank,regulation of protein metabolic process (GO:0051246),-0.3552332812536106,-1.126329409076789,0.2645739910313901,0.6686324147618876,1.0,14/44,14.38%,ROCK2;APOE;APP;KLF4;KLF2;LTBP4;ACE;FKBP1A;MAP2K5;HGS;VPS35;MDM2;HSP90AB1;NEDD8
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5366465948089645,1.1262350211535745,0.3240343347639485,0.7923993824180751,1.0,3/10,8.83%,OGT;ZNF692;SDHAF3
prerank,ameboidal-type cell migration (GO:0001667),0.41374221105611886,1.126065380623979,0.29772329246935203,0.791682899032032,1.0,9/51,8.08%,ITGA4;SEMA6D;SEMA5A;PKN1;ERBB4;SEMA6C;GPC3;PDLIM1;NANOS1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4725465720618079,-1.12602413684144,0.30134357005758156,0.668645272687388,1.0,5/13,10.52%,ROCK2;AKAP13;ASAP3;ACTG1;FHOD1
prerank,positive regulation of protein processing (GO:0010954),-0.4346879567782101,-1.1259131543105199,0.3235294117647059,0.6681575415857426,1.0,4/19,5.50%,GSN;CCBE1;CLEC3B;LPCAT3
prerank,positive regulation of response to stimulus (GO:0048584),-0.3673887536355538,-1.125525143758938,0.288981288981289,0.6684152080618647,1.0,9/40,17.34%,IL15;B2M;WNT5A;PRKCD;MAVS;YPEL3;FXR2;HOMER1;RSAD2
prerank,macrophage migration (GO:1905517),-0.47267336862819836,-1.1252844155125667,0.3282442748091603,0.6683334391227592,1.0,8/13,40.03%,P2RX4;P2RY12;EDNRB;CCR2;CKLF;CCL2;CXCL17;CCL5
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3132709009446693,-1.1250677230595127,0.25205479452054796,0.6680838816333431,1.0,35/93,23.13%,PLCB1;CCN2;SH3RF1;APP;SASH1;XDH;RASSF2;SDCBP;PTK2B;MFHAS1;SH3RF2;SH3RF3;TAOK2;TNFRSF19;FZD7;DAB2IP;ZC3H12A;RELL1;FLT4;SPHK1;WNT16;MAPK8IP1;HIPK2;ARL6IP5;MAP3K4;RIPK1;GADD45G;TPD52L1;EDA2R;CCL19;VEGFA;KLHDC10;SEMA4C;EDAR;GADD45B
prerank,intracellular protein transport (GO:0006886),-0.27015020013589175,-1.124971347814962,0.14427860696517414,0.6675674414143619,1.0,120/304,29.02%,RANBP3L;LAMP2;KIF13B;ARL4A;TBC1D22A;SGSM2;SNX9;SNX6;KIF13A;ARHGEF2;TLK1;COPZ2;SEC31A;RABGAP1L;APPL2;STX7;USP6NL;SMURF1;TBC1D8B;GGA2;STX3;STAT3;ARFIP2;TBC1D8;RASSF9;COPA;CCHCR1;EHD1;AKT1;BAG3;AP3B1;C2CD5;STX1A;USO1;RAB21;AP4M1;VPS35;TBC1D10A;IPO7;LMAN1;RPL11;FAM53C;RAB7A;TGFB1;STX6;IPO13;AP2A1;EVI5;RAN;SCFD2;CALR;ARL5A;TBC1D2;SURF4;PKD1;NAPA;TBC1D25;SEC23IP;RAB18;IPO8;HOMER3;NXT2;TPR;RAB3GAP2;AP4E1;TBC1D13;RAB29;SAR1A;STX2;SAR1B;RAB6A;HPS4;CHP1;NUP88;RAB32;VPS26C;MAIP1;ARFIP1;SYK;RABL3;VPS28;TMED9;YWHAH;SNX8;TBC1D14;NUP214;RAB24;AP3D1;ACD;WDR11;TMED2;AP4B1;AKT2;NXT1;TBC1D5;XPO4;TBC1D4;TBC1D22B;SEC31B;ARL4D;NUP155;TBC1D17;LTBP2;RANBP17;EIF4ENIF1;PICK1;STX17;RAB19;PREB;STX19;ARF4;CSE1L;EIF2D;PTTG1IP;NUP62;TBC1D16;RAB22A;LAPTM5;TNPO2;CTTN
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.464472663592616,1.1248442116196844,0.32629558541266795,0.7935283935199813,1.0,7/25,11.01%,CACNA1C;FGF13;CTNNA3;ATP2A2;RYR2;TBX18;RANGRF
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3589645740427506,-1.1248252247650892,0.2731707317073171,0.6671592726465216,1.0,17/49,25.42%,SGMS1;CAV1;NUPR1;GSDME;P4HB;MCL1;BCL2L11;BECN1;BCAP31;BID;PLAUR;BBC3;NDUFA13;EIF2AK3;BCL2L1;TP53;RACK1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3736621031963168,-1.1246374270024495,0.2745995423340961,0.6668942538901593,1.0,13/37,20.88%,FHIT;TAF1;SDCBP;PML;RPL11;TRIM39;HSP90AB1;HIPK2;RPL23;HFE;RPS7;PARK7;UBXN1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3943416630724987,-1.1242504285680956,0.29494949494949496,0.6671252000958536,1.0,8/26,11.65%,ROCK2;ASAP3;SHANK3;SYNPO2;SYNPO;ACTG1;FHOD1;PFN1
prerank,aortic valve morphogenesis (GO:0003180),0.45314468120160695,1.1233398376597803,0.31684981684981683,0.7959137557488761,1.0,6/30,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,cardiac myofibril assembly (GO:0055003),0.506368984599203,1.1230105032609872,0.35319148936170214,0.7955523863712443,1.0,1/15,0.19%,PDGFRB
prerank,positive regulation of double-strand break repair (GO:2000781),0.42575212336694995,1.1230050237658613,0.3125,0.7944615280737329,1.0,14/39,16.94%,WAS;FOXM1;SPIRE1;FMN2;FANCB;SLF2;TIMELESS;SETMAR;PRKDC;SHLD3;KMT5B;PARP1;MRNIP;DDX11
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3486480713675875,-1.1228348087617077,0.27546296296296297,0.6701097622768267,1.0,16/46,12.98%,ALDH1A1;ZNF423;LGR4;IL15;ADAMTS5;NPR3;FOXC2;ID1;ACOT11;MAP2K6;LNPEP;NOVA2;FLCN;NOVA1;IP6K1;PGAM5
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4687942356939305,-1.122758109813887,0.3333333333333333,0.6695550565102524,1.0,1/13,0.33%,ZMIZ1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3953475247605049,1.1225721953392307,0.2867012089810017,0.7943919920752446,1.0,12/65,10.95%,ITGA1;SH3KBP1;AFAP1L2;GPER1;RHBDF1;SPRY2;EPN1;MVB12A;CNOT9;HIP1;DGKD;ARHGEF7
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5155832762625272,1.122429404479948,0.3468950749464668,0.7936140743853528,1.0,2/12,5.16%,PARP8;TNKS
prerank,regulation of axonogenesis (GO:0050770),0.41435304419428975,1.1219467600866637,0.30756302521008405,0.7936700473304614,1.0,16/51,11.84%,CHN1;PTEN;CDH2;LINGO1;LRRC4C;PLXNB1;METRN;NTRK2;ROBO2;MARK2;SLITRK1;ARHGAP35;BRSK1;PAK3;PAK1;PLXNB3
prerank,glycogen metabolic process (GO:0005977),-0.4038494865766448,-1.1215776120037517,0.2979591836734694,0.6718748706547657,1.0,4/27,6.03%,PRKAG2;PHKB;PHKA2;PYGB
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4414913136512193,-1.1215586162360758,0.28336755646817247,0.6711692324269759,1.0,9/16,28.31%,CAV1;PARP14;HGS;LEPROT;ADIPOR1;PTPN2;PIBF1;INPP5F;SOCS1
prerank,cellular response to copper ion (GO:0071280),-0.44351032905975757,-1.121302583845387,0.34714003944773175,0.6711428147450923,1.0,9/16,19.78%,MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3805094822185031,-1.1210698347320338,0.3271889400921659,0.6710040572565268,1.0,8/35,3.18%,SULF1;FLT1;APOE;CAV1;SPARC;XDH;PTPRM;THBS1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4389927442528624,-1.1210550982273735,0.3198458574181118,0.6703042410877726,1.0,6/18,23.07%,DAB2;EZR;RAB21;MAPK3;SNX3;RDX
prerank,insulin receptor signaling pathway (GO:0008286),-0.3290704547827182,-1.1207849144260638,0.26811594202898553,0.6703137644263987,1.0,21/69,13.88%,SORBS1;RHOQ;FOXO1;IGF1R;BAIAP2;FOXC2;ATP6V0A4;AP3S1;IGF2;SLC39A14;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;ATP6V0A1;TCIRG1;FER;CAV2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4385426044629459,-1.120616063037567,0.3216374269005848,0.670008354559887,1.0,6/19,16.21%,WNT4;VIM;BMP4;EMILIN1;TGFB1;CREB3L1
prerank,I-kappaB phosphorylation (GO:0007252),-0.5051650558870452,-1.1205988601848855,0.3352601156069364,0.6693007836597313,1.0,7/10,44.66%,ERC1;DAB2IP;TLR4;MAP3K7;TLR7;TLR2;TLR3
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4334502151582812,1.1203123147965042,0.31296296296296294,0.7964023037582213,1.0,4/29,6.72%,PDGFRB;PTK2;FGF2;IRS1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.25755507564700014,-1.120143867976796,0.125,0.6697348933468982,1.0,106/509,13.93%,IGF1;PDGFD;FN1;FLT1;EGFR;ROCK2;DCN;NFAT5;PDGFRA;NTRK3;AKAP13;LPAR1;OSBPL8;VWF;TEK;TGFA;IQGAP1;APP;F3;CAV1;NUPR1;JCAD;KSR1;SASH1;ESR1;TGM2;FGFR2;THBS1;IGF1R;GJA1;PTPRJ;TGFBR1;NR3C2;ANGPT1;MAP3K14;NOD1;ADGRV1;TCF7L2;PDCD4;GSDME;CFLAR;GAS6;IGF2;DDX60;TNFSF10;FGF1;LGALS9;IAPP;RPS20;PRKCB;IKBKE;WNT5A;RHOA;KL;PLK2;MFHAS1;FKBP1A;PIK3AP1;FNIP1;P2RX4;TFRC;EEF1D;TBX1;GOLPH3;ADRA1B;USP15;PIK3CB;BIRC3;KIT;TNFRSF19;ECM1;NOS1AP;CDH13;TNFRSF1A;BCL2L11;IFI35;EPHA8;BECN1;FRS2;IL18;RPL37;DAB2IP;KDR;FLCN;CASP8;MAVS;MYOC;TRIM27;TNFAIP8L3;PLEKHG5;TRIP6;TGFB1;FGFR4;PUM1;FLT4;FLT3LG;RELA;SPHK1;MET;PLCG2;WNT16;TXN;RET;TICAM1;CAV2;HSP90AB1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.46889114461734843,-1.1198964080387606,0.3134057971014493,0.6696110227586555,1.0,8/14,23.69%,AKT1;NNMT;DDB1;PPARGC1A;PTPN2;ARPP19;SLC45A3;AKT2
prerank,positive regulation of transferase activity (GO:0051347),-0.288491046671968,-1.1198697117474092,0.2182410423452769,0.6689396980278459,1.0,33/142,16.08%,EPHA4;EPHA3;FLT1;EGFR;PDGFRA;EPHA7;NTRK3;LMO4;TEK;FGFR2;IGF1R;EPHB4;KLF4;IGF2;DDR1;TIE1;KIT;DTX3L;NAF1;EPHA8;KDR;TGFB1;FGFR4;FLT4;EPHB2;MET;RET;HSP90AB1;MAPK3;RAD50;SERINC1;CD200;MAP3K4
prerank,apoptotic cell clearance (GO:0043277),-0.38697623177109014,-1.1198672713732483,0.298728813559322,0.6682116786534458,1.0,6/30,4.95%,RHOBTB1;TGM2;THBS1;TXNDC5;ANXA1;GAS6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3897832022979524,-1.119770069087185,0.2928416485900217,0.6677424518350245,1.0,18/32,14.00%,HDAC7;JCAD;THBS1;MEOX2;KLF4;FOXC2;ANXA1;HDAC9;RHOA;MAP2K5;CARD10;KDR;FGFBP1;GATA2;PTGS2;RHOJ;SRPX2;HDAC5
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4386001100829283,-1.1188166675885742,0.30943396226415093,0.6694517502597498,1.0,8/18,14.00%,HDAC4;CCN3;FRS2;BHLHE41;FZD7;HDAC1;TMEM119;HDAC5
prerank,phosphatidylserine metabolic process (GO:0006658),0.4400643655311907,1.118750133037029,0.3180952380952381,0.7989722479907093,1.0,2/32,0.78%,MBOAT2;PLA1A
prerank,triglyceride catabolic process (GO:0019433),0.4957827717103684,1.1185617018305314,0.3611111111111111,0.798336938757081,1.0,3/19,6.99%,FABP3;LIPC;LIPH
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3700002053112645,1.1172401417891944,0.30317460317460315,0.8003341662354853,1.0,17/94,17.07%,DYNLL1;PRKAR2B;SCLT1;DYNC1I2;CSNK1E;CEP41;AHI1;NPHP4;CEP97;TUBB4A;TCTN3;DCTN1;DCTN3;CEP76;CEP135;CEP162;NDE1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5179595627606297,1.1164854443604262,0.3625,0.8009747063909116,1.0,4/13,10.14%,CHST3;CHST7;CHST2;CHST5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4695802151887134,-1.1162736579464334,0.3157894736842105,0.6752570183676334,1.0,4/12,10.50%,ROCK2;APOE;FKBP1A;FLOT2
prerank,positive regulation of T cell activation (GO:0050870),-0.3303524975889064,-1.1160619122956192,0.2605633802816901,0.6751365171762799,1.0,19/62,22.78%,ZMIZ1;IL15;IL6ST;ANXA1;VCAM1;LGALS9;CD47;TFRC;FLOT2;SLC7A1;SIRPA;RHOH;CYRIB;CD81;PNP;CD274;MDK;CCL19;XBP1
prerank,monocarboxylic acid transport (GO:0015718),-0.35043075035590665,-1.115951037646783,0.2853881278538813,0.6746839017832897,1.0,11/51,5.98%,ABCC4;SLC6A13;SLCO2B1;SLC16A2;SLC6A12;SLCO2A1;ABCG2;SLCO1C1;SLC16A1;SLC16A6;SLC16A11
prerank,negative regulation of GTPase activity (GO:0034260),-0.411965412540474,-1.1154446794387747,0.30916030534351147,0.675245538173975,1.0,10/22,23.07%,LRCH1;LRRK2;WNK1;CPEB2;DAB2IP;F11R;GMIP;SH3BP4;TMED2;RDX
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.38560369076873097,-1.1154236864413505,0.2860169491525424,0.6745690107244883,1.0,13/31,27.78%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;DNAJB12;PRKN;ATXN3;HSPA1B
prerank,energy reserve metabolic process (GO:0006112),-0.44150011403165024,-1.115096346488148,0.3188118811881188,0.6747270904288281,1.0,3/19,1.78%,PRKAG2;LEPR;PHKB
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3486891641382957,-1.1150061122052026,0.3031026252983294,0.6742291036027283,1.0,13/50,13.22%,EGFR;NFAT5;APP;SASH1;NR3C2;NOD1;PDCD4;LGALS9;RHOA;IFI35;TRIP6;RELA;SPHK1
prerank,plasma membrane repair (GO:0001778),0.5004421435612402,1.1149278133990554,0.32954545454545453,0.8035746693355983,1.0,2/13,1.93%,DYSF;MYH9
prerank,regulation of keratinocyte proliferation (GO:0010837),0.47716372632213827,1.1146635241379688,0.3650107991360691,0.8031024986151621,1.0,1/22,0.17%,PTPRK
prerank,protein glycosylation (GO:0006486),-0.2973726448982751,-1.1145320949456652,0.24307692307692308,0.674676145599674,1.0,35/125,20.67%,ST3GAL4;LARGE1;B4GALT1;ST3GAL6;MAN1C1;ST3GAL1;ST3GAL2;EOGT;STT3A;PLOD2;ST3GAL3;TET3;STT3B;FUT8;MGAT1;ST6GALNAC2;SERP2;SLC39A8;ST8SIA2;B3GALNT1;POGLUT1;MGAT2;ENTPD5;GFPT2;ALG6;AQP11;PLOD1;ST3GAL5;RPN2;GFPT1;DOLPP1;ST8SIA5;PLOD3;B3GALNT2;MOGS
prerank,sensory perception of taste (GO:0050909),0.5400666143193338,1.1136534076416318,0.3456521739130435,0.804411856864722,1.0,3/10,12.48%,TAS1R1;ASIC2;ASIC3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4695856977974324,1.1135289199411205,0.36327345309381237,0.8035904054856492,1.0,6/23,12.37%,SLC12A2;SLC12A6;TFAP2B;SLC9A7;SLC12A5;SLC12A4
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4341264198136096,-1.1131983824520357,0.337890625,0.677361469484834,1.0,2/18,1.99%,CAMK1D;MCU
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.41095859126222933,1.1130787028417972,0.30511463844797176,0.8036148041177852,1.0,9/43,6.72%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;OGT;GRB10;PIP4K2C;IRS1
prerank,regulation of superoxide anion generation (GO:0032928),-0.45969539009552507,-1.1126009687259215,0.341747572815534,0.6782182552856655,1.0,6/14,27.39%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,positive regulation of cell population proliferation (GO:0008284),0.30982569588305586,1.1123744273590639,0.2555012224938875,0.8041771272684382,1.0,46/423,7.54%,PDGFRB;PTEN;IL34;TBX2;S1PR3;MEF2C;PID1;GCNT2;CDK6;BMP5;NOTCH1;TBX20;SLC25A33;RBPMS2;PTK2;GPER1;LAMC1;TBX3;NODAL;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;MECP2;TBX6;CXCL5;PDCD10;FGF2;SPDYA;LAMB1;TSPAN31;SCN5A;TFAP2B;CXCR2;NTRK2;IL4;SOX4;CHRNA7;IRS1;EMP2;LIG4;HRAS;OSMR;FGF10
prerank,negative regulation of TOR signaling (GO:0032007),0.4399498249476371,1.1121048701595837,0.326007326007326,0.8037036956166608,1.0,9/36,14.46%,SPAAR;UBR1;SESN3;AKT1S1;NPRL3;DDIT4;UBR2;NPRL2;PRKAA1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.33786901621508836,1.112064748407625,0.297111416781293,0.802716981055566,1.0,15/190,3.76%,PDE4D;PTEN;LIMD1;PDE3A;PHLPP1;RORA;UBR1;GPER1;DGKG;NF1;SPRED1;SH3BP1;SH2B3;ITPR1;BCL2L10
prerank,response to fatty acid (GO:0070542),0.49210217679525897,1.1112692358569904,0.33755274261603374,0.8034207011444268,1.0,3/17,6.72%,PID1;FFAR2;IRS1
prerank,cellular response to alcohol (GO:0097306),-0.35577600935823933,-1.1111130506088576,0.3051948051948052,0.6812489791906573,1.0,15/42,14.62%,ADCY5;ADCY1;CDH1;LRP6;SMO;GRAMD1C;GRAMD1A;ADCY7;GOLPH3;ADAM15;CTNNA1;PTCH1;AHR;LARP1;SFRP1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5006985250521279,-1.1101628909772465,0.36300174520069806,0.6829432027730967,1.0,4/10,8.79%,THBS1;CTTNBP2NL;PRKCB;AKT1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.43190694051913975,1.1101407340357217,0.30812854442344045,0.8049603670363445,1.0,5/34,5.94%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1
prerank,nuclear migration (GO:0007097),-0.4626718707707038,-1.1092954077831796,0.35067437379576105,0.6844060422095112,1.0,6/13,23.47%,CLMN;SYNE3;SYNE2;FBXW11;DYNC1H1;PAFAH1B1
prerank,regulation of AMPA receptor activity (GO:2000311),0.45445794321267247,1.1090119490691879,0.358,0.80650799306357,1.0,3/25,4.32%,MEF2C;CACNG7;MINK1
prerank,intermediate filament organization (GO:0045109),-0.44090703418256805,-1.1087839712801093,0.32448979591836735,0.6850118409443622,1.0,6/17,28.45%,VIM;GFAP;DNAJB6;BFSP1;DSP;BFSP2
prerank,renal filtration (GO:0097205),-0.49100379127642346,-1.1087524707361627,0.32558139534883723,0.6843466387197331,1.0,5/10,6.58%,SULF1;ITGA3;CD34;SULF2;TBC1D8B
prerank,response to interleukin-4 (GO:0070670),-0.49987672529907967,-1.1085330017379798,0.35064935064935066,0.684168355878556,1.0,4/10,25.46%,LEF1;SHPK;XBP1;TCF7
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.43913519918146615,-1.1085321525594383,0.3405088062622309,0.6834291263164214,1.0,5/17,16.22%,BMP4;SFRP4;TMEM100;ATOH8;NKX6-1
prerank,regulation of inclusion body assembly (GO:0090083),-0.49053891035350183,-1.1082130006094433,0.32397003745318353,0.683573154612138,1.0,4/11,15.51%,SNCAIP;DNAJB2;DNAJB6;DNAJA4
prerank,peptide metabolic process (GO:0006518),0.38713856964727056,1.1081575809509778,0.3125,0.8074414044123854,1.0,6/75,4.08%,ENPEP;DMD;GGT1;CPM;ANPEP;GSTT2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.42287885836190975,-1.1071260280960853,0.33013435700575816,0.6856137800940296,1.0,12/18,33.60%,DCN;MCU;KDR;VPS35;BNIP3;DDHD1;RALBP1;PRKN;DNM1L;PINK1;RALA;MIEF2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2956513092792077,-1.1069602072972073,0.2395543175487465,0.6853213045734226,1.0,34/110,19.62%,ROCK2;FOXO1;APOE;APP;SMURF2;KLF4;NKD1;CSF1;KLF2;WWP2;SMURF1;SLC6A9;WNT5A;EGLN2;PLK2;MAP2K5;AKT1;IDE;IL18;DAB2IP;ASB5;RAB7A;TGFB1;WWP1;PAEP;DDB1;CDKN1B;OAZ1;NFKBIA;AGTR1;AGT;FZR1;VCP;VPS28
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4169539446185466,1.106260693291925,0.3292894280762565,0.8107678616560228,1.0,5/48,8.32%,PDE4D;IL1B;PTPN22;PDE4B;IL12RB1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.37422913492949905,1.106166039816094,0.32401315789473684,0.8098969179171479,1.0,1/82,0.06%,DYNLL1
prerank,nerve growth factor signaling pathway (GO:0038180),0.5383776137203743,1.1059807266829145,0.36610878661087864,0.8092517778645314,1.0,2/10,7.06%,RAPGEF2;RAP1A
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.44706634218235686,-1.105740642042707,0.3416988416988417,0.6877045163632932,1.0,6/15,23.23%,PRKCH;CSF1;IL18;AGTR1;AGT;LPL
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4758517610239048,-1.1054069323365212,0.35546875,0.6878324696671633,1.0,7/12,24.85%,ACTG1;LAMA5;LAMA3;ACTB;VANGL2;ZDHHC7;SCRIB
prerank,regulation of ruffle assembly (GO:1900027),0.44385896863525487,1.1049864880528495,0.348,0.8104683497544652,1.0,3/23,7.27%,EPS8;EPS8L1;HRAS
prerank,positive regulation of neuron projection development (GO:0010976),0.37362846787340015,1.1041466510104736,0.3360128617363344,0.8113925430235488,1.0,22/85,11.97%,SERPINI1;RAPGEF2;BMP5;ROR1;SCARF1;PTN;PLPPR5;ATP1B2;RIT2;NTRK2;CAPRIN2;RAP1A;FUT9;MARK2;ARHGAP35;LYN;ABL2;TOX;VLDLR;CUX2;PLXNB3;EP300
prerank,regulation of cell differentiation (GO:0045595),0.3430245507882397,1.1037588486162635,0.3068017366136035,0.8111786545000224,1.0,18/148,6.88%,MBOAT2;HEY2;CDK6;PTK2;TRPS1;PHLDB2;ZFHX3;ROCK1;NF1;NR1D2;HEMGN;MOSMO;CLASP2;TFAP2B;RUNX2;SIK1;EMP2;BIN1
prerank,estrogen metabolic process (GO:0008210),-0.44389980070694507,-1.1037105616439873,0.36151079136690645,0.6913124372837276,1.0,8/15,40.14%,CYP1B1;SULT1A1;HSD17B7;HSD17B8;HSD17B14;HSD17B10;HSD17B11;HSD17B1
prerank,heme biosynthetic process (GO:0006783),-0.403700162574131,-1.1036486964462837,0.3425742574257426,0.6907166874444061,1.0,13/22,33.25%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,folic acid-containing compound metabolic process (GO:0006760),0.47213296031173824,1.1027832040325973,0.3528225806451613,0.812352892025333,1.0,4/19,7.68%,SLC19A1;DHFR;GGH;MTHFD2
prerank,regulation of fibroblast migration (GO:0010762),0.4604383438835415,1.1025860641906913,0.3333333333333333,0.8117111846229568,1.0,7/20,10.95%,PTK2;PRR5L;FGF2;ITGB1;APPL1;GNA12;ARHGEF7
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.37645901567856954,1.1022577636964264,0.32166666666666666,0.8114126624335334,1.0,11/74,5.20%,PTEN;GCNT2;BMP5;RGCC;PHLDB2;FERMT2;IL17RD;SPRED1;IL1B;SPRY2;CLASP2
prerank,response to lipopolysaccharide (GO:0032496),0.34690244320826236,1.1021045345264744,0.32220609579100146,0.8106997476655612,1.0,15/138,6.53%,GGT5;MEF2C;GGT1;NR1H3;SCARB1;IL1B;PTPN22;CXCL5;AXL;CXCL10;TNIP2;OTUD5;PDE4B;SNCA;CACTIN
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.4844916273521283,-1.1007950193224794,0.36363636363636365,0.6972330986540898,1.0,8/11,42.96%,P4HB;PARK7;STK26;PRKN;LANCL1;PINK1;MMP3;GATA4
prerank,triglyceride biosynthetic process (GO:0019432),-0.4202531012107857,-1.1006775027403204,0.326133909287257,0.6967979747768722,1.0,2/18,3.10%,AGMO;LPGAT1
prerank,icosanoid metabolic process (GO:0006690),0.4077987578594209,1.0997458271925162,0.30418943533697634,0.8151890249750741,1.0,2/40,0.90%,GGT5;GGT1
prerank,negative regulation of developmental growth (GO:0048640),0.4428839099713358,1.0995936105000723,0.36607142857142855,0.8144407522502182,1.0,10/30,16.70%,PTEN;MAP2;FGF13;CDKN1A;WWC1;FGFR3;MAG;TRIM46;SLC6A4;RNF6
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3012212667599326,-1.099551719947672,0.2347560975609756,0.6989988664799318,1.0,43/113,25.69%,UNC13B;TRABD2B;ABCA1;CDH5;ESR1;RAP1B;ASAP1;PIEZO1;RASIP1;FNIP1;TFRC;ERCC5;BCL2L11;DAB2IP;GBP5;CUL4A;TGFB1;SH3GLB1;ATM;TAL1;RPA1;DDB1;TLR4;BID;PARK7;VCP;SYK;RHOC;PLEK;VEGFA;PIH1D1;ERCC1;LCP1;PSMC2;ICE1;ERCC2;RPA3;PSMC5;ERCC3;MYD88;TP53;RACK1;RPS3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.413086930461842,1.0992485887486227,0.3272058823529412,0.8141759347211172,1.0,4/39,5.92%,ITGA1;SH3KBP1;SPRY2;EPN1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3607718155656347,1.0990489481468333,0.3323397913561848,0.8135702507242746,1.0,13/108,6.83%,DLC1;ATP2A3;MAP3K5;COL4A3;GPER1;NODAL;GRAMD4;BCL2L10;CARD9;DDX3X;SNCA;BCL2L13;CASP9
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4527929446248419,1.099017745886794,0.33264033264033266,0.812553746338388,1.0,7/23,13.94%,NOTCH1;ERBB4;CRLF3;IL4;PRLR;OCIAD1;JAK2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4473272011151977,-1.097804948207511,0.3534971644612476,0.7027250472652605,1.0,3/16,3.19%,WNT4;VIM;BMP4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4436834096853207,1.0975886755428574,0.34307992202729043,0.8149145380420002,1.0,3/30,2.05%,CSPG4;CHST3;CHST7
prerank,organic cation transport (GO:0015695),-0.4175378468565842,-1.0974079788561608,0.36345776031434185,0.703010734440963,1.0,10/20,23.97%,SLC47A1;SLC22A4;SLC22A5;SLC22A18;SLC25A19;SLC22A2;SLC25A26;SLC25A29;SEC14L1;RALBP1
prerank,toxin transport (GO:1901998),-0.4939059648591967,-1.096971497327327,0.3711151736745887,0.7033771099596211,1.0,4/10,18.35%,ANTXR2;ADAM10;SLC22A2;RAB29
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4496677873630339,1.0969643591883191,0.361328125,0.815281135135224,1.0,8/26,13.35%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7;TMEM108;CUX2;NLGN3
prerank,regulation of receptor binding (GO:1900120),0.5125534098970347,1.0968989193752545,0.3613963039014374,0.8143634786407076,1.0,2/10,6.32%,ATP2A3;ATP2A2
prerank,platelet aggregation (GO:0070527),-0.3771839246428069,-1.0968412898414046,0.3286573146292585,0.7029580582529853,1.0,10/33,13.89%,FN1;PDGFRA;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;ACTB;PPIA
prerank,neuron development (GO:0048666),0.3431126541232456,1.0956545538924478,0.320863309352518,0.816189943193543,1.0,20/141,9.93%,FRY;MEF2C;RAPGEF2;MAP2;ETV1;ROCK1;ATP7A;CNTNAP2;LAMB1;RYK;CNTN4;NTRK2;B4GALT6;PPT1;TENM4;BLOC1S1;TMEM108;LYN;ACTL6B;PLP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.35692075344557106,-1.095648200756998,0.30201342281879195,0.7053840452841728,1.0,13/40,11.72%,DAB2;SMAD3;COL1A1;PDPN;TGFBR2;TGFBR1;LEF1;TCF7L2;SDCBP;FOXC1;TIAM1;BCL9L;TGFB1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.46516045237101367,1.095138370930593,0.37623762376237624,0.8163503201440943,1.0,6/23,6.72%,GNG2;ADCY6;PDE4B;SNCA;RYR2;GABPA
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4899853887508875,-1.0946629677672834,0.3735632183908046,0.7073353230411662,1.0,1/10,2.28%,ST3GAL1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.45753243552905665,1.0945872368704659,0.346,0.816576306590389,1.0,2/21,4.24%,CEL;PPARD
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.46697663100175313,-1.0940231080649618,0.35852713178294576,0.7082943562259455,1.0,4/13,16.00%,NAMPT;IL33;KDR;TLR4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.39404995428061923,-1.093766800176505,0.3288201160541586,0.7082167362557812,1.0,11/24,24.69%,DNMT3A;RBBP7;H3-3A;JARID2;TRIM27;PPHLN1;EZH2;SMYD5;MPHOSPH8;DNMT1;EPC1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4348797897766305,-1.0929261511929653,0.38345864661654133,0.7096622377252763,1.0,5/16,10.78%,JCAD;THBS1;PPP1R16B;FGFBP1;GATA2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.41138627841314723,-1.092530006966336,0.35,0.7099974898749658,1.0,6/20,16.50%,TGM2;RAP1GDS1;PML;TMCO1;SELENOK;BCAP31
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3361925002393315,-1.0923299841512506,0.33488372093023255,0.7097523525090286,1.0,23/52,29.71%,PPP1R13B;NPEPPS;TFDP2;CASP8;SH3GLB1;TOMM7;SAE1;PPP3CC;BID;LEPROT;HPS4;BBC3;YWHAH;E2F1;USP36;BAP1;YWHAE;TP53;SFN;FZD5;TFDP1;RHOU;NMT1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.3196604210101416,-1.0920763254861579,0.28809523809523807,0.7096522041617035,1.0,17/64,19.15%,PLA2G4A;CPT1A;CPT2;CYP1B1;DAGLB;GPX4;ACOX1;MGLL;ACADL;PTGS2;EPHX2;GSTM2;ELOVL1;GPX1;ALOX12;ACSL4;EPHX1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.48887229092124085,-1.092070276274739,0.3824091778202677,0.7089158477107704,1.0,4/11,16.42%,ITM2A;NECAB1;ITM2C;BACE2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3823662949846312,-1.0920325791371919,0.33043478260869563,0.7082791248796643,1.0,18/31,38.95%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;YWHAH;E2F1;YWHAE;TP53;SFN;TFDP1;NMT1;HIP1R;ZNF205;PPP3R1;BAX;GSK3A
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4186681050612924,1.0914882748701757,0.34601449275362317,0.8226861696044371,1.0,14/37,18.78%,PHLDB2;ROCK1;CLASP2;MAPRE2;TPPP;MARK2;BICD2;CAMSAP3;PHLDB1;PRKAA1;CDK2AP2;TRAF3IP1;GSK3B;STMN4
prerank,endothelial tube morphogenesis (GO:0061154),-0.4981036394754466,-1.0912965103808112,0.36162361623616235,0.7094757915629867,1.0,4/10,7.12%,BMP4;ACVRL1;RHOA;RHOB
prerank,response to acidic pH (GO:0010447),-0.4593792336287748,-1.090884076485944,0.3523809523809524,0.7098586490104071,1.0,6/13,25.50%,CTSS;RAB11FIP5;CHP1;SLC9A1;GPR4;PKD1L3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.42748113634176266,-1.0907238067302196,0.3528225806451613,0.7094903404306355,1.0,6/17,18.11%,APOE;FGF1;LPCAT3;RAN;SREBF1;ERLIN2
prerank,T cell mediated immunity (GO:0002456),-0.4606152309705588,-1.0904555361884525,0.3622641509433962,0.709479352731553,1.0,2/13,2.12%,CTSH;CD55
prerank,negative regulation of cell activation (GO:0050866),-0.4466135637772985,-1.0903338438230745,0.3472727272727273,0.7090581426323624,1.0,4/14,3.28%,PDGFRA;APOE;NOS3;THBD
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4791510898462403,1.090025291049891,0.36538461538461536,0.8249107446093951,1.0,2/16,3.66%,SLC25A33;ATP7A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4773346163754458,-1.0895890824511465,0.37281553398058254,0.7102430238722529,1.0,5/11,26.13%,KCNJ2;KCNQ1;ATP1A1;YWHAE;KCNH2
prerank,cell proliferation in forebrain (GO:0021846),0.5103921824624119,1.0895324425311452,0.3893617021276596,0.824988348554111,1.0,5/10,24.04%,HOOK3;AKNA;CEP120;DOCK7;NUMBL
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3839945637972133,1.0884545110110178,0.34775374376039936,0.8264076204842479,1.0,14/69,14.40%,SLC30A10;MEF2C;AGAP2;UNC5B;NTRK2;LIG4;PPT1;NFATC4;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,negative regulation of macroautophagy (GO:0016242),-0.3941326172822008,-1.0881284760122218,0.35053763440860214,0.7132576913380205,1.0,8/26,11.49%,NUPR1;LRRK2;CLEC16A;NRBP2;AKT1;CHMP4B;CHMP4A;PHF23
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4537185758908796,-1.0874166942374288,0.36813186813186816,0.7144064059222204,1.0,10/15,42.87%,MDM2;TAF9B;PRKN;CD44;PTTG1IP;KDM1A;CD74;MUC1;TAF9;MIF
prerank,extracellular transport (GO:0006858),-0.46652060050364164,-1.0872531131013772,0.378,0.7140543835932597,1.0,9/12,41.11%,WWP2;ARRDC1;SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,positive regulation of cellular process (GO:0048522),0.29494703076588663,1.0870596525023688,0.2715617715617716,0.8285857714371325,1.0,55/565,7.92%,TRPC3;PDGFRB;PTEN;IL34;TBX2;S1PR3;IL15RA;GCNT2;COLEC12;BMP5;NOTCH1;SLC25A33;PTK2;GPER1;TBX3;ZFHX3;MERTK;PABIR1;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;ETS1;MECP2;TBX6;CXCL5;PPP3CA;PDCD10;FGF2;AKAP6;CIDEB;SPDYA;ACTN4;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;DDX3X;TPPP;RYR2;SOX4;CHRNA7;IRS1;EMP2;SUPV3L1;HRAS;OSMR;FGF10;NCMAP;RIPK2;TENM4;CSPP1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3506892516970698,1.0865422915566236,0.3261205564142195,0.8287518519424529,1.0,12/101,7.27%,PDGFRB;IL34;RAPGEF2;RGCC;FERMT2;IL1B;PDCD10;FGF2;SPDYA;DDX3X;SNCA;HRAS
prerank,response to gamma radiation (GO:0010332),0.4518388193798947,1.0864171487072471,0.3612662942271881,0.8279500921255712,1.0,8/24,17.84%,MAP3K20;LIG4;HRAS;ATR;FANCD2;PRKAA1;HSF1;TLK2
prerank,anterior/posterior axis specification (GO:0009948),0.4926996890560339,1.0863748972117102,0.38144329896907214,0.82695906398122,1.0,5/15,19.38%,TBX3;CDX1;WLS;TASOR;DDIT3
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.37722800087225866,-1.0862406624884375,0.33984375,0.7159926899464103,1.0,8/28,12.89%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,positive regulation of chemokine production (GO:0032722),-0.3421858254087934,-1.0858748995010334,0.3048016701461378,0.7162366641126091,1.0,9/44,10.57%,APP;IL6R;LGALS9;WNT5A;HIF1A;IL33;IL17RA;IL18;MAVS
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.33467490861883803,-1.0858562282177735,0.3292079207920792,0.715533760188793,1.0,12/50,10.88%,NXN;HDAC8;CAV1;SMAD7;TAF1;ARRB1;SH3RF2;AKT1;DTX3L;PINX1;IVNS1ABP;PRKCG
prerank,extracellular matrix assembly (GO:0085029),0.4520532541020459,1.085455321405535,0.3817829457364341,0.8281183016333014,1.0,6/23,4.54%,TNXB;MYH11;ATP7A;PXDN;NTNG2;LAMB1
prerank,defense response to bacterium (GO:0042742),-0.29671054501530436,-1.085218076821129,0.26548672566371684,0.7164328291764542,1.0,23/105,16.45%,ANXA3;IL6R;LBP;NOD1;RPS19;GBP4;PRKCD;PLA2G6;STAB1;PGLYRP1;IRGM;OAS2;GSDMD;MAVS;GBP6;OPTN;RPL39;GBP7;GBP2;SERPINE1;TLR4;HMGB2;MR1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4960944790139844,1.0849647572409242,0.3800813008130081,0.8281689095256204,1.0,4/15,10.14%,CHST3;CHST7;CHST2;CHST5
prerank,positive regulation of heart contraction (GO:0045823),0.472842230015804,1.0849629212043903,0.35578947368421054,0.8270966160106953,1.0,3/19,6.43%,ATP1A2;ATP2A2;RYR2
prerank,regulation of neuroblast proliferation (GO:1902692),0.4868926175182883,1.0849221002479104,0.3618421052631579,0.8261141660312354,1.0,3/15,5.04%,NF1;PTN;TAFA3
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44952769853633534,-1.0846700937448124,0.38011695906432746,0.7170750054405485,1.0,5/15,15.69%,EGFR;CDH13;RHBDF2;FER;CEACAM1
prerank,development of primary male sexual characteristics (GO:0046546),-0.37181893810837396,-1.0838697755122984,0.35462555066079293,0.7184475523180455,1.0,5/34,8.47%,WNT4;LHFPL2;AR;WNT5A;KIT
prerank,regulation of protein localization to centrosome (GO:1904779),0.5205266870176227,1.0838474576112442,0.3686534216335541,0.8274586060254923,1.0,4/10,18.81%,UBXN2B;APC;GSK3B;MARK4
prerank,regulation of cell development (GO:0060284),0.4232308598426071,1.0837404823916656,0.35454545454545455,0.8266310581134341,1.0,4/36,2.65%,HEY2;HEYL;PER2;IL1B
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.44173941224986285,1.083629916025526,0.3685185185185185,0.825777900779041,1.0,4/25,9.37%,NDST3;B3GALT1;FUT9;B3GNT8
prerank,translesion synthesis (GO:0019985),-0.34909629118468966,-1.0835790152576752,0.33705357142857145,0.7184727306134475,1.0,20/42,31.70%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;USP43;UBE2L6;POLI;POLE2;RFC1;USP10;RPA3;POLD1;DTL;ISG15;PCNA;PARP10;RFC5
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4331850199749415,-1.0834043501697928,0.36450381679389315,0.7181693302471673,1.0,3/17,3.19%,WNT4;VIM;BMP4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.4863913811496472,-1.0833138947040482,0.3694852941176471,0.7176589772486762,1.0,4/11,10.34%,SMAD7;ANXA1;RC3H2;ZC3H12A
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.489721177000372,1.0830600891462883,0.39337474120082816,0.8260170595945703,1.0,2/16,2.01%,CLDN10;CLDN15
prerank,carboxylic acid transport (GO:0046942),-0.3360709092187923,-1.0830515281942992,0.3300970873786408,0.7176373956485964,1.0,18/55,15.66%,SLC6A13;SLC13A3;SLC6A6;SLC16A2;SLC6A12;SLC16A1;SLC16A6;SLC16A11;SLC6A9;SLC7A5;PSAP;SLC38A5;SLC3A2;SLC38A6;SLC16A13;LLGL2;SLC7A1;SLC66A1
prerank,catecholamine metabolic process (GO:0006584),-0.4471969219594417,-1.0829119329227197,0.34953271028037386,0.7172652048563101,1.0,1/14,0.58%,SNCAIP
prerank,steroid biosynthetic process (GO:0006694),0.39652445363067046,1.082795173197998,0.3432574430823117,0.8255382553380047,1.0,17/56,16.11%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6;SQLE;LSS;DHCR7;STAR;SRD5A1;PRLR;TM7SF2;CYP11B1;HMGCR;OSBPL7;HSD3B7;ACOX2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.46253199480322765,1.0824040876267815,0.3706896551724138,0.825400467001467,1.0,2/20,1.04%,PDGFRB;VTN
prerank,phospholipid dephosphorylation (GO:0046839),0.41597105357968367,1.0824029173205638,0.3575418994413408,0.8243404761794241,1.0,13/37,19.92%,PTEN;PLPPR5;INPP5J;MTMR12;INPP5B;MTMR7;SACM1L;PLPPR2;MTMR11;PIP4P1;PLPPR1;TPTE;SGPP1
prerank,protein insertion into membrane (GO:0051205),-0.36718393114449455,-1.0823194661037507,0.35490196078431374,0.7180498611721527,1.0,12/32,24.58%,EGFR;APP;TRAM2;STX1A;ALDH3A2;REEP1;VAPA;MAIP1;GET1;SEC61B;CCDC47;WDR83OS
prerank,motile cilium assembly (GO:0044458),0.4799925982314115,1.0820767638786903,0.3683083511777302,0.8240437437254637,1.0,1/12,2.37%,RSPH6A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3660760503053359,1.082002082048936,0.3193548387096774,0.8231649105055071,1.0,10/80,4.59%,EPS8;PLCE1;PIK3R1;PIK3CA;CDC42EP1;ABI2;PLPPR5;WASL;AGRN;EPS8L1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.48124656393062043,1.081150516807428,0.36645962732919257,0.8240449897772566,1.0,1/17,0.75%,COX4I2
prerank,DNA biosynthetic process (GO:0071897),-0.42734300915904777,-1.0810657684231828,0.3919694072657744,0.7205837084510013,1.0,8/16,29.53%,POLH;PPIA;RFC3;TYMS;POLA1;CDKN2D;POLD1;WRN
prerank,regulation of striated muscle contraction (GO:0006942),0.4512776944738351,1.0805952477433152,0.369140625,0.824313979036904,1.0,4/27,7.63%,DMD;ATP1A2;RYR2;MYL3
prerank,protein localization to cilium (GO:0061512),-0.3717831351111841,-1.0802567612137493,0.3448979591836735,0.7218963393076827,1.0,12/32,26.67%,ZNF423;EHD1;ARL3;TULP3;TTC21B;SNX10;RAB29;WDR35;TULP1;TMEM107;BBS9;IFT122
prerank,nuclear membrane organization (GO:0071763),0.46499441305659783,1.0797861693105273,0.35685483870967744,0.8251046156457976,1.0,6/19,16.80%,GPER1;TOR1B;UBXN2B;EMD;DCTN1;TOR1A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2530651207805666,-1.0797157076085453,0.2052401746724891,0.722574693377135,1.0,90/327,20.87%,BNC2;ZMIZ1;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;NFIA;NR3C1;KAT6B;ESR1;SUFU;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;PFDN5;BHLHE40;SIX1;ACVRL1;ATXN1;IRF2;FOXC1;CHD3;HINFP;NR2C2;STAT3;ZNF219;ERC1;POLR2A;TRRAP;VSX1;GON4L;RREB1;REXO4;HIF1A;CRABP2;FZD7;SLC39A8;TULP3;CARM1;ESRRG;PML;BRCA2;NFYC;PATZ1;HINT1;NSD1;SRSF10;AHR;RELA;GLRX2;CALR;SOX17;CLOCK;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;ASCC1;NFYB;ACTR8;NFIL3;RHOH;SOX12;CEBPB;PPARGC1A;PLAG1;NFXL1;ATF7;HMGN5;SBNO1;EZH2;NFATC2;E2F1;TEAD2;YAF2;HP1BP3;THAP1;LMX1B;NAB2;NONO
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.3000624900821542,-1.07970667934593,0.3194029850746269,0.7218539429922228,1.0,29/90,19.55%,LEPR;ADIPOR2;CAV1;IGF1R;GJA1;APPL2;PRDM16;CPT2;GNAS;CMKLR1;IL18;ESRRG;EHMT1;ACADL;UCP2;KDM3A;PRKAB1;KDM6B;PDGFC;CNOT3;MFAP2;FABP5;ADRB2;CEBPB;GADD45G;PPARGC1A;DYNC1H1;ADIPOR1;SYK
prerank,synaptonemal complex organization (GO:0070193),0.4824011909855165,1.0796883490581566,0.3804573804573805,0.8232243467665966,1.0,5/15,17.32%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.4824011909855165,1.0796883490581566,0.3804573804573805,0.8232243467665966,1.0,5/15,17.32%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38789040540802355,-1.079636223532606,0.35320088300220753,0.721293392489348,1.0,9/27,18.89%,ABCA1;PRKCH;CSF1;IL18;ITGB3;PPARA;NFKBIA;AGTR1;AGT
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4591607057356005,1.0795794574769029,0.40081799591002043,0.8224386693830182,1.0,7/21,13.46%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,regulation of protein secretion (GO:0050708),0.3422299383459249,1.0791767368959504,0.3442879499217527,0.8223532006825356,1.0,21/119,11.57%,CACNA1C;SLC12A2;RAPGEF4;PER2;ITPR2;IL1B;GIPR;RHBDF1;ITPR1;SNAP25;FRMD4A;TFAP2B;RAP1A;CACNA1D;ACHE;GCK;CACNA1A;MYOM1;ERP29;STXBP5L;KCNG2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.38285447794894123,1.0790387523065836,0.3674496644295302,0.8216137836141528,1.0,15/59,12.89%,PTEN;MECP2;MED10;MED13;RUNX2;AGO3;CDKN1A;CCNC;MITF;MED1;TNRC6C;MED20;BCLAF1;TNRC6B;THRA
prerank,positive regulation of actin nucleation (GO:0051127),0.5082533207488724,1.0789551546963705,0.37849462365591396,0.8207696225295955,1.0,4/11,10.24%,WASF3;ABI2;WASF2;NCKAP1
prerank,antibacterial humoral response (GO:0019731),0.4785478756522623,1.0786145656153372,0.3515151515151515,0.8204906154289175,1.0,8/16,22.66%,WFDC3;CAMP;RNASE6;DMBT1;SLPI;JCHAIN;ANG;RNASE7
prerank,cellular protein catabolic process (GO:0044257),-0.33430793882236165,-1.0783900134236395,0.36185819070904646,0.7237615135038299,1.0,19/59,13.79%,ADAMTS12;CTSH;CAPN2;CTSC;DENND3;AP2A2;CLTA;CTSB;IDE;DAB2IP;CASP8;BNIP3L;RAB7A;TCIRG1;CTSS;AP2A1;MDM2;BNIP3;UBE2G2
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3210069092411902,-1.07807494959024,0.3182957393483709,0.7238750561614216,1.0,16/66,12.89%,SMAD3;CDH1;LIMK2;PARP9;YAP1;TFRC;PRKCD;AKT1;DTX3L;BAG3;PINX1;CARD10;ZC3H12A;MAVS;TGFB1;RAN
prerank,regulation of phosphorylation (GO:0042325),0.3462115980609515,1.0778959261435754,0.321483771251932,0.8210472814641144,1.0,25/120,12.14%,DYNLL1;GLMN;PTK2;ROCK1;FNIP2;CADM4;GRM5;NUP43;OGT;SLC2A6;TESK1;IL4;ANKLE2;EMP2;CDKN1A;NUP35;GCK;LYN;PRKRIP1;MCM7;SEC13;NDC1;EIF6;EP300;BTBD10
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3628422423066184,-1.0778855077206622,0.344017094017094,0.723611130857199,1.0,11/34,11.72%,SMAD3;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;TRIO;ANKRD26;FLCN;GATA2;TGFB1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4170928349651007,1.0778282574732918,0.3913857677902622,0.8201663595912766,1.0,8/36,8.28%,MEF2C;NOTCH1;RGCC;MECP2;SVBP;FGF2;STC1;NR2F2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4120528997441599,1.0772535199163473,0.3774597495527728,0.82044215282064,1.0,14/44,16.11%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;PSAT1;SQLE;DHCR7;TM7SF2;HMGCR;OSBPL7;HSD3B7;ACOX2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4279419855324431,1.0770815130619995,0.35661764705882354,0.8197806211201879,1.0,8/32,11.32%,TRPC1;GPER1;AKAP6;CXCL10;NPSR1;SNCA;PKD2;CASQ1
prerank,negative regulation of viral life cycle (GO:1903901),-0.44896466726227036,-1.0768875654122834,0.37425742574257426,0.7253946468246476,1.0,9/15,30.10%,GSN;LY6E;IFITM3;PPIA;IFITM2;SNX3;TRIM11;CIITA;BST2
prerank,positive regulation of growth (GO:0045927),-0.31319951261986767,-1.076298075660798,0.3427230046948357,0.7262247750302221,1.0,15/64,15.55%,PLCB1;EGFR;USP47;TGFBR1;ADAM10;SDCBP;INO80;H3-3A;AKT1;MMP14;MFSD2A;DDX49;SPHK1;SFRP1;CXCL16
prerank,negative regulation of defense response (GO:0031348),-0.3083885740412401,-1.0759720966534347,0.3190348525469169,0.7262941890256305,1.0,17/77,12.53%,CDH5;PTGIS;TEK;APOE;KLF4;CCN3;LPCAT3;ENPP3;MFHAS1;PRKCD;C1QTNF3;PCBP2;TNFRSF1A;METRNL;IRAK3;VPS35;PPARA
prerank,regulation of cilium movement (GO:0003352),-0.49358287960318264,-1.0759357708364696,0.38333333333333336,0.7256406152095295,1.0,6/10,38.85%,CFAP43;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,regulation of microtubule nucleation (GO:0010968),0.5092531945679544,1.0756695150338997,0.3877995642701525,0.8220396740869403,1.0,5/10,14.11%,MECP2;ARHGEF7;RANGRF;PAK1;DCTN1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.34096879533251473,-1.0755748383488617,0.3642241379310345,0.725898710476579,1.0,7/46,7.63%,PLCB1;ANXA2;RAP1B;PITPNA;PDCD4;P4HB;TALDO1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5154717336087294,1.0754607953354025,0.3903966597077244,0.8215014674773179,1.0,3/11,5.88%,COLEC12;RFTN1;TNIP2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.4128753926394646,-1.0753871764314968,0.36853002070393376,0.7256343374587351,1.0,5/18,21.23%,FBN1;TCTA;GPR137;TLR4;FSTL3
prerank,protein localization to membrane (GO:0072657),0.32405941512571107,1.0753530245091916,0.3248587570621469,0.8207108460539353,1.0,33/187,11.23%,LIN7A;ITGA4;CACNB2;RAPGEF2;FERMT2;ROCK1;RFTN1;PTN;RAB8B;TSPAN15;NRXN1;SPTBN1;AGRN;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;NKD2;RAB38;EHD3;ZDHHC2;EPHA2;ARL5C;TSPAN17;DLG2;BRAF;NPC1;NDC1
prerank,regulation of MAP kinase activity (GO:0043405),0.3476302616811628,1.0745610203236855,0.3317307692307692,0.8214821516600099,1.0,12/92,5.90%,PDGFRB;IL34;SPRY4;NF1;IL1B;SH2B3;PDCD10;FGF2;SPRY2;TRIB2;CD300A;UCHL1
prerank,negative regulation of protein binding (GO:0032091),0.3731973803263297,1.074181912162429,0.3673139158576052,0.8213711656208087,1.0,11/71,9.80%,ITGA4;ATP2A3;MAP2;ROCK1;GNL3L;ATP2A2;TTBK1;CDKN1A;NES;PDGFB;CSNK1E
prerank,regulation of fibroblast proliferation (GO:0048145),-0.33676052796935746,-1.0740787261184852,0.33874709976798145,0.7284067632918778,1.0,15/45,20.00%,IGF1;FN1;PDGFRA;SKI;GAS6;WNT5A;S100A6;DAB2IP;SPHK1;NDUFS4;SFRP1;PDGFC;FTH1;AGT;E2F1
prerank,positive regulation of viral transcription (GO:0050434),-0.3915487060030734,-1.0740255292823107,0.36344969199178645,0.7278162503353085,1.0,10/25,29.68%,MDFIC;POLR2A;POLR2F;CDK9;POLR2E;RSF1;NELFCD;POLR2G;CTDP1;SUPT4H1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.4323744581601666,-1.0737707597169155,0.39272030651340994,0.7277881915533967,1.0,5/16,9.95%,DPYSL3;DPYD;UPB1;UPP2;NT5E
prerank,positive regulation of protein import (GO:1904591),-0.3724221530885662,-1.0734326157326763,0.3617886178861789,0.727970163778384,1.0,10/30,17.88%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN;TPR;PDCD5
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.31608537969372047,1.073334146098283,0.32677165354330706,0.8222817823152762,1.0,25/259,7.06%,DYNLL1;CARMIL1;RAPGEF2;AIF1L;NOTCH1;ARHGEF6;MYLK;VCL;DZIP1L;IFT43;RILPL2;SPEF1;RAB8B;TTLL3;CYS1;MINK1;TTC36;IFT81;CCDC57;IFT20;ITGB1;NEK1;SCLT1;EMP2;RAP1A
prerank,iron ion transport (GO:0006826),-0.340664307226268,-1.0727688072015287,0.3348314606741573,0.7289465941231595,1.0,14/47,18.08%,STEAP3;CP;SCARA5;ATP6V0A4;SLC39A14;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;HFE;ATP6V0A2;FTH1;REP15
prerank,brain development (GO:0007420),0.3364467693154187,1.0727505851621177,0.34054834054834054,0.8226046840332423,1.0,26/136,12.16%,PTEN;ADGRL3;PCDH18;CDH2;RAPGEF2;ZFHX3;NF1;COL4A1;HESX1;TMX2;UGP2;JHY;CNTNAP2;ROGDI;CNTN4;ROBO2;PPT1;NCOA6;NES;UFM1;GRIN2B;CTNNA2;DDIT4;SOX6;UBE3A;VPS51
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.30623189873699963,-1.072675153409751,0.3139240506329114,0.7284598666700811,1.0,13/80,8.79%,DAPK1;EPHA7;UACA;SH3RF1;THBS1;USP47;KLF4;NOD1;GAS6;TNFSF10;MAP2K5;FNIP1;AKT1
prerank,AMP metabolic process (GO:0046033),-0.4469493315819407,-1.0722656222056695,0.39805825242718446,0.7287786588395974,1.0,5/13,20.61%,AMPD3;XDH;NT5E;NT5C1A;ADSS1
prerank,inner ear morphogenesis (GO:0042472),-0.39650004573574926,-1.072199371689426,0.3712574850299401,0.7282196062199067,1.0,6/22,12.69%,CHD7;FGFR2;SIX1;TBX1;TTC39C;EPHB2
prerank,photoreceptor cell development (GO:0042461),0.48804188185153846,1.0721248424409457,0.3921971252566735,0.8230015417296681,1.0,1/14,0.82%,RORB
prerank,positive regulation of response to external stimulus (GO:0032103),-0.28124743650404166,-1.0720606439195057,0.2869822485207101,0.7278457524925837,1.0,33/128,18.89%,BMP6;APP;IL15;SASH1;THBS1;THBD;PDCD4;DDX60;IL16;WNT5A;CD47;STX3;USP15;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;GBP5;TGFB1;PUM1;USF1;CYBA;CD180;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGTR1;AGT
prerank,postsynaptic membrane organization (GO:0001941),0.47058356672005064,1.0711188994652432,0.3822314049586777,0.8243491609568223,1.0,2/17,3.21%,CEL;NRXN1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3849972244028033,1.0709382999806574,0.3475177304964539,0.8237088111929345,1.0,8/54,4.13%,MEF2C;RGCC;NF1;AKT3;SH3BP1;ETS1;MECP2;FGF2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3698239735594877,-1.0708113123298921,0.36673773987206826,0.7302986360011783,1.0,12/29,21.28%,WWOX;CAV1;THBS1;TNFSF10;PPP2R1B;PML;RET;SFRP1;BID;RIPK1;AGT;DEDD2
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.36704011533863046,-1.0705574587946034,0.35714285714285715,0.7302401306125609,1.0,11/32,15.05%,IGF1;APP;NUPR1;TMSB4X;HIF1A;P2RX7;PPARA;ENTPD5;ENO1;PRKAA2;BEND3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4368702192577347,1.0702762232008125,0.3638132295719844,0.8242306591885037,1.0,4/27,9.62%,PLA2R1;SPRED1;ATR;SNAI2
prerank,response to chemokine (GO:1990868),0.4849220969804719,1.070211331365172,0.3818565400843882,0.8233433382377807,1.0,3/13,3.73%,SLC12A2;SH2B3;STK39
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.49106181810377947,-1.0699445797192533,0.3894927536231884,0.7311499908638457,1.0,5/10,27.45%,CSGALNACT1;DSEL;PXYLP1;XYLT1;B3GAT3
prerank,regulation of protein ubiquitination (GO:0031396),-0.29066240188494397,-1.0687338737765644,0.3261538461538461,0.7335921686606964,1.0,41/108,28.02%,NXN;HDAC8;CAV1;SASH1;TGFBR1;ANGPT1;SMAD7;LRRK2;ARRB1;FKBP1A;SH3RF2;BIRC3;AKT1;PINX1;IVNS1ABP;PRKCG;DNAJB2;PHF23;FANCI;UBB;SPHK1;HSP90AB1;WASHC1;SIRT7;PARK7;CHP1;VPS28;CDK5RAP3;UBXN1;FAM107A;BAG2;BRCA1;PRKN;PSMD10;CENPX;RPS3;BAG5;BCL10;PRR7;HSPA1B;PTTG1IP
prerank,protein homotetramerization (GO:0051289),-0.3255460259462942,-1.0685131376029282,0.3340961098398169,0.7334563775275832,1.0,10/49,11.31%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;SAMHD1;ACACA;GBP5
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2712367433987489,-1.0684940040967923,0.2986577181208054,0.732777575569449,1.0,62/171,27.46%,SMAD3;IQGAP1;PTPN3;APP;GAS1;SDCBP;CDC16;FOXC1;MAEA;OBSL1;BTG3;ANAPC4;PSME2;TGFB1;SMOC2;MDM2;PSMB4;TRIM35;SPHK1;PIM3;TAL1;CAV2;PSMD8;PSMB1;MEIS2;PSMD11;DDB1;CDK9;EIF4EBP1;PSME3;CDKN1B;CCDC8;RNF40;ANAPC16;PSMA2;PSMD4;PIM2;FZR1;PSMD3;USP22;THAP1;PSMB7;CDK5RAP3;CDC27;ANAPC5;CDKN1C;CUL9;USP2;PSMC2;ERCC2;PSMD10;PSMC5;ERCC3;SCRIB;CDK11B;TMEM8B;L3MBTL1;ANGEL2;NEK7;SRA1;MKI67;PSMD7
prerank,innate immune response in mucosa (GO:0002227),0.519010544673897,1.068259568517662,0.3797979797979798,0.8269261058293143,1.0,2/10,6.10%,CAMP;IL4
prerank,regulation of sodium ion transport (GO:0002028),-0.3591527223342099,-1.0682553283222265,0.3653444676409186,0.7326327794425035,1.0,15/34,20.69%,SNTA1;DLG1;WNK4;WNK1;GPD1L;P2RX4;AHCYL1;SLMAP;P2RX7;ATP1A1;CNKSR3;NOS1;YWHAH;NKAIN4;SCN3B
prerank,monocyte differentiation (GO:0030224),-0.4932315315395037,-1.0678874554736093,0.4124293785310734,0.7329408500561537,1.0,3/10,3.99%,IL31RA;BMP4;PIR
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.48341809181233164,1.0674015294419106,0.40756302521008403,0.8278163816683758,1.0,3/14,4.63%,ZEB1;SPRED1;SPRY2
prerank,cellular response to organonitrogen compound (GO:0071417),0.35602078665533377,1.0664046345194522,0.3609375,0.8291004688185565,1.0,14/99,8.88%,MEF2C;SPAAR;PDE3A;RAPGEF2;CPEB1;AKAP6;HTR1B;GABRG2;HCN2;RAP1A;MTOR;PKD2;RYR3;HCN3
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.47661200993215336,-1.0661382599585867,0.38461538461538464,0.7366627443672322,1.0,2/11,1.01%,AFDN;TJP2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.44400959690934183,-1.0660555434926078,0.4069097888675624,0.7361422088633816,1.0,4/12,16.16%,ESR1;ZC3H12A;TGFB1;ELAVL1
prerank,cellular response to interleukin-4 (GO:0071353),-0.474824180168163,-1.0659531850029975,0.4066543438077634,0.7356707375779298,1.0,4/10,25.46%,LEF1;SHPK;XBP1;TCF7
prerank,inflammatory response (GO:0006954),0.3177778537601643,1.0658134573270546,0.3490566037735849,0.8294179786859137,1.0,22/195,10.81%,GGT5;PIK3CD;TBXA2R;AFAP1L2;ADORA2A;IL1B;CD96;CCRL2;IL2RA;CXCL5;ADCY8;TACR1;CXCL10;CXCR2;IL4;KLRG1;RIPK2;IL22;NFATC4;ADGRE5;LOXL3;BLNK
prerank,neutrophil activation (GO:0042119),-0.4634707716940091,-1.0657697992475206,0.3973634651600753,0.735431171391156,1.0,4/12,20.99%,IL15;PRKCD;SYK;TYROBP
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4970340763228307,1.0657173070866395,0.37748344370860926,0.8286014555489738,1.0,1/12,0.21%,CSPG4
prerank,positive regulation of stem cell proliferation (GO:2000648),0.45624575378785465,1.0651158928874143,0.3727810650887574,0.8289562689480133,1.0,5/17,16.26%,FERMT2;N4BP2L2;KAT7;HNRNPU;CCNE1
prerank,response to glucocorticoid (GO:0051384),-0.38063543046906523,-1.0650722305552307,0.3847695390781563,0.7364895544929607,1.0,5/26,9.57%,NR3C1;SLIT2;ADAM9;ANXA1;BCL2L11
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.28735225277338305,-1.064902997084247,0.32285714285714284,0.7361828371009056,1.0,39/110,28.52%,TRABD2B;ABCA1;CDH5;GSN;APOE;IAPP;PRKCZ;FNIP1;HSPA5;TFRC;IRGM;BCL2L11;GFAP;DAB2IP;TGFB1;SH3GLB1;TAL1;NAPA;BID;SAR1A;PARK7;SAR1B;VCP;SYK;RHOC;HJURP;LCMT1;VEGFA;PIH1D1;ICE1;HCK;RACK1;RPS3;BIK;SLF1;PREB;MPP7;AIDA;CLU
prerank,atrial septum morphogenesis (GO:0060413),0.5072727638371268,1.0647723601672179,0.38589211618257263,0.8287719476120611,1.0,2/10,1.24%,HEY2;TBX20
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4826247672717518,-1.064742968410861,0.4173076923076923,0.7358422428273532,1.0,5/10,19.04%,DNMT3A;PCGF5;IGF2;PCGF3;ZFP57
prerank,positive regulation of cell cycle process (GO:0090068),0.3577814182014501,1.064705524785903,0.35748031496062993,0.8279031635212408,1.0,12/91,10.38%,PDGFRB;MAP3K20;RGCC;IL1B;CUL3;OPN1MW;CSPP1;PCID2;CDC14B;PDGFB;UBXN2B;NUSAP1
prerank,central nervous system development (GO:0007417),0.3117064732897779,1.0646577886942963,0.3478835978835979,0.8269936907348885,1.0,44/250,11.30%,SERPINI1;PTEN;ADGRL3;PCDH18;CDH2;ADORA2A;TBX3;ZFHX3;NF1;COL4A1;HESX1;TMX2;UGP2;TBX6;GRIK1;JHY;CNTNAP2;DNER;ACAN;ROGDI;MOG;CNTN4;ASIC2;TPPP;SOX4;ANKLE2;LIG4;ROBO2;CNTN6;PPT1;NCOA6;NES;PKD2;ADAM23;UFM1;MARCKS;GRIN2B;NCKAP1;DDIT4;LOXL3;SPOCK1;SOX6;AHI1;IL1RAPL2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2502709687289773,-1.0643267840054034,0.25888324873096447,0.7361102326049457,1.0,98/366,20.87%,BNC2;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;FOXO3;APP;NFIA;NR3C1;KAT6B;ESR1;SUFU;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;PFDN5;BHLHE40;SIX1;ACVRL1;TOM1L1;ATXN1;IRF2;FOXC1;CHD3;HINFP;NR2C2;STAT3;ZNF219;ERC1;POLR2A;TRRAP;VSX1;GON4L;RREB1;REXO4;HIF1A;CRABP2;FZD7;SLC39A8;TULP3;CARM1;ESRRG;PML;ATXN2;BRCA2;NFYC;PATZ1;HINT1;NSD1;SRSF10;AHR;TCOF1;RELA;GLRX2;CALR;SOX17;CLOCK;RPL10;ZBTB4;GEMIN5;HOXB7;SOX7;SOX18;SMC3;HCFC2;ASCC1;NFYB;ACTR8;NFIL3;RHOH;SOX12;CEBPB;PPARGC1A;PLAG1;NFXL1;ATF7;HMGN5;SBNO1;EZH2;RABL3;NFATC2;E2F1;TEAD2;YAF2;HP1BP3;THAP1;LMX1B;NAB2;NONO
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34819050303232674,1.0641928747317866,0.35276073619631904,0.82706250037497,1.0,8/112,2.11%,PTPRK;SOX5;LIMS1;MEF2C;PDE3A;GCNT2;PTK2;FERMT2
prerank,cardiac conduction system development (GO:0003161),-0.38573765097213264,-1.0636182280722326,0.37154989384288745,0.7371981646272966,1.0,4/24,3.35%,NOTCH2;GJB6;BMP4;GJA1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4169494722767711,1.0633779036636026,0.38721804511278196,0.8279132156088875,1.0,10/32,13.46%,MAP2;SPEF1;FGF13;NAV3;CLASP2;SNCA;CAMSAP3;APC;TUBB4A;APC2
prerank,establishment of vesicle localization (GO:0051650),-0.40635032737067617,-1.0631212072561693,0.391713747645951,0.7377216037977621,1.0,4/18,5.41%,RAB11A;LIMK2;RAB27A;CCDC186
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.42978669366859623,-1.0627154391279914,0.3772455089820359,0.738053422554255,1.0,4/15,5.77%,ITGA5;KLF4;FGF1;BMPER
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.32577345412971487,-1.062513172564936,0.3567961165048544,0.7378698505456371,1.0,12/56,11.13%,PLCB1;EGFR;RAB11A;ANXA1;ADAMTS1;CCND2;CDC16;CCND3;UBE2E2;AKT1;RAD51B;ANAPC4
prerank,cholesterol transport (GO:0030301),0.3936285251065851,1.0624899190764407,0.39419795221843,0.828847180417128,1.0,7/45,6.99%,CEL;SCARB1;LDLRAP1;LDLR;MSR1;ABCA5;LIPC
prerank,mitotic cell cycle phase transition (GO:0044772),0.3212649479438346,1.0615945142762047,0.35501355013550134,0.8299405759621242,1.0,31/203,14.56%,DYNLL1;EPS8;CDK6;BTRC;FOXM1;CUL3;CRLF3;PPP2R2A;SPDYA;CCDC57;AJUBA;CLASP2;PRKAR2B;CDKN1A;NES;DYNC1I2;CSNK1E;CEP41;TACC3;BRSK1;LATS2;RB1;CDK14;TUBB4A;PPP1R12A;CCNH;EIF4E;DCTN1;ANAPC7;SKP1;DCTN3
prerank,cell chemotaxis (GO:0060326),0.3733355043136755,1.0612941328785042,0.3758278145695364,0.8296387645596721,1.0,10/60,9.71%,PDGFRB;SEMA5A;BCAR1;CCRL2;ACKR3;CXCR2;ACKR2;CCR9;PDGFB;EPHA2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.46300151188814553,-1.0612773680736634,0.39805825242718446,0.7403429268527264,1.0,3/12,5.41%,GSN;LY6E;IFITM3
prerank,embryonic eye morphogenesis (GO:0048048),-0.47234895956925665,-1.061212069400618,0.4042145593869732,0.7397652643847595,1.0,6/11,7.37%,FBN1;EFEMP1;MFAP5;LRP6;RARG;FBN2
prerank,dermatan sulfate metabolic process (GO:0030205),0.49333743572222816,1.0606756431431923,0.38530066815144765,0.8300047686385332,1.0,1/13,0.21%,CSPG4
prerank,regulation of lamellipodium assembly (GO:0010591),0.4139639407475118,1.0606734310945005,0.3956043956043956,0.8289970666029335,1.0,9/34,11.84%,PLCE1;PIK3R1;WAS;PIK3CA;ABI2;WASF2;EPHA2;NCKAP1;PLXNB3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3607165370874736,-1.0604560374704017,0.3991228070175439,0.7409656733212321,1.0,12/29,24.18%,CNOT7;STAT2;WNT5A;USP18;NLRC5;SAMHD1;MAVS;HSP90AB1;RNASEL;PTPN2;PTPN6;TRIM6
prerank,serine family amino acid metabolic process (GO:0009069),0.4694532953696711,1.0601707453656628,0.3728448275862069,0.8291009102167958,1.0,6/16,12.85%,CTH;BAAT;SEPHS2;GLYAT;SRR;DAO
prerank,positive regulation of cell cycle (GO:0045787),-0.31391143758204426,-1.0601619876095438,0.3287671232876712,0.7409949644308966,1.0,19/62,16.09%,EGFR;APP;NUPR1;FGFR2;LRP6;CCND2;CCND3;AKT1;RPS15A;SMOC2;MDM2;CALR;SPHK1;CCND1;TAL1;PKD1;MEIS2;EIF4EBP1;CDKN1B
prerank,positive regulation of cell adhesion (GO:0045785),-0.3061409777581307,-1.060027462436644,0.32439678284182305,0.7405890996247642,1.0,20/74,14.19%,AFDN;EPHA4;VIT;TGM2;PTPRJ;FOXC2;SMAD7;ADAM9;CXCL12;NDNF;P4HB;CD47;STX3;FBLN2;FLCN;CHRD;ATM;MEGF10;RET;FRMD5
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.37056536231300846,-1.0599272236944441,0.37639198218262804,0.740121307532816,1.0,11/30,19.35%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4652465145942446,-1.0599022994543257,0.3956442831215971,0.7394488546135919,1.0,6/11,30.35%,FOLH1;LCMT1;ATG12;ATG7;ICMT;AGBL1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4372889477637293,-1.0598411064608744,0.3849129593810445,0.7388677787767856,1.0,5/15,20.99%,ADAM9;MAPK14;EHD1;EHD2;TYROBP
prerank,histone acetylation (GO:0016573),-0.31336503008612027,-1.059721560498247,0.3654320987654321,0.7384864342583479,1.0,28/69,28.19%,KAT6B;KAT2B;LEF1;KAT14;TRRAP;TADA1;TRIM16;MEAF6;TADA2A;BRCA2;BEND3;YEATS2;NAA40;BRPF3;CHD5;MORF4L2;TAF5;HAT1;JADE1;BRD1;BRPF1;SGF29;BRD8;EPC1;ING4;ATF2;TAF6L;JADE3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3361211969106692,-1.059625206352727,0.3469387755102041,0.7380082808236147,1.0,13/47,18.11%,ROCK2;WNT4;PTGIS;CAV1;CD34;C1QTNF3;ZC3H12A;ACADL;PGP;CEACAM1;SNAI1;SIRPA;ERLIN2
prerank,positive regulation of vasculogenesis (GO:2001214),0.5105204797763359,1.0593802912690728,0.4012875536480687,0.8299191063761602,1.0,3/10,7.06%,RAPGEF2;RIN2;RAP1A
prerank,ether lipid biosynthetic process (GO:0008611),-0.48271241724324887,-1.059370910485288,0.41682242990654206,0.737953753123798,1.0,1/10,1.13%,PLA2G4A
prerank,sterol metabolic process (GO:0016125),-0.31192974600566054,-1.0592062342683246,0.3557692307692308,0.737660843230397,1.0,11/60,12.05%,PRKAG2;ABCA1;APOE;CYP26B1;LBR;LIPA;CYP27A1;CYP1B1;OSBPL1A;INSIG2;STARD3
prerank,connective tissue development (GO:0061448),-0.35490803980556274,-1.059029776054411,0.3458333333333333,0.7374537524356789,1.0,7/35,7.19%,SULF1;ZBTB16;ITGB8;CREB3L2;SULF2;SLC39A13;NAMPT
prerank,myofibril assembly (GO:0030239),0.39652159711500606,1.0587727778286502,0.37410071942446044,0.8303177041616396,1.0,3/42,5.47%,PDGFRB;TMOD1;TMOD3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3276543318659483,-1.05869203088249,0.36319612590799033,0.7376663366123127,1.0,10/48,10.91%,ROBO1;SLIT2;GAS6;CNOT7;STAT2;PARP14;USP18;NLRC5;SAMHD1;IRAK3
prerank,sterol transport (GO:0015918),0.45686438979448946,1.0583915804576776,0.4042145593869732,0.8302104745611382,1.0,4/19,5.38%,LDLRAP1;ARV1;LDLR;MSR1
prerank,skeletal muscle organ development (GO:0060538),-0.37310646525217994,-1.058341831422218,0.385395537525355,0.7379265015213315,1.0,9/26,11.93%,LARGE1;CAV1;CFLAR;MYL6;SIX1;STRA6;ZBTB18;DISP1;SVIL
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3778226958060231,-1.0581686500536196,0.3817427385892116,0.7376336681364033,1.0,14/27,38.14%,MAP3K1;IRAK2;IRAK3;UBB;TLR4;MYD88;MAP3K7;TLR6;CD36;TLR1;TAB2;TLR5;LY96;CD14
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5025414046461159,1.0579595930943284,0.3979381443298969,0.8301576086604592,1.0,2/11,8.32%,CARD9;IL12RB1
prerank,stress fiber assembly (GO:0043149),-0.428252914840033,-1.0573210803672783,0.39173228346456695,0.7383602797763246,1.0,6/15,7.79%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),-0.428252914840033,-1.0573210803672783,0.39173228346456695,0.7383602797763246,1.0,6/15,7.79%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,negative regulation of response to wounding (GO:1903035),0.4549599026501121,1.057221404834977,0.3948412698412698,0.8308473615493227,1.0,3/19,4.13%,AJAP1;RTN4RL1;FGF2
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2976895727178773,-1.0568843740392913,0.34271099744245526,0.7387502356587762,1.0,27/84,19.62%,VGLL4;FOXO1;APOE;EZR;SMURF2;SNX9;NKD1;ADAM9;WWP2;SMURF1;TNFRSF1B;WNT5A;EGLN2;PLK2;IDE;DAB2IP;VPS35;ASB5;RAB7A;WWP1;DDB1;CDKN1B;OAZ1;FZR1;VCP;SH3D19;VPS28
prerank,muscle cell development (GO:0055001),0.42454653127194175,1.0568754894689891,0.37109375,0.8306222188153379,1.0,4/30,2.06%,DMD;HEY2;DYSF;MYH11
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4515991731515244,-1.0568751388458102,0.4015151515151515,0.7380637010240169,1.0,3/12,5.91%,APOE;IAPP;PFDN5
prerank,negative regulation of ossification (GO:0030279),0.441449070031372,1.0567746263253597,0.40081799591002043,0.8298445203855311,1.0,2/23,1.19%,MEF2C;NOTCH1
prerank,negative regulation of response to external stimulus (GO:0032102),0.34219942516576923,1.0565811350299295,0.37325038880248834,0.829275454282438,1.0,12/105,7.25%,PTEN;RORA;AJAP1;RTN4RL1;GPER1;NR1H3;LRFN5;FGF2;PPARD;IL4;CACTIN;AOAH
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3091187246275766,-1.0562422237803197,0.3567961165048544,0.7389683044267286,1.0,21/65,24.73%,FBXL7;FHL1;USP47;ZFYVE19;CHFR;PINX1;NABP1;PSME2;PSMB4;PSMD8;PSMB1;PSMD11;PSME3;PSMA2;PSMD4;PSMD3;PSMB7;CDK5RAP3;PSMC2;PSMD10;PSMC5
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.4768263820936622,-1.0562210077363186,0.4058252427184466,0.7383153889549164,1.0,5/10,26.03%,SETD7;KMT5A;EHMT1;SETD6;SETD4
prerank,plasma membrane invagination (GO:0099024),-0.37525602250470086,-1.0562152306372412,0.3888888888888889,0.7376161114062261,1.0,5/29,6.67%,GULP1;GSN;ELMO1;SNX9;RHOA
prerank,regulation of cell cycle (GO:0051726),0.3049811351356807,1.0560389713940097,0.35714285714285715,0.829456354884026,1.0,39/271,12.21%,PTPRK;FAP;MAP3K20;APBB2;CDK6;NOTCH1;AFAP1L2;PER2;RGCC;GPER1;TBX3;SIPA1;FOXM1;CRLF3;RPS6KA2;BRINP1;NUPR2;SIK1;BIN1;HRAS;FGF10;CDKN1A;NEK6;PKD2;GRK5;RNF112;CDC14B;HTRA2;TTLL12;TAF6;CITED2;SETMAR;ASAH2;WDR12;RPRD1B;SND1;EP300;APC;RB1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4038901143650866,1.0559910195413644,0.36973180076628354,0.8285700627641123,1.0,6/39,6.10%,ITGA4;SEMA5A;RGCC;GPER1;TNIP2;IL4
prerank,regulation of phagocytosis (GO:0050764),0.3783498122767548,1.0556784895658045,0.35650623885918004,0.8283189616107011,1.0,5/53,2.65%,IL15RA;DYSF;SCARB1;MERTK;IL1B
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4213913386757548,-1.055414499697809,0.383587786259542,0.7389445647346999,1.0,4/16,8.24%,AUTS2;ARHGAP17;ALS2;PIK3CB
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.405976238676744,-1.0552620012570162,0.3995859213250518,0.7386414081020599,1.0,5/20,9.92%,CD55;IL1R1;B2M;PRKCZ;IL18
prerank,cellular response to acid chemical (GO:0071229),0.42111211159116524,1.0544505790678413,0.3915547024952015,0.8301775713733724,1.0,2/27,1.53%,SPAAR;CPEB1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4029330316487245,-1.0539726815441368,0.3762993762993763,0.741257072792974,1.0,3/18,2.92%,EGFR;LCOR;ESR1
prerank,regulation of microtubule-based movement (GO:0060632),0.49138979085086937,1.0538691542510694,0.3905191873589165,0.8305566931954758,1.0,1/11,1.49%,MAP2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.44824520605507795,1.053863975468989,0.4025423728813559,0.8295685500166358,1.0,5/20,12.36%,BMP5;GPER1;SIK1;PRMT3;ERLIN1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4398201114282729,-1.0529852166841076,0.4057971014492754,0.7430515119186435,1.0,5/13,14.33%,APP;SHANK3;ADCY1;EPHB2;SHISA7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4356815027782325,1.052931898888027,0.39029126213592236,0.8307526602820425,1.0,6/25,13.40%,AFAP1L2;GPER1;CNOT9;HIP1;DGKD;BCAR3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.44033584510646473,-1.052687045844751,0.42105263157894735,0.7431265934088362,1.0,4/13,10.16%,NRP1;TGFBR2;SEMA3E;KDR
prerank,catecholamine biosynthetic process (GO:0042423),-0.46140136726175324,-1.0526451852578147,0.40185185185185185,0.7425203469661948,1.0,3/11,17.48%,MOXD1;GCH1;DDC
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.38021268683339243,-1.0523942318273842,0.39,0.7424678587697225,1.0,5/24,3.51%,NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.43284850124183005,1.0520558197619896,0.3950850661625709,0.8317184941199862,1.0,1/23,0.58%,MBOAT2
prerank,cellular response to estrogen stimulus (GO:0071391),-0.43745935386903795,-1.0519376102559388,0.4074074074074074,0.7429986836600533,1.0,8/14,28.86%,TRIM24;AR;SFR1;SFRP1;RARA;NCOA4;SRA1;SERPINB9
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4632821284764862,1.0519227028923048,0.39235412474849096,0.831055289876947,1.0,1/18,1.05%,PRDM1
prerank,aortic valve development (GO:0003176),0.4188430351753325,1.051365449052246,0.39888682745825604,0.831344922344628,1.0,6/34,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,activation of protein kinase A activity (GO:0034199),0.4570098005007241,1.0513141093821992,0.39959839357429716,0.8304711832060504,1.0,8/16,10.38%,PRKAR1B;ADCY3;ADCY8;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,pentose-phosphate shunt (GO:0006098),-0.4608937199303847,-1.0512139786740482,0.4174573055028463,0.7441057803138234,1.0,6/11,22.43%,TALDO1;DERA;PGD;RPIA;PGLS;SHPK
prerank,pulmonary valve morphogenesis (GO:0003184),0.46350141193623506,1.0507564976883759,0.4179389312977099,0.8307724981348276,1.0,4/17,1.24%,HEY2;HEYL;NOTCH1;TBX20
prerank,growth hormone receptor signaling pathway (GO:0060396),0.47221389541974973,1.0505622212689103,0.42792792792792794,0.830233372320547,1.0,6/14,13.94%,PTK2;PIK3R1;LYN;PTPN1;PRLR;JAK2
prerank,cellular response to gamma radiation (GO:0071480),0.45911687558706765,1.0505542137625088,0.4049429657794677,0.8292655685465364,1.0,3/17,9.57%,MAP3K20;HRAS;ATR
prerank,regulation of interleukin-8 production (GO:0032677),-0.3083928573893581,-1.0502140616354538,0.3769230769230769,0.7459976064497732,1.0,20/69,19.55%,F3;ANXA4;LBP;KLF4;NOD1;ANXA1;ARRB1;LGALS9;MAP2K5;STAT3;TMSB4X;MAVS;RELA;SSC5D;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5;SYK
prerank,cellular lipid catabolic process (GO:0044242),0.4260239870192388,1.04969112631537,0.3761996161228407,0.8302822797907173,1.0,3/27,7.25%,CEL;PPARD;AOAH
prerank,positive regulation of MAP kinase activity (GO:0043406),0.35962761612080785,1.0494438792332057,0.38666666666666666,0.8298798207449848,1.0,5/66,4.13%,PDGFRB;IL34;MAP3K5;PDCD10;FGF2
prerank,receptor-mediated endocytosis (GO:0006898),0.34149744707470736,1.0492679144300863,0.38288288288288286,0.8292778139803063,1.0,22/132,10.64%,SGIP1;COLEC12;IGF2R;SCARB1;SCARF1;LDLRAP1;GRK3;LDLR;ACKR3;LRP1B;AP1G1;MSR1;ITGB1;CXCR2;SNCA;PPT1;PIKFYVE;AP2S1;TMEM108;AP2B1;RABEPK;VLDLR
prerank,negative regulation of signal transduction (GO:0009968),0.304065206995685,1.0484741543730953,0.3790849673202614,0.830131758657435,1.0,27/249,6.84%,NOTCH3;PTEN;PID1;BMP5;SPRY4;BTRC;TNS2;IL1B;CHAC1;TSPAN15;PIP4K2A;CADM4;FGF2;SOSTDC1;SPRY2;SLC27A4;SIAH2;MOSMO;SOCS5;GRB10;GPC3;PIP4K2C;SNCA;CACTIN;IRS1;KCTD6;APPL1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.314622101801474,1.0480425827459297,0.37276478679504815,0.8300835759476045,1.0,26/214,7.54%,PDGFRB;PTEN;SLC30A10;GCNT2;RAPGEF2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;SPRED1;ERBB4;IL1B;PTPN22;ACKR3;FGF2;SPRY2;CARD9;ROS1;NTRK2;HTR2C;CHRNA7;YWHAZ;RAP1A;HRAS;FGF10
prerank,membrane lipid catabolic process (GO:0046466),-0.4786039141885603,-1.0479937013196303,0.425891181988743,0.7509252440491857,1.0,6/10,25.12%,CYP1B1;FUCA1;NAGA;ENPP2;SGPL1;PDXDC1
prerank,regulation of potassium ion transport (GO:0043266),0.40611336409097665,1.0478297708405981,0.39332096474953615,0.8296043799662811,1.0,8/31,12.16%,CASQ2;DPP10;KCNAB3;ANK3;CACNA1D;KCNE5;KCNIP1;KCNIP4
prerank,zinc ion transport (GO:0006829),0.44906979943393716,1.0478287831185384,0.398422090729783,0.828631622290967,1.0,1/21,0.46%,SLC30A10
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3168161220317693,-1.0475091524433053,0.3598130841121495,0.7514802017094087,1.0,17/55,24.73%,FBXL7;FHL1;USP47;PINX1;PSME2;PSMB4;PSMD8;PSMB1;PSMD11;PSME3;PSMA2;PSMD4;PSMD3;PSMB7;PSMC2;PSMD10;PSMC5
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3588952031717916,-1.047499709115094,0.3717391304347826,0.7507994841274823,1.0,9/32,12.69%,DAPK1;ACTN2;APP;DLG1;SLC6A9;PTK2B;CAPN1;CAMK2A;EPHB2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3168862318021431,-1.0474894827239074,0.36,0.7500944344807087,1.0,8/56,3.01%,EPHA4;EPHA3;FLT1;EGFR;EFEMP1;PDGFRA;TEK;FGFR2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.40052095197922355,-1.0474575909591481,0.397979797979798,0.7494675442747535,1.0,9/19,25.30%,ZMIZ1;GAS6;MMP14;RHOH;PPP2R3C;SYK;MDK;XBP1;NCKAP1L
prerank,cellular protein localization (GO:0034613),0.30186564485725376,1.047390553987106,0.3634085213032581,0.828690275964001,1.0,42/285,11.38%,PTPRK;TBC1D1;DMD;HEY2;PIGU;JAM3;VCL;FERMT2;STX16;GRTP1;COG7;CNTNAP2;COX18;TBC1D30;GAS8;GGA3;ESAM;ARL4C;DNAJC27;TBC1D12;RIC1;EMP2;RUNDC1;FGF10;RAB28;TBC1D2B;MYO6;RAB38;TMED7;TBC1D10C;BICD2;TMED4;STXBP2;ARL5C;SEC13;WLS;ERP29;STX4;COPB2;AXIN2;AHI1;ARFRP1
prerank,response to organic cyclic compound (GO:0014070),0.3782344012222811,1.0470315799379115,0.40069686411149824,0.8285203651361885,1.0,4/52,4.42%,GGT5;GGT1;IL1B;DHFR
prerank,regulation of chromatin organization (GO:1902275),-0.43656257041163304,-1.046999359827789,0.42990654205607476,0.7499194522531298,1.0,3/14,4.96%,MLLT3;TLK1;IGF2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.36672665873874827,1.0467446325650207,0.37753510140405616,0.8282043277773096,1.0,7/73,6.83%,DLC1;ATP2A3;COL4A3;BCL2L10;SNCA;BCL2L13;CASP9
prerank,regulation of lipid storage (GO:0010883),-0.3969687668918319,-1.0467429864604523,0.39697542533081287,0.7498817269711078,1.0,7/22,23.23%,IKBKE;ZC3H12A;ITGB3;FTO;NFKBIA;PTPN2;LPL
prerank,icosanoid biosynthetic process (GO:0046456),-0.4765427324331667,-1.046643979735741,0.42193308550185876,0.7494174670486498,1.0,1/10,1.13%,PLA2G4A
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4090371265834914,-1.0462541646942851,0.4068825910931174,0.7496056131277296,1.0,5/19,17.42%,HSPA5;HK2;AKT1;PML;TAPT1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4974068635111373,1.046106352732138,0.429769392033543,0.8286845631880324,1.0,3/10,9.19%,RAPGEF2;AXL;LYN
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3407695985871811,-1.046036882281378,0.4026548672566372,0.749458923150877,1.0,7/41,7.21%,AFDN;PLPP3;BMP7;PODXL;SMAD7;PIEZO1;CD47
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4101459993572025,-1.0459127054595905,0.39272030651340994,0.7490345725469515,1.0,10/18,28.05%,VGLL4;EZR;ATRAID;DAB2IP;VPS35;RGP1;CDK5RAP3;RDX;PTTG1IP;DACT1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3232672174776215,-1.0457828465687822,0.38004750593824227,0.7486671958748295,1.0,5/53,3.78%,EYA2;EYA1;EGFR;EYA4;DDX5
prerank,negative regulation of response to stimulus (GO:0048585),0.36088750818189136,1.0452399719898586,0.3833922261484099,0.8296429450159077,1.0,6/60,5.07%,SLC30A10;CDK6;NR1H3;AKT3;SH2B3;SOCS5
prerank,reverse cholesterol transport (GO:0043691),-0.4352757559631827,-1.044990888305409,0.412573673870334,0.7500264039978284,1.0,2/13,2.03%,ABCA1;APOE
prerank,regulation of glycolytic process (GO:0006110),-0.30513663258303886,-1.0448687801460121,0.37433155080213903,0.7495984883411173,1.0,5/68,2.61%,PRKAG2;IGF1;HDAC4;APP;NUPR1
prerank,positive regulation of macrophage activation (GO:0043032),-0.4200602083712339,-1.0447446608188389,0.426,0.7492178806200913,1.0,5/17,10.36%,LBP;THBS1;WNT5A;IL33;KARS1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3171783945445407,1.044259829407824,0.3834048640915594,0.8308660827544341,1.0,27/166,9.32%,PDGFRB;PTH1R;PLD1;RGCC;NR1H3;SCARB1;ZEB2;IL1B;LDLR;ATP7A;FGF2;YTHDF3;FABP3;DDX3X;SNCA;SOX4;IRS1;KAT7;APPL1;NMD3;MTOR;ARNT;PRKD2;PKD2;GCK;EIF3C;PDGFB
prerank,peptidyl-proline modification (GO:0018208),-0.37572085292090823,-1.044214710676277,0.4132231404958678,0.7498959365772621,1.0,9/25,23.14%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA;FKBP7;PPIL1;FKBP10
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.38810247999452097,-1.0441710642104673,0.41140529531568226,0.7486083319313448,1.0,6/23,14.76%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.38810247999452097,-1.0441710642104673,0.41140529531568226,0.7486083319313448,1.0,6/23,14.76%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,gliogenesis (GO:0042063),0.4754930557856423,1.044015032310806,0.4089935760171306,0.8304675303595733,1.0,3/15,4.33%,CDH2;CDK6;METRN
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3401644110205232,-1.043881715446754,0.39414414414414417,0.7486259601150013,1.0,10/39,12.53%,BMP6;PODXL;KLF4;CDH1;FXYD5;WNK1;MAP2K5;AKT1;TGFB1;PPARA
prerank,protein kinase B signaling (GO:0043491),0.42784427884124043,1.043612434173107,0.3988212180746562,0.8304361658588104,1.0,2/23,2.65%,PTEN;IL1B
prerank,positive regulation of B cell activation (GO:0050871),0.384110120505923,1.0435277454314893,0.39138240574506283,0.8296544987441571,1.0,4/50,6.10%,MEF2C;SH3KBP1;TNIP2;IL4
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4723679641055886,-1.0435242783650678,0.42213883677298314,0.7488402546937849,1.0,4/10,13.32%,ADAM10;WNT5A;WNK1;OXSR1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3768814864669997,-1.0433817785520303,0.41282565130260523,0.748524502570769,1.0,14/24,33.25%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;CPOX;SUCLA2;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4743710150226238,-1.0432004848156358,0.4018348623853211,0.7483017332643146,1.0,2/10,15.69%,LGALS9;CEACAM1
prerank,epithelial cell migration (GO:0010631),0.39637702673993497,1.042352629690541,0.3927958833619211,0.8313276640279572,1.0,6/37,3.05%,FAP;PKN1;ROCK1;ZEB2;STARD13;PIK3CA
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.2914828242365664,-1.042306059962391,0.34048257372654156,0.7498667310861413,1.0,14/84,13.40%,IGF1;DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;IGF2BP2;CPEB3;CALR;SPHK1;CNOT8;LARP1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4517426433362285,1.0421111922477253,0.41030927835051545,0.8308692490799878,1.0,2/20,2.72%,GGT1;CHAC1
prerank,T cell homeostasis (GO:0043029),-0.47206879236756216,-1.0419625280492142,0.437137330754352,0.7500078036808399,1.0,10/10,52.83%,AKT1;PPP2R3C;NCKAP1L;FAS;FADD;ZC3H8;JAK3;FOXP3;RIPK3;PMAIP1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.4086423302486709,-1.0419608498326178,0.39763779527559057,0.7493110496230678,1.0,5/18,21.00%,NR3C1;ANXA1;BCL2L11;ZFP36L2;FAM107A
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.40095176038086294,-1.0417864392227547,0.40310077519379844,0.7490915158456254,1.0,8/18,20.99%,LBP;SBNO2;ENPP3;IFI35;KARS1;PLCG2;SYK;TYROBP
prerank,cholesterol efflux (GO:0033344),-0.3894270089974997,-1.0417765596065003,0.42084168336673344,0.7484146814556482,1.0,3/20,6.93%,ABCA1;APOE;NPC2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.37536275960982096,-1.041773979448935,0.4223968565815324,0.7477244922681437,1.0,7/25,13.59%,SLIT2;CAPZB;LIMK2;YAP1;PRKCD;EVL;TCHP
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3159456836603122,-1.041498871494083,0.37055837563451777,0.7476916695905181,1.0,15/59,19.24%,ROCK2;MAP3K14;IRAK2;ERC1;BIRC3;AKT1;TNFRSF1A;DAB2IP;RELA;UBB;TICAM1;TLR4;RIPK1;NFKBIA;IKBKG
prerank,negative regulation of organelle assembly (GO:1902116),-0.34819091821431647,-1.041441213393549,0.41333333333333333,0.7471451604901228,1.0,10/35,16.20%,NUPR1;KAT2B;LRRK2;LIMK2;YAP1;CHMP4B;CHMP4A;PHF23;TCHP;NBDY
prerank,calcium-mediated signaling (GO:0019722),0.35060774743895357,1.0413764219517112,0.39838709677419354,0.8316122594271886,1.0,11/93,8.04%,CACNA1C;PLCE1;CCRL2;ACKR3;GRM5;PPP3CA;CXCR2;ATP2A2;RYR2;ACKR2;CCR9
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.38627144656487855,-1.0412304675150066,0.4084507042253521,0.746976551080213,1.0,3/24,2.61%,EPHA7;FOXO3;NUPR1
prerank,establishment of protein localization to organelle (GO:0072594),-0.3033582619358858,-1.0411031145100214,0.373134328358209,0.7466220681098309,1.0,27/72,28.85%,LAMP2;RAB11A;APPL2;STAT3;HK2;AKT1;IPO7;FAM53C;IPO13;RAN;IPO8;NXT2;TPR;LAMP5;NUP88;SYK;ZDHHC15;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;HK1;CSE1L;PTTG1IP;NUP62;TNPO2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3884961151983539,-1.0410652071543733,0.42857142857142855,0.7460177994377684,1.0,9/24,12.42%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4
prerank,sphingosine biosynthetic process (GO:0046512),-0.46317646518346806,-1.0408706919846396,0.4368029739776952,0.7450937165180602,1.0,4/11,13.74%,ACER2;ACER3;SPHK1;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),-0.46317646518346806,-1.0408706919846396,0.4368029739776952,0.7450937165180602,1.0,4/11,13.74%,ACER2;ACER3;SPHK1;SPTLC2
prerank,negative regulation of receptor internalization (GO:0002091),-0.45881885097323105,-1.0407097173133963,0.4361904761904762,0.7448407355002518,1.0,5/12,23.92%,RIN3;SDCBP;ATXN2;ANKRD13D;ANKRD13A
prerank,negative regulation of DNA replication (GO:0008156),0.465940734041136,1.040458018205252,0.4,0.8327042418655516,1.0,5/13,17.17%,ATR;WAPL;CDAN1;RAD17;TERF1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.36129106492364055,-1.0403651273278953,0.403470715835141,0.744981652208126,1.0,3/29,2.98%,NOTCH2;IGF1;TGM2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4368886769112216,1.0402913490787165,0.40194174757281553,0.8321187302391425,1.0,3/22,4.93%,PLA2R1;SPRED1;HEXIM1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.43060282625456237,1.0399529135027168,0.4088176352705411,0.8318937418493901,1.0,7/24,8.54%,VTN;IL1B;CADM4;GRB10;TMEM204;ARNT;PRKD2
prerank,positive regulation of cytokinesis (GO:0032467),-0.3549374236024859,-1.0397755591314082,0.39748953974895396,0.7458101756349309,1.0,6/32,11.93%,PKP4;CDC14A;PRKCE;RHOA;SPAST;SVIL
prerank,peptidyl-asparagine modification (GO:0018196),-0.35890778627744246,-1.0397106058779078,0.38495575221238937,0.7452771736923978,1.0,11/31,19.35%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,regulation of acrosome reaction (GO:0060046),0.49516864339136357,1.0394168006580689,0.4282655246252677,0.8320940074633774,1.0,2/10,5.12%,CACNA1H;SERPINA10
prerank,ephrin receptor signaling pathway (GO:0048013),0.347687167561786,1.0392496960562203,0.3946540880503145,0.8315410844824243,1.0,25/82,13.42%,CHN1;KALRN;PTK2;SDC2;NCK2;ROCK1;WASL;ARPC5;ANKS1B;HRAS;AP2S1;LYN;EPHA2;GRIN2B;AP2B1;ARPC4;ARHGEF7;PAK3;PAK1;EPHA10;SRC;EPHB1;PSEN1;ARPC1A;RASA1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3876348765434414,-1.0391442253574146,0.42398286937901497,0.746037818816738,1.0,4/22,5.74%,AEBP1;AKAP13;APOE;MAP1B
prerank,cellular response to insulin stimulus (GO:0032869),-0.27843093649902484,-1.0388075378122137,0.35542168674698793,0.7461637043310501,1.0,31/124,14.00%,SORBS1;RHOQ;FOXO1;ENPP1;IGF1R;KAT2B;BAIAP2;FOXC2;HDAC9;ATP6V0A4;AP3S1;IGF2;SLC39A14;SYAP1;NAMPT;CPEB2;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;INSIG2;ATP6V0A1;RAB8A;TCIRG1;USF1;FER;LPIN3;CAV2;HDAC5
prerank,negative regulation of vascular permeability (GO:0043116),-0.4442873198330662,-1.0384715302427843,0.4087301587301587,0.7463264591054857,1.0,6/12,6.39%,SLIT2;CLDN5;PTPRJ;ANGPT1;RAMP2;DDAH1
prerank,positive regulation of hydrolase activity (GO:0051345),0.33078882060606063,1.0382983718939212,0.3718518518518519,0.8327369193608526,1.0,19/137,7.93%,RGS6;LIMS1;DOCK10;RAPGEF2;RASGRP2;MTCL1;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;RIC1;RAP1A;HRAS;RGS7;MAP4K4
prerank,sodium ion transmembrane transport (GO:0035725),0.35023612522914754,1.0375942986513058,0.3983739837398374,0.8333115372849609,1.0,18/84,9.14%,SLC12A2;ATP1A2;ATP1A4;SLC5A1;FXYD2;SLC24A4;SLC24A2;SCN2A;ATP1B2;SCN5A;ASIC2;HCN2;SCN8A;SLC9A7;PKD2;SLC6A15;HCN3;SCN9A
prerank,activation of GTPase activity (GO:0090630),0.35432805362010367,1.0370710104612084,0.38402457757296465,0.833534909811158,1.0,16/89,9.71%,ARHGAP42;TBC1D1;SIPA1;GRTP1;GARNL3;SYDE1;SLC27A4;TBC1D30;TBC1D12;ARHGEF26;RUNDC1;TBC1D2B;MTSS2;RALGAPA1;TBC1D10C;EPHA2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.29662388592926636,-1.0368728376013359,0.3736842105263158,0.7497394653893151,1.0,14/78,9.75%,SORBS1;DAB2;EPHA3;EGFR;PRKCH;RHOQ;DLG1;ITGA3;AR;STX7;PRKCE;STX3;AKT1;MMP14
prerank,calcineurin-mediated signaling (GO:0097720),-0.46461834179955397,-1.0365677390199932,0.42463235294117646,0.7491243268702359,1.0,5/10,19.88%,NFAT5;NFATC1;PPP3CC;NFATC2;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.46461834179955397,-1.0365677390199932,0.42463235294117646,0.7491243268702359,1.0,5/10,19.88%,NFAT5;NFATC1;PPP3CC;NFATC2;PPP3CB
prerank,lymphocyte differentiation (GO:0030098),0.3570286759158758,1.036350642454235,0.3840947546531303,0.8341698196172173,1.0,10/68,6.81%,ITGA4;PIK3CD;PTPN22;AXL;GPR89A;GPR89B;ITGB1;IL4;SOX4;KAT7
prerank,coenzyme A biosynthetic process (GO:0015937),0.4885255026558546,1.0360956922230955,0.42411642411642414,0.8318777543158982,1.0,6/11,26.32%,COASY;ACOT7;SLC25A16;PANK1;PANK3;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4885255026558546,1.0360956922230955,0.42411642411642414,0.8318777543158982,1.0,6/11,26.32%,COASY;ACOT7;SLC25A16;PANK1;PANK3;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4885255026558546,1.0360956922230955,0.42411642411642414,0.8318777543158982,1.0,6/11,26.32%,COASY;ACOT7;SLC25A16;PANK1;PANK3;PPCDC
prerank,somite development (GO:0061053),-0.4555718832433868,-1.035865980650177,0.43838028169014087,0.7501750349746605,1.0,3/11,12.21%,MEOX2;SMO;PTCH1
prerank,positive regulation of dendrite development (GO:1900006),0.492589747379246,1.0357189379396445,0.4156378600823045,0.8317923320724756,1.0,2/10,2.44%,BMP5;PTN
prerank,response to amino acid (GO:0043200),0.4023556719757314,1.0356348431208857,0.3821892393320965,0.8310161173884257,1.0,2/31,1.53%,SPAAR;CPEB1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.32423616974670144,-1.035500356526128,0.3877551020408163,0.7504133883313737,1.0,12/47,15.48%,TGFBR3;EGFR;FOXO1;IGF1R;LGALS9;TAOK2;DAB2IP;QARS1;PPIA;MAPK8IP1;MAPK3;ARL6IP5
prerank,regulation of cell motility (GO:2000145),-0.27627410822557763,-1.0354340909004374,0.40716612377850164,0.7498949126205999,1.0,20/121,9.94%,PLXNA2;EGFR;ROCK2;LMO4;FBLN1;PLXNA4;MACF1;ARHGAP18;DIAPH1;FGF1;SPOCK2;CAVIN1;RHOA;RHOB;TMSB4X;TBCCD1;CCDC125;AKT1;PLXND1;ROBO4
prerank,positive regulation of protein polymerization (GO:0032273),0.3632188698635649,1.0354295297972544,0.39322033898305087,0.8305450331966397,1.0,11/65,11.25%,CARMIL1;NCK2;VASP;CDC42EP1;NAV3;TPPP;TTBK1;BIN1;NCKAP1;LMOD1;PAK1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3544022844660688,1.0353404444508372,0.37006578947368424,0.8298136939310913,1.0,13/70,16.18%,MBOAT2;NR1H3;SLC44A2;LIPC;PLAAT1;ABHD3;ACHE;STARD7;PLA2G4E;CHKB;ABHD4;LPCAT1;LPIN2
prerank,phospholipid metabolic process (GO:0006644),-0.30095100569035016,-1.0352564178387442,0.3948051948051948,0.7496477170144845,1.0,33/71,38.96%,PLA2G4A;PLPP3;AGPAT4;SMPD3;GPX4;PIP4K2B;TNFAIP8L3;PLPP1;PLA2G15;PGP;PLCD1;CLN8;AGPAT2;ENPP2;LPL;PLPPR4;PLPP2;MBOAT1;PLBD2;PLA2G4F;SMPD1;ANGPTL3;AGPAT1;FITM2;FADS1;LGALS13;ABHD12;PLA2G5;GDE1;PLCB2;PLPPR3;PLBD1;PLB1
prerank,RNA interference (GO:0016246),0.4592216398596992,1.0348366143983045,0.40461215932914046,0.8299564866396945,1.0,5/17,12.46%,CLP1;AGO3;TARBP2;TSN;CELF1
prerank,sympathetic nervous system development (GO:0048485),-0.41692853821006426,-1.0346908456435246,0.408203125,0.7503871937377039,1.0,2/15,1.09%,NRP2;NRP1
prerank,zinc ion transmembrane transport (GO:0071577),0.44176934470530854,1.0346707836746343,0.41141732283464566,0.8293725531649355,1.0,1/22,0.46%,SLC30A10
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4346780411765166,-1.034663774282557,0.4383561643835616,0.7497720378599333,1.0,7/13,23.60%,IL6ST;STAT1;STAT3;OAS2;CANX;TYK2;CRLF1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3982190970759274,-1.034553011628677,0.42658730158730157,0.7493826643106202,1.0,2/19,1.99%,CAMK1D;MCU
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3335704646721132,1.0345143962020547,0.4005805515239477,0.8287808234030067,1.0,15/125,10.81%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;NEK6;DYNC1I2;TUBG2;NUSAP1;TACC3;XPO1;SEC13
prerank,regulation of immune response (GO:0050776),-0.2734740190561378,-1.0342969737479768,0.35947712418300654,0.749345988127368,1.0,20/135,10.39%,COL1A2;COL3A1;COL1A1;FOXP1;CXADR;IL15;CLEC2D;B2M;VCAM1;CD34;APPL2;IRF1;ADCY7;ICAM1;ERAP1;FKBP1A;BIRC3;SAMHD1;RNF135;CASP8
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.38242599440547587,-1.034269546581164,0.4012345679012346,0.7487212269608343,1.0,4/22,12.53%,SORBS1;APOE;AKT1;PPARA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3580253386239631,-1.033780376928604,0.3946830265848671,0.7492891302195535,1.0,8/29,15.65%,APOE;APP;SLC4A10;RAB3GAP1;CAMK2A;EPHB2;SHISA7;MCTP1
prerank,fibrinolysis (GO:0042730),-0.43674013976328474,-1.0335927736758712,0.4224299065420561,0.7491224020680617,1.0,9/13,52.04%,SERPINE1;PLAUR;HRG;PLAT;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,neural tube development (GO:0021915),-0.42025057442611846,-1.0335910828541814,0.425891181988743,0.7484497335392007,1.0,4/15,14.65%,ALDH1A2;TGFB1;PTCH1;PKD1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4410305066877682,1.0329021604523998,0.4190283400809717,0.8314811938155506,1.0,4/18,10.76%,GINS1;GINS3;GINS4;MCM7
prerank,lipoprotein catabolic process (GO:0042159),-0.4540160199356061,-1.0328808170293504,0.44660194174757284,0.7495221223244922,1.0,8/11,28.58%,APOE;LYPLA1;NOTUM;ABHD17C;LYPLAL1;LYPLA2;CTSD;ABHD17A
prerank,regulation of protein kinase A signaling (GO:0010738),0.43743988547650386,1.0326884281343534,0.3916349809885932,0.8310158141782157,1.0,7/20,10.38%,PRKAR1B;AKAP6;PRKAR2B;PRKAR2A;AKAP12;AKAP7;PRKAR1A
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.38270339792775643,1.0325352087102708,0.41035120147874304,0.8304100942923929,1.0,5/43,5.92%,ITGA1;SH3KBP1;SPRY2;SOCS5;EPN1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.37887220631538965,-1.0323545324119563,0.4330543933054393,0.7501582722537139,1.0,10/26,13.92%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4;SARS1
prerank,regulation of protein kinase activity (GO:0045859),0.33796183827239684,1.032212490168376,0.4059097978227061,0.8301467170116414,1.0,16/106,9.06%,PLCE1;RAPGEF2;PTK2;PPM1E;NF1;SPRED1;AGAP2;SPDYA;TRIB2;DBNDD2;SNCA;RAP1A;AKT1S1;CDKN1A;ANKRD54;TARBP2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4788352459838722,1.0318475547741552,0.41596638655462187,0.8300199684096528,1.0,3/13,10.23%,RCL1;TBL3;NOP14
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.43937184220445585,1.0318047349474722,0.4086444007858546,0.8291778620495159,1.0,3/19,2.15%,LIMS1;FERMT2;ROCK1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.46553226107786355,-1.0317285881401215,0.43227091633466136,0.7510122499122018,1.0,5/10,39.25%,ALDH7A1;HNMT;SMOX;DMGDH;SLC44A1
prerank,regulation of GTPase activity (GO:0043087),0.3155145210265023,1.0315614215783726,0.3939393939393939,0.8288011388332469,1.0,23/177,7.93%,CHN1;RGS6;LIMS1;PRKG1;DOCK10;RAPGEF2;PTK2;RASGRP2;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;NTRK2;ARFGEF1;RIC1;RAP1A;HRAS;RGS7;MAP4K4
prerank,positive regulation of cell death (GO:0010942),-0.30986666999535967,-1.0312290907815163,0.3938679245283019,0.7516175416492904,1.0,9/59,7.97%,EFNB2;SLC6A13;SLC6A6;BMP4;LRRK2;ACER2;RARG;WNT5A;PRODH
prerank,sister chromatid segregation (GO:0000819),-0.3564441237718383,-1.0311085002092175,0.4173728813559322,0.7512016834555781,1.0,18/31,32.00%,INO80;TOP2B;NCAPG2;RAN;ZW10;SMC4;CENPK;DSN1;SMC1A;TOP2A;SPAG5;KIF18B;NDC80;KIFC1;NSL1;CDCA8;SGO1;KIF18A
prerank,negative regulation of cellular component organization (GO:0051129),0.34987115029192795,1.0310142691309314,0.4049586776859504,0.8291272460026267,1.0,7/74,6.26%,CARMIL1;FAP;WASL;SACS;SPRY2;SCAMP5;DDX3X
prerank,cellular response to chemokine (GO:1990869),0.3790583282816184,1.0309090055585113,0.43771626297577854,0.8284394481857494,1.0,6/46,5.43%,SLC12A2;SH2B3;CXCL5;STK39;ACKR3;CXCL10
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4648251014670075,-1.0300293204069628,0.4197080291970803,0.7531716366121687,1.0,3/10,7.84%,RARB;RARG;TBX1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3654281647837075,-1.029801459472245,0.4066390041493776,0.7530702893714563,1.0,8/29,19.24%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,regulation of myoblast differentiation (GO:0045661),0.41133043076580955,1.0296498799256344,0.4249512670565302,0.8304125455542457,1.0,5/32,4.42%,MEF2C;NOTCH1;TBX3;RBM24;SOSTDC1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4406885770331236,-1.0295166575866865,0.4041353383458647,0.7530609642720995,1.0,4/12,19.63%,AR;TGFB1;AP2A1;TMEFF2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4384785901228397,1.029427511117882,0.41818181818181815,0.8299960913680756,1.0,2/21,2.34%,NDST3;EXTL3
prerank,mitotic cytokinesis (GO:0000281),-0.3260952065029067,-1.0292406064787252,0.42857142857142855,0.7530425811043387,1.0,18/47,20.04%,ROCK2;SNX9;PDCD6IP;USP8;RHOB;MYH10;ARL3;SON;TTC19;SPAST;EFHC1;CHMP4B;EFHC2;MITD1;KLHDC8B;STAMBP;CIT;RHOC
prerank,retina homeostasis (GO:0001895),-0.3735168627354002,-1.0287069310380368,0.4115308151093439,0.7537243812911995,1.0,10/23,30.02%,B2M;ACTG1;POC1B;ACTB;POTEF;WHRN;TULP1;CDH3;PRDX1;HSPB1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.46176218671495906,1.0285871629856849,0.4104803493449782,0.8309472617106684,1.0,2/16,1.89%,PDGFRB;BCAR1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4442565040278442,-1.028102182732917,0.43478260869565216,0.7545961923389792,1.0,5/12,30.40%,AKT1;PPP1R3B;PPP1R3F;INPP5K;KHK
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.40646521278541764,1.0278039552105485,0.41894353369763204,0.8317075601229964,1.0,1/33,0.44%,IL34
prerank,autonomic nervous system development (GO:0048483),-0.403738505971341,-1.0275781905771495,0.43520309477756286,0.7551748136584903,1.0,2/17,1.09%,FN1;NRP1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3973225911502397,-1.027508925639774,0.43687374749499,0.7546723446248212,1.0,7/20,24.88%,ADAM9;ADAM10;TGFB1;RELA;PSEN2;MBTPS1;NCSTN
prerank,regulation of actin filament polymerization (GO:0030833),0.35696583909626955,1.027490149491868,0.41887417218543044,0.8314815858287521,1.0,17/69,15.13%,CARMIL1;PLEKHG2;NCK2;VASP;SSH2;CDC42EP1;ESAM;ARFGEF1;BIN1;NCKAP1;LMOD1;PAK3;WASHC5;RASA1;ABITRAM;CDC42EP4;MYADM
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.35080290482973,1.0274264066579422,0.4131534569983137,0.830697117256588,1.0,12/76,9.80%,PTEN;CBFA2T3;PTK2;PABIR1;RBX1;SOCS5;TRIB2;RCHY1;ZER1;NKD2;DET1;CSNK1E
prerank,negative regulation of complement activation (GO:0045916),-0.4612320901653369,-1.0273278854593444,0.4507874015748031,0.7544699083841564,1.0,2/10,2.12%,SERPING1;CD55
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.36313089172957086,-1.0269364667316656,0.39959839357429716,0.7547532387129797,1.0,13/29,24.55%,LIMA1;SLIT2;SHANK3;KANK3;PRKCD;FKBP4;PFN1;TWF1;CYRIB;SSH3;ARPIN;PRKN;KANK1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.27402864045323616,-1.0268917671685773,0.38484848484848483,0.7541823547861202,1.0,41/124,20.91%,PLCB1;WNT4;SMURF2;LEF1;NFATC1;FZD2;TCF7L2;AP2A2;MOV10;SFRP4;SMURF1;WNT5A;RHOA;PLCB3;FZD4;TIAM1;FZD7;CAMK2A;PSME2;PFN1;CCDC88C;AP2A1;PSMB4;ARHGEF19;PSMD8;PSMB1;SFRP1;PSMD11;FZD8;CALM1;PSME3;TNRC6A;WNT11;FZD1;PSMA2;PSMD4;AGO1;PSMD3;PPP3CB;PSMB7;VANGL2
prerank,apoptotic process (GO:0006915),0.3061511289962953,1.0262979581355354,0.40027322404371585,0.8323101358336591,1.0,37/203,12.79%,DLC1;FAP;TNFRSF21;TNFAIP1;ARHGEF6;ADORA2A;FASTKD2;IL1B;PIK3CA;IL2RA;AKAP1;PRUNE2;BCL2L10;PPARD;CIDEB;SCN2A;OGT;BCL2L13;CASP9;LIG4;PAK6;CDIP1;STK3;MTOR;BNIP2;PAK5;NCKAP1;IFT57;HIP1;DDIT4;MCM2;BCLAF1;YARS1;EP300;FAM162A;MRPS30;KREMEN1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4354030916352085,-1.026090592068453,0.4217557251908397,0.755464542021289,1.0,8/13,18.63%,EDEM2;SEC16B;TMEM30A;BCAP31;TM9SF4;SAR1A;SAR1B;CD81
prerank,regulation of protein polymerization (GO:0032271),0.4134066447896354,1.0258148927552841,0.4381818181818182,0.832439180047866,1.0,9/35,13.57%,PLEKHG2;MAP2;ESAM;TPPP;TTBK1;CAMSAP3;PAK3;RASA1;ABITRAM
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2702341701560206,-1.025388984005925,0.40604026845637586,0.7564393741522978,1.0,40/149,19.24%,PRKCH;APP;CAV1;NOD1;ARHGEF2;CFLAR;IRAK2;AR;LGALS9;PRKCZ;PRKCB;WNT5A;CARD14;TFRC;STAT3;ERC1;IL18;FLOT2;IRAK3;TRIM27;CAMK2A;RELA;TNFRSF11A;UBB;FER;SPHK1;CLOCK;TICAM1;PPIA;TLR4;RIPK1;MAP3K13;ALK;TRIM8;NFKBIA;TRIM14;EDA;AGT;LAMTOR5;IKBKG
prerank,sulfur compound biosynthetic process (GO:0044272),0.33752687022146344,1.0249988582178458,0.4,0.8332601352732864,1.0,17/104,10.14%,CSPG4;GGT5;GGT1;CHST3;GGTA1;CHST7;CHAC1;CTH;ACAN;SLC26A1;B4GALT6;TPK1;CHST2;MAT2A;CHSY3;MGST3;CHST5
prerank,melanosome transport (GO:0032402),-0.4006974689731686,-1.0244838950591164,0.42994241842610365,0.7573284830082982,1.0,6/18,20.47%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,pigment granule transport (GO:0051904),-0.4006974689731686,-1.0244838950591164,0.42994241842610365,0.7573284830082982,1.0,6/18,20.47%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4149011785693716,1.024379771267708,0.44356435643564357,0.8336745289466919,1.0,8/29,17.32%,MEI4;MEIOB;REC8;TEX12;FANCD2;TRIP13;STAG3;SYCP2
prerank,positive regulation of cellular respiration (GO:1901857),-0.45379363333371764,-1.024370043122791,0.44294003868471954,0.7568985012017166,1.0,8/11,33.03%,NUPR1;IL10RB;PRELID1;PARK7;VCP;IFNAR1;IFNLR1;PINK1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.31613582746893915,-1.0242689567025833,0.3886363636363636,0.7564981874886695,1.0,18/49,23.07%,LRCH1;LRRK2;SLC39A14;WNK1;SH3RF2;CPEB2;CST3;ECM1;DAB2IP;CAMK2A;F11R;GMIP;NOS1;SH3BP4;CHP1;TMED2;SH2D4A;RDX
prerank,cellular glucose homeostasis (GO:0001678),-0.332230312812664,-1.0242322167441662,0.4174107142857143,0.7559034146610023,1.0,10/41,11.09%,UNC13B;FOXO1;IGF1R;GAS6;SLC39A14;HK2;HIF1A;KCNB1;FOXK1;ERN1
prerank,dephosphorylation (GO:0016311),0.3183578643703449,1.023690222389095,0.3959537572254335,0.8342624036187375,1.0,11/147,4.85%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;PTPN22;SSH2;PLPPR5;PPP3CA;PPP2R2A;PTPN4
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44537455814852384,-1.0233095579935063,0.44036697247706424,0.7575959439087927,1.0,6/12,14.00%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4173528779820649,1.0229412877507684,0.44106463878326996,0.8349727025906574,1.0,2/25,1.41%,HEY2;PER2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.37392354822630736,1.0228306958085842,0.4181184668989547,0.8342922843219878,1.0,11/48,12.55%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1;CAPRIN2;IL1RAPL1;DOCK1;ARHGEF7;CUX2;PRKDC
prerank,cellular response to organic cyclic compound (GO:0071407),0.32654147263002165,1.0225876008511643,0.4177396280400572,0.8339136072402785,1.0,22/141,9.48%,MEF2C;GNG2;PDE3A;RAPGEF2;RORA;ATP1A2;GPER1;IL1B;ADCY3;ADCY8;NCOA3;ADCY6;AKAP6;GABRG2;HCN2;RAP1A;FAM210B;PKD2;RYR3;HCN3;PDGFB;MED1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4549151184127693,-1.022471026657647,0.4411764705882353,0.7589982029230204,1.0,2/10,15.83%,ADGRV1;WHRN
prerank,negative regulation of type I interferon production (GO:0032480),-0.3345705892091404,-1.0224454400716738,0.4263392857142857,0.7583869056765496,1.0,16/40,29.27%,IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;PPM1B;SIRPA;UBA7;NPLOC4;UBE2L6;RNF216;PTPRS;REL;TAX1BP1;ISG15
prerank,regulation of protein sumoylation (GO:0033233),-0.4076693049625949,-1.0223602225057529,0.45956607495069035,0.757925527530541,1.0,2/17,1.07%,ZMIZ1;HDAC4
prerank,cell differentiation in hindbrain (GO:0021533),0.48267312688123554,1.0222430528711701,0.43137254901960786,0.833787332072598,1.0,2/11,4.13%,ATP7A;CEND1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.4142221154344726,-1.0220434900648365,0.44283121597096187,0.7580270689426059,1.0,5/16,18.22%,PHKB;PHKA2;PYGB;CALM1;GAA
prerank,negative regulation of DNA binding (GO:0043392),0.41308474843524545,1.021187549824703,0.4263565891472868,0.8351355619317706,1.0,3/28,5.16%,HEY2;PER2;TNKS
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3336313438319301,-1.0202815695160574,0.41898148148148145,0.76177045041777,1.0,17/40,26.40%,IGF1;TNFSF10;AKT1;BCL2L11;BNIP3;PLSCR3;BID;GPX1;PRELID1;PDCD5;PLAUR;BBC3;BCL2L1;PRKN;PSMD10;TP53;BIK
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.44112403664767685,1.0202423322900431,0.4204322200392927,0.8362603254182377,1.0,4/20,6.84%,BCL2L10;IL4;CASP9;APPL1
prerank,response to estrogen (GO:0043627),-0.3516202929896607,-1.0196653684568084,0.45979381443298967,0.7625987493018654,1.0,5/31,7.78%,CAV1;ESR1;TRIM24;AR;SFR1
prerank,regulation of gastrulation (GO:0010470),0.44168401561532206,1.019605433002946,0.4170403587443946,0.8366953032899987,1.0,4/14,12.82%,PHLDB2;CLASP2;TENM4;PHLDB1
prerank,anterior/posterior pattern specification (GO:0009952),-0.3101855343962923,-1.0194610406436173,0.4034229828850856,0.7624388252530147,1.0,17/53,15.78%,HOXB6;PCSK5;HOXB3;BMPR2;TGFBR1;HOXA5;SKI;HOXA3;BHLHE40;HOXC6;TBX1;BHLHE41;HOXB9;HOXC4;HOXB7;HOXB5;HHEX
prerank,cellular response to starvation (GO:0009267),-0.26522341091974344,-1.0194005450582138,0.41846153846153844,0.7619304664277369,1.0,50/147,27.04%,PRKAG2;LAMP2;FOXO1;FOXO3;BMPR2;LRRK2;DAP;WIPI2;ITFG2;FNIP1;HSPA5;KLF10;CLEC16A;ATP6V1G1;BECN1;DAPL1;ATP6V0B;FLCN;ZC3H12A;SH3GLB1;PRKAG3;TCIRG1;PPARA;MFSD2A;MAPK3;SFRP1;PRKAA2;SREBF1;MTMR3;GABARAPL1;RRAGB;CEBPB;RRP8;LAMTOR5;ZFYVE1;KPTN;PRKAG1;ATP6V1F;STK26;XBP1;EIF2AK3;RIPOR1;ATG7;TP53;FAS;EIF2AK4;RRAGC;ATF2;ATP6V0D1;PICK1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.35485482250588396,-1.0190874552095308,0.45102040816326533,0.7620211229682414,1.0,6/30,11.05%,VAMP5;MACF1;KIF13A;GGA2;GOLPH3;OPTN
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.35899766383154985,-1.0190356940628795,0.4444444444444444,0.7614785262584147,1.0,11/29,31.55%,SMAD3;TUT4;TUT7;PUM1;SNIP1;AGO1;DICER1;ZC3H7A;ZC3H7B;AGO2;SMAD2
prerank,intestinal absorption (GO:0050892),-0.43494372167141215,-1.0188898238848225,0.45703125,0.7611861547300887,1.0,4/13,14.53%,TJP2;KCNQ1;F11R;UGCG
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2658674896959377,-1.0188415917742497,0.3806970509383378,0.7606452453327905,1.0,42/132,27.96%,CELF2;RPS14;LUC7L;RPS19;GEMIN7;EIF2S2;DENR;NAF1;RPL11;RPS5;RPL24;STRAP;SRSF10;RPS27;MRPS7;RPL10;HSP90AB1;GEMIN5;RAMAC;RPS15;SNRPF;SNRPD1;SNRPD2;RPSA;RPL38;RPLP0;SRSF6;RRP7A;DICER1;SRPK1;RPS27L;SRSF5;WDR77;SRPK2;RRS1;CELF5;SNRPC;PRPF19;PUF60;SNRPB;SNRPE;EIF2D
prerank,GPI anchor metabolic process (GO:0006505),0.39822496028139914,1.0186924580648993,0.4069529652351738,0.8377982012239406,1.0,7/26,19.03%,PIGU;PIGO;PIGZ;DPM3;PIGH;PGAP1;GPLD1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43173065678060013,1.018389352861456,0.41358024691358025,0.8375162816167571,1.0,8/21,21.65%,MED13;MITF;MED1;BCLAF1;MED4;DHX36;MED30;MED16
prerank,positive regulation of JNK cascade (GO:0046330),-0.30026116004519804,-1.018357324822041,0.4105263157894737,0.7611576626410418,1.0,18/70,14.76%,PLCB1;CCN2;SH3RF1;APP;RASSF2;SDCBP;PTK2B;MFHAS1;SH3RF2;SH3RF3;TAOK2;TNFRSF19;FZD7;DAB2IP;FLT4;WNT16;MAPK8IP1;HIPK2
prerank,digestive tract morphogenesis (GO:0048546),-0.4297131231744671,-1.01835320698143,0.4331450094161959,0.7604968591503596,1.0,7/14,17.17%,PDGFRA;FGFR2;STRA6;BBS7;ID2;SOX17;EPHB3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3094360276385857,-1.0182680370921864,0.435,0.7600443749807536,1.0,11/54,11.42%,NXN;HDAC8;CAV1;SMAD7;ARRB1;SH3RF2;AKT1;PINX1;IVNS1ABP;PRKCG;RPL11
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.45615757961442116,1.018175899849197,0.42917547568710357,0.837060532615736,1.0,1/15,0.21%,CSPG4
prerank,cellular response to reactive oxygen species (GO:0034614),0.3628982941026994,1.0167602528650315,0.43127147766323026,0.8392235463643998,1.0,3/59,3.24%,PTPRK;MAP3K5;NCF1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.29592852400121816,-1.016499760097189,0.4533678756476684,0.7637303139764179,1.0,10/72,12.34%,FLRT2;RBFOX2;FGFR2;FGF1;KL;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F
prerank,neural crest cell development (GO:0014032),0.38366759108642756,1.01613166201136,0.4296028880866426,0.8397115765752392,1.0,6/44,4.95%,CDH2;SEMA6D;SEMA5A;ERBB4;NRG1;SEMA6C
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.28793478747572243,-1.016054749722841,0.42133333333333334,0.7642127566652486,1.0,17/87,18.81%,FLRT2;RBFOX2;FGFR2;FGF1;NDNF;KL;TBX1;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;MAPK3;SFRP1;POLR2E;ZFP36L2;FLRT1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.44705850921783263,1.0155065259844636,0.42936802973977695,0.8401926790754296,1.0,4/16,13.20%,NCBP2;CACTIN;PRPF39;DDX23
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3700967212745553,-1.0154995463686989,0.43564356435643564,0.764899015238744,1.0,5/24,12.83%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.36620903361433343,-1.0153094213094018,0.44532803180914515,0.764727017772474,1.0,8/26,11.69%,POR;APOE;NPR3;PIK3CB;AKT1;NOS1AP;HIF1A;GCH1
prerank,negative regulation of protein depolymerization (GO:1901880),0.4205687441039395,1.0152383593421443,0.4523809523809524,0.8398501627136878,1.0,8/24,13.46%,SPEF1;PIK3CA;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,positive regulation of defense response (GO:0031349),-0.2801768180329706,-1.0149361390653266,0.3952254641909814,0.7649864077761197,1.0,23/89,18.89%,APP;IL15;PDCD4;IL16;WNT5A;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;GBP5;CYBA;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;NPAS2;AGTR1;AGT
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.326324746267753,-1.0144330029940507,0.4431554524361949,0.7655490898503655,1.0,10/40,16.45%,LBP;GBP4;PGLYRP1;GSDMD;GBP6;RPL39;GBP7;GBP2;HMGB2;MR1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.43594709528119563,-1.0144143660952152,0.4458955223880597,0.764932977841996,1.0,5/12,26.76%,SMO;SIX1;AGT;VEGFA;GDNF
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4244632520743994,-1.0143837785594907,0.45348837209302323,0.7643345127543766,1.0,12/14,42.07%,RELA;RAB29;CD81;IKBKG;RPS3;BCL10;KCNN4;CARD11;TRAT1;CD226;TESPA1;LCK
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.45891356328993893,1.0143186644442488,0.4781659388646288,0.8409567963523532,1.0,4/15,8.54%,NOTCH1;SEMA5A;FGF2;PRKD2
prerank,negative regulation of cell growth (GO:0030308),-0.26846671398580785,-1.0142188993234007,0.4331395348837209,0.764084850081197,1.0,32/121,17.53%,SMAD3;SMARCA2;VGLL4;FHL1;SLIT2;ENPP1;BMPR2;GJA1;PTPRJ;RBBP7;CCN3;NPR1;ACVRL1;OSGIN2;NDRG3;DIP2B;ADAM15;ULK2;FLCN;PML;DNAJB2;TGFB1;PRDM11;SOX17;TCHP;ENO1;IP6K2;SFRP1;CDKN1B;SEMA3G;WNT11;GNG4
prerank,regulation of translational initiation (GO:0006446),0.35485694597128425,1.014071496307677,0.4256410256410256,0.8406054311052227,1.0,10/63,6.26%,NCK2;EIF4EBP2;EIF4EBP3;DAZL;RPS6KB2;MTIF2;YTHDF3;NCBP2;BOLL;DDX3X
prerank,histone H3-K9 demethylation (GO:0033169),-0.45458775472524554,-1.0136961376746791,0.4612546125461255,0.7646444134312601,1.0,6/11,35.59%,KDM7A;KDM3A;HR;KDM1A;JMJD1C;KDM4A
prerank,steroid catabolic process (GO:0006706),-0.45587496861662063,-1.0134683964589841,0.45688073394495415,0.7645446695570938,1.0,10/10,54.45%,SPP1;YWHAH;HSD17B14;HSD17B11;HSD11B1;CYP24A1;FGF23;CYP27B1;CYP19A1;HSD17B6
prerank,cellular response to hexose stimulus (GO:0071331),-0.3671793625155503,-1.0132686671050446,0.4451345755693582,0.7643557126429087,1.0,7/23,14.67%,UNC13B;IGF1R;GAS6;SLC39A14;KCNB1;ERN1;PRKAA2
prerank,regulation of protein binding (GO:0043393),-0.2775168052878059,-1.0132012688192409,0.4012539184952978,0.763859356843148,1.0,30/114,15.44%,DAB2;HDAC4;APP;CAV1;CLDN5;BMP4;B2M;LRRK2;TAF1;TCF7L2;FKBP1A;AMFR;IFIT2;PRKCD;TIAM1;AKT1;DTX3L;IFIT1;IDE;ADD1;DNAJB2;RPL11;RAN;ACTB;HDAC5;PKD1;HIPK2;ZFPM1;TMBIM6;HFE
prerank,protein localization to vacuole (GO:0072665),-0.41972468373510097,-1.013009066171471,0.44509803921568625,0.7636703505662584,1.0,6/13,28.21%,SH3GLB1;SH3BP4;CD81;LAMTOR5;KPTN;ATP13A2
prerank,positive regulation of programmed cell death (GO:0043068),-0.2425533023921092,-1.0127637286940026,0.4292929292929293,0.7636105570874288,1.0,64/272,17.88%,DAPK1;UNC13B;PAWR;AKAP13;TIAM2;FOXO1;FOXO3;ARHGEF3;SLIT2;ITGA6;TGM2;STK17B;VAV2;BMP4;RASSF2;MCF2L;ARHGEF2;LRRK2;HOXA5;IGFBP3;TNFSF10;QRICH1;RARG;IAPP;SFRP4;ANO6;PTPA;RHOB;CYP1B1;ADAMTSL4;IFIT2;ARHGEF1;TRIO;TIAM1;AIFM1;BCL2L11;UTP11;ATF6;DAB2IP;FLCN;CASP8;BNIP3L;FGD4;PLEKHG5;UBB;TRIM35;ARHGEF18;ATM;BNIP3;ARHGEF19;PPID;RASGRF2;IP6K2;SFRP1;RPS6;ARL6IP5;NET1;BID;GNA13;STPG1;RIPK1;CSRNP3;PSEN2;PDCD5
prerank,cellular response to glucose starvation (GO:0042149),-0.32712096247055245,-1.0127506401587252,0.45788336933045354,0.7629815485635141,1.0,15/41,23.27%,PRKAG2;FOXO3;ITFG2;HSPA5;BECN1;ZC3H12A;SH3GLB1;PRKAG3;PRKAA2;MTMR3;RRP8;KPTN;PRKAG1;XBP1;EIF2AK3
prerank,regulation of myelination (GO:0031641),0.4124688498284076,1.0124812920273316,0.4256619144602851,0.8430509921361125,1.0,6/25,10.65%,TNFRSF21;PTN;TPPP;NCMAP;TENM4;NKX6-2
prerank,fatty acid oxidation (GO:0019395),-0.30911819776308264,-1.0117398423847026,0.4083129584352078,0.7648137054304243,1.0,17/57,21.23%,ADIPOR2;CPT2;SLC25A17;ACOX1;ECI2;ACADL;ALDH3A2;AUH;BDH2;ACAD10;ECHDC2;ACADS;ILVBL;ALOX12;PPARGC1A;ADIPOR1;DECR1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2827480653447717,1.010627860778297,0.43636363636363634,0.8460819213770694,1.0,25/417,3.37%,PTPRK;TBX2;KCTD1;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NR1D2;NRG1;CBX5;PHC3;NAB1;PHC2;MECP2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.38220653667303217,1.0103180634123274,0.42935779816513764,0.8458173597017075,1.0,4/38,3.88%,IL34;NCK2;DOK7;GRM5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3159310997795221,-1.0103073208790891,0.4207920792079208,0.7676256899421866,1.0,6/52,8.11%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2
prerank,T-helper cell differentiation (GO:0042093),-0.41801861773796384,-1.0094632398764418,0.46641074856046066,0.7690132111312538,1.0,4/14,15.88%,FOXP1;LEF1;ZFPM1;TMEM98
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3150907536492187,-1.008879821668326,0.42592592592592593,0.7697711618247112,1.0,14/51,14.94%,BMP7;GAS7;NRK;SRGAP2;LRRK2;NBL1;ALS2;TRIO;DTNBP1;TAOK2;DAB2IP;UBB;DCLK1;ANKRD27
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.39009181666800613,-1.0088244587717505,0.442,0.7692398206384611,1.0,5/17,16.00%,CD55;STAT3;IL18;BACH2;TLR4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.48505597792991495,1.0088117886139707,0.4553376906318083,0.8482871176465404,1.0,1/11,0.66%,MEF2C
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.35565551070674184,-1.0087254464708841,0.44282744282744285,0.7688384664727118,1.0,8/30,19.24%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,hemidesmosome assembly (GO:0031581),-0.43979204537913474,-1.0080752270217366,0.46564885496183206,0.7697707340887562,1.0,6/11,17.63%,ITGA6;PLEC;ITGB4;LAMA3;LAMC2;CD151
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.39116614477706324,-1.0077527138164035,0.4339622641509434,0.7699148289695408,1.0,7/19,19.39%,MAOB;PRDX2;ACOX1;CYBA;GPX1;PARK7;NOX1
prerank,muscle cell migration (GO:0014812),-0.4536383381862886,-1.0076664688039316,0.4526112185686654,0.76945916549641,1.0,5/10,13.46%,CCN3;SIX1;DDR1;ITGB3;MEGF10
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.36825025931740396,-1.0073643436953963,0.43259557344064387,0.7695744824550398,1.0,4/26,3.54%,ERRFI1;TGFA;APP;SNX6
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4835219026018004,1.0069124806343155,0.4312896405919662,0.8514313148961582,1.0,2/10,1.54%,NOTCH1;RGCC
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3441564447920361,-1.0064463160661976,0.4466230936819172,0.7712491147939019,1.0,10/36,18.50%,NRP1;TGFA;SHANK3;TAF1;HIF1A;EPHB2;HDAC1;HFE;ADRB2;PARK7
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.37990949411007735,-1.0064434441068617,0.4779116465863454,0.7705960716531572,1.0,3/21,4.15%,CAV1;LRP6;FZD2
prerank,cholesterol metabolic process (GO:0008203),0.3488580768352612,1.0063982223890469,0.425531914893617,0.8516793363699592,1.0,13/68,13.50%,CEL;SCARF1;LDLRAP1;ARV1;PPARD;ABCA5;IL4;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;CYP11B1
prerank,sphingolipid catabolic process (GO:0030149),-0.40653183710704877,-1.0062195427513927,0.4442307692307692,0.7705004351766341,1.0,8/15,25.56%,ACER2;ACER3;SPHK1;SMPDL3A;ENPP2;SGPL1;PDXDC1;GLA
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4657938490942518,1.0060889441546808,0.43383947939262474,0.8514794388779225,1.0,3/11,9.19%,JAK1;ANK3;LYN
prerank,cellular response to ketone (GO:1901655),-0.3398120969200877,-1.0058107991368592,0.46,0.7708249326348774,1.0,11/35,14.62%,ROCK2;ADCY5;NR3C1;ADCY1;AR;GOLPH3;ADAM15;AHR;LARP1;SPP1;SFRP1
prerank,toll-like receptor signaling pathway (GO:0002224),-0.28345453081916505,-1.00567805648244,0.4327956989247312,0.7705094216743501,1.0,21/84,19.24%,SCARA3;LBP;MAP3K1;IRAK2;LGALS9;PIK3AP1;BIRC3;CTSB;SFTPA2;SFTPA1;CASP8;IRAK3;CTSS;UBB;PLCG2;TICAM1;MAPKAPK3;TLR4;RIPK1;HSP90B1;IKBKG
prerank,protein import (GO:0017038),-0.2857952646821495,-1.0056617272207982,0.44173441734417346,0.7698897967438362,1.0,32/84,28.85%,LAMP2;APOE;APPL2;STAT3;SLC25A17;AKT1;IPO7;FAM53C;IPO13;PXMP2;RAN;ACBD5;ALDH3A2;GDAP1;PXMP4;IPO8;NXT2;TPR;TOMM22;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;PEX26;EIF4ENIF1;CSE1L;PTTG1IP;NUP62;CLU;TNPO2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4552236652329576,1.0048974095742236,0.4358407079646018,0.8531959464420628,1.0,3/14,7.46%,IL1B;FFAR2;OSMR
prerank,endothelial cell development (GO:0001885),0.4156590694819367,1.0048230079771634,0.4272030651340996,0.8524481515111988,1.0,2/25,1.03%,PDE4D;RAPGEF2
prerank,modulation by host of viral genome replication (GO:0044827),-0.42470125728162267,-1.0036676081412825,0.4763636363636364,0.7742493317468714,1.0,7/13,25.99%,IFI27;ZC3H12A;VAPA;FBXL2;PRKN;EIF2AK4;TBC1D20
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3850509774476614,-1.0032996534046443,0.4785276073619632,0.774470380783934,1.0,8/20,19.50%,MCU;SLC8A3;MCUB;SPG7;AFG3L2;MICU2;MICU1;MAIP1
prerank,multivesicular body organization (GO:0036257),-0.3429355597128515,-1.0032628639845513,0.4473684210526316,0.7739070760780118,1.0,6/31,11.44%,RAB11A;RAB27A;PDCD6IP;HGS;CHMP4B;CHMP4A
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.39159204466673014,-1.0027689364988905,0.45977011494252873,0.7743992964748532,1.0,7/16,17.42%,LRRK2;HSPA5;BCAP29;SEC16B;VAPA;BCAP31;TAPT1
prerank,cytoplasmic translational initiation (GO:0002183),-0.39707799130594407,-1.0026066613763929,0.4675572519083969,0.7741289557051294,1.0,10/17,37.85%,EIF4A1;EIF2S2;DENR;EIF4A2;EIF2D;EIF3D;RBM4;DHX29;EIF4B;EIF3I
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4250836946261759,1.0025696753641395,0.452,0.8563780402012601,1.0,5/18,8.54%,CRTC1;RPS6KA4;ADCY8;CRTC3;PRKD2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.396457754088014,-1.0021088621689749,0.4759036144578313,0.774735122476855,1.0,5/15,9.74%,CNOT7;STAT2;USP18;NLRC5;SAMHD1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.49542983112427397,1.0018831613288688,0.458980044345898,0.8569647990889742,1.0,2/10,2.76%,NR1H3;PTPN22
prerank,negative regulation of cell motility (GO:2000146),0.3320756375452621,1.0017362514796666,0.4623493975903614,0.8563479921291403,1.0,6/108,2.35%,DLC1;PTPRK;PTEN;VCL;NF1;WAS
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3285563537870416,-1.0017067174587317,0.4617067833698031,0.7750621004433791,1.0,10/39,10.06%,SNCAIP;ROCK2;APOE;EZR;RAP1B;RAPGEF1;TIE1;IRGM;GFAP;DAB2IP
prerank,membrane lipid metabolic process (GO:0006643),-0.3735383770381645,-1.0016945462010611,0.45267489711934156,0.7744371265525587,1.0,5/22,15.42%,ST3GAL6;AGMO;CYP1B1;SPHK1;SERINC1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4621495486242172,1.0015324277123185,0.451063829787234,0.85586307592823,1.0,5/12,14.16%,HOOK3;KIF3A;BICD2;DCTN1;CEP19
prerank,response to muramyl dipeptide (GO:0032495),-0.4303934795120026,-1.0004432398835854,0.4602272727272727,0.7769957545511255,1.0,3/12,4.03%,VIM;NOD1;ARHGEF2
prerank,axonal fasciculation (GO:0007413),-0.4418897303793227,-1.000070785434538,0.49612403100775193,0.7773001064688211,1.0,2/12,0.65%,EPHA4;EPHA3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.38754398461421957,0.99977141756636,0.4697508896797153,0.8587098488210554,1.0,7/36,14.31%,MAP3K20;RAD1;TIMELESS;ATR;SETMAR;ATRIP;RAD17
prerank,microvillus organization (GO:0032528),0.45787701104733014,0.9996184575109707,0.4376321353065539,0.8581602136840946,1.0,4/13,7.93%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.44410100197622704,-0.9992396678445465,0.4753199268738574,0.7786447082251793,1.0,8/12,42.87%,RPL26;TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.45473680667443767,-0.9990612040009272,0.49523809523809526,0.7784224853612327,1.0,3/10,10.34%,SMAD7;RC3H2;ZC3H12A
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4353396261228921,0.9987779990520078,0.43956043956043955,0.8590921701266666,1.0,2/17,1.04%,PDGFRB;VTN
prerank,positive regulation of potassium ion transport (GO:0043268),0.3838281868691573,0.998574556084053,0.45660377358490567,0.8586188206376149,1.0,7/38,10.17%,GNG2;KCNJ12;KCNMB1;AKAP6;KCNE5;KCNJ3;KCNJ6
prerank,error-free translesion synthesis (GO:0070987),-0.36622401313529834,-0.9984344545645301,0.44793713163064836,0.7792500361934646,1.0,12/22,31.70%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3742101474612129,0.9981559090232432,0.44652908067542213,0.8586363532599762,1.0,9/41,12.70%,IL34;DOK7;NCF1;GRM5;NTRK2;PDGFB;SRC;DLG3;PTPN1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.45951689901746706,0.9980242445724348,0.4560327198364008,0.8580185547291708,1.0,4/12,10.77%,GINS4;MCM6;MCM7;MCM2
prerank,glycerol metabolic process (GO:0006071),0.4788546490597887,0.9978740181059935,0.44650205761316875,0.8574392356902698,1.0,3/10,9.01%,COQ2;GOT1;GK
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.43438308638002915,0.9977863139070378,0.4543478260869565,0.8567079006524482,1.0,6/17,13.78%,PDCD10;CARD9;TAOK3;LYN;SCIMP;STK25
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.27545605088302516,-0.997718827252303,0.4647887323943662,0.7803574324825295,1.0,36/104,29.71%,KSR1;LRP6;SLC8A3;CCND2;RHOA;SYAP1;CALM2;CCND3;AKT1;HGS;IRGM;CCNG1;DAB2IP;PPEF2;UVRAG;ACTB;CCND1;CALM1;PARP16;CDKN1B;ADRB2;EZH2;TRIB1;CSF1R;CDK5RAP3;CCNF;PIH1D1;SERTAD1;CDC25A;CDK7;CDKN2D;TRIB3;ABL1;MNAT1;CDKN3;RPTOR
prerank,nucleic acid-templated transcription (GO:0097659),-0.32322989455189804,-0.9975402732778328,0.4575569358178054,0.7801164127965938,1.0,15/42,26.08%,THRB;POLR2A;NR4A2;MMS19;PWP1;MEF2A;POLR2F;DTX1;POLR2E;E2F1;THAP1;POLR2G;EPC1;PPP5C;RRAGC
prerank,positive regulation of wound healing (GO:0090303),0.37908543208996026,0.9975227719518899,0.4384057971014493,0.8563613142553765,1.0,8/36,8.26%,VTN;PTK2;MYLK;FERMT2;ITGB1;ARFGEF1;HRAS;MTOR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.46365969663187223,0.9973154312320491,0.46551724137931033,0.8558938850137271,1.0,2/12,5.25%,RMDN1;CHAMP1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.27926959031384746,-0.9969975885061534,0.4375,0.7808302170228739,1.0,36/88,29.11%,PRKAG2;PTPRB;CAV1;DEPTOR;LRP6;SLC8A3;DTNBP1;AKT1;DAB2IP;TRIM27;CEP85;QARS1;PPIA;CORO1C;DUSP10;CEACAM1;CDKN1B;GSKIP;PDPK1;PARK7;CHP1;TRIB1;CDK5RAP3;CDKN1C;UBASH3B;INPP5K;SH3BP5;GNAQ;PYDC1;PAK2;SFN;PPM1F;TRIB3;PTPRQ;ABL1;ADARB1
prerank,protein dephosphorylation (GO:0006470),0.3116497955510943,0.9969181743717324,0.45821325648414984,0.8558487293127695,1.0,11/135,4.85%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;TNS2;PTPN22;SSH2;PPP3CA;PPP2R2A;PTPN4
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46107867604337227,0.9968347706383559,0.4735772357723577,0.8551345048108019,1.0,5/13,11.22%,UBA2;DESI1;DESI2;UBA1;UBA6
prerank,natural killer cell mediated immunity (GO:0002228),-0.4026392538737399,-0.9966150665619556,0.4658040665434381,0.7810900184989936,1.0,10/15,48.44%,CEBPG;RAET1E;TUBB4B;ULBP1;LYST;PLEKHM2;SLAMF7;KLRD1;KIF5B;KLRK1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4580353323581588,0.9962771336704866,0.4827586206896552,0.8554812863293407,1.0,6/13,19.72%,KPNA4;NUP35;CBLB;KPNA1;RANBP2;KPNA3
prerank,negative regulation of leukocyte migration (GO:0002686),0.48282216511743,0.9959839901050881,0.4555084745762712,0.8552484925728435,1.0,2/10,5.44%,BMP5;CD300A
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3164374686517159,0.9953634842500176,0.44933920704845814,0.8557295296154821,1.0,20/128,14.56%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;DYNC1I2;CSNK1E;CEP41;BRSK1;CDK14;TUBB4A;PPP1R12A;CCNH;DCTN1;SKP1;DCTN3
prerank,regulation of protein modification process (GO:0031399),-0.3099263618873244,-0.9953547997048539,0.46846846846846846,0.7836274881582918,1.0,15/50,15.34%,FN1;CDH5;KAT2B;IGF2;STAT2;FNIP1;PPP1R16B;FLCN;PML;CCDC88C;FER;ATG10;NDUFS4;CORO1C;CDK9
prerank,negative regulation of ion transport (GO:0043271),0.41004887453312494,0.9953511149593761,0.43761996161228406,0.8548598857288066,1.0,4/24,7.19%,CASQ2;HTR1B;SNCA;STC1
prerank,regulation of acute inflammatory response (GO:0002673),0.43426397430172164,0.9950459828563781,0.4635108481262327,0.8546558261040016,1.0,3/18,7.46%,FFAR2;IL4;OSMR
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.40800456987615424,-0.9945810832039107,0.4764595103578154,0.7849502391432825,1.0,8/15,25.07%,STAT3;HIF1A;IL17RA;GBP5;TICAM1;TLR4;IL17D;MYD88
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.3196436972939307,-0.9941048590460669,0.46304347826086956,0.7854463206971862,1.0,6/39,10.02%,MCU;MYRIP;RBP4;TCF7L2;NNAT;NLGN2
prerank,membrane organization (GO:0061024),0.29266528227048755,0.9940165463961763,0.44640434192673,0.8559412338711029,1.0,47/227,15.29%,SGIP1;DYSF;SH3KBP1;IGF2R;FNBP1;LDLRAP1;ATP2C1;LDLR;SPTBN1;TMCC1;TOR1B;WASL;RIMS1;COX18;SYNGR1;ARPC5;EPN1;ANK3;CHMP2B;BIN1;HACE1;PIK3C2A;SGCZ;PPT1;SYT1;AP2S1;AP2B1;CPTP;UBXN2B;HIP1;ARPC4;SYT2;NPC1;KIF20A;SYP;DVL2;EMD;VTI1B;SERP1;ARPC1A;FCHO1;RAB5A;VPS33B;ANK2;CHMP3;MYADM;PLEKHA3
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4066428004169572,-0.9938503534294931,0.4602587800369686,0.7847551635998001,1.0,8/15,35.11%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1;BLOC1S4;SNAPIN;AP3S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4066428004169572,-0.9938503534294931,0.4602587800369686,0.7847551635998001,1.0,8/15,35.11%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1;BLOC1S4;SNAPIN;AP3S2
prerank,RNA metabolic process (GO:0016070),0.3103191972603728,0.9938117906020519,0.4550898203592814,0.8554918468731143,1.0,30/127,15.10%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;NCBP2;PCBP3;AGO3;DDX3X;ADARB2;HNRNPR;RBMS1;XRN2;SUPV3L1;PAPOLA;RNASE6;POLR2C;PCBP1;LAGE3;HNRNPA1;SND1;HNRNPUL1;PABPC4;RNASEH1;FASTKD1;LSM8;HNRNPU;HNRNPC;HNRNPH2;DHX36
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.405928802866806,0.9937376195903422,0.49209486166007904,0.8547595696906968,1.0,2/25,0.63%,GLMN;PTH1R
prerank,negative regulation of JNK cascade (GO:0046329),-0.34461103254067604,-0.9933963653976875,0.48459958932238195,0.7851995844895796,1.0,11/31,28.28%,MECOM;PDCD4;SH3RF2;MAPK8IP1;DUSP10;SIRPA;ZMYND11;HIPK3;PRKN;DACT1;AIDA
prerank,nitrogen compound transport (GO:0071705),-0.2573248192207616,-0.9932767410353389,0.4582043343653251,0.7848505780471582,1.0,24/141,12.15%,SLC7A11;SLC6A13;PDPN;SLC6A6;CERT1;SLC6A12;ABCG2;CALCRL;RAMP2;SLC7A2;RCN3;TXNIP;SLC7A5;SLC22A4;SLC7A7;TOM1;CUBN;SLC7A14;SLC38A5;SLC22A5;ARRDC1;SLC3A2;RAB7A;SLC35F3
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3006373670665906,-0.9929530333464235,0.4504950495049505,0.7849276212082444,1.0,14/65,10.67%,FOXP1;IL31RA;IL15;TGFBR2;BMP4;LEF1;PIR;CSF1;SBNO2;LGALS9;MAPK14;KIT;CASP8;PML
prerank,myoblast fusion (GO:0007520),-0.43210890200230445,-0.9928443041531614,0.4827586206896552,0.7845663433810354,1.0,7/12,18.63%,JAM2;ADAMTS5;CD9;ADAMTS15;NOS1;PTGFRN;CD81
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.35312413309169277,-0.9927791385613459,0.46540880503144655,0.7840628370240986,1.0,4/24,13.04%,PLA2G4A;LPGAT1;ABCA3;PLA2G15
prerank,positive regulation of MAPK cascade (GO:0043410),0.29091453820010443,0.9926248775623949,0.485006518904824,0.8562445514555407,1.0,28/245,7.54%,PDGFRB;IL34;SLC30A10;GCNT2;RAPGEF2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ROCK1;ERBB4;PTPN22;ACKR3;PDCD10;FGF2;SPRY2;PELI2;RYK;CARD9;RIT2;NTRK2;TAOK3;HTR2C;CHRNA7;RAP1A;HRAS;FGF10
prerank,response to copper ion (GO:0046688),-0.36868002245188275,-0.9924992275537262,0.47695390781563124,0.7840927730642556,1.0,9/20,19.78%,MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of chemotaxis (GO:0050921),0.367361579615323,0.9922801154249938,0.4369287020109689,0.8561113883331626,1.0,4/43,4.13%,PDGFRB;SEMA5A;PTN;FGF2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4036395111321906,0.992021785471701,0.4312617702448211,0.8557573968354197,1.0,11/24,22.43%,TTLL3;TTLL11;NAA11;CEP41;TPGS1;CFAP20;PARP1;TTLL10;TTLL5;TTLL7;AGTPBP1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.42657442953859587,0.9919757026845402,0.45596868884540115,0.8549464840863473,1.0,7/18,12.53%,SLC1A4;GRIK1;GRID1;CDH8;GRIA2;GRIK5;GRIK2
prerank,regulation of hippo signaling (GO:0035330),0.44792812747675137,0.9915059682632967,0.4601593625498008,0.8550852932519845,1.0,3/17,5.01%,LIMD1;SCHIP1;AJUBA
prerank,regulation of phospholipase C activity (GO:1900274),0.43169424918106736,0.9914128900897107,0.475103734439834,0.854372975320255,1.0,3/15,7.27%,PDGFRB;FGF2;HRAS
prerank,actin filament capping (GO:0051693),-0.38635167092563716,-0.9910853172372074,0.4619666048237477,0.7862663327937934,1.0,10/18,14.43%,ADD3;GSN;CAPZB;VILL;TRIOBP;ADD1;AVIL;SVIL;TWF1;CAPZA2
prerank,barbed-end actin filament capping (GO:0051016),-0.38635167092563716,-0.9910853172372074,0.4619666048237477,0.7862663327937934,1.0,10/18,14.43%,ADD3;GSN;CAPZB;VILL;TRIOBP;ADD1;AVIL;SVIL;TWF1;CAPZA2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4415291335613751,0.9905640331759576,0.44329896907216493,0.8553657741527311,1.0,5/15,14.19%,HECW2;NEK6;TACC3;PTTG1;ANAPC7
prerank,cellular response to leucine starvation (GO:1990253),0.47008155534056395,0.9902941262050041,0.45813953488372094,0.8550386380765026,1.0,2/10,8.26%,SESN3;MTOR
prerank,regulation of RNA splicing (GO:0043484),-0.2876788618612196,-0.990157831035336,0.4768856447688564,0.7878984293487558,1.0,23/69,26.32%,AHNAK;MBNL1;RBM20;RPS13;POLR2A;AFF2;SON;CLK1;ERN1;SRSF10;GRSF1;MBNL2;TMBIM6;AHNAK2;PTBP3;HNRNPL;SRPK1;RPS26;SRPK2;ZNF326;HNRNPF;CWC22;CLK3
prerank,regulation of nervous system process (GO:0031644),-0.39006304884418036,-0.9900839467681383,0.4798387096774194,0.7874091215754506,1.0,4/18,4.67%,ROCK2;APP;NOS3;SLC8A3
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4181051965355204,-0.9897948285985079,0.48554913294797686,0.7875048966120806,1.0,7/13,36.36%,CAV1;RNF185;BCAP31;ATXN3;USP13;RNFT1;HERPUD1
prerank,cell cycle G2/M phase transition (GO:0044839),0.313380019806903,0.9892650567521062,0.47467438494934877,0.8563470911219458,1.0,20/129,14.56%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;DYNC1I2;CSNK1E;CEP41;BRSK1;CDK14;TUBB4A;PPP1R12A;CCNH;DCTN1;SKP1;DCTN3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4118802967541608,-0.989264477326416,0.48785046728971965,0.7881601691226463,1.0,3/14,5.37%,SULF1;THBS1;SULF2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.42123104911202924,-0.9892088588119929,0.4990512333965844,0.7876449666556544,1.0,2/13,3.54%,ERRFI1;SNX6
prerank,regulation of cellular pH (GO:0030641),-0.3468979209236506,-0.9891009386551988,0.49572649572649574,0.7872594116905111,1.0,9/29,19.66%,SLC9A2;SLC4A10;LACC1;SLC9A9;SLC9B1;TM9SF4;SLC4A2;CHP1;SLC9A1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4445584403810775,-0.9884436616642464,0.5142348754448398,0.7881845272787498,1.0,5/10,20.92%,PRKCH;FOXC1;TRIM16;ETV4;NUMA1
prerank,response to exogenous dsRNA (GO:0043330),0.4290699694752621,0.988400702478569,0.45286885245901637,0.8572752118513313,1.0,2/18,2.28%,COLEC12;RFTN1
prerank,sterol biosynthetic process (GO:0016126),-0.3387368788690873,-0.9883984306839557,0.4829787234042553,0.7876400542203958,1.0,2/33,3.05%,PRKAG2;LBR
prerank,cellular response to glucose stimulus (GO:0071333),-0.3373006054373985,-0.9881250252381513,0.4704641350210971,0.7876436597941399,1.0,8/30,14.97%,UNC13B;IGF1R;GAS6;SLC39A14;KCNB1;ERN1;PRKAA2;RAB11FIP5
prerank,establishment of protein localization to membrane (GO:0090150),-0.2923527564371816,-0.9880773708244742,0.48507462686567165,0.7871162303479263,1.0,16/66,17.60%,AFDN;EGFR;SYNE3;RAB11A;SDCBP;RAB3GAP1;NACA;TAOK2;PARD3;ZDHHC24;REEP1;AQP11;FRMPD1;BID;MICALL1;RAB3GAP2
prerank,axonal transport (GO:0098930),-0.3322350190863455,-0.9880076753197605,0.4904051172707889,0.7866496497396003,1.0,12/36,23.47%,AP3S1;KIF1B;DTNBP1;AP3B1;HIF1A;SPAST;RAB21;FBXW11;BLOC1S6;DYNC1H1;AP3D1;PAFAH1B1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3363213985444123,0.9879452980119534,0.45395799676898224,0.8564554108992436,1.0,10/78,11.62%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;KIF3A;AP2B1;SEC13;KIF3C
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3363213985444123,0.9879452980119534,0.45395799676898224,0.8564554108992436,1.0,10/78,11.62%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;KIF3A;AP2B1;SEC13;KIF3C
prerank,UV-damage excision repair (GO:0070914),-0.42024368252923194,-0.9877051579314797,0.49070631970260226,0.7867647025921118,1.0,5/12,25.99%,INO80;DDB1;ERCC1;ACTR5;POLA1
prerank,peroxisomal membrane transport (GO:0015919),0.3993725604316067,0.9874607890770613,0.46506986027944114,0.8565868669571804,1.0,8/27,15.33%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;PEX12
prerank,lytic vacuole organization (GO:0080171),-0.3315524201979926,-0.9863004483349188,0.47530864197530864,0.7894903897994622,1.0,12/32,28.26%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN5;CLN6;MBTPS1;ACP3;MYO7A
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.40037095075467066,-0.9858725220562827,0.4674329501915709,0.7898873518206578,1.0,5/14,15.56%,EZR;RHOA;MYO9A;PATJ;OPHN1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2979661730323712,-0.985790245327824,0.4722222222222222,0.7894457810103728,1.0,14/56,12.29%,ROCK2;SNX9;PDCD6IP;RHOA;USP8;RHOB;MYH10;ARL3;SON;TTC19;SPAST;EFHC1;CHMP4B;EFHC2
prerank,negative regulation of hippo signaling (GO:0035331),0.4691113185102614,0.985581601659842,0.48132780082987553,0.8597541889831171,1.0,2/12,5.01%,LIMD1;AJUBA
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3328525624975986,-0.9851228897059475,0.4774590163934426,0.7904073029753377,1.0,5/31,4.10%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2
prerank,lipoxygenase pathway (GO:0019372),-0.40719785199567143,-0.9850822307169478,0.4854368932038835,0.7898732886432333,1.0,5/14,17.85%,GPX4;PTGS2;PON3;GPX1;ALOX12
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3997689875734227,0.9848017863654204,0.4660377358490566,0.8605925560628461,1.0,4/27,7.95%,PER2;CRTC1;SIK1;PPP1CC
prerank,lysosome localization (GO:0032418),0.37476209565073765,0.9846961343345821,0.4519230769230769,0.8599364429559275,1.0,2/37,1.93%,PIK3CD;MYH9
prerank,transferrin transport (GO:0033572),-0.3367223046358663,-0.9845741322066175,0.4682203389830508,0.7904181855121446,1.0,15/33,28.05%,STEAP3;ATP6V0A4;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;HFE;ATP6V0A2;REP15;MCOLN1;ATP6V1F;ATP6AP1;ATP6V0D1;ATP6V0C
prerank,regulation of chemotaxis (GO:0050920),0.39050765531142784,0.9844130106047222,0.45621181262729127,0.8596436371712566,1.0,1/30,0.19%,PDGFRB
prerank,hexose transmembrane transport (GO:0008645),0.4159260099294041,0.9839110658375151,0.46464646464646464,0.8598578296712167,1.0,5/21,8.07%,SLC5A1;PPARD;SLC45A1;SLC2A6;SLC2A3
prerank,cellular response to lipid (GO:0071396),0.3016265311479891,0.9836016926669863,0.4713114754098361,0.8596753603011462,1.0,27/191,9.60%,MEF2C;PID1;RORB;RORA;ATP1A2;GPER1;NR1H3;IL1B;FFAR2;CXCL5;AXL;ADCY3;ADCY8;NCOA3;ADCY6;BRINP1;CXCL10;TNIP2;PDE4B;CACTIN;IRS1;FAM210B;BRINP3;LYN;HTRA2;MED1;MAP4K1
prerank,regulation of neuron apoptotic process (GO:0043523),0.32964309850551804,0.9832239795620634,0.47619047619047616,0.859565985751433,1.0,19/96,14.40%,SLC30A10;MEF2C;NF1;AGAP2;UNC5B;TFAP2B;NTRK2;LIG4;PPT1;AKT1S1;NFATC4;GRM4;CPEB4;TRIM2;SET;KDM2B;RASA1;MAG;SIX4
prerank,cellular protein modification process (GO:0006464),0.2615652272821606,0.9831608633651789,0.532051282051282,0.8588140732925679,1.0,128/982,11.07%,ART3;PTPRK;PTEN;CEL;PRKG1;MAP3K20;PIK3CD;PARP8;PIGU;CDH2;IGFBP7;PRKCSH;GCNT2;CDK6;MAP3K5;SDC2;METAP2;PTPN9;SNRK;ST8SIA4;LAMC1;PEAK1;MFGE8;PPM1E;FRK;PKN1;WSB1;MARK1;BTRC;USP25;PRKAR1B;HUNK;MERTK;NUAK2;PTAR1;ROCK1;AKT3;FNIP2;PTPN22;CUL3;SSH2;ST8SIA1;CTH;CHML;RPS6KA4;MMP15;LIMK1;RBX1;GRK3;CDK15;CDC42BPA;STK39;JAK1;STK38L;COG7;PPP3CA;PPP2R2A;MINK1;LAMB1;RYK;PTPN4;TESK2;PSMB11;EPAS1;SOCS5;SERPINA10;TNKS;SPARCL1;TRIB2;GPC3;ROS1;NEK1;ATE1;TTBK1;TAOK3;ASB8;PSMF1;SIK1;MSRA;YWHAZ;KCTD6;B3GALT1;PAK6;UBE2E1;LMTK3;MAP4K4;PPP1CC;STK24;STK3;MTOR;STC2;PTPRT;ACVR2B;MIA3;HLCS;NEK6;PRKD2;GRK5;RAB38;FUT9;MARK2;CSK;OARD1;LYN;CDC14B;PDGFB;B3GNT8;ANO8;BIRC6;MAP4K1;MTMR7;CSNK1E;PAK5;COQ8A;MAPK10;CHST5;NUAK1;BTBD6;TEC;BRSK1;SOCS6;DYRK3;ABL2;GAD1;PAK3;LATS2;BRAF;NPC1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3837325323838596,-0.9831197767617953,0.498015873015873,0.7933264296548466,1.0,8/18,28.65%,CCN3;KCNB1;SFRP1;MIDN;PRKN;SIRT4;ADRA2A;CHGA
prerank,positive regulation of T cell differentiation (GO:0045582),-0.3178335501672792,-0.9828238511988863,0.49107142857142855,0.7933894716929305,1.0,14/36,30.22%,ZMIZ1;GLI2;LEF1;GLI3;DUSP10;RHOH;SOX12;PNP;MDK;XBP1;NCKAP1L;SOCS1;IL7;VSIR
prerank,liver development (GO:0001889),-0.33807892844609666,-0.9823747521234414,0.474025974025974,0.793782808440344,1.0,7/32,13.23%,TGFBR3;WNT4;ANXA1;LSR;CEBPG;ZIC3;MET
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2918639700545049,-0.9823469245525481,0.47368421052631576,0.7932034086252615,1.0,36/62,36.43%,ARHGEF2;LRRK2;CXCL12;TPT1;AKT1;MCL1;YBX3;MDM2;PPIA;ENO1;TMBIM6;CREB3;CREB3L1;SNAI1;PARK7;PLAUR;NDUFA13;XBP1;BCL2L1;PRKN;BAG5;CDKN2D;SOD2;PTTG1IP;CLU;SYVN1;HSPB1;HYOU1;PINK1;RTKN2;MAPK7;VNN1;EPO;NME5;HERPUD1;PPIF
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3329666293460045,0.9822879922937804,0.4599358974358974,0.8598843743121635,1.0,10/79,11.62%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;KIF3A;AP2B1;SEC13;KIF3C
prerank,nucleosome assembly (GO:0006334),-0.3341690422646736,-0.9822066904583588,0.48514851485148514,0.7928972473571249,1.0,17/31,37.44%,KAT6B;UBN1;H3-3A;ANP32B;HMGB2;RSF1;NAP1L2;BRD2;HAT1;CHAF1A;ASF1A;NAA60;SPTY2D1;IPO4;ASF1B;ATRX;GRWD1
prerank,negative regulation of cation channel activity (GO:2001258),0.40758376621143194,0.982070947287628,0.4750499001996008,0.8594897303353629,1.0,1/26,0.51%,CASQ2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.29473235925285546,0.9818554660078005,0.48760330578512395,0.8590528101826775,1.0,14/199,3.08%,PLCL1;PTEN;MEF2C;HEY2;BMP5;NOTCH1;RGCC;NR1H3;NODAL;IL17RD;ROCK1;SPRED1;IL1B;RPS6KA4
prerank,regulation of mitotic nuclear division (GO:0007088),0.3495362362878956,0.9815335162418584,0.45840407470288624,0.8588503086982832,1.0,3/55,2.65%,PDGFRB;RGCC;IL1B
prerank,positive regulation of histone methylation (GO:0031062),-0.36046879437323465,-0.9814949653085154,0.4768611670020121,0.793940986440715,1.0,1/24,0.09%,AUTS2
prerank,steroid metabolic process (GO:0008202),0.3382333219271679,0.9814257810905297,0.4720394736842105,0.8581953757196524,1.0,10/72,13.50%,CYP7B1;RDH5;ARV1;BAAT;NPC1;LSS;STAR;SRD5A1;PRLR;CYP11B1
prerank,cellular response to retinoic acid (GO:0071300),-0.3159988776280273,-0.9810631127612861,0.5,0.7943389785802503,1.0,11/42,13.56%,EPHA3;WNT6;WNT9A;WNT5A;PTK2B;TBX1;FZD4;FZD7;WNT5B;ATM;RET
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.38111207321290635,0.980976599392794,0.45540796963946867,0.858293925926856,1.0,6/33,10.51%,AFAP1L2;GPER1;NCF1;CNOT9;HIP1;DGKD
prerank,negative regulation of neuron death (GO:1901215),0.3292853167266686,0.9796635941270012,0.47419354838709676,0.8602154789698777,1.0,19/93,14.40%,SLC30A10;MEF2C;AGAP2;UNC5B;INPP5A;NTRK2;SNCA;LIG4;PPT1;NFATC4;HTRA2;CPEB4;BTBD10;SET;KDM2B;TRAF2;RASA1;MAG;SIX4
prerank,protein acetylation (GO:0006473),-0.3411686635436658,-0.9792463618845684,0.4925373134328358,0.798080637348086,1.0,11/30,24.90%,FOXO1;KAT2B;NAA35;SPHK1;CLOCK;NAA40;NAT10;NAA80;NAT9;HAT1;ING4
prerank,necroptotic process (GO:0070266),-0.38954391704592495,-0.9792230782867238,0.49304174950298213,0.7974919017655011,1.0,5/16,17.36%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1
prerank,positive regulation of cell development (GO:0010720),0.3790382037921165,0.9791346398342071,0.46167883211678834,0.8605142395901012,1.0,2/31,1.66%,PDE3A;GPER1
prerank,protein homooligomerization (GO:0051260),-0.26196487024914794,-0.9786401219073037,0.48823529411764705,0.7983237613075508,1.0,27/114,16.63%,ALDH1A2;RNF213;KCNJ2;SCARA5;B2M;CLYBL;PDCD6IP;APPL2;SSBP1;UPB1;ALS2;GLRA3;GLS;EHD1;SAMHD1;RNF135;ACACA;SPAST;GSDMD;DISP1;GBP5;ATL2;NINJ1;BEND3;AQP11;ELAVL1;PNPT1
prerank,protein processing (GO:0016485),0.32250777745123194,0.9785759358227661,0.4946564885496183,0.8607987244628262,1.0,6/102,3.09%,TMPRSS4;GGT1;CPM;METAP2;ADAM19;ECE1
prerank,vasculature development (GO:0001944),0.4393084347989933,0.9784028702325946,0.47186147186147187,0.8603026036021565,1.0,2/16,3.05%,PDGFRB;PIK3CA
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.41845031791137155,-0.9781680642241438,0.4876660341555977,0.7988323831514544,1.0,3/12,8.14%,DPYSL3;DPYD;CTPS1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.38586074185914915,-0.9781072581440924,0.46641074856046066,0.7983189713151568,1.0,9/16,33.16%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.3493628733346821,-0.977784243521949,0.5177165354330708,0.7984663711827443,1.0,11/27,26.57%,RNASE4;NYNRIN;ZC3H12A;ERN1;XRN1;TOE1;DICER1;NUDT16;ZC3H12B;NHP2;POP1
prerank,endodermal cell fate commitment (GO:0001711),-0.43943939203442495,-0.9777541092724776,0.514018691588785,0.7978824280418413,1.0,2/10,13.40%,RTF1;SOX17
prerank,positive regulation of organelle assembly (GO:1902117),-0.3096093238444426,-0.9777141772974456,0.4874715261958998,0.797340215246618,1.0,20/44,28.08%,ASAP1;SDCBP;PDCD6IP;SDC4;RAB3GAP1;PIP4K2B;SH3GLB1;G3BP1;SDC1;TAPT1;RAB3GAP2;STX18;DYNC1H1;NUMA1;PLK4;LCP1;CCP110;G3BP2;SPAG5;NUP62
prerank,protein targeting to lysosome (GO:0006622),-0.3741634084117656,-0.9773304714171483,0.50293542074364,0.7975758931107185,1.0,9/20,30.94%,LAMP2;HGS;AP4M1;RAB7A;ZFYVE16;NCOA4;CLU;LAPTM5;NEDD4
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.41740246378699275,-0.9773014945125172,0.5018939393939394,0.7969986087015001,1.0,4/12,15.67%,CLCN2;LPCAT3;RAN;SREBF1
prerank,protein modification process (GO:0036211),-0.27837032515953014,-0.9769910140065493,0.4899713467048711,0.7971491918496966,1.0,24/76,24.65%,ST3GAL6;ST3GAL1;CPE;YES1;PHKA2;PLOD2;WWP2;SEPHS1;DUSP12;ST8SIA2;NEDD8;FBXL2;UBA3;MANBA;UBA7;RPN2;UBE2M;UBE2L6;PHEX;LCMT1;BAP1;AKT2;LOX;UBL4A
prerank,microvillus assembly (GO:0030033),0.44398394811353326,0.9769850826404308,0.4722222222222222,0.8625070746841215,1.0,4/14,7.93%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2977105897565063,-0.9762228838165175,0.5121359223300971,0.7984242896866938,1.0,12/56,16.00%,LBP;NOD1;IRAK2;LACC1;CTSB;SFTPA2;SFTPA1;CTSS;UBB;PLCG2;MAPKAPK3;TLR4
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3636340216735079,-0.9761650168033726,0.5,0.7979145163581763,1.0,4/22,14.24%,BMP7;B2M;CALR;DTX1
prerank,positive regulation of B cell proliferation (GO:0030890),0.3923101574723398,0.9760807283307033,0.47191011235955055,0.8635562079116141,1.0,2/29,6.10%,MEF2C;IL4
prerank,neuron differentiation (GO:0030182),-0.24919022559916879,-0.9755885157652489,0.47115384615384615,0.7987143150611421,1.0,28/165,15.56%,PBX1;WNT4;GLI2;PBX3;WNT6;DTNB;TGFBR1;LRP6;FZD2;WNT9A;HS6ST1;WNT5A;WNK1;NRBP2;FZD4;VSX1;LHX6;NR4A2;FZD7;WNT5B;ITM2C;ID2;ATOH8;MET;WNT16;UGCG;FZD8;OPHN1
prerank,transepithelial transport (GO:0070633),0.4275229987345339,0.9754975588631668,0.4673684210526316,0.8639153939184614,1.0,1/15,0.67%,SLC12A2
prerank,sensory perception of sound (GO:0007605),0.32454564583843637,0.9754899735870023,0.4625,0.8630546223073167,1.0,3/88,1.29%,GRM7;ROR1;COL4A3
prerank,ncRNA 3'-end processing (GO:0043628),0.4450888346665093,0.975314787886249,0.46421267893660534,0.8625786516872487,1.0,3/14,14.28%,INTS6L;SSB;INTS12
prerank,protein polyglutamylation (GO:0018095),0.46236481909820537,0.975065770680514,0.45594713656387664,0.8622357242000235,1.0,6/11,21.30%,TTLL11;CEP41;TPGS1;CFAP20;TTLL5;TTLL7
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.43448266893761567,-0.9749977879104141,0.5178907721280602,0.7994596537601565,1.0,3/10,9.92%,LGALS9;PRKCZ;IL18
prerank,regulation of blood coagulation (GO:0030193),0.400276102626582,0.9746856670193311,0.4627151051625239,0.8621826870857295,1.0,2/27,1.04%,FAP;VTN
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3260774944365843,-0.9742401504128406,0.5202702702702703,0.8005856124593863,1.0,12/38,17.36%,SP100;NOS3;THBS1;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SFRP1;SERPINE1;GPX1;RIPK1
prerank,response to molecule of bacterial origin (GO:0002237),0.3384520859144082,0.9740361609731133,0.4564102564102564,0.8627689589242205,1.0,6/69,6.31%,GGT5;GGT1;IL1B;PTPN22;OTUD5;SNCA
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.38569330112890876,0.9739474549916924,0.46421663442940037,0.862076933969842,1.0,15/31,25.12%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;PEX12;TOMM40;PEX2;TOMM70;PEX5;DNAJC19;PEX6;PAM16;TIMM17A;DNLZ
prerank,Golgi organization (GO:0007030),0.3119069184585828,0.9738802411703731,0.48632218844984804,0.8613538679680592,1.0,31/112,17.73%,ARHGAP21;SYNE1;STX16;COG7;PDCD10;ATP8B2;CLASP2;COG1;VTI1A;ARFGEF1;YWHAZ;HACE1;BLZF1;TMED7;TMED4;UBXN2B;ARHGEF7;VPS51;TRIP11;GCC2;VTI1B;TJAP1;VMP1;STK25;RAB1A;CSNK1A1;HTT;PRKD1;GOLGA8B;GOLGA5;GORASP1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3321034313058739,0.9736879964026659,0.478330658105939,0.8608635839503898,1.0,16/78,15.17%,PTEN;RGCC;SPDYA;HEXIM1;CDKN1A;NR2F2;PKD2;INCA1;PDGFB;CCNYL1;LATS2;APC;CCNH;BLM;PSRC1;GTF2H1
prerank,cranial nerve development (GO:0021545),-0.4305426616238417,-0.9736669721953889,0.5057471264367817,0.8012904595323957,1.0,1/11,1.50%,CHD7
prerank,lipid transport (GO:0006869),0.3182690012222794,0.9732574156117965,0.500763358778626,0.8609173997786064,1.0,11/97,6.76%,PITPNC1;SLCO3A1;SCARB1;SLC51B;ABCD2;LDLR;PPARD;SLC27A4;FABP3;ABCA5;PRELID3A
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4524951733453153,0.9728134324688045,0.4802494802494803,0.8610959698263134,1.0,3/12,16.22%,GNL3L;CCT3;CCT7
prerank,protein phosphorylation (GO:0006468),0.2714510416344149,0.9727083005176577,0.529685681024447,0.8604458915370841,1.0,77/478,11.59%,PDGFRB;MAST4;PRKG1;MAP3K20;PIK3CD;CDK6;MAP3K5;PTK2;SNRK;PEAK1;FRK;PKN1;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;ERBB4;RPS6KA4;LIMK1;GRK3;CDK15;ABI2;CDC42BPA;STK39;JAK1;STK38L;RPS6KB2;MINK1;CSNK1G1;RYK;RPS6KA2;TESK2;TNKS;TRIB2;ROS1;NEK1;NTRK2;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;MAP4K4;STK24;STK3;MTOR;ACVR2B;NEK6;PRKD2;GRK5;MARK2;CSK;LYN;PDGFB;BIRC6;ATR;MAP4K1;CSNK1E;PAK5;COQ8A;MAPK10;NUAK1;TEC;BRSK1;DYRK3;ABL2;PAK3;LATS2;BRAF;PAK1;PRKX;HIPK1
prerank,gene silencing by miRNA (GO:0035195),0.3860579350618258,0.9726110275376657,0.46,0.8597711191471568,1.0,7/32,12.53%,LIMD1;AJUBA;AGO3;TARBP2;TNRC6C;EIF6;TNRC6B
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.42555082737123984,-0.9722380071139075,0.5008976660682226,0.8040116869521063,1.0,8/11,41.41%,P2RX4;CDH13;PLCG2;TREM2;P2RX3;TRAT1;CCL4;NEUROD2
prerank,regulation of steroid metabolic process (GO:0019218),0.4020028340691321,0.9719735360912137,0.4722753346080306,0.8602592796485402,1.0,7/23,19.85%,RORA;ARV1;STAR;ASAH1;RORC;FMO5;STUB1
prerank,neuron apoptotic process (GO:0051402),0.4161552612626301,0.9719459897352706,0.4802494802494803,0.8594679453673001,1.0,3/19,7.07%,TNFRSF21;SCN2A;LIG4
prerank,regulation of dendritic spine development (GO:0060998),0.4089625728329337,0.9717135276721239,0.4626262626262626,0.8590723591740594,1.0,1/19,0.66%,MEF2C
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.42194689882091463,0.9714303207156122,0.4789915966386555,0.8588472155466782,1.0,2/15,5.20%,FAP;CLASP2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.40585315694457946,-0.9713143670287183,0.5029126213592233,0.8056002243314185,1.0,5/13,15.78%,NIBAN2;HGS;DAB2IP;EMILIN1;HHEX
prerank,response to ionizing radiation (GO:0010212),-0.2839733401046343,-0.9711365160212956,0.49242424242424243,0.8054259663349598,1.0,23/70,25.48%,EYA1;ANXA1;MAPK14;INO80;RHOB;EEF1D;NHEJ1;NABP1;XRCC4;ATM;CLOCK;INIP;NET1;BABAM2;IKBIP;BABAM1;RAD51;BRCA1;BRAT1;STK11;RNF8;TP53;HUS1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3393589490838452,0.9709377395065762,0.4853195164075993,0.8590961813295025,1.0,15/62,13.27%,MEF2C;CDK6;MYL9;HOXA9;AGO3;KMT2B;LYN;CNOT4;PRMT1;TNRC6C;EIF6;RBM15;EP300;TNRC6B;CTR9
prerank,sulfur amino acid catabolic process (GO:0000098),0.46753321099610845,0.9708845074810776,0.4751131221719457,0.8583501543221886,1.0,2/10,5.39%,CTH;TXN2
prerank,positive regulation of cellular component movement (GO:0051272),-0.3494692581187388,-0.9707640438157159,0.49377593360995853,0.805669050478431,1.0,11/24,24.31%,PDPN;TGFBR1;SPOCK2;CAVIN1;RPS19;NTN1;CSF1R;CCL19;VEGFA;AKT2;STK11
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4023011909387125,0.9707422442247737,0.46124031007751937,0.8577925634431558,1.0,5/24,7.53%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,positive regulation of apoptotic process (GO:0043065),0.2804439758574088,0.970468015881652,0.5024813895781638,0.8575606958146501,1.0,44/293,13.09%,DLC1;ARHGEF17;FAP;MAP3K20;KALRN;PLEKHG2;MAP3K5;ARHGEF6;GPER1;NF1;RYBP;SLC27A4;RPS6KA2;ITGB1;TNFRSF8;TFAP2B;DDX3X;SNCA;ARHGEF12;ARHGEF26;SOX4;SIK1;CASP9;BIN1;SOS2;RNPS1;STK3;TNFAIP8;CCAR2;ARHGEF9;HTRA2;MTCH2;PNMA1;ARHGEF7;LATS2;SFRP2;BCLAF1;ARHGEF4;APC;FAM162A;KCNMA1;RRP1B;TRAF6;PSEN1
prerank,protein-containing complex subunit organization (GO:0043933),0.3103060511385184,0.9704401982683197,0.47530864197530864,0.8567713310461766,1.0,7/109,4.01%,LIN7A;LAMC1;WASF3;WAS;WIPF1;WASL;RIMS1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3560050138585577,0.9701281668432336,0.4863481228668942,0.8565941932248972,1.0,14/52,11.09%,PIK3R1;EPB41L2;PTPN9;GPER1;EPB41;SPTBN1;DPP10;ITGB1;NKD2;EFCAB7;STAC;EPHA2;RANGRF;STX4
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.46420175783409173,0.9697882952468776,0.45861297539149887,0.8564475548543141,1.0,3/10,7.85%,KCNE4;ANK3;KCNE5
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.36174478636024704,0.9691761783072613,0.4782608695652174,0.8568486480431319,1.0,8/44,10.17%,GNG2;KCNJ12;KCNMB1;AKAP6;ATP1B2;KCNE5;KCNJ3;KCNJ6
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.44357338969643767,0.968876509059394,0.47854077253218885,0.8566728447719553,1.0,2/12,5.08%,IL1B;CARD9
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.26658755905286324,-0.968526679618555,0.5137362637362637,0.810416008553739,1.0,30/101,20.06%,SAMD4A;VGLL4;VIM;CYFIP2;THBS1;EZR;KLF4;LARP4B;CSF1;NIBAN1;RPS4X;AKT1;UPF3A;CASP8;VPS35;TBC1D10A;CPEB3;TGFB1;FGFR4;FBXW11;RPL26;ATG10;FXR2;ELAVL1;NFKBIA;ZCCHC4;AGTR1;AGT;NAT10;METTL5
prerank,macrophage activation (GO:0042116),-0.32691340337188834,-0.9681807818617982,0.5010660980810234,0.8105400943037822,1.0,5/34,4.84%,FOXP1;APP;LBP;SBNO2;CD93
prerank,"transcription, DNA-templated (GO:0006351)",-0.24061755455087788,-0.9681561608146924,0.554006968641115,0.8099347518178454,1.0,67/207,27.36%,MAF;NFIX;GLIS3;FOXO3;TSC22D1;DDX5;PIR;MLLT3;TAF1;TRIM24;THRB;NOCT;POLR2A;RTF1;IRF9;RREB1;PMF1;NR4A2;IVNS1ABP;MMS19;PWP1;MEF2A;POLR2F;POLR3GL;EAF1;ELOB;DTX1;TAF4B;CDK9;GTF3C2;MNT;GTF3C5;POLR2E;TBPL1;BRF2;GTF3C1;UBTF;TEFM;E2F1;TAF9B;TTF1;POLRMT;THAP1;TCEA1;ELOC;RSF1;MRPL12;NFE2L3;NELFCD;HSF2BP;TAF5;XBP1;CEBPD;ERCC2;POLR2G;HIPK3;EPC1;CBFB;PPP5C;ERCC3;TP53;RRAGC;TAF11;COPS2;CDK7;CTDP1;NAT14
prerank,protein transport (GO:0015031),-0.22736557581090247,-0.967892148267864,0.5285714285714286,0.8099749832034943,1.0,86/332,20.69%,ABCA1;VAMP5;LAMP2;STEAP3;APOE;MACF1;ARL4A;TBC1D22A;SGSM2;SNX9;SNX6;CALCRL;KIF13A;ARHGEF2;TLK1;ATP6V0A4;RAMP2;COPZ2;SEC31A;RABGAP1L;RCN3;STX7;USP6NL;PRKCB;TXNIP;TBC1D8B;GGA2;STX3;TFRC;ARFIP2;GOLPH3;TOM1;TBC1D8;COPA;EHD1;ATP6V1G1;AP3B1;ATP6V0B;STX1A;ARRDC1;TMEM167A;USO1;RAB21;AP4M1;OPTN;VPS35;TBC1D10A;ATP6V0A1;RAB7A;STX6;RAB8A;TCIRG1;AP2A1;EVI5;UNC119B;SCFD2;ARL5A;TBC1D2;HFE;ARL6IP5;ATP6V0A2;NAPA;TBC1D25;SEC23IP;RAB18;RAB3GAP2;TBC1D13;REP15;RAB29;SAR1A;STX2;SAR1B;RAB6A;HSP90B1;PPY;RAB32;VPS26C;ARFIP1;RABL3;TMED9;YWHAH;ARRDC4;SNX8;MCOLN1;CANX;TBC1D14
prerank,regulation of lymphocyte migration (GO:2000401),-0.43276761672980796,-0.9677852575597187,0.5314183123877917,0.8096274435962414,1.0,3/10,9.46%,JAM2;AKT1;STK10
prerank,negative regulation of neuron projection development (GO:0010977),0.34996251061759315,0.9675370330727084,0.4946808510638298,0.8586951980400842,1.0,6/56,4.72%,PTEN;RTN4RL1;PTPN9;LINGO1;ADCY6;MYLIP
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3123588304346302,-0.9674843776128985,0.49440715883668906,0.8097196278045908,1.0,14/45,21.24%,EGFR;BMP4;DDX5;RBM20;POLR2A;ERN1;TGFB1;RELA;GRSF1;PNPT1;SIRT7;RIPK1;ZC3H18;RIOK2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4054306467699919,0.9673028923312426,0.47128712871287126,0.8583483430122205,1.0,2/22,2.65%,GPER1;IL1B
prerank,Rap protein signal transduction (GO:0032486),0.45786987249834504,0.9672833011203785,0.4879120879120879,0.8575504204146511,1.0,2/10,7.06%,RAPGEF2;RAP1A
prerank,ventricular septum development (GO:0003281),0.369003087284101,0.9669260576067022,0.4863883847549909,0.8574971413256862,1.0,4/37,1.75%,HEY2;HEYL;NOTCH1;SLIT3
prerank,genitalia development (GO:0048806),-0.4126218190403817,-0.9667790152996489,0.5027422303473492,0.8107820646075268,1.0,4/12,14.65%,CHD7;WNT5A;STRA6;PKD1
prerank,histone deacetylation (GO:0016575),-0.3126232740102236,-0.966685847235787,0.5125858123569794,0.8103794578789643,1.0,14/43,20.77%,HDAC4;TBL1XR1;HDAC8;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SMARCAD1;MORF4L2;SIN3A
prerank,lysine catabolic process (GO:0006554),-0.4081691516595152,-0.96658985159552,0.5129151291512916,0.809327023063489,1.0,5/12,28.88%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,lysine metabolic process (GO:0006553),-0.4081691516595152,-0.96658985159552,0.5129151291512916,0.809327023063489,1.0,5/12,28.88%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,phosphate ion homeostasis (GO:0055062),-0.4378640251077689,-0.9664847184279085,0.5404411764705882,0.8089567584282443,1.0,3/10,11.91%,ENPP1;SFRP4;FGFR4
prerank,regulation of intracellular pH (GO:0051453),-0.33160767430021537,-0.9663987014178915,0.5134529147982063,0.8085177878238536,1.0,10/34,19.66%,SLC9A2;SLC4A10;LRRK2;SLC9A9;SLC9B1;TM9SF4;SLC4A2;CHP1;NOX1;SLC9A1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4347735879801941,-0.9663037865144597,0.4906716417910448,0.8081194580769809,1.0,2/10,2.74%,APP;SHANK3
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.24727615190478855,-0.9657439301432924,0.5090252707581228,0.8088428865318192,1.0,35/170,17.14%,PRDM6;IGF1;AFF3;ROCK2;FOXP1;APOE;APP;CDH1;TAPBP;HINFP;NOVA2;AFF2;ATRAID;IGF2BP2;AFF1;PCBP2;HIF1A;ZC3H12A;PRDM5;TRIM27;NOVA1;AHR;ZNF462;PRDM11;YBX3;TRIM39;PTHLH;TRIM17;RNF187;KDM6B;MTMR3;CAVIN4;HNRNPAB;SIRPA;EDN3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4116043204883926,0.9648716521712892,0.4757085020242915,0.8601673053436714,1.0,6/22,17.22%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23;ZDHHC9
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4116043204883926,0.9648716521712892,0.4757085020242915,0.8601673053436714,1.0,6/22,17.22%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23;ZDHHC9
prerank,membrane repolarization (GO:0086009),0.44434285116384986,0.96484942597432,0.4978813559322034,0.8593777633962055,1.0,4/15,7.85%,ATP1A2;KCNE4;ATP1B2;KCNE5
prerank,hippo signaling (GO:0035329),-0.34632113485900046,-0.9648298227685511,0.5021097046413502,0.8103645824262112,1.0,4/26,6.47%,TJP2;TEAD4;YAP1;TEAD1
prerank,L-amino acid transport (GO:0015807),-0.3359527019004595,-0.9647220448855998,0.5010706638115632,0.8099825631643155,1.0,10/28,21.33%,SLC1A3;SLC7A2;SLC7A5;SLC38A5;SLC3A2;ARL6IP5;SLC7A1;SLC25A22;SLC36A1;SLC1A1
prerank,negative regulation of B cell activation (GO:0050869),0.4093694415924129,0.9646614310982162,0.47544204322200395,0.8589365807247986,1.0,3/21,9.19%,TNFRSF21;CD300A;LYN
prerank,organelle assembly (GO:0070925),0.27032558930972156,0.964539137206279,0.5232843137254902,0.8583453969874163,1.0,46/384,11.55%,DYNLL1;LIMD1;STARD9;NOTCH1;DZIP1L;IFT43;RILPL2;CDS2;RAB8B;TTLL3;CYS1;TMOD1;TTC36;IFT81;CCDC57;CENPW;IFT20;TNKS;MAPRE2;LSM3;YTHDF3;TMOD3;RBM14;NEK1;ATG16L1;CHMP2B;DDX3X;ATP2A2;SCLT1;FAM161A;NEK6;CORO1A;RAB38;EHD3;MVB12A;CDC14B;TP53INP2;CEP41;KIF3A;UBXN2B;LMOD1;SQLE;POGZ;AHI1;YTHDF2;CCDC66
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4611482842318081,0.9645244139064844,0.4889867841409692,0.8575415616598727,1.0,1/10,2.03%,DCLRE1B
prerank,regulation of intracellular transport (GO:0032386),-0.32137511210762487,-0.9643627307105249,0.5113636363636364,0.8101435703197182,1.0,17/38,28.21%,GAS1;LRRK2;RNF139;NDEL1;RINT1;ATP9A;TTC21B;REEP5;DYNC1H1;DYNLT2B;DNAJC30;NUMA1;NUP214;LCP1;SPAG5;INPP5F;ATP13A2
prerank,endochondral bone morphogenesis (GO:0060350),0.4522698440737748,0.9643017528161884,0.48863636363636365,0.857123608302768,1.0,1/11,0.66%,MEF2C
prerank,positive regulation of bone resorption (GO:0045780),-0.42226875775585093,-0.9634858830163552,0.5101289134438306,0.8115598414432994,1.0,8/11,40.06%,TNFRSF11A;SPP1;SYK;ATP6AP1;PRKCA;DEF8;MC4R;ADAM8
prerank,GPI anchor biosynthetic process (GO:0006506),0.37379294778622874,0.9633396075135389,0.4785276073619632,0.8583156611285189,1.0,7/30,16.73%,PIGU;PIGO;PIGZ;DPM3;PIGH;PIGX;PGAP1
prerank,synaptic vesicle cycle (GO:0099504),0.3736449587663344,0.963327171755112,0.48,0.8575115910447978,1.0,10/30,18.40%,SNAP25;RIMS1;SNCA;SLC32A1;BRSK1;RAB5A;CDK5;SYNDIG1;VAMP2;CPLX1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2757590851139322,0.9632487316093201,0.5316129032258065,0.8568199434518698,1.0,24/308,5.11%,GLMN;SOX5;PLA2R1;PIK3CD;TBXA2R;GCNT2;SMTNL2;PER2;RGCC;NODAL;FERMT2;ROCK1;TRPV2;PTN;IL1B;NCOA3;G0S2;FGF2;PPARGC1B;SYDE1;OGT;EPAS1;CARD9;GRB10
prerank,adipose tissue development (GO:0060612),-0.42721181312511997,-0.9632101461094755,0.49808429118773945,0.8115788789404101,1.0,5/11,22.78%,NAMPT;SPTLC2;DYRK1B;DGAT2;XBP1
prerank,cellular response to calcium ion (GO:0071277),0.3335549307278556,0.9629704102326511,0.4888888888888889,0.8565255330329952,1.0,14/67,11.39%,MEF2C;RASGRP2;ADCY8;ITPKB;CPNE7;SCN5A;SYT1;PKD2;RYR3;HPCA;SYT2;CPNE4;BRAF;CHP2
prerank,protein autophosphorylation (GO:0046777),-0.25095028245735584,-0.9623760156231659,0.5233333333333333,0.8129900213549291,1.0,47/157,21.29%,DAPK1;EPHA4;FLT1;EGFR;PDGFRA;TEK;FGFR2;STK17B;IGF1R;EPHB4;LRRK2;TAF1;DDR1;PTK2B;KIT;TAOK2;AKT1;STK10;EPHA8;BMX;ULK2;KDR;ERN1;CAMK2A;MKNK2;FGFR4;FLT4;FER;PIM3;OXSR1;ATM;MAPK3;MAPKAPK3;VRK2;EPHB3;RIPK1;MAP3K13;ALK;PDPK1;MAP3K3;PIM2;FES;CSF1R;SLK;CAD;RIOK2;PASK
prerank,cell-cell junction organization (GO:0045216),0.330284394319219,0.9621293380443191,0.4846029173419773,0.8575096724726818,1.0,11/79,7.04%,GJC1;LIMS1;CDH2;CDH4;CADM2;GJA4;CDH8;CDH19;CDH20;CDH7;CDH22
prerank,cellular response to exogenous dsRNA (GO:0071360),0.44459013737327197,0.9619130091023398,0.48497854077253216,0.857131614901578,1.0,1/12,1.07%,COLEC12
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3259206325109899,-0.9618333717295736,0.5108225108225108,0.8136606412851707,1.0,8/33,22.75%,FBN1;CSF1;TCTA;GPR137;TLR4;CEBPB;FSTL3;UBASH3B
prerank,programmed necrotic cell death (GO:0097300),-0.37492146722992425,-0.9615624943357423,0.5050301810865191,0.8136867948265998,1.0,10/18,38.14%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1;DNM1L;PPIF;CYLD;LY96;CD14
prerank,stem cell differentiation (GO:0048863),-0.3120366144894654,-0.9615167004661931,0.511520737327189,0.8131386959379656,1.0,14/39,22.56%,OSR1;FGFR2;MLLT3;LRP6;ACE;KIT;JARID2;PUM1;SFRP1;PSMD11;LMBR1L;METTL5;SP7;SETD6
prerank,cellular respiration (GO:0045333),0.36196035023363227,0.9605601978825582,0.5104529616724739,0.8592226739308776,1.0,11/41,18.89%,COX4I2;UQCRFS1;SLC25A13;BLOC1S1;UQCRC2;ETFA;ETFB;MTFR1;ETFDH;OXA1L;NDUFA5
prerank,positive regulation of hormone secretion (GO:0046887),-0.37580380345745107,-0.9605068163572598,0.5037453183520599,0.814899699123644,1.0,10/17,39.88%,C1QTNF3;SPP1;HFE;EDN3;VAMP8;GRP;EDN1;SNX4;NMB;SOX11
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3594368941343612,-0.9603210599440528,0.5251937984496124,0.8146715773332628,1.0,5/22,12.50%,SLC16A2;LRRK2;APPL2;GATA2;ID2
prerank,histone H3 deacetylation (GO:0070932),-0.3936579297651005,-0.9600037714019163,0.5150300601202404,0.8148347992691847,1.0,7/15,18.49%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT7;SIRT2;SMARCAD1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.359870882540926,-0.9599572596777515,0.521484375,0.8143041995654797,1.0,8/20,16.42%,SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;SEMA3B;SEMA3G;SEMA6B
prerank,positive regulation of vacuole organization (GO:0044090),-0.43188056321366786,-0.9599394870560052,0.540796963946869,0.8137086375786449,1.0,5/10,17.60%,ANXA2;RAB3GAP1;PIP4K2B;SH3GLB1;RAB3GAP2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34731408233684175,0.9598048254812248,0.5044563279857398,0.8600032800737096,1.0,11/49,12.53%,MEF2C;MYL9;AGO3;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;RBM15;EP300;TNRC6B
prerank,negative regulation of histone methylation (GO:0031061),-0.43402227323634296,-0.9585757878552803,0.5093984962406015,0.8163712952290122,1.0,5/10,32.03%,JARID2;DNMT1;BRCA1;AASS;KDM1A
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4307495667493664,-0.9579842677884688,0.5219123505976095,0.8170967394124621,1.0,2/10,7.53%,QRICH1;HSPA5
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3156352639294706,-0.9579419629393494,0.5370786516853933,0.816560779564909,1.0,15/42,29.28%,SMARCA2;INO80;CHD3;ANP32E;HDAC1;ACTB;SMARCC1;ACTR8;SMARCAD1;MBD2;SMARCA4;RNF8;ACTR5;SMARCD2;SMARCA1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3190759009934288,0.9577672621853037,0.49079754601226994,0.8635167016228964,1.0,3/85,1.29%,GRM7;ROR1;COL4A3
prerank,smooth muscle tissue development (GO:0048745),0.45182077934448495,0.9575379006721889,0.4923747276688453,0.8631750298525446,1.0,2/10,2.16%,MYLK;NF1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.413374898427109,-0.9574647112010097,0.5363128491620112,0.8170488269500962,1.0,6/12,25.15%,LRRK2;CCDC115;CLN5;CLN6;TMEM165;TMEM199
prerank,cell junction organization (GO:0034330),0.33129144962561746,0.9574494251877168,0.5033898305084745,0.8625317567689287,1.0,13/71,7.39%,LIMS1;APBB2;VASP;FERMT2;RAB8B;SH3BP1;RAB39B;GRM5;AGRN;SNCA;CHRNA7;FBLIM1;PPFIBP2
prerank,response to unfolded protein (GO:0006986),-0.30196649425754807,-0.9568549201570123,0.5333333333333333,0.8178716607972547,1.0,18/48,27.78%,HSPB8;SERPINH1;STT3B;HSPA5;BAG3;DAB2IP;OPTN;ERN1;DNAJB2;HSP90AB1;TMBIM6;DNAJB5;HSPA13;HSPA9;HSPB2;PRKN;HSPH1;HSPA1B
prerank,regulation of cellular protein localization (GO:1903827),0.3568387273406799,0.9568384755007543,0.48007246376811596,0.8629989745273844,1.0,13/45,17.68%,MAP2;GPC5;GPC3;CSNK1E;CCDC66;PTPN1;PRKAA1;PARP1;TRIM67;DVL3;TRIM46;TOR1A;GPC6
prerank,muscle filament sliding (GO:0030049),0.37142671370323,0.9568272517275888,0.5151515151515151,0.8613555237320053,1.0,3/38,7.63%,DMD;TMOD1;MYL3
prerank,actin-myosin filament sliding (GO:0033275),0.37142671370323,0.9568272517275888,0.5151515151515151,0.8613555237320053,1.0,3/38,7.63%,DMD;TMOD1;MYL3
prerank,double-strand break repair (GO:0006302),-0.24848569704543239,-0.9565566154085666,0.557632398753894,0.8179178623749876,1.0,50/158,26.30%,EYA1;PARP9;INO80;POLM;BAZ1B;SFR1;ERCC5;DCLRE1C;DTX3L;RAD51B;NHEJ1;SAMHD1;PARP3;BRCA2;NABP1;AP5Z1;XRCC4;ATM;RPA1;RAD50;HMGB2;PAXX;CYREN;ACTR8;SMARCAD1;PIAS4;VCP;RECQL;BABAM2;UBXN1;BABAM1;RAD52;RAD51C;MCM8;BAP1;ERCC1;SLX4;RAD51;CHEK2;BRCA1;RPA3;RNF8;PPP5C;ZSWIM7;RAD54B;ACTR5;HUS1;POLA1;APLF;PRPF19
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4138209209626415,0.9564523015919255,0.49586776859504134,0.8613376637537254,1.0,2/18,9.19%,BCAR1;LYN
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.46730627990707385,0.9559467644932055,0.5185185185185185,0.8615758250518767,1.0,6/10,25.00%,DERL3;UBAC2;INSIG1;ERLEC1;OS9;YOD1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.23965985920214114,-0.9557186859187388,0.5878136200716846,0.8193302665749183,1.0,63/193,25.89%,FBXL7;RNF213;SMURF2;FBXO10;RNF146;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;RNF144B;TTC3;SMURF1;CDC16;AMFR;RNF185;RC3H2;CHFR;DTX3L;KCTD10;ARRDC1;ZNRF3;UBE4B;ANAPC4;RNF125;WDR81;MDM2;UBB;UBE2G2;NEDD8;PSMD11;DDB1;FBXL14;ANKIB1;SPSB4;RNF40;UBR4;SPSB2;ANAPC16;NPLOC4;FZR1;PSMD3;RNF217;ELOC;UBE2L6;RFFL;RNF126;CDC27;ANAPC5;RNF144A;RBBP6;XBP1;PSMC2;KLHL15;PRKN;RNF19B;RNF8;BFAR;UBE2H;RNF11;ATXN3
prerank,fatty acid catabolic process (GO:0009062),0.3343263091381207,0.9554700707438785,0.4966887417218543,0.8616766160365534,1.0,8/67,8.57%,CEL;SLC27A2;ABCD2;PPARD;HADHB;SLC27A4;ABHD3;ECI1
prerank,regulation of DNA metabolic process (GO:0051052),-0.3099116966826252,-0.954829507741094,0.5462962962962963,0.8208075997300995,1.0,12/44,20.91%,HDAC8;TOM1L1;SMG6;POLH;MPV17;CDK9;WDR18;SMG5;SIRT7;SMARCAD1;THOC1;MPHOSPH8
prerank,protein deubiquitination (GO:0016579),-0.23605183204496202,-0.9545053460587574,0.6296296296296297,0.8209271966242342,1.0,78/242,27.04%,SMAD3;ESR1;USP47;SMURF2;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;RHOA;INO80;USP8;USP15;BIRC3;TRRAP;USP18;HGS;HIF1A;IL33;FOXK1;BECN1;USP34;ZC3H12A;USP5;USP11;USP35;PSME2;MINDY1;USP49;ATXN7L3;MDM2;PSMB4;UBB;ACTB;INO80D;PSMD8;PSMB1;NEDD8;PSMD11;PSME3;RIPK1;ACTR8;ADRB2;NFKBIA;STAMBP;PSMA2;PSMD4;IKBKG;PSMD3;VCP;TAF9B;SNX3;BABAM2;USP22;PSMB7;USP36;BABAM1;BAP1;USP2;PSMC2;CCP110;BRCA1;PRKN;USP10;PSMD10;SUDS3;PSMC5;TP53;ACTR5;MINDY2;SENP8;ABRAXAS2;ATXN3;INO80E;CDC25A;SMAD4;ENY2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.4589201769861868,0.9544613868884037,0.5064377682403434,0.8629574751964539,1.0,5/10,26.99%,PDE6A;SAG;CNGB1;GNB1;PDE6B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3795027932650927,-0.9544069483898007,0.5422138836772983,0.8205052016273356,1.0,10/17,34.85%,MDM2;SNAI1;RFFL;PRKN;PSMD10;CD44;TWIST1;PTTG1IP;KDM1A;CD74
prerank,nucleosome organization (GO:0034728),-0.28677716081894594,-0.9544057974944277,0.5513626834381551,0.8198699029311438,1.0,17/55,24.86%,KAT6B;INO80;BPTF;H3-3A;ANP32E;ANP32B;SMARCC1;HMGB2;MCM3AP;CTCF;RSF1;NAP1L2;BRD2;SMARCA4;CHAF1A;RNF8;ASF1A
prerank,glial cell development (GO:0021782),0.38830292925064935,0.9542062113347659,0.49390243902439024,0.862670003831338,1.0,4/25,6.60%,CDK6;NF1;TPPP;SOX4
prerank,JNK cascade (GO:0007254),0.3588419602095791,0.9541831983972991,0.49107142857142855,0.8618850986941219,1.0,5/40,10.08%,MAP3K5;ARHGEF6;MINK1;RIPK2;MAPK10
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4084571025859483,0.9540816561143296,0.4903100775193798,0.8612500947670626,1.0,4/21,2.15%,PTK2;PEAK1;VCL;ROCK1
prerank,regulation of integrin activation (GO:0033623),0.4348175901027671,0.9536414087757658,0.5079365079365079,0.861404702742147,1.0,3/15,6.67%,JAM3;FERMT2;FBLIM1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.42079290523087426,-0.9535962104453247,0.5194805194805194,0.8211206183300364,1.0,6/10,34.63%,HDAC5;PIH1D1;BRCA1;SMAD4;SPHK2;CHEK1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4405524566481103,0.9533496148587688,0.5053304904051172,0.8611771808024112,1.0,5/12,23.67%,KAT7;WRNIP1;BLM;METTL4;TIPIN
prerank,protein localization to cell periphery (GO:1990778),0.2987417008707088,0.9531587822673759,0.524812030075188,0.8607217264935731,1.0,20/133,9.71%,LIN7A;CACNB2;RAPGEF2;ROCK1;RAB8B;TSPAN15;SPTBN1;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;NKD2;EHD3;ZDHHC2;EPHA2
prerank,protein localization to cell junction (GO:1902414),0.4053663424844086,0.9530332460571653,0.5078125,0.8601825482784734,1.0,6/22,14.63%,JAM3;FERMT2;JAK1;KIF3A;NPHS1;CGNL1
prerank,regulation of intracellular protein transport (GO:0033157),-0.32783259502137874,-0.9526924234472633,0.5205479452054794,0.8225925743250637,1.0,16/32,28.21%,PTPN14;BMP4;NDEL1;IFI27;TGFB1;RUFY3;SIRT7;TPR;OAZ1;RAB29;LCP1;RIPOR1;ICE1;ZFAND1;B3GAT3;ATP13A2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.4340501916492762,-0.9526370346357192,0.5674676524953789,0.8214440677294612,1.0,6/10,37.59%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,DNA dealkylation (GO:0035510),-0.4340501916492762,-0.9526370346357192,0.5674676524953789,0.8214440677294612,1.0,6/10,37.59%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,Golgi inheritance (GO:0048313),0.45533596228179213,0.9524075646336433,0.5053995680345572,0.8606483233982313,1.0,3/11,13.78%,PDCD10;YWHAZ;STK25
prerank,chromatin assembly (GO:0031497),-0.31124858044779574,-0.9519923902836916,0.5524017467248908,0.8223093518901075,1.0,16/38,32.69%,KAT6B;H3-3A;ANP32B;EZH1;HMGB2;CTCF;RSF1;NAP1L2;BRD2;CHAF1A;ASF1A;TP53;NAA60;PAF1;POLE3;SPTY2D1
prerank,cellular response to interleukin-2 (GO:0071352),0.44222915959137865,0.9519273399931414,0.5041152263374485,0.8600256287575955,1.0,2/11,3.74%,IL2RA;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.44222915959137865,0.9519273399931414,0.5041152263374485,0.8600256287575955,1.0,2/11,3.74%,IL2RA;JAK1
prerank,regulation of mRNA metabolic process (GO:1903311),0.4507584528637041,0.9513846600339065,0.48008849557522126,0.8603020991010434,1.0,3/11,13.28%,PTCD2;SRPK3;SAFB2
prerank,photoperiodism (GO:0009648),0.38065888006242427,0.9510938108767835,0.5094339622641509,0.8600635347931119,1.0,4/28,7.95%,PER2;CRTC1;SIK1;PPP1CC
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2951863096338428,0.9510344276444852,0.5237410071942447,0.8593589832250834,1.0,17/150,6.53%,PDE4D;PTEN;DMD;PID1;NCK2;PPM1E;NF1;SPRED1;PRR5L;CADM4;SPRY2;TRIB2;INPP5J;TESK1;DBNDD2;SNCA;CACTIN
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.327913660198324,-0.9505094232414902,0.5511022044088176,0.8251021207419093,1.0,11/33,17.01%,GLUL;DDAH1;ALDH4A1;PRODH;GLS;DGLUCY;GCLC;SLC39A8;OAT;NIT2;FPGS
prerank,acylglycerol biosynthetic process (GO:0046463),0.4006401285364375,0.9502921172797872,0.5126705653021443,0.8600868670304596,1.0,1/23,0.50%,PLCE1
prerank,lipid homeostasis (GO:0055088),-0.2872731264800604,-0.9502060700333684,0.5421686746987951,0.8252080546721932,1.0,12/57,16.79%,ABCA1;RBP1;APOE;RCN3;TLCD2;ACOX1;USF1;PRKAA2;ADCK1;ACOX3;USF2;CLN8
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.3482142480238733,-0.9500859511435745,0.5343035343035343,0.824886819884761,1.0,8/23,20.86%,WEE1;PLK2;ZFYVE19;CHFR;NABP1;ZW10;PRCC;CDK5RAP3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.30370494246268565,-0.9500696003704423,0.5497835497835498,0.8242948734266969,1.0,11/46,12.89%,SMAD3;CDH1;TCF7L2;GAS6;PRKCD;ANP32B;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3889268372404699,0.9499085724536127,0.5038461538461538,0.8600170912938083,1.0,4/28,10.67%,MAP2;CLASP2;MAPRE2;CAMSAP3
prerank,negative regulation of lipid storage (GO:0010888),-0.3681602908506221,-0.9489015204553287,0.5354166666666667,0.8263111167539052,1.0,6/19,20.12%,ABCA1;OSBPL8;ITGB3;PPARA;NFKBIA;PTPN2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3984154428906394,0.9483229342281059,0.5078431372549019,0.8624873623479975,1.0,4/23,4.21%,MEF2C;NRG1;RBM24;AKAP6
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4222055826639638,-0.9474664337267683,0.5287356321839081,0.8290038165866603,1.0,3/10,6.74%,EZR;RHOA;MYO9A
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3288799638670913,-0.9471268497474306,0.5527426160337553,0.8291950992881143,1.0,8/30,21.31%,CD34;LGALS9;PRKCZ;STAT3;PLCG2;TLR4;SYK;CD274
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4104029373039053,-0.9468485189238514,0.5514563106796116,0.8292302358790506,1.0,7/12,31.45%,HSPA5;CHMP4B;CHMP4A;SEC61A1;SEC61B;GET3;SEC63
prerank,regulation of cation transmembrane transport (GO:1904062),0.37440452475812475,0.9467879315030425,0.5057034220532319,0.8648361515622048,1.0,11/29,14.06%,FGF12;DPP10;KCNAB3;SCN5A;PDZK1;CACNA1D;KCNE5;KCNIP1;RANGRF;KCNIP4;SLC30A5
prerank,regulation of rRNA processing (GO:2000232),-0.3785482933916612,-0.9467869384265339,0.5454545454545454,0.8287301498561978,1.0,6/16,23.79%,KAT2B;SIRT7;USP36;RIOK2;NUDT16;TRMT112
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.39057125823854655,-0.9464733910728309,0.5651340996168582,0.8288249113653361,1.0,8/15,25.20%,TCF7L2;GAS6;ANP32B;BAG3;TPR;XPO4;YWHAE;TP53
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.41385709171457175,-0.946405633866669,0.5357142857142857,0.8283568300613041,1.0,3/11,7.60%,IL6ST;STAT1;STAT3
prerank,regulation of translation (GO:0006417),-0.24294430441426026,-0.9457901027786143,0.5959595959595959,0.8291659393594454,1.0,52/173,25.81%,DAPK1;SAMD4A;IGFBP5;FOXO3;APP;VIM;THBS1;LARP4B;NIBAN1;CNOT7;RNF139;DDX6;CTIF;RPS4X;IGF2BP2;UPF3A;ATXN2;CPEB3;TCOF1;EIF4G3;CALR;RPL26;EIF4A2;CNOT8;LARP1;RPL10;GEMIN5;FXR2;EIF5B;ELAVL1;EIF2B2;PAIP2B;EIF4E2;ZCCHC4;TYMS;EIF1B;NAT10;METTL5;PASK;RPS27L;EIF2AK3;MTRF1;CSDE1;MIF4GD;EIF3B;SAMD4B;RPS6KA3;MTG1;RPL13A;RACK1;RPS3;EIF2AK4
prerank,regulation of chromatin binding (GO:0035561),-0.42080730125598165,-0.9457285418085142,0.5284403669724771,0.8286974559835508,1.0,2/10,8.93%,PARP9;DTX3L
prerank,DNA damage checkpoint signaling (GO:0000077),0.38986679332825797,0.9456468426334392,0.5114068441064639,0.8663940885759571,1.0,5/28,14.31%,MAP3K20;RAD1;ATR;ATRIP;RAD17
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2504049835705918,-0.9456192512019589,0.6005830903790087,0.8283393993455482,1.0,37/121,24.73%,SAMD4A;VIM;CNOT7;MOV10;PRKCD;RC3H2;AKT1;IGF2BP2;ZC3H12A;PSME2;PUM1;PSMB4;UBB;CNOT8;PSMD8;PSMB1;PSMD11;FXR2;EXOSC5;PSME3;ELAVL1;PNPT1;XRN1;PSMA2;CSDC2;ZFP36L2;PSMD4;PSMD3;PSMB7;NUP214;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMD10;PSMC5
prerank,regulation of proteolysis (GO:0030162),-0.2909349002753562,-0.945307718204829,0.5384615384615384,0.8284255328258663,1.0,11/48,14.38%,CAV1;CYFIP2;LTBP4;RNF139;CST3;AKT1;CASP8;TBC1D10A;FGFR4;FBXW11;NEDD8
prerank,presynaptic endocytosis (GO:0140238),0.3761011806027788,0.9452983000902706,0.4932301740812379,0.8663034087721361,1.0,6/24,15.49%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.4169759203060265,-0.9452184732747133,0.5596153846153846,0.8280074692843753,1.0,4/11,18.25%,LRP6;WNT5A;NR4A2;FZD1
prerank,gas transport (GO:0015669),0.46223689146654195,0.9451899345543616,0.5191873589164786,0.8657064984464834,1.0,1/10,3.56%,MB
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.38403281904798,-0.9451146165310693,0.5488029465930019,0.8276191189512307,1.0,5/16,14.48%,PARP9;DTX3L;PARP3;SHLD1;KMT5C
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4426370310483658,0.9447420685002954,0.48822269807280516,0.8658249104696318,1.0,2/11,3.80%,MERTK;AXL
prerank,regulation of protein acetylation (GO:1901983),0.4368803793733701,0.9446001238394738,0.5065502183406113,0.8652935996287758,1.0,8/12,30.43%,DDX3X;FAM161A;GSK3B;CAMK1;TERF2IP;CEP295;RAPGEF3;SIRT1
prerank,homologous chromosome segregation (GO:0045143),0.39805185342650007,0.9445665062119427,0.49015748031496065,0.8645335274482477,1.0,5/20,13.17%,FMN2;MEI4;MEIOB;PTTG1;FANCD2
prerank,regulation of interferon-gamma production (GO:0032649),0.3323299289915297,0.9440465622477416,0.5024875621890548,0.8647527671592956,1.0,6/71,8.32%,PDE4D;IL1B;PTPN22;AXL;PDE4B;IL12RB1
prerank,cellular response to ionizing radiation (GO:0071479),0.34898492480530696,0.9440461381569207,0.5016778523489933,0.8639408696329589,1.0,13/47,17.84%,MAP3K20;TNKS1BP1;LIG4;HRAS;CDKN1A;RAD1;ATR;NIPBL;TANK;BLM;RHNO1;HSF1;TLK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.337150326866151,0.9439660979062444,0.5322862129144852,0.8632882754238215,1.0,6/63,7.54%,MEF2C;NCK2;IL1B;CD46;IL4;FGF10
prerank,smoothened signaling pathway (GO:0007224),-0.31796115781454304,-0.9438926815837333,0.5522041763341067,0.8298649088297345,1.0,9/32,22.14%,GLI2;SMO;PTCH1;GLI3;HIPK2;EVC2;STK36;GLI1;TMEM17
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3988902262069406,-0.9433987957933916,0.5420393559928444,0.8303346996323446,1.0,3/13,12.83%,HIF1A;SPAST;UBB
prerank,negative regulation by host of viral process (GO:0044793),-0.4309405106793979,-0.9433083808416527,0.5687022900763359,0.8298976854412751,1.0,4/10,25.81%,ZC3H12A;VAPA;PRKN;EIF2AK4
prerank,cilium organization (GO:0044782),0.28247603135780036,0.9432277877927594,0.5557083906464925,0.8640061119644157,1.0,20/209,9.99%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RAB8B;TTLL3;CYS1;TTC36;IFT81;CCDC57;IFT20;NEK1;SCLT1;FAM161A;PKD2;EHD3;CDC14B;CEP41;KIF3A
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37886202631748356,-0.9425648603370947,0.555984555984556,0.8309993225663345,1.0,8/15,29.82%,CNOT7;CPEB3;TNRC6A;TENT4B;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,regulation of vacuole organization (GO:0044088),0.3994621703082827,0.9415318304409803,0.4878048780487805,0.8667246460349614,1.0,9/20,18.49%,IFT20;TBC1D12;PIKFYVE;NPRL3;NPRL2;UBQLN2;RAB5A;ENO2;RAB1B
prerank,regulation of biomineral tissue development (GO:0070167),0.38186365482103957,0.9411641569251884,0.5172413793103449,0.8666939250132653,1.0,3/26,2.15%,HEY2;NOTCH1;ROCK1
prerank,melanosome organization (GO:0032438),-0.3364558274786906,-0.9410517358791367,0.5625,0.83388485379245,1.0,14/26,33.33%,SHROOM2;KIF13A;DTNBP1;AP3B1;BLOC1S6;RAB29;HPS4;RAB32;AP3D1;LYST;AP1M1;BLOC1S4;ABCB6;SNAPIN
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4365522598679803,0.9405848214328143,0.4924078091106291,0.8670604126278089,1.0,4/12,13.04%,MAP2;SNCA;ARHGEF7;TUBB4A
prerank,regulation of protein targeting to membrane (GO:0090313),0.3752919167331624,0.9405748506609785,0.4753787878787879,0.866268452972096,1.0,5/28,7.53%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,regulation of membrane depolarization (GO:0003254),-0.37167141450980334,-0.94023662976446,0.5330739299610895,0.8351086226704435,1.0,5/18,6.94%,PTPN3;FHL1;SMAD7;LRRK2;GPD1L
prerank,protein localization to centrosome (GO:0071539),-0.37236915575007656,-0.9395828969806962,0.5714285714285714,0.8360328230587456,1.0,7/17,29.43%,GOLGB1;SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,positive regulation of axon extension (GO:0045773),-0.3500428701176703,-0.9395057018273161,0.5542168674698795,0.8355795441484574,1.0,10/22,22.64%,NRP1;MACF1;SEMA7A;NTN1;RUFY3;MAP3K13;ZFYVE27;MEGF8;VEGFA;DBN1
prerank,response to prostaglandin E (GO:0034695),0.4548186550217122,0.9394221795154157,0.5118790496760259,0.8678305583832768,1.0,2/10,3.98%,GNG2;ADCY6
prerank,rRNA transcription (GO:0009303),-0.3781483275036144,-0.9392442321481969,0.5633802816901409,0.8356017170792778,1.0,6/17,19.30%,CAVIN1;TCOF1;GTF3C2;GTF3C5;SIRT7;GTF3C1
prerank,cellular response to radiation (GO:0071478),0.35113242691926494,0.9392358157589712,0.5090252707581228,0.8674153871458135,1.0,10/40,14.53%,TNKS1BP1;OPN1MW;OPN1MW3;LIG4;CDKN1A;RAD1;RRH;OPN3;TANK;BLM
prerank,regulation of platelet aggregation (GO:0090330),0.41527170694928545,0.9388650100882119,0.48068669527896996,0.8673416830001738,1.0,2/17,3.61%,PRKG1;SH2B3
prerank,phagosome acidification (GO:0090383),-0.3419146717644407,-0.9387355416662481,0.5691699604743083,0.8361008072799,1.0,16/26,39.10%,ATP6V0A4;ATP6V1G1;ATP6V0B;ATP6V0A1;RAB7A;TCIRG1;ATP6V0A2;ATP6V1F;ATP6V0D1;ATP6V0C;ATP6V1D;RAB20;ATP6V1E1;ATP6V0D2;RAB39A;ATP6V1G2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.44960806136017745,0.9382122864525579,0.5121951219512195,0.8678956063755988,1.0,1/11,0.86%,PARP8
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.32641238406665923,-0.9380379035734501,0.5364806866952789,0.8371325493146129,1.0,6/29,11.96%,TGFBR3;FGFR2;SMAD7;FKBP1A;TGFB1;S1PR1
prerank,cilium assembly (GO:0060271),0.2704574841679736,0.9372374327603668,0.5765765765765766,0.8691269550990038,1.0,49/296,16.20%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RSPH6A;RAB8B;TTLL3;CYS1;JHY;TTC36;IFT81;CCDC57;IFT20;GAS8;NEK1;PRKAR2B;SCLT1;RSPH1;LRGUK;FAM161A;CFAP46;EHD3;CDC14B;DYNC1I2;CSNK1E;CEP41;KIF3A;IFT57;AHI1;NPHP4;CCDC66;KIF3C;CFAP20;TRIP11;CEP97;FUZ;TUBB4A;TCTN3;DCTN1;CEP19;CEP126;DCTN3;IFT80;MAK;CEP76;RAB1A;CEP135;TNPO1
prerank,protein destabilization (GO:0031648),-0.3266166402337792,-0.937153341505849,0.5668103448275862,0.838624554261584,1.0,9/32,14.60%,GSN;CTSH;RNF139;IRGM;CCDC88C;MDM2;FBXW11;SOX17;SERF2
prerank,regulation of muscle cell differentiation (GO:0051147),0.3753896090370621,0.9370219655605324,0.5337301587301587,0.8687710998717306,1.0,2/31,0.93%,MEF2C;CDH2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3812774897313209,0.9367747027672692,0.5147347740667977,0.8684988951775668,1.0,3/28,7.54%,SH3KBP1;TNIP2;FGF10
prerank,myelination (GO:0042552),0.3357946496185612,0.9367650947360892,0.5117967332123412,0.8677106492468623,1.0,7/46,6.75%,TNFRSF21;NF1;ABCD2;SCN2A;B4GALT6;TPPP;SCN8A
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.39317331039192366,-0.9364520745052649,0.5688976377952756,0.8394987218473945,1.0,7/13,24.03%,ABCA1;CD9;CDH13;CD81;SYK;LPL;ITGB2
prerank,cellular response to dsRNA (GO:0071359),0.42072065853469864,0.9356234440366048,0.5,0.8691827988106756,1.0,1/15,1.07%,COLEC12
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3890380289500168,-0.9355984371313693,0.5409181636726547,0.8408191574629963,1.0,4/14,26.57%,GAS6;PTPN2;RFFL;PYDC1
prerank,transcription by RNA polymerase II (GO:0006366),0.26523004653781435,0.9354073930685521,0.6079691516709511,0.8687727612084164,1.0,9/305,2.77%,NOTCH3;SOX5;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,innate immune response (GO:0045087),0.2830703373897191,0.9350858513993606,0.5679347826086957,0.868634681230723,1.0,26/217,9.77%,PIK3CD;COLEC12;PTK2;NCF2;FRK;NCF1;MID2;AKAP1;ANKHD1;WFDC3;CARD9;CAMP;TRIM62;CXCL10;TRIM43;IL4;DDX3X;SNCA;ALPK1;RIPK2;RNASE6;CORO1A;TIFA;ZDHHC1;LYN;CR2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.41250940738037734,0.9345668190565042,0.5188284518828452,0.8688950183916722,1.0,6/17,18.73%,CPEB1;NCBP2;CPSF6;CTR9;HSF1;CPSF7
prerank,response to glucose (GO:0009749),-0.2993706712828869,-0.9344997063592285,0.5560439560439561,0.8427387252297165,1.0,11/46,16.95%,UNC13B;THBS1;IGF1R;TCF7L2;GAS6;SLC39A14;KCNB1;ERN1;PRKAA2;NKX6-1;EIF2B2
prerank,positive regulation of cartilage development (GO:0061036),0.3992477521383774,0.9342952753468381,0.49452954048140046,0.8686440145183157,1.0,1/17,0.56%,SOX5
prerank,regulation of cell size (GO:0008361),0.38901444191232587,0.9338883356657258,0.5051334702258727,0.8686622731232096,1.0,3/23,8.26%,PTEN;AKT1S1;MTOR
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.3935365117230245,-0.9336566164228016,0.5361552028218695,0.8440961223145718,1.0,7/13,29.93%,SUFU;MDFI;PKD1;NFKBIA;DBN1;NFKBIE;KEAP1
prerank,negative regulation of viral process (GO:0048525),-0.2844568572704846,-0.9335474867668586,0.5813397129186603,0.8437377673718911,1.0,30/57,36.01%,IFITM3;STAT1;OAS2;IFIT1;MAVS;PML;TRIM27;TRIM35;PPIA;IFITM2;RNASEL;RSAD2;TRIM8;TRIM14;SRPK1;TRIM11;TRIM6;SRPK2;PLSCR1;ISG15;ZFP36;BST2;ILF3;PARP10;OASL;TRIM21;FAM111A;TRIM13;PROX1;ISG20
prerank,negative regulation of establishment of protein localization (GO:1904950),0.4445511310090919,0.9334932275914105,0.5369565217391304,0.8686590798435203,1.0,2/10,4.03%,NDFIP2;CORO2B
prerank,L-glutamate transmembrane transport (GO:0015813),-0.41732106088498777,-0.9329641193805921,0.5481481481481482,0.8444268033391729,1.0,4/10,21.33%,SLC1A3;ARL6IP5;SLC25A22;SLC1A1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3130914665160618,0.932642429277252,0.5420711974110033,0.8695817893407516,1.0,18/86,14.99%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1;NAV3;BIN1;EFEMP2;NCKAP1;LMOD1;PAK1;CFL2;RB1;PSEN1;DCTN1;PSRC1;CDC42EP4
prerank,regulation of cell cycle process (GO:0010564),-0.2551538636666625,-0.9325675747881509,0.6069364161849711,0.8447338026152179,1.0,34/104,28.43%,RAB11A;KIF13A;PLK2;CALM2;OBSL1;BECN1;FLCN;SH3GLB1;GIT1;UVRAG;CEP85;CAV2;SFRP1;DBF4;CALM1;MYO19;CCDC8;DYNC1H1;NUMA1;PLK4;CETN2;NUDT16;CUL9;RMI2;CCP110;BCL2L1;L3MBTL1;KLHL21;PLK5;CTNNB1;SPAG5;MKI67;KLHL9;FSD1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.42603347951961845,0.9321120265749943,0.5098425196850394,0.8698984383184585,1.0,2/13,6.10%,PID1;IL4
prerank,phospholipid biosynthetic process (GO:0008654),-0.3054092533997441,-0.9320711379362182,0.5701357466063348,0.8452424888937697,1.0,3/36,2.86%,SGMS1;AGPAT4;SGMS2
prerank,amyloid-beta metabolic process (GO:0050435),-0.3754218611691021,-0.9319926551624427,0.5669291338582677,0.8447833512292623,1.0,6/16,24.88%,ACE;IDE;BACE2;PSEN2;APEH;NCSTN
prerank,cellular zinc ion homeostasis (GO:0006882),0.37310321953619535,0.9314387705457496,0.5440613026819924,0.8704814948527685,1.0,1/26,0.46%,SLC30A10
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2798495677395945,0.9313206739483018,0.5810055865921788,0.86992099352497,1.0,28/184,16.47%,DYNLL1;HECW2;RGCC;BTRC;CUL3;PSMB11;PRKAR2B;PSMF1;APPL1;UBE2E1;NEK6;CDC14B;DYNC1I2;CSNK1E;CEP41;PSME4;TUBB4A;ANAPC2;MAD2L1;DCTN1;ANAPC7;SKP1;DCTN3;CEP76;CEP135;PSMB5;XPC;KCNH5
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3043510263683193,0.9310937056879888,0.5588235294117647,0.8695837404254239,1.0,17/100,10.61%,GLMN;CBFA2T3;PABIR1;RBX1;RYBP;OGT;SOCS5;TRIB2;DESI1;RCHY1;ZER1;NKD2;GNA12;CCAR2;DET1;CSNK1E;XPO1
prerank,hyaluronan metabolic process (GO:0030212),0.38776339439514046,0.9301391377256447,0.5247933884297521,0.8707151972798512,1.0,4/23,4.13%,CEMIP2;IL1B;HYAL4;FGF2
prerank,regulation of actin nucleation (GO:0051125),-0.3974602046581685,-0.9299694375481521,0.5607985480943739,0.8489538845867155,1.0,5/12,27.04%,GSN;ARFIP2;ARFIP1;ARPIN;PICK1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.36902244381013444,-0.9299564148268794,0.568738229755179,0.8483447428393769,1.0,4/18,13.62%,SLC25A4;CAMK2A;BNIP3;SPG7
prerank,regulation of transport (GO:0051049),-0.31659890696788173,-0.9298640217444494,0.5829694323144105,0.8479355375792814,1.0,8/36,15.50%,LEPR;NRP1;RAB11A;LRRK2;ACTG1;ACTB;ARL6IP5;REEP5
prerank,T cell activation involved in immune response (GO:0002286),-0.39531548336570466,-0.9296946204721941,0.5805168986083499,0.8477014846993268,1.0,4/12,25.81%,ICAM1;MDK;LCP1;EIF2AK4
prerank,actomyosin structure organization (GO:0031032),0.3177718100283701,0.9293325386304933,0.547107438016529,0.8715883921895861,1.0,13/75,6.50%,TNFAIP1;EPB41L2;MYH9;ROCK1;CUL3;EPB41;ITGB5;CDC42BPA;TMOD1;PDCD10;ITGB1;TMOD3;PDLIM1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3330741180774147,0.9286875322483776,0.5362068965517242,0.8721165349242259,1.0,11/57,10.06%,MAP3K5;GPER1;NODAL;GRAMD4;CIDEB;CARD9;DDX3X;TTBK1;RIPK2;HTRA2;GRIN2B
prerank,cellular response to UV (GO:0034644),0.31891079087464,0.9285717942484987,0.532258064516129,0.871552198744275,1.0,20/76,21.90%,PTPRK;CASP9;CDKN1A;ERCC4;ATR;EP300;OPN3;DHX36;PARP1;FMR1;XPC;IMPACT;RHNO1;MMP1;SDE2;CREBBP;DDB2;CERS1;HYAL1;EIF2S1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.37587620547504325,-0.9284178861440309,0.581081081081081,0.8500394719507883,1.0,9/15,28.80%,SMAD7;DTX3L;RPL11;RPL23;RPS7;PARK7;BAG2;BAG5;ABL1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2757140389011135,-0.9280223837727174,0.6030534351145038,0.8503739513733015,1.0,15/71,14.95%,ADAMTS12;CTSH;CAPN2;CTSC;PDCD6IP;CHFR;CTSB;IDE;CASP8;CHMP4B;CTSS;MDM2;UBB;NEDD8;DDB1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.39855960802236423,-0.927735260364129,0.5816135084427767,0.8497337670329701,1.0,1/12,0.25%,IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.39855960802236423,-0.927735260364129,0.5816135084427767,0.8497337670329701,1.0,1/12,0.25%,IGF1
prerank,neuron remodeling (GO:0016322),-0.41493515754431143,-0.9274552427556713,0.5662188099808061,0.8497609136312725,1.0,3/10,9.67%,APP;ANKS1A;EPHA8
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.42020547910157513,0.9272753564196901,0.5362318840579711,0.8734817358400297,1.0,3/15,6.72%,LDLRAP1;PPARD;IRS1
prerank,diol biosynthetic process (GO:0034312),-0.38597698283421156,-0.9271492473487511,0.5697674418604651,0.8498448253738735,1.0,5/15,13.74%,ACER2;ACER3;GCH1;SPHK1;SPTLC2
prerank,membrane protein proteolysis (GO:0033619),-0.3110587427804861,-0.9271157602076893,0.575,0.8492825121207084,1.0,10/37,17.75%,CTSH;ADAM9;ADAM10;ERAP1;TGFB1;RELA;RET;AFG3L2;BACE2;PSEN2
prerank,cellular response to fluid shear stress (GO:0071498),0.43190120734000614,0.926977781518267,0.5419103313840156,0.8732882409728525,1.0,3/12,8.54%,MEF2C;SREBF2;PKD2
prerank,regulation of protein catabolic process (GO:0042176),-0.25516975073140125,-0.9269137457034615,0.6114130434782609,0.8491322637791884,1.0,29/99,20.05%,EGFR;FOXO1;SMURF2;NKD1;WWP2;SMURF1;WNT5A;EGLN2;PLK2;HGS;EEF1A1;IDE;GFAP;DAB2IP;PRKCG;IRAK3;ASB5;RAB7A;MDM2;WWP1;DDB1;CDKN1B;ODC1;SIRT2;OAZ1;FZR1;VCP;VPS28;SNX3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.38458598039036684,0.9267600546989243,0.5420944558521561,0.8729720690956849,1.0,2/22,2.65%,GCNT2;IL1B
prerank,glial cell differentiation (GO:0010001),-0.32619473989695014,-0.9260997946736619,0.5802469135802469,0.8503250272588877,1.0,4/28,7.60%,NFIB;ADGRG6;SLC8A3;STAT3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.316196902211305,-0.9260572679490746,0.5855130784708249,0.8497844335221012,1.0,6/29,17.50%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5
prerank,regulation of ATP biosynthetic process (GO:2001169),0.40834393072520975,0.9259270477748539,0.5227722772277228,0.8739418181485258,1.0,2/16,6.10%,PID1;IL4
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.27240186901256463,-0.9256654121341374,0.5876543209876544,0.8500103348940597,1.0,15/72,12.93%,CDH5;APOE;LIMA1;SLIT2;SHANK3;ARHGEF2;KANK3;HDGFL3;IAPP;PFDN5;PRKCD;EMILIN1;EML2;PFN1;TWF1
prerank,protein modification by small protein removal (GO:0070646),-0.22426766919423535,-0.9256080738402648,0.726530612244898,0.8495215084536922,1.0,79/252,26.78%,SMAD3;ESR1;USP47;SMURF2;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;RHOA;INO80;USP8;USP15;BIRC3;TRRAP;USP18;HGS;HIF1A;IL33;FOXK1;BECN1;USP34;ZC3H12A;USP5;USP11;USP35;PSME2;SENP3;COPS4;USP49;MDM2;PSMB4;UBB;COPS8;ACTB;INO80D;PSMD8;PSMB1;NEDD8;PSMD11;PSME3;RIPK1;ACTR8;ADRB2;NFKBIA;STAMBP;PSMA2;PSMD4;IKBKG;PSMD3;VCP;TAF9B;SNX3;BABAM2;USP22;PSMB7;USP36;BABAM1;BAP1;USP2;PSMC2;CCP110;BRCA1;PRKN;USP10;PSMD10;SUDS3;PSMC5;TP53;ACTR5;SENP8;ABRAXAS2;ATXN3;INO80E;COPS7A;COPS2;CDC25A;SMAD4
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2524639790410231,-0.9254173861344379,0.6436781609195402,0.8493458779095923,1.0,15/98,10.39%,SORBS1;EPHA3;EGFR;PPP1R13B;PRKCH;CEMIP;DLG1;TFDP2;ITGA3;PRKCE;STX3;AKT1;C2CD5;KCNB1;CASP8
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3484301011187965,-0.9251169354626958,0.5518590998043053,0.8494005348897503,1.0,3/20,5.37%,SULF1;THBS1;SULF2
prerank,negative regulation of glycolytic process (GO:0045820),0.43656628094819583,0.9251098671429144,0.5369127516778524,0.8740754277251075,1.0,1/10,0.87%,CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.43656628094819583,0.9251098671429144,0.5369127516778524,0.8740754277251075,1.0,1/10,0.87%,CBFA2T3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2808234424910257,-0.9251003398210021,0.6139088729016786,0.8481812380664085,1.0,18/56,25.84%,NDUFV3;DMAC2;NDUFAF5;NDUFS4;NDUFB8;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFA10;NDUFB4;NDUFB7;NDUFS1;NDUFS7;NDUFS8;NDUFB10;NDUFA3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2808234424910257,-0.9251003398210021,0.6139088729016786,0.8481812380664085,1.0,18/56,25.84%,NDUFV3;DMAC2;NDUFAF5;NDUFS4;NDUFB8;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFA10;NDUFB4;NDUFB7;NDUFS1;NDUFS7;NDUFS8;NDUFB10;NDUFA3
prerank,regulation of cell junction assembly (GO:1901888),0.37455899263806713,0.9246773901873239,0.5428015564202334,0.8741396150640104,1.0,3/27,2.15%,MEF2C;RAPGEF2;ROCK1
prerank,protein lipidation (GO:0006497),0.32743362358801287,0.9243016266868701,0.5443037974683544,0.8741582659906155,1.0,13/59,14.07%,PIGU;ZDHHC14;PIGO;ZDHHC1;ZDHHC2;PIGZ;ZDHHC16;DPM3;ZDHHC17;ZDHHC21;HHAT;ZDHHC23;PIGH
prerank,positive regulation of leukocyte migration (GO:0002687),0.37173764453689034,0.9241855615813024,0.5401459854014599,0.8736080281628604,1.0,4/27,8.51%,JAM3;PTN;IL4;MIA3
prerank,negative regulation of platelet activation (GO:0010544),-0.3749883129689644,-0.9240534454263775,0.5803921568627451,0.8499111958239906,1.0,6/16,8.02%,PDGFRA;APOE;NOS3;THBD;CD9;PRKCD
prerank,mitochondrial transport (GO:0006839),-0.28295237589410194,-0.9236856064596584,0.5986696230598669,0.8501366627307314,1.0,19/53,24.04%,MTX2;SLC25A4;SLC25A24;STARD3;TOMM7;BNIP3;SPG7;GDAP1;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;MAIP1;TIMM9;TMEM14A;BCL2L1;TIMM44
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.4216569113891376,-0.9233401250283152,0.553072625698324,0.8503038816563444,1.0,4/10,27.00%,HK2;GFPT2;GFPT1;HK1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2953467043964447,0.9232939613801426,0.5752351097178683,0.8746609868639721,1.0,17/117,12.25%,GGT5;GGT1;PER2;SLC16A3;ACSF2;PPARD;SLC27A4;BAAT;ACOT12;AOAH;HLCS;MCCC1;PDHX;ACOT2;NPC1;GLYAT;GATM
prerank,plasma membrane organization (GO:0007009),-0.28064294640246173,-0.9231913238233862,0.6121951219512195,0.8500078761547112,1.0,19/61,18.44%,MYOF;COL5A1;SNX9;CAVIN2;FNBP1L;PLSCR2;A4GALT;ANO6;TLCD2;PLSCR4;P2RX7;CHMP4A;UGCG;AHNAK2;SYTL4;PLSCR3;EHD2;MICALL1;STX2
prerank,protein targeting to peroxisome (GO:0006625),0.37368384271890126,0.9230738569012443,0.5521472392638037,0.8743256400100622,1.0,9/29,15.33%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;LONP2;PEX12
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3381368506768033,-0.9228794918757823,0.5797413793103449,0.8500683718713169,1.0,6/23,17.85%,GPX4;GSTM1;PTGS2;EPHX2;GSTM2;ALOX12
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.41194220610345184,0.9226496939481745,0.5443298969072164,0.8743262762805485,1.0,2/15,4.24%,NR1H3;PPARD
prerank,dicarboxylic acid metabolic process (GO:0043648),0.33245942131769857,0.9222570502906775,0.5280289330922242,0.8742970373562634,1.0,6/52,8.83%,GGT1;SLC19A1;DHFR;MTHFD2;GOT1;SDHAF3
prerank,basement membrane organization (GO:0071711),0.4158325127806502,0.9218197600143846,0.5298969072164949,0.8743719126616964,1.0,5/14,4.54%,NID1;COL4A1;PXDN;NTNG2;LAMB1
prerank,response to insulin (GO:0032868),-0.26333953404022603,-0.9216827308848379,0.5983827493261455,0.8520811503521905,1.0,17/80,14.00%,SORBS1;RHOQ;FOXO1;ENPP1;KAT2B;HDAC9;SLC39A14;SYAP1;CPEB2;AKT1;C2CD5;INSIG2;RAB8A;USF1;FER;LPIN3;HDAC5
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3092116280682129,-0.9216017516556795,0.5961538461538461,0.8516269304313867,1.0,13/35,16.08%,DLG1;SASH1;XDH;EZR;LGALS9;MFHAS1;DUSP1;DAB2IP;ZC3H12A;RELL1;SPHK1;DUSP10;MAP3K4
prerank,response to cAMP (GO:0051591),-0.300543796086068,-0.9215307108035132,0.5843621399176955,0.8511651358491992,1.0,10/37,13.96%,IGFBP5;EZR;RAP1B;STAT1;RAPGEF1;KCNQ1;AKAP9;SLC5A5;AHR;NDUFS4
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3822478868510352,-0.9210540197517636,0.5749525616698292,0.8516035075745458,1.0,4/14,23.25%,SAP30BP;FNTA;NNMT;CTBP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3532614130897934,0.920794756450131,0.5543672014260249,0.8756894286512714,1.0,5/44,3.13%,CARMIL1;RGCC;PPM1E;FERMT2;LIMK1
prerank,fat cell differentiation (GO:0045444),-0.2804445680815044,-0.9207446349086146,0.5956937799043063,0.8516741320615583,1.0,12/57,11.84%,SMAD6;OSBPL8;FOXO1;KLF4;TCF7L2;PRDM16;ERAP1;C1QTNF3;BBS7;NR4A2;METRNL;WNT5B
prerank,establishment of endothelial barrier (GO:0061028),0.36651635494861345,0.9202197763780068,0.5198487712665406,0.8760431327475026,1.0,2/29,1.03%,PDE4D;RAPGEF2
prerank,positive regulation of catalytic activity (GO:0043085),-0.2993624604472733,-0.9198207458188183,0.5931818181818181,0.8530976598656873,1.0,16/37,30.55%,CAV1;IGF2;MAPK14;SSBP1;NHEJ1;FGFR4;XRCC4;MAPK3;PSEN2;MT3;MSH6;NCSTN;B3GAT3;ABL1;WRN;APH1A
prerank,Golgi to lysosome transport (GO:0090160),0.4348265279208931,0.9194224496151991,0.5198329853862212,0.8768475244294134,1.0,4/11,12.58%,SORT1;AP1G1;EHD3;ANKFY1
prerank,positive regulation of integrin activation (GO:0033625),-0.39657058364792547,-0.9192997466869336,0.5851272015655578,0.8536503577150301,1.0,3/11,5.97%,RAP1B;PIEZO1;RASIP1
prerank,positive regulation of cation channel activity (GO:2001259),-0.3060618324476062,-0.9190699224362339,0.5952941176470589,0.8535764216707238,1.0,11/40,18.19%,ACTN2;SHANK3;CALM2;TMSB4X;LRRC38;CTSS;EPHB2;GSTM2;CALM1;ADRB2;P2RY6
prerank,hepaticobiliary system development (GO:0061008),-0.3453097809963142,-0.9190037679875008,0.5754527162977867,0.8531020977323418,1.0,3/20,4.37%,TGFBR3;WNT4;LSR
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25287183915984746,0.9189246930346561,0.6554132712456344,0.8770532636453271,1.0,82/497,14.40%,PTPRK;TBX2;KCTD1;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NR1D2;NRG1;CBX5;PHC3;NAB1;PHC2;MECP2;PPARD;DHFR;PHC1;HEXIM1;TFAP2B;ARID5A;IL4;RUNX2;DDX3X;CBX3;SFPQ;KAT7;CDKN1A;NANOS1;NR2F2;TRIM33;CCAR2;MYB;TIMELESS;PDGFB;MTERF3;CNOT9;ATR;EID1;PSPC1;MALSU1;RLIM;NKX6-2;CITED2;LOXL3;SFMBT2;WAPL;KAT6A;RCOR1;SFRP2;SAMD13;SPEN;RBM15;BCLAF1;RB1;FOXS1;THRA;TSC22D4;SET;TRAF6;PAIP2;NIPBL;CRY1;CIART;CNOT10;CDAN1;LSM14A;DMAP1;PUS7;ATF7IP;RAD17;SIX4
prerank,regulation of vasculature development (GO:1901342),0.3864000895468972,0.9188497341786425,0.5432595573440644,0.8764130172639893,1.0,7/26,13.03%,NF1;ETS1;FGF2;TSPAN12;EMP2;EPHA2;RNH1
prerank,mitochondrion localization (GO:0051646),0.39107509333183943,0.9187293575956068,0.5296442687747036,0.8758573629858971,1.0,6/19,17.67%,MARK1;MARK2;TRAK1;TRAK2;MFN1;HAP1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4342507951797345,0.9183125740956973,0.5213483146067416,0.8759439962577534,1.0,6/10,22.69%,CBARP;FMR1;GPR35;GNB5;CALM3;DRD2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3059155883259002,-0.9181575338377448,0.6075949367088608,0.8544096998118565,1.0,9/36,8.00%,PLCB1;LEF1;NFATC1;FZD2;TCF7L2;MOV10;WNT5A;PLCB3;FZD4
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4124790461305056,-0.918016598693168,0.5803402646502835,0.8540862461115981,1.0,7/11,11.23%,ADIPOR2;CD34;NDNF;PRCP;KDR;GATA2;ITGB3
prerank,cochlea morphogenesis (GO:0090103),0.4388792606982959,0.9179904836238751,0.5515021459227468,0.8757637761432479,1.0,5/10,19.98%,MYO3B;TBX18;HPN;HOXA1;PAX2
prerank,response to nutrient levels (GO:0031667),0.39801900251835026,0.9179365955109464,0.5276679841897233,0.8750749653296088,1.0,4/17,16.75%,UCN2;MTOR;PRKAA1;RPS6KB1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.39824783794508356,-0.9179131083241269,0.5636363636363636,0.853689565266196,1.0,8/11,38.19%,PPHLN1;TPR;SETDB1;MPHOSPH8;DNMT1;SIRT6;TRIM28;SETDB2
prerank,peptidyl-serine modification (GO:0018209),0.28280107595316006,0.9179078559026332,0.5941422594142259,0.8743658012466737,1.0,32/166,12.55%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;MBOAT4;GALNT13;GALNT1;MTOR;NEK6;PRKD2;MARK2;NAA11;PDGFB;ATR;MAP4K1;CSNK1E;BRSK1;DYRK3;LATS2;PRKX;HIPK1;GALNT4;PRKDC
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.39346070990784465,-0.9177316698878537,0.5725047080979284,0.8534677599364914,1.0,5/12,22.59%,WNK1;AKT1;PPARA;MDK;ASS1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.40494338260525214,0.9176925221196597,0.53099173553719,0.8740373100129457,1.0,4/14,13.79%,ADK;ADSL;PPAT;IMPDH2
prerank,neutrophil chemotaxis (GO:0030593),0.3364878988158784,0.9176337304342562,0.5511265164644714,0.8733782208690332,1.0,6/53,7.43%,PIK3CD;CXCL5;CXCL10;CXCR2;PDE4B;PIKFYVE
prerank,heart process (GO:0003015),-0.3786123642984285,-0.917625628059448,0.5817120622568094,0.8530622973117253,1.0,2/14,5.78%,SGCD;ACE
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4208263720660891,0.9170480858781033,0.5301455301455301,0.8738078562578755,1.0,3/12,6.39%,IL1B;TAFA3;TTBK1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4333107815756457,0.9170298365123006,0.5361702127659574,0.8730665021608908,1.0,2/11,7.43%,PXDN;GPX3
prerank,zinc ion homeostasis (GO:0055069),0.3608540627646113,0.9166485072593009,0.5527831094049904,0.8730515360621633,1.0,1/28,0.46%,SLC30A10
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.39060782770645386,-0.9163833968584721,0.587360594795539,0.8552345512118467,1.0,5/14,27.19%,ACOX1;ECI2;ACOX3;AMACR;CROT
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.42473491002210667,0.9160088782056307,0.5319148936170213,0.8736282216450721,1.0,2/12,2.10%,HEYL;NODAL
prerank,receptor metabolic process (GO:0043112),-0.284508837144166,-0.9158432240313376,0.59,0.8558139095613289,1.0,17/53,19.55%,CAV1;CALCRL;RAMP2;CD9;DNM3;SMURF1;TFRC;BECN1;TGFB1;GRK2;SH3GLB1;UVRAG;PHETA1;ARFGEF2;REP15;CD81;SYK
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3646485535558588,-0.9153441029754172,0.6007677543186181,0.8563181764329358,1.0,5/16,19.62%,TMEM50A;CHMP4B;CHMP4A;LEPROT;VPS28
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.346207759974136,0.9148596556876954,0.5507246376811594,0.8752240047575818,1.0,5/43,5.55%,PDGFRB;RBPMS2;LDLRAP1;FGF2;HTR1B
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2801647607389454,-0.9141799983203159,0.6400911161731208,0.8582835660280799,1.0,20/54,31.93%,NSA2;SDAD1;RPL11;PAK1IP1;RPL24;RPL26;RPL14;RPL10;RPL7;RPL10A;EBNA1BP2;RPLP0;MRPL1;RPL35A;RRS1;NHP2;MAK16;RPF1;RPL23A;HEATR3
prerank,lysosome organization (GO:0007040),-0.30435287383753934,-0.9136793205652255,0.6258064516129033,0.8587828591457899,1.0,13/36,28.26%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN5;CLN6;MBTPS1;TMEM165;ACP3;MYO7A
prerank,melanocyte differentiation (GO:0030318),0.43156474831986374,0.9135820957193617,0.5331858407079646,0.8769606280810863,1.0,2/11,3.87%,MEF2C;MREG
prerank,negative regulation of cell division (GO:0051782),-0.40636657449924757,-0.913488197587601,0.5754189944134078,0.8585967446920585,1.0,2/11,8.39%,TXNIP;ZFYVE19
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3661396292306074,0.9134832481343772,0.5386029411764706,0.8763704504124074,1.0,13/29,20.00%,CNOT2;KCTD6;VPS18;UFM1;CNOT9;VPS11;PAK1;KANK2;STRN3;DDRGK1;CNOT1;KMT2D;WBP2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3117058108124104,0.9130660401565891,0.5606557377049181,0.8764405752591179,1.0,10/74,12.24%,LIMD1;NOTCH1;RBX1;PSMB11;EPAS1;PSMF1;ARNT;CITED2;EP300;PSME4
prerank,regulation of microtubule depolymerization (GO:0031114),0.37628554634924527,0.9123927618788455,0.5766129032258065,0.8770275385352327,1.0,7/25,13.46%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,negative regulation of telomere maintenance (GO:0032205),-0.3665539822112852,-0.9116709937856321,0.5878003696857671,0.8620189372074418,1.0,7/15,23.12%,TNKS2;SMG6;PINX1;ATM;RAD50;ERCC1;SLX4
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3663041574311202,0.9114461797664811,0.5372549019607843,0.8781244312945149,1.0,9/26,14.68%,HEYL;NODAL;CNOT2;VPS18;CNOT9;VPS11;KANK2;CRY1;STRN3
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4407048295632115,0.9114199529707694,0.5553097345132744,0.8773938529732541,1.0,2/10,7.68%,DHFR;MTHFD2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.32338031776349146,0.9113982071679656,0.5545927209705372,0.8766566696743187,1.0,9/61,10.59%,PDGFRB;RGCC;MECP2;FGF2;FGF10;EYA3;PRKD2;PDGFB;TOX
prerank,cellular response to hormone stimulus (GO:0032870),0.31432250743029017,0.9113190674080405,0.5792988313856428,0.8760509525926915,1.0,10/69,9.48%,MEF2C;ATP1A2;GPER1;CACNA1H;SLIT3;NCOA3;ARID5A;ROBO2;GCK;MED1
prerank,protein ubiquitination (GO:0016567),-0.20599191560208746,-0.9106612012413023,0.8874172185430463,0.8636801980885679,1.0,128/471,24.81%,RNF220;FBXL7;PDZRN3;SH3RF1;RNF213;HERC6;SASH1;NPEPPS;SMURF2;FBXO10;RNF38;RNF146;ZNRF1;ASB2;TAF1;RNF43;TRIM24;SPSB1;RNF19A;ARRB1;WWP2;TNKS2;RNF144B;HIF3A;RNF139;SMURF1;KLHL2;CDC16;SH3RF2;RNF103;AMFR;SH3RF3;UBE2E2;LNPEP;RTF1;NHLRC3;MKRN2;RNF185;RC3H2;CHFR;DTX3L;HIF1A;KCTD10;RNF135;MGRN1;ARRDC1;ZNRF3;USP5;UBE4B;TRIM27;PSME2;CUL4A;ASB5;RNF125;TRIM63;UBE2Q2;MDM2;PSMB4;UBB;TRIM39;TRIM35;FBXW11;RNF181;ELOB;BRAP;UBE2G2;WWP1;PSMD8;PSMB1;DTX1;NEDD8;PSMD11;RNF115;DDB1;TRIM17;FBXL2;FBXL14;ANKIB1;PSME3;RNF187;ASB1;PELI1;SPSB4;UBE3D;RNF40;FBXL19;SPSB2;ANAPC16;TRIM14;TRIM47;LONRF1;PSMA2;TRIM41;FBXO41;PSMD4;PSMD3;VCP;ARRDC4;RNF217;USP22;ELOC;UBE2L6;PSMB7;RNF126;CDC27;RMND5A;RNF144A;GAN;RBBP6;RNF182;DZIP3;CUL5;CUL9;DDA1;FBXO17;CCNF;RNF122;PSMC2;TRIM11;BRCA1;TRIM6;PRKN;RNF19B;PSMD10;RNF8;PSMC5;CBFB;BFAR
prerank,cellular amide metabolic process (GO:0043603),-0.24862618209210643,-0.9100458744154399,0.6225895316804407,0.8644560174116711,1.0,25/102,20.10%,AEBP1;PLPP3;PCCA;ST3GAL1;CPE;SMPD3;ACOT11;NAAA;PCCB;NSMAF;CPXM2;SLC5A6;ALDH1L1;CPXM1;PLPP1;PLA2G15;NNMT;ACOT6;ACOT9;CLN8;FPGS;CPD;NIT1;GNE;ORMDL3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.28312780870045734,0.9095972959748942,0.5994397759103641,0.8786534190408724,1.0,28/153,11.82%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;PIKFYVE;MTOR;NEK6;PRKD2;MARK2;PDGFB;ATR;MAP4K1;CSNK1E;BRSK1;DYRK3;LATS2;PRKX;HIPK1;NLK
prerank,regulation of transferase activity (GO:0051338),-0.3553145994206143,-0.9090668564899578,0.6043737574552683,0.8659629275042376,1.0,5/17,19.26%,SMG6;PINX1;NLRC5;ATM;PPP1R3F
prerank,positive regulation of transmembrane transport (GO:0034764),-0.39271605801923476,-0.9090341392359303,0.5868263473053892,0.8653975222529173,1.0,5/13,22.15%,ANO6;C2CD5;P2RX7;AZIN1;NR4A3
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3739217489730646,-0.9086264308748838,0.6023391812865497,0.8656629831722794,1.0,6/13,24.85%,EZR;RHOA;MYO9A;OPHN1;ZDHHC7;SCRIB
prerank,vitamin transport (GO:0051180),-0.31636713719432025,-0.90826255916471,0.5863453815261044,0.8658794597461534,1.0,10/29,25.88%,PDPN;ABCG2;CUBN;SLC5A6;SLC35F3;SLC52A3;SLC52A1;SLC19A2;CD320;SLC25A32
prerank,vesicle organization (GO:0016050),-0.29035474047420223,-0.9077796938400036,0.6035634743875279,0.8663141675141924,1.0,14/46,18.56%,CAV1;FNBP1L;CD34;SRGN;USP8;ALS2;ALS2CL;CAV2;SNX10;PHETA1;ARFGEF2;ZFYVE16;SAR1A;SAR1B
prerank,female gonad development (GO:0008585),-0.34952639308339056,-0.9076848709533866,0.6092843326885881,0.865906247310504,1.0,8/19,27.80%,KIT;EIF2B2;CEBPB;VEGFA;FOXL2;EIF2B5;COL9A3;EIF2B4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4354195722117114,0.907417161244725,0.5493562231759657,0.8822687344336932,1.0,2/10,6.88%,ATP1A2;BIN1
prerank,RNA polyadenylation (GO:0043631),-0.32466890185548536,-0.9073878741684898,0.5978494623655914,0.8653368960036886,1.0,12/26,31.21%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,mRNA polyadenylation (GO:0006378),-0.32466890185548536,-0.9073878741684898,0.5978494623655914,0.8653368960036886,1.0,12/26,31.21%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.40785197409258245,-0.907324176990072,0.6074766355140186,0.8648490455010347,1.0,3/10,10.91%,KLF4;MAP2K5;IRAK3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4222475694124266,0.9069761047712133,0.5574468085106383,0.8823693658627182,1.0,4/11,21.48%,IL4;JAK2;HDAC2;TAF7
prerank,folic acid metabolic process (GO:0046655),0.3871187847723405,0.9065801628243487,0.5447316103379721,0.8824132208619053,1.0,3/18,7.68%,SLC19A1;DHFR;MTHFD2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3563763519395995,-0.9063985204910046,0.5893909626719057,0.8663321979932791,1.0,4/19,10.16%,PTPRJ;VCAM1;ADGRL1;KDR
prerank,phospholipid transport (GO:0015914),0.32867276389812317,0.906308325404063,0.5662650602409639,0.8821860315620776,1.0,5/52,6.76%,PITPNC1;SCARB1;LDLR;ATP8B2;PRELID3A
prerank,spliceosomal complex assembly (GO:0000245),-0.28854365073159866,-0.9061646082704478,0.6031390134529148,0.8662464916572769,1.0,14/46,27.50%,CELF2;LUC7L;SRSF10;SNRPD1;SNRPD2;SRSF6;SRPK1;SRSF5;SF3A3;SRPK2;CELF5;PRPF19;PUF60;SNRPE
prerank,positive regulation of JUN kinase activity (GO:0043507),0.37998409899155616,0.905843819019975,0.5723014256619144,0.882327276128689,1.0,7/23,15.88%,MAP3K5;TAOK3;PAK1;DVL2;TRAF6;TRAF2;DVL3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.26101645597957357,-0.905803876955594,0.632,0.8664355325618525,1.0,13/76,13.22%,HDAC4;CAV1;ANGPT1;SMAD7;LRRK2;FKBP1A;BIRC3;ZC3H12A;PHF23;FANCI;UBB;SAE1;SPHK1
prerank,regulation of primary metabolic process (GO:0080090),-0.23762053741054417,-0.9057888736289947,0.6878980891719745,0.8658396506673284,1.0,33/126,20.78%,ROCK2;TBL1XR1;APOE;CHD9;ACACA;PSAP;CARM1;NFYC;PSME2;TNFAIP8L3;FGFR4;PLPP1;ID2;PPARA;PSMB4;PRKAB1;IDI1;PSMD8;PSMB1;PSMD11;PSME3;SREBF1;ZFP69;ODC1;NFYB;OAZ1;PSMA2;ACACB;PSMD4;ADIPOR1;PSMD3;SIN3A;PSMB7
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4112069914573162,-0.9056589080224647,0.6003649635036497,0.8654979450187767,1.0,7/11,42.87%,TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23594857634483238,-0.905141229885116,0.716012084592145,0.8660182057913551,1.0,55/144,27.65%,SMAD3;PPP1R13B;CEMIP;NPEPPS;TFDP2;CDH1;TCF7L2;GAS6;PRKCD;ANP32B;BAG3;C2CD5;KCNB1;ZC3H12A;CASP8;MAVS;SEC16B;TGFB1;SH3GLB1;TOMM7;RAN;SAE1;TMEM30A;PPP3CC;BID;RUFY3;LEPROT;TM9SF4;TPR;OAZ1;RAB29;SAR1A;SAR1B;CD81;HPS4;CHP1;BBC3;YWHAH;E2F1;USP36;BAP1;AKT2;RIPOR1;ICE1;ITGB2;XPO4;YWHAE;TP53;AKAP5;ZFAND1;SFN;FZD5;ITGAM;B3GAT3;HCLS1
prerank,regulation of embryonic development (GO:0045995),-0.3075940859521864,-0.9051239327522083,0.5903083700440529,0.8654423744367425,1.0,7/34,13.40%,PLCB1;NIBAN2;NR2C2;EHMT1;POGLUT1;TDG;SOX17
prerank,response to steroid hormone (GO:0048545),-0.31086233799552737,-0.9049843914213817,0.5969498910675382,0.8651089098751338,1.0,8/31,13.39%,NR3C1;CAV1;THBS1;AR;YAP1;TGFB1;ATP1A1;ATP1A3
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.35802621569765447,-0.9049228042680826,0.5813528336380256,0.8646291768266314,1.0,3/17,3.36%,OSR1;CAV1;MAFG
prerank,cell projection organization (GO:0030030),-0.3153774349834137,-0.9043751123403517,0.610989010989011,0.86519504680675,1.0,3/30,3.41%,GSN;RHOQ;PARVB
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.37507589428880106,-0.9037056523090576,0.5909090909090909,0.8660363644072233,1.0,8/14,38.75%,HSPA5;BCL2L11;DAB2IP;TMEM33;BFAR;FICD;UFL1;BAX
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.37322337164179714,0.9036043233930172,0.543233082706767,0.885978394596546,1.0,8/28,13.57%,PLEKHG2;WAS;SH3BP1;ESAM;ARHGAP35;PAK3;RASA1;ABITRAM
prerank,negative regulation of metabolic process (GO:0009892),0.32474310909825393,0.9031257211379655,0.568561872909699,0.8861544518761701,1.0,4/54,2.65%,PLCL1;NOTCH1;NR1H3;IL1B
prerank,long-chain fatty acid import into cell (GO:0044539),0.43651014550429595,0.9030547902880597,0.5304347826086957,0.8855131024888635,1.0,4/10,16.75%,SLC27A2;SLC27A4;SPX;RPS6KB1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3066884733200408,0.9028810152327807,0.5888,0.8850691514236678,1.0,6/76,3.27%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3051577094059307,-0.9025553303777532,0.6191536748329621,0.8679551116600008,1.0,10/32,23.91%,FOXN3;RINT1;TAOK2;TRIM39;ATM;FZR1;BABAM2;CDK5RAP3;BABAM1;BRCA1
prerank,negative regulation of calcium ion transport (GO:0051926),0.4003937813684343,0.9023449057191025,0.55,0.88538695583191,1.0,4/15,13.91%,ATP1A2;STC1;PACSIN3;CBARP
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.40442229071992847,0.90209534664938,0.5296523517382413,0.8851140635096519,1.0,4/15,9.80%,DAAM2;SPEF1;GPC3;CSNK1E
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2621638091195642,-0.9020484782769689,0.6623711340206185,0.8684934079365081,1.0,30/80,22.74%,SGSM2;SNX6;TRAPPC10;SNX32;ERC1;VPS50;VPS35;TRIM27;TBC1D10A;LMAN1;RAB7A;STX6;EVI5;RGP1;SURF4;WASHC1;PHETA1;RAB29;RAB6A;HEATR5A;VPS52;TMED9;SNX3;SPAG9;SNX8;TBC1D14;RNF126;CLN5;RAB7B;SNX2
prerank,receptor internalization (GO:0031623),-0.29018038224007436,-0.9018603956677939,0.6244131455399061,0.8682990245699446,1.0,8/44,7.55%,CAV1;CALCRL;RAMP2;CD9;DNM3;ARRB1;SCYL2;TFRC
prerank,positive regulation of immune system process (GO:0002684),0.3950787877246399,0.9018249250828665,0.5398773006134969,0.8848946826411141,1.0,1/16,0.77%,PIK3CD
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2847423747378802,-0.9017308112419089,0.6323851203501094,0.8679540092138033,1.0,18/46,29.34%,HK2;AIFM1;AKT1;TOMM7;GDAP1;DNAJC15;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;TIMM9;TIMM44;HK1;TIMM50;TIMM10;TSPO
prerank,cell differentiation in spinal cord (GO:0021515),0.4253324946633378,0.9016667208699187,0.5767634854771784,0.8844528189552634,1.0,4/10,12.92%,SOX4;MDGA2;SOX6;ZC4H2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3259812587068127,0.9014853534452759,0.5748709122203098,0.8840584393073869,1.0,8/54,6.29%,GCNT2;SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,T cell differentiation (GO:0030217),0.3320717985639995,0.9014250261989012,0.556350626118068,0.8834080414211036,1.0,6/40,7.07%,PIK3CD;PTPN22;GPR89A;GPR89B;SOX4;LIG4
prerank,positive regulation of protein kinase activity (GO:0045860),0.2809548042585819,0.9013751757628222,0.6184397163120567,0.8827432303287611,1.0,29/148,12.97%,IL34;RAPGEF2;PTK2;AGAP2;DOK7;GRM5;PDCD10;MINK1;SPDYA;DDX3X;SNCA;TTBK1;TAOK3;EMP2;RAP1A;PAK6;CDKN1A;MAP4K4;STK3;MARK2;PDGFB;PAK5;PAK3;ETAA1;PAK1;SRC;DLG3;PTPN1;TRAF6
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3887965016354039,0.9013382380008667,0.5544147843942505,0.8820578312662599,1.0,5/21,7.85%,CACNA2D1;KCNE4;SCN5A;CACNA1D;KCNE5
prerank,actin polymerization or depolymerization (GO:0008154),0.3276153888068724,0.9010370867101383,0.5646853146853147,0.8818585391992261,1.0,7/50,3.97%,ARHGAP6;WASF3;WAS;CORO7;ABI2;SPIRE1;WASL
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.25952521458561495,-0.9009219680052172,0.6615384615384615,0.8690935645826124,1.0,13/73,13.93%,EGFR;NTRK3;APP;CAV1;GAS6;FNIP1;TFRC;AKT1;IRGM;AKAP9;TGFB1;TXN;HSP90AB1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.38463064581922063,-0.9009130354567483,0.6039426523297491,0.8684957230790811,1.0,8/13,34.85%,MDM2;SNAI1;PSMD10;CD44;TWIST1;PTTG1IP;KDM1A;CD74
prerank,cellular response to sterol (GO:0036315),-0.38351151070512246,-0.900821958355951,0.6003717472118959,0.8680660509787554,1.0,6/13,12.21%,LRP6;SMO;GRAMD1C;GRAMD1A;INSIG2;PTCH1
prerank,negative regulation of protein polymerization (GO:0032272),-0.31881238835233044,-0.9007357593515494,0.6117886178861789,0.8676298239246312,1.0,7/27,12.93%,CDH5;SLIT2;KANK3;PRKCD;EML2;PFN1;TWF1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.30124000797569417,0.9005939433489906,0.5879478827361564,0.8820022287477242,1.0,14/87,12.24%,PTEN;CDK6;RGCC;RBX1;MYO16;PSMB11;PSMF1;CDKN1A;PKD2;KANK2;RBL1;APC;RB1;PSME4
prerank,regulation of cellular component organization (GO:0051128),0.2839007257639592,0.9000589355818694,0.6120689655172413,0.8822146017833107,1.0,27/135,14.49%,PLCE1;RAPGEF2;RASGRP2;BCAR1;ROCK1;STK38L;NRG3;RIT2;ROS1;RAP1A;MTOR;AP2S1;PAK5;ALKBH4;ERMN;NCLN;HIP1;ABL2;CAMSAP3;SPOCK1;PACSIN3;PTPN1;SLITRK2;TRAF2;HNRNPU;URI1;RAB5A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.382969976982542,0.8998323408598891,0.560546875,0.8819073523366213,1.0,9/22,17.67%,AKAP6;RYR2;PKD2;STAC;CASQ1;VMP1;ANK2;HTT;HAP1
prerank,histone H2A acetylation (GO:0043968),-0.36009831899202616,-0.8995054324505396,0.6003976143141153,0.8697863638399408,1.0,7/16,28.66%,TRRAP;MEAF6;NAA40;MORF4L2;BRD8;EPC1;SPHK2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2550305518956309,-0.8992296724908417,0.6483516483516484,0.8697820480383753,1.0,12/84,14.85%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;SON;NOVA1;SRSF10;MBNL2;FXR2;NUP98
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.37530748130040303,0.8992072105667627,0.5482041587901701,0.8824109298748083,1.0,7/23,18.34%,METAP2;GUCY2D;PDE6A;GRK4;GUCY2F;METAP1;SAG
prerank,cell junction maintenance (GO:0034331),-0.36685898981459725,-0.8983967336721452,0.6140684410646388,0.8709353201735798,1.0,8/14,36.57%,NLGN2;CLDN1;CSF1R;CBLN2;F2R;PRTN3;CBLN1;PARD6A
prerank,histone H2A ubiquitination (GO:0033522),0.39240398158496287,0.8980146742208378,0.5381526104417671,0.8840283751741712,1.0,8/17,22.22%,RYBP;UBR2;KDM2B;SKP1;TRIM37;UBE2B;DDB2;UBE2A
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3561634824260143,0.8980055065103747,0.5562130177514792,0.8825182968587204,1.0,7/29,16.39%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3561634824260143,0.8980055065103747,0.5562130177514792,0.8825182968587204,1.0,7/29,16.39%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,protein kinase A signaling (GO:0010737),-0.39402958974279506,-0.8978496062513228,0.5952380952380952,0.8714843619345033,1.0,8/12,41.58%,EZR;PRKACB;RDX;LCP1;PRKACA;RAB13;TCP11X2;TCP11
prerank,regulation of kinase activity (GO:0043549),0.3029920090850038,0.8978368752583022,0.6140625,0.8821219595267928,1.0,10/89,6.77%,PDGFRB;PLCE1;ROR1;MERTK;ERBB4;AXL;RYK;ROS1;NTRK2;EMP2
prerank,homeostasis of number of cells (GO:0048872),0.4199737240247966,0.8971261704378196,0.5603271983640081,0.8827817731781155,1.0,2/12,5.08%,NOTCH1;CARD9
prerank,negative regulation of MAPK cascade (GO:0043409),0.3010241605166197,0.8970608170083483,0.590032154340836,0.8821374427972021,1.0,11/87,5.90%,PTEN;GPER1;SPRY4;NF1;SPRED1;FOXM1;IL1B;SH2B3;SPRY2;CD300A;UCHL1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.417815891308115,0.8967880019416168,0.5653153153153153,0.8819407357691567,1.0,4/11,15.92%,FGF2;ITPKB;IPMK;IPPK
prerank,calcium-ion regulated exocytosis (GO:0017156),0.35399864879884396,0.8962161185199098,0.5523255813953488,0.8823402328170594,1.0,13/27,24.20%,RIMS1;RIMS2;SYT1;SYT2;SYT12;SYT11;VAMP2;SYT13;SYT3;ARL8B;VAMP7;SYT10;SYT6
prerank,negative regulation of lymphocyte activation (GO:0051250),0.38474186954617046,0.8958641427441555,0.5776892430278885,0.8822510987531537,1.0,2/21,3.86%,PTPN22;PAG1
prerank,regulation of axon guidance (GO:1902667),-0.40590063811947985,-0.8957889195657545,0.604355716878403,0.8754409497005544,1.0,2/10,12.61%,NRP1;ZSWIM6
prerank,positive regulation of lipid storage (GO:0010884),0.38271489561146377,0.8955472105529291,0.5562130177514792,0.8821329886179957,1.0,4/21,8.79%,SCARB1;SREBF2;MSR1;VSTM2A
prerank,endomembrane system organization (GO:0010256),0.2729792083227843,0.8955326227729972,0.6120448179271709,0.8814046628084976,1.0,45/178,17.73%,ARHGAP21;DYSF;SYNE1;SPTBN1;TMCC1;TOR1B;COG7;SYNGR1;ATP8B2;CLASP2;COG1;ANK3;CHMP2B;ARFGEF1;HACE1;VPS18;BLZF1;HOOK3;MIA3;RNF112;TMED7;TMED4;UBXN2B;VPS11;ARHGEF7;AKTIP;SYP;VPS51;WASHC5;PLEKHJ1;TRIP11;USP50;SERP1;TJAP1;VMP1;VPS33B;RAB1A;CSNK1A1;HTT;DNM1;TOR1A;PRKD1;GOLGA8B;GOLGA5;GORASP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3272994907292386,0.8952753938908052,0.6007067137809188,0.8811849375807461,1.0,3/51,2.44%,IL34;PTK2;PTN
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.28022323427637674,-0.8952144796860217,0.6415094339622641,0.8760906765488727,1.0,5/49,7.53%,LDLRAD4;SMAD6;IAPP;PRKCZ;HSPA5
prerank,positive regulation of type 2 immune response (GO:0002830),-0.37113415191418353,-0.8951555663120961,0.5943396226415094,0.8756160749426241,1.0,5/14,22.21%,PRKCZ;IL18;RSAD2;CD81;RARA
prerank,positive chemotaxis (GO:0050918),-0.3606401284351328,-0.8949780403264492,0.6,0.8753899429258669,1.0,3/17,3.58%,NRP1;PTPRJ;ANGPT1
prerank,regulation of viral entry into host cell (GO:0046596),0.362851485529893,0.8947979874822517,0.5578747628083491,0.8813906971867441,1.0,3/30,5.31%,TMPRSS4;MID2;TRIM62
prerank,negative regulation of cholesterol transport (GO:0032375),0.42681112401079746,0.8946584954193496,0.5503355704697986,0.8809131508545107,1.0,1/10,5.31%,SREBF2
prerank,protein maturation (GO:0051604),0.2939289330131126,0.8940276478473316,0.6167192429022083,0.8813836487765369,1.0,8/95,4.99%,TMPRSS4;CPM;METAP2;ADAM19;TSPAN15;ECE1;TASP1;OGT
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.23873479959859625,0.8935957922234326,0.779107725788901,0.8815254140835684,1.0,119/834,12.65%,NOTCH3;MEF2C;HEY2;PID1;RORB;HEYL;DPF3;BMP5;NOTCH1;RORA;PIK3R1;NCK2;RGCC;CRTC1;MAML2;GPER1;ETV1;NR1H3;TBX3;ZFHX3;RGMA;NR2F1;ZEB2;WAS;TCF15;GRHL3;FOXM1;CDX1;NKX6-3;NR1D2;RPS6KA4;NCOA7;ETS1;CRLF3;NCOA3;WASL;AGRN;PPP3CA;FGF2;MED10;PPARGC1B;PPARD;THAP3;BCL11B;OGT;EPAS1;MED13;TNKS;ELK1;SREBF2;CXCL10;RBM14;ESRRA;TFAP2B;TNIP2;IL4;RUNX2;DDX3X;CAPRIN2;SOX4;SFPQ;GABPA;KAT7;MLLT6;HRAS;KANSL3;CRTC3;TCERG1;RIPK2;NCOA6;NPAT;MYO6;NR2F2;SS18;ARNT;PRKD2;PKD2;CCNC;E2F5;JAG1;EFCAB7;SENP1;MYB;PRPF6;LHX4;MITF;PDGFB;ZNF507;MED1;MAML3;TOX2;FHL5;TAF6;TCF12;PCBP1;CITED2;GLYR1;DRAP1;POGZ;KAT6A;AHI1;LAGE3;CHP2;RPRD1B;SFRP2;RBL1;BCLAF1;AKNA;NFKB2;EP300;WWC1;MLIP;ETV5;MLLT10;DVL2;PFKM;SOX30;PRKDC;RRP1B
prerank,regulation of ATP metabolic process (GO:1903578),0.32210957815804137,0.8932144575188408,0.5887372013651877,0.8815328297071098,1.0,12/54,11.97%,SLC25A33;ATP7A;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;NDC1;ATP5IF1;EIF6;EP300
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.39201174830677443,0.8931036526659684,0.565677966101695,0.8809989284501685,1.0,3/17,6.99%,NR1H3;SORT1;LIPC
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4026446700156005,0.8930027988943332,0.5687103594080338,0.8804469189584082,1.0,2/14,5.08%,IL1B;CARD9
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4256997259032993,0.8918082980219008,0.5407554671968191,0.882061183072453,1.0,4/10,17.44%,CCAR2;ETAA1;CRY1;RPA2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3939993159225955,0.8918052426967895,0.5738758029978587,0.8813155652411979,1.0,3/15,6.99%,SCARB1;ABCA5;LIPC
prerank,organonitrogen compound catabolic process (GO:1901565),0.3242906733467763,0.8914512019915236,0.5704697986577181,0.8812768442122476,1.0,8/57,8.26%,ENPEP;CTH;ANPEP;TXN2;LIPC;PPT1;TRHDE;MTOR
prerank,positive regulation of cell growth (GO:0030307),-0.24471000682697192,-0.8910484466964247,0.7071005917159763,0.8834282771336008,1.0,21/96,17.39%,IGF1;EGFR;MACF1;USP47;SEMA7A;TGFBR1;ADAM10;SDCBP;SMURF1;INO80;H3-3A;AKT1;MMP14;MFSD2A;DDX49;SPHK1;SFRP1;CXCL16;NTN1;RUFY3;MAP3K13
prerank,regulation of cholesterol efflux (GO:0010874),-0.31475989847084335,-0.8909859380106037,0.6109936575052854,0.8829131357551497,1.0,8/30,20.40%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,response to interleukin-6 (GO:0070741),-0.39099431767532117,-0.8908801965963794,0.6231060606060606,0.8825077429430535,1.0,3/10,4.62%,ST3GAL6;PTGIS;SBNO2
prerank,regulation of interleukin-10 production (GO:0032653),0.32382292674489166,0.890789010164649,0.5871080139372822,0.8818552817410692,1.0,4/44,6.10%,TNFRSF21;CD46;TRIB2;IL4
prerank,positive regulation of neuron death (GO:1901216),-0.27983344107285485,-0.8907695741893971,0.6365740740740741,0.8821131844591354,1.0,4/46,2.61%,EFNB2;EPHA7;FOXO3;NUPR1
prerank,regulation of protein localization (GO:0032880),-0.2706978712013184,-0.8904809315617624,0.6519607843137255,0.8821112658545596,1.0,13/58,17.92%,AFDN;DLG1;RABGAP1L;USP8;FKBP1A;TRIM27;ITGB3;STX6;DNAJB6;HSP90AB1;TRIM17;TPR;TRIM14
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3305454308478685,0.8901874206476302,0.5611888111888111,0.8822888220570974,1.0,4/46,4.63%,PTEN;GPER1;SPRED1;SPRY2
prerank,myotube differentiation (GO:0014902),0.4025587197610813,0.8901460440505714,0.556237218813906,0.8816174343277555,1.0,3/17,3.86%,MEF2C;CACNA1H;SORT1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.3092323736880901,-0.8898945994337281,0.6385068762278978,0.8827699843702355,1.0,7/31,22.78%,RBP4;TFRC;EPHB2;SHLD1;KMT5C;CLCF1;XBP1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.3333274473360701,-0.8894919207160829,0.6045548654244306,0.8830496361764856,1.0,3/22,5.68%,CD55;B2M;STX7
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.30495578607332446,-0.8894354038550681,0.6317991631799164,0.8825511032433047,1.0,7/32,14.26%,FOXO3;APP;PRKCD;ATXN2;TCOF1;RPL10;GEMIN5
prerank,response to reactive oxygen species (GO:0000302),0.3246742245134336,0.8894268238206419,0.610726643598616,0.8822757825199435,1.0,3/54,4.10%,PTPRK;NCF1;PDCD10
prerank,negative regulation of MAP kinase activity (GO:0043407),0.33018228899697255,0.889219816406785,0.5807692307692308,0.8819221104739645,1.0,8/44,5.90%,SPRY4;NF1;IL1B;PTPN22;SH2B3;SPRY2;CD300A;UCHL1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.32323118441427345,-0.8892113371070736,0.621031746031746,0.8823883986138202,1.0,14/23,27.64%,ENPP1;SUFU;GLIS2;TULP3;MGRN1;PTCH1;GLI3;VCP;MEGF8;RACK1;RFX4;IFT122;PTCH2;GPR161
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32934425948267065,-0.8891625148084336,0.6257088846880907,0.8818823819320785,1.0,4/22,6.76%,LACC1;TNFRSF1B;WNT5A;SLC7A5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4050051125710332,-0.8887368923215417,0.6345776031434185,0.8821830824675013,1.0,7/10,35.84%,AKT1;TICAM1;TLR4;MYD88;TREM2;TLR6;CD36
prerank,regulation of interleukin-13 production (GO:0032656),0.4063163383370363,0.8885918991494295,0.5711252653927813,0.8824877466153812,1.0,2/13,6.10%,TNFRSF21;IL4
prerank,protein-containing complex disassembly (GO:0032984),-0.27831117781947967,-0.8884343410376344,0.6354430379746835,0.8822172357575772,1.0,11/54,21.35%,LAMP2;CAV1;LRP6;FZD2;WIPI2;UVRAG;RPL23;GABARAPL1;FZD1;VCP;VAMP8
prerank,regulation of exocytosis (GO:0017157),0.31980732987158234,0.888264241580937,0.5996275605214153,0.8823675592220127,1.0,17/46,19.46%,RAB8B;CLASP2;RIMS2;RAB3B;SNCA;LGI3;SYT1;IL1RAPL1;STX4;STXBP5L;RAB5A;CHMP3;HAP1;VAMP2;CPLX1;STXBP5;CADPS
prerank,copper ion transport (GO:0006825),-0.38687613497770884,-0.8882621213168119,0.6225045372050817,0.8819548069728627,1.0,2/11,5.17%,STEAP3;ATOX1
prerank,regulation of leukocyte migration (GO:0002685),-0.35397392175637366,-0.888073710009816,0.610655737704918,0.8817280224698474,1.0,9/16,41.43%,ANXA1;RHOH;CD81;VEGFA;NCKAP1L;HMOX1;BST1;RAC2;RHOG
prerank,regulation of response to external stimulus (GO:0032101),0.2896298207673359,0.8879384141944249,0.6242603550295858,0.8822046178859589,1.0,8/121,3.79%,ACE2;GGT1;SPAAR;IL1RL2;METAP2;PTPN22;NR1D2;GUCY2D
prerank,male gonad development (GO:0008584),-0.3006483818738458,-0.8876253842893016,0.6231263383297645,0.8820648089208166,1.0,12/34,31.42%,WNT4;AR;WNT5A;KIT;GATA6;NCOA4;CSDE1;COL9A3;BIK;ADAM21;WNT2B;KITLG
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3705948734442537,-0.8872619246898236,0.6138059701492538,0.8822390773079121,1.0,5/13,16.63%,CNOT7;MOV10;ZC3H12A;CNOT8;PNPT1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4238574998679816,0.8872502897437331,0.5878524945770065,0.8827994590389869,1.0,4/11,13.39%,SIK1;GCK;EP300;CRY1
prerank,heterochromatin assembly (GO:0031507),-0.3408739062383507,-0.8868893547228979,0.6363636363636364,0.8823818106702715,1.0,7/20,23.18%,H3-3A;HDAC1;EZH1;BEND3;SIRT2;RRP8;MBD2
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.33248159934712984,-0.8862739580837811,0.6186440677966102,0.8831294153893008,1.0,5/22,13.22%,IL15;SLC7A5;IL18;TGFB1;SPHK1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.27207507559173666,-0.8862120903749693,0.6374133949191686,0.8826487125896232,1.0,17/49,24.29%,ADAMTS9;DENND3;STT3B;SIDT2;IDE;DAB2IP;DNASE1L1;UBE2G2;PNPT1;MANBA;RIPK1;NGLY1;DFFB;FBXO17;CHEK2;EXOSC7;PRKN
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2776167987827333,0.8858902188296393,0.6594202898550725,0.8847482922488442,1.0,24/159,8.86%,ADGRL3;CDH2;CDH4;CLDN10;CLDN15;PCDHB11;ATP2C1;LRRC4C;LRFN5;IGSF11;ITGB1;CNTN4;CDH8;CDH19;CDH20;CDH7;CDH22;CRB1;ROBO2;CNTN6;TENM4;PTPRT;IL1RAPL1;SLITRK1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3360084512433135,-0.8857112556471876,0.629277566539924,0.8830812658948778,1.0,4/20,13.22%,APOE;SHANK3;CPEB3;LRP8
prerank,regulation of dephosphorylation (GO:0035303),-0.36265629699552865,-0.8852316387127257,0.6156941649899397,0.883476551506176,1.0,6/15,23.01%,PPP1R16B;SMG6;MTMR3;SMG5;CDK5RAP3;INPP5K
prerank,cellular response to oxidative stress (GO:0034599),0.28574329767562273,0.8846428637950099,0.6309341500765697,0.8864916337561911,1.0,12/118,9.29%,PTPRK;PLA2R1;NCF2;PRR5L;NCF1;SOD3;SNCA;MSRA;GPX3;ARNT;PKD2;HTRA2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.40935357368428765,0.8842088407748108,0.5729166666666666,0.8866187002808583,1.0,1/12,0.82%,RORB
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.41094752086387404,0.8839072878360529,0.5589519650655022,0.8857399481824685,1.0,3/12,6.12%,SPRY4;ACTN4;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.41094752086387404,0.8839072878360529,0.5589519650655022,0.8857399481824685,1.0,3/12,6.12%,SPRY4;ACTN4;AP1AR
prerank,positive regulation of phospholipase activity (GO:0010518),0.36400205684663467,0.8835521114250013,0.5773809523809523,0.885712989446254,1.0,2/22,4.13%,PDGFRB;FGF2
prerank,regulation of trophoblast cell migration (GO:1901163),0.4124745421698871,0.883537102109994,0.5693581780538303,0.884998883565705,1.0,4/14,8.36%,NODAL;SYDE1;YTHDF3;ARHGDIB
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3680829278379261,-0.8833937809050444,0.6128440366972477,0.8867525735070528,1.0,2/14,6.33%,IGF1;TNFRSF1B
prerank,histone H4-K16 acetylation (GO:0043984),0.37096792287339553,0.8830613693887391,0.5786290322580645,0.8852164214828513,1.0,8/19,19.79%,OGT;KAT7;KANSL3;KANSL1;KMT2A;MSL2;MCRS1;WDR5
prerank,regulation of establishment of protein localization (GO:0070201),0.40792381887679396,0.8829729381379162,0.5633187772925764,0.8846459164516025,1.0,3/13,16.11%,CORO2B;CEP120;CEP135
prerank,regulation of telomere capping (GO:1904353),-0.32138896616691237,-0.8825077388387914,0.6303901437371663,0.888035183856893,1.0,6/23,16.08%,TNKS2;SMG6;ATM;MAPK3;RAD50;MAP3K4
prerank,DNA methylation (GO:0006306),-0.3160543373566963,-0.8821654378589412,0.621900826446281,0.8881187010464107,1.0,8/23,27.41%,DNMT3A;GATAD2A;EHMT1;BEND3;ZFP57;DNMT1;PICK1;MTRR
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39120703038345805,-0.8820662309874747,0.6391382405745063,0.8877127749806412,1.0,4/10,25.20%,ESR1;PSMC2;PSMC5;TP53
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3072747493228099,-0.8819440150614649,0.6324435318275154,0.8873548340089515,1.0,10/26,22.21%,FBN1;TCTA;C1QC;ZFPM1;CEACAM1;GPR137;TLR4;PTPN2;FSTL3;RARA
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.24873444593804456,-0.8816947661149331,0.7128205128205128,0.8872661850506085,1.0,35/85,28.52%,DAB2;NUPR1;SMAD7;LRRK2;TAF1;RNF19A;RNF144B;SH3RF2;RNF185;BBS7;DAB2IP;USP5;ECSCR;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;PSMC2;PRKN;RNF19B;PSMD10;PSMC5;RACK1;ATXN3;CEBPA;HSPA1B;TRIB3;CLU
prerank,protein localization to lysosome (GO:0061462),-0.31418643793390333,-0.8815893850233294,0.6415094339622641,0.8868911941420867,1.0,12/28,30.94%,HGS;AP4M1;RAB7A;ZFYVE16;SH3BP4;CD81;LAMTOR5;KPTN;NCOA4;ATP13A2;LAPTM5;NEDD4
prerank,natural killer cell activation (GO:0030101),0.36697567097342987,0.8803450844617506,0.5767716535433071,0.8891083716497721,1.0,4/23,10.59%,PIK3CD;AXL;KAT7;TOX
prerank,determination of bilateral symmetry (GO:0009855),0.37108872842812834,0.8803392890712299,0.59765625,0.8883744179092525,1.0,3/24,10.66%,NOTCH1;PKD2;CITED2
prerank,regulation of endocytosis (GO:0030100),0.3091466366107194,0.880232814358165,0.5966666666666667,0.887866815500567,1.0,15/61,14.49%,NEDD4L;ROCK1;RIT2;GPC3;CBLL1;SCAMP5;SNCA;AP2S1;HIP1;ABL2;PACSIN3;SRC;PTPN1;ABCA7;RAB5A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3008780728002632,-0.8795240862602803,0.6578411405295316,0.8905888432535515,1.0,9/31,26.51%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;POLR2G;LSM7
prerank,negative regulation of protein metabolic process (GO:0051248),-0.27650477512776817,-0.87927507017935,0.6605080831408776,0.8904865114790407,1.0,10/48,14.38%,EGFR;APOE;IAPP;PFDN5;FLOT2;PRKCG;IRAK3;ITGB3;HSP90AB1;PFDN2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.41388114126032394,0.8791520598046587,0.5863539445628998,0.8892809824079299,1.0,1/12,0.74%,DOCK10
prerank,positive regulation of establishment of protein localization (GO:1904951),0.38560863023536013,0.8788561418898323,0.5805785123966942,0.8891396229765508,1.0,5/18,16.22%,CORO2B;CEP120;CCT3;CEP135;CCT7
prerank,regulation of isotype switching (GO:0045191),-0.36911397279868935,-0.8785091483946561,0.6314814814814815,0.8914557545512057,1.0,4/14,14.48%,TFRC;PARP3;SHLD1;KMT5C
prerank,regulation of TORC1 signaling (GO:1903432),0.34667693714185027,0.8780344301003955,0.5872420262664165,0.8900261446818274,1.0,2/33,2.46%,SPAAR;SESN3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3684577891717367,-0.8779988204642903,0.6223908918406073,0.8919351495098173,1.0,7/13,29.82%,CNOT7;CPEB3;TNRC6A;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3089140376872607,0.8779623506187663,0.6194398682042833,0.889444559537612,1.0,16/67,16.28%,TBC1D1;PLD1;WAS;IFT20;MYO10;TBC1D2B;GAP43;TBC1D10C;EPHA2;TBC1D9B;TBC1D19;ABITRAM;RAB5A;FSCN1;TBC1D10B;FMR1
prerank,T cell activation (GO:0042110),0.30710723816590696,0.8771378790670287,0.6366559485530546,0.8903204470488552,1.0,8/69,6.60%,PIK3CD;NCK2;PTPN22;PPP3CA;GPR89A;GPR89B;IL4;SOX4
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.21969799464753925,-0.8764766043884241,0.7927272727272727,0.8945259378957685,1.0,53/208,20.25%,AKAP13;LPAR1;ESR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;ZFAND6;LGALS9;PRKCB;IKBKE;WNT5A;RHOA;PLK2;FKBP1A;STAT1;TFRC;EEF1D;BIRC3;TNFRSF19;ECM1;TNFRSF1A;DAB2IP;TLE1;ZC3H12A;CASP8;MAVS;OPTN;TRIM27;PLEKHG5;RELA;TRIM39;PLCG2;TICAM1;VAPA;PPM1B;PELI1;RIPK1;TRIM8;RHOH;TRIM14;TRAF3IP2;PDPK1;MAP3K3;CANT1;CC2D1A;LAMTOR5;PIM2;IKBKG;LGALS1;RHOC;EDA2R
prerank,response to progesterone (GO:0032570),-0.33913464075956135,-0.8759537655874523,0.6482617586912065,0.8949979136576521,1.0,4/18,11.72%,CAV1;THBS1;YAP1;TGFB1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.40375716400989264,0.8758560969029798,0.5692307692307692,0.8920545598089062,1.0,1/11,1.19%,NOTCH1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3360993976945112,-0.875151239702222,0.6459143968871596,0.8960177699571032,1.0,2/20,1.65%,DAB2;RHOQ
prerank,mononuclear cell differentiation (GO:1903131),-0.318281395868549,-0.875132177420747,0.6257545271629779,0.8954334505705347,1.0,4/24,4.95%,IL31RA;BMP4;PIR;GAS6
prerank,regulation of T cell chemotaxis (GO:0010819),-0.38569321052102634,-0.8751188399779773,0.6261859582542695,0.8948530220934965,1.0,4/11,13.32%,ADAM10;WNT5A;WNK1;OXSR1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3224982096915666,0.8748334275034599,0.6062717770034843,0.8933589076199868,1.0,13/52,11.09%,PIK3R1;PTPN9;GPER1;ATP2C1;SPTBN1;DPP10;ITGB1;NKD2;STAC;ZDHHC2;EPHA2;RANGRF;STX4
prerank,protein tetramerization (GO:0051262),-0.25380934098116115,-0.8745013642938219,0.7047146401985112,0.8955108226633909,1.0,21/67,24.75%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;SAMHD1;ACACA;GBP5;KCNC3;PKD1;HOMER1;ACACB;HSD17B8;MCOLN1;FARSA;TRPM4;ALDOA;TRPA1;FARSB
prerank,mitotic cytokinetic process (GO:1902410),-0.3222661972867561,-0.8740487513149786,0.6565040650406504,0.8958641594473017,1.0,6/20,17.44%,PDCD6IP;RHOA;CHMP4B;CHMP4A;MITD1;KLHDC8B
prerank,positive regulation of TOR signaling (GO:0032008),-0.27949848832055124,-0.8736454913651879,0.673202614379085,0.8960899729662716,1.0,18/40,36.10%,GAS6;FNIP1;CLEC16A;GOLPH3;FLCN;GPR137;RRAGB;SIK3;LAMTOR5;PIH1D1;NCKAP1L;RRAGC;RPTOR;HTR6;TREM2;SLC38A9;RRAGD;WDR59
prerank,mitochondrial protein processing (GO:0034982),0.41977408081407974,0.8736192162156126,0.5757575757575758,0.8949454511004985,1.0,4/11,16.74%,IMMP2L;YME1L1;MIPEP;PMPCB
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2655733160743647,-0.8733050113175036,0.6748768472906403,0.8961985281212996,1.0,14/52,20.62%,SAMD4A;CNOT7;TUT4;EDC3;TUT7;DDX6;RC3H2;CNOT8;EXOSC5;CNOT3;LSM5;PNLDC1;CNOT11;PAN3
prerank,regulation of presynapse assembly (GO:1905606),0.37697681952149303,0.8732196644393193,0.5790554414784395,0.8942168347400142,1.0,6/18,13.10%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,regulation of presynapse organization (GO:0099174),0.37697681952149303,0.8732196644393193,0.5790554414784395,0.8942168347400142,1.0,6/18,13.10%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3112359937581269,-0.8731328205227159,0.6510721247563352,0.8959294201471508,1.0,5/26,12.83%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.33513893665510663,-0.872847422685377,0.6540084388185654,0.895926527136823,1.0,2/19,2.03%,IGF1;APOE
prerank,cilium-dependent cell motility (GO:0060285),-0.32420250675906764,-0.8726987708132316,0.6686626746506986,0.8956165125360521,1.0,11/22,35.45%,EFHC1;EFHC2;DNAH3;DNAH8;DRC1;DNAH2;CCDC65;DNAAF2;CFAP44;TEKT2;DNAH17
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.375072438146132,-0.8723934184934629,0.6206896551724138,0.8956706171203339,1.0,5/12,18.44%,SNAP23;STX3;STX1A;SNAP47;STX2
prerank,chromatin assembly or disassembly (GO:0006333),-0.3911319017520153,-0.8723908260737425,0.637546468401487,0.8950583307571209,1.0,1/11,2.34%,HDAC8
prerank,negative regulation of axon extension (GO:0030517),0.3462675451503243,0.8723674965368142,0.6,0.8951088113184082,1.0,4/30,4.95%,SEMA6D;SEMA5A;MAP2;SEMA6C
prerank,regulation of mast cell activation (GO:0033003),0.41164863228392173,0.8723367928128105,0.5708245243128964,0.894427970129728,1.0,4/10,22.03%,LYN;CD84;TSLP;MILR1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3741449008594304,0.8716877611057103,0.5783132530120482,0.8949200732571723,1.0,3/19,6.72%,IL1B;ABCD2;IRS1
prerank,regulation of protein localization to membrane (GO:1905475),0.3525242715035519,0.8716268574583845,0.5900383141762452,0.8943097741454261,1.0,10/28,15.49%,LDLRAP1;SPTBN1;GPC5;GPC3;APPL1;PDZK1;ZDHHC2;NECAB2;VTI1B;CDK5
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3778090333757196,0.871575425754982,0.5979166666666667,0.8936761844461188,1.0,9/18,17.60%,RIMS1;RIMS2;SYN1;RAP1A;VPS18;RAB5A;PREPL;FMR1;GSK3B
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.36718483457398043,-0.870706388187299,0.6203703703703703,0.8979141105240359,1.0,3/14,14.48%,TFRC;SHLD1;KMT5C
prerank,nuclear export (GO:0051168),-0.2468428202214081,-0.8706931015630999,0.7404371584699454,0.8973294591413914,1.0,27/80,30.97%,RANBP3L;SMURF1;ATXN1;CCHCR1;NXF1;TGFB1;RAN;CALR;PKD1;TPR;SRSF2;SRSF6;CHP1;THOC1;NUP214;SRSF5;THOC7;XPO4;SRSF11;NUP155;RANBP17;CSE1L;NUP62;THOC5;XPO5;LSG1;SRSF7
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.31224140789974425,0.8706279249727772,0.6265270506108203,0.8948150519496137,1.0,17/57,16.50%,MEF2C;BEGAIN;CACNG7;MINK1;GRIA2;NETO1;GRIN2B;GSG1L;DLG2;DLG3;DLGAP2;NPTXR;DLGAP1;SHISA8;GRIN2A;GRIA4;GRIA1
prerank,regulation of cellular metabolic process (GO:0031323),0.3271552347358327,0.870559848361773,0.6097122302158273,0.894206344876225,1.0,2/45,2.55%,PID1;FOXM1
prerank,negative regulation of protein modification process (GO:0031400),0.29749152371467785,0.8704702371448594,0.6374367622259697,0.8936610645413701,1.0,5/79,3.09%,PTEN;DMD;PID1;PRR5L;CADM4
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.39804554990301844,-0.8704567145953056,0.6558558558558558,0.8971970694922299,1.0,4/10,15.59%,APOD;LRCH1;AKT1;CD200
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.26380351532033525,-0.8699594866202256,0.6797235023041475,0.8976161871163947,1.0,13/59,14.87%,ROCK2;TGFBR2;TGFBR1;LRRK2;ACVR1;TAF1;WNK1;PRKCD;AKT1;CAMK2A;OXSR1;HIPK2;DYRK1B
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3618191270066067,0.8697892584539005,0.592814371257485,0.8942086115271995,1.0,10/24,17.17%,GNL3L;TNKS;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PARP1;PIF1;TERF1
prerank,positive regulation of cytokine production (GO:0001819),0.25258515273393484,0.8696959830552154,0.7268106734434562,0.8936466266104985,1.0,14/292,3.51%,PDE4D;GLMN;PLA2R1;PIK3CD;RORA;AFAP1L2;RGCC;NODAL;RFTN1;IL1B;PTPN22;CD46;FFAR2;SPTBN1
prerank,regulation of microtubule-based process (GO:0032886),0.34344509243786103,0.8693924136379677,0.5977443609022557,0.893501692414843,1.0,15/36,18.81%,PHLDB2;ROCK1;CLASP2;TPPP;MARK2;BICD2;CAMSAP3;APC;PHLDB1;PRKAA1;MAP10;CDK2AP2;TRAF3IP1;GSK3B;MARK4
prerank,regulation of coagulation (GO:0050818),-0.3837317094527528,-0.8688054896687488,0.6594982078853047,0.8994010289685972,1.0,5/11,31.26%,CAV1;EPHB2;PROCR;F2R;HRG
prerank,signal peptide processing (GO:0006465),-0.38376551669751224,-0.8685863598583842,0.6556169429097606,0.8992392437515223,1.0,4/11,24.08%,PCSK5;SPCS1;CLN5;SEC11C
prerank,ribosome assembly (GO:0042255),-0.2776757271709642,-0.8684532394634048,0.6944444444444444,0.8988930071568013,1.0,14/47,22.26%,RPS14;RPS19;RPL11;RPS5;RPL24;RPS27;MRPS7;RPL10;RPS15;RPSA;RPLP0;MPV17L2;RRP7A;RPS27L
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3758781599573811,-0.8684525731018906,0.6953271028037383,0.8982810990511806,1.0,5/13,20.99%,GPD1L;STX3;HSP90AB1;TM9SF4;TYROBP
prerank,ncRNA export from nucleus (GO:0097064),0.3353361734937429,0.8683000625550621,0.6003616636528029,0.8947741906497458,1.0,11/36,18.32%,NUP43;NOL6;NCBP2;SSB;NUP35;SEC13;NDC1;PHAX;RANBP2;TSC1;NUP133
prerank,regulation of cell projection organization (GO:0031344),-0.37176376927737964,-0.8681530459765302,0.6514851485148515,0.8982606264404649,1.0,4/13,12.93%,MACF1;MOV10;MYO9A;MFSD2A
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.37964884943215105,-0.8680212952023703,0.6412639405204461,0.897906622640782,1.0,5/11,27.39%,MAVS;TICAM1;TYROBP;ITGB2;ITGAM
prerank,epithelial tube morphogenesis (GO:0060562),0.3466158455926138,0.867972011927277,0.6070110701107011,0.8946753820262039,1.0,9/32,11.57%,MEF2C;TBX20;COL4A1;RYR2;FGF10;PRKD2;PKD2;PAK1;PRKX
prerank,inner dynein arm assembly (GO:0036159),-0.3929063114385756,-0.8677735009858732,0.6420454545454546,0.8977760824716653,1.0,9/10,58.36%,CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73;ZMYND10;DNAAF5
prerank,microtubule anchoring at centrosome (GO:0034454),0.40750258466850675,0.8675864368253425,0.6070686070686071,0.8946403167732017,1.0,4/10,14.16%,HOOK3;KIF3A;DCTN1;CEP19
prerank,myeloid cell differentiation (GO:0030099),-0.27295727024221766,-0.8670737235351191,0.6941176470588235,0.8985735493962983,1.0,18/47,27.65%,ZBTB16;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;TAL1;HIPK2;ZFPM1;PTPN2;HSPA9;ACIN1;RASGRP4;TET2;ALAS2;CEBPA;HCLS1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.283828151835036,0.8666634087996884,0.6602564102564102,0.8956283583188164,1.0,5/88,4.92%,MYO1B;CORO7;SORCS1;SORT1;AP1G1
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.3364938150671533,-0.8665562170114166,0.6479400749063671,0.8989762541124259,1.0,6/18,18.89%,POR;EDN3;PARK7;AGTR1;SIRT3;AGT
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.354488973122026,-0.8665428986242079,0.655367231638418,0.8983933606630727,1.0,3/14,8.00%,ENPP1;ENPP3;CMPK1
prerank,granulocyte chemotaxis (GO:0071621),0.31591213615776587,0.8664872132008885,0.6038394415357766,0.8952423490400441,1.0,6/55,7.43%,PIK3CD;CXCL5;CXCL10;CXCR2;PDE4B;PIKFYVE
prerank,DNA alkylation (GO:0006305),-0.32976872787956324,-0.8657787018392438,0.6387755102040816,0.8987453380244538,1.0,4/19,15.05%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,DNA methylation or demethylation (GO:0044728),-0.32976872787956324,-0.8657787018392438,0.6387755102040816,0.8987453380244538,1.0,4/19,15.05%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2030034099615587,-0.8657661986284313,0.8861386138613861,0.8981607521762991,1.0,84/341,21.33%,FBXL7;TBL1XR1;RNF213;SMURF2;FBXO10;RNF146;ZNRF1;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;WWP2;RNF144B;TTC3;SMURF1;TOM1L1;CDC16;MAEA;AMFR;IFI27;NHLRC3;RNF185;DCAF11;RC3H2;CHFR;DTX3L;PCBP2;KCTD10;ARRDC1;ZNRF3;PML;UBE4B;ANAPC4;PSME2;CUL4A;RNF125;WDR81;MDM2;PSMB4;FBXW11;CLOCK;UBE2G2;WWP1;PSMD8;PSMB1;NEDD8;PSMD11;RNF115;DDB1;FBXL14;ANKIB1;PSME3;RNF187;PELI1;SPSB4;UBE3D;RNF40;FBXL19;SIRT2;UBR4;SPSB2;ANAPC16;PSMA2;NPLOC4;PPP2R5C;PSMD4;FZR1;PSMD3;VCP;VPS28;RNF217;ELOC;UBE2L6;RFFL;PSMB7;RNF126;UBXN1;CDC27;RMND5A;ANAPC5;RNF144A
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.3261766144493025,-0.8653231880192493,0.6572008113590264,0.8984419430584271,1.0,7/21,21.62%,SMO;EVC;TTC23;SFRP1;TXNDC15;STK36;GLI1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.39671033543481915,0.8652323327212678,0.6031042128603105,0.8969668020134476,1.0,3/13,11.09%,AP1G1;IL4;STX4
prerank,B cell mediated immunity (GO:0019724),0.4064690609348296,0.8650093347857855,0.5978494623655914,0.8966597313498348,1.0,2/10,19.03%,CARD9;CD27
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3918941920147283,0.8649783479015127,0.574468085106383,0.8959906917701622,1.0,4/12,9.87%,PTPN22;CD300A;LYN;PAX5
prerank,neutral amino acid transport (GO:0015804),-0.30495173337458037,-0.8648435310657826,0.6776859504132231,0.8988264518879229,1.0,11/28,22.02%,SLC6A6;SLC6A9;SLC7A5;SLC38A5;SLC3A2;SLC38A6;LLGL2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3249351749493048,-0.8641390856004567,0.6685823754789272,0.8996249531264762,1.0,6/22,12.57%,IGF1;ROCK2;IL6ST;P2RX4;MEF2A;LMCD1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4051861910011822,0.8638229203418601,0.5864332603938731,0.897491422008089,1.0,1/12,2.04%,FADS2
prerank,negative regulation of translational initiation (GO:0045947),0.38936631635177255,0.8637150237716461,0.569937369519833,0.896975393979051,1.0,2/13,2.94%,EIF4EBP2;EIF4EBP3
prerank,hyaluronan catabolic process (GO:0030214),0.3656211680860812,0.8635365456153168,0.5904365904365905,0.8965691156873119,1.0,3/18,4.13%,CEMIP2;HYAL4;FGF2
prerank,protein stabilization (GO:0050821),-0.22088903631390555,-0.8632307266874985,0.8122743682310469,0.9009076631213172,1.0,40/168,21.69%,IGF1;EPHA4;ATP1B3;LAMP2;PLPP3;RASSF2;SMAD7;TAF1;STXBP4;PRKCD;IRGM;BAG3;FLOT2;RAB21;RPL11;PFN1;WDR81;TRIM39;CALR;SOX17;HSP90AB1;HYPK;PARVA;RPL23;SUGT1;RPS7;PPARGC1A;PARK7;HPS4;CHP1;MT3;PIM2;RABL3;GET1;TAF9B;USP36;TYROBP;IFT46;BAG2;TMEM88
prerank,regulation of lipid metabolic process (GO:0019216),-0.2438640377314409,-0.8626997335602566,0.7470588235294118,0.901409082771519,1.0,20/88,19.51%,PRKAG2;TBL1XR1;CAV1;CHD9;NPC2;ACACA;PSAP;CARM1;NFYC;TNFAIP8L3;FGFR4;PLPP1;ID2;PPARA;IDI1;SREBF1;ZFP69;NFYB;ACACB;ADIPOR1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3187011234304698,-0.8626521061751182,0.6607843137254902,0.9008801716702469,1.0,10/22,23.13%,SASH1;XDH;MFHAS1;ZC3H12A;RELL1;SPHK1;MAP3K4;GADD45G;VEGFA;GADD45B
prerank,regulation of axon extension (GO:0030516),-0.28406992782293783,-0.8624400037174834,0.6995305164319249,0.9006929484564643,1.0,16/37,29.02%,APOE;MACF1;SEMA7A;DIP2B;NTN1;SEMA3G;RUFY3;MAP3K13;ZFYVE27;MT3;SIN3A;DBN1;PTPRS;RTN4R;ABL1;CTTN
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2991147839376407,0.8620663366994206,0.6490384615384616,0.8987099538952595,1.0,17/71,13.38%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;MYO10;WASF2;LYN;DOCK1;NCKAP1;ARPC4;PAK1;SRC;ARPC1A
prerank,SNARE complex assembly (GO:0035493),-0.38847854095680656,-0.8615735556841443,0.6554934823091247,0.9018795156705619,1.0,3/10,21.35%,STXBP6;UVRAG;VAMP8
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.30060433325133046,-0.8614082462169745,0.6427015250544662,0.9015961959962687,1.0,9/30,20.88%,FHIT;SDCBP;RPL11;TRIM39;HSP90AB1;HFE;STYX;PARK7;UBXN1
prerank,protein alkylation (GO:0008213),0.36944589720917387,0.8613735489906329,0.5801980198019802,0.8992945881875802,1.0,7/22,17.26%,METTL21A;EEF1AKMT1;PRMT1;PRMT3;METTL22;FAM98A;SNRPD3
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3363409087821177,-0.8613590517595505,0.658203125,0.9010956835428215,1.0,10/17,39.84%,BID;BBC3;BCL2L1;SFN;SOD2;TIMM50;CLU;DNM1L;BAX;GGCT
prerank,regulation of urine volume (GO:0035809),-0.3845498554040454,-0.8613468460479105,0.6471698113207547,0.9005175995758908,1.0,2/10,5.40%,NPR3;NPR1
prerank,proteasome assembly (GO:0043248),-0.3831821122274336,-0.8606783094527019,0.6377079482439926,0.9012357105694857,1.0,4/11,24.51%,POMP;PSMD11;PSMD4;PSMD10
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.29928081042724775,0.860431396130963,0.6407766990291263,0.9003700817549979,1.0,17/70,13.38%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;MYO10;WASF2;LYN;DOCK1;NCKAP1;ARPC4;PAK1;SRC;ARPC1A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29981944024315266,0.8604282344436878,0.6459731543624161,0.8996461032223697,1.0,14/66,12.21%,PTEN;CDK6;RGCC;MYO16;DDX3X;LSM10;APPL1;FGF10;CDKN1A;PKD2;KANK2;RBL1;APC;RB1
prerank,negative regulation of growth (GO:0045926),0.27578875335906744,0.8603238527914902,0.6533127889060092,0.8991033576526782,1.0,7/121,3.53%,TMPRSS4;RERG;APBB2;NOTCH1;SLIT3;SIPA1;CRLF3
prerank,cellular copper ion homeostasis (GO:0006878),-0.35538514102086605,-0.8602366473779602,0.6514598540145985,0.9014735065802384,1.0,2/14,5.17%,APP;ATOX1
prerank,ganglioside biosynthetic process (GO:0001574),-0.35153733221935907,-0.860224570878451,0.6679611650485436,0.9008843184453481,1.0,6/15,16.35%,ST3GAL1;ST3GAL2;ST6GALNAC3;ST8SIA2;ST6GALNAC6;ST3GAL5
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3808942967033476,0.8598022259899716,0.6013071895424836,0.8993432928893108,1.0,1/16,1.20%,RORA
prerank,granulocyte differentiation (GO:0030851),0.3724817963804876,0.8593973121418811,0.5944206008583691,0.8993965721907002,1.0,4/18,11.97%,CBFA2T3;CDKN1A;DEK;EP300
prerank,negative regulation of RNA splicing (GO:0033119),-0.327498985743907,-0.8593705872166233,0.6539235412474849,0.9019871600405764,1.0,7/19,21.77%,RPS13;SRSF10;TMBIM6;SRSF6;PTBP3;RPS26;PCBP4
prerank,sodium-independent organic anion transport (GO:0043252),0.4120941823968443,0.8589912628497939,0.5533769063180828,0.899425959700221,1.0,2/10,4.36%,SLCO3A1;SLCO5A1
prerank,protein deneddylation (GO:0000338),-0.3963578556475309,-0.8583530618397551,0.650994575045208,0.9034274467546327,1.0,4/10,26.70%,COPS4;COPS8;COPS7A;COPS2
prerank,autophagy of nucleus (GO:0044804),-0.34639764576833276,-0.8582572699305571,0.6705653021442495,0.9030247158105866,1.0,5/16,25.08%,WIPI2;ULK2;ATG2A;ATG12;ATG7
prerank,mesoderm development (GO:0007498),0.3749113085414728,0.8581614510530804,0.6087786259541985,0.9003231499403738,1.0,3/18,3.42%,TBX3;TCF15;TBX6
prerank,sarcomere organization (GO:0045214),-0.29561813322303904,-0.8579391187907491,0.6645962732919255,0.9030433622755566,1.0,14/27,43.04%,ACTN2;CSRP2;MYOM2;KRT19;CAPN3;TNNT3;MYPN;MYLK3;TCAP;FHOD3;OBSCN;MYH6;CSRP1;SYNPO2L
prerank,membrane raft organization (GO:0031579),0.3846458763722544,0.855901519647164,0.5870967741935483,0.9038887680778258,1.0,6/15,15.13%,RFTN1;EMP2;PPT1;NPC1;ABCA7;MYADM
prerank,regulation of cilium assembly (GO:1902017),0.2995599574053253,0.8550159897335322,0.6298076923076923,0.904829856186305,1.0,15/62,16.55%,TBC1D1;TBC1D30;IFT20;TESK1;TBC1D2B;ARHGAP35;TBC1D10C;TBC1D9B;CEP97;TBC1D19;FUZ;CEP120;TBC1D10B;KCTD17;HTT
prerank,regulation of cellular localization (GO:0060341),-0.2714149376059001,-0.8548923379483258,0.6832151300236406,0.9085359711435109,1.0,6/46,6.87%,GSN;ADCY5;LRRK2;PARD6G;EFNA5;STXBP4
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3782906812320165,0.8548889262654334,0.6171079429735234,0.9043420839060049,1.0,3/14,5.61%,ELAVL4;DAZL;BOLL
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.42183011655779235,0.8548782482262722,0.6324786324786325,0.9036431418500874,1.0,4/10,14.90%,BEGAIN;DLGAP2;NPTXR;DLGAP1
prerank,lipid droplet formation (GO:0140042),0.4074054255867682,0.8546327168628529,0.5986842105263158,0.9033854020071186,1.0,2/10,10.93%,CDS2;SQLE
prerank,mitotic spindle organization (GO:0007052),0.2675422458090197,0.8544785116929369,0.6957142857142857,0.9029451555026242,1.0,21/153,14.65%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;NEK6;DYNC1I2;TUBG2;XPO1;SEC13;TOGARAM2;MZT1;NUDC;MAD2L1;LSM14A;KIFC2;CEP126;RANBP2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4116832652897404,0.8544691269207312,0.59375,0.9015174650103925,1.0,4/11,24.81%,CCT3;CCT7;LARP7;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4116832652897404,0.8544691269207312,0.59375,0.9015174650103925,1.0,4/11,24.81%,CCT3;CCT7;LARP7;DKC1
prerank,regulation of RNA export from nucleus (GO:0046831),0.4076066598294801,0.8539327385423355,0.6,0.9017889427823775,1.0,4/11,22.32%,NCBP2;CPSF6;NSUN2;AKAP8L
prerank,cellular response to hypoxia (GO:0071456),0.2696280982698084,0.8537396539307464,0.7013574660633484,0.9014221711257313,1.0,13/126,8.50%,LIMD1;RORA;CPEB1;RGCC;RBX1;FMN2;KCND2;SCN2A;PSMB11;EPAS1;PSMF1;MTOR;ARNT
prerank,proteoglycan biosynthetic process (GO:0030166),0.339733564800051,0.8534232956393741,0.6155234657039711,0.9013053350743148,1.0,2/31,2.34%,NDST3;EXTL3
prerank,regulation of histone methylation (GO:0031060),-0.3605222279072552,-0.8529436917484179,0.6490196078431373,0.9118660177676053,1.0,7/13,30.89%,JARID2;NSD1;NNMT;PIH1D1;AASS;PAF1;TET1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.402250492677078,0.852606003311306,0.6121593291404612,0.902116751858571,1.0,3/12,13.50%,CACNA1H;STAR;CYP11B1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.36220751516963856,-0.852385373162757,0.664179104477612,0.9123174086704025,1.0,6/13,25.42%,LRRK2;MET;TXN;PARK7;NR4A3;RACK1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2420220661507787,-0.8522387859863703,0.7486338797814208,0.9120124088174717,1.0,27/85,21.86%,SMURF2;MAGI2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMD8;PSMB1;PSMD11;PSME3;WNT11;FZD1;PSMA2;PSMD4;PSMD3;PSMB7;VANGL2;AP2M1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2938462405043873,0.852207620708686,0.6682692307692307,0.9021757398121186,1.0,17/73,13.38%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;MYO10;WASF2;LYN;DOCK1;NCKAP1;ARPC4;PAK1;SRC;ARPC1A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3336397080242793,0.8518730949002697,0.6124031007751938,0.9020878054386021,1.0,7/33,11.56%,PTK2;JAM3;RAC3;LYN;SNAI2;EPHA2;SFRP2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.28324889249021995,0.8518298678480205,0.6870229007633588,0.9014623073362231,1.0,10/101,6.53%,MEF2C;NR1H3;IL1B;PTPN22;CXCL5;AXL;CXCL10;TNIP2;PDE4B;CACTIN
prerank,multivesicular body assembly (GO:0036258),-0.2911030557533585,-0.85156774048048,0.6659528907922913,0.9127161064125966,1.0,5/30,11.44%,RAB11A;PDCD6IP;HGS;CHMP4B;CHMP4A
prerank,cellular response to cAMP (GO:0071320),0.34499684383786433,0.8512437419092775,0.6078431372549019,0.901895989419347,1.0,6/30,8.88%,RAPGEF2;AKAP6;HCN2;RAP1A;PKD2;HCN3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.38016584123068387,0.8511664409333908,0.6148936170212767,0.9013221242135109,1.0,3/15,8.54%,SEMA5A;FGF2;PRKD2
prerank,regulation of organelle organization (GO:0033043),-0.24272594784555146,-0.8499913465456747,0.75,0.915305823304843,1.0,27/80,24.29%,CLIC4;DIAPH1;EZR;CAPN2;ARMH3;USP6NL;CLEC16A;GOLPH3;MAVS;AKAP9;VPS35;LMAN1;F11R;SURF4;MAPK3;TBC1D25;SIRT7;STX18;SAR1A;SAR1B;TMED9;TMEM33;STMN3;NEXN;RDX;CAPN6;PRKN
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.28169263460281446,-0.849836146505266,0.696969696969697,0.9149882638896577,1.0,13/38,24.38%,ESR1;STAT1;DAB2IP;TLE1;ZC3H12A;CASP8;TRIM39;PPM1B;RIPK1;RHOH;ZMYND11;MAPKBP1;USP10
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.33394670501373336,-0.8496844231335836,0.6699029126213593,0.9146808096904901,1.0,9/17,33.16%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,positive regulation of translation (GO:0045727),0.27702831604707173,0.8495711702530239,0.6698564593301436,0.9036202701708013,1.0,32/94,19.74%,PLD1;FASTKD2;DAZL;RPS6KB2;MRPS27;YTHDF3;BOLL;DDX3X;SOX4;MTOR;EIF3C;EIF6;YTHDF2;FASTKD3;PRKDC;TRMT10C;UPF3B;PRR16;LARP6;DHX36;FMR1;RMND1;RPS6KB1;C1QBP;PKM;NSUN5;HNRNPD;HABP4;POLR2D;RBM3;EEF2;EIF3E
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.39446108711015326,0.8489600808404898,0.6050955414012739,0.9033322851431221,1.0,2/13,3.74%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.39446108711015326,0.8489600808404898,0.6050955414012739,0.9033322851431221,1.0,2/13,3.74%,IL15RA;JAK1
prerank,positive regulation of developmental growth (GO:0048639),0.3071374595663197,0.8488413955247857,0.6654929577464789,0.9028448662978585,1.0,5/49,5.38%,NEDD4L;LIMK1;RIMS1;AGRN;RIMS2
prerank,negative regulation of translation (GO:0017148),-0.23405921468042157,-0.8487835458023719,0.7908847184986595,0.9159004173548169,1.0,21/87,18.73%,DAPK1;SAMD4A;ROCK2;IGFBP5;CNOT7;RNF139;DDX6;CPEB2;IGF2BP2;CPEB3;PUM1;CALR;CNOT8;LARP1;FXR2;FTO;EIF4EBP1;TPR;PAIP2B;EIF4E2;TYMS
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.31242505162879275,-0.8486854088472127,0.6789883268482491,0.915478956491377,1.0,2/24,1.65%,DAB2;RHOQ
prerank,carbohydrate derivative transport (GO:1901264),-0.3286560815143661,-0.8478098533181875,0.6363636363636364,0.916590859107045,1.0,6/18,15.47%,PLTP;LBP;NPC2;MFSD2A;SLC25A19;SLC29A1
prerank,macrophage chemotaxis (GO:0048246),-0.37535668384352616,-0.8473171192544668,0.6568265682656826,0.9169532219649628,1.0,7/10,51.89%,EDNRB;CKLF;CCL2;CXCL17;CCL5;CCL3;LGALS3
prerank,mammary gland development (GO:0030879),0.35914500781421743,0.8472726446261188,0.6227544910179641,0.9051069001376703,1.0,7/21,13.94%,TBX3;ERBB4;NRG1;ARHGAP35;WNT3;PRLR;JAK2
prerank,protein modification by small protein conjugation (GO:0032446),-0.19558376256759513,-0.8472067090757658,0.9625,0.9165660504583321,1.0,81/361,21.38%,RNF220;FBXL7;EYA1;PDZRN3;RNF213;SMURF2;FBXO10;RNF38;ASB2;RNF43;TRIM24;SPSB1;ARRB1;WWP2;HIF3A;RNF139;SMURF1;KLHL2;CDC16;RNF103;AMFR;RTF1;MKRN2;CHFR;DTX3L;HIF1A;KCTD10;RNF135;STX1A;MGRN1;ARRDC1;ZNRF3;USP5;TRIM27;CUL4A;ASB5;TRIM63;UBE2Q2;MDM2;UBB;TRIM39;TRIM35;SAE1;FBXW11;ATG10;RNF181;ELOB;BRAP;UBE2G2;WWP1;DTX1;NEDD8;NUP98;DDB1;TRIM17;FBXL2;UBA3;RNF187;ASB1;SPSB4;RNF40;UBA7;TPR;SPSB2;ANAPC16;TRIM14;TRIM47;UBE2M;TRIM41;PIAS4;NUP88;VCP;ARRDC4;ELOC;URM1;CDK5RAP3;CDC27;NUP214;TRPM4;RNF144A;GAN
prerank,water transport (GO:0006833),-0.36969654636054433,-0.8468960984651717,0.6535714285714286,0.91657333062757,1.0,1/12,1.42%,PDPN
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.250346102837408,-0.8467367622091823,0.7616580310880829,0.9162640275807898,1.0,29/72,32.87%,ERCC5;POLR2A;CUL4A;COPS4;POLR2F;UBB;COPS8;RPA1;DDB1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;ERCC1;ERCC2;POLR2G;RPA3;ERCC3;PRPF19;COPS7A;COPS2;CDK7;POLD1;MNAT1;PCNA;GTF2H3;RFC5;PPIE
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.28057115505780506,0.8463439373009586,0.6848673946957878,0.9062252803927944,1.0,15/94,9.71%,ATP2A3;MAP3K5;FNIP2;CHAC1;CUL3;ITPR1;BCL2L10;CIDEB;SCN2A;DDX3X;CASP9;CDKN1A;STK24;HTRA2;EPHA2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.34738975136184125,-0.8462333871416171,0.6937984496124031,0.916604902771407,1.0,7/15,25.42%,CPEB2;ZC3H12A;MKNK2;VCP;GSTO2;ATF3;ZFAND1
prerank,myelination in peripheral nervous system (GO:0022011),-0.35673022186147096,-0.8460685684447167,0.6851851851851852,0.9163196808408649,1.0,6/13,21.16%,ADGRG6;SKI;PARD3;MYOC;SIRT2;DICER1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2883864484524292,-0.84532833534829,0.7257019438444925,0.9171950318923907,1.0,7/33,13.20%,ESR1;DDX5;AR;H3-3A;KLK2;CARM1;CALR
prerank,snRNA 3'-end processing (GO:0034472),0.36267949795661075,0.8451830977369055,0.6141732283464567,0.9076763586157289,1.0,4/19,17.38%,INTS6L;INTS1;INTS12;USB1
prerank,long-term synaptic potentiation (GO:0060291),-0.3171341318106556,-0.8450238653973415,0.6728016359918201,0.9171870842123848,1.0,5/21,8.66%,SLC8A3;PRKCZ;PTK2B;PLK2;GRIN2D
prerank,regulation of regulated secretory pathway (GO:1903305),0.32288585607958625,0.8449722629686985,0.6494252873563219,0.9073587411872326,1.0,12/34,18.06%,RIMS1;RIMS2;SYN1;VPS18;SYT1;SYT2;RAB5A;PREPL;SYT12;SYT11;GSK3B;SYT13
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2500963743300651,-0.8449535411553069,0.753731343283582,0.9167143506762608,1.0,16/68,21.92%,RHOQ;ENPP1;AMPD3;LRRK2;ACOT11;SULT1A1;HINT1;RAN;PTHLH;ACOT6;ACOT9;TPST1;TPST2;ADSS1;DBI;NT5C2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34778232427136174,0.8445867123645153,0.6056338028169014,0.9073755646960818,1.0,4/20,11.97%,NOTCH1;RUNX2;CHD6;EP300
prerank,N-terminal protein amino acid modification (GO:0031365),0.3801882142522749,0.8445489611497158,0.5826086956521739,0.9067348866715893,1.0,5/14,20.88%,METAP2;NAA11;NAA15;METAP1;NTMT1
prerank,negative regulation of viral transcription (GO:0032897),0.3918581446827749,0.8435720683134387,0.6376811594202898,0.9078905712323524,1.0,3/13,5.31%,MID2;HEXIM1;TRIM62
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3806680166138796,0.8434864508410015,0.6043478260869565,0.9073427647889991,1.0,5/16,13.25%,REC8;POGZ;MAU2;RB1;NIPBL
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.34081329046004516,-0.8433927832938507,0.6660412757973734,0.9190919489965038,1.0,6/16,16.86%,TNKS2;SMG6;NAF1;PINX1;ATM;SMG5
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.35066105125200386,-0.8433417592708302,0.6485436893203883,0.9185824228513184,1.0,11/14,51.58%,CSF1;TYROBP;ATP6AP1;POU4F1;CCR1;OCSTAMP;IL23A;TNF;TNFSF11;IL12B;IL23R
prerank,RNA processing (GO:0006396),0.25415573635699656,0.8432729263257,0.7262411347517731,0.9070217340431876,1.0,46/176,20.86%,RBPMS;APOBEC1;FASTKD2;ELAVL4;DHX15;CLP1;LSM3;NCBP2;ADARB2;HNRNPR;RBMS1;SFPQ;SRRM1;XRN2;RNPS1;CPSF6;TCERG1;SNRNP25;CCAR2;PRPF6;DDX47;SCNM1;HNRNPUL1;PABPC4;CELF1;DDX23;HNRNPU;HNRNPC;KIN;SF3B3;LSM1;KHSRP;SNRPD3;USB1;LIN28B;HNRNPD;FUS;HNRNPA2B1;SNRNP48;RBM3;LSM6;LUC7L3;RNGTT;PPP2R1A;SRSF9;SRRM4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.31540502492178524,-0.8430443042139635,0.6802575107296137,0.9185448208076388,1.0,9/21,20.62%,SAMD4A;CNOT7;TUT4;TUT7;CNOT8;CNOT3;PNLDC1;CNOT11;PAN3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2425857512401465,-0.8419808639909471,0.7605263157894737,0.9200335958755195,1.0,15/70,18.12%,SMAD3;IL6R;TNFRSF1B;IFI27;MCL1;BAG3;TNFRSF1A;DAB2IP;CASP8;P2RX7;TGFB1;BID;DEDD;RIPK1;PDPK1
prerank,cellular response to nitrogen compound (GO:1901699),-0.31665287204091486,-0.8419769037065494,0.691358024691358,0.9194382832720909,1.0,1/20,0.88%,ROCK2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3202544331346882,-0.8419473713499651,0.703187250996016,0.9188938031107831,1.0,3/20,13.25%,WNT4;C1QTNF3;PGP
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.28789524485978246,-0.8418999845814102,0.7209302325581395,0.9183868153878416,1.0,13/30,28.31%,CAV1;PARP14;PRKCZ;PRKCD;SFRP1;PTPN2;SAMSN1;PTPN6;NTF3;SH3BP5;PIBF1;INPP5F;SOCS1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2718875895557746,-0.8417795000285434,0.7145708582834331,0.9180422075061132,1.0,15/39,28.48%,ABCA1;STEAP3;RCN3;GOLPH3;TMEM167A;RAB8A;PPY;CANX;TANGO2;RAB3D;TVP23B;ARL4D;LTBP2;PREB;RAB3A
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.35153675185905997,-0.8417632144423967,0.69140625,0.9174798801472072,1.0,6/15,26.57%,NYNRIN;ZC3H12A;DICER1;NUDT16;ZC3H12B;POP1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3613736669556487,0.8416418078283173,0.6061855670103092,0.9093129865833554,1.0,2/17,7.15%,RAPGEF2;ADCY9
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3304106988447633,-0.8414975445656525,0.6804511278195489,0.917397658737935,1.0,4/18,11.72%,SMAD3;PDPN;EMILIN1;TGFB1
prerank,response to light stimulus (GO:0009416),0.29976265548068903,0.8413009284636299,0.6706896551724137,0.9092031187141831,1.0,20/55,23.43%,OPN1MW;OPN1MW3;TYR;ERCC4;CCAR2;MAPK10;BRSK1;RRH;USP1;OPN3;CRY1;UVSSA;ERCC8;CPT1B;UBE2B;DDB2;COPS3;UBE2A;DRD2;CIRBP
prerank,mRNA catabolic process (GO:0006402),-0.270320568404506,-0.841055577507674,0.7205240174672489,0.9176625481232454,1.0,14/44,22.89%,DDX5;TUT4;TUT7;THRAP3;ERN1;NUDT12;NBDY;PNPT1;XRN1;LSM5;ZFP36L2;AGO1;NUDT16;DHX34
prerank,cardiolipin metabolic process (GO:0032048),-0.35365953323314664,-0.8408088473770162,0.6744186046511628,0.9175135988948759,1.0,3/13,15.94%,PLA2G4A;PLA2G6;PLSCR3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.29107168494493624,-0.8406504194188089,0.7240618101545254,0.917233697969324,1.0,10/31,23.12%,TNKS2;NAF1;PML;ATM;MAPK3;RAD50;MAP3K4;MAP2K7;ERCC1;SLX4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.21917846210789405,-0.8404645269933699,0.8737201365187713,0.9169893077262744,1.0,40/158,20.25%,AKAP13;LPAR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;LGALS9;PRKCB;IKBKE;RHOA;PLK2;FKBP1A;TFRC;EEF1D;BIRC3;TNFRSF19;ECM1;TNFRSF1A;CASP8;MAVS;TRIM27;PLEKHG5;RELA;TICAM1;VAPA;PELI1;RIPK1;TRIM8;TRIM14;TRAF3IP2;MAP3K3;CANT1;CC2D1A;LAMTOR5;PIM2;IKBKG;LGALS1;RHOC;EDA2R
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.34880005955871685,-0.8403517419876055,0.6697761194029851,0.916613529825858,1.0,3/13,12.60%,NFAT5;RHOA;RELA
prerank,apoptotic mitochondrial changes (GO:0008637),-0.28974613217374734,-0.8394233427359374,0.6974248927038627,0.9177701640223564,1.0,14/32,28.52%,HK2;IFIT2;VPS35;CAMK2A;BNIP3;BID;BBC3;BCL2L1;NDUFS1;BIK;SFN;SOD2;TIMM50;CLU
prerank,synaptic vesicle recycling (GO:0036465),0.32392204659641255,0.8393925327787484,0.6283524904214559,0.9121027110469876,1.0,7/31,15.49%,CEL;SNCA;SYT1;SYT2;NLGN3;RAB5A;CDK5
prerank,protein import into nucleus (GO:0006606),-0.2459904341670968,-0.8390312175412145,0.763855421686747,0.9178949310787872,1.0,24/66,28.85%,APPL2;STAT3;AKT1;IPO7;FAM53C;IPO13;RAN;KPNA6;RGPD1;RPL23;IPO8;NXT2;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;CSE1L;PTTG1IP;NUP62;TNPO2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.339857641127527,0.8385617708850331,0.6456692913385826,0.9129709180645716,1.0,3/30,2.10%,HEYL;PKN1;NODAL
prerank,cellular response to metal ion (GO:0071248),0.2629336494693098,0.8380934756833185,0.7116843702579666,0.913150063617468,1.0,20/123,11.39%,MEF2C;SLC12A2;RASGRP2;CACNA1H;NCF1;ADCY8;ITPKB;CPNE7;SCN5A;ANK3;SNCA;SYT1;PKD2;RYR3;HPCA;SYT2;DLG2;CPNE4;BRAF;CHP2
prerank,positive regulation of immune response (GO:0050778),-0.2440787044888475,-0.8380230996853982,0.7602905569007264,0.9192325207429313,1.0,16/64,28.66%,IL15;IL6ST;LGALS9;IFI35;KARS1;GBP5;CYBA;RSAD2;CD81;XBP1;ITGB2;POLR3D;PLSCR1;EIF2AK4;ITGAM;SPHK2
prerank,intracellular cholesterol transport (GO:0032367),-0.33650726846702905,-0.8374698216446811,0.6823529411764706,0.9197283697191824,1.0,3/15,6.93%,ABCA1;LRP6;NPC2
prerank,response to axon injury (GO:0048678),-0.3253972918937522,-0.8369797086743095,0.6640471512770137,0.9200572873645455,1.0,3/18,7.45%,DPYSL3;APOD;P2RX4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3477047948290979,-0.8367302262691351,0.7061068702290076,0.9199236869286744,1.0,5/14,28.45%,ETNK2;LPIN3;ETNK1;ETNPPL;CHKA
prerank,mitochondrial gene expression (GO:0140053),0.3095624213808866,0.8366076016332187,0.6725352112676056,0.9152265003703258,1.0,16/42,20.36%,SLC25A33;FASTKD2;NOA1;TFAM;GATB;GFM2;IARS2;PTCD3;GATC;MRPS34;MRPS12;MRPS18B;TFB2M;MRPL47;MRPS17;MRPL2
prerank,regulation of complement activation (GO:0030449),0.3221436389347844,0.8362447703242036,0.6344463971880492,0.9151957224955681,1.0,6/40,9.77%,VTN;IL1B;CD46;C7;SUSD4;CR2
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.25000216491812505,-0.835663848578933,0.7570332480818415,0.9213125635898215,1.0,23/62,30.81%,MLLT3;POLR2A;RTF1;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;ERCC3;CDK7;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.23062318370334076,-0.8356064082972154,0.8112676056338028,0.9208289283916854,1.0,29/91,25.20%,TAF1;MN1;CDC16;ANAPC4;PSME2;PSMB4;TRIM39;PSMD8;PSMB1;PSMD11;DDB1;DBF4;PSME3;CDKN1B;TCIM;ANAPC16;PSMA2;PSMD4;FZR1;PSMD3;PSMB7;CDC27;ANAPC5;PSMC2;ERCC2;PSMD10;PSMC5;ERCC3;TP53
prerank,regulation of mRNA stability (GO:0043488),-0.21575514189208767,-0.8353189079192792,0.8619631901840491,0.9207831060445739,1.0,40/145,24.73%,SAMD4A;ROCK2;VIM;THRAP3;NOCT;PRKCD;RC3H2;AKT1;IGF2BP2;PSME2;PUM1;PSMB4;UBB;TENT5A;LARP1;PSMD8;PSMB1;PSMD11;FXR2;FTO;EXOSC5;PSME3;ELAVL1;XRN1;PSMA2;CSDC2;ZFP36L2;PSMD4;TENT5C;PSMD3;E2F1;PSMB7;NUP214;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMD10;PSMC5
prerank,regulation of cell growth (GO:0001558),0.24970281474768005,0.8351979665224821,0.755464480874317,0.916453238491067,1.0,20/204,8.74%,PLCE1;RERG;APBB2;SLC25A33;RASGRP2;SLIT3;BCAR1;SIPA1;PABIR1;CRLF3;NRG3;AKAP6;ROS1;DDX3X;CAPRIN2;SUPV3L1;PPT1;CDKN1A;MTOR;CCAR2
prerank,regulation of glucose metabolic process (GO:0010906),0.3280226595612825,0.8351923832362738,0.6612244897959184,0.9157443866943635,1.0,5/34,8.83%,RORA;OGT;IRS1;ZNF692;SDHAF3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3024859531020332,-0.8348983199398395,0.7157464212678937,0.9210150406752557,1.0,11/27,23.70%,VPS13A;GOLPH3;VPS13D;OBSL1;OPTN;GBP5;ARL5A;RAB6A;ZDHHC15;GAK;RIPOR1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2923589279601775,0.8347326907302103,0.6737704918032786,0.9158808636947554,1.0,8/62,11.23%,LIMD1;NUP43;AJUBA;DND1;NUP35;POLR2C;SEC13;NDC1
prerank,actin nucleation (GO:0045010),0.35009973760306434,0.8345815293717522,0.6541501976284585,0.9154596369757869,1.0,6/21,13.38%,SPIRE1;ARPC5;ARPC5L;LMOD1;ARPC4;ARPC1A
prerank,response to hydrogen peroxide (GO:0042542),-0.2707123136042328,-0.8340394151683104,0.7172897196261683,0.9219855101210197,1.0,13/45,18.50%,ADAM9;ANXA1;RHOB;CYP1B1;PRKCD;RELA;GLRX2;NET1;SIRPA;GPX1;RIPK1;OSER1;PARK7
prerank,intracellular sterol transport (GO:0032366),-0.3435876465435299,-0.833467897107361,0.7009708737864078,0.9224232790093343,1.0,3/13,13.20%,ABCA1;NPC2;STARD4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.24386216635040944,-0.8327739950253819,0.7741116751269036,0.9231804458949378,1.0,28/70,28.33%,B2M;TAPBP;SNAP23;LNPEP;PSME2;PSMB4;CYBA;CALR;PSMD8;PSMB1;PSMD11;PSME3;PDIA3;PSMA2;PSMD4;IKBKG;PSMD3;PSMB7;CYBB;VAMP8;PSMC2;TAP2;PSMD10;PSMC5;FCGR1A;MFSD6;PSMD7;TAP1
prerank,positive regulation of nervous system process (GO:0031646),-0.3276146150145075,-0.832749021866281,0.6881918819188192,0.9226293228813076,1.0,4/18,10.02%,UNC13B;TNFRSF1B;PARD3;NLGN2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.29021059249834424,-0.832443794603315,0.723175965665236,0.9226049765976146,1.0,14/30,25.51%,NOS3;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SERPINE1;GPX1;RIPK1;PARK7;RFFL;BCL2L1;BRCA1;FAS
prerank,snRNA processing (GO:0016180),0.3680603815156779,0.8320043317009069,0.6224066390041494,0.9195819653507559,1.0,3/16,14.28%,INTS6L;INTS1;INTS12
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2770670943922365,0.831969382068533,0.7096774193548387,0.9189286167584881,1.0,9/95,6.53%,MEF2C;NR1H3;IL1B;CXCL5;AXL;CXCL10;TNIP2;PDE4B;CACTIN
prerank,protein localization to mitochondrion (GO:0070585),-0.3674446747306905,-0.8318809169595083,0.6951672862453532,0.9230687303570897,1.0,8/11,33.30%,LRRK2;HK2;AKT1;MAIP1;HK1;ISG15;PINK1;RALA
prerank,protein import into peroxisome membrane (GO:0045046),0.34546352894306154,0.8316877661908738,0.6325678496868476,0.9187802660419256,1.0,6/22,15.33%,RAB8B;ABCD2;ATAD1;PEX3;PEX19;PEX12
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.35824912113258334,0.8316841043872389,0.6089494163424124,0.9180715220156154,1.0,10/19,23.51%,GNL3L;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,response to X-ray (GO:0010165),-0.3363669407402249,-0.8311308224772321,0.6724470134874759,0.923830760476396,1.0,4/14,20.78%,ANXA1;XRCC4;ATM;IKBIP
prerank,DNA double-strand break processing (GO:0000729),-0.3192862868946551,-0.8306921048019182,0.6986301369863014,0.9240161376122756,1.0,6/18,23.91%,ATM;RAD50;SMARCAD1;RAD52;SLX4;BRCA1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.342994801100308,-0.8303445690594456,0.6818181818181818,0.9240386600003068,1.0,5/14,22.17%,TNKS2;PINX1;BRCA2;TPP1;ACD
prerank,aminoglycan biosynthetic process (GO:0006023),0.301634040938663,0.8302302305170376,0.6816666666666666,0.9200202568305504,1.0,7/49,7.13%,GCNT2;SDC2;SDC3;AGRN;GPC5;GPC3;B3GALT1
prerank,protein secretion (GO:0009306),-0.25420294367288854,-0.8296124099983878,0.7543859649122807,0.9248368711155558,1.0,8/56,11.94%,ABCA1;STEAP3;PCSK5;ANXA1;RCN3;GOLPH3;TMEM167A;RAB8A
prerank,protein complex oligomerization (GO:0051259),-0.23859682701358556,-0.8289954465719874,0.8005390835579514,0.9253554371005335,1.0,21/85,16.63%,MCU;RNF213;PDCD6IP;UPB1;ALS2;GLRA3;EHD1;RNF135;SPAST;ZC3H12A;GSDMD;ATL2;KCNC3;TMEM120B;CLDN1;NINJ1;BEND3;AQP11;HOMER1;ELAVL1;PNPT1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.365689235118696,-0.8289570265960596,0.6685185185185185,0.9248194580416753,1.0,3/11,14.36%,LRRK2;ATP9A;MAPK3
prerank,positive regulation of neuron migration (GO:2001224),0.3979107510941492,0.8287451267183783,0.6216216216216216,0.9220874977677491,1.0,1/11,1.03%,RAPGEF2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.32236812863782127,0.8287187865274723,0.6407766990291263,0.921413921874575,1.0,9/35,12.55%,CDK6;ETS1;FAM210B;ARNT;ANKRD54;LYN;MED1;PRMT1;PRKDC
prerank,mRNA destabilization (GO:0061157),-0.26599781517015464,-0.8285488624633816,0.7397849462365591,0.9249315149524173,1.0,8/38,12.00%,ROCK2;TUT4;MOV10;TUT7;RC3H2;ZC3H12A;CPEB3;PUM1
prerank,neutrophil migration (GO:1990266),0.30151467052956765,0.8283915370112603,0.6854700854700855,0.9213141436842609,1.0,6/58,7.43%,PIK3CD;CXCL5;CXCL10;CXCR2;PDE4B;PIKFYVE
prerank,protein import into mitochondrial matrix (GO:0030150),0.3640533632443366,0.8280369035552727,0.6073752711496746,0.9212865784138176,1.0,9/18,25.12%,GRPEL2;TOMM40L;TIMM23;TOMM40;TOMM70;DNAJC19;PAM16;TIMM17A;DNLZ
prerank,T cell proliferation (GO:0042098),-0.3413935247724953,-0.8279179785190406,0.6892655367231638,0.9254944055724939,1.0,7/13,42.22%,CTPS1;LMBR1L;PPP3CB;DOCK8;PIK3CG;CRTAM;TNFRSF4
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.40379372322294915,0.8278977411218921,0.6224256292906178,0.9208235797377499,1.0,3/11,8.10%,MAP3K5;PDCD10;STK24
prerank,negative regulation of catalytic activity (GO:0043086),0.3431799659568451,0.8273790982812026,0.656188605108055,0.9210600107255897,1.0,5/24,13.39%,NOTCH1;NES;CCAR2;ATP5IF1;PPP1R12A
prerank,response to sterol (GO:0036314),0.3935206152714628,0.8272668938096622,0.6415094339622641,0.920552971539957,1.0,1/11,1.20%,RORA
prerank,superoxide metabolic process (GO:0006801),0.32964756288834657,0.8270341118662615,0.6470588235294118,0.9202497894058412,1.0,4/29,5.98%,NCF2;NCF1;ATP7A;SOD3
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3543536130472179,0.826684709438379,0.6301369863013698,0.920204517265846,1.0,8/20,18.63%,CHRNA3;AGRN;CHRNA7;RGS10;CHRNB2;RGS8;CHRM3;CHRM2
prerank,peptidyl-lysine modification (GO:0018205),-0.22827893880446898,-0.8266603481802856,0.8136986301369863,0.9272286494687404,1.0,24/99,21.11%,EYA1;HDAC4;LOXL1;KAT2B;HDAC9;PLOD2;NNAT;STX1A;SENP3;SAE1;NUP98;PLOD1;P3H4;SIRT7;TPR;SIRT2;PARK7;SIRT3;PIAS4;NUP88;PLOD3;ETFBKMT;NUP214;TRPM4
prerank,myeloid dendritic cell activation (GO:0001773),-0.35596613986184583,-0.8263125598060079,0.6808118081180812,0.9272497268162408,1.0,1/12,3.00%,TGFBR2
prerank,monosaccharide transmembrane transport (GO:0015749),0.3693965808735161,0.825140478953183,0.645021645021645,0.9223910541935667,1.0,5/16,17.11%,SLC5A1;SLC2A6;SLC2A9;SLC23A2;SLC23A1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.29306228466468265,-0.8250635556463873,0.7357001972386588,0.9289597661023749,1.0,7/26,20.92%,OCLN;AKAP9;TRPV4;MET;TOGARAM1;FES;NUMA1
prerank,dendrite self-avoidance (GO:0070593),-0.3231533766802399,-0.8249833916968884,0.6933867735470942,0.9285162325633948,1.0,3/16,9.94%,BSG;PALLD;ROBO4
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.36625674993081364,0.8247119485590862,0.650294695481336,0.9224847830585441,1.0,7/17,13.90%,ROCK1;GGA3;NTRK2;CHRNA7;BIN1;RTN1;ABCA7
prerank,neuron projection fasciculation (GO:0106030),0.40082942950986594,0.8246862465556504,0.6514161220043573,0.9218312395649512,1.0,3/10,8.93%,SEMA5A;CNTN4;ARHGAP35
prerank,RNA destabilization (GO:0050779),0.3619551497093656,0.8245743049973291,0.6184486373165619,0.9213149395787655,1.0,5/18,12.46%,ROCK1;RBM24;YTHDF3;YTHDF2;CELF1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2854015498062363,-0.8244823810534158,0.7274549098196392,0.9287640826113092,1.0,14/33,27.78%,FOXO3;HOXA5;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2;FES;RAB7B;BRD1;NCKAP1L;MTURN;HSPA1B
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.25264077742146,-0.8244801010624505,0.7803203661327232,0.9281741259173003,1.0,21/52,31.11%,SEC31A;HSPA5;ERN1;ADD1;EXTL2;DNAJB11;DNAJC3;PARP16;PDIA6;PDIA5;GFPT1;TPP1;XBP1;SHC1;ATP6V0D1;PREB;SYVN1;EDEM1;ZBTB17;YIF1A;HYOU1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.35262842222622437,0.8238505191112149,0.6356107660455487,0.9219648104673991,1.0,1/18,1.34%,PIK3R1
prerank,sensory perception (GO:0007600),0.3124789088595136,0.823594154484704,0.6727941176470589,0.9217061429995262,1.0,11/45,17.51%,ADORA2A;TRPV2;OPRK1;CHRNA7;TMEM150C;SCN9A;ASIC3;CHRNB2;NIPSNAP1;GNAL;TTC8
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2686197960707427,-0.8235431900008342,0.7631578947368421,0.9292839320771952,1.0,14/42,24.75%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;VARS2;EARS2;FARSA;PPA1;FARSB
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.31585192365644,-0.8227814188179392,0.7246653919694073,0.930040406387301,1.0,2/20,1.65%,DAB2;RHOQ
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.37203512408668116,-0.8224805626180962,0.6943396226415094,0.929346480092965,1.0,2/10,21.06%,CACNA2D4;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.37203512408668116,-0.8224805626180962,0.6943396226415094,0.929346480092965,1.0,2/10,21.06%,CACNA2D4;TULP1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.30891156659551555,-0.8223806723420504,0.7209302325581395,0.9289268580962805,1.0,6/20,21.54%,ACACA;FAR2;ACSL4;HSD17B8;DGAT2;GCDH
prerank,neuron fate commitment (GO:0048663),-0.3445427247976775,-0.8220660100231738,0.7279843444227005,0.9289116873487293,1.0,8/14,44.02%,TGFBR1;ID2;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,lymphocyte mediated immunity (GO:0002449),0.3777359480671596,0.821573545515958,0.6439232409381663,0.9247354335978959,1.0,2/12,8.70%,CD46;JAG1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3500478104552843,0.8215463736573219,0.6417004048582996,0.9240819847073661,1.0,2/23,4.13%,PIK3CD;FGF2
prerank,neuromuscular junction development (GO:0007528),0.34118689187020823,0.8215106712752384,0.6570327552986512,0.9234487300450714,1.0,5/24,7.39%,CACNB2;DOK7;AGRN;ANK3;PPFIBP2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2776871354953399,-0.8213538923607577,0.7477477477477478,0.9296131183416664,1.0,8/34,15.25%,PTPRB;PTPN13;PTPRJ;DUSP1;DUSP16;PGP;DUSP7;DUSP10
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3564450062524098,-0.8211302298267946,0.6964285714285714,0.9294504488976296,1.0,7/11,35.97%,UBN1;H3-3A;HAT1;ASF1A;IPO4;ASF1B;ATRX
prerank,regulation of steroid biosynthetic process (GO:0050810),0.39151844008238706,0.8200699409731119,0.6238532110091743,0.9254848301316309,1.0,1/11,1.15%,BMP5
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.3061602490080829,-0.8197845689118232,0.7311608961303462,0.9312009578158538,1.0,7/21,22.43%,TALDO1;HK2;DERA;PGD;RPIA;PGLS;SHPK
prerank,positive regulation of isotype switching (GO:0045830),-0.3404633439586957,-0.8194611656702633,0.6904761904761905,0.9311886565947619,1.0,6/15,22.07%,TFRC;TGFB1;SHLD1;KMT5C;CLCF1;TNFSF13
prerank,negative regulation of hemostasis (GO:1900047),-0.35384366452134164,-0.8191300799277765,0.6869070208728653,0.9312013127647382,1.0,3/12,4.45%,APOE;THBD;CD34
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.26016986045514845,0.8190172793008325,0.7407407407407407,0.9267383043244167,1.0,27/122,15.14%,PDGFRB;PLD1;RGCC;IL1B;FGF2;YTHDF3;IL4;DDX3X;SOX4;IRS1;KAT7;NMD3;MTOR;PRKD2;GCK;EIF3C;PDGFB;PRMT1;EIF6;PRKDC;BCAR3;UPF3B;JAK2;PRR16;LARP6;ABCB10;FAF1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.36570010285830307,0.8187507374751513,0.631578947368421,0.9264840106150142,1.0,4/17,7.85%,CACNA2D1;KCNE4;SCN5A;KCNE5
prerank,protein-DNA complex assembly (GO:0065004),-0.21667214359520692,-0.8184735234946529,0.8888888888888888,0.9318135984071836,1.0,34/116,24.86%,KAT6B;TCF4;H3-3A;ERCC5;ANP32B;PSME2;CUL4A;PSMB4;UBB;PSMD8;PSMB1;RPA1;PSMD11;DDB1;PSME3;HMGB2;PSMA2;PSMD4;PSMD3;PSMB7;RSF1;NAP1L2;CETN2;BRD2;MCM8;PSMC2;RAD51;CHAF1A;ERCC2;RPA3;PSMD10;PSMC5;ERCC3;ASF1A
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3666777955815646,-0.8183851243572708,0.7013232514177694,0.9313874246017295,1.0,4/11,12.28%,NOVA2;IGF2BP2;PCBP2;NOVA1
prerank,dendritic cell differentiation (GO:0097028),-0.3046236774504078,-0.818041196150696,0.7314629258517034,0.9313778812853764,1.0,3/22,5.60%,TGFBR2;GAS6;LGALS9
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3464827142739297,0.8179374590300306,0.6601178781925344,0.9272639880690438,1.0,4/22,9.15%,RAPGEF2;NTRK2;RAP1A;TMEM108
prerank,organelle fusion (GO:0048284),0.3387057118937268,0.8178069433068268,0.6225296442687747,0.9267891334600297,1.0,7/22,15.85%,PLD6;VPS18;VPS11;STX4;MFF;MFN1;MIEF1
prerank,mesoderm formation (GO:0001707),0.3694331125010689,0.817484275269917,0.6264591439688716,0.9266738880535379,1.0,3/17,6.44%,TBX20;ITGB1;ITGA8
prerank,protein polyubiquitination (GO:0000209),-0.19655575331323646,-0.8171181273411471,0.9303482587064676,0.9324260390479109,1.0,83/297,24.81%,FBXL7;RNF213;HERC6;SASH1;NPEPPS;SMURF2;FBXO10;RNF146;ZNRF1;TAF1;SPSB1;RNF19A;WWP2;TNKS2;RNF144B;TTC3;SMURF1;CDC16;AMFR;IFI27;UBE2E2;LNPEP;NHLRC3;RC3H2;CHFR;DTX3L;RNF135;UBE4B;ANAPC4;TRIM27;PSME2;RNF125;UBE2Q2;MDM2;PSMB4;UBB;FBXW11;UBE2G2;WWP1;PSMD8;PSMB1;PSMD11;RNF115;FBXL14;ANKIB1;PSME3;RNF187;PELI1;UBE3D;FBXL19;TRIM14;TRAF3IP2;LONRF1;PSMA2;FBXO41;PSMD4;FZR1;PSMD3;RNF217;UBE2L6;RFFL;PSMB7;RNF126;CDC27;RMND5A;ANAPC5;RNF144A;RBBP6;DZIP3;DDA1;FBXO17;CCNF;PSMC2;RNF216;BRCA1;TRIM6;PRKN;RNF19B;PSMD10;RNF8;PSMC5;CBFB;BFAR
prerank,regulation of hormone secretion (GO:0046883),-0.3365312055364956,-0.8171034314273491,0.7109826589595376,0.9318589256280013,1.0,2/15,4.07%,SNX6;ANXA1
prerank,mitochondrion distribution (GO:0048311),-0.35016692412043204,-0.8170935254385113,0.7051792828685259,0.9312875616019932,1.0,3/12,16.23%,LRRK2;MEF2A;MSTO1
prerank,transcription by RNA polymerase I (GO:0006360),-0.2776155367720038,-0.8169614198990931,0.7568710359408034,0.9309169895579472,1.0,14/34,30.71%,TAF1;CAVIN1;POLR2F;TCOF1;MAPK3;POLR2E;UBTF;TTF1;ERCC2;ERCC3;CDK7;POLR1C;MNAT1;GTF2H3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.369287624371804,-0.816373770381881,0.7276264591439688,0.9313097845301741,1.0,3/10,21.48%,RNF125;NPLOC4;SEC14L1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3630111607213592,0.81635935061842,0.6590909090909091,0.9280703002958964,1.0,2/17,1.66%,ATP1A2;GPER1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3328141136679718,-0.8157677755415613,0.6994106090373281,0.9317516821226977,1.0,4/15,18.83%,ENTPD1;CMPK1;ENTPD5;ENTPD2
prerank,positive regulation of transport (GO:0051050),0.27592589654514826,0.8156464936681015,0.7350993377483444,0.9286947721043023,1.0,8/85,6.31%,NEDD4L;IL15RA;NR1H3;MERTK;IL1B;GPC3;CBLL1;SNCA
prerank,regulation of cellular catabolic process (GO:0031329),-0.2398808563525069,-0.8153367687231868,0.7760814249363868,0.9318963202016184,1.0,13/62,17.44%,DAPK1;NUPR1;LRRK2;WDR41;ACER2;PSAP;PIP4K2B;RAB8A;ATM;FBXL2;GPR137;MTMR3;RRAGB
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3491543785650038,0.815312067962041,0.6724470134874759,0.9285728928093709,1.0,4/21,6.93%,SPRY4;SH3BP1;SPRY2;LZTR1
prerank,mRNA modification (GO:0016556),0.34764185393847136,0.8153009408670914,0.6358490566037736,0.9278825414292184,1.0,8/22,20.81%,TRMT61A;CBLL1;TRUB1;TRMT10C;PUS7;ZC3H13;NSUN2;WTAP
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.27654834295769753,-0.8151505764487724,0.7318087318087318,0.9316331580375292,1.0,19/33,36.43%,ANXA1;RHOB;CYP1B1;PRKCD;RELA;NET1;SIRPA;RIPK1;OSER1;PARK7;RPS3;TRPM2;ABL1;ANKZF1;SIGMAR1;HDAC6;MAPK7;AQP1;PPIF
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3692931121036426,-0.8149741111670631,0.7240740740740741,0.9313399175806888,1.0,5/10,22.68%,LRRK2;TXN;RIPK1;PARK7;STK26
prerank,cAMP biosynthetic process (GO:0006171),0.3859400806356596,0.8149039367924837,0.6724511930585684,0.9279116777985852,1.0,4/10,7.15%,ADCY3;ADCY8;ADCY6;ADCY9
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3008691084568509,-0.8148500809061887,0.7349896480331263,0.9309926253667612,1.0,3/24,6.22%,BMPR2;NIBAN2;ACVRL1
prerank,regulation of telomere maintenance (GO:0032204),-0.28854288396396,-0.8143386190646226,0.7195121951219512,0.9313019523063774,1.0,5/26,16.86%,HDAC8;SMG6;PML;RAD50;SMG5
prerank,copper ion homeostasis (GO:0055070),-0.32236819395368144,-0.8138723292810929,0.7178988326848249,0.9315692421688766,1.0,2/17,5.17%,APP;ATOX1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.23667900044463736,-0.8138074151510235,0.7855297157622739,0.9310990094451695,1.0,21/72,24.83%,ENPP1;EDC3;RNASE4;ERCC5;REXO4;ZC3H12A;CUL4A;DNASE1L1;UBB;RPA1;RAD50;DDB1;SPO11;RFC3;PNRC2;DICER1;RFC1;ERCC1;ERCC2;RPA3;ERCC3
prerank,early endosome to late endosome transport (GO:0045022),-0.31271873567535813,-0.8136544380623778,0.705050505050505,0.9308006828880651,1.0,5/20,14.94%,EEA1;BECN1;RAB7A;WDR81;ANKRD27
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3523483824119275,0.8128688907733692,0.636734693877551,0.9308211666508334,1.0,6/18,15.49%,LDLRAP1;SPTBN1;APPL1;ZDHHC2;VTI1B;CDK5
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3542105424848637,-0.8127276404017248,0.7075098814229249,0.9318970434603375,1.0,4/12,17.87%,ABCA1;ITGB3;PPARA;NFKBIA
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3403896230832387,-0.8127056347990788,0.7325800376647834,0.9313451103986888,1.0,2/13,7.21%,IRAK2;PIK3AP1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2519692754309921,-0.8119221426598698,0.8035320088300221,0.9321512475163167,1.0,13/49,19.55%,F3;LBP;NOD1;LGALS9;STAT3;MAVS;RELA;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5;SYK
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.35325772032257907,0.8118788745613538,0.6742738589211619,0.9319617134119477,1.0,5/17,13.05%,SPRED1;CADM4;SPRY2;DDIT4;SPRED2
prerank,histone mRNA metabolic process (GO:0008334),-0.2818054304734196,-0.8118295731417263,0.7227926078028748,0.9317418996626017,1.0,10/27,27.50%,TUT4;TUT7;MTPAP;ATM;SNRPF;XRN1;TENT4B;CPSF2;SNRPB;SNRPE
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.37956588071918385,0.8109874107979844,0.6541019955654102,0.9321843879305257,1.0,4/10,10.64%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.37956588071918385,0.8109874107979844,0.6541019955654102,0.9321843879305257,1.0,4/10,10.64%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,protein palmitoylation (GO:0018345),0.32822935126152875,0.8109425527452591,0.664804469273743,0.9315587649830848,1.0,8/30,13.42%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;HHAT;ZDHHC23
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.23342905066089875,-0.8106610890462118,0.8354114713216958,0.9332263701976129,1.0,31/78,28.52%,DAB2;CAV1;SMAD7;LRRK2;TAF1;RNF19A;RNF144B;SH3RF2;BBS7;USP5;DNAJB2;MDM2;ELOB;ANKIB1;BCAP31;SIRT2;FZR1;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;PRKN;RNF19B;PSMD10;RACK1;CEBPA;HSPA1B;TRIB3;CLU
prerank,hexose metabolic process (GO:0019318),-0.26194996302802864,-0.8105534496041837,0.7654584221748401,0.9328147545392754,1.0,18/39,34.27%,APOD;SORD;FUCA1;SLC35A2;CHST15;AKR1A1;GAA;FPGT;ALDOA;BRAT1;FUCA2;HK1;GALT;GDPGP1;KHK;IRS2;DCXR;CHST1
prerank,protein oxidation (GO:0018158),-0.35283748720651686,-0.8104048502282171,0.7097345132743362,0.9324808642459742,1.0,1/11,1.64%,LOXL1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.37039966628927234,-0.8099914112133725,0.7110266159695817,0.9325556450434125,1.0,2/10,6.64%,APPL2;ANO6
prerank,mitochondrion organization (GO:0007005),0.24845934002500694,0.8099824469494469,0.7945402298850575,0.9326080173656557,1.0,16/165,8.64%,PID1;HIGD1B;SLC25A33;IMMP2L;AKT3;PLD6;PTCD2;ATP7A;FANCG;ESRRA;GABPA;SUPV3L1;TIMM22;MTFP1;TFAM;RAB38
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.23231093141863027,-0.8098090498354783,0.8273381294964028,0.9322833240934412,1.0,22/73,21.52%,HDAC4;DNMT3A;KAT2B;RBBP7;IGF2;H3-3A;BAZ1B;JARID2;TRIM27;POLR2F;TDG;ACTB;HDAC5;PPHLN1;POLR2E;GPX1;ZFP57;EZH2;SMYD5;CTCF;MPHOSPH8;DNMT1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.30982323412805135,-0.8096679428344495,0.7227926078028748,0.9319398837653264,1.0,4/21,8.64%,MFHAS1;PTPA;FKBP1A;PPP1R16B
prerank,regulation of lipid catabolic process (GO:0050994),0.3532333382648122,0.809599643535435,0.6774193548387096,0.9326462707948423,1.0,7/19,23.91%,IL1B;RARRES2;PRKAA1;LONP2;PDE3B;TYSND1;ABCD1
prerank,regulation of lymphocyte activation (GO:0051249),0.3734100924259429,0.809188378678288,0.6479166666666667,0.932710814216082,1.0,1/12,3.86%,PAG1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.29579111045199097,-0.8091547388580921,0.7254098360655737,0.9321962013870345,1.0,6/23,13.93%,PARP9;PARP14;STAT1;IRGM;NLRC5;HSP90AB1
prerank,amide biosynthetic process (GO:0043604),-0.25516630143769686,-0.8089064230400979,0.7844036697247706,0.9320365693072051,1.0,4/47,2.86%,PAM;PCSK5;SGMS1;SGMS2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3741386714387547,0.8082322413276005,0.6624472573839663,0.9336994376462139,1.0,4/12,18.20%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.23607511471591797,-0.8077542810672459,0.8241206030150754,0.9333428194254401,1.0,21/68,27.41%,AOX1;PCCA;ENPP1;SLC2A1;PCCB;CUBN;SLC5A6;ALDH1L1;SLC25A19;NNMT;SLC52A3;FPGS;CYB5R3;SLC52A1;SLC19A2;GSTO2;CD320;PDXK;SLC25A32;PNPO;MTRR
prerank,maintenance of protein location in nucleus (GO:0051457),0.33981606517571283,0.8074831577481262,0.68389662027833,0.9343857126522078,1.0,1/20,1.27%,SYNE1
prerank,regulation of TOR signaling (GO:0032006),0.28694358866473674,0.8066897487148107,0.7370242214532872,0.9351376841623915,1.0,14/67,14.46%,UBR1;PIK3CA;ROS1;AKT1S1;GNA12;NPRL3;DYRK3;DDIT4;SEC13;UBR2;TTI1;NPRL2;MIOS;PRKAA1
prerank,protein localization to chromosome (GO:0034502),-0.2711196449004666,-0.80594745656287,0.7511415525114156,0.935894170286938,1.0,10/34,22.41%,ESR1;TNKS2;PINX1;PARP3;XRCC4;RPA1;TPP1;CTCF;ACD;MCM8
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2703504823599053,-0.8058637043242124,0.7957894736842105,0.9354643440601769,1.0,5/34,10.28%,ROCK2;ACTN2;MFHAS1;CTNNA1;FLCN
prerank,myelin assembly (GO:0032288),0.38833898846252046,0.8057837661742343,0.6423529411764706,0.9360629714476124,1.0,3/10,7.88%,TPPP;NCMAP;TENM4
prerank,telomere capping (GO:0016233),0.3554619505869339,0.8052849775564318,0.647887323943662,0.9361940223186691,1.0,5/16,21.67%,DCLRE1B;PRKDC;TERF1;TINF2;CTC1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.29784519751066924,0.804743901526643,0.695575221238938,0.936501752701615,1.0,11/48,12.55%,FNIP2;BCL2L10;CIDEB;CASP9;CDIP1;HTRA2;EPHA2;DDIT4;HIPK1;EP300;PRKDC
prerank,mitochondrion disassembly (GO:0061726),-0.2710408477921423,-0.8046364893469927,0.7635574837310195,0.9369391132503794,1.0,9/34,25.08%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG12;PRKN;ATG7
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3449069203573042,0.8040139868280849,0.6646216768916156,0.9371067293679785,1.0,5/18,20.44%,COX18;FASTKD3;COX20;OXA1L;SURF1
prerank,negative regulation of endocytosis (GO:0045806),0.32347016786430355,0.8040077318411882,0.6680080482897385,0.9364167692271145,1.0,11/24,23.71%,NR1H3;CD300A;SCAMP5;PACSIN3;ABCA7;PRKD1;SYT11;SNX33;LILRB1;PICALM;ARF6
prerank,negative regulation of kinase activity (GO:0033673),-0.23773588139587376,-0.8039858993841261,0.8228438228438228,0.937469676706954,1.0,25/62,28.29%,PRKAG2;DEPTOR;LRP6;DTNBP1;AKT1;TRIM27;CEP85;QARS1;PPIA;CEACAM1;CDKN1B;GSKIP;PDPK1;PARK7;CHP1;TRIB1;CDKN1C;UBASH3B;INPP5K;GNAQ;PYDC1;PAK2;SFN;PPM1F;TRIB3
prerank,regulation of vesicle-mediated transport (GO:0060627),0.26694950230855563,0.8038711503922846,0.765,0.9359680703560282,1.0,17/91,12.70%,PLD1;SCARB1;RAB8B;RIT2;RIMS2;RAB3B;LGI3;SYT1;AP2S1;HIP1;ABL2;STX4;STXBP5L;PACSIN3;DENND10;SRC;PTPN1
prerank,membrane depolarization (GO:0051899),0.32078685839427507,0.8037104078049828,0.6585365853658537,0.9355468653808341,1.0,9/32,14.99%,CACNA1H;SCN2A;SCN5A;SCN8A;SCN9A;CACNA1A;ATP5IF1;SCN1A;CHRNB2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3260543113198239,0.803624323256093,0.6606786427145709,0.9350110494299115,1.0,6/26,15.52%,HECW2;CUL3;NEK6;RB1;ANAPC7;NSMCE2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3080447076833141,-0.8034747152472214,0.7258687258687259,0.9377583830831208,1.0,1/18,0.59%,PLCB1
prerank,negative regulation of catabolic process (GO:0009895),0.3023921341424617,0.8020207602750921,0.6950998185117967,0.9371105677382975,1.0,4/47,4.06%,CBFA2T3;AGAP2;IL1B;FMN2
prerank,regulation of pseudopodium assembly (GO:0031272),0.385132632771183,0.8019914571850757,0.6688741721854304,0.9357662488080876,1.0,3/10,14.99%,CDC42EP1;APC;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.385132632771183,0.8019914571850757,0.6688741721854304,0.9357662488080876,1.0,3/10,14.99%,CDC42EP1;APC;CDC42EP4
prerank,histone methylation (GO:0016571),-0.2844525962868146,-0.8017422121457279,0.7536231884057971,0.9401081678962965,1.0,9/26,26.21%,SMYD3;CARM1;EHMT1;NSD1;SIRT7;EZH2;SETD6;TRMT112;FBL
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3478303686669104,0.8010329376466192,0.6798418972332015,0.9368444500449117,1.0,4/18,13.09%,LDLRAP1;ADAM19;ACHE;PSEN1
prerank,TOR signaling (GO:0031929),0.3270945453294107,0.800399632329143,0.6948818897637795,0.9372728862596706,1.0,5/26,9.22%,EIF4EBP2;PRR5L;RPS6KB2;MTOR;NPRL3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3728755463596191,0.7997183472577849,0.6861167002012073,0.9377927309882228,1.0,2/11,9.97%,UQCRFS1;UQCRC2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.3507087798818018,-0.7997134469212056,0.7110266159695817,0.9429834734951864,1.0,1/12,0.40%,UNC13B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.36040185919761475,-0.7993314925649562,0.7229601518026565,0.9430678263495019,1.0,4/10,21.54%,IVD;ACADL;ACADS;GCDH
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3192477377371372,0.7992844916081048,0.6875,0.937835907354875,1.0,14/30,25.35%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;MVK;NSDHL;ACAA2;FDFT1;CYP51A1;FDPS
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.31299594059173236,-0.7991467167602936,0.7620889748549323,0.9427890915383544,1.0,2/17,3.41%,EZR;PTPRJ
prerank,macroautophagy (GO:0016236),0.2535976722952513,0.7986393848131192,0.804093567251462,0.9382566528407311,1.0,36/118,23.26%,DYNLL1;PIP4K2A;ATG16L1;CHMP2B;MVB12A;MTMR14;MTERF3;SRC;VTI1B;UBXN6;PRKAA1;PLEKHM1;VPS33B;MFN1;CHMP3;TOMM40;HDAC10;EI24;PIK3C3;ULK3;SNF8;LIX1L;CSNK2A2;VTA1;NBR1;GABARAP;PRKAB2;TOMM70;VPS37B;GABARAPL2;ARL8B;VPS16;ATG13;VPS36;VAMP7;VDAC1
prerank,integrated stress response signaling (GO:0140467),-0.33022425586717064,-0.7984882230961241,0.731006160164271,0.9433084916681568,1.0,2/14,7.53%,QRICH1;HSPA5
prerank,Golgi ribbon formation (GO:0090161),-0.34266584193867916,-0.7984533344848809,0.7342007434944238,0.9427806251006178,1.0,4/13,11.75%,MYO18A;GOLPH3;OPTN;STX6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.35354480314490977,0.7983741127236531,0.6556291390728477,0.9380292166055767,1.0,6/14,15.67%,AK8;NMNAT3;AK7;AK5;AK4;AK3
prerank,regulation of lipase activity (GO:0060191),-0.33382103947306596,-0.7981379309394853,0.7284894837476099,0.9427066449999676,1.0,2/13,6.67%,PCSK5;RHOA
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2984087523683655,0.7980179908433128,0.7468354430379747,0.9379603957477193,1.0,10/42,18.74%,WAS;FANCB;TIMELESS;CGAS;SHLD3;PPP4C;PARP1;MRNIP;RPA2;FUS
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.3097432473655838,-0.7979114708332982,0.7290076335877863,0.942509980935036,1.0,10/17,35.75%,P4HB;AKT1;PPIA;BAG5;SOD2;HSPB1;TREM2;MAPK7;VNN1;NME5
prerank,oligodendrocyte development (GO:0014003),0.3543190951273244,0.7978400030340845,0.6760869565217391,0.9375793459287498,1.0,4/15,10.64%,B4GALT6;TPPP;PLP1;EIF2B3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3810967904510428,0.7974065670340019,0.6463963963963963,0.9376484180380255,1.0,3/11,11.25%,BCAR1;HPN;PAK1
prerank,vacuolar acidification (GO:0007035),-0.29484367055901817,-0.7974006324842114,0.7413793103448276,0.942776629963883,1.0,9/21,26.91%,ATP6V0A4;ATP6V0A1;TCIRG1;ATP6V0A2;CCDC115;CLN5;CLN6;TMEM199;ATP6V0D1
prerank,gonad development (GO:0008406),-0.25718250757330524,-0.7973843141595771,0.7866666666666666,0.9422233793207675,1.0,11/41,26.73%,WNT4;AR;WNT5A;KIT;GATA6;BASP1;NCOA4;CSDE1;COL9A3;BIK;ADAM21
prerank,regulation of hemopoiesis (GO:1903706),0.3849356072809654,0.7972206633573922,0.6514522821576764,0.937288735591436,1.0,1/10,2.44%,PTN
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.22307000800003793,-0.7970174465781226,0.8415300546448088,0.9422503188948891,1.0,29/94,25.07%,PLCB1;IL1R1;NOD1;IRAK2;MAP3K8;IRAK3;PSME2;RELA;PSMB4;UBB;FBXW11;PSMD8;PSMB1;MAPK3;PSMD11;PSME3;PELI1;NFKBIA;MAP3K3;PSMA2;PSMD4;IKBKG;PSMD3;PSMB7;PSMC2;PSMD10;EGR1;PSMC5;MYD88
prerank,protein insertion into ER membrane (GO:0045048),-0.2692553626644089,-0.7962315055154624,0.7692307692307693,0.9430016796481058,1.0,12/37,24.65%,APP;TRAM2;EMC2;STX1A;ALDH3A2;VAPA;GET1;SEC61B;EMC6;CCDC47;WDR83OS;UBL4A
prerank,peptidyl-lysine methylation (GO:0018022),-0.28214496164793873,-0.7961038563835656,0.7524752475247525,0.9426567665618439,1.0,4/26,10.84%,SMYD3;SETD7;KMT5A;EHMT1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.37501361960148705,0.7960815194633168,0.6799163179916318,0.9385812586457919,1.0,4/11,21.11%,NCBP2;PAPOLA;DHX36;ZFP36L1
prerank,nucleotide-excision repair (GO:0006289),-0.21934006283049867,-0.7956543368681448,0.8791208791208791,0.9428105476164195,1.0,32/101,27.18%,ERCC5;POLR2A;MMS19;BRCA2;CUL4A;COPS4;POLR2F;UBB;COPS8;RPA1;DDB1;POLR2E;HMGN1;RFC3;TCEA1;CETN2;RFC1;ERCC1;SLX4;ERCC2;POLR2G;RPA3;ERCC3;TP53;HUS1;ATXN3;POLA1;PRPF19;COPS7A;COPS2;CDK7;POLD1
prerank,regulation of T cell differentiation (GO:0045580),0.3168583808872778,0.7953280656915093,0.6957328385899815,0.9392735699382047,1.0,3/33,6.10%,PRDM1;IL2RA;IL4
prerank,protein localization to chromatin (GO:0071168),-0.30625762350587377,-0.7951994755718191,0.7612244897959184,0.942972426897558,1.0,5/18,23.43%,ESR1;PPHLN1;MCM8;PIH1D1;SGF29
prerank,regulation of nuclear division (GO:0051783),-0.29947109764754853,-0.794877424153935,0.7592954990215264,0.9429463646103867,1.0,6/20,27.43%,OBSL1;CAV2;CCDC8;CUL9;L3MBTL1;MKI67
prerank,DNA repair (GO:0006281),-0.19190096113624042,-0.7946415021620779,0.983402489626556,0.9427775451483832,1.0,80/284,27.51%,EYA1;USP47;ASCC3;PARP9;PDS5B;INO80;HINFP;BAZ1B;ERCC5;TRRAP;DCLRE1C;DTX3L;REXO4;RAD51B;PARP3;MMS19;BRCA2;NABP1;POLH;XRCC4;FANCI;APEX2;UBB;TDG;UVRAG;ATM;RPA1;INIP;KMT5C;ADPRS;RAD50;DDB1;FTO;ASCC1;ACTR8;PARK7;RFC3;PIAS4;VCP;RECQL;BABAM2;UBXN1;POLI;POLE2;BABAM1;SMC1A;RAD52;CETN2;RAD51C;NEIL3;BAP1;RMI2;EXO5;ERCC1;SLX4;RAD51;CHEK2;ERCC2;BRCA1;MSH6;RPA3;RNF8;PPP5C;ERCC3;ASF1A;CENPX;TP53;NUDT1;ACTR5;HUS1;ALKBH5;ATXN3;POLA1;APLF;NEIL1;WDR33;CDKN2D;POLD1;FANCM;FANCA
prerank,relaxation of muscle (GO:0090075),0.3734208826726916,0.7944958863331754,0.6829787234042554,0.940080056361922,1.0,2/13,3.05%,ATP1A2;PIK3CA
prerank,positive regulation of cellular senescence (GO:2000774),-0.35690074071545286,-0.7944612326377903,0.7129798903107861,0.9424910496981984,1.0,2/10,14.10%,B2M;YPEL3
prerank,regulation of phosphate metabolic process (GO:0019220),0.34564411630241254,0.7944021204263406,0.6687898089171974,0.9395582126288956,1.0,5/16,14.31%,IL4;SMG7;MCM7;PSEN1;RAD17
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2821625833034112,-0.793847192463608,0.7479508196721312,0.9429152190152611,1.0,14/26,35.75%,LRRK2;AKT1;TXN;PPIA;PARK7;PRKN;BAG5;SOD2;HSPB1;PINK1;MAPK7;PYCR1;VNN1;NME5
prerank,mitotic spindle assembly (GO:0090307),-0.2630356793704455,-0.7933365825806148,0.828125,0.9431178483641114,1.0,18/42,33.11%,RAB11A;RHOA;SMC3;TOGARAM1;CEP192;SMC1A;CHEK2;MISP;ABRAXAS2;ARHGEF10;PIBF1;TPX2;KIFC1;KIF4A;STAG2;GOLGA2;KIF23;PRC1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.37339342156642685,-0.7933338838271665,0.7481884057971014,0.9425433544052044,1.0,1/10,1.63%,TGFA
prerank,mitochondrial transcription (GO:0006390),0.37578458152799,0.7929587627766548,0.6588486140724946,0.9413760915543997,1.0,2/10,8.51%,SLC25A33;TFAM
prerank,relaxation of cardiac muscle (GO:0055119),0.36732815604493874,0.7926718748088429,0.6926315789473684,0.9411724731253862,1.0,2/13,3.05%,ATP1A2;PIK3CA
prerank,regulation of interleukin-17 production (GO:0032660),-0.2760549517504275,-0.792252708662385,0.776595744680851,0.9437011590845968,1.0,6/31,16.00%,IL15;SLC7A5;IL18;TGFB1;SPHK1;TLR4
prerank,positive regulation of cell aging (GO:0090343),-0.34890158552102246,-0.7921997039482638,0.7242647058823529,0.9432218546112922,1.0,2/11,14.10%,B2M;YPEL3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.37640447175684866,0.7920879617558321,0.6989247311827957,0.941495929251927,1.0,1/10,2.81%,EMC7
prerank,apical protein localization (GO:0045176),-0.3600966610704849,-0.7914910637514735,0.7360308285163777,0.9438091177728601,1.0,2/10,3.06%,SHROOM2;SHROOM3
prerank,base-excision repair (GO:0006284),-0.251116235890013,-0.7913554248578893,0.8018867924528302,0.9434538904651024,1.0,16/48,31.70%,USP47;ERCC5;APEX2;TDG;RPA1;ADPRS;RFC3;RFC1;NEIL3;RPA3;NEIL1;POLD1;NTHL1;WRN;PCNA;RFC5
prerank,Golgi to endosome transport (GO:0006895),0.3522559160286394,0.7910141281335098,0.6960985626283368,0.9426421266410359,1.0,3/16,6.12%,CORO7;SORT1;AP1AR
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.30540665824960483,-0.7905533692566575,0.7671232876712328,0.9441575985486189,1.0,8/20,18.35%,ARRB1;BRD7;DIP2B;TADA2A;MAPK3;PRKAA2;NOS1;PPARGC1A
prerank,piRNA metabolic process (GO:0034587),0.3427684915078182,0.7901036051598453,0.709349593495935,0.9436113011944277,1.0,3/19,15.41%,PLD6;TDRKH;EXD1
prerank,mRNA methylation (GO:0080009),0.35609712628492374,0.7899422165005168,0.6497975708502024,0.9431925718918226,1.0,6/15,20.81%,TRMT61A;CBLL1;TRMT10C;ZC3H13;NSUN2;WTAP
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.29902118549104595,-0.7897091616795772,0.7827004219409283,0.9449413439386491,1.0,3/22,7.15%,ROCK2;PTPA;FKBP1A
prerank,protein neddylation (GO:0045116),0.36547099425701435,0.7893118500580161,0.6773547094188377,0.9436629930263432,1.0,6/13,22.68%,RBX1;UBE2F;DCUN1D2;RNF7;DCUN1D4;DCUN1D1
prerank,spinal cord development (GO:0021510),-0.33615090440860085,-0.7891905986270761,0.7389635316698656,0.9452191659559798,1.0,2/12,2.75%,GLI2;VIT
prerank,entry into host (GO:0044409),-0.3320363930449678,-0.7887580145744293,0.7461832061068703,0.945309028601812,1.0,7/13,33.09%,CDH1;MET;PPIA;CTNNB1;CXCR4;CTNND1;GRB2
prerank,skeletal muscle tissue development (GO:0007519),0.3067090877676712,0.7882461210405337,0.6907020872865275,0.9448101413638721,1.0,3/32,7.71%,MEF2C;POPDC3;IGSF8
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3258261856717429,0.78760915692126,0.6975308641975309,0.9452346485616845,1.0,5/23,13.39%,CBFA2T3;SIK1;GCK;EP300;CRY1
prerank,amino sugar biosynthetic process (GO:0046349),-0.3336346238664344,-0.787533025261537,0.7360308285163777,0.9467386903359235,1.0,3/12,19.13%,GFPT2;GFPT1;UAP1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.34266484324409396,0.7872670385026517,0.6887550200803213,0.9451292137177228,1.0,3/18,8.51%,PTPN22;PAG1;MIA3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.330701030441788,0.787237405942481,0.6926147704590818,0.9444851605023762,1.0,4/22,9.19%,NR1H3;PTPN22;APPL1;LYN
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.31516597897245513,-0.7872315373010824,0.7732793522267206,0.9466565387166642,1.0,5/16,11.81%,LARGE1;ST6GALNAC3;A4GALT;ST8SIA2;ST6GALNAC6
prerank,macrophage activation involved in immune response (GO:0002281),0.36468451671361496,0.7870461025780755,0.6917960088691796,0.9441227170721257,1.0,1/13,1.13%,DYSF
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.31873836659906457,-0.7867373272736231,0.7762645914396887,0.946842415508623,1.0,5/15,14.75%,ARPC2;IQGAP2;ARPC1B;TRIM27;WASHC1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2550178369210808,-0.7866305636233651,0.8027210884353742,0.9464269609811712,1.0,12/38,24.29%,NPEPPS;LRRK2;LMAN1;SH3GLB1;TOMM7;SAE1;SREBF1;LEPROT;HPS4;USP36;BAP1;PRKN
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.34444025813289586,0.7864939929270145,0.6731182795698925,0.944439017772156,1.0,2/17,6.21%,CACNA1H;SCAMP5
prerank,ceramide biosynthetic process (GO:0046513),-0.25756421038247956,-0.7856843819249348,0.8091954022988506,0.9472810725327604,1.0,9/40,16.79%,SGMS1;SGMS2;ST6GALNAC3;ST8SIA2;DEGS2;ST6GALNAC6;SPTLC2;ST3GAL5;CLN8
prerank,gluconeogenesis (GO:0006094),0.2982807872856857,0.7854739355547133,0.737037037037037,0.9455045986264112,1.0,13/39,24.98%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2;ENO2;SLC37A4;PGM1;MDH1;PGK1;ATF4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.28374702248060496,0.7848667628218021,0.7232142857142857,0.945880276220139,1.0,7/53,10.61%,GLMN;RHBDF1;ALAD;PSMF1;DESI1;GNA12;XPO1
prerank,chromosome organization (GO:0051276),-0.21577560264732965,-0.7841601228450786,0.8768328445747801,0.9491670573137725,1.0,35/99,30.86%,HDAC8;SETD7;TCF7L2;H3-3A;TOP2B;EHMT1;CUL4A;COPS4;HDAC1;UBB;COPS8;EZH1;HDAC5;DDB1;CENPT;HHEX;HMGB2;HMGN1;EZH2;CETN2;TOP2A;SMARCA4;MSH6;SATB1;BRWD1;L3MBTL1;NUP155;COPS7A;COPS2;CENPH;NDC80;ABL1;SUPT4H1;DOT1L;CDCA8
prerank,histone H4-K8 acetylation (GO:0043982),0.3442929134262231,0.7837770268063026,0.7066381156316917,0.94638693305632,1.0,6/15,19.79%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,histone H4-K5 acetylation (GO:0043981),0.3442929134262231,0.7837770268063026,0.7066381156316917,0.94638693305632,1.0,6/15,19.79%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,polyamine metabolic process (GO:0006595),0.3592268415821038,0.783178430441883,0.687374749498998,0.9467709361576042,1.0,4/13,16.82%,OAZ2;DHPS;AOC1;HDAC10
prerank,regulation of phosphatase activity (GO:0010921),-0.2880732404722073,-0.782846922759738,0.7448132780082988,0.9505871044888363,1.0,7/24,23.05%,PTPA;SH3RF2;TIPRL;HSP90B1;CHP1;CDK5RAP3;SH2D4A
prerank,peptidyl-threonine modification (GO:0018210),0.27264208739965207,0.782462995377343,0.7568493150684932,0.9473083469889176,1.0,15/66,12.55%,GALNTL6;ROCK1;CDC42BPA;STK39;TNKS;TTBK1;GALNT13;GALNT1;PRKD2;MARK2;DYRK3;HIPK1;NLK;GALNT4;PRKDC
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.32180349494658356,0.7823693989015472,0.7071713147410359,0.9467836281216366,1.0,2/24,1.94%,NR1H3;USP25
prerank,B cell differentiation (GO:0030183),0.28788910102885396,0.781837466219971,0.7321100917431193,0.9470349080960605,1.0,3/46,6.10%,ITGA4;ITGB1;IL4
prerank,cholesterol biosynthetic process (GO:0006695),0.3110051454233188,0.7818196522092964,0.7077798861480076,0.9463803052157286,1.0,14/31,25.35%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;MVK;NSDHL;ACAA2;FDFT1;CYP51A1;FDPS
prerank,response to interferon-alpha (GO:0035455),-0.31459632349333366,-0.7817858445469935,0.7689243027888446,0.9516613113173202,1.0,4/16,17.43%,GAS6;IFITM3;IFITM2;TPR
prerank,positive regulation of protein maturation (GO:1903319),-0.3455871064890857,-0.781589836971415,0.7348927875243665,0.9513906045570781,1.0,1/11,1.88%,CCBE1
prerank,erythrocyte development (GO:0048821),0.37326997924267513,0.7814617874563737,0.6928406466512702,0.9463192687252142,1.0,3/10,15.05%,SH2B3;MED1;ABCB10
prerank,cytosolic transport (GO:0016482),0.2542412394917461,0.7809642548091917,0.7863924050632911,0.9465014343803264,1.0,26/108,15.56%,DENND2A;STX16;CORO7;SORT1;AP1G1;VTI1A;RIC1;EMP2;PIKFYVE;HOOK3;EHD3;TBC1D10C;BAIAP3;AKTIP;ARFRP1;VPS51;PLEKHJ1;ANKFY1;GCC2;VTI1B;DCTN1;TMEM87B;RHOBTB3;RAB5A;PREPL;TBC1D10B
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3236566552410998,-0.7806223704402638,0.7525150905432596,0.9522908303699656,1.0,5/14,22.36%,ANXA1;PRKCZ;IL18;RARA;CCL19
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2320980439258814,-0.7805022078664299,0.8658227848101265,0.9518969592928364,1.0,23/64,30.81%,MLLT3;POLR2A;RTF1;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;ERCC3;CDK7;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2727146824850706,0.7798235231534383,0.7680140597539543,0.9477966868011258,1.0,7/65,5.04%,RORA;CPEB1;RGCC;FMN2;KCND2;SCN2A;EPAS1
prerank,regulation of neuron death (GO:1901214),0.2609928062846412,0.7797390303567661,0.7824675324675324,0.9472498832608752,1.0,15/82,13.27%,MEF2C;MAP3K5;INPP5A;SNCA;CHRNA7;AKT1S1;HTRA2;GRM4;GRIN2B;SARM1;DDIT4;TRIM2;BTBD10;EPHB1;TRAF2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.33370607704567157,-0.7795156622830021,0.73828125,0.9528039424353554,1.0,4/11,19.51%,CAV1;HGS;LEPROT;ADIPOR1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2584969765710871,-0.7794615728580502,0.8183807439824945,0.9522961078844654,1.0,14/38,26.95%,RBBP7;UBN1;CENPC;H3-3A;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;HAT1;ASF1A;CENPX;CENPH
prerank,ganglioside metabolic process (GO:0001573),-0.2926669189283258,-0.7791109426617848,0.7810650887573964,0.9522668581561822,1.0,8/20,22.61%,ST6GALNAC3;HEXA;HEXB;ST8SIA2;ST6GALNAC6;ST3GAL5;NEU3;CLN6
prerank,glutamate metabolic process (GO:0006536),0.3339664602918167,0.7777878196811182,0.7056367432150313,0.9499567054676236,1.0,4/19,11.55%,GGT1;GOT1;GAD1;GLS2
prerank,interstrand cross-link repair (GO:0036297),0.2835193988459139,0.7776271004888463,0.763986013986014,0.9495329252947331,1.0,11/53,14.35%,DCLRE1B;FANCF;FANCG;FANCB;ERCC4;ATR;FANCE;USP1;FANCD2;ATRIP;XRCC3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.29709319184358085,-0.7775987078395205,0.7624750499001997,0.9540011235527268,1.0,6/20,16.00%,LBP;PRKCE;IL18;TGFB1;TICAM1;TLR4
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.2400105024338794,-0.7769912146200505,0.8584474885844748,0.9543974093795425,1.0,18/58,26.30%,POLM;DCLRE1C;NHEJ1;XRCC4;UVRAG;ATM;RAD50;HMGB2;PAXX;CYREN;PIAS4;BABAM2;BABAM1;ERCC1;BRCA1;RNF8;POLA1;PRPF19
prerank,regulation of receptor recycling (GO:0001919),0.3557663104586124,0.7767102933861584,0.7176220806794055,0.9504549917653135,1.0,3/16,6.31%,ECE1;AP1AR;SNCA
prerank,tRNA methylation (GO:0030488),0.3017253220988799,0.776671809242651,0.7368421052631579,0.9498373010442219,1.0,13/34,24.15%,TRMT61A;TRMT5;TRMT1;THUMPD2;TRMT10C;MTO1;NSUN2;METTL6;DALRD3;TRMT1L;GTPBP3;TRDMT1;TRMT10A
prerank,neuron projection organization (GO:0106027),0.34588790396833846,0.7766358226134488,0.6887966804979253,0.9492120965696287,1.0,8/15,25.34%,ABCD2;CHRNA7;PSEN1;DCTN1;GSK3B;LGMN;ABCD1;ARF1
prerank,ncRNA transcription (GO:0098781),-0.3308936895768577,-0.7764434542679481,0.7883895131086143,0.9546624193554031,1.0,3/13,19.30%,CAVIN1;SIRT7;GTF3C1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.29911950199924126,0.7762627427726736,0.6914285714285714,0.9491843085899324,1.0,8/31,18.06%,CACNA1H;SCAMP5;SYT1;SYT2;CBARP;SYT12;SYT11;SYT13
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3285900145661472,-0.7762547754889466,0.758220502901354,0.9543710524009761,1.0,3/13,10.57%,GAS6;WNT5A;MAVS
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3370144916530985,-0.7759721370158783,0.7429643527204502,0.9542316592219787,1.0,3/11,19.13%,GFPT2;GFPT1;UAP1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2794516174852738,-0.7758190270089192,0.8096192384769539,0.9538820510679645,1.0,7/26,15.38%,APP;SMOC2;MDM2;SPHK1;TAL1;MEIS2;EIF4EBP1
prerank,protein homotrimerization (GO:0070207),-0.32037039082515517,-0.7758099913125494,0.741106719367589,0.9527516790003228,1.0,4/14,16.63%,SCARA5;CLYBL;DISP1;PNPT1
prerank,protein trimerization (GO:0070206),-0.32037039082515517,-0.7758099913125494,0.741106719367589,0.9527516790003228,1.0,4/14,16.63%,SCARA5;CLYBL;DISP1;PNPT1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3406265279251369,0.7757575566195393,0.6979166666666666,0.949330929095035,1.0,1/16,1.66%,GPER1
prerank,skeletal muscle contraction (GO:0003009),0.3419795392598164,0.7756989188187133,0.6940726577437859,0.9487422929516861,1.0,3/19,15.58%,RCSD1;STAC;CCDC78
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.29110666921307976,-0.7755553821634832,0.7784552845528455,0.9525697067470721,1.0,2/21,8.31%,EPHA7;BIRC3
prerank,cellular response to pH (GO:0071467),-0.3037522657894085,-0.7750059260976678,0.768642447418738,0.9528380744549403,1.0,7/17,31.62%,RAB11FIP5;CHP1;SLC9A1;MCOLN1;PKD1L3;HVCN1;KCNK4
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3435991634519191,-0.7749163294382662,0.7620817843866171,0.9524047041614503,1.0,1/11,5.85%,WIPI2
prerank,regulation of autophagosome assembly (GO:2000785),0.3142253107310405,0.7745336632077612,0.7046332046332047,0.9500278730892928,1.0,11/33,14.49%,PIP4K2A;IFT20;FEZ2;TBC1D12;PIP4K2C;PIKFYVE;NPRL3;NPRL2;FEZ1;UBQLN2;RAB5A
prerank,regulation of gluconeogenesis (GO:0006111),0.3158560502396796,0.7732432894628609,0.7250996015936255,0.9515268330044757,1.0,7/27,13.39%,OGT;SIK1;ZNF692;SDHAF3;GCK;EP300;CRY1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3643607513841315,0.7727776813327673,0.7103004291845494,0.9516442974791814,1.0,3/10,11.97%,KAT7;BLOC1S1;EP300
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3661899855323542,0.7727483343558641,0.6948775055679287,0.9510061427200203,1.0,1/12,1.34%,PIK3R1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.2780596397042811,-0.7723364814077791,0.8306451612903226,0.9557342995856936,1.0,5/25,13.24%,LRRK2;P2RX4;CMKLR1;CDH13;PLCG2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3008411137721737,0.7722276217499996,0.7219152854511971,0.9511984032100009,1.0,1/33,0.42%,PTEN
prerank,nucleoside salvage (GO:0043174),0.37830218771604196,0.7721508069513788,0.7127882599580713,0.9506469468613463,1.0,3/10,7.95%,DCK;TK1;TK2
prerank,signal transduction in response to DNA damage (GO:0042770),0.2846362348741873,0.7721171423822406,0.754653130287648,0.9500121681173931,1.0,5/49,9.57%,MAP3K20;CASP9;RAD1;MYO6;ATR
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.26373568179106355,0.7716900152494389,0.7725806451612903,0.9501129741325247,1.0,16/83,16.75%,CDK6;CUL3;CDK15;CRLF3;SPDYA;DHFR;CDKN1A;NPAT;LATS2;RB1;CDK14;CCNH;EIF4E;CDK5;CCNE1;RPS6KB1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3081333532006201,-0.7715961296907466,0.777992277992278,0.9562798351212873,1.0,4/17,15.91%,CXCL12;ANO6;SERPINE1;CREB3
prerank,mitotic recombination (GO:0006312),-0.3173211345521189,-0.7715348203079498,0.7610294117647058,0.9557933397282284,1.0,7/15,24.87%,TEP1;RAD50;TPRKB;RAD52;ERCC1;RAD51;RAD54B
prerank,apoptotic DNA fragmentation (GO:0006309),-0.30976690640558047,-0.7713599641562361,0.7604562737642585,0.9554662135488675,1.0,7/16,36.82%,HMGB2;DICER1;DFFB;FOXL2;EXOG;ENDOG;DNASE2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3391011313666572,0.77124350220532,0.6991869918699187,0.9502206884535941,1.0,7/19,15.04%,MTCL1;CRB1;MARK2;DLG2;PARD3B;DLG3;FSCN1
prerank,positive regulation of catabolic process (GO:0009896),0.26815321808869447,0.7709611463215479,0.77,0.9500392853270293,1.0,6/65,7.09%,NEDD4L;HECW2;IL1B;OAZ2;GPC3;HACE1
prerank,sulfur amino acid metabolic process (GO:0000096),0.3210875493113209,0.7698434946892923,0.7267552182163188,0.9512859157834622,1.0,3/24,6.76%,CTH;TXN2;MSRA
prerank,positive regulation of DNA recombination (GO:0045911),0.31607765444107316,0.7689844974645293,0.748995983935743,0.9520182825536488,1.0,8/27,18.74%,WAS;FANCB;TIMELESS;SHLD3;KMT5B;PARP1;MRNIP;FUS
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22194271030693885,-0.76848445460141,0.9007832898172323,0.9591954767719265,1.0,22/72,24.73%,MAP3K14;CARD14;BIRC3;AKT1;CARD10;PSME2;RELA;PSMB4;COPS8;FBXW11;PSMD8;PSMB1;PSMD11;PSME3;PSMA2;PSMD4;PSMD3;PSMB7;DICER1;PSMC2;PSMD10;PSMC5
prerank,regulation of astrocyte differentiation (GO:0048710),0.36554214100955423,0.7684834696398644,0.6795698924731183,0.9521633256169603,1.0,2/12,6.88%,NOTCH1;BIN1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.2681064919272158,-0.7674389605163653,0.8140495867768595,0.9601623372357175,1.0,17/30,35.26%,CXCL12;TPT1;MDM2;SNAI1;THOC1;BCL2L1;PSMD10;CD44;RPS3;TWIST1;CDKN2D;PTTG1IP;CLU;THOC5;KDM1A;CD74;DDX39B
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20641850174110823,-0.7673051865576663,0.933933933933934,0.9597942269040735,1.0,34/114,25.20%,FOXO3;MAP3K14;TNFRSF11B;TNFRSF1B;PTK2B;CARD14;STAT1;TMSB4X;BIRC3;TNFRSF1A;EIF5A;PSME2;RELA;TNFRSF11A;PSMB4;PSMD8;PSMB1;PSMD11;PSME3;RIPK1;NFKBIA;PSMA2;EDA;PSMD4;PSMD3;EDA2R;PSMB7;TNFSF13;EDAR;PSMC2;PSMD10;PSMC5;TNFSF8;TP53
prerank,positive regulation of cellular protein localization (GO:1903829),-0.22829368031563796,-0.7667709098070387,0.8862433862433863,0.9600037936374916,1.0,20/69,20.99%,LIMK2;PARP9;YAP1;GPD1L;STX3;TFRC;AKT1;DTX3L;CARD10;TGFB1;HSP90AB1;PRKAA2;TM9SF4;PARK7;LAMTOR5;VPS28;ORMDL3;CDK5RAP3;NUMA1;TYROBP
prerank,endosome organization (GO:0007032),-0.25028333756529353,-0.7651280782257549,0.8152173913043478,0.9618169985871966,1.0,10/41,17.26%,EEA1;RAB27A;USP8;ALS2;ALS2CL;CLCN3;SNX10;CORO1C;PHETA1;ARFGEF2
prerank,nucleocytoplasmic transport (GO:0006913),-0.24843252473778651,-0.7650018863425838,0.8313008130081301,0.9614271060740595,1.0,9/40,17.07%,ATXN1;GEMIN7;BACH2;GEMIN5;NUP98;SNRPF;SNRPD1;SNRPD2;NXT2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3069971385265102,0.7644384736340356,0.7248062015503876,0.9583021738394112,1.0,2/27,5.01%,LIMD1;AJUBA
prerank,DNA metabolic process (GO:0006259),-0.18399518852436328,-0.7640637584211202,0.9957264957264957,0.9621981204224486,1.0,109/270,37.25%,SP100;TCF7L2;PDS5B;INO80;HINFP;TOP2B;ERCC5;TRRAP;REXO4;RAD51B;SAMHD1;NT5E;PARP3;MMS19;NABP1;POLH;DNASE1L1;UBB;RAN;GLRX2;TDG;UVRAG;ATM;RPA1;INIP;KMT5C;ADPRS;RAD50;DDB1;DBF4;CBS;HMGB2;SIRT7;SMARCAD1;PARK7;RFC3;TYMS;VCP;RECQL;TOP3A;POLI;POLE2;DFFB;DNMT1;SMC1A;RAD52;RAD51C;TOP2A;RFC1;NEIL3;ACD;MCM8;RMI2;ERCC1;SLX4;CDC45;RAD51;BRCA1;MSH6;RPA3;ERCC3;ASF1A;SRPK2;NUDT1;HUS1;POLA1;NEIL1;POLD1;NTHL1;FANCA;PRIM2;MCM3;TOP1;MNAT1;WRN;EID3;PCNA;MCM5;MCM10;EXO1;GTF2H3;DOT1L;RAD54L;DMC1;RFC5;POLE3;FANCL;RAD51AP1;UHRF2;HUS1B;RAD51D;CHEK1;LONP1;RECQL5;CDC34;TOPBP1;UHRF1;PRIMPOL;FANCC;ENDOG;CDK1;STN1;DCTPP1;FEN1;DNASE2;ZRANB3;TRIM28;CDC6;TICRR
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3482690424957597,0.7638410090350727,0.7238493723849372,0.9585842522105881,1.0,2/12,3.66%,OAZ2;ATP7A
prerank,respiratory chain complex IV assembly (GO:0008535),0.32502961398221214,0.7637023525890534,0.7315573770491803,0.9581482091071621,1.0,6/21,20.44%,COX18;FASTKD3;COA6;COX20;OXA1L;SURF1
prerank,anterograde axonal transport (GO:0008089),-0.253392387955547,-0.7636755808156238,0.8568329718004338,0.9621814332905789,1.0,6/37,10.66%,AP3S1;KIF1B;DTNBP1;AP3B1;SPAST;RAB21
prerank,protein targeting (GO:0006605),-0.20470990669345684,-0.7628458833069193,0.9454022988505747,0.9627723995144837,1.0,44/118,31.45%,LAMP2;KIF13B;SDCBP;ZFAND6;NACA;RASSF9;TAOK2;PARD3;AP4M1;RPL11;ZDHHC24;TOMM7;GDAP1;AQP11;TIMM13;BCAP31;HOMER3;MICALL1;SPCS1;AP4E1;TOMM22;TIMM8B;HPS4;TOMM34;TOMM5;ZDHHC15;TIMM9;SEC61A1;VPS37D;AP4B1;TIMM44;ZDHHC7;YIF1B;RABGEF1;LTBP2;RAB3IP;ZDHHC12;TIMM10;EDEM1;TSPO;SRP14;ICMT;SPCS2;SEC63
prerank,histone lysine methylation (GO:0034968),-0.258214652242138,-0.7623609928276812,0.8268839103869654,0.9628637350994467,1.0,18/33,40.43%,SMYD3;SETD1B;PRDM5;EZH2;SETDB1;SETD6;TRMT112;WDR5B;DOT1L;RBBP5;WDR82;KDM6A;ASH2L;DYDC2;SETDB2;DPY30;SMYD2;N6AMT1
prerank,cellular response to chemical stress (GO:0062197),-0.21000619593418687,-0.7623207484921203,0.93048128342246,0.9623487217739047,1.0,40/96,30.49%,FOXO1;FOXO3;CAV1;LRRK2;CPEB2;PRDX2;ZC3H12A;SLC25A24;VKORC1L1;TRPV4;CYBA;ATM;PPIA;PRKAA2;VRK2;PNPT1;GPX1;SIRT2;PPARGC1A;STX2;PARK7;BRF2;MT3;NOX1;CYBB;TXNRD2;RAD52;PYCR2;ATG7;ZFAND1;FAS;SOD2;PRDX1;HSPA1B;GSR;ATP13A2;ABL1;NUDT2;KEAP1;CHCHD2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.22477932605290912,-0.7618566015983388,0.8861386138613861,0.962443541085106,1.0,26/67,28.33%,B2M;TAPBP;SNAP23;PSME2;PSMB4;CYBA;CALR;PSMD8;PSMB1;PSMD11;PSME3;PDIA3;PSMA2;PSMD4;IKBKG;PSMD3;PSMB7;CYBB;VAMP8;PSMC2;TAP2;PSMD10;PSMC5;FCGR1A;PSMD7;TAP1
prerank,cognition (GO:0050890),0.29056659107439303,0.7614930413231097,0.7612208258527827,0.9611432681739571,1.0,17/42,19.41%,NF1;SLC1A4;GRM5;CHMP2B;CHRNA7;CUX2;TUSC3;NIPBL;CHRNB2;METTL23;JAKMIP1;LINS1;TTC8;NSUN5;DGCR2;SETD5;HOXA1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.31598081895525554,0.7610654824309099,0.7314629258517034,0.961171078556124,1.0,3/24,6.27%,NCKAP5;FGF13;TPPP
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.24307479034720805,-0.7610323063708718,0.8584686774941995,0.9630863507324943,1.0,11/43,21.30%,FOXN3;RINT1;TAOK2;CHFR;NABP1;TRIM39;ATM;FZR1;BABAM2;CDK5RAP3;BABAM1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21179748639180698,-0.7608210629706047,0.9326145552560647,0.9628376733985475,1.0,33/88,33.30%,FBXL7;DMAC2;PSME2;CUL4A;PSMB4;FBXW11;PSMD8;PSMB1;PSMD11;FBXL2;FBXL14;PSME3;PSMA2;PSMD4;PSMD3;PSMB7;CUL5;FBXO17;CCNF;PSMC2;PSMD10;PSMC5;FBXL6;PSMD7;FBXL12;FBXL13;FBXL22;FBXO44;KIF14;PSMB9;FBXO38;PSMD12;FBXL20
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3459025889043733,0.7606228362703509,0.7010752688172043,0.9612421387392558,1.0,2/13,7.37%,NCBP2;CPSF6
prerank,proteasomal protein catabolic process (GO:0010498),0.22809173787182324,0.7604788256826023,0.8870056497175142,0.9608054453054988,1.0,27/201,12.24%,NEDD4L;TNFAIP1;HECW2;BTRC;TRIM9;CUL3;RBX1;SIAH2;PSMB11;UCHL1;FBXO45;SPOPL;ATE1;PSMF1;HACE1;SIAH3;KCTD13;UBE2G1;HECW1;UBXN2B;SOCS6;KBTBD7;SPOP;KCTD5;TRIM2;APPBP2;PSME4
prerank,retinal metabolic process (GO:0042574),-0.3350534173400743,-0.7602995006380517,0.8061594202898551,0.9630013805662522,1.0,2/12,7.87%,ABCA4;CYP1B1
prerank,regulation of ERAD pathway (GO:1904292),0.3578695062425757,0.7598675947158806,0.7091295116772823,0.9611366671955553,1.0,1/11,1.94%,USP25
prerank,regulation of JUN kinase activity (GO:0043506),0.30000612761953593,0.7597346559277751,0.7476280834914611,0.9606644601211444,1.0,7/33,13.27%,MAP3K5;PTPN22;TAOK3;PAK1;DVL2;TRAF6;TRAF2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.28205411333909924,-0.759476687146875,0.8147410358565738,0.9636360470410734,1.0,13/22,34.14%,DUSP1;DUSP16;DUSP7;PPM1B;DUSP10;PPM1G;PPP5C;PPM1F;PPP1CA;DUSP8;DUSP4;DUSP18;PPM1A
prerank,synaptic vesicle endocytosis (GO:0048488),0.28715052699599525,0.7591286805613394,0.75,0.9609794416439977,1.0,10/33,20.17%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;DNM1;VAMP2;SNAP91;AMPH
prerank,negative regulation of hormone secretion (GO:0046888),-0.3441876363232743,-0.7590789195987623,0.7581818181818182,0.9636119341380421,1.0,3/10,14.97%,GJA1;RAB11FIP1;RAB11FIP5
prerank,regulation of DNA replication (GO:0006275),-0.23711935656188957,-0.7589806351175347,0.8624454148471615,0.9631531992512808,1.0,3/49,6.22%,EGFR;GLI2;ACVRL1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.22593601681384284,-0.7586446890194657,0.8977556109725686,0.9630615486677533,1.0,17/57,26.77%,FOXN3;RINT1;TAOK2;TRIM39;ATM;CCND1;FZR1;BABAM2;CDK5RAP3;BABAM1;RPS27L;CHEK2;BRCA1;STK33;TP53;HUS1;ATF2
prerank,positive regulation of intracellular transport (GO:0032388),-0.2487407202513306,-0.7581644133377392,0.8354166666666667,0.9631601485735422,1.0,17/38,27.45%,ACTN2;EHD1;EHD2;RUFY3;TPR;OAZ1;STX18;RAB29;DYNC1H1;NUMA1;RIPOR1;ICE1;STK11;ZFAND1;TBC1D20;SPAG5;B3GAT3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3576753736643979,0.7577680461701779,0.6890380313199105,0.9624998753999798,1.0,2/10,9.62%,JAM3;SNAI2
prerank,non-motile cilium assembly (GO:1905515),-0.2622093197010091,-0.7574624414242673,0.8347826086956521,0.9635729101286176,1.0,11/30,29.49%,TOGARAM1;TMEM216;VANGL2;TBC1D32;TMEM17;C2CD3;TMEM107;PIBF1;IFT122;CCDC13;DISC1
prerank,rRNA methylation (GO:0031167),0.3151019570654126,0.7573762669366806,0.7473002159827213,0.9624403751704167,1.0,3/22,5.34%,MRM3;FBLL1;NSUN3
prerank,protein hydroxylation (GO:0018126),-0.3072898221448867,-0.757367047901457,0.7823639774859287,0.9631272388411143,1.0,5/15,20.17%,PLOD2;EGLN3;PLOD1;P3H4;PLOD3
prerank,cell-cell junction maintenance (GO:0045217),0.3680478058929807,0.7573645665950252,0.694560669456067,0.9617779140776299,1.0,1/11,2.11%,FERMT2
prerank,membrane fusion (GO:0061025),0.29485819288833914,0.7573368156817925,0.7538461538461538,0.9611360143838759,1.0,9/33,17.94%,DYSF;RIMS1;HACE1;UBXN2B;VTI1B;VPS33B;DNM1;VAMP2;GCA
prerank,protein K48-linked ubiquitination (GO:0070936),0.27490603251510554,0.7571921477648684,0.7911714770797963,0.9607113568021226,1.0,9/54,12.06%,NEDD4L;CUL3;RBX1;UBE2E3;HACE1;UBE2E1;UBE2G1;KBTBD7;UBE3A
prerank,positive regulation of lipid localization (GO:1905954),-0.3384884829468099,-0.7571814446227728,0.7795414462081128,0.96282411660713,1.0,5/11,34.00%,IKBKE;ZC3H12A;LPL;HILPDA;C3
prerank,ion homeostasis (GO:0050801),0.30639243122712667,0.7570692733207148,0.755834829443447,0.9602139754687894,1.0,2/30,3.48%,NEDD4L;UNC80
prerank,tryptophan metabolic process (GO:0006568),0.35311476720324114,0.7563254209536137,0.6949891067538126,0.9607721696277058,1.0,1/11,3.66%,ATP7A
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3273378591718283,0.7562673764809753,0.7350096711798839,0.9601813969655743,1.0,6/20,10.43%,RGCC;SPDYA;TTBK1;PKD2;PDGFB;CCNYL1
prerank,neuromuscular synaptic transmission (GO:0007274),0.33461035272677003,0.7560729024579176,0.7211155378486056,0.9598235809920503,1.0,4/18,8.65%,CHRNA3;RIMBP2;ERC2;SLC5A7
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.24019622440316835,-0.7559082513793015,0.8843373493975903,0.9640660780263309,1.0,7/48,16.99%,ZMIZ1;KAT2B;BAZ1B;POLR2F;ACTB;ZMIZ2;POLR2E
prerank,microtubule nucleation (GO:0007020),0.3177005975292797,0.7548572091103974,0.7433808553971487,0.9610679224509524,1.0,4/19,10.29%,CCDC57;CLASP2;TPPP;TUBG2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2990383439776499,0.7543429223504047,0.75,0.9612390848999656,1.0,8/32,18.79%,SLC44A2;ABHD3;ACHE;STARD7;CHKB;LPCAT1;LPIN2;CSNK2A2
prerank,coenzyme A metabolic process (GO:0015936),0.3386324719033739,0.7532721750296931,0.7014314928425358,0.9623308711606686,1.0,9/14,31.51%,COASY;ACOT7;SLC25A16;PANK1;PANK3;PPCDC;DCAKD;ACLY;ACAT1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.32218768488161664,0.7531089843226604,0.751937984496124,0.9619304072262137,1.0,3/20,5.31%,LDLRAP1;ARV1;SREBF2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2903070542738659,0.7522309917798313,0.7742574257425743,0.9626398985693639,1.0,8/33,19.58%,CLP1;NCBP2;LSM10;PAPOLA;SYMPK;SNRPD3;CPSF7;MED18
prerank,organelle fission (GO:0048285),0.3058036176453032,0.7518341472332112,0.7354838709677419,0.9626153895080033,1.0,8/24,16.71%,TMCC1;MTFP1;WASHC5;MFF;PEX19;MTFR1;MIEF1;DNM1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.34399943703067754,-0.7514579816040612,0.7969348659003831,0.9696383870927087,1.0,2/10,6.61%,LRP6;WNT5A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.29116900194536693,0.7508687291982579,0.7620817843866171,0.9634683946402612,1.0,6/36,8.74%,USP25;RYBP;OGT;ALAD;PSMF1;CCAR2
prerank,nucleotide biosynthetic process (GO:0009165),-0.29050649074998597,-0.7506760750304339,0.80859375,0.9701222814729278,1.0,7/18,23.03%,ME1;PRPS2;NMNAT1;PRPS1;PRPS1L1;PNP;RRM2B
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.2532987978913685,-0.7502035619954243,0.870020964360587,0.9702222591754364,1.0,13/33,28.90%,EZR;PTPRJ;RELA;CEACAM1;RAB29;CD81;IKBKG;PTPN2;DGKZ;RPS3;BCL10;LAPTM5;KCNN4
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.277964169786017,-0.7501319198335407,0.8237704918032787,0.9697424786949624,1.0,6/23,22.21%,GAS6;LGALS9;ZC3H12A;TLR4;CD274;RARA
prerank,regulation of response to oxidative stress (GO:1902882),-0.3314906792113447,-0.7499512871734427,0.7819548872180451,0.9694054439412846,1.0,6/11,37.14%,MCTP1;GGT7;PRKN;PINK1;ALOX5;HEBP2
prerank,neurotransmitter uptake (GO:0001504),0.34681292660796936,0.7493574497180602,0.7310756972111554,0.9652880145502013,1.0,2/12,3.91%,ATP1A2;SNAP25
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2815567203003052,0.7491795710389626,0.7672253258845437,0.964912579326056,1.0,5/42,5.43%,SH2B3;CXCL5;STK39;ACKR3;CXCL10
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2779592143444536,0.7491193777366413,0.786096256684492,0.9643234591443625,1.0,14/44,18.08%,ROCK1;PRR5L;RBM24;YTHDF3;NANOS1;TNRC6C;YTHDF2;CELF1;TNRC6B;DHX36;KHSRP;CNOT1;RC3H1;ZC3HAV1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.26967308189844896,-0.7486179907148879,0.8136272545090181,0.9706477180626748,1.0,7/23,28.62%,ELOVL7;FAR2;ELOVL1;ACSL4;DGAT2;ACSBG1;ACSF3
prerank,linoleic acid metabolic process (GO:0043651),0.3327737818620265,0.7479803262508511,0.7145708582834331,0.9655327768912114,1.0,1/17,2.04%,FADS2
prerank,cell cycle G1/S phase transition (GO:0044843),0.2672420347849468,0.7479001904495606,0.7894736842105263,0.9649803245840782,1.0,11/61,16.75%,CDK6;CUL3;CRLF3;SPDYA;CDKN1A;LATS2;RB1;CCNH;EIF4E;CCNE1;RPS6KB1
prerank,secondary alcohol metabolic process (GO:1902652),-0.23919900438287534,-0.7477423384938864,0.88,0.971286133779932,1.0,7/42,16.79%,ABCA1;APOE;CYP27A1;OSBPL1A;STARD3;IDH3G;CLN8
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21258939434428825,0.7472892002075308,0.956140350877193,0.9653080682842442,1.0,55/314,16.45%,NEDD4L;TNFAIP1;UBR1;HECW2;BTRC;TRIM9;FAM8A1;CUL3;RBX1;DERL3;SIAH2;PSMB11;FAF2;FOXRED2;UCHL1;FBXO45;SPOPL;PSMF1;UBR3;SGTB;HACE1;UBE2J2;UBE2E1;SIAH3;KCTD13;UBE2G1;HECW1;UBXN2B;KBTBD7;PTTG1;SPOP;KCTD5;TRIM2;RNF121;UBR2;APPBP2;RB1;PSME4;ERLIN1;ANAPC2;RMND5B;MAD2L1;ANAPC7;SKP1;UBQLN2;AMN1;DNAJC18;RNF103-CHMP3;FAF1;ARMC8;ZFAND2A;PSMB5;TMUB2;ERCC8;KCTD17
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23027581733490024,0.7468546087398737,0.8857979502196194,0.9653442914496345,1.0,6/145,6.55%,DYNLL1;MECP2;RBX1;PSMB11;PRKAR2B;PSMF1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.32868989408524296,-0.7465332746797901,0.8104693140794224,0.97229280971473,1.0,4/10,24.39%,HDAC4;SAE1;PIAS4;PIAS3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3168909472554295,-0.7463217472446301,0.787109375,0.9720071865068849,1.0,3/13,17.80%,STX7;MR1;CYRIB
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2650936386576374,-0.7462913192736788,0.8305785123966942,0.9714759609167714,1.0,6/27,18.28%,NAAA;ETNK2;PLA2G6;PLA2G15;LPIN3;ETNK1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.23754400160379963,-0.7457772435224648,0.8939051918735892,0.9715417236049426,1.0,1/41,0.05%,PRKAG2
prerank,electron transport chain (GO:0022900),-0.3018003016689902,-0.7457418255919672,0.7913669064748201,0.9710113962594393,1.0,4/15,18.35%,POR;PDIA5;CYB561;PPARGC1A
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.29573743383909834,0.7450264279007333,0.7640449438202247,0.9675625323083078,1.0,2/33,2.03%,TNKS1BP1;DCLRE1B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3387547195904841,0.7436223706705983,0.7293388429752066,0.9691863851253644,1.0,4/13,18.20%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.295045554148732,0.7435906378670518,0.7495183044315993,0.9685566464580115,1.0,5/29,8.26%,NR1H3;SCARB1;LDLR;FABP3;MTOR
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.29484949749589207,0.7435177958270022,0.7833935018050542,0.9679888254162792,1.0,4/32,8.15%,CXCL5;CAMP;CXCL10;RNASE6
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2755113359091783,-0.7433404165251494,0.8195329087048833,0.9736581201151908,1.0,11/23,31.53%,LMAN1;SURF4;NPLOC4;HSP90B1;VCP;TMED9;SEC61B;PREB;SYVN1;SEC16A;AUP1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.2225771382483129,0.7417879606365757,0.8857979502196194,0.9700689593689329,1.0,26/173,14.59%,DYNLL1;CUL3;SPTBN1;COG7;COG1;SPTB;ANK3;COL7A1;VTI1A;SPTA1;GOLT1A;MIA3;KLHL12;TMED7;DYNC1I2;TMED4;SEC13;RANGRF;COPB2;PROC;TRIP11;VTI1B;COG6;DCTN1;DCTN3;ANK2
prerank,homocysteine metabolic process (GO:0050667),0.34196510201887637,0.7416520724133088,0.7536231884057971,0.969602882507888,1.0,1/11,2.99%,CTH
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2506520729893418,-0.7412394434815989,0.8448637316561844,0.975878109791295,1.0,8/29,28.62%,ELOVL7;ACACA;ELOVL1;ACSL4;HSD17B8;GCDH;ACSBG1;ACSF3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.3456307698014713,0.7411076922478468,0.735357917570499,0.9697683343518664,1.0,1/13,1.15%,BMP5
prerank,negative regulation of locomotion (GO:0040013),-0.32044150300839525,-0.7410086907856359,0.8007662835249042,0.9756065088662507,1.0,4/12,20.12%,FBLN1;CCDC125;FRMD5;PTPN2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2751501942449409,-0.740653581610415,0.8333333333333334,0.9754896291795675,1.0,7/25,16.12%,FOXO3;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2
prerank,membrane repolarization during action potential (GO:0086011),-0.3084689754132225,-0.7406189104319787,0.7824427480916031,0.9749578853573273,1.0,3/13,13.39%,KCNJ2;KCNQ1;ATP1A1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.3376772991257633,-0.7402013466151347,0.8119349005424955,0.9749274930074651,1.0,6/10,50.97%,TLR4;NCKAP1L;VSIR;IL12A;FOXP3;IL12B
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.3008537922461291,-0.7401384003052663,0.8073394495412844,0.9744426124501254,1.0,3/15,9.57%,NR3C1;ANXA1;BCL2L11
prerank,positive regulation of chromosome organization (GO:2001252),0.3360000639737609,0.7395127681989013,0.7322175732217573,0.9716360603660701,1.0,5/15,16.94%,LIG4;SHCBP1L;PPP1R10;DHX36;DDX11
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.26430164305169357,-0.7391090465567802,0.8475991649269311,0.9752430689757885,1.0,8/24,31.70%,UBB;RPA1;RFC3;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3195580409163381,0.7380686527756763,0.7740585774058577,0.9732218800860384,1.0,2/21,2.43%,MYH9;ADAM19
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.27885376064954415,-0.7371106541253714,0.8290766208251473,0.9767324901179725,1.0,9/20,35.89%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.27885376064954415,-0.7371106541253714,0.8290766208251473,0.9767324901179725,1.0,9/20,35.89%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,T cell differentiation in thymus (GO:0033077),-0.30395816998035474,-0.7367718005479913,0.7866666666666666,0.9766043067447413,1.0,7/14,36.46%,GLI3;MR1;ZFP36L2;RABL3;ADAM17;FADD;SHH
prerank,response to organonitrogen compound (GO:0010243),-0.24667328935599953,-0.7364233239101604,0.8724373576309795,0.9764684254620833,1.0,14/38,30.01%,RCN3;RNF139;GLRA3;RNF185;IRAK3;VCP;DNAJB12;CCDC47;KYNU;PRKN;RRAGC;TRPM2;SYVN1;MEAK7
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.3000679978337062,0.7357414150482774,0.7419962335216572,0.9761434063286768,1.0,2/22,3.29%,CD46;IL2RA
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2090586742157693,-0.7354589955736497,0.9287749287749287,0.9771398771656056,1.0,26/88,21.86%,SMURF2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMD8;PSMB1;PSMD11;PSME3;WNT11;FZD1;PSMA2;PSMD4;PSMD3;PSMB7;VANGL2;AP2M1
prerank,positive regulation of protein acetylation (GO:1901985),0.3335805635413072,0.7350563850991959,0.7356076759061834,0.97653878018496,1.0,3/12,14.46%,DDX3X;FAM161A;PRKAA1
prerank,carboxylic acid catabolic process (GO:0046395),-0.3169424207601118,-0.7341287515529042,0.8082191780821918,0.9782599484244244,1.0,8/12,53.29%,PON3;BCKDK;IL4I1;AMDHD2;GNPDA1;PON1;ACOT4;RENBP
prerank,mRNA stabilization (GO:0048255),0.27061745779610974,0.734026819773767,0.7923497267759563,0.9774662929949138,1.0,9/40,14.58%,RBM24;ELAVL4;DAZL;BOLL;DND1;AXIN2;HNRNPU;HNRNPC;TENT5D
prerank,cellular response to interleukin-7 (GO:0098761),-0.2872850577344116,-0.7339246895589636,0.8304093567251462,0.9773703340981009,1.0,10/17,32.62%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;SOCS1;IL7;IRS2;STAT5B;IL2RG
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2872850577344116,-0.7339246895589636,0.8304093567251462,0.9773703340981009,1.0,10/17,32.62%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;SOCS1;IL7;IRS2;STAT5B;IL2RG
prerank,protein O-linked glycosylation via serine (GO:0018242),0.34411054552272796,0.7336333568681791,0.7483731019522777,0.9773978291851637,1.0,3/10,12.20%,GALNT13;GALNT1;GALNT4
prerank,regulation of stem cell differentiation (GO:2000736),0.24390849919458482,0.7335482409281263,0.8417508417508418,0.9768655505483103,1.0,22/89,19.84%,NOTCH1;PTN;TCF15;RBM24;PSMB11;PSMF1;JAG1;MYB;TCF12;YTHDF2;PSME4;PRKDC;OCIAD1;HNRNPU;PUS7;KMT2A;PSMB5;NSUN2;PSMB8;PSMA1;PSMA5;PSMD13
prerank,histone lysine demethylation (GO:0070076),-0.2697972355317047,-0.7333599656841302,0.8279352226720648,0.9774769690159574,1.0,4/25,16.15%,KDM7A;KDM5B;KDM3A;KDM6B
prerank,regulation of oxidoreductase activity (GO:0051341),0.3249330180938171,0.7326903040090263,0.7552301255230126,0.9775288308942941,1.0,3/13,18.11%,ATP7A;ABL2;OXA1L
prerank,rRNA catabolic process (GO:0016075),0.32634860881409355,0.7318755106666588,0.7510121457489879,0.9781034823265582,1.0,2/16,10.61%,PELO;TRIR
prerank,regulation of small molecule metabolic process (GO:0062012),0.2928121719446731,0.7311819544883839,0.7677543186180422,0.9784829016931912,1.0,2/28,3.07%,RORA;ARV1
prerank,nucleic acid metabolic process (GO:0090304),-0.21910308567177822,-0.7310898226541889,0.9253731343283582,0.979676680785224,1.0,12/69,14.80%,RBFOX2;ENPP1;POLR2A;PCBP2;NT5E;MMS19;ATXN2;DNASE1L1;POLR2F;RAN;DDX24;RAD50
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2938883098946654,-0.730827001577417,0.8140417457305503,0.9794216804738203,1.0,7/16,34.86%,CAV1;TRIM27;TRIM14;TRIM6;FUCA2;TRIM21;EXOC2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2242779893670381,-0.7306716350220458,0.8872901678657075,0.9790367916716464,1.0,17/53,24.73%,PSME2;PSMB4;PSMD8;PSMB1;PSMD11;PSME3;ODC1;OAZ1;PSMA2;PSMD4;PSMD3;BCKDK;PSMB7;AZIN1;PSMC2;PSMD10;PSMC5
prerank,protein acylation (GO:0043543),-0.2404020200703633,-0.7302878910108794,0.8976034858387799,0.9789327352844162,1.0,13/38,24.90%,GLUL;FOXO1;KAT2B;SELENOK;SPHK1;CLOCK;NAT10;ZDHHC15;ZDHHC8;NAA80;NAT9;ZDHHC7;ING4
prerank,RNA catabolic process (GO:0006401),0.2732106027975685,0.7301216843586296,0.8044692737430168,0.979452728744128,1.0,14/46,19.97%,AGO3;XRN2;SUPV3L1;RNASE6;YTHDF2;SND1;PABPC4;RNASEH1;RNH1;CNOT10;DIS3L2;LSM2;HNRNPD;LSM6
prerank,acyl-CoA metabolic process (GO:0006637),-0.24337493388388798,-0.7298667394965695,0.8757763975155279,0.9788814633374275,1.0,10/35,23.52%,SUCLG2;ACOT11;HMGCS2;ACACA;ACOT6;ACOT9;SUCLA2;ACACB;DBI;OXSM
prerank,Fc receptor signaling pathway (GO:0038093),-0.1941438064660304,-0.7298625339463026,0.9885386819484241,0.9783175654136803,1.0,33/110,24.73%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;KIT;PSME2;RELA;PSMB4;FER;FBXW11;PLCG2;PSMD8;PSMB1;MAPK3;PSMD11;CALM1;PSME3;PDPK1;PSMA2;PSMD4;IKBKG;PSMD3;SYK;NFATC2;PPP3CB;PSMB7;LCP2;MAP2K7;PSMC2;SHC1;PSMD10;PSMC5
prerank,regulation of endocytic recycling (GO:2001135),-0.3171679300647208,-0.7290674190348606,0.8170055452865065,0.9787329893324833,1.0,4/11,16.03%,ACTN2;EHD1;ATP9A;EHD2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.3386639751783265,0.7285926176345914,0.751004016064257,0.9810666027208479,1.0,2/12,8.32%,IL1B;IL12RB1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2843139903504555,-0.7283561291063336,0.8274509803921568,0.9790233164857324,1.0,3/18,10.84%,SETD7;SETD1B;EHMT1
prerank,polyol biosynthetic process (GO:0046173),-0.2920092613328613,-0.7282910158431217,0.8145315487571702,0.9785401014907429,1.0,5/16,14.59%,CYP27A1;ACER3;IP6K1;ISYNA1;IP6K2
prerank,proton transmembrane transport (GO:1902600),0.2832573969373724,0.7279120948160257,0.7960644007155635,0.9814604431745539,1.0,3/36,6.08%,ATP1A2;ATP1A4;ATP6V0E2
prerank,regulation of mast cell degranulation (GO:0043304),0.34445499871488566,0.7278205575078789,0.7597402597402597,0.980928548239908,1.0,4/14,10.27%,CD300A;IL4;LYN;STXBP2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3326331416552041,-0.7263459488461239,0.8373831775700935,0.9803212650477983,1.0,2/10,7.60%,GHR;STAT3
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3208735362821338,-0.7262846814522838,0.7912280701754386,0.9798112939060847,1.0,4/10,28.52%,HSP90AB1;NAB2;EGR1;CLU
prerank,autophagosome maturation (GO:0097352),-0.24943793127288785,-0.7256616337118141,0.8828633405639913,0.9800083761117117,1.0,7/32,21.35%,LAMP2;WIPI2;UVRAG;CALM1;GABARAPL1;VCP;VAMP8
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.24457299702753585,-0.7253276670517788,0.8949771689497716,0.9798538206873249,1.0,16/37,31.70%,ERCC5;CUL4A;UBB;RPA1;DDB1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;POLD1;NTHL1;PCNA;GTF2H3;RFC5
prerank,regulation of spindle organization (GO:0090224),-0.2832472904076439,-0.7242772163518474,0.8345864661654135,0.9804852937140194,1.0,7/18,28.43%,PARP3;DYNC1H1;NUMA1;GNAI1;TPX2;NUP62;FSD1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.26669345733395156,-0.7241592051667457,0.8396039603960396,0.9800791852901507,1.0,8/23,26.70%,CUL4A;COPS4;UBB;COPS8;DDB1;CETN2;COPS7A;COPS2
prerank,autophagy of peroxisome (GO:0030242),-0.30850186433541876,-0.7232319255922994,0.8306122448979592,0.9806387351554049,1.0,2/12,13.42%,ACBD5;ATM
prerank,axonemal dynein complex assembly (GO:0070286),-0.2579146367170237,-0.7231554680708032,0.8801652892561983,0.9801677935835943,1.0,19/27,48.59%,DNAH8;ODAD2;DRC1;ODAD3;DNAL1;CCDC65;DNAAF2;DNAI4;CFAP100;TTC12;DNAH17;CCDC40;DNAAF4;DNAH1;ODAD1;DNAAF3;DNAAF1;DNAI3;CFAP73
prerank,regulation of dopamine secretion (GO:0014059),0.29205299137903346,0.7231396752756913,0.7712031558185405,0.9873306339408515,1.0,11/25,24.20%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT10;SYT6
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3058022695693844,0.722853156448108,0.75,0.987084350556078,1.0,2/20,4.26%,CDK6;HOXA9
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2867121869224154,0.7216297558178454,0.7825311942959001,0.9882027547659079,1.0,5/36,6.52%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,protein heterooligomerization (GO:0051291),0.31691371973939997,0.7212766923524139,0.7559912854030502,0.9880568858759284,1.0,7/17,20.94%,CPSF6;PKD2;MAT2A;GRIN2B;KCNC2;CPSF7;GRIN1
prerank,RNA methylation (GO:0001510),0.25187509900896365,0.7210324590460483,0.8370497427101201,0.9877695098734727,1.0,21/60,25.69%,FBLL1;NSUN3;TRMT61A;TRMT5;CBLL1;THUMPD2;RBM15;TRMT10C;MTO1;ZC3H13;NSUN2;TFB2M;NSUN5;WTAP;METTL6;DIMT1;GTPBP3;TRDMT1;TRMT10A;METTL16;TGS1
prerank,striated muscle cell development (GO:0055002),0.32843008402145146,0.7207653910917815,0.7569892473118279,0.9874782368600744,1.0,3/14,10.63%,TMOD1;TMOD3;LMOD1
prerank,positive regulation of telomerase activity (GO:0051973),-0.2393309024675031,-0.720558009566041,0.8861047835990888,0.9826993292766861,1.0,10/33,26.45%,KLF4;NAF1;HSP90AB1;MAPK3;MAP3K4;ACD;WRAP53;MAP2K7;CTNNB1;NEK7
prerank,neuromuscular process controlling balance (GO:0050885),0.34161809439022184,0.7204608323828546,0.7505285412262156,0.9872621016401968,1.0,1/12,3.21%,NRXN1
prerank,regulation of telomerase activity (GO:0051972),-0.22769271076134312,-0.7202802445135202,0.9,0.9824502439224108,1.0,14/45,26.45%,KLF4;SMG6;NAF1;PINX1;ATM;HSP90AB1;MAPK3;MAP3K4;ACD;WRAP53;MAP2K7;TP53;CTNNB1;NEK7
prerank,positive regulation of secretion (GO:0051047),-0.317969317049551,-0.7191567688098385,0.8102189781021898,0.9832146891685745,1.0,4/11,37.61%,NPR1;XBP1;AQP1;SCIN
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.32390349457006473,-0.7190437454967549,0.8185185185185185,0.9827845775002202,1.0,5/10,35.97%,JARID2;DNMT1;BRCA1;KDM1A;ATRX
prerank,positive regulation of mRNA processing (GO:0050685),0.30365430632768986,0.718852003456329,0.761252446183953,0.9890052743031861,1.0,6/21,19.44%,NCBP2;TRA2A;DAZAP1;DHX36;RBMX;RBM3
prerank,histone monoubiquitination (GO:0010390),0.2953688734961526,0.7188181231977453,0.751937984496124,0.9883711611377445,1.0,6/24,16.92%,RYBP;UBE2E1;KDM2B;CTR9;SKP1;TRIM37
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2731409276477107,-0.7187635696853012,0.8433734939759037,0.9814322545806538,1.0,12/20,40.30%,ZW10;ATM;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;CDC20;BUB1;KLHL22
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2731409276477107,-0.7187635696853012,0.8433734939759037,0.9814322545806538,1.0,12/20,40.30%,ZW10;ATM;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;CDC20;BUB1;KLHL22
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2731409276477107,-0.7187635696853012,0.8433734939759037,0.9814322545806538,1.0,12/20,40.30%,ZW10;ATM;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;CDC20;BUB1;KLHL22
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.28408126444689413,0.7187362780857557,0.7918968692449355,0.987128750969678,1.0,7/32,14.65%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,tRNA export from nucleus (GO:0006409),0.28408126444689413,0.7187362780857557,0.7918968692449355,0.987128750969678,1.0,7/32,14.65%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2583505847486918,-0.7187357929995108,0.8729838709677419,0.9808993911539929,1.0,8/26,23.93%,PCBP2;IRAK3;PPM1B;SIRT2;TRIB1;SIGIRR;LYAR;MAPKBP1
prerank,regulation of pH (GO:0006885),-0.3174600539829143,-0.7181006349317435,0.831758034026465,0.9810647197417462,1.0,3/11,11.87%,ATP6V0A4;LACC1;CLCN3
prerank,bicarbonate transport (GO:0015701),-0.26121192045082087,-0.7180767377881018,0.872651356993737,0.9805384554130158,1.0,2/25,3.14%,SLC26A7;SLC4A10
prerank,regulation of amyloid-beta clearance (GO:1900221),0.31962027178298275,0.7179909856940848,0.7611940298507462,0.9875613528033489,1.0,4/16,14.91%,ROCK1;IL4;ABCA7;HMGCR
prerank,carbohydrate transport (GO:0008643),0.3382594366418295,0.7179236673851688,0.7617021276595745,0.9869891364914603,1.0,3/11,17.11%,SLC5A1;SLC23A2;SLC23A1
prerank,alpha-amino acid metabolic process (GO:1901605),0.2648262544108426,0.7178632789573831,0.8121546961325967,0.9864085555448979,1.0,6/45,11.73%,NAALAD2;ATP7A;SLC25A13;GOT1;GLS2;SRR
prerank,response to hexose (GO:0009746),-0.26132907101519803,-0.7176436703079669,0.8764705882352941,0.9804779567581952,1.0,8/25,31.56%,THBS1;TCF7L2;EIF2B2;LPL;EIF2B5;EIF2B4;KHK;IRS2
prerank,regulation of immune effector process (GO:0002697),0.27288194378199404,0.7176037991512189,0.8038194444444444,0.9861315733256735,1.0,5/41,9.77%,VTN;CD46;C7;SUSD4;CR2
prerank,ncRNA catabolic process (GO:0034661),-0.2517946174760172,-0.7174661766512708,0.8627049180327869,0.9801296120976443,1.0,8/28,26.57%,TUT4;EXOSC5;XRN1;TENT4B;DEDD2;NUDT16;EXOSC7;POP1
prerank,immunoglobulin mediated immune response (GO:0016064),0.3422947274916603,0.7169526718438352,0.7553648068669528,0.9864358161345008,1.0,1/10,5.08%,CARD9
prerank,fatty acid beta-oxidation (GO:0006635),-0.2266276758498928,-0.7167220867359776,0.9255813953488372,0.9804013871282429,1.0,14/51,21.54%,IVD;CPT2;SLC25A17;ACOX1;ECI2;ACADL;AUH;BDH2;ACAD10;ECHDC2;ACOX3;ACADS;DECR1;GCDH
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2642465463323171,0.716548776137489,0.8194945848375451,0.9863526765493332,1.0,7/50,6.84%,RORA;BTRC;IFT81;MOSMO;GAS8;GPC3;KCTD6
prerank,negative regulation of coagulation (GO:0050819),0.32865040479766594,0.7164376404976932,0.7669491525423728,0.9858422073626875,1.0,1/14,1.04%,VTN
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.22666709413761404,-0.7160402126452056,0.9191011235955057,0.9806542767822943,1.0,1/41,0.05%,PRKAG2
prerank,mitotic sister chromatid segregation (GO:0000070),-0.19973931354581573,-0.7158421553546991,0.9635854341736695,0.9803166707282672,1.0,37/98,33.71%,RAB11A;PDCD6IP;PDS5B;KMT5A;INO80;PINX1;BECN1;CHMP4B;CHMP4A;NCAPG2;RAN;ZW10;SMC4;CENPK;DSN1;SMC1A;CENPE;RRS1;PIBF1;SPAG5;KIF18B;CHMP5;NUP62;NDC80;KIFC1;NSL1;DCTN2;KIF14;CDCA8;CEP55;SGO1;KIF23;KIF18A;CSNK2B;CHMP6;PRC1;EML3
prerank,nuclear membrane reassembly (GO:0031468),0.2614865972629449,0.7150065962254814,0.8473413379073756,0.9872944155056772,1.0,15/54,20.75%,PPP2R2A;NUP43;CHMP2B;ANKLE2;NUP35;UBXN2B;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.19063485672845532,-0.7148552700512473,0.9911504424778761,0.9808892058250304,1.0,33/109,24.73%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;PSME2;RELA;PSMB4;FER;FBXW11;PLCG2;PSMD8;PSMB1;MAPK3;PSMD11;CALM1;PSME3;PDPK1;PSMA2;PSMD4;IKBKG;PSMD3;SYK;NFATC2;PPP3CB;PSMB7;NR4A3;LCP2;MAP2K7;PSMC2;SHC1;PSMD10;PSMC5
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2338074752910519,-0.7137508118555239,0.8792372881355932,0.9816075114677778,1.0,9/40,18.46%,KMT5A;PRKCD;IER3;MCL1;POLH;FXR2;CDK9;SIRT7;NPAS2
prerank,mammary gland epithelium development (GO:0061180),-0.2963827463478313,-0.7137223124745321,0.8336594911937377,0.9810871734172565,1.0,6/14,24.85%,WNT4;AKT1;ID2;CSF1R;AKT2;SCRIB
prerank,midbody abscission (GO:0061952),-0.2759398739587702,-0.7131837470361434,0.8536082474226804,0.981132658336337,1.0,4/17,16.78%,PDCD6IP;CHMP4B;CHMP4A;MITD1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.23881698898496811,-0.7131399630877377,0.9043659043659044,0.9806259501083547,1.0,4/34,6.76%,RBP4;LACC1;WNT5A;SLC7A5
prerank,regulation of store-operated calcium entry (GO:2001256),0.3301727397501549,0.7127748866186681,0.7478260869565218,0.9897756769899833,1.0,4/10,16.18%,STIM1;CASQ1;SLC8B1;CD84
prerank,alanine transport (GO:0032328),0.3441715617234073,0.7121542513262877,0.7432432432432432,0.9900066324814524,1.0,1/10,2.21%,SLC1A4
prerank,zymogen activation (GO:0031638),0.27343173632212925,0.71207478789821,0.8114901256732495,0.9894605061509822,1.0,3/39,7.77%,GGT1;CIDEB;RIPK2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.31956432373736526,-0.7120515872930825,0.8390151515151515,0.9812949231760346,1.0,5/10,25.20%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3121056547255017,0.7116468324505222,0.7687747035573123,0.9894235253992526,1.0,5/17,10.43%,RGCC;SPDYA;PKD2;PDGFB;CCNYL1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.32888374118238184,0.7116422455540798,0.7685774946921444,0.9887622675819467,1.0,2/13,4.92%,AXL;AP1G1
prerank,nucleotide metabolic process (GO:0009117),-0.2635599314738043,-0.7112057264647601,0.857707509881423,0.9816800460939564,1.0,7/23,18.84%,FHIT;ENPP3;ME1;CMPK1;NMNAT1;PARK7;PNP
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2160131411892942,0.7103403288405968,0.9375866851595007,0.9899935883821354,1.0,12/175,8.01%,LIMS1;PID1;TNFRSF21;GPER1;TRAF5;PSMB11;ACTN4;TNFRSF8;CACTIN;PSMF1;TRAF3;CDIP1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.24887247007637203,-0.7102552418669084,0.8755555555555555,0.9821564911855392,1.0,8/27,25.57%,CDC16;UBE2E2;ANAPC4;FZR1;CDC27;ANAPC5;PRKN;UBE2H
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.27451267696785275,-0.7101260339435834,0.8638211382113821,0.9817293240706161,1.0,5/18,28.62%,ELOVL7;ELOVL1;ACSL4;ACSBG1;ACSF3
prerank,positive regulation of rRNA processing (GO:2000234),-0.3215581276355679,-0.7093526795424313,0.810126582278481,0.9820174321703314,1.0,3/10,23.79%,SIRT7;RIOK2;TRMT112
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2328137352658145,-0.7092165555190058,0.8864628820960698,0.981596554412274,1.0,13/38,27.50%,GEMIN7;STRAP;SRSF10;GEMIN5;PRPF3;SNRPF;SNRPD1;SNRPD2;WDR77;SNRPC;PRPF19;SNRPB;SNRPE
prerank,magnesium ion transport (GO:0015693),-0.30183690329250806,-0.7088058983702232,0.8387681159420289,0.9814705194983502,1.0,1/12,4.14%,SLC41A1
prerank,autophagy of mitochondrion (GO:0000422),-0.235391757682399,-0.7087715133564633,0.8911111111111111,0.9809557522557356,1.0,13/38,34.61%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG12;PRKN;ATG7;ATG14;PINK1;RB1CC1;PHB2
prerank,positive regulation of sodium ion transport (GO:0010765),0.3273446849674205,0.7087496012972482,0.7466960352422908,0.9916145068819641,1.0,3/12,7.51%,SCN5A;ANK3;PRSS8
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2860439639050944,0.7086670229913115,0.8252788104089219,0.9910667223775274,1.0,7/27,11.97%,PHF20L1;KAT7;MRGBP;TAF6;RUVBL1;KAT6A;EP300
prerank,regulation of viral release from host cell (GO:1902186),0.30834924838007727,0.7085541163606585,0.8205128205128205,0.9905770503643262,1.0,3/21,6.13%,MID2;TRIM62;CHMP2B
prerank,regulation of synapse organization (GO:0050807),0.2909463604893365,0.7084541410318526,0.8011472275334608,0.9900602781375679,1.0,4/26,10.34%,MEF2C;YWHAZ;IL1RAPL1;CTNNA2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3000736354610192,-0.7069072575975132,0.845724907063197,0.9824286618573391,1.0,6/13,18.63%,SEC16B;TMEM30A;TM9SF4;SAR1A;SAR1B;CD81
prerank,regulation of histone acetylation (GO:0035065),-0.23717734941438368,-0.7060400613396817,0.9040816326530612,0.9827993375849594,1.0,11/33,23.91%,ARRB1;BRD7;TADA2A;FLCN;HDAC5;MAPK3;NOS1;PPARGC1A;PARK7;CTBP1;BRCA1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.21458581363454807,-0.7057656599229424,0.9325,0.9825542859039377,1.0,19/57,26.40%,DCN;MCU;TNFSF10;BCL2L11;KDR;VPS35;BNIP3;ADCK1;BID;PDCD5;PPARGC1A;PARK7;PLAUR;BBC3;DDHD1;RALBP1;PRKN;TP53;BIK
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2840565689016,-0.7056916071450287,0.8415841584158416,0.9820781093407437,1.0,6/16,29.21%,AMPD3;ATIC;LHPP;ADSS1;PAICS;NUDT2
prerank,protein heterotetramerization (GO:0051290),0.31790647299120856,0.7055262731401936,0.7822222222222223,0.9934884990961892,1.0,5/13,20.94%,CPSF6;PKD2;GRIN2B;CPSF7;GRIN1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2503165350843321,-0.705491392278738,0.8714596949891068,0.9817412342567481,1.0,10/24,25.20%,KLF2;HSPA5;HIF1A;ATF6;CREB3L1;CEBPB;MT3;VEGFA;ATF3;TP53
prerank,tryptophan catabolic process (GO:0006569),-0.30949139545984083,-0.7053509693916526,0.8407407407407408,0.9813509127683101,1.0,10/11,56.89%,AFMID;KYNU;IL4I1;HAAO;AADAT;KYAT1;IDO2;TDO2;IDO1;ACMSD
prerank,covalent chromatin modification (GO:0016569),-0.29056830035556463,-0.7048474956251526,0.8358490566037736,0.9813350787140509,1.0,5/14,23.18%,HDAC1;SIRT7;PARK7;MT3;MBD2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.2693074185814313,-0.7047693051456567,0.8666666666666667,0.9808739495609263,1.0,5/19,22.64%,CUX1;OBSL1;LRP8;SS18L1;DBN1
prerank,positive regulation of myelination (GO:0031643),0.3280628675269823,0.7044463911171905,0.7643020594965675,0.9942939824329335,1.0,3/11,7.88%,TPPP;NCMAP;TENM4
prerank,embryonic axis specification (GO:0000578),-0.2861196080257265,-0.7042048181610995,0.8197674418604651,0.9808957017475372,1.0,1/15,0.78%,SMAD6
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.2453307078053312,-0.7041850240096287,0.8969957081545065,0.980362047913755,1.0,9/30,22.48%,NPEPPS;SH3GLB1;TOMM7;SAE1;LEPROT;PDCD5;HPS4;USP36;BAP1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2637693567636205,0.7033152605385465,0.8318264014466547,0.9951634275891706,1.0,14/45,20.01%,GCNT2;GRM5;NANOS1;ZC3H10;YTHDC1;EIF4E;METTL18;PUM3;TSC1;MATR3;RC3H1;METAP1;RBM3;DDX25
prerank,DNA geometric change (GO:0032392),-0.25387570777529556,-0.7031997161123439,0.8674948240165632,0.9808684071098603,1.0,5/24,19.93%,ASCC3;ANXA1;RAD50;HMGB2;RECQL
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3199423296540835,0.7030230440979719,0.7860082304526749,0.9948983524320276,1.0,2/16,7.54%,PTPN22;FGF10
prerank,chemical homeostasis (GO:0048878),0.25237464382390823,0.7025236795664,0.8620689655172413,0.9949343739901182,1.0,3/61,2.77%,NEDD4L;NR1H3;NR1D2
prerank,negative regulation of protein secretion (GO:0050709),0.2663324756865951,0.7016190203902977,0.8438661710037175,0.995508910668368,1.0,4/38,6.72%,NR1H3;IL1B;RHBDF1;IRS1
prerank,respiratory electron transport chain (GO:0022904),0.31674647474025575,0.7014982235604694,0.776595744680851,0.995004469843692,1.0,6/14,18.89%,UQCRFS1;SLC25A13;ETFA;ETFB;ETFDH;NDUFA5
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.29082104786472684,0.7006712369731041,0.7895716945996276,0.9954947504781141,1.0,8/25,18.98%,SORT1;CHMP2B;MVB12A;DENND10;UBXN6;CHMP3;LEPROTL1;VTA1
prerank,endocytic recycling (GO:0032456),0.2584569171000112,0.7003711130588598,0.8648648648648649,0.9952201447622911,1.0,1/50,0.61%,ANKRD50
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2240533833957906,-0.6996789107341544,0.9108910891089109,0.984084231006494,1.0,16/50,29.60%,CCND2;CCND3;CCNG1;ACTB;CCND1;HSP90AB1;CDKN1B;CDK5RAP3;CDKN1C;CCNF;SERTAD1;CDC25A;CDK7;CDKN2D;MNAT1;CDKN3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.2759949117892331,-0.6996101058565273,0.8786692759295499,0.9836064522144911,1.0,3/16,17.80%,STX7;CEACAM1;CYRIB
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.32423034186406197,0.6995287129483589,0.7987551867219918,0.9943111304243208,1.0,4/12,15.52%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.32423034186406197,0.6995287129483589,0.7987551867219918,0.9943111304243208,1.0,4/12,15.52%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.32423034186406197,0.6995287129483589,0.7987551867219918,0.9943111304243208,1.0,4/12,15.52%,CUL3;RB1;ANAPC7;NSMCE2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.2386096421908882,-0.699434524520442,0.8829568788501027,0.9832256640521514,1.0,12/32,30.71%,TAF1;CAVIN1;POLR2F;MAPK3;POLR2E;UBTF;ERCC2;ERCC3;CDK7;POLR1C;MNAT1;GTF2H3
prerank,negative regulation of signaling (GO:0023057),0.27917709995338835,0.6992143960006159,0.8159509202453987,0.9940811268375371,1.0,3/25,6.12%,IL1B;SOCS5;AP1AR
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.24515458736966594,-0.6987756654849449,0.8943965517241379,0.9833789620828316,1.0,11/30,31.31%,HSPA5;ENTPD5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.32320537562551943,0.6985964378029477,0.7861635220125787,0.9942370499735411,1.0,6/13,22.31%,SART3;PRPF6;PRPF31;LSM2;AAR2;SRSF12
prerank,cilium movement (GO:0003341),0.25616903742564906,0.697890894775601,0.8509874326750448,0.9945032946296533,1.0,8/47,17.51%,RSPH6A;SPEF1;GAS8;CAMSAP3;CCDC63;ODAD4;DNAH9;CFAP61
prerank,tRNA aminoacylation (GO:0043039),-0.2313454123983951,-0.6974478906489999,0.9177489177489178,0.9842090177892259,1.0,11/37,24.75%,LARS2;RARS2;KARS1;CARS1;QARS1;SARS1;HARS1;MARS2;FARSA;PPA1;FARSB
prerank,regulation of G0 to G1 transition (GO:0070316),0.27460306054540107,0.6971378196025455,0.8477876106194691,0.9948044101339774,1.0,5/38,6.52%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.28888498201964435,-0.6969882799271158,0.8336713995943205,0.9841161451841683,1.0,3/14,13.07%,CARD14;CARD10;COPS8
prerank,telomere maintenance via recombination (GO:0000722),-0.3093898795153387,-0.6963258851607579,0.8576512455516014,0.9842485571563747,1.0,5/11,23.46%,TEP1;RAD50;TPRKB;ERCC1;RAD51
prerank,response to ethanol (GO:0045471),0.3259814335408251,0.696235202257157,0.8021276595744681,0.9953229051136107,1.0,5/14,22.73%,GRIN2B;CHRNB2;GRIN2A;GRIN1;SOD1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.2919923987223868,0.6960248811804608,0.8192307692307692,0.9949373689507599,1.0,3/26,6.26%,NR1H3;PTPN22;DDX3X
prerank,microtubule polymerization (GO:0046785),0.27743580554694847,0.6959094792578133,0.8276515151515151,0.9944206604299348,1.0,5/28,10.29%,FGF13;CCDC57;CLASP2;TPPP;TUBG2
prerank,recombinational repair (GO:0000725),-0.1998246318381378,-0.6950917697506728,0.9710144927536232,0.9849692296518195,1.0,32/77,35.00%,INO80;SFR1;ERCC5;RAD51B;SAMHD1;BRCA2;NABP1;AP5Z1;RPA1;RAD50;RECQL;RAD52;RAD51C;MCM8;SLX4;RAD51;BRCA1;RPA3;ZSWIM7;RAD54B;HUS1;AP5S1;WRN;RAD51AP1;HELQ;RMI1;HUS1B;RAD51D;NSMCE1;MORF4L1;ZFYVE26;RECQL5
prerank,global genome nucleotide-excision repair (GO:0070911),0.2869970810780042,0.6950407540562441,0.8128654970760234,0.9949455204025126,1.0,9/26,20.72%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3287781505618259,0.6949993056168632,0.7916666666666666,0.994340828655436,1.0,3/12,7.95%,DCK;TK1;TK2
prerank,regulation of mitochondrion organization (GO:0010821),-0.21713096130935788,-0.694903916677069,0.9387755102040817,0.9846103204167863,1.0,22/47,33.60%,LRRK2;STAT2;IAPP;GOLPH3;FLCN;VPS35;SREBF1;PLSCR3;MYO19;SIRT7;CYRIB;PPARGC1A;USP36;PRKN;INF2;FZD5;ATP13A2;HDAC6;DNM1L;TREM2;PINK1;MIEF2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3029646266355283,-0.6948201859264576,0.8568807339449541,0.9841576229242087,1.0,3/11,17.77%,ARRB1;GRK2;ADRB2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.26796670600786954,-0.6947423733771696,0.8775510204081632,0.9836878602562427,1.0,13/18,45.92%,RAB11A;RAD51B;CCND1;RAD51C;CDC25A;DTL;CDC25B;CDK1;RCC2;CCNB1;CDC25C;VPS4B;BRD4
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.25957461104018925,-0.694624738583345,0.8776371308016878,0.9832537487592973,1.0,7/23,21.99%,BCL2L11;TIMM13;TOMM22;TIMM8B;MAIP1;TIMM9;NDUFA13
prerank,positive regulation of RNA splicing (GO:0033120),0.2722350613761563,0.6937757193704327,0.8486590038314177,0.9953128349101327,1.0,6/29,19.44%,PIK3R1;TRA2A;DAZAP1;HABP4;RBMX;RBM3
prerank,negative regulation of immune system process (GO:0002683),0.3146682405289056,0.6935258277940488,0.7956043956043956,0.9949987123438172,1.0,2/16,9.19%,GPER1;LYN
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3246686518061785,0.6932381090662457,0.7802197802197802,0.9947289548148932,1.0,6/13,18.72%,CIDEB;RIPK2;PERP;GRIN2A;ASPH;NLRC4
prerank,tRNA transport (GO:0051031),0.2705193009279881,0.6930289046203121,0.8391866913123844,0.9943669707585314,1.0,7/35,14.65%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.32526506583771064,0.6928422956898616,0.7889125799573561,0.9939592054383496,1.0,9/14,26.42%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SRSF12;SAP18;SRSF4;SFSWAP
prerank,V(D)J recombination (GO:0033151),0.3276294316940607,0.6923753318618094,0.7940552016985138,0.9939111601497923,1.0,2/11,12.55%,LIG4;PRKDC
prerank,mitochondrial fusion (GO:0008053),0.297357051969888,0.6916961617099637,0.8063872255489022,0.9941853963861721,1.0,4/18,15.85%,PLD6;MFF;MFN1;MIEF1
prerank,regulation of organelle assembly (GO:1902115),0.239813551289286,0.6916715727730368,0.8979933110367893,0.9935512641797037,1.0,15/72,15.78%,TBC1D1;IFT20;TBC1D12;PIKFYVE;TBC1D2B;NPRL3;TBC1D10C;VPS11;TBC1D9B;TBC1D19;NPRL2;UBQLN2;RAB5A;TBC1D10B;CEP76
prerank,phagosome-lysosome fusion (GO:0090385),-0.31297881459458593,-0.6915920741839436,0.8451730418943534,0.9858153715491237,1.0,7/10,38.66%,RAB7A;RAB7B;SYT7;RAB20;CLN3;PLA2G5;RAB39A
prerank,neuron maturation (GO:0042551),0.2965837087138348,0.6915446664469743,0.812375249500998,0.9930522482330119,1.0,4/18,9.42%,SCARF1;B4GALT6;ADGRB3;ACTL6B
prerank,morphogenesis of an epithelium (GO:0002009),0.2937810901520139,0.691069248060121,0.8278529980657641,0.9930049298878141,1.0,6/25,12.95%,VCL;TIMELESS;TBX18;AHI1;PRKX;KDM2B
prerank,negative regulation of mRNA processing (GO:0050686),0.32167680142964633,0.690119025410229,0.7991452991452992,0.9936382138179417,1.0,9/15,26.42%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SRSF12;SAP18;SRSF4;SFSWAP
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.2878481015621286,0.6897161506719257,0.8092243186582809,0.9935091018070856,1.0,5/20,15.74%,GRK3;SNCA;CRY1;APLP1;YWHAB
prerank,response to endoplasmic reticulum stress (GO:0034976),0.22480992440470032,0.6892730954525129,0.9227202472952086,0.993429127454577,1.0,7/107,6.32%,ATP2A3;MAP3K5;PIK3R1;CHAC1;ITPR1;SCAMP5;ATP2A2
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2228581842556298,-0.6889172882496793,0.9352051835853131,0.9879443275574133,1.0,14/37,32.91%,ENTPD1;SIDT2;DNASE1L1;ENTPD5;PNPT1;ENTPD2;DFFB;NUDT16;EXOSC7;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,spermatid development (GO:0007286),0.2686686530098499,0.6888644756001046,0.8198874296435272,0.9933097569322288,1.0,6/32,14.82%,PLD6;RSPH1;YTHDC2;SOX30;CCDC63;ACRBP
prerank,regulation of humoral immune response (GO:0002920),0.2611717331457439,0.6888238087357932,0.8509532062391681,0.9927085874955371,1.0,5/44,9.77%,VTN;CD46;C7;SUSD4;CR2
prerank,regulation of centriole replication (GO:0046599),-0.27584970460508706,-0.6879101136564015,0.8737864077669902,0.9883376303949724,1.0,6/17,28.08%,KAT2B;PLK2;PLK4;ALMS1;BRCA1;NUP62
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2290071338390613,-0.6879019911586045,0.9264367816091954,0.9877873639653655,1.0,16/39,31.70%,ERCC5;CUL4A;UBB;RPA1;DDB1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;POLD1;NTHL1;PCNA;GTF2H3;RFC5
prerank,regulation of viral transcription (GO:0046782),-0.22590217645288857,-0.68756802356539,0.9086859688195991,0.9875341910666543,1.0,15/39,29.82%,MDFIC;IFITM3;POLR2A;TRIM27;POLR2F;CDK9;POLR2E;TRIM14;RSF1;NELFCD;TRIM11;POLR2G;CTDP1;SUPT4H1;ZFP36
prerank,synaptic vesicle exocytosis (GO:0016079),-0.22281016571060733,-0.6867705893326096,0.9300411522633745,0.9877576529787891,1.0,9/40,18.93%,UNC13B;SNAP23;STX3;STX1A;SNAP47;BLOC1S6;UNC13C;STX2;PIP5K1C
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2538267178149447,-0.6866955188699686,0.8959183673469387,0.9872792314735465,1.0,6/23,24.34%,REXO4;DNASE1L1;HMGB2;DICER1;DFFB;FOXL2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3222934275281617,0.6865022476415055,0.7965738758029979,0.9950881293707439,1.0,1/13,1.76%,NR1H3
prerank,epithelial cell development (GO:0002064),0.29217214696553634,0.6856658752208658,0.8032786885245902,0.9954898246444526,1.0,2/20,5.51%,RILPL2;ROS1
prerank,regulation of Golgi organization (GO:1903358),-0.2738679488078722,-0.6856294259297542,0.8538011695906432,0.9877323792983499,1.0,5/17,17.86%,ARMH3;USP6NL;AKAP9;MAPK3;STX18
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.280536055880994,-0.6856281879619266,0.882466281310212,0.9871839828315534,1.0,12/15,57.97%,KYNU;FAH;IL4I1;HGD;HAAO;AADAT;KYAT1;IDO2;TDO2;IDO1;ACMSD;GSTZ1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2556538955431873,-0.685470877236379,0.8966202783300199,0.9867759152385657,1.0,2/22,3.41%,EZR;PTPRJ
prerank,gastrulation (GO:0007369),0.3134314681787869,0.6854676806955232,0.7950819672131147,0.9950712834789578,1.0,3/15,15.82%,GPC3;LMBRD1;TASOR
prerank,regulation of protein kinase C signaling (GO:0090036),-0.2782242070405037,-0.6850184269650874,0.8802281368821293,0.9866519464476389,1.0,5/14,16.98%,ADGRV1;WNT5A;GPD1L;FLT4;WNT11
prerank,response to UV (GO:0009411),0.22787626650788279,0.6848140648256652,0.9148936170212766,0.9952714890422618,1.0,1/95,0.17%,PTPRK
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.3205527757549367,0.6846423627446059,0.7958333333333333,0.9948225169067735,1.0,4/12,18.25%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,cobalamin metabolic process (GO:0009235),0.3027929785811331,0.6845054162998907,0.8153526970954357,0.9943629838787488,1.0,3/17,14.24%,MMADHC;MMAB;LMBRD1
prerank,protein targeting to membrane (GO:0006612),0.23232550619196088,0.6837661650043713,0.9147157190635451,0.9946353974320573,1.0,13/83,13.80%,ZDHHC14;RAB8B;NCF1;ABCD2;ATAD1;SGTB;PIKFYVE;ZDHHC1;ZDHHC2;ZDHHC21;PEX3;ZDHHC23;PEX19
prerank,fatty acid transport (GO:0015908),0.30167384970801375,0.6829433602796022,0.8217821782178217,0.994995368390907,1.0,3/17,5.71%,PPARD;SLC27A4;FABP3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.27819331395750313,0.6825081345376551,0.8360323886639676,0.994931396546348,1.0,12/28,23.43%,WAS;AUNIP;SETMAR;PRKDC;SHLD3;KMT5B;MRNIP;HSF1;HMGA2;PNKP;KDM4D;NUDT16L1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.27998775130694825,0.6822956847649804,0.8410852713178295,0.9945385529458425,1.0,7/25,21.55%,CUL3;UGGT2;ZER1;YME1L1;TOR1A;STUB1;POMT2
prerank,regulation of protein localization to cell surface (GO:2000008),0.26739695098457256,0.6811633553017092,0.8630393996247655,0.9953377607388989,1.0,1/33,0.85%,NEDD4L
prerank,histone H4 acetylation (GO:0043967),-0.21666603114341887,-0.6799909411948863,0.9441860465116279,0.9908520692990687,1.0,17/47,28.19%,LEF1;TRRAP;TRIM16;MEAF6;BRCA2;KANSL2;BEND3;NAA40;CHD5;MORF4L2;HAT1;JADE1;BRD8;EPC1;ING4;ATF2;JADE3
prerank,regulation of defense response to virus by host (GO:0050691),0.2820087205082154,0.6795812686894089,0.8593155893536122,0.9966783989986608,1.0,6/30,9.77%,PTPN22;IL4;IL12RB1;ZDHHC1;TARBP2;CGAS
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.2769351490852999,-0.6794707376124504,0.8809073724007561,0.9907701843639624,1.0,2/16,5.32%,KAT2B;NAA35
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.21057120730798753,-0.6793266626244603,0.9440559440559441,0.990350451204816,1.0,16/50,24.73%,PSME2;PSMB4;PSMD8;PSMB1;PSMD11;PSME3;ODC1;OAZ1;PSMA2;PSMD4;PSMD3;PSMB7;AZIN1;PSMC2;PSMD10;PSMC5
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3238572923991847,0.6790704352312409,0.7840172786177105,0.9966724968074431,1.0,2/10,11.97%,TARBP2;TSN
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3092313544864074,0.678699379127619,0.8152173913043478,0.9964815374496275,1.0,2/13,9.05%,YAE1;ISCA1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3087635076563743,-0.6784795868726468,0.8618042226487524,0.9905668786357678,1.0,5/10,28.28%,PDCD4;MAPK8IP1;DUSP10;HIPK3;AIDA
prerank,carbohydrate catabolic process (GO:0016052),-0.22459616112519415,-0.6784408881271198,0.9428571428571428,0.9900594477107207,1.0,12/38,28.40%,HK2;DERA;NAGA;ENO1;MANBA;MAN2C1;MAN2B2;NEU3;ALDOA;LDHA;HK1;ENO3
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2710140010064163,0.6782970606849611,0.8412408759124088,0.9963229154751366,1.0,9/30,19.68%,SLC27A2;ABCD2;SLC27A4;ACOT2;ACOX2;TECR;ELOVL6;PEX2;ELOVL2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.2732590805082727,-0.6782950368997248,0.874274661508704,0.9896408071395558,1.0,1/15,1.40%,STOX2
prerank,translational elongation (GO:0006414),-0.18749290881529662,-0.6782180915279425,0.9828571428571429,0.9891617750581113,1.0,32/101,31.06%,MRPL33;EEF1D;EEF1A1;EEF1B2;MRPS7;MRPS6;MRPS24;MRPS18A;MRPL52;CHCHD1;MRPL24;MRPL15;EEFSEC;MRPL39;MRPL46;MRPL17;MRPL12;MRPL1;MRPS26;MRPL35;GTPBP2;MRPL4;RACK1;MRPL21;MRPL54;MRPL34;MRPL50;MRPS2;MRPS23;MRPL49;EEF1A2;MRPL43
prerank,intraciliary retrograde transport (GO:0035721),0.3165729617072456,0.6781788281367137,0.7787418655097614,0.9958111786714867,1.0,1/12,2.33%,IFT43
prerank,translational termination (GO:0006415),-0.18735868847172718,-0.6779369223446058,0.9865951742627346,0.9888812553162114,1.0,29/95,29.61%,MRPL33;MRRF;MRPS7;MRPS6;MRPS24;MRPS18A;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL39;MRPL46;MTRF1L;MRPL17;MRPL12;MRPL1;MTRF1;APEH;TRMT112;MRPS26;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPL50;MRPS2;MRPS23;MRPL49
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.30721014359234955,0.6768281071269698,0.8336798336798337,0.9968558089926863,1.0,4/15,16.22%,RUVBL1;NOP10;CCT3;CCT7
prerank,cardiocyte differentiation (GO:0035051),-0.2962315583393966,-0.6767728510224861,0.8487712665406427,0.9894154846172764,1.0,3/10,16.15%,AKAP13;GATA6;KDM6B
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30698078992138644,0.676132099202248,0.8259911894273128,0.9970675830087762,1.0,2/14,4.31%,PPP3CA;PPP2R2A
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2775359564502412,-0.6757402192986445,0.8888888888888888,0.9898207940317315,1.0,6/15,29.43%,SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,regulation of protein transport (GO:0051223),-0.24181119614535634,-0.6753607258388605,0.9014084507042254,0.989606672669331,1.0,11/27,28.21%,WWP2;NDEL1;DISP1;RHBDF2;LLGL2;CHP1;ARFIP1;SNX3;LCP1;PPM1F;ATP13A2
prerank,apoptotic nuclear changes (GO:0030262),0.2809447545011978,0.6751441689966364,0.8362573099415205,0.9976509156840717,1.0,1/24,1.66%,GPER1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.28226491643892093,-0.6751159349933369,0.8768939393939394,0.9892844176204412,1.0,3/13,19.13%,GFPT2;GFPT1;UAP1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.24940028512203197,0.6750307845928304,0.8977853492333902,0.9964889867943211,1.0,14/51,20.75%,PPP2R2A;NUP43;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,mitotic nuclear membrane organization (GO:0101024),0.24940028512203197,0.6750307845928304,0.8977853492333902,0.9964889867943211,1.0,14/51,20.75%,PPP2R2A;NUP43;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.28754734210201494,0.6747113238727347,0.7931769722814499,0.9962544203223557,1.0,3/16,12.60%,FANCB;CGAS;SHLD3
prerank,mitotic nuclear division (GO:0140014),0.23236873089251414,0.6744328779079334,0.9199346405228758,0.9959296177903674,1.0,1/71,0.31%,EPS8
prerank,glycolipid biosynthetic process (GO:0009247),0.25457794665268085,0.6734226151276591,0.8811320754716981,0.996456115024187,1.0,4/38,6.24%,PIGU;ST8SIA1;PIGO;B4GALT6
prerank,protein K48-linked deubiquitination (GO:0071108),0.27613281872578516,0.6728686579886083,0.8451242829827916,0.9964712698233731,1.0,6/23,17.38%,USP25;OTUD5;OTUB1;USP50;USP33;OTUD7B
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.2965984665860959,-0.6726997827741537,0.8647619047619047,0.9909306759376231,1.0,5/11,25.20%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,establishment of mitotic spindle localization (GO:0040001),0.2762417759671159,0.67218867518986,0.8355140186915888,0.9966532320378999,1.0,10/28,17.85%,CLASP2;ITGB1;UBXN2B;NUSAP1;MAD2L1;DCTN1;HTT;NDE1;CENPA;INSC
prerank,amyloid precursor protein catabolic process (GO:0042987),0.30431264159356897,0.6711829577531745,0.8391752577319588,0.9971822898209489,1.0,3/14,13.90%,ADAM19;PSEN1;ABCA7
prerank,regulation of response to interferon-gamma (GO:0060330),-0.2804329447371169,-0.671004591380713,0.8851485148514852,0.991929323231426,1.0,4/14,20.12%,PARP9;STAT1;HSP90AB1;PTPN2
prerank,methylguanosine-cap decapping (GO:0110156),-0.3029877658797695,-0.6697185710020586,0.8731884057971014,0.9925009048652984,1.0,2/10,19.64%,EDC3;PNRC2
prerank,glucose metabolic process (GO:0006006),0.23425109268581326,0.6694920887768999,0.8987993138936535,0.9985876850643186,1.0,8/58,13.39%,PER2;PPARD;SLC25A13;TFAP2B;GOT1;ALDOC;GPI;CRY1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2414286685616123,0.6692173524640501,0.8950930626057529,0.9982678370877529,1.0,10/54,13.71%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300;CNOT10
prerank,cellular response to misfolded protein (GO:0071218),0.2865509264738774,0.6684495177531568,0.8343685300207039,0.9985157657424297,1.0,6/20,21.55%,CUL3;UGGT2;DNAJC18;TOR1A;STUB1;POMT2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.23573268918931706,-0.6683831400904977,0.9021739130434783,0.9930996611586914,1.0,9/29,22.88%,PINX1;PPIA;HSP90AB1;ANKRD28;RPA1;RAD50;RFC1;ACD;WRAP53
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2353265037931077,-0.667858468708322,0.9185336048879837,0.9924404711897372,1.0,10/29,26.95%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2353265037931077,-0.667858468708322,0.9185336048879837,0.9924404711897372,1.0,10/29,26.95%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,regulation of mRNA processing (GO:0050684),0.2695518333368743,0.667529082669978,0.8653465346534653,0.998956799599691,1.0,8/32,18.20%,PTCD2;SRPK3;PAPOLA;KHDRBS2;YTHDC1;SAFB2;QKI;LARP7
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.27949342189842685,-0.6655636212366434,0.8979591836734694,0.9938105960010094,1.0,6/13,30.28%,SDAD1;RAN;RPS15;NUP88;RRS1;LSG1
prerank,nuclear pore complex assembly (GO:0051292),-0.3062206359388193,-0.6649591568702331,0.8958333333333334,0.9937895473062714,1.0,9/10,48.91%,NUP98;TPR;NUP153;NUP107;RTN4;NUP93;TMEM170A;AHCTF1;NUP205
prerank,regulation of leukocyte activation (GO:0002694),0.29415819638891916,0.6649538989431495,0.8283261802575107,1.0,1.0,2/14,9.19%,GPER1;LYN
prerank,ESCRT complex disassembly (GO:1904896),0.31805566395146445,0.6646371337798386,0.8166666666666667,1.0,1.0,2/10,18.98%,CHMP2B;VTA1
prerank,ESCRT III complex disassembly (GO:1904903),0.31805566395146445,0.6646371337798386,0.8166666666666667,1.0,1.0,2/10,18.98%,CHMP2B;VTA1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3133354086895341,0.6645572482329767,0.8177874186550976,0.9998565824575505,1.0,2/12,6.72%,ABCD2;IRS1
prerank,ureteric bud morphogenesis (GO:0060675),-0.26105540237429237,-0.6644504683478907,0.8742857142857143,0.9936341915024902,1.0,2/16,6.19%,BMP4;SIX1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.30725478095393477,0.6640907482952829,0.8363228699551569,0.9997612405355588,1.0,4/12,13.69%,RLIM;YTHDC1;RBM15;HNRNPU
prerank,dopaminergic neuron differentiation (GO:0071542),-0.2531430709937079,-0.6639581454307552,0.8911290322580645,0.9935067199936988,1.0,8/19,36.46%,LRP6;NR4A2;LMX1B;VEGFA;CTNNB1;LMX1A;WNT2;SHH
prerank,glycerophospholipid catabolic process (GO:0046475),-0.23834301255818668,-0.663810891976394,0.925,0.9930956353465024,1.0,4/27,13.37%,PLA2G4A;PLA2G6;PLA2G15;ABHD16A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.22287723811661472,-0.6636891450864425,0.9326086956521739,0.9926444003964643,1.0,6/34,16.00%,LGR4;MFHAS1;DAB2IP;IRAK3;TICAM1;TLR4
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2405163468179075,-0.6634173429777424,0.9053497942386831,0.9923135547772759,1.0,10/25,31.31%,HSPA5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,negative regulation of cilium assembly (GO:1902018),-0.2836054384632198,-0.6633023281677907,0.8592321755027422,0.9918527973162912,1.0,3/12,13.59%,LIMK2;YAP1;TCHP
prerank,regulation of type I interferon production (GO:0032479),-0.19033099188731215,-0.6625723738446256,0.9805555555555555,0.9918967761149916,1.0,35/84,38.14%,IRF1;IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;LRRFIP1;POLR2F;RELA;POLR3GL;G3BP1;POLR2E;UBA7;NPLOC4;UBE2L6;RNF216;POLR3D;MYD88;POLA1;CTNNB1;TAX1BP1;POLR1C;ISG15;ZBP1;RNF26;PQBP1;TRIM21;ITCH;POLR3A;DDX41;CYLD;IRF5;STAT6;CD14
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25998775484553793,-0.66243599126883,0.8685714285714285,0.9914588498596876,1.0,1/17,1.18%,NSA2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.192824475720871,-0.6620038919429395,0.9785202863961814,0.9912434881724407,1.0,19/73,24.74%,YAP1;LMO2;FOXC1;GATA2;PSME2;PSMB4;TAL1;PSMD8;PSMB1;PSMD11;PSME3;PSMA2;PSMD4;PSMD3;PSMB7;PSMC2;PSMD10;PSMC5;CBFB
prerank,cellular response to superoxide (GO:0071451),-0.30209293699216183,-0.6613644553620139,0.8763837638376384,0.9912067913450932,1.0,6/10,27.57%,NOS3;PRDX2;ADPRS;MT3;SOD2;PRDX1
prerank,response to peptide (GO:1901652),-0.22054921883795306,-0.6613270693229395,0.9498956158663883,0.9906976481250874,1.0,9/33,24.41%,ANXA1;STAT2;STAT1;STAT3;EIF2B2;MMP2;ERBIN;GNAI1;EIF2B5
prerank,miRNA mediated inhibition of translation (GO:0035278),0.31248145292874735,0.6608935063551419,0.8148893360160966,1.0,1.0,3/11,11.51%,AGO3;TNRC6C;EIF6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.31248145292874735,0.6608935063551419,0.8148893360160966,1.0,1.0,3/11,11.51%,AGO3;TNRC6C;EIF6
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2695140424036802,0.6608691691531542,0.858252427184466,1.0,1.0,4/25,12.59%,GPER1;CIDEB;FAM162A;MFF
prerank,regulation of synapse maturation (GO:0090128),0.319581279818129,0.660804946597992,0.8291139240506329,1.0,1.0,3/10,13.46%,NRXN1;YWHAZ;ANAPC2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.24678245664634987,-0.6607562319616334,0.9027777777777778,0.9906098408737607,1.0,12/21,40.30%,ZW10;ATM;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;CDC20;BUB1;KLHL22
prerank,regulation of transposition (GO:0010528),-0.2803698313956621,-0.6605396742788735,0.8868274582560297,0.9902735953629961,1.0,7/13,42.56%,SIRT7;SMYD5;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.22827414963559556,-0.6604003049953511,0.9348739495798319,0.989852062482354,1.0,8/28,24.94%,BAG3;TNFRSF1A;DAB2IP;CASP8;BID;DEDD;DEDD2;CRADD
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2273866853328847,0.6597510390166603,0.9168026101141925,1.0,1.0,13/72,13.71%,RGCC;TNKS1BP1;FOXM1;CNOT2;SOX4;CDKN1A;MYO6;CNOT9;CNOT4;PRMT1;EP300;RPS6KA6;CNOT10
prerank,negative regulation of double-strand break repair (GO:2000780),0.2613252498244043,0.6582169253254626,0.8653465346534653,1.0,1.0,9/30,23.43%,FANCB;CGAS;AUNIP;OTUB1;SHLD3;HSF1;HMGA2;FBH1;NUDT16L1
prerank,negative regulation of histone modification (GO:0031057),-0.2767335577458087,-0.6576100788178897,0.8878143133462283,0.9915112616605264,1.0,6/14,28.66%,JARID2;CTBP1;BRCA1;AASS;TWIST1;SPHK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2795326818862812,0.6569576105298882,0.8702594810379242,1.0,1.0,8/22,20.72%,RBX1;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3188116544156037,0.6565344820126693,0.8395604395604396,1.0,1.0,1/10,3.66%,ATP7A
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2849654651376264,0.6560612548347593,0.8369781312127237,1.0,1.0,2/18,5.44%,NF1;CD300A
prerank,presynapse organization (GO:0099172),0.3117772056303736,0.6560451136605949,0.8175965665236051,1.0,1.0,1/10,2.49%,LRRTM3
prerank,regulation of defense response to virus (GO:0050688),-0.2682852684379581,-0.6553006278565224,0.906764168190128,0.9927163984582629,1.0,8/14,37.93%,PCBP2;PPM1B;ELMOD2;RNF216;RNF26;IFNLR1;ITCH;ZMPSTE24
prerank,mRNA metabolic process (GO:0016071),0.2174020708327632,0.6549691753558313,0.9498432601880877,1.0,1.0,25/90,21.42%,DHX15;LSM3;NCBP2;PCBP3;AGO3;LSM10;HNRNPR;SFPQ;CPSF6;TCERG1;SSB;YTHDF2;CELF1;RNH1;CNOT10;DIS3L2;KIN;LSM2;SNRPD3;HSF1;HNRNPA2B1;LSM6;SRSF9;SRRM4;PTBP1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.2837164162149789,-0.6546454192620182,0.8672897196261682,0.9926827034904044,1.0,3/11,15.05%,SETD1B;TET3;BEND3
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.2884637149300957,-0.6538612795265752,0.8766355140186916,0.9927448914343323,1.0,5/10,35.77%,NAF1;RPUSD4;NHP2;RPUSD2;RPUSD3
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2202561093870352,-0.6537539567872378,0.9445628997867804,0.9923054660672046,1.0,5/33,16.00%,IRF1;OAS2;RNF135;MAVS;TLR4
prerank,tRNA metabolic process (GO:0006399),0.28638106106447825,0.6536934403215914,0.8491735537190083,1.0,1.0,9/17,26.55%,SSB;DARS2;ADAT1;AARS1;POP7;POP5;FARS2;RPP30;DTD1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3086147200924984,0.6535766567331662,0.8364779874213837,1.0,1.0,3/11,17.17%,CCT3;CCT7;TERF1
prerank,axonal transport of mitochondrion (GO:0019896),-0.2862195312526748,-0.6535428010205467,0.8836772983114447,0.991925061895226,1.0,3/11,17.83%,HIF1A;SPAST;ACTR10
prerank,pre-miRNA processing (GO:0031054),-0.273669341755113,-0.6535269132991023,0.8978102189781022,0.9913969658707225,1.0,4/14,21.16%,TUT4;TUT7;AGO1;DICER1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.2742401622232522,-0.6530950258442448,0.8841698841698842,0.991198998331406,1.0,3/13,14.33%,SLC4A10;RAB3GAP1;SHISA7
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3074595349016019,0.6529806863207583,0.8351648351648352,1.0,1.0,1/11,6.49%,LPO
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.28442248431518513,-0.6522809383028969,0.8966165413533834,0.9912703472166198,1.0,5/10,28.31%,PARP14;PTPN2;PIBF1;INPP5F;SOCS1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2043085033078148,-0.6516622683010456,0.9658536585365853,0.9906830142309441,1.0,17/50,29.19%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;NUP88;AGO1;NUP214;POLR2G;NUP37;NUP155;NUP62;AGO2
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2043085033078148,-0.6516622683010456,0.9658536585365853,0.9906830142309441,1.0,17/50,29.19%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;NUP88;AGO1;NUP214;POLR2G;NUP37;NUP155;NUP62;AGO2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.1872487063670748,0.6513592578691203,0.9973614775725593,1.0,1.0,80/264,25.28%,SRPK3;DHX15;CLP1;LSM3;NCBP2;RBM14;SART3;CACTIN;HNRNPR;SFPQ;SRRM1;RNPS1;PAPOLA;POLR2C;CRNKL1;SNRNP25;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;CLNS1A;PPIH;SPEN;RBM15;SCNM1;HNRNPA1;HNRNPUL1;DDX46;PRMT7;DDX23;LSM8;UPF3B;HNRNPU;HNRNPC;HNRNPH2;COIL;PRPF31;SF3B3;ELAVL2;LSM2;SNRPD3;CDK13;RBM19;HNRNPD;CPSF7;FUS;HNRNPA2B1;POLR2D;RBMX;SNRNP48;PNN;CWC27;LSM6;SRSF9;PTBP1;PPIL3;SRSF12;DDX1;DDX42;PABPC1;CWF19L2;GTF2F2;SMNDC1;HNRNPK;DHX35;POLR2L;DHX16;EFTUD2;EIF4A3;SRSF4;SF3B2;SF3B1;POLR2H;CTNNBL1;CASC3;RSRC1;POLR2J
prerank,miRNA metabolic process (GO:0010586),-0.2505361059448693,-0.651127431315098,0.9126984126984127,0.9905588039774335,1.0,8/20,32.93%,TUT4;TUT7;RAN;TENT4B;DICER1;AGO2;XPO5;BCDIN3D
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2547620920009972,-0.6506972129983486,0.8906560636182903,0.9903612202554292,1.0,5/18,29.57%,SIRT7;UBTF;LYAR;EIF2AK3;RASL11A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.22989786408843232,-0.6506244009615965,0.9301848049281314,0.9898748347478077,1.0,7/29,20.08%,COPZ2;TRAPPC10;COPA;TRAPPC3;NAPA;RAB6A;COPB1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2935422021564035,0.6505067494284704,0.8502109704641351,1.0,1.0,3/12,13.79%,ADSL;PPAT;IMPDH2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2928254249046849,0.649368098835659,0.8427672955974843,1.0,1.0,3/14,13.06%,SLC25A33;TFAM;FASTKD1
prerank,nuclear transport (GO:0051169),-0.2642829902095658,-0.6491859158067168,0.9135338345864662,0.9904084799846167,1.0,6/16,32.15%,NUP98;NXT2;PSIP1;NXT1;ANP32A;RBM15B
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.22671117383950046,-0.648984817589818,0.9267326732673268,0.9900147864435073,1.0,7/28,20.92%,OCLN;AKAP9;GIT1;MET;TOGARAM1;FES;NUMA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2857700354121102,0.6489172785731541,0.8641188959660298,1.0,1.0,9/21,20.72%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2857700354121102,0.6489172785731541,0.8641188959660298,1.0,1.0,9/21,20.72%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24023287767450485,0.6486828988825246,0.9081272084805654,1.0,1.0,10/48,11.97%,NOA1;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;NDC1;EIF6;EP300
prerank,pseudouridine synthesis (GO:0001522),0.30217809710249843,0.6486648578393828,0.83125,1.0,1.0,3/13,14.25%,TRUB1;NOP10;PUS7
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21332187623344778,0.6482175367321916,0.9678899082568807,1.0,1.0,23/105,20.74%,BTRC;CLEC10A;FFAR2;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMB8;PSMA1;PSMA5;PSMD13;CREBBP;PSMB2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2933881651070286,-0.6481944551460148,0.8921389396709324,0.9901149582306241,1.0,3/10,15.51%,DNAJB2;DNAJB6;DNAJA4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.28561449771199227,0.647869600034928,0.8413361169102297,1.0,1.0,4/16,11.56%,ACKR3;CCAR2;SNAI2;SFRP2
prerank,negative regulation of histone acetylation (GO:0035067),0.2957465827358329,0.6469692745026588,0.8425720620842572,1.0,1.0,2/11,12.93%,SNCA;SET
prerank,organophosphate biosynthetic process (GO:0090407),0.24906658699455755,0.6467442511648535,0.8974820143884892,1.0,1.0,8/37,17.46%,FGF2;ITPKB;TPK1;GK;IPMK;LPCAT1;IPPK;PIP5K1A
prerank,isotype switching (GO:0045190),0.30812861827925353,0.6462227609876068,0.8516260162601627,1.0,1.0,1/10,7.07%,LIG4
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2775324273350487,0.6459548213860287,0.8674463937621832,1.0,1.0,5/24,9.77%,PTPN22;IL4;IL12RB1;ZDHHC1;CGAS
prerank,acetyl-CoA metabolic process (GO:0006084),-0.26217445678122786,-0.6459507613079754,0.9092702169625246,0.9912365064820063,1.0,3/15,18.61%,HMGCS2;ACACA;ACACB
prerank,negative regulation of cell communication (GO:0010648),0.2601646703804902,0.6443992447938512,0.8679245283018868,1.0,1.0,2/21,5.07%,IL1B;SOCS5
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3010917426890011,0.6440968836346062,0.8427672955974843,1.0,1.0,5/13,27.10%,ALG12;ALG1;ALG11;DPAGT1;MPDU1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.18890795270666877,-0.6437466560569496,0.9925187032418953,0.9923126381655317,1.0,18/69,23.20%,STT3B;RNF103;AMFR;HSPA5;RNF185;UBXN4;UBE4B;DNAJB2;EDEM2;UBE2G2;ERLIN2;DNAJC10;NPLOC4;HSP90B1;VCP;SEC61B;FBXO17;DNAJB12
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.22644736578304342,0.6436731967604434,0.9365351629502573,1.0,1.0,7/69,12.28%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COA6;COX5A
prerank,mitochondrial translational termination (GO:0070126),-0.18050099619576473,-0.6436492549987309,0.9836512261580381,0.9918431156442543,1.0,27/88,29.61%,MRPL33;MRRF;MRPS7;MRPS6;MRPS24;MRPS18A;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL39;MRPL46;MTRF1L;MRPL17;MRPL12;MRPL1;MTRF1;MRPS26;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPL50;MRPS2;MRPS23;MRPL49
prerank,vasodilation (GO:0042311),0.29424763908829765,0.643142723853832,0.860125260960334,1.0,1.0,1/13,1.66%,GPER1
prerank,positive regulation of histone acetylation (GO:0035066),0.27427212499510856,0.6426036844891165,0.8792079207920792,1.0,1.0,4/23,10.82%,IL1B;RPS6KA4;KAT7;GLYR1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.21330915308387732,0.6423532464623547,0.9514563106796117,1.0,1.0,5/87,5.26%,SLC25A33;IMMP2L;COX18;UQCRFS1;NDUFB2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3060709573325553,0.6422885503179775,0.8459821428571429,1.0,1.0,2/10,12.93%,SNCA;SET
prerank,phospholipid catabolic process (GO:0009395),-0.2356470908331502,-0.6421621113001572,0.9109311740890689,0.9923207396535568,1.0,12/24,40.26%,PLA2G4A;SMPDL3A;ENPP2;GDPD3;PLBD2;PLA2G4F;SMPD1;ANGPTL3;ABHD12;GDE1;PLBD1;PNPLA6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2549664369376527,0.6417056867402938,0.8895027624309392,1.0,1.0,14/30,23.51%,GNL3L;CDKN1A;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;CERS1;CTC1;DACH1;EXOSC10
prerank,spindle assembly (GO:0051225),0.22444361990615647,0.6410094849379245,0.9363166953528399,1.0,1.0,9/67,14.06%,STARD9;TNKS;CLASP2;MAPRE2;NEK6;TOGARAM2;MZT1;LSM14A;KIFC2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2864600375730637,0.6405813236158768,0.8535031847133758,1.0,1.0,2/14,7.37%,NCBP2;CPSF6
prerank,vitamin D metabolic process (GO:0042359),-0.2729137069653709,-0.6403923765530237,0.9007633587786259,0.9930330200542948,1.0,8/13,50.84%,CUBN;PIAS4;CYP2R1;VDR;CYP1A1;CYP24A1;FGF23;CYP27B1
prerank,histone ubiquitination (GO:0016574),0.2688476075199191,0.6402018679327153,0.8662790697674418,1.0,1.0,7/21,22.22%,PHC1;UBE2E1;UBR2;CTR9;UBE2B;HUWE1;UBE2A
prerank,tetrapyrrole metabolic process (GO:0033013),0.27965125395071505,0.6394653252465151,0.8486707566462167,1.0,1.0,3/18,14.24%,MMADHC;MMAB;LMBRD1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.30087316963270916,0.6381674960859476,0.8568507157464212,1.0,1.0,3/11,10.35%,P4HA1;P3H2;P4HTM
prerank,positive regulation of type I interferon production (GO:0032481),-0.1856856851163584,-0.6373191569519805,0.9836956521739131,0.9946490628159219,1.0,12/73,16.99%,IRF1;STAT1;OAS2;RNF135;MAVS;LRRFIP1;POLR2F;RELA;POLR3GL;G3BP1;TLR4;POLR2E
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.2640656925028354,0.6371860439276579,0.871900826446281,1.0,1.0,6/25,16.77%,SRRM1;PRPF6;DDX23;SF3B3;LSM1;KHSRP
prerank,RNA stabilization (GO:0043489),-0.22016835523909778,-0.6366686074320514,0.9290322580645162,0.99455008978881,1.0,9/33,20.00%,THRAP3;NOCT;NAF1;TENT5A;LARP1;ZCCHC17;ELAVL1;TENT5C;E2F1
prerank,DNA duplex unwinding (GO:0032508),-0.19880065180306938,-0.6363099375481625,0.9836065573770492,0.9942454033711177,1.0,14/50,24.83%,ASCC3;ANXA1;SSBP1;CUL4A;UBB;RPA1;RAD50;DDB1;MCMDC2;RECQL;CETN2;RAD51;ERCC2;ERCC3
prerank,peptide hormone secretion (GO:0030072),-0.22495542393061518,-0.6359269440517833,0.9510357815442562,0.9939790500294649,1.0,2/26,4.23%,ANXA1;LTBP4
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.26735978491155327,-0.6359217226287671,0.9116022099447514,0.9934464891639294,1.0,5/13,27.29%,UPP2;TDG;NT5C;NEIL1;NTHL1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2243482374330839,0.6357379711228168,0.9390444810543658,1.0,1.0,11/63,13.71%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300;PRKDC;CNOT10
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2578546390582063,0.6351528612297501,0.8949416342412452,1.0,1.0,6/25,18.39%,HEXIM1;TCERG1;HNRNPU;EAF2;LARP7;CDK13
prerank,purine-containing compound salvage (GO:0043101),0.2871400993099199,0.6349965563975499,0.8592436974789915,1.0,1.0,2/12,7.94%,ADK;DCK
prerank,intracellular pH reduction (GO:0051452),0.2487473751613109,0.6315726513840287,0.8962818003913894,1.0,1.0,6/33,10.45%,GPR89A;GPR89B;DMXL1;ATP6V0E2;RAB38;ATP6V1B2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.29110840959323525,0.6296088687779767,0.842741935483871,1.0,1.0,4/13,18.25%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,maturation of LSU-rRNA (GO:0000470),-0.2237178164226072,-0.6290917133254276,0.948936170212766,0.997585283314633,1.0,9/26,31.23%,NSA2;RPL7;RPL10A;FTSJ3;MRPL1;NHP2;MAK16;RPF1;URB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.2759351147644077,0.6290240984262144,0.89587852494577,1.0,1.0,2/18,3.35%,NRXN1;CACNG7
prerank,negative regulation of phosphatase activity (GO:0010923),-0.22706698268155315,-0.6285513367629337,0.9371069182389937,0.997407905913846,1.0,6/25,23.05%,PTPA;FKBP1A;SH3RF2;TIPRL;CHP1;SH2D4A
prerank,response to UV-B (GO:0010224),-0.27258577785735505,-0.6280905041458911,0.8951310861423221,0.9971753391696477,1.0,4/12,24.31%,MFAP4;RELA;CRIP1;STK11
prerank,negative regulation of ATPase activity (GO:0032780),-0.24810116204646665,-0.6271257326046709,0.9186507936507936,0.9972979856416374,1.0,7/16,38.93%,PXK;IFIT1;PLN;TP53;TNNI3;PPIF;VCPKMT
prerank,glycerolipid catabolic process (GO:0046503),-0.24404305424478862,-0.6266849059763893,0.9454545454545454,0.9970537013689565,1.0,1/19,1.13%,PLA2G4A
prerank,regulation of microtubule polymerization (GO:0031113),0.2415059930637699,0.6266594220227212,0.9064220183486239,1.0,1.0,8/40,14.71%,MAP2;NAV3;SNCA;CAMSAP3;PAK1;TUBB4A;DCTN1;PSRC1
prerank,protein autoprocessing (GO:0016540),-0.24985263505971186,-0.6261149320862214,0.9226305609284333,0.9968848026256851,1.0,3/17,17.29%,CASP4;AFG3L2;MYRF
prerank,transcription preinitiation complex assembly (GO:0070897),0.29666381531536307,0.6257542593933592,0.867237687366167,1.0,1.0,5/12,21.48%,POLR1E;TBP;TAF7L;DR1;TAF7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.21496346442563827,0.6256881372268569,0.9675213675213675,1.0,1.0,17/68,20.30%,CLP1;NCBP2;LSM10;PAPOLA;POLR1E;TBP;SYMPK;POLR1A;CCNH;GTF2H5;GTF2H1;SNRPD3;POLR1B;CPSF7;MED18;GTF2H4;TAF1D
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.24637421696075346,-0.6249926105701937,0.91875,0.9971269399555301,1.0,11/18,47.60%,SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4;OFD1;NPHP3;DNAAF1;ADCY10
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2662826899040258,-0.6249669963812251,0.927734375,0.9966093835745538,1.0,1/12,2.34%,HDAC8
prerank,snRNA metabolic process (GO:0016073),0.2713250056902421,0.6249234478791584,0.8648648648648649,1.0,1.0,3/17,14.28%,RBM7;INTS1;INTS12
prerank,determination of left/right symmetry (GO:0007368),0.23959687649876166,0.6248892881423866,0.9293286219081273,1.0,1.0,3/36,10.66%,NOTCH1;PKD2;CITED2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2097938556346509,-0.6247003844215168,0.9719222462203023,0.9962447871245761,1.0,13/35,30.76%,PDCD6IP;PARP3;CHMP4B;TPR;DYNC1H1;NUMA1;GNAI1;TPX2;CHMP5;HSPA1B;NUP62;FSD1;CCSAP
prerank,potassium ion export across plasma membrane (GO:0097623),0.2912992135018224,0.6240366563862082,0.8607594936708861,1.0,1.0,2/13,7.85%,KCNE4;KCNE5
prerank,maturation of SSU-rRNA (GO:0030490),-0.2081870679924706,-0.6235924997405055,0.9578947368421052,0.9964568931804393,1.0,5/34,12.55%,RPS14;RPS19;RPS8;RPS16;UTP6
prerank,regulation of phospholipase activity (GO:0010517),-0.2812859939977257,-0.6232677994681294,0.9188679245283019,0.9961515076715964,1.0,1/10,3.01%,FGFR2
prerank,mRNA processing (GO:0006397),0.1801362511359703,0.6228391629478603,1.0,1.0,1.0,88/287,25.09%,DHX15;CLP1;LSM3;NCBP2;RBM14;SART3;CACTIN;HNRNPR;SFPQ;SRRM1;RNPS1;PAPOLA;CPSF6;TCERG1;POLR2C;CRNKL1;SNRNP25;TRA2A;PRPF6;RNMT;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;RPRD1B;SPEN;RBM15;HNRNPA1;HNRNPUL1;CELF1;DDX46;DDX23;LSM8;UPF3B;HNRNPU;CCNH;GTF2H5;HNRNPC;HNRNPH2;GTF2H1;KIN;PRPF31;SF3B3;ELAVL2;ZC3H11A;LSM2;SNRPD3;RBM19;HNRNPD;CPSF7;FUS;HNRNPA2B1;POLR2D;RBMX;SNRNP48;PNN;GTF2H4;CWC27;LSM6;POLDIP3;RNGTT;SRSF9;SRRM4;PTBP1;PPIL3;SRSF12;AKAP8L;DDX42;PABPC1;CWF19L2;GTF2F2;THOC2;SMNDC1;HNRNPK;DHX35;POLR2L;DHX16;EFTUD2;EIF4A3;SRSF4;SF3B2;SF3B1;POLR2H;CTNNBL1;CASC3;RSRC1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2726664724731536,-0.6228311381512182,0.9055555555555556,0.995885387618005,1.0,4/11,27.86%,KAT2B;CCNF;BRCA1;CENATAC
prerank,phasic smooth muscle contraction (GO:0014821),-0.281034492686842,-0.6219732942770567,0.9023508137432188,0.9958698248893605,1.0,6/10,45.25%,EDN3;GDNF;EDNRB;EDN1;TIFAB;HTR1D
prerank,megakaryocyte differentiation (GO:0030219),0.28809869064910115,0.6214203362750452,0.8561320754716981,1.0,1.0,2/11,9.48%,SH2B3;MED1
prerank,negative regulation of cell cycle process (GO:0010948),0.22193581218949185,0.6212411128232717,0.9527687296416938,1.0,1.0,6/61,6.52%,GPER1;CBX5;PHC3;RYBP;PHC1;CBX3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.2707638378651355,-0.6208090742698877,0.9185185185185185,0.9960756938369704,1.0,2/11,13.16%,MFHAS1;CYBA
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2659639161646812,-0.6204294294773098,0.9182608695652174,0.9957849203260459,1.0,1/13,5.24%,ADHFE1
prerank,autophagosome assembly (GO:0000045),-0.19011378437275903,-0.6201227065012916,0.9901234567901235,0.9954352768796193,1.0,14/52,27.16%,WIPI2;SMURF1;IRGM;BECN1;ULK2;RAB7A;ATG2A;GABARAPL1;ATG101;EMC6;ATG12;ATG7;STX17;RAB19
prerank,fatty acid biosynthetic process (GO:0006633),-0.18034690526859132,-0.6200957421588282,0.9851116625310173,0.9949187171432508,1.0,13/63,23.52%,ELOVL7;HACD4;HACD3;GPX4;ACACA;PTGS2;EPHX2;ELOVL1;ALOX12;HSD17B8;XBP1;LPL;OXSM
prerank,establishment of spindle localization (GO:0051293),0.27873336447192265,0.6200453154813125,0.8794178794178794,1.0,1.0,2/14,10.38%,CLASP2;NUSAP1
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.17904121983100565,-0.6190218997942104,0.9913294797687862,0.9950356798022109,1.0,23/80,28.74%,CAV1;ANGPT1;SMAD7;LRRK2;FKBP1A;BIRC3;PHF23;FANCI;UBB;SPHK1;SPSB4;ARRDC4;CDK5RAP3;FAM107A;BRCA1;PSMD10;CENPX;BCL10;FANCM;PTTG1IP;TRIB3;RPS2;LAPTM5
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.27536116717154935,-0.6186887306712439,0.9083969465648855,0.9947114641820906,1.0,5/11,29.01%,TIMM13;TIMM8B;TIMM9;NDUFA13;TIMM10
prerank,regulation of viral life cycle (GO:1903900),0.2602858453268151,0.618653612835134,0.8671726755218216,1.0,1.0,2/21,5.31%,AXL;TRIM62
prerank,acylglycerol catabolic process (GO:0046464),0.2514882646102825,0.6182141443091131,0.904,1.0,1.0,3/30,6.99%,FABP3;LIPC;LIPH
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.18024176043639786,0.6180137107002905,1.0,1.0,1.0,73/241,25.28%,DHX15;CLP1;LSM3;NCBP2;RBM14;SART3;CACTIN;HNRNPR;SFPQ;SRRM1;RNPS1;PAPOLA;POLR2C;CRNKL1;SNRNP25;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;SPEN;RBM15;HNRNPA1;HNRNPUL1;DDX46;DDX23;LSM8;UPF3B;HNRNPU;HNRNPC;HNRNPH2;PRPF31;SF3B3;ELAVL2;LSM2;SNRPD3;RBM19;HNRNPD;CPSF7;FUS;HNRNPA2B1;POLR2D;RBMX;SNRNP48;PNN;CWC27;LSM6;SRSF9;PTBP1;PPIL3;SRSF12;DDX42;PABPC1;CWF19L2;GTF2F2;SMNDC1;HNRNPK;DHX35;POLR2L;DHX16;EFTUD2;EIF4A3;SRSF4;SF3B2;SF3B1;POLR2H;CTNNBL1;CASC3;RSRC1;POLR2J
prerank,positive regulation of histone modification (GO:0031058),-0.21331534258234358,-0.6174291075479044,0.9623893805309734,0.9949351874220368,1.0,8/33,18.35%,ARRB1;BRD7;SAP30BP;TADA2A;MAPK3;CDK9;NOS1;PPARGC1A
prerank,regulation of cellular response to heat (GO:1900034),-0.1770346887829885,-0.6167097383954565,0.9891304347826086,0.9948045358437827,1.0,26/77,29.71%,CD34;HSPB8;BAG3;FKBP4;CAMK2A;ATM;DNAJB6;HSP90AB1;MAPK3;RPA1;NUP98;TPR;NUP88;NUP214;BAG2;RPA3;NUP37;DNAJC2;YWHAE;BAG5;NUP155;HSPH1;HSPA1B;NUP62;BAG1;RPTOR
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.28922191435114547,0.6165081677262338,0.8449438202247191,1.0,1.0,4/11,16.94%,MTOR;NOL11;IPPK;DDX11
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2512359779297685,-0.6163191001366136,0.9239766081871345,0.9945149252754666,1.0,9/16,36.36%,PIGN;PIGL;PIGW;PIGB;PIGC;PIGA;PIGG;PIGV;DPM2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.2711666653004027,0.6162456220682263,0.8650306748466258,1.0,1.0,7/15,22.58%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.2711666653004027,0.6162456220682263,0.8650306748466258,1.0,1.0,7/15,22.58%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,regulation of chromosome organization (GO:0033044),0.25711334431792715,0.6160766225923723,0.8941398865784499,1.0,1.0,7/22,18.69%,LIG4;SETMAR;WAPL;RB1;SHCBP1L;PIF1;HNRNPD
prerank,establishment of spindle orientation (GO:0051294),-0.2171200111714806,-0.6159907652008574,0.9529914529914529,0.9941785737312373,1.0,9/28,28.41%,GJA1;NDEL1;FBXW11;ZW10;LLGL2;NUMA1;PAFAH1B1;MISP;NDC80
prerank,mitochondrial fission (GO:0000266),0.2634618159017793,0.6159619712381613,0.8723404255319149,1.0,1.0,5/16,16.71%,MTFP1;MFF;MTFR1;MIEF1;DNM1
prerank,protein localization to synapse (GO:0035418),0.27757954208524904,0.6156313610031771,0.841541755888651,1.0,1.0,2/12,12.88%,NRXN1;NPHS1
prerank,negative regulation of transferase activity (GO:0051348),-0.2187929995081895,-0.6156147951039476,0.964509394572025,0.9938782939888464,1.0,13/28,31.56%,SMAD7;DTX3L;PINX1;EIF4A2;CDKN1B;PARK7;CDKN1C;INPP5K;TP53;BAG5;ABL1;ZFP36;IRS2
prerank,hexose biosynthetic process (GO:0019319),0.22899436956126634,0.615583040880736,0.9197860962566845,1.0,1.0,7/42,15.62%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,indolalkylamine catabolic process (GO:0046218),-0.27955221058885527,-0.6155183056167336,0.906764168190128,0.9934075902133634,1.0,9/10,56.89%,KYNU;IL4I1;HAAO;AADAT;KYAT1;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.2878420516097668,0.6152873166796339,0.8662420382165605,1.0,1.0,2/11,12.47%,AKAP6;RNF207
prerank,divalent inorganic cation homeostasis (GO:0072507),0.24782484929256257,0.615138881605784,0.8991935483870968,1.0,1.0,4/25,12.06%,TFAP2B;ANK3;SNCA;FAM20A
prerank,kinetochore organization (GO:0051383),-0.2564787566852397,-0.6148418309168883,0.9332096474953617,0.9932917721732317,1.0,8/13,36.06%,CENPC;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2
prerank,retrograde axonal transport (GO:0008090),0.2813750939031544,0.6142617231608466,0.8781431334622823,1.0,1.0,7/16,22.73%,TMEM108;DLG2;HAP1;DST;KIF1A;NEFL;SOD1
prerank,nuclear body organization (GO:0030575),0.28848202521472793,0.6138330693294667,0.8764044943820225,1.0,1.0,3/12,13.13%,ETS1;DYRK3;USP50
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.28592857883999045,-0.6138211422905816,0.926605504587156,0.9933834849335145,1.0,3/10,24.85%,LGALS9;CD274;SCRIB
prerank,cellular response to amino acid starvation (GO:0034198),0.21384950676758122,0.6134866624103683,0.9627118644067797,1.0,1.0,13/71,17.28%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,oligodendrocyte differentiation (GO:0048709),-0.23595267845379952,-0.6134425075014762,0.9412844036697248,0.9930729780643526,1.0,7/19,28.15%,SLC8A3;SOX13;EIF2B2;MYRF;EIF2B5;EIF2B4;SOX10
prerank,organophosphate catabolic process (GO:0046434),-0.27265712366791534,-0.6133789500271741,0.907942238267148,0.9925775777072661,1.0,7/11,47.70%,ENPP2;PLBD2;ANGPTL3;ABHD12;PLBD1;PDXP;PON1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.25502563869503836,-0.612668090530967,0.9378531073446328,0.9924571045402649,1.0,2/15,10.02%,USP46;NLGN2
prerank,lipoprotein localization (GO:0044872),0.297551622012227,0.6126019940001378,0.8580246913580247,1.0,1.0,3/11,13.63%,MIA3;ZDHHC17;VMP1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.28564985342222377,0.6125464515973428,0.89171974522293,1.0,1.0,3/11,9.84%,TPK1;DCK;DCTD
prerank,regulation of exit from mitosis (GO:0007096),0.2316685685156694,0.6092269462980345,0.8994614003590664,1.0,1.0,6/38,14.19%,RGCC;UBE2E1;CDC14B;ANAPC2;MAD2L1;ANAPC7
prerank,serine family amino acid catabolic process (GO:0009071),0.2960370192884143,0.6090232296539412,0.8475750577367206,1.0,1.0,3/10,15.69%,GCSH;DAO;DLD
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2648019617682519,0.6089046251748329,0.9087301587301587,1.0,1.0,4/19,11.97%,CDIP1;DDIT4;HIPK1;EP300
prerank,RNA splicing (GO:0008380),0.20039737541629893,0.6079833773867499,0.9824281150159745,1.0,1.0,34/95,26.21%,DHX15;NCBP2;SFPQ;SRRM1;RNPS1;TCERG1;SNRNP25;CCAR2;PRPF6;DDX47;SCNM1;DDX23;HNRNPC;SF3B3;LSM1;KHSRP;SNRPD3;USB1;FUS;SNRNP48;LSM6;LUC7L3;PPP2R1A;PTBP1;SMNDC1;NOL3;DHX16;SRSF4;SF3B2;SF3B1;RSRC1;SNRNP35;TARDBP;ZCRB1
prerank,lipoprotein transport (GO:0042953),0.30011892210270213,0.6075519148960885,0.8765432098765432,1.0,1.0,3/10,13.63%,MIA3;ZDHHC17;VMP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.20561618565531808,-0.6068335632131107,0.9557522123893806,0.9951607849181777,1.0,9/32,26.45%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.26343223580248476,0.6064397179146667,0.886,1.0,1.0,3/16,9.66%,MEIOB;ERCC4;HFM1
prerank,aerobic electron transport chain (GO:0019646),0.21482095538800006,0.6064343107575102,0.9568965517241379,1.0,1.0,3/68,5.26%,COX4I2;UQCRFS1;NDUFB2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2497630631654191,-0.6054119631804492,0.9230769230769231,0.9954397510603139,1.0,7/15,30.86%,RAB3GAP1;SPCS1;RAB3GAP2;SEC61A1;EDEM1;SRP14;SPCS2
prerank,mismatch repair (GO:0006298),-0.2158381619030751,-0.6053730025844116,0.9465811965811965,0.9949334837016625,1.0,9/27,30.65%,TDG;RPA1;ERCC1;MSH6;RPA3;POLD1;ABL1;PCNA;EXO1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2321897798853632,-0.6047743987235752,0.9302788844621513,0.9947232060509114,1.0,6/20,26.38%,AMPD3;ATIC;LHPP;ADSS1;NT5C2;PAICS
prerank,tyrosine metabolic process (GO:0006570),0.27512397212980993,0.6038514456293057,0.8881856540084389,1.0,1.0,11/11,72.51%,TYR;THAP4;TAT;PAH;TH;GSTZ1;IYD;DCT;HGD;IL4I1;FAH
prerank,regulation of spindle assembly (GO:0090169),-0.21728622302998152,-0.6034564577684388,0.9557894736842105,0.9948960325401116,1.0,10/25,33.71%,PDCD6IP;CHMP4B;TPR;DYNC1H1;NUMA1;SPAG5;CHMP5;HSPA1B;CCSAP;EML3
prerank,histone exchange (GO:0043486),-0.20461278738534322,-0.6034381678235687,0.9674620390455532,0.9943819821369001,1.0,12/37,26.95%,RBBP7;CENPC;ANP32E;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;RNF8;CENPX;CENPH
prerank,cellular response to DNA damage stimulus (GO:0006974),0.17193439213907047,0.6031381824494872,1.0,1.0,1.0,71/336,17.84%,FNIP2;CBX5;RBM24;BCL2L10;FMN2;CIDEB;SPDYA;FANCF;FANCG;FBXO45;NUPR2;TAOK3;CBX3;CASP9;CDKN1A;NCOA6;UBA1;ERCC4;RAD1;SLF2;OARD1;LYN;MSH3;TIMELESS;HTRA2;CBX1;MBD4;SUSD6;ATR;EPHA2;CGAS;CSNK1E;BRSK1;MCM7;ZDHHC16;ETAA1;AKTIP;UBA6;PAK1;OTUB1;APC;PSME4;PRKDC;PARP4;PSEN1;NIPBL;TANK;CRY1;PWWP3A;ATRIP;MUTYH;KMT5B;RAD17;XRCC3;BLM;SUV39H1;TDP1;GTF2H1;KIN;PARP1;FMR1;ERCC8;XPC;MRNIP;SMC6;DDX11;CHD1L;SUMO1;APEX1;MASTL;TLK2
prerank,regulation of centrosome duplication (GO:0010824),-0.20999262570479688,-0.6028615677804007,0.9549356223175965,0.9941670080061075,1.0,8/29,27.86%,PDCD6IP;PLK2;CHMP4B;NAT10;CCNF;ALMS1;CHMP5;CENATAC
prerank,defense response to fungus (GO:0050832),0.26969493059012745,0.602704738512413,0.8858921161825726,1.0,1.0,3/17,15.68%,CARD9;RARRES2;FAM3A
prerank,negative regulation of protein transport (GO:0051224),0.2501598183679168,0.6022852067738877,0.9007936507936508,1.0,1.0,4/25,10.97%,RHBDF1;NDFIP2;CSK;ERP29
prerank,protein K63-linked deubiquitination (GO:0070536),0.23534091115336714,0.602067584056164,0.9157088122605364,1.0,1.0,5/31,17.38%,USP25;OTUD5;USP50;USP33;OTUD7B
prerank,chromatin remodeling at centromere (GO:0031055),-0.20941286118488936,-0.6020035521040508,0.964509394572025,0.9941176969970424,1.0,10/31,26.95%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.22405612197546282,-0.6019988279924446,0.9491869918699187,0.9935960118440996,1.0,6/22,23.37%,PWP1;UBTF;PIH1D1;LYAR;EIF2AK3;SMARCA4
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.2723812385618104,-0.6017853471863717,0.9384057971014492,0.9931852478384088,1.0,6/10,38.92%,VEGFA;CTNNB1;DISC1;KDM1A;CX3CL1;CX3CR1
prerank,nucleus organization (GO:0006997),0.22546023568647916,0.6017244968957339,0.9372881355932203,1.0,1.0,9/47,18.32%,SYNE1;CHMP2B;BIN1;NUP35;NDC1;CHMP3;TOR1A;WDR73;NUP133
prerank,insulin secretion (GO:0030073),0.25938548644322384,0.6016078902525145,0.8872651356993737,1.0,1.0,3/19,8.73%,RIMS2;MAFA;RAB11FIP2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.22703307947313572,-0.6014892998719868,0.9594017094017094,0.9928173900157496,1.0,4/23,13.96%,CCDC186;KIF1B;CCDC88C;TUBA1B
prerank,telomere maintenance (GO:0000723),0.2225654495386834,0.6009679846574466,0.9532871972318339,1.0,1.0,16/50,21.67%,DCLRE1B;ERCC4;ATR;PRKDC;XRCC3;BLM;PARP1;NSMCE2;PTGES3;SMC6;TERF1;RPA2;APEX1;ZBTB48;TINF2;CTC1
prerank,protein monoubiquitination (GO:0006513),0.2296836014947286,0.6008438720074115,0.940959409594096,1.0,1.0,6/36,15.33%,CUL3;RBX1;UBE2E1;KLHL12;CTR9;PEX12
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.27265276089983537,-0.5996887050577407,0.9213893967093236,0.9931898677197835,1.0,5/10,35.06%,BAG3;SIRT2;JUN;HIF1AN;NCK1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.20068561899940757,0.5988992673219381,0.9905660377358491,1.0,1.0,5/86,6.55%,LIMD1;RBX1;PSMB11;EPAS1;PSMF1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.23501469559352256,-0.5987361157812309,0.9254901960784314,0.9926738193300543,1.0,5/19,24.14%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.23501469559352256,-0.5987361157812309,0.9254901960784314,0.9926738193300543,1.0,5/19,24.14%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.211323779066205,-0.5986665863527697,0.9621848739495799,0.992188091978035,1.0,12/29,30.71%,ERCC5;CUL4A;UBB;RPA1;DDB1;CETN2;ERCC2;RPA3;ERCC3;CDK7;MNAT1;GTF2H3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2471927057031264,-0.5981176250328027,0.943359375,0.9919517517961334,1.0,5/15,27.84%,LEF1;SMARCA4;TAF11;CTDP1;JUN
prerank,quinone biosynthetic process (GO:1901663),0.2760170502860656,0.5973716657299784,0.8770833333333333,1.0,1.0,4/14,20.30%,COQ2;COQ8A;PDSS1;FDXR
prerank,chromosome condensation (GO:0030261),0.23133492932591762,0.5970570037343835,0.9397163120567376,1.0,1.0,13/36,26.51%,GPER1;NUSAP1;RB1;SET;NCAPD3;CSNK2A2;SMC2;AKAP8L;NCAPH;BANF2;BANF1;CSNK2A1;NCAPD2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.27165996986438984,0.5969961100043385,0.8858921161825726,1.0,1.0,14/14,72.86%,CLP1;DDX1;TSEN15;FAM98B;CPSF4;RTRAF;CSTF2;RTCB;TRPT1;TSEN54;ZBTB8OS;CPSF1;TSEN34;TSEN2
prerank,lipid droplet organization (GO:0034389),0.24716316691798706,0.5966932853391241,0.8992094861660079,1.0,1.0,3/22,10.93%,CDS2;FAF2;SQLE
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.23824227724369182,-0.593853508434585,0.9303675048355899,0.9936327116668043,1.0,5/16,26.87%,CEBPG;RAET1E;TUBB4B;ULBP1;LYST
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.2611854781516799,0.5934288374963819,0.8842975206611571,1.0,1.0,3/15,13.13%,DDX3X;CPTP;USP50
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.25836200699968975,0.5914689040307117,0.9134808853118712,1.0,1.0,4/18,16.22%,RUVBL1;NOP10;CCT3;CCT7
prerank,response to amino acid starvation (GO:1990928),0.20583745449968024,0.5910174627962392,0.9795221843003413,1.0,1.0,13/72,17.28%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,sensory perception of pain (GO:0019233),-0.2225955555899697,-0.5886344814652869,0.9601593625498008,0.9956451586437658,1.0,11/21,38.18%,P2RX4;P2RX7;RETREG1;TRPA1;PTGES;CCR2;CCL2;KCNK4;OPRL1;ALOXE3;PROK2
prerank,stress granule assembly (GO:0034063),0.24944590756808316,0.5883178569449627,0.9282945736434108,1.0,1.0,6/20,17.61%,YTHDF3;DDX3X;YTHDF2;LSM14A;PRRC2C;OGFOD1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2650248264043411,0.5879578592171546,0.8789808917197452,1.0,1.0,5/16,17.47%,RBM24;DND1;DHX36;KHSRP;RC3H1
prerank,synaptic vesicle membrane organization (GO:0048499),0.25846982140776004,0.586536126544511,0.9125799573560768,1.0,1.0,4/17,11.64%,SNAP25;SYNGR1;STX4;SYP
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.246722912998346,-0.5864885793825341,0.9439252336448598,0.9961404975681504,1.0,4/12,25.69%,CCND1;RPS27L;TP53;PLK5
prerank,response to histamine (GO:0034776),0.2820282671741642,0.5852323252565702,0.8995726495726496,1.0,1.0,5/10,22.69%,GABRG2;AOC1;GABRB3;GABRB2;DRD2
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.24810497769483192,-0.5851509869413075,0.9417293233082706,0.9962137592742043,1.0,3/12,17.99%,PRPS2;PRPS1;PRPS1L1
prerank,histone H2A monoubiquitination (GO:0035518),0.25359022255245534,0.5844170165949387,0.9123505976095617,1.0,1.0,6/17,20.72%,RYBP;KDM2B;SKP1;BMI1;TRIM37;DDB2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.23757327012576698,0.5832694795142211,0.9388560157790927,1.0,1.0,4/25,10.41%,ADK;ADSL;DCK;PPAT
prerank,body fluid secretion (GO:0007589),-0.23768584040964663,-0.5830288266834656,0.9428571428571428,0.9966807008280335,1.0,2/15,6.84%,NPR1;SLC22A4
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21348276737530492,-0.5813131994948848,0.9621848739495799,0.9968855684912713,1.0,8/23,28.41%,GJA1;NDEL1;FBXW11;ZW10;NUMA1;PAFAH1B1;MISP;NDC80
prerank,intracellular protein transmembrane transport (GO:0065002),0.21853603012585457,0.5812427410237418,0.9450354609929078,1.0,1.0,19/42,27.54%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;PEX12;TOMM40;PEX2;SEC61A2;TOMM70;PEX5;DNAJC19;PEX6;PAM16;TIMM17A;DNLZ;ZFAND2B;TIMM17B;SEC62
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.21506814731347107,-0.5805947112389052,0.95625,0.9966716703626789,1.0,2/23,8.38%,LGALS9;PIK3R6
prerank,centromere complex assembly (GO:0034508),-0.19296441904957146,-0.5799304790340267,0.9751552795031055,0.996431630484755,1.0,12/36,28.53%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPE;CENPU;CENPX;CENPH;CENPF
prerank,telomere maintenance via telomerase (GO:0007004),-0.20569245129217845,-0.5794607818512308,0.9562363238512035,0.9961285974596316,1.0,9/28,26.30%,PINX1;HSP90AB1;ANKRD28;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.26637294739478545,0.579304370065345,0.9166666666666666,1.0,1.0,2/14,6.72%,ABCD2;IRS1
prerank,positive regulation of chromatin organization (GO:1905269),-0.2547358487104585,-0.5780156469626787,0.9484732824427481,0.9961963681341686,1.0,4/12,22.17%,H3-3A;TAL1;SIN3A;ACD
prerank,negative regulation by host of viral transcription (GO:0043922),-0.25224764035286634,-0.5776533393327883,0.9523809523809523,0.9958463909057235,1.0,8/12,52.25%,HDAC1;INPP5K;JUN;CCL5;CCL4;CCL3;POU2F3;REST
prerank,ribosomal large subunit assembly (GO:0000027),0.23685961525628157,0.5772011755914469,0.934156378600823,1.0,1.0,5/24,16.79%,FASTKD2;RSL24D1;BRIX1;RPF2;MRPL20
prerank,cellular response to lectin (GO:1990858),0.1891271714958422,0.5754101729699527,0.9879154078549849,1.0,1.0,22/104,20.74%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMB8;PSMA1;PSMA5;PSMD13;CREBBP;PSMB2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.1891271714958422,0.5754101729699527,0.9879154078549849,1.0,1.0,22/104,20.74%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMB8;PSMA1;PSMA5;PSMD13;CREBBP;PSMB2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.23856622643411673,0.5753649264037453,0.9354838709677419,1.0,1.0,7/22,20.74%,PSMB11;PSME4;PSMB5;PSMB8;PSMA1;PSMA5;PSMB2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.26894122380782953,0.5753353387562296,0.8945233265720081,1.0,1.0,4/11,24.81%,FBLL1;LARP7;EXOSC10;DKC1
prerank,B cell activation involved in immune response (GO:0002312),-0.2363445372229856,-0.5751245278611026,0.9576923076923077,0.9963773020366432,1.0,3/13,24.71%,CD180;MSH6;RNF8
prerank,acyl-CoA biosynthetic process (GO:0071616),0.24903622402248576,0.5744737838820795,0.9203354297693921,1.0,1.0,3/16,15.00%,PPT1;PPT2;MLYCD
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.19919389105190508,-0.5732952964108292,0.978401727861771,0.9966148890695845,1.0,21/29,51.58%,STX7;CYRIB;RAET1E;TYROBP;ITGAM;PVR;FADD;NOS2;SLAMF6;CD226;IL12A;CRTAM;STAP1;IL23A;LAMP1;KLRD1;CD160;KLRK1;SPI1;IL12B;IL23R
prerank,phagosome maturation (GO:0090382),0.22400532416030555,0.5720765176487762,0.9579349904397706,1.0,1.0,6/35,10.45%,MREG;ATP6V0E2;PIKFYVE;CORO1A;RAB38;ATP6V1B2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.23678139446803398,-0.5719617770800949,0.94831013916501,0.9966594862548152,1.0,7/15,36.36%,NPLOC4;HSP90B1;VCP;SEC61B;SYVN1;AUP1;HERPUD1
prerank,regulation of immunoglobulin production (GO:0002637),-0.21097088079141346,-0.5703697553450093,0.9769230769230769,0.996784012439263,1.0,4/23,22.78%,RBP4;EPHB2;CLCF1;XBP1
prerank,DNA-dependent DNA replication (GO:0006261),-0.15012309104680102,-0.569405652601391,1.0,0.9966213472894736,1.0,50/128,36.53%,BAZ1A;SSBP1;PSME2;PSMB4;UBB;CDK2AP1;PSMD8;PSMB1;RPA1;PSMD11;DBF4;PSME3;SIRT7;PSMA2;MCMDC2;RFC3;PSMD4;PSMD3;TEFM;RECQL;PSMB7;POLE2;RFC1;MCM8;CDC45;PSMC2;RAD51;RPA3;PSMD10;PSMC5;SRPK2;POLA1;POLD1;PSMD7;PRIM2;MCM3;WRN;MCM5;MCM10;RFC5;POLE3;PSMB9;PSMD12;PSMA8;RECQL5;CDC34;TOPBP1;PRIMPOL;TWNK;GINS2
prerank,protein methylation (GO:0006479),0.2152605965159932,0.5690326758723924,0.9537037037037037,1.0,1.0,12/40,20.88%,METTL21A;EEF1AKMT1;PRMT1;PRMT3;METTL22;PRMT7;SETD3;FAM98A;SNRPD3;NSD3;ATPSCKMT;NTMT1
prerank,rRNA modification (GO:0000154),0.23852803306549536,0.5687598457808436,0.9357601713062098,1.0,1.0,9/21,24.81%,FBLL1;NSUN3;NOP10;TFB2M;DIMT1;GAR1;TSR3;THUMPD1;DKC1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.19847676581178259,-0.5665686902832027,0.9722772277227723,0.9972070391664537,1.0,10/29,26.94%,THRAP3;NOCT;TENT5A;LARP1;ELAVL1;TENT5C;E2F1;DHX34;GDNF;EIF4ENIF1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2412836348600679,0.566463684926955,0.9241245136186771,1.0,1.0,4/20,20.29%,PSMG3;PTGES3;PSMG2;HOPX
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.21267865759655813,-0.5661057875687975,0.9564356435643564,0.996869467754289,1.0,6/20,35.89%,AKR1B1;STARD3;CYP46A1;TSPO;TSPOAP1;HSD17B10
prerank,regulation of chromosome segregation (GO:0051983),-0.22842973450269438,-0.5653699533132558,0.953757225433526,0.996651669841029,1.0,11/16,50.78%,PUM1;NUMA1;RMI2;MKI67;CDC6;BUB1;IHO1;KIF2C;AURKB;HORMAD1;PUM2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2272838541038717,0.5641012402129405,0.9372623574144486,1.0,1.0,6/29,11.22%,WDR46;RRP36;TBL3;NOP14;UTP4;TSR2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.200592749535373,-0.5639949018853136,0.98125,0.9966751479926494,1.0,11/30,30.71%,CAVIN1;POLR2F;POLR2E;UBTF;TTF1;ERCC2;ERCC3;CDK7;POLR1C;MNAT1;GTF2H3
prerank,ubiquinone metabolic process (GO:0006743),0.25739190611608903,0.5636701709024526,0.9109730848861284,1.0,1.0,4/15,20.30%,COQ2;COQ8A;PDSS1;FDXR
prerank,reticulophagy (GO:0061709),-0.23857213103156166,-0.5628858307837536,0.9631782945736435,0.9965868686763156,1.0,3/12,16.57%,ULK2;RETREG1;ATG2A
prerank,7-methylguanosine RNA capping (GO:0009452),0.2230150933140298,0.562869988946256,0.9503676470588235,1.0,1.0,13/31,25.28%,NCBP2;POLR2C;RNMT;CCNH;GTF2H5;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2230150933140298,0.562869988946256,0.9503676470588235,1.0,1.0,13/31,25.28%,NCBP2;POLR2C;RNMT;CCNH;GTF2H5;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.22680948499238204,0.5618423777058336,0.958,1.0,1.0,6/27,15.66%,AK8;RRM1;DCTD;AK7;AK5;AK4
prerank,protein sumoylation (GO:0016925),-0.17545701550385168,-0.559329115823101,0.9876543209876543,0.9973414787650416,1.0,12/49,26.26%,EYA1;STX1A;SAE1;NUP98;TPR;PIAS4;NUP88;NUP214;TRPM4;PIAS3;NUP37;NUP155
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.20461030565582172,-0.5581762188786512,0.9663366336633663,0.9972058568177263,1.0,5/22,22.23%,TOM1L1;RNF115;VPS28;RNF126;VPS37D
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.15569257605174325,-0.5571294174146503,0.994269340974212,0.9970465530160442,1.0,21/84,24.73%,CDC16;ANAPC4;PSME2;PSMB4;UBB;PSMD8;PSMB1;PSMD11;PSME3;ANAPC16;PSMA2;PSMD4;FZR1;PSMD3;PSMB7;CDC27;ANAPC5;ECRG4;PSMC2;PSMD10;PSMC5
prerank,microtubule depolymerization (GO:0007019),0.24649036124958495,0.5569639918865014,0.9464668094218416,1.0,1.0,1/17,3.27%,NCKAP5
prerank,ubiquinone biosynthetic process (GO:0006744),0.2560780183518318,0.556519873435988,0.9140461215932913,1.0,1.0,4/15,20.30%,COQ2;COQ8A;PDSS1;FDXR
prerank,microtubule-based transport (GO:0099111),-0.23257029558826686,-0.556436834628851,0.9646365422396856,0.9967782359432159,1.0,8/12,41.11%,SPEF2;ROPN1L;DYNC1I1;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18619541010973867,0.556191119078688,0.996742671009772,1.0,1.0,23/95,19.16%,FANCB;GINS4;SFPQ;MCM6;MEIOB;REC8;ERCC4;PALB2;AUNIP;MCM7;MCM2;NIPBL;REV3L;XRCC3;SEM1;BLM;RNF138;PARP1;NSMCE2;SMC6;RPA2;POLL;XRCC2
prerank,regulation of protein neddylation (GO:2000434),0.2688219164024891,0.5557688132722567,0.9177777777777778,1.0,1.0,5/10,24.98%,EPAS1;DCUN1D2;DCUN1D4;DCUN1D1;RPL5
prerank,receptor recycling (GO:0001881),-0.24790070475635334,-0.5533319661262946,0.9616087751371115,0.9973547305348723,1.0,3/10,18.08%,PHETA1;ARFGEF2;REP15
prerank,RNA modification (GO:0009451),0.19643407073424562,0.5527827396386674,0.9898648648648649,1.0,1.0,12/54,18.21%,NSUN3;TRMT61A;TRUB1;SSB;TRMT1;RBM15;NOP10;PUS7;ELP5;AARS1;NSUN2;NSUN5
prerank,phagolysosome assembly (GO:0001845),0.25362641830341126,0.5526912436099382,0.9066666666666666,1.0,1.0,2/12,8.59%,PIKFYVE;CORO1A
prerank,negative regulation of interferon-beta production (GO:0032688),-0.24672745224440157,-0.5517641290804541,0.9519408502772643,0.9973626759781158,1.0,4/10,27.13%,PPM1B;SIRPA;PTPRS;REL
prerank,L-serine metabolic process (GO:0006563),-0.25275209676424304,-0.551737019408702,0.9538461538461539,0.996853400724294,1.0,3/10,19.49%,CBS;SERINC3;SERINC5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2392425384122147,0.5488630876049928,0.9415322580645161,1.0,1.0,1/17,2.81%,EMC7
prerank,mitotic metaphase plate congression (GO:0007080),0.19882334960958487,0.5473039083291706,0.977112676056338,1.0,1.0,4/51,6.13%,RMDN1;CUL3;CHAMP1;CHMP2B
prerank,positive regulation of histone deacetylation (GO:0031065),0.2536151603294424,0.5453861753604972,0.9353448275862069,1.0,1.0,5/12,22.32%,PRKD2;NIPBL;PRKD1;AKAP8;AKAP8L
prerank,protein localization to kinetochore (GO:0034501),-0.2270645690718922,-0.5453598434174621,0.966796875,0.9984240226992387,1.0,3/14,15.37%,ZW10;IK;CENPT
prerank,regulation of cellular response to stress (GO:0080135),0.17640959607170587,0.5450011043054784,1.0,1.0,1.0,26/115,18.32%,ADCY8;CORO2B;NUP43;AJUBA;CASP9;AKT1S1;NUP35;MTOR;NEK6;CCAR2;ATR;NUAK1;DNAJC7;DYRK3;SEC13;NDC1;EP300;RANBP2;RSL1D1;CAMK2G;MAPK1;PTGES3;RPA2;GSK3B;HSF1;NUP133
prerank,iron-sulfur cluster assembly (GO:0016226),-0.19475192129050062,-0.542675795212474,0.9802371541501976,0.9987725723338436,1.0,11/24,38.57%,MMS19;ISCA2;CIAPIN1;HSPA9;NUBP1;CIAO2B;IBA57;NUBP2;CIAO2A;GLRX3;NFS1
prerank,DNA modification (GO:0006304),-0.20461211941343008,-0.5412004934391071,0.979757085020243,0.9987340327019444,1.0,7/22,27.29%,PARP3;TDG;EXOSC5;NEIL3;ACD;NEIL1;NTHL1
prerank,glycolytic process (GO:0006096),0.2133306654470467,0.5398527061100079,0.9523809523809523,1.0,1.0,9/28,24.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2;PGM1;PFKFB2;PGK1
prerank,RNA biosynthetic process (GO:0032774),-0.18775974268745754,-0.5396462183622859,0.9878296146044625,0.9987192569844964,1.0,9/31,27.72%,POLR2A;TBPL1;BRF2;TTF1;RSF1;TAF5;POLA1;NAT14;PRIM2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.23069838609549764,0.5385362822904173,0.9390243902439024,1.0,1.0,7/21,23.33%,NES;TOX;SMARCD3;NAP1L1;FZD9;DRD2;FZD3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2143771815816438,0.5374155346387839,0.975095785440613,1.0,1.0,7/32,16.26%,CDK15;DHFR;NPAT;RB1;CDK14;CDK5;CCNE1
prerank,histone H2B ubiquitination (GO:0033523),-0.24559855737482575,-0.5368401811825336,0.9509803921568627,0.9990723194125999,1.0,4/10,30.79%,DTX3L;RNF40;RNF8;PAF1
prerank,"phototransduction, visible light (GO:0007603)",-0.2191738698901406,-0.5365149761332405,0.9789272030651341,0.9986423520594441,1.0,3/14,26.31%,ABCA4;RP1;GNAQ
prerank,mitochondrial translation (GO:0032543),0.17660897792897887,0.5365022731540623,0.9984591679506933,1.0,1.0,30/104,22.69%,FASTKD2;NOA1;MRPS27;MTIF2;MRPL55;MRPL58;GATB;GFM2;MRPS30;IARS2;PTCD3;GFM1;GATC;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPL47;MRPS17;MRPL37;MRPL2;MRPL40;MRPL11;TSFM;DAP3;MRPS15;MRPL42
prerank,canonical glycolysis (GO:0061621),0.2190481505874119,0.5364610207979208,0.9627329192546584,1.0,1.0,6/24,18.18%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2190481505874119,0.5364610207979208,0.9627329192546584,1.0,1.0,6/24,18.18%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,ERAD pathway (GO:0036503),0.18023529361757956,0.5359114268544821,0.993517017828201,1.0,1.0,16/83,16.80%,FAM8A1;DERL3;FAF2;FOXRED2;UGGT2;SGTB;UBE2J2;RNF121;GET4;ERLIN1;UBXN6;UBQLN2;DNAJC18;RNF103-CHMP3;TMUB2;TOR1A
prerank,long-term memory (GO:0007616),-0.20665345870996704,-0.5335178085636192,0.9775510204081632,0.9990037561002663,1.0,1/19,2.03%,APOE
prerank,negative regulation of DNA recombination (GO:0045910),-0.17413940082052795,-0.5329889351635299,0.9956803455723542,0.9986429831355101,1.0,11/43,24.24%,POLR2A;PARP3;POLR2F;SHLD1;POLR2E;ACD;RMI2;KLHL15;MSH6;POLR2G;PARPBP
prerank,tRNA wobble base modification (GO:0002097),-0.21921566941513837,-0.532323642221602,0.9711538461538461,0.9983189421106301,1.0,6/14,36.06%,ELP3;URM1;KTI12;ADAT2;CTU2;CTU1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.17405166789046245,-0.5321466527261195,0.9952718676122931,0.997859098476084,1.0,15/41,30.94%,WWP2;UBE2E2;RNF135;TRIM27;RNF115;PELI1;TRAF3IP2;RNF126;PRKN;RNF8;BFAR;PRPF19;UBE2V1;RNF152;NEDD4
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.19484080791213979,-0.5315871693521226,0.9781746031746031,0.9974977420090736,1.0,9/22,34.07%,MMS19;ISCA2;CIAPIN1;HSPA9;NUBP1;CIAO2B;IBA57;NUBP2;CIAO2A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.255623520104961,0.5303886826605629,0.9244444444444444,1.0,1.0,3/10,13.67%,ATP5PO;VPS9D1;ATP5F1A
prerank,telomere organization (GO:0032200),0.20074782903549357,0.5278065048763524,0.9842381786339754,1.0,1.0,10/43,17.66%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;PARP1;PTGES3;TERF1;RPA2;APEX1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2205728404010736,0.5262868711860429,0.9723865877712031,1.0,1.0,4/24,11.56%,ACKR3;CCAR2;SNAI2;SFRP2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.23457664182235569,0.526266441571179,0.949685534591195,1.0,1.0,1/16,4.92%,AP1G1
prerank,tRNA modification (GO:0006400),0.18638221002962024,0.5261789644133739,0.988391376451078,1.0,1.0,18/62,24.70%,TRMT61A;TRMT5;TRUB1;SSB;TRMT1;THUMPD2;PUS7;ELP5;MTO1;AARS1;NSUN2;ALKBH1;METTL6;THUMPD1;GTPBP3;TRDMT1;TRMT10A;TRMT9B
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.187393707319151,-0.525485405045365,0.9858299595141701,0.9985900733860299,1.0,9/27,32.89%,LPAR1;LPAR6;LPAR4;AGTR1;GPR4;F2R;F2RL2;GPR20;OPRL1
prerank,regulation of T cell activation (GO:0050863),0.20149509115127504,0.5247713155281236,0.9750889679715302,1.0,1.0,2/42,3.86%,PTPN22;PAG1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2082084557199751,-0.524578039723862,0.9866920152091255,0.9983099229055269,1.0,11/18,52.22%,BID;TMEM14A;HIP1R;ZNF205;SLC25A5;BAX;GSK3A;BOK;MPV17L;TMEM102;MUL1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.21120506614109846,0.5242757873275905,0.9670781893004116,1.0,1.0,6/25,18.18%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2561169462197898,0.5242572963798324,0.9448123620309051,1.0,1.0,4/10,23.90%,LYN;MAPK1;NBR1;GREM1
prerank,pyruvate metabolic process (GO:0006090),0.18442840848934391,0.524107781397824,0.9910071942446043,1.0,1.0,11/52,18.18%,SLC16A3;GCK;ALDOC;PDHX;SRR;GPI;PFKM;PCK2;DLD;PKM;ENO2
prerank,positive regulation of telomere capping (GO:1904355),-0.20726272857841854,-0.5238071037699761,0.9900199600798403,0.9979794019933366,1.0,5/17,26.45%,TNKS2;MAPK3;MAP3K4;MAP2K7;NEK7
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.22770447260009763,-0.5228111131072616,0.9662288930581614,0.9977268952078848,1.0,4/12,24.31%,ACO1;IDH3G;ASS1;SIRT4
prerank,synaptic vesicle transport (GO:0048489),-0.23069239826182608,-0.5211717881769938,0.9732313575525813,0.997610364687111,1.0,2/11,15.66%,RAB27A;SYNJ1
prerank,organelle disassembly (GO:1903008),0.20861413456732217,0.5199615068140903,0.9796296296296296,1.0,1.0,6/33,14.10%,PELO;MTIF2;UFM1;DYRK3;GFM2;ATG2B
prerank,nucleosome disassembly (GO:0006337),0.2354167280154438,0.5198796460009794,0.9629629629629629,1.0,1.0,4/14,19.36%,SET;SMARCD3;NFE2;SMARCD1
prerank,chromatin disassembly (GO:0031498),0.2354167280154438,0.5198796460009794,0.9629629629629629,1.0,1.0,4/14,19.36%,SET;SMARCD3;NFE2;SMARCD1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.23628374136848715,0.5197645382040328,0.9657387580299786,1.0,1.0,12/12,76.39%,SETMAR;RAD17;NAE1;CLSPN;ORC1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;STK33;CHEK2
prerank,transcription by RNA polymerase III (GO:0006383),-0.18421534106212098,-0.5195148656305316,0.9846491228070176,0.997512346611673,1.0,7/27,26.26%,IVNS1ABP;POLR3GL;GTF3C2;GTF3C5;GTF3C1;ICE1;SNAPC4
prerank,DNA replication checkpoint signaling (GO:0000076),0.23157101594876295,0.5192243144277179,0.9549180327868853,1.0,1.0,16/16,76.87%,TIMELESS;RAD17;TIPIN;DNA2;RAD9A;NAE1;CLSPN;ORC1;RAD9B;CDT1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;CDC45
prerank,autophagosome organization (GO:1905037),0.18643102105809944,0.5187689269164462,0.9859402460456942,1.0,1.0,21/50,26.94%,ATG16L1;ATP2A2;TP53INP2;UBXN2B;VMP1;ATG2B;UBQLN2;RAB1A;PIK3C3;ULK3;RAB1B;GABARAP;GABARAPL2;ATG13;ATG16L2;ATG9A;UBXN2A;TMEM41B;AMBRA1;ATG5;ATG3
prerank,dendritic cell chemotaxis (GO:0002407),-0.21289414373543364,-0.5183593879288619,0.9808429118773946,0.9972587443669083,1.0,10/14,49.30%,TRPM4;CCL19;CCR2;TRPM2;CXCR4;PIK3CG;CCL5;CCR1;CCR6;HMGB1
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.20703772430051268,-0.5181554357108314,0.9848197343453511,0.9967895074677104,1.0,6/17,27.29%,ERCC5;TDG;NEIL3;ACD;NEIL1;NTHL1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2241412884470681,-0.5171744609958734,0.984375,0.9965118579399473,1.0,4/12,27.68%,SLC20A2;SLC37A1;SLC37A2;SLC25A11
prerank,meiosis I (GO:0007127),0.21659590363435777,0.5169950544376491,0.9634888438133874,1.0,1.0,4/23,15.97%,MEIOB;BRDT;PTTG1;SLC25A31
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.22906584760407486,0.5160244929984078,0.955193482688391,1.0,1.0,3/17,14.00%,ALG12;ALG1;DHDDS
prerank,rRNA 3'-end processing (GO:0031125),-0.23186855170801446,-0.5154796232749407,0.9772296015180265,0.9964042782929053,1.0,3/10,30.80%,ERI3;EXOSC7;RPS21
prerank,microglial cell activation (GO:0001774),-0.19500879134228033,-0.5149934808608116,0.9799196787148594,0.9960130221507401,1.0,1/21,2.15%,APP
prerank,replication fork processing (GO:0031297),-0.17018799492579972,-0.5148623260921769,0.9977973568281938,0.9955293381603707,1.0,19/38,42.99%,SAMHD1;BRCA2;CDK9;THOC1;RAD51;CENPX;FANCM;WRN;PCNA;FAM111A;PRIMPOL;ATRX;ZRANB3;ALYREF;NUCKS1;GEN1;EME1;TONSL;RTEL1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.2374128652406367,0.5140832940786705,0.9352051835853131,1.0,1.0,1/11,6.99%,LIPC
prerank,outer dynein arm assembly (GO:0036158),0.22802611752887997,0.5131904428103526,0.9613821138211383,1.0,1.0,14/14,77.22%,CCDC63;ODAD4;DNAH5;DNAAF5;ZMYND10;LRRC49;DNAAF1;ODAD1;DNAAF4;DNAH17;DNAL1;ODAD3;ODAD2;DNAH8
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.22099077976038442,-0.5114083976089726,0.9739478957915831,0.9958302025167285,1.0,1/12,6.44%,PRKCB
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23632824762981094,0.5108826910085438,0.9717171717171718,1.0,1.0,15/15,76.39%,FANCD2;RAD17;MDC1;MUS81;TIPIN;RAD9A;MRE11;EME2;RAD9B;EME1;NEK11;HUS1B;ATF2;HUS1;CHEK2
prerank,DNA packaging (GO:0006323),-0.20625938750672107,-0.5102138778860101,0.9718045112781954,0.9955732150883215,1.0,10/16,48.86%,AIFM1;HAT1;CHAF1A;TP53;NAA10;RBBP4;CHAF1B;NOC2L;M1AP;H1-0
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.1722721184559692,-0.5101318866590882,0.9933774834437086,0.9950773377007669,1.0,11/35,31.70%,TDG;RPA1;ADPRS;RFC3;RFC1;RPA3;NEIL1;POLD1;NTHL1;PCNA;RFC5
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.222723237402982,0.5082051866872966,0.9475806451612904,1.0,1.0,2/15,10.58%,CUL3;DYRK3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.21855821335422398,0.5080468318159878,0.9515789473684211,1.0,1.0,2/19,7.94%,ADK;DCK
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.22535454508454456,0.5069813303290949,0.959915611814346,1.0,1.0,1/17,4.92%,AP1G1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.15112477695564483,-0.5061731152541886,0.9947916666666666,0.9954265787018499,1.0,16/69,26.78%,POLR2A;NABP1;POLR2F;INTS11;RPRD2;CDK9;POU2F1;POLR2E;POU2F2;TAF5;ICE1;POLR2G;INTS5;TAF11;SNAPC4;CDK7
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.2360712599183588,0.5057927369761227,0.9755102040816327,1.0,1.0,6/11,28.47%,UGGT2;TOR1A;POMT2;BAG6;UGGT1;DERL1
prerank,modulation by host of symbiont process (GO:0051851),-0.1776943224103393,-0.5051315069317641,0.9957894736842106,0.9951256095539213,1.0,8/31,27.84%,LEF1;SAP30BP;HDAC1;INPP5K;SMARCA4;TAF11;CTDP1;JUN
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.16887186519185965,-0.505120214286705,0.9912280701754386,0.9946210076124511,1.0,9/35,26.45%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,regulation of interferon-beta production (GO:0032648),-0.15874807125534565,-0.5038465015535628,1.0,0.9943784236818878,1.0,12/46,29.27%,IRF1;OAS2;RNF135;MAVS;PPM1B;TLR4;SIRPA;RNF216;POLR3D;PTPRS;REL;ISG15
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.19473375628440037,-0.5024540799528492,0.9883495145631068,0.9941623380851531,1.0,8/19,33.28%,AR;BRF2;NAB2;ICE1;CEBPA;RPTOR;ICE2;ZNF76
prerank,snRNA transcription (GO:0009301),-0.1493988560137816,-0.5015022669121378,0.9973958333333334,0.9938671887136695,1.0,16/70,26.78%,POLR2A;NABP1;POLR2F;INTS11;RPRD2;CDK9;POU2F1;POLR2E;POU2F2;TAF5;ICE1;POLR2G;INTS5;TAF11;SNAPC4;CDK7
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.1865066154847857,0.5011701035009825,0.9914821124361158,1.0,1.0,12/51,17.17%,GNL3L;TNKS;ATR;HNRNPA1;SRC;HNRNPU;HNRNPC;CCT3;MAPK1;CCT7;PIF1;TERF1
prerank,male meiosis I (GO:0007141),0.22108501820921744,0.5000551156914099,0.9582463465553236,1.0,1.0,16/16,77.91%,BRDT;SLC25A31;FOXJ3;ING2;FOXJ2;ZSCAN21;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;MYBL1;DDX4;TDRD9;SYCP3;HSF2BP
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.18894818649415918,0.4992282061259525,0.9927667269439421,1.0,1.0,7/40,16.94%,MSH3;TIMELESS;ATR;SETMAR;ETAA1;BLM;DDX11
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.20501991168735756,0.49814036713522186,0.9801980198019802,1.0,1.0,2/22,7.42%,KAT7;TCERG1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.1709714861257067,0.4978198276444781,1.0,1.0,1.0,17/70,20.74%,TCF15;PSMB11;N4BP2L2;PSMF1;MYB;TCF12;YTHDF2;PSME4;PRKDC;PUS7;KMT2A;PSMB5;PSMB8;PSMA1;PSMA5;PSMD13;PSMB2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.20569530561003793,0.4957864730631008,0.9613034623217923,1.0,1.0,11/22,28.80%,MED13;MED1;MED4;DHX36;MED30;MED16;MED14;SUB1;PSMC3;MED17;PSMC4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.18519984319245225,-0.4956013714969408,0.9831932773109243,0.9944502890198851,1.0,3/21,13.50%,RAB11A;RAD51B;CCND1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2209317252926908,0.49548820061284243,0.9744136460554371,1.0,1.0,1/17,2.65%,IL1B
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.23418305734205347,0.4949984994665575,0.9632829373650108,1.0,1.0,3/10,17.17%,XRCC3;BLM;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.23418305734205347,0.4949984994665575,0.9632829373650108,1.0,1.0,3/10,17.17%,XRCC3;BLM;TERF1
prerank,t-circle formation (GO:0090656),0.23418305734205347,0.4949984994665575,0.9632829373650108,1.0,1.0,3/10,17.17%,XRCC3;BLM;TERF1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.2037274056040015,0.49298444741254743,0.9861660079051383,1.0,1.0,9/26,19.77%,OGT;CTR9;SETD3;KMT5B;SUV39H1;KMT2A;KMT2D;SETD5;ATPSCKMT
prerank,mRNA transport (GO:0051028),0.1606024466953649,0.49263168967031584,0.9984756097560976,1.0,1.0,22/101,21.11%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;SMG7;SEC13;YTHDC1;NDC1;KIF5C;SYMPK;UPF3B;EIF4E;RANBP2;FMR1;ZC3H11A;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;ZFP36L1
prerank,DNA replication (GO:0006260),0.16230446776494045,0.49256848861104985,1.0,1.0,1.0,33/105,25.75%,RBMS1;KAT7;MCM6;RAD1;WRNIP1;TIMELESS;ATR;MCM7;MCM2;SET;REV3L;ATRIP;RAD17;BLM;ORC4;KIN;NAP1L1;PIF1;RPA2;RHNO1;POLL;ORC6;POLG;MCMBP;PNKP;DUT;TIPIN;NT5M;DNA2;IGHMBP2;POLG2;RECQL4;MCM4
prerank,nuclear envelope organization (GO:0006998),0.2043165734094205,0.49225450617439753,0.9770554493307839,1.0,1.0,5/20,23.38%,TOR1B;EMD;TOR1A;LEMD3;SUN2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.21673746373820102,0.49221333195015154,0.961456102783726,1.0,1.0,4/16,14.53%,MCM6;MCM7;MCM2;BLM
prerank,protein targeting to mitochondrion (GO:0006626),0.1778135676424787,0.4909428417542167,0.9908592321755028,1.0,1.0,9/52,16.74%,IMMP2L;TIMM22;GRPEL2;TOMM40L;MFF;TIMM23;TOMM40;MIPEP;PMPCB
prerank,synaptic vesicle localization (GO:0097479),0.2211453825808205,0.49070765113761683,0.9628865979381444,1.0,1.0,4/13,16.80%,KIF5C;CDK5;SYNDIG1;TOR1A
prerank,vesicle transport along microtubule (GO:0047496),0.20644291494511008,0.49063102574604645,0.9834558823529411,1.0,1.0,8/23,19.49%,TRAK1;KIF3A;TRAK2;RAB1A;HTT;NDE1;HAP1;KIF1A
prerank,histone H3-K4 methylation (GO:0051568),0.19710016213191087,0.49012928440240844,0.9818181818181818,1.0,1.0,7/26,19.79%,OGT;KMT2B;SETMAR;CTR9;KMT2A;KMT2D;WDR5
prerank,positive regulation of interferon-alpha production (GO:0032727),0.21381401504082934,0.4887186968509987,0.9752577319587629,1.0,1.0,3/19,15.10%,DDX3X;RIPK2;DHX36
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.1947647499635402,-0.48613199919329114,0.988,0.995620267108416,1.0,7/17,36.36%,NPLOC4;HSP90B1;VCP;SEC61B;SYVN1;AUP1;HERPUD1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.21264902265443428,0.48527726758542483,0.9683544303797469,1.0,1.0,5/19,18.79%,SREBF2;HTRA2;CAMKK2;HTT;CSNK2A2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.22821378024448935,0.4820065710981788,0.9741379310344828,1.0,1.0,3/10,21.13%,LYN;CD24;LILRB1
prerank,mRNA export from nucleus (GO:0006406),0.15578129008287708,0.4795148337886293,0.9984917043740573,1.0,1.0,21/102,20.83%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;PCID2;SMG7;SEC13;YTHDC1;NDC1;SYMPK;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;HNRNPA2B1;POLR2D;DDX25;POLDIP3;SRSF9
prerank,negative regulation of defense response to virus (GO:0050687),0.22829260206858348,0.4783831677382197,0.9764453961456103,1.0,1.0,3/10,17.45%,TARBP2;C1QBP;TRAF3IP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.19112669654015482,-0.47749764582027776,0.9887640449438202,0.9964444976431985,1.0,6/16,33.40%,DDX5;SRSF6;PUF60;HNRNPM;PQBP1;CELF4
prerank,nuclear membrane disassembly (GO:0051081),0.21595585724764899,0.47690858027001415,0.9690522243713733,1.0,1.0,4/14,22.32%,NEK6;DCTN1;NEK9;AKAP8L
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.20657649421913432,0.4768305448705483,0.9772727272727273,1.0,1.0,1/19,3.26%,UGP2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.22884760230981674,0.4767679537613632,0.9708333333333333,1.0,1.0,10/10,77.13%,CCT3;CCT7;DKC1;TCP1;CCT6A;CCT4;CCT8;CCT2;CCT5;WRAP53
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.20674764810672813,0.4759821563052486,0.9859154929577465,1.0,1.0,5/16,23.43%,TRA2A;DAZAP1;RBMX;RBM3;CIRBP
prerank,steroid hormone biosynthetic process (GO:0120178),0.19514477579815537,0.47516769642854656,0.9900199600798403,1.0,1.0,5/29,13.50%,MED1;DHCR7;STAR;SRD5A1;CYP11B1
prerank,mitotic chromosome condensation (GO:0007076),0.1951085639108696,0.4732364709896748,0.9851024208566108,1.0,1.0,10/26,26.51%,NUSAP1;RB1;SET;NCAPD3;CSNK2A2;SMC2;AKAP8L;NCAPH;CSNK2A1;NCAPD2
prerank,regulation of DNA recombination (GO:0000018),0.1879676374361951,0.4719972451632597,0.9855072463768116,1.0,1.0,6/32,17.44%,IL4;MSH3;KPNA1;PPP4C;BLM;RPA2
prerank,phosphate ion transport (GO:0006817),-0.18896838159319979,-0.47197626330877446,0.9866156787762906,0.9967111856795023,1.0,4/16,27.68%,SLC20A2;SLC37A1;SLC37A2;SLC25A11
prerank,tRNA wobble uridine modification (GO:0002098),-0.19152415812717913,-0.4713998193086044,0.9884169884169884,0.9962755323692578,1.0,6/14,36.06%,ELP1;ELP3;URM1;KTI12;CTU2;CTU1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.20114496139488663,0.46583173319207694,0.9777327935222672,1.0,1.0,6/18,22.93%,PCID2;ZC3H11A;NUP133;DDX25;POLDIP3;THOC2
prerank,DNA catabolic process (GO:0006308),0.2287290697929451,0.46374904975936315,0.9764453961456103,1.0,1.0,5/11,25.35%,XRN2;SETMAR;MUS81;FBH1;DNASE1L2
prerank,RNA 3'-end processing (GO:0031123),0.16283379785367844,0.46263463597220983,0.9983416252072969,1.0,1.0,8/69,11.50%,CLP1;NCBP2;SRRM1;SUPV3L1;RNPS1;PAPOLA;SYMPK;RPRD1B
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2037232371448977,0.4622067179386621,0.9804772234273319,1.0,1.0,6/17,24.57%,CHAMP1;RB1;CENPA;SPDL1;MTBP;ZWILCH
prerank,negative regulation of viral release from host cell (GO:1902187),0.21597808495154985,0.4617806615951879,0.9746835443037974,1.0,1.0,4/13,21.03%,MID2;CHMP3;TRIM26;TRIM5
prerank,DNA recombination (GO:0006310),0.18165203782843412,0.46131072499204545,0.9943820224719101,1.0,1.0,9/37,19.16%,SUPV3L1;LIG4;MSH3;TSN;XRCC3;BLM;HDAC10;RHNO1;XRCC2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.1824325212956016,0.46120327193956623,0.9888475836431226,1.0,1.0,2/29,5.83%,LIMK1;MAGEC2
prerank,aminoglycan metabolic process (GO:0006022),0.22614863168465968,0.4600841947283776,0.9626373626373627,1.0,1.0,10/10,77.40%,B3GALT6;CHST9;B3GAT1;B3GAT2;B4GALT7;XYLT2;GAL3ST3;B3GAT3;XYLT1;CLN6
prerank,regulation of histone deacetylation (GO:0031063),-0.1949210236585572,-0.45975799419006275,0.9903288201160542,0.9972306705546785,1.0,4/13,35.20%,SAP30BP;CTBP1;SPHK2;APLNR
prerank,neuromuscular process (GO:0050905),0.20305860650776097,0.45820717792500026,0.9749478079331941,1.0,1.0,1/16,3.21%,NRXN1
prerank,regulation of catecholamine secretion (GO:0050433),0.1791167485743737,0.4499194336333162,0.9959349593495935,1.0,1.0,11/29,24.20%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT10;SYT6
prerank,nuclear pore organization (GO:0006999),0.20389822389573148,0.4481969817224156,0.9774127310061602,1.0,1.0,3/14,18.32%,NUP35;NDC1;NUP133
prerank,RNA export from nucleus (GO:0006405),0.1465286148368946,0.4475089910226917,1.0,1.0,1.0,14/100,14.65%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;SMG7;SEC13;YTHDC1;NDC1;SYMPK;HNRNPA1;UPF3B;EIF4E;RANBP2
prerank,protein-DNA complex disassembly (GO:0032986),-0.1772950335514123,-0.44739821625101456,0.9942748091603053,0.9980023955153309,1.0,8/16,44.35%,SMARCC1;RPL23;SMARCA4;SMARCD2;MYC;GRWD1;HMGA1;SMARCE1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.16252642139169848,-0.4468014444931477,0.9938271604938271,0.9975536845069992,1.0,11/22,42.89%,ERI3;FTSJ3;EXOSC7;RRS1;ABT1;RPS21;URB1;RPP40;ERI1;UTP20;KRI1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2081422534242583,0.44473316743475316,0.9780701754385965,1.0,1.0,1/13,3.75%,DERL3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.20763669741666363,0.4439915630327064,0.978401727861771,1.0,1.0,1/10,6.31%,SNCA
prerank,aerobic respiration (GO:0009060),0.18929144227612466,0.44344865897260755,0.9818548387096774,1.0,1.0,5/20,20.44%,BLOC1S1;UQCRC2;MTFR1;OXA1L;SURF1
prerank,tRNA 5'-leader removal (GO:0001682),-0.1873757686317871,-0.4429063115850967,0.9980353634577603,0.9974080579337905,1.0,6/13,37.40%,PRORP;RPP38;POP1;RPP25L;RPP21;RPP40
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.19098369174577307,0.44151643179966843,0.9916492693110647,1.0,1.0,3/20,11.97%,AGO3;TARBP2;TSN
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.19705875565676725,0.44147783810343244,0.9815195071868583,1.0,1.0,1/15,4.94%,CLP1
prerank,protein localization to condensed chromosome (GO:1903083),0.20147438630011447,0.441290735380227,0.9816700610997964,1.0,1.0,1/12,5.25%,CHAMP1
prerank,DNA replication initiation (GO:0006270),0.16911843338957394,0.43752084823179327,0.998211091234347,1.0,1.0,8/37,19.53%,MCM6;MCM7;MCM2;PRIM1;ORC4;POLE4;RPA2;ORC6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.14402220664388637,0.4372347385812429,1.0,1.0,1.0,13/96,14.65%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;SMG7;SEC13;YTHDC1;NDC1;SYMPK;UPF3B;EIF4E;RANBP2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17116582826875226,0.43275223909727456,0.9962825278810409,1.0,1.0,4/31,12.87%,LSS;STAR;SRD5A1;PRLR
prerank,regulation of mitotic spindle assembly (GO:1901673),0.18486285505123953,0.4318753693146471,0.990530303030303,1.0,1.0,5/19,18.99%,CHMP2B;CEP97;HNRNPU;CHMP3;DRG1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.17370998591996667,0.4280198382069362,0.9939516129032258,1.0,1.0,7/25,22.54%,KAT7;CCAR2;EAF2;SETD5;CCNK;TSFM;CCNT2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.1985723654706668,0.4278374510908444,0.987012987012987,1.0,1.0,5/13,23.27%,PCID2;MAD2L1;XRCC3;DYNC1LI1;CDK5RAP2
prerank,tRNA processing (GO:0008033),0.15019564576083558,0.42443409400554954,1.0,1.0,1.0,21/61,26.45%,CLP1;TRMT61A;TRUB1;SSB;TRMT1;ADAT1;TRMT10C;ELP5;AARS1;NSUN2;POP7;DDX1;POP5;TSEN15;THUMPD1;TRDMT1;TRMT10A;TRMT9B;FAM98B;FARS2;RPP30
prerank,regulation of interferon-alpha production (GO:0032647),0.1790680719744494,0.4204769102272543,0.9958333333333333,1.0,1.0,2/23,7.77%,DDX3X;RIPK2
prerank,mitochondrial translational elongation (GO:0070125),0.13966745942591371,0.40977564921177323,1.0,1.0,1.0,24/88,22.69%,MRPS27;MRPL55;MRPL58;GFM2;MRPS30;PTCD3;GFM1;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPL47;MRPS17;MRPL37;MRPL2;MRPL40;MRPL11;TSFM;DAP3;MRPS15;MRPL42
prerank,RNA transport (GO:0050658),0.13795247100994887,0.40070890305167095,1.0,1.0,1.0,23/71,26.79%,RFTN1;NCBP2;SRRM1;RNPS1;KIF5C;HNRNPA1;UPF3B;EIF4E;FMR1;ZC3H11A;HNRNPA2B1;POLDIP3;SRSF9;ZFP36L1;RAE1;THOC2;EIF4A3;SRSF4;CASC3;RBFOX1;CDC40;SRSF3;FLOT1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.180518429498317,-0.40014307725790194,0.9981024667931688,0.9996222343553002,1.0,2/10,22.94%,NAF1;PIH1D1
prerank,mRNA 3'-end processing (GO:0031124),0.13531213661607142,0.39991355362385717,1.0,1.0,1.0,8/78,11.50%,CLP1;NCBP2;SRRM1;RNPS1;PAPOLA;CPSF6;SYMPK;RPRD1B
prerank,C4-dicarboxylate transport (GO:0015740),0.18410926291639598,0.3996498180423643,0.996116504854369,1.0,1.0,1/14,5.53%,SLC25A13
prerank,pre-replicative complex assembly (GO:0036388),0.13940392432217943,0.39786180294426754,1.0,1.0,1.0,14/64,20.74%,PSMB11;PSMF1;MCM6;MCM7;MCM2;PSME4;ORC4;PSMB5;PSMB8;PSMA1;PSMA5;ORC6;PSMD13;PSMB2
prerank,lipid biosynthetic process (GO:0008610),0.13738456439769453,0.39758837280971415,1.0,1.0,1.0,20/77,24.52%,LIPC;LIPH;LSS;STAR;SRD5A1;PRLR;PRKAA1;OLAH;HMGCR;MLYCD;LPCAT1;PDSS1;PIP5K1A;MVK;FDXR;ACSL1;AGPAT5;FDFT1;NDUFAB1;CYP51A1
prerank,cellular response to UV-A (GO:0071492),0.18254867750009188,0.39345581029309556,0.9897119341563786,1.0,1.0,4/11,23.35%,OPN3;MMP1;CERS1;MME
prerank,tRNA 5'-end processing (GO:0099116),-0.1557281335812104,-0.386575655928469,1.0,0.9995948220611791,1.0,7/15,37.40%,PRORP;RPP38;POP1;RPP25L;RPP21;HSD17B10;RPP40
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.17315771917215966,0.383096700252236,0.9979253112033195,1.0,1.0,4/13,19.67%,PTPN1;ABCA7;DDRGK1;PPP1R15A
prerank,regulation of centrosome cycle (GO:0046605),-0.14146749336764683,-0.38018186562043393,1.0,0.9992641335399202,1.0,2/21,11.44%,PDCD6IP;CHMP4B
prerank,ncRNA metabolic process (GO:0034660),0.14546620072876523,0.3770274069914695,1.0,1.0,1.0,5/37,16.77%,PLD6;TARBP2;TDRKH;EXD1;KHSRP
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.17637459201606814,0.36527297702123834,0.9978991596638656,1.0,1.0,10/10,82.37%,APC;KNSTRN;CDC42;RACGAP1;ECT2;NEK2;CCNB1;RCC2;SPAG5;SIRT2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.1315296474893941,0.36112225674947923,1.0,0.9999637263002942,1.0,11/53,22.24%,HTR1B;HTR2C;NPY1R;MTNR1A;HTR4;CHRM3;CHRM2;SSTR2;CNR1;NPY;CNR2
prerank,androgen metabolic process (GO:0008209),0.15546629848470195,0.36103637668834443,0.9937888198757764,0.9994077175928575,1.0,2/18,12.78%,MED1;SRD5A1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.14050728277247587,0.3187259826248342,1.0,0.9997967045100052,1.0,14/14,85.96%,WDR12;RPF2;DDX18;NOL9;PES1;ZNHIT6;ZNHIT3;BOP1;NIFK;RPL35;RPL7L1;URB1;FTSJ3;RPL7
